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The work presented in this thesis arose from an interest in the
pharmacology of peripheral arterial chemosensors and in the mechanism
of chemoreception. Publications have been grouped into five sections,
with each section representing different aspects of the work.
Section 1 is concerned with the study of various reflexes evoked by
stimulating the carotid chemoreceptors with drugs and also includes
the finding that capsaicin reduces carotid chemosensitivity.
Section 2 contains papers which describe the results of neuro¬
pharmacologies! experiments performed to characterise the acetylcholine
(ACh) receptors of the carotid body. Quantitative analysis of the
data provided objective evidence that the increase in chemosensory
discharge evoked by ACh results from actions on a nicotinic ACh
receptor similar to that present in autonomic ganglia. The discovery
was made that ACh causes chemodepression in rabbits via actions on
muscarinic ACh receptors. Dopamine (DA) depresses chemoreceptor
discharge in cats and rabbits, and the use of selective agonists and
antagonists revealed that this effect is mediated via D2 DA receptors.
Section 3 relates to the discoveries that the polypeptide substance P
can affect chemosensory discharge and is present in the cat carotid
body, and that opioid peptides are potent inhibitors of chemoreceptor
activity. The greater part of the chemodepression evoked by [Met]-
enkephalin can be attributed to actions on delta opioid receptors.
The interaction between various peptides and amines has been examined,
and the 5-hydroxytryptamine receptors of the carotid body have been
characterised using selective antagonists.
Section 4. Prostaglandins were found to be capable of stimulating
respiration, but appear not to have any direct action on the peripheral
chemoreceptors. Adenosine and ATP do affect chemoreceptor discharge,
and the adenosine receptor involved has been partially characterised
by the use of selective agonists and antagonists.
Section 5 includes miscellaneous publications on work which was
indirectly related to the study of chemoreceptors. The last paper is
a review of chemoreceptor pharmacology.
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ON THE DIRECT
AND CROSSED COMPONENTS OF REFLEX RESPONSES TO
UNILATERAL STIMULATION OF THE CAROTID BODY
CHEMORECEPTORS IN THE DOG
BY D. S. MCQUEEN AND A. UNGAR
From the Department of Pharmacology, University of Edinburgh,
1 George Square, Edinburgh EIJ8 9JZ
(Received 9 February 1971)
SUMMARY
1. In dogs under chloralose-urethane anaesthesia the chemoreceptors of
the two carotid bodies were separately stimulated.
2. The distribution of three primary reflex responses to carotid body
stimulation was studied: parasympathetic bradycardia, sympathetic
vasoconstriction, and increase in somatic phrenic nerve activity.
3. The reflex bradycardia evoked by either carotid body was mediated
by both vagus nerves, but when either vagus was blocked a greater
response could be obtained from the contralateral than from the ipsilateral
carotid body.
4. The reflex vasoconstriction evoked by either carotid body was seen
in both hind limbs, with no predominance in either limb.
5. The reflex increase in phrenic nerve activity evoked by either carotid
body was seen in both phrenic nerves, with no predominance in either
nerve.
INTRODUCTION
Among the primary reflex responses to carotid body chemoreceptor
stimulation in the dog are hyperpnoea, bradycardia due mainly to increased
vagal tone, and systemic vasoconstriction due entirely to increased
sympathetic tone (Daly & Scott, 1958; Bernthal, Motley, Schwind &
Weeks, 1945). In spontaneously breathing dogs the primary bradycardia
and vasoconstriction may be masked by secondary effects of the increase
in pulmonary ventilation (Daly & Scott, 19C2, 19C3). A similar situation
is found in the eat (Scott, 1906) and in the rabbit (Ivorner & Edwards,
1900).
Eedorchuk (1957) found that, after ablation of one carotid body in
decerebrate cats, intravenous injections of chemoreceptor stimulant
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drugs caused an increase in impulse traffic in the phrenic nerve on the side
of the intact carotid body and no increase on the side of the ablated carotid
body. Fedorehuk (1954) also found that stimulation of one carotid body
caused a reflex release of catecholamines predominantly or solely from the
adrenal gland on the same side. Nazarenko (1958) studying the reflex
bradycardia on carotid body stimulation in decerebrate cats concluded
that the right carotid body exerts its effect entirely through the right vagus
nerve, while the left carotid body acts tlirough both vagi.
We have studied the distribution between the two sides of the body of
the somatic respiratory, the parasympathetic cardiac and the sympa¬
thetic vascular effects of the stimulation of one carotid body at a time in
dogs. Our results indicate that the parasympathetic effect is mainly
ipsilateral, while the sympathetic and somatic effects are evenly distri¬
buted on the two sides.
Preliminary accounts of this work have been published (McQueen &
Ungar, 1969a, b, c).
METHODS
Mongrel dogs of either sex weighing between 6-8 and 21-5 kg, and two cats
weighing 3 0 and 3-5 kg respectively were used.
Anaesthesia. Dogs were premedieated with morphine sulphate (1 mg/kg sub-
eutaneously) and anaesthetized 30 min later with a mixture of a-chloralose (55
mg/kg) and urethane (550 mg/kg) injected intravenously as a solution containing
2-5% a-chloralose and 25% urethane in a mixture of equal volumes of 0-9%
aqueous sodium chloride und polyethylene glycol 200. To maintain anaesthesia a
2 % solution of a-chloralose was infused at a rate adjusted according to the state
of the animal's reflexes.
One cat was anaesthetized by an intraperitoneal injection of pentobarbitone
(25 mg/kg) and the other was decerebrated at the intercollicular level under ether
anaesthesia.
Respiration. In all animals the trachea was cannulatcd in the neck.
The lungs of eight dogs were artificially ventilated with a 00% oxygen 40%
nitrogen mixture by a Starling 'Ideal' pump. Their chests were opened by splitting
the sternum in the mid line, and held open by a self-retaining retractor after ligature
of the internal thoracic vessels.
In twenty dogs under artificial ventilation decamethonium iodide (0-25 mg/kg)
was given intravenously to prevent respiratory movements when the chernoreceptors
were stimulated.
Blood from a cannulated femoral artery was sampled at 15 min intervals through¬
out the experiment. The 7'.l CO . /'„ 0 and pH were estimated by means of a Radio¬
meter PA 927 gas monitor. Arterial R,:o, was held between 30 and 35 torr by adjust¬
ment of the stroke of the respiratory pump which ran at 20 rev/min. Tho plasma
bicarbonate concentration was held between 20 and 25 mM by intravenous injections
of molar sodium bicarbonate solution, the base deficit being calculated from the
nomogram of Singer & Hastings (1948).
The 1\ „ was always above 150 torr. Under these conditions we assumed that there
was no resting cheinoreceptor tone, so that the results should not have been com-
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plicated by withdrawal of resting tone when tho vagi or carotid sinus nerves were cut
or blocked.
Elimination of secondary reflexes from the lungs. In the animals with open chests
the thoracic vagal trunks were cut, on the left sido between the aorta and the left
pulmonary artery, and on tho right sido at the level of tho azygos vein. This pro¬
cedure eliminates the pulmonary branches of the vagi but does not affect tho cardiac
branches (Daly & Scott, 19G3).
In animals with intact chests, where cardiac reflexes wore not being studied, both
vagosympathetic trunks wore cut in the neck.
Elimination of reflexes from the bladder. Each animal's bladder was catheterized
to prevent progressive filling with tho resulting influence on autonomic reflexes
(Oberholzer, 19(53).
Blood pressure compensation. In five dogs with open chests a blood pressure com¬
pensator was connected to the left subclavian artery in order to reduce fluctuations
in arterial pressure on chcmoroceptor stimulation. The compensator consisted of an
inverted conical flask of 1 litre capacity containing about 200 ml. 0-9% sodium
chloride solution. The outlet was connected to the artery by wide bore silicone rubber
tubing, and the air space in the flask connected to a source of compressed air set to
the animal's resting arterial pressure.
Temperature control. A thermistor probe (Standard Telephones Cables type
F23) was inserted into the animal's rectum, and connected through an A.E.I.
'Sunvette' temperature controller to an infra-red heater. The animal's temperature
was held at 37 + 0-5° C.
Stimulation of the carotid body chemoreceptors. Nylon catheters (0-75 mm o.d.) were
inserted through both superior thyroid arteries, their tips lying in the common
carotid arteries about 3 cm upstream of the origins of the superior thyroid arteries.
Each carotid body was independently stimulated by infusion through the appro¬
priate catheter, with a Watson Marlow MHRE pump, of a solution of suberyl
dicholine di-iodide (83 pyi) in a phosphate buffer at pH 7-4. The infusions lasted
10 8ec, and were separated by intervals of 5 min, the two carotid bodies being
stimulated alternately. Theamountofsnbcryldicholine di-iodide (SDC) infusedduring
a stimulus varied from 3 to 58 n-molo (2-35 /rg), the usual effective dose being 30 n-
mole (18 fig).
SDC has peripheral nicotinic actions but no central nervous effects at the dosage
used. It is rapidly metabolized by pseudocholinesterase (Anichkov & Belen'kii,
1963). We have found that this time cycle of dosage can be followed fur several horn's
without tachyphylaxis in the reflex responses. This confirms similar findings in tho
cat (Mikhel'son, Rybovlov, Gorclik & Dardymov, 1957).
Block of conduction in the vagi. Each vagosympathetic trunk in the neck was dis¬
sected and placed on a cooling device (Daly, Ha/.zledine & Ungar, 1967). The two
nerves were cooled in turn to between 0 and — 2° C during cycles of alternate
carotid body stimulation.
The bradycardia obtained by electrical stimulation of tho cut vagus nerve was
abolished on cooling to 5° C, and returned to its previous magnitude on rewarming
even after cooling to — 4° C.
Recording procedure. A Honeywell 2106 twelve channel ultra-violet oscillograph
was used. Honeywell M400/350 galvanometers gave a frequency response flat to
320 Hz. Kodak Linagraph 1843 paper was used.
Arterial pressure. Arterial pressure was measured by means of a Bell and Howell
L222 transducer from a catheter (2 mm o.d.) in either a femoral or a radial artery.
The output from the transducer was amplified by a Fenlow AD2000 amplifier and
recorded on a channel of the oscillograph.
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Measurement of changes in limb vascular resistance. A nylon catheter (2 mm o.d.)
was inserted through each femoral artery just below the inguinal ligament so that its
tip lay in tho abdominal aorta. The catheter was connected by a loop of silicone
rubber tubing, which passed through a Watson Marlow MHRE pump, to a cannula
inserted caudally into the same femoral artery. A tapo was tied tightly around the
limb between tho catheter and the cannula, avoiding the femoral vein. This per¬
fusion system provided a constant flow against arterial pressures up to 250 mm Hg.
The time taken for blood to traverse the perfusion tube was about 12 sec at the
pump speed usually used.
The perfusion pressure in each limb was recorded from a 'Y' piece in the perfusion
tubing in a similar way to that described for systemic arterial pressure. As the limbs
were perfused at constant flow, pressure changes were taken to be proportional to
changes in vascular resistance.
Cardiac period [R-R interval). Tho electrocardiogram was recorded from chest
leads chosen to give prominent R waves. A trigger circuit was set so that each R
wave reset a linear rarnp generator (Computing Techniques SA 6). The height of each
ramp, recorded on a channel of the oscillograph, was proportional to the R-R
interval. The mean cardiac period during the first 10 see of each test of carotid body
stimulat ion was compared with the mean cardiac period before, and after stimulation.
Electrical activity in the. phrenic nerves. Each phrenic nerve was cut between liga¬
tures at tho level of the seventh cervical transverse process, and placed on bipolar
platinum electrodes in a pool of mineral oil. Impulses were amplified by a differential
input FET amplifier passing a band of frequencies between 10 and 1 KHz.
Activity above a threshold set to exclude the resting noise was averaged with a
time constant of 20 msec, and recorded on a channel of the oscillograph.
The amplitude of tho averaged record was taken as a measure of the impulse
traffic in an inspiratory burst. Changes during carotid body stimulation were cal¬
culated as tho mean increase in amplitude of inspiratory peaks expressed as a per¬
centage of tho mean resting amplitude before and after stimulation.
Drugs. The following drugs wore used: a-chloraloso (B.D.H. or Koch Light
Laboratories Ltd), polyethylene glycol 200 (B.D.H.), ethyl carbamate (urethane)
(B.D.H. or May and Baker Ltd.), decamethonium iodide (K and K Labs Inc., New
York), morphine sulphate (Macarthys Ltd), atropine sulphate (B.D.H.), subervl
dicholine di-iodide (kindly prepared bv Dr J. N. T. Gilbert, Department of Pharma¬
ceutical Chemistry, School of Pharmacy, London University) and guanethidinc
sulphate (Ciba).
RESULTS
Reflex bradycardia. We carried out preliminary experiments in order to
establish
(i) whether the changes in heart rate recorded were due entirely to
stimulation of receptors on the side into which the stimulant was infused.
(ii) whether the changes in heart rate were mediated entirely by para¬
sympathetic fibres in the two vagus nerves.
In two dogs tests of carotid body stimulation were carried out on both
sides before and after section of one carotid sinus nerve. In both animals
the cardiac response to stimulation on the denervated side was abolished,
while the response to stimulation on the intact side was unaffected.
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In two dogs tests of carotid body stimulation were carried out before
and after intravenous administration of atropine sulphate (180 n-mole/kg
or 125 /tg/kg and 360 n-mole/kg or 250 //g/kg). The reflex bradycardia was
abolished, while the concomitant vasoconstriction in the hind limbs was
unaffected.
In five dogs tests of carotid body stimulation were carried out before
and after division of both vagosympathetic trunks in the neck. Reflex
bradycardia was abolished in all of these.
Twenty-eight tests of carotid body stimulation were carried out on six
dogs with intact chests artificially ventilated and paralysed with decame-
thonium iodide. In four out of thirteen tests the reflex slowing of the heart
was potentiated by cooling the left vagus, and in six out of fifteen tests it
was potentiated by cooling the right vagus. We attributed this effect,
which invalidates any quantitative comparison between the two sides, to
blocked sensory fibres in the vagi from pulmonary stretch receptors, and
possibly also from aortic baroreceptors (see Discussion).
Forty-three tests of carotid body stimulation were carried out on seven
dogs with open chests after cutting both vagi between the origins of their
cardiac and pulmonary branches (see Methods). A typical record of a set
of responses is shown in Fig. 1. The results are shown in Table 1. While
both vagi were intact, stimulation of either carotid body gave rise to a
similar degree of slowing of the heart. While the left vagus was blocked,
stimulation of the right carotid body gave rise to greater slowing than did
stimulation of the left carotid body in six out of seven dogs. Conversely,
wliile the right vagus was blocked, stimulation of the left carotid body
gave rise to greater slowing than did stimulation of the right carotid body
in all of the seven dogs. These differences are statistically significant
(P < 0-01). Whichever vagus was blocked, the degree of slowing produced
by stimulation of the ipsilateral carotid body was about half that produced
by stimulation of the contralateral carotid body. While the left vagus was
blocked both the ipsilateral and contralateral responses were about twice
the size of the corresponding ipsilateral and contralateral responses
obtained while the right vagus was blocked.
Reflex vasoconstriction. As with the reflex bradycardia we carried out
preliminary experiments in order to establish
(i) whether the changes in hind limb resistance recorded were due
entirely to stimulation of receptors on the side into which the SDG was
infused.
(ii) whether the changes were mediated entirely by sympathetic
adrenergic fibres.
In three dogs stimulation of each carotid body gave rise to reflex
vasoconstriction. After section of one carotid sinus nerve in each dog
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vasoconstriction was only seen when the innervated carotid body was
stimulated.
In three dogs guanethidine sulphate (3-5 /imole/kg) was injected close-
arterially into one hind limb while both hind limbs were perfused at
constant flow. A test of chemoreceptor stimulation was carried out before
the guanethidine had time to circulate. In each experiment the reflex
vasoconstriction previously observed in that limb was abolished, with no




Perfusion pressure 150 -






Cardiac period 1 sec
Cool right 1 1 15 sec
vagus
Fig. 1. Reflex responses to stimulation of the right carotid body of a dog.
The records from above downwards show arterial pressure in the right
hind limb, perfused at constant flow, mean systemic arterial pressure, and
cardiac period (R-R interval). Tho marker at the top indicates the period
of stimulation by infusion of SDC into the right common carotid artery.
The responses before, during and after cold block of the right vagosympa¬
thetic trunk in the neck are shown in blocks A, B and C respectively.
Sixty-six tests of carotid body stimulation were carried out in eight dogs,
artificially ventilated and paralysed with decamethonium iodide, after
cutting both vagosympathetic nerves in the neck. The results arc shown in
Table 2. Whichever carotid body was stimulated, the difference between
the means of the responses in the two hind limbs is smaller than their
standard errors.
In two dogs both forelimbs were similarly perfused at constant flow.
Whichever carotid body was stimulated, a balanced vasoconstriction was
seen in both forelimbs.
Table1.
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Phrenic neurogram. As in the previous sections, we carried out a pre¬
liminary experiment to establish whether the changes in phrenic activity
recorded were due entirely to stimulation of receptors on the side into
which SDC was infused.
In one dog tests of carotid body stimulation were carried out on both sides
before and after section of one carotid sinus nerve while electrical activity
was recorded from both phrenic nerves. The reflex increase in activity in
both prenic nerves previously evoked from the denervated side was
abolished, but the response from the other side was unaffected.
Table 3. The effect of stimulation of each carotid body on the averaged electrical
activities of both phrenic nerves. One hundred tests in six dogs, artificially ventilated
and paralysed with decamethonium iodide, after cutting both vagosympathetic
trunks in the nock
Mean % increase in phrenic activity
A
Left carotid Bight, carotid
Control body stimulated body stimulated
Animals f > t K , A ,
r
A Mean Left Right Left Right
Weight b.p. Mean P„ COs phrenic phrenic phrenic phrenic
Sex (kg) (mm Hg) (torr) nerve nerve nerve nerve
F 17-5 138 35 86 51 115 70
M 11-8 143 39 62 56 36 37
M 13-4 169 48 53 53 51 50
M 21-5 126 40 39 35 21 21
F 12-6 158 38 24 21 30 26
M 160 106 49 36 40 45 63
Moans + s.e. 48+7 44 ±4 49 ±6 45 ±5
One hundred tests of carotid body stimulation were carried out in six
dogs, artificially ventilated and paralysed with decamethonium iodide,
after cutting both vagosympathetic nerves in the neck. The results are
shown in Table 3. Whichever carotid body was stimulated, the difference
between the means of the responses in the phrenic nerves is smaller than
their standard errors.
In view of the disparity between our results and those of Fedorchuk
(1957), who worked on cats, we repeated our experiments on one anaes¬
thetized and one decerebrate cat. In both of these experiments wc obtained
uniform increases in activity in the two phrenic nerves, whichever carotid
body was stimulated. A record of a pair of tests in the decerebrate cat is
shown in Fig. 2.
Systemic arterial pressure. The responses to carotid body stimulation
that wc studied were accompanied by variable changes in systemic arterial
pressure, and these can give rise to secondary reflex changes in heart rate,
io d. s. McQueen and a. unoar
vascular tone and respiratory drive by affecting the baroreceptors of the
carotid sinuses and aortic arch (Heymans & Neil, 1958).
In the experiments on reflex bradycardia the changes in systemic pres¬
sure were biphasic (see Fig. 1) and our measurements of reflex slowing were
made before the onset of the sustained rise in pressure. In the other two












Fig. 2. Reflex responses to stimulation of the left carotid body (^4) and the
right carotid body (B) of a decerebrate cat. The records from above down¬
wards show mean systemic arterial pressure, averaged electrical activity
in the left phrenic nerve, and averaged electrical activity in the right
phrenic nerve.
cut (see Fig. 2). Here our measurements, made in the first ten seconds of
the response, should not have been affected by reflex changes secondary
to the pressure rise.
In order to establish whether such changes were altering the size of our
primary responses, we carried out tests of carotid body stimulation with
and without a blood pressure compensator.
In three animals tests of reflex bradycardia, in three animals tests of
reflex vasoconstriction, and in one animal tests of reflex increase in
phrenic activity were carried out with and without the blood pressure
compensator. In none of these experiments did we see any change in the
size of the primary reflex responses.
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DISCUSSION
The methods used in these experiments have enabled us to study three
primary reflex responses to chemoreoeptor stimulation, and to stimulate
the chemoreceptors of the two carotid bodies separately.
Acetylcholine-like drugs, if used at much higher concentrations than
those affecting chemoreceptors, have been shown to stimulate baro-
receptor endings in the cat (Diamond, 1955). We exclude the possibility
that SDC stimulated the baroreceptors in our experiments for the following
reasons:
(i) Jarisch, Landgren, Neil & Zotterman (1952) gave intracarotid in¬
jections to cats and dogs of drugs that stimulate both chemoreceptors and
baroreceptors. They found that stimulation of chemoreceptor fibres
occurred immediately, whereas impulse traffic in baroreceptor fibres in¬
creased after delays of at least 15 sec. There would thus be no stimulation
of baroreceptors in our experiments during the time when reflex responses
were recorded.
(ii) McQueen (1970) studied the problem under similar conditions to
those of the present experiments. One carotid body was embolized with
lycopodium, using the technique of Heymans & Bouckaert (1933). This
procedure did not affect either the cardiac or the vascular reflex responses
to occlusion of the common carotid artery, showing that the baroreceptor
reflex was intact, nor did it affect the reflex responses to infusion of SDC
into the contralateral common carotid artery. The responses to infusion of
SDC into the ipsilateral common carotid artery were totally abolished,
even at twenty times the greatest dosage used in these experiments.
(iii) Supporting evidence was provided by the observation that intra¬
carotid injections of SDC and sodium cyanide that evoked equal respira¬
tory responses also evoked equal increases hi hind limb resistance and
cardiac period. Any stimulation of the baroreceptors would have been
expected to potentiate the bradycardia, but to counteract the vaso¬
constriction.
Reflex bradycardia. Pagano (1900) working before the discovery of the
sensory function of the carotid bodies, described the bradycardia following
the injection of nicotine or of prussic acid into the common carotid artery
of a dog. He found that the bradycardia could be much reduced or even
abolished by cutting the vagus nerve on the side on which the injection
was given. Nazarenko (1958) injected potassium cyanide intravenously
into decerebrate cats having one carotid body excised and one vagus nerve
cut in the neck, and made a non-parametric comparison of the incidence
of bradycardia in the four combinations of unilateral carotid body excision
and unilateral vagotomy. He concluded from his results that the retlex
i2 d. s. McQueen and a. ungar
evoked by the right carotid body is mediated only by the right vagus,
while the reflex from the left carotid body is mediated by both vagi.
Our results indicate that the reflex from either carotid body is mediated
by both vagi, as shown in Fig. 3. Each vagus nerve, however, pre¬
dominantly mediates the reflex from the carotid body on the same side. We
thus seem to agree with Pagano, but not with Nazarenko. This conflict
could be due to a species difference between dogs and cats, but it could
also be due to two differences in technique:
Fig. 3. Spot diagram of ipsilatoral against contralateral responses: reflex
bradycardia. Graphical representation of the results in Table 1. The percen¬
tage increase in cardiac period evoked by stimulation of the left carotid
body is plotted against that evoked by stimulation of the right carot id body
in each experimental situation. Open circles represent tests inwhich the right
vagosympathetic trunk was cooled; filled circles represent tests in which
the left vagosympathetic trunk was cooled. The line of equality is indicated.
(i) Intravenous injections of potassium cyanide would stimulate the
aortic bodies as well as the carotid bodies, but sensory inpulses would only
reach the brain on the side of the intact vagus.
(ii) The pulmonary inflation reflex, which modifies the response to
chemoreceptor stimulation (Daly & Scott, 19G2, 1963) would have been
active though only on the side of the intact vagus in Nazarenko's experi¬
ments, whereas in our experiments it was totally eliminated.
A factor common to our experiments and Nazarenko's is the withdrawal
of sensory influence from the heart and great vessels when one or the
other vagus nerve is blocked or cut. There are thus different backgrounds
of reflex activity in the three situations with one or the other or both
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vagi conducting. It is impossible to make quantitative comparisons among
the reflexes elicited against these different backgrounds. We have therefore
only compared the effects of stimulating the two carotid bodies, in each
state of the vagi.
Another possible factor is a component of withdrawal of sympathetic
tone in the reflex bradycardia. We studied the reflex bradycardia during
only the first ten seconds of the response and found it to be abolished by
atropine or bilateral vagotomy. Our results are not incompatible with a
sympathetic component in the steady state, as found by Daly & Scott
(19C2).
Fig. 4. Spot diagram of ipsilateral against contralateral responses: reflex
vasoconstriction. Graphical representation of the results in Table 2. Open
circles represent effects of stimulation of the right carotid body (RCB) and
filled circles represent the effects of stimulation of the left carotid body
(LCB). Percentage changes in right hind limb resistance are plotted on tho
abscissa and percentage changes in left hind limb resistance on the ordi¬
nate. The line of equality is indicated.
Reflex vasoconstriction. Our results confirm the findings of Dal}' & Scott
(1962) that a primary reflex response to carotid body stimulation is
vasoconstriction, mediated entirely by sympathetic adrenergic nerves.
It is evident from Fig. 4 that whichever carotid body we stimulated,
we saw a reflex vasoconstriction in both hind limbs, and that the response
on neither side was consistently larger than that on the other. This sympa¬
thetically mediated reflex thus differs in its pattern of distribution from
the parasympathetically mediated bradycardia. /
The only previous work of which we are aware on the distribution of a
sympathetically mediated reflex from the carotid bodies is that of
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Fedorchuk (1954), who found that the reflex release of catecholamines
occurred solely or predominantly from the adrenal gland on the same side
as a stimulated carotid body in the cat. McQueen & Ungar (1970) did not
find such a predominance in the dog.
Reflex increase in phrenic activity. Our results, illustrated in Fig. 5,
indicate that stimulation of either carotid body gives rise to uniform
increases in activity in both phrenic nerves in the dog. Our two experi¬
ments in cats suggest that the pattern is similar.
Fig. 5. Spot diagram of ipsilateral against contralateral responses: reflex
increase in phrenic nerve activity. Open circles represent the effects of
stimulation of the right carotid body (RCB), and closed circles the effects
of stimulation of the left carotid body (LCB). Percentage changes in activity
in the right phrenic nerve are plotted on the abscissa, and percentage changes
in the left phrenic nerve on the ordinate. The line of equality is indicated.
We thus differ from Fedorchuk (1957) who found that after ablation
of one carotid body, an intravenous injection of cytisine only increased
activity in the phrenic nerve on the side of the intact carotid body. Having
excluded the possibility of a species difference between dogs and cats, the
possibility remains that denervation of one group of receptors may alter
the pattern of responses to stimulation of the remaining receptors.
We conclude from our results that the central pathways from chemo-
receptor afferent fibres to cardio-inhibitor fibres in the vagi must be
different from their pathways both to the sympathetic fibres to the limbs
and to phrenic motoneurones. Pathways to the first are predominantly
ipsilateral, but with the last two there seems to be a balanced influence on
the two sides.
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The direct and crossed vagal components of the reflex bradycardia
following stimulation of the carotid body chemoreceptors in the
dog
By D. S. McQukks* and A. Unoak. Department of Pharmacology, The
School of Pharmacy. University of London, I'.ij'M) Hruntarick Sq. London,
W.C. 1
Nazarenko (l!>f>8) found that the bradycardia following intravenous
injection of potassium cyanide into eats with one carotid body extirpated
could be abolished in two out of six animals by ipsilateral cervical vago¬









Fi^. 1. Tho rlTn'Ot nf cuuline tlu* rijjhl and It-It vajii «»n tin* ivflrx hratlycaniia from
t-iifh carotid laxly ill six dnjs. F«»r oach vaijus coolixl, tho difference between reduo-
t i«»n «»f bradycardia lr«»in t it* !• *f t and ri'jlit carot id In-dies is stat ist ieally significant
at the I. w| of |>r«»i»sil>ility indicjifd.
We used dogs, pre-treated with morphine, under choralose-urcthane
anaesthesia, with lungs ventilated by a Starling Ideal' pump. The two
carotid bodies were stimulated independently by infusion through the
superior thyroid arteries cannulated towards the heart, of iIo-lOouM of
suberyl dieholine over la see. In some experiments sodium cyanide
was used and gave similar results. The carotid bodies were stimulated
in turn, before and after cooling each vagus nerve in the neck to — 2°C.
Our first- results were irregular, vagal cooling giving sometimes at
increase, and sometimes a decrease in the bradycardia. Since the vagi carry
* M.K.C. Research Srholur. fr.T.o.
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impulses from pulmonary receptors which modify the cardiac responses to
chemorcceptor stimulation (Italy & Scott. 1903) we repeated our experi¬
ments in open chested dogs after cutting the pulmonary branches of the
vagi so that complicating effects from the lungs could be excluded. The
results now became consistent, vagal cooling giving a reduced bradycardia
in forty out of forty-one tests in six dogs. The pooled results are represented
in the histogram.
We conclude that when the eheinoreceptors arc stimulated, cardio-
inhibitor activity in each vagus nerve is induced predominantly by the
carotid body on the same side, but that there is a consistent component
from the opposite side. This pattern is masked if the afferent, pathways
from pulmonary receptors are intact.
RKKKRKNCKS
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The direct and crossed components of the reflex vasoconstriction
in the hind limbs of the dog following stimulation of the carotid
body chemoreceptors
By D. S. McQueen* and A. Ungar. Department of Pharmacology, The
School of Pharmacy, University of London, Brunswick Square, London,
W.C. 1
Bernthal, Motley, Schwind & Weeks (1945) showed that the reflex
vasoconstriction in the hind limb following carotid body chemoreceptor
stimulation is due solely to increased sympathetic tone.
There is evidence that when the carotid body of one side is stimulated
the resulting reflex bradycardia is mediated predominantly by the vagus
nerve on the same side (Anichkov & BeleirKii, 1963; McQueen & Ungar,
1969). Fcdorchuk (1954) also found the reflex release of catecholamines
from the adrenal medulla following stimulation of one carotid body to be





Hind limb: L R L R
Carotid body: Left Right
Fig. 1. The effects of st imulation of one carotid body on the vascular resistance
of the separately perfused hind limbs. Pooled results of 29 tosts in 7 dogs.
We have examined the sympathetically mediated increase in hind limb
vascular resistance obtained on carotid body chemoreceptor stimulation
and have found no evidence of ipsilateral predominance.
Dogs were pre-treated with morphine, anaesthetised with chloralose and
urethane, and artificially ventilated by a Starling Ideal pump. Both vago¬
sympathetic trunks were cut in the neck. The hind limbs were separately
perfused at constant flow with blood from the same animal. The two carotid
bodies were independently stimulated by suberyl dicholine (McQueen &
Ungar, 1969) and changes in the vascular resistances of the limb were
determined.
* M.R.C. Research Scholar.
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Stimulation of either carotid body gave an increase in the vascular
resistance of both hind limbs in each of eight dogs. The responses in both
hind limbs when the carotid bodies were stimulated in turn are shown in
Fig. 1. There are no significant differences between the responses.
There thus appear to be differences between the efferent pathways of
reflexes from the carotid bodies such that sympathetically mediated vaso¬
constriction is equally distributed on the two sides, while parasym-
pathetically mediated bradycardia is predominantly ipsilateral.
REFERENCES
Anichkov, S. V. & Belen'Kii, M. l. (1963). Pharmacology of the Carotid Body Osmore¬
ceptors. Pergamon.
Bernthal, T., Motley, H. E., Schwind, F. J. & Weeks. W. F. (1945). Am. J. Physiol.
143, 220.
Fedorchijk, Ye. S. (1954). Bull. exp. Biol. Meil. U.S.S.B. 6, 7.
McQueen, D. S. & Uxgar, A. (1969). J. Physiol. 202. 3n/>.
4
fFrom the Proceedings of the Physiological Society, 18-19 July 19(59
Journal of Physiology, 204, 131-132P
The direct and crossed components of the reflex increase in
phrenic nerve activity following stimulation of the carotid body
chemoreceptors in the dog
By D. S. McQueen* and A. Ungar. Department of Pharmacology, The
School of Pharmacy, University of London, 29/39 Brunswick Sq., London,
W.C. 1
Fedorchuk (1957), using decerebrate cats having the carotid body of one
side denervated, injected chemoreceptor stimulant drugs intravenously.
She found an increase in electrical activity in the phrenic nerve on the side
of the intact carotid body and none on the side of the denervated carotid
body.
We have compared the changes in electrical activity of both phrenic
nerves following selective stimulation of the two carotid bodies in turn.
Dogs were premedicated with morphine and anaesthetized with a-
chloralose and urethane; their lungs were artificially ventilated by a
Starling Ideal pump. Both vagosympathetic trunks were cut in the neck
in order to exclude secondary reflexes from pulmonary stretch receptors.
Electrical activity in the central cut end of each phrenic nerve in the neck
was integrated and recorded with an ultra-violet oscillograph. Each carotid
body was independently stimulated by the method described by McQueen
& Ungar (1969) with suberyl dicholine as stimulant.
Stimulation of either carotid body resulted in increased activity in both
phrenic nerves. In sixty-nine tests on three dogs the mean differences
between the increments in activity in the two phrenic nerves when one or
other carotid body was stimulated were not statistically significant
(.P > 0-2).
We conclude that there are both direct and crossed components in the
reflex influence of the carotid body chemoreceptors upon the diaphragm
of the dog, and that unilateral chemoreceptor stimulation does not disturb
the balance of respiratory motor activity on the two sides.
references
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The direct and crossed components of the reflex release of cate¬
cholamines from the adrenal medulla of the dog following stimu¬
lation of the carotid body chemoreceptors
By D. S. McQueen*]" and A. Ungar.* Department of Pharmacology,
School of Pharmacy, London University, Brunswick Square, London,
W.C.I
Anichkov & Belen'kii (1963) state that in decerebrate cats, with one
carotid sinus nerve cut and one adrenal gland removed, intravenous
injections of nicotine produced a pressor effect if the intact sinus and
intact adrenal gland were on the same side but not if they were on
opposite sides of the body. This implies a predominantly ipsilateral reflex
pathway from the carotid body to the adrenal medulla.
We have measured the separate changes in catecholamines released
from the two adrenal medullae while selectively stimulating the two
carotid bodies in turn.
Our experiments were performed on dogs, pre-treated with morphine,
anaesthetized with a-chloralose and urethane and artificially ventilated.
Table 1. Output of catecholamines from both adrenal glands before (control) and
during (test) unilateral carotid body chemoreceptor stimidation. Pooled results of
thirty-two tests in seven dogs
Noradrenaline Adrenaline
Left Right Left Right
adrenal adrenal adrenal adrenal
gland gland gland gland
Left Control 6-5 6-7 18-9 18-8 ng/kg min
carotid Test 11-4 14-0 41-7 41-7 ng/kg min
body P > 0-2 P > 0-5
Right Control 7-4 3-2 19-6 9-8 ng/kg min
carotid Test 21-8 13-4 74-8 39-9 ng/kg min
body P > 0-3 P > 0-2
Both cervical vagosympathetic nerve trunks were cut and the animals
were eviscerated. Adrenal venous blood was collected through cannulae in
the lumbar veins, the adrenolumbar veins being occluded at their junctions
with the vena cava. The concentrations of adrenaline and noradrenaline
in the adrenal venous blood were estimated using a modification of the
method of Haggendal (1963).
* Present address: Department of Pharmacology, University of Edinburgh,
1 George Square, Edinburgh,
f M.R.C. Research Scholar.
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Each carotid body was independently stimulated by infusion of suberyl
dicholine di-iodide as described by McQueen & Ungar (1969). Samples
for estimation of catecholamines were collected before, and during each
stimulus.
For both adrenaline and noradrenaline there is no statistically significant
difference between the amounts released from the two adrenal glands
following stimulation of either carotid body.
There is a significantly greater amount of adrenaline released than of
noradrenaline.
We conclude that there are equipotent direct and crossed components
in the reflex influence of the carotid body chemoreceptor upon the adrenal
medulla of the dog and that chemoreceptor stimulation releases both
adrenaline and noradrenaline.
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Can drugs replace hypoxic drive in respiratory depression?
1). S. McQulin and A. Ungar*
Department of Pharmacology, University of Edinburgh
The respiratory control of cats deeply anaesthetized with pentobarbitone or with
chloralosc depends on hypoxic drive from the arterial chcmorcccptors. Changing their
inspired gas from air to pure oxygen will severely depress or even arrest the respiratory
movements. We have compared the effectiveness of suberyl dicholinc diiodide (SDC)
with that of nikethamide in this situation. SDC stimulates the arterial chemoreceptors,
and docs not act centrally (Mikhel'son. Rybovlev. Gorelik & Dardymov. 1957)
live cats were anaesthetized with chloralosc. The anaesthetic solution was slowly
infused intravenously until their P,, ,while breathing air. rose to between 55 and 60
torr (about twice the level for unanaesthelized cats). SDC (50 /rg/min) and niketha¬
mide (12-5 mg/min) were infused in turn for periods of 5 min, allowing 30 min for
recovery after each drug infusion The results are shown in Table I.
■ a it i I I Menu result \ Jiain Jt\, cuts t Jctnah . 7 1 A e I <//i</.-i i lilaiaiaa-
Breathing air Uicaihuii: uxvgcn
Control SDC Nikethamide Control SDC Nikethamide
I'ml/min 4.16±74 577 184 674195 27.1 ; 46 .194 ! 46 176 : 79
Tidal volume ml 5.1 a 6 69 y6 47 • 6 42 j 8 51 9 12 : 5
Bespiratorv rate
hreaths.min 8 5 > I 8-5 - 1 14-1 I 7-4 : 2 8-9 ; 2 12-9 4 2
l\, torr 58 ; 5 50 | 6 49 -5 70 . 6 52 4 60 ; 5
SDC infused at 50 /ig.'min and nikethamide at 12 5 mg/minutc.
The results were analysed by paired t tests (C-^0-01 being taken as significant).
SDC increased ventilation ( V) by an effect on tidal volume, with no significant effect
on respiratory rale. SDC was significantly more effective in lowering /':l-< o, during
oxygen breathing than during air breathing, although the increases in V were similar.
Nikethamide increased V by an effect on respiratory rate with no significant effect
on tidal volume. Nikethamide was significantly less effective in increasing RMV
during oxygen breathing than during air breathing.
l or a given increase in t, SDC was more effective than nikethamide in lowering
'Veil.- This would be expected of a drug acting on tidal volume rather than respiratory
rate.
The response to SDC was sustained during infusions lasting 30 minutes.
We conclude that SDC may have advantages over centrally acting drugs for the
replacement of hypoxic drive, making it possible for pure oxygen to be breathed in
respiratory depression.
RtiKt.RI.NCh
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Treatment of newborn rats with capsaicin reduces baro- and chemo-reflex
activity
By Susan M. Bond, F. Cervero* and D. S. McQueen. Departments of Pharmacology
and * Physiology, University Medical School, Edinburgh EH8 9AG
Substance P (SP)-like material has been found in the nucleus tractus solitarius
where baroreceptor and cheinoreceptor primary afferent fibres terminate, and it has
been suggested that SP is a transmitter at the central nerve terminals of baro-
and ehemoreceptor afferent nerve fibres (Gillis, Helke, Hamilton. Norman &
Jacobowitz, 1980). Treatment of newborn rats with capsaicin causes a degeneration
ofunmyelinated afferent neurones (Jancso, Kiraly & Jancso-Gabor, 1977) and reduces
immunoreactivity to various peptides in unmyelinated afferent fibres (Gamse, Holzer
& Lembeck, 1980), so might be expected to reduce baro- and chemoreceptor reflex
activity.
We have studied reflex blood pressure and respiratory changes (see McQueen, 1973)
in response to either 60 sec bilateral carotid occlusion (BCO) or intravenous sodium
cyanide in adult Sprague-Dawley rats anaesthetized with pentobarbitone
(40 mg.kg-1 i.p.). The animals had been treated under halothane anaesthesia with
a single injection of either capsaicin (50 mg. kg-1 s.C.) or drug vehicle (50%
polyethylene glycol:50% saline) 2-4 days after birth. Mean b.p. rose in response to
BCO by 24-9+19 mmHg (mean + s.e.) from an average pre-occlusion value of
114 + 5-2 mmHg in ten vehicle-treated rats, but only by 14-1 + 19 mmHg from
109+10 mmHg in seven capsaicin-treated animals; the difference between mean
pressor responses is statistically significant (P<0-01, Wilcoxon two-sample test).
Respiratory responses measured during the first 20 sec following cyanide injections
(2-5-800 pg i.v.) were greater in control animals than in those which had received
capasicin. For example, in vehicle-treated rats a near-peak response was obtained
with 100 /zg-NaCN, respiratory minute volume (RMV) increasing from a pre-injection
level of 174 + 17 ml. min""1 to 412 + 64 ml. min-1 (n = 8), whereas in capsaicin-treated
animals, whose mean body weight was not significantly different from that of the
controls (P > 0 05), the same dose of cyanide increased RMV from 132 + 21 to
235 + 31 ml. min"1 (n = 7; P < 005 vs. vehicle-treated). Pa COl averaged 4 0 kPa in
controls and 4-5 kPa in capsaicin-treated rats (n = 4).
We can conclude that both baroreceptor and chemoreceptor reflex activity are
significantly reduced in pentobarbitone anaesthetized adult rats which have been
treated neonatally with capsaicin, and that this is likely to result from the destruction
of unmyelinated baro- and chemoreceptor afferent fibres, although actions on the
chemosensory mechanism in the carotid body cannot be excluded.
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INFLUENCE OF NEONATALLY ADMINISTERED CAPSAICIN ON
BARORECEPTOR AND CHEMORECEPTOR REFLEXES IN THE
ADULT RAT
SUSAN M. BOND. F. CERVERO* & D.S. McQUEEN
Departments of Pharmacology and Physiology*. University of Edinburgh Medical School. Teviot Place. Edinburgh
EH89AG
1 Baroreceptor and chemoreceptor reflex activity was studied in anaesthetized adult rats which
had been treated neonatally with a single injection of capsaicin (50 mg/kg s.c.).
2 Pressor responses to bilateral carotid artery occlusion were significantly lower in capsaicin-
treated rats compared with vehicle-treated controls. Pressor responses to intravenously injected
noradrenaline were similar in the two groups of rats.
3 Resting respiratory minute volume and tidal volume were lower in anaesthetized capsaicin-
treated animals than in vehicle-treated controls, but there was no significant difference in respiratory
frequency.
4 Tlie increases in respiration evoked by intravenous administration of the peripheral arterial
chemoreceptor stimulant, sodium cyanide, or by breathing a hypoxic gas mixture, were significantly
lower in capsaicin-treated rats compared with the controls
5 It is concluded that baroreceptor and chemoreceptor reflex activity are significantly reduced in
anaesthetized adult rats which had been treated neonatally with capsaicin, and that this is likely to
result from the destruction of unmyelinated baro- and chemoreceptor afferent fibres.
Introduction
Substance P (SP)-like material is present in the
carotid bodies of cats (Lundberg, Hokfelt, Fahrenk-
rug, Nilsson & Terenius, 1979; Cuello & McQueen,
1980; Wharton. Polak, Pearse, McGregor, Bryant,
Bloom, Emson, Bisgard & Wills, 1980) and rats
(Jacobowitz & Helke, 1980). in nerve fibres of the rat
carotid sinus and aortic arch (Helke. O'Donohue &
Jacobowitz. 1980), and in the petrosal and nodose
ganglia which contain the cell bodies of baroreceptor
and chemoreceptor nerves (Lundberg. Hokfelt, Nils-
son, Terenius, Rehfeld. Eldc & Said, 1978; Gillis,
Helke, Hamilton, Norman & Jacobowitz, 1980;
Helke et al., 1980). SP-like material has also been
detected in the nucleus tractus solitarii (NTS) of the
medulla oblongata (Cuello & Kanazawa, 1978;
Ljungdahl, Hokfelt & Nilsson, 1978; Helke et al.,
1980; Gillis et al.. 1 980), a region where many baro-
and chemoreceptor primary afferent nerves termi¬
nate (Crill & Reis, 1968; Lipski, McAllen & Spyer,
1977; Palkovits & ZSborszky, 1977). Intracranial
sectioning of cranial nerves IX and X, which contain
baro- and chemoreceptor fibres, causes a reduction
of SP-like material in the NTS (Gillis et al., 1980).
and microinjection of SP into the intermediate parts
of the NTS has been reported to evoke hypotension
and bradycardia in rats and cats (Haeusler & Oster-
0007-1 188/82/1 105 I 7-08 $01.00
walder, 1980a; but cf. Talman & Reis, 1981), a
response which is very similar to that obtained by
activating the baroreflex. These findings have led to
the suggestion that SP is a neurotransmitter at the
central terminals of baro- and chemoreceptor affer¬
ent nerve endings (Gillis et al.. 1980; Haeusler &
Osterwalder. 1980b; Helke et al.. 1980).
Treatment of newborn rats with capsaicin causes a
degeneration of unmyelinated primary afferent
neurones (Jancsd, Kirily & Jancsd-Gabor, 1977;
Nagv. Vincent, Staines, Fibiger, Reisine & Yamam-
ura. 1980; Scadding, 1980) and a reduction of SP-
like immunoreactivity in the relay nuclei of unmyeli¬
nated afferent fibres in the central nervous system
(Nagy et al., 1980; Gamse, Holzer & Lembeck,
1980; Nagy, Hunt, Iversen & Emson, 1981). The SP
content of other nuclei within the CNS which do not
receive an unmyelinated projection of peripheral
origin is not affected in animals treated neonatally
with capsaicin (Gamse et al.. 1980; Nagy et al.,
1980). These observations indicate that administra¬
tion of capsaicin to neonates causes the degeneration
of a substantial proportion of peripheral unmyeli¬
nated afferent fibres, including those containing SP.
Among the unmyelinated afferent fibres affected
by neonatal treatment with capsaicin are those which
©'I"he Macmillan Press Ltd 1982
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Icrminate in the sensory nuclei of cranial nerves V.
IX and X (Jancs6 & Kirfily. 1980). This raises the
possibility that cardiovascular control may be im¬
paired in animals treated at birth with capsaicin, so in
the course of a study on the relevance of unmyeli¬
nated afferent fibres to the mechanisms of nocicep¬
tion (Ccrvero & McRitchie, 1981). we decided to test
baroreceptor and chemoreceptor reflexes in rats
which had been treated nconatally with capsaicin.
The objectives were to analyse the relative contribu¬
tion of unmyelinated afferent fibres to these reflexes
and to obtain further evidence concerning the role of
SP in these sensory pathways. A preliminary account
of some of the results has been published (Bond.
Cervero & McQueen. 1982).
Methods
Sprague Dawley rats were used in this study. When
the animals were betweeji two and four days old they
were anaesthetized with halothane (1% in oxygen)
and littermates received either a single subcutaneous
injection of capsaicin (50 mg/kg) or drug vehicle (1:1
polyethylene glycol 200:0.9% w/v aqueous sodium
chloride). Three to seven months later the rats were
used for the study of baro- and chemoreceptor reflex¬
es. Most of the animals were males, the average body
weights being 469±48g (controls) and 460±47g
(capsaicin-treated).
Surgical procedures and recording techniques
Animals were anaesthetized with pentobarbitone
(40 mg/kg, i.p.) and the trachea was cannulated, as
were a femoral artery and vein. At the end of several
experiments a catheter was also inserted into the
rostral end of a common carotid artery and was used
for measuring the pressure in the carotid sinus during
bilateral carotid artery occlusion (BCO). Blood pres¬
sure was measured via a pressure transducer and
displayed on a chart recorder (Devices, M4). Respi¬
ration was measured with an integrating
pneumotachograph, as previously described (Mc¬
Queen, 1973). The animals breathed either room air,
100% 02, or a hypoxic gas mixture (10%02:90%
N2). Blood samples were taken from the femoral
artery for the measurement of arterial blood gas
tensions and pH (Radiometer BMS3).
Barorecepter function test
Bilateral carotid occlusion Rats were anaesthetized
with pentobarbitone and breathed room air spon¬
taneously. Small artery clips were applied to both
common carotid arteries low in the neck for 60 s, with
at least 5 min between successive occlusions. Systolic,
diastolic, and mean (diastolic +■ J pulse pressure)
blood pressures were determined before bilateral
carotid occlusion (BCO) and at the peak of the
pressor response to BCO (Figure 1). In some experi¬
ments occlusion was maintained for 120 s, but the
pressor responses were not significantly different
from those obtained using the shorter period of BCO.
Three occlusions were performed in each animal:
before, 5 min and 30 min after a supplemental dose of
anaesthetic (6 mg, i.v.) and the average rise in mean
BP was calculated. The level of anaesthesia affected
the basal pressure but had little influence on pressor
responses in these animals. Some experiments were
also performed in which a comparison was made
between the pressor response observed during air-
breathing with that obtained when the animal
breathed 100% 02.
Noradrenaline
The pressor responses to doses of noradrenaline
injected intravenously were determined in anaes¬
thetized rats.
Chemoreceptor function tests
Sodium cyanide The peripheral arterial chemo-
receptors were activated by intravenous injection
(0.1 ml + 0.2 ml wash over 2-4 s) of various doses of
sodium cyanide in spontaneously breathing rats. At
least 5 min was allowed to elapse between successive
injections. The increase in respiratory volume during
the 20 s period immediately following the injection
was calculated and plotted against dose to provide a
dose-response curve. Cyanide experiments were per¬
formed after testing the baroreceptors by BCO in
order to minimize the total number of animals used.
Hypoxic gas After completion of the surgical proce¬
dures and before performing any other tests the
animals were switched from breathing room air to
breathing 10% O2:90% N2 for 4 min, and the reflex
increase in respiratory minute volume (RMV) deter¬
mined. An arterial blood sample was taken before
and 3 min after changing to hypoxic gas. The level of
anaesthesia (assessed qualitatively) was similar in the
two groups of rats.
Drugs
The drugs used were capsaicin (8 methyl-N-vanillyl-
6-nonenamide, Sigma), sodium cyanide (BDH) and
(-)-noradrenaline bitartrate (Koch Light).
Statistical analysis
Differences between group means were compared by








Figure 1 Pressor response to bilateral carotid occlusion (marker) in a control rat (a) compared with that obtained in
a capsaicin-treated animal (b) Prolonging the period of occlusion did not significantly increase the response.
the Wilcoxon rank test, or'Student's / test when there
were insufficient data for the non-parametric test,
and the null hypothesis rejected if P<0.05.
Results
Baroreceptor function test
Bilateral carotid occlusion Reflex pressor responses
to BCO (e.g. Figure 1) were determined in ten con¬
trol (vehicle-treated) rats and seven which had been
treated neonatally with capsaicin. Pre-occlusion
mean BP was slightly lower in the capsaicin-treated
anaesthetized animals breathing air than in the con¬
trols (see Figure 2a), but this difference was not
statistically significant. During BCO the averaged
reflex hypertension, whether expressed in terms of
mean BP (Figure 2a), systolic BP or diastolic pres¬
sure was significantly lower (P<0.01) in capsaicin-
treated rats as compared with controls. On average
the peak pressor response occurred 33.7 ±9s
(s.e.mean) after applying the clips in control rats and
24.6 ± 7 s in capsaicin-treated animals (P> 0.05).
In seven control and four capsaicin-treated rats a
comparison was made of the pressor response to
BCO during air-breathing with that obtained in the
same animal while breathing 100% Oj. The results
are shown in Figure 2b. Basal mean BP was higher in
controls breathing O2 than when they breathed air,
but the pressor responses were not significantly dif¬
ferent. In the case of the capsaicin-treated animals
basal blood pressure was higher during 02-breathing,
but the pressor responses were not significantly dif¬
ferent from those obtained while breathing air
(P>0.05). On average the peak pressor response
during 02-breathing occurred 40.7 ± 8 s after apply¬
ing the clips in controls and 31.7±9s in capsaicin-
treated rats. The pressor responses in the controls
were significantly greater than in the capsaicin-
treated animals when breathing either air or oxygen
(PC0.05).
In two rats measurements of mean carotid sinus
pressure showed that pressure fell on average to
32mmHg immediately following BCO and reco¬
vered to 50 mmHg by 30 s, at which level it remained
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Figure 2 (a) The maximum rise in mean BP obtained
during 60s bilateral carotid occlusion (BCO) averaged
from 10 control and 7 capsaicin-treated anaesthetized
rats; vertical lines show s.e.mcan. (b) In 7 controls and 4
capsaicin-treated animals the averaged pressor response
to BCO during air-breathing (open columns) is com¬
pared to that obtained in the same animal during ventila¬
tion with 100% O2 (hatched columns). The averaged
mean BP ±s.e.mean measured just prior to BCO is
given below the bar graphs.
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carotid sinus nerves virtually abolished the reflex
hypertension.
During the first 20 s of BCO there was a tendency
for respiration to increase, particularly in control
animals breathing air, but the rather variable nature
of this response is reflected in the large standard
errors (see Figure 3). The increase in respiration
during BCO was smaller in capsaicin-treated rats and
was abolished when these animals breathed
100% O2, whereas in control rats the respiratory
response to BCO was still present during 02 brea¬


















Figure 3 The averaged increase in respiratory minute
volume (RMV, ±s.e.mean) observed during the first
20 s of a 60 s period of BCO during air breathing (open
columns, data from 10 control and 7 capsaicin-treated
rats) are shown. The hatched columns represent the
respiratory change observed when 6 controls and 4
capsaicin-treated animals breathed 100% 02.The aver¬
aged mean basal RMV is.e.mean measured just prior
to BCO is given below the bar graphs.
Pressor responses to (-)-noradrenaUne Norad¬
renaline was injected intravenously in two control
and three capsaicin-treated rats and the averaged
pressor responses evoked were plotted against the
dose of noradrenaline. Results obtained are shown in
Figure 4 from which it can be seen that although there
may be differences between the two groups in the
slopes of their dose-response lines, their pressor re¬
sponses to noradrenaline (0.5-10pg) were not sig¬
nificantly different (P>0.05, 2-tailed rtest, assum¬
ing normal distribution).
Chemoreceptorfunction tests
Sodium cyanide Respiratory responses to intraven¬
ous injection of various doses of the peripheral arteri¬
al chemoreceptor stimulant sodium cyanide (e.g.
Figure 5) were studied in eight control and seven
capsaicin-treated anaesthetized rats which were bre¬
athing air, and the results are summarized in Figure 6.
Respiratory responses to cyanide were rather vari-
30 -
O-1
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Figure 4 Averaged rise in mean BP in vehicle-treated
controls (• •, n = 2) and in capsaicin-treated rats
(x—x, n = 3) plotted against dose of (-)-noradrenaline
injected intravenously (logio scale). Lines were fitted to
the data by the method of least squares.
Mean BP measured immediately before injection of
noradrenaline averaged 113±4.5mmHg in the control
group and 103 + 4 in the capsaicin-treated rats
(P>0.05).
able from animal to animal, as previously described
(Colinet-Lagneaux, Troquet & Hermann-Gedang,
1966), and this is reflected in the rather high standard
errors. The variability probably results from factors
such as the level of anaesthesia, acid-base balance,
and variation between individual animals in their
responsiveness.
Measurements made in the pre-cyanide control
period showed that respiratory minute volume
(RMV) and tidal volume (Vt) were significantly
lower (P< 0.01) in the capsaicin-treated rats as com¬
pared with the vehicle-treated controls, but there was
no significant difference in respiratory frequency (f)
(P> 0.05). The mean basal values for capsaicin-
treated rats (controls in brackets) were:
RMV 112 ± 16 ml min"1 (156±10); V, 2.0±0.2
(2.8±0.1); f 56±5 (56±2) breaths min"1. Control
rats showed a significantly (P<0.05) greater in¬
crease in RMV in response to injections of 10.25,50,
100 and 200 pg sodium cyanide (Figure 6). The
low doses of cyanide (2.5-5 pg) had no appreciable
effect on respiration in either group, whereas the very
high, near-toxic, doses (400-800pg) evoked re-







Figure 5 Respiratory response to an intravenous injection of 100 pg sodium cyanide at the arrow: (a) in a control,
(b) in a capsaicin-treated rat. Each step in the ramped output from the pneumotachograph represents one breath,
and the total height of each ramp is the respiratory volume in 10s. Records read from left to right.
sptratory increases which, although greater in the
control rats, were not significantly different from
those obtained in capsaicin-treated animals; they
caused substantial falls in BP. The increased RMV in
both groups resulted from rises in f and Vt, but the
latter was much more pronounced in control rats. In
two control rats sodium cyanide (lOOpgi.v.) evoked
an increase in RMV within the first 20 s of injection
which was abolished by cutting both carotid sinus
nerves.
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Figure 6 Pooled data from 8 control (•) and 7
capsaicin-treatcd rats (x) showing the mean respiratory
minute volume (RMV) averaged over the first 20s
following intravenous injection of sodium cyanide
(2.5-800 |ig - logm scale); vertical lines show s.e.mcan.
Lines were fitted to the data points by eye
mixture (10% O2) an increase in respiration occurred
in the two groups of rats, but both the absolute RMV
and the increase in RMV were significantly greater in
the controls (Table 1). Individual animals varied
somewhat in their responsiveness and this is reflected
in the high standard errors. The PaCC>2 measured
during air-breathing was significantly higher in
capsaicin-treated rats, as compared with the controls.
Discussion
Our results show that there is a significant reduction
in baroreceptor and chemoreceptor reflex activity in
adult rats which had been treated neonatally with
capsaicin. It must be stressed that the experiments
were performed under anaesthesia, so the effects we
obtained may be peculiar to the anaesthetized ani¬
mal. The contribution made by the anaesthetic agent
could be determined by studying reflex activity in
conscious capsaicin-treated rats.
Baroreceptor reflex
In a preliminary report Lorez, Haeusler & Aeppli
(1981) state that treatment of neonatal rats with the
same dose of capsaicin as we used did not change
baroreceptor reflex function in adult animals. There
was a reduction in the number of primary afferent
SP-containing fibres in the rootlets of cranial nerves
IX and X, but although the number of SP-containing
fibres terminating in the nucleus tractus solitarius was
markedly reduced in capsaicin-treated rats, SP-
containing cells in this nucleus were unchanged. In
the absence of more detailed information concerning
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Table 1 Respiratory minute volume, arterial blood gas tensions, and pH measured in three control and three
capsaicin-treated anaesthetized rats during air-breathing and again when breathing a hypoxic gas mixture (10% O2)
Control Capsaicin
RMV (ml min-1) Air 129 + 27 93±14
10%O3 270123 185 + 23*
Paco2(kPa) Air 4.04 + 0.12 4.67 ±0.08'
10% o2 2.51 ±0.26 3.03 ±0.19
Pao2 Air 10.40±0.40 9.83 ± 0.19
10% o2 5.56 ±0.24 6.04 ±0.32
PH Air 7.44 ± 0.01 7.40 ±0.03
10% o2 7.51 ±0.01 7.51 ±0.01
Respiratory volume was measured over a 10s period starting at the peak of the respiratory response to hypoxia
(49 ± 8 s after switching from air in controls, 53 ± 7 s in capsaicin-treated animals). Males were used for these tests
(body weight of controls 350 + 18 g; capsaicin-treated 342 ± 29 g). Values are expressed as means ± sc.mean.
" P < 0.05 compared with vehicle-treated controls. 1 kPa = 7.5 mmHg
the experiments of Lorez etai, we are unable to offer
any explanation of why it is that we found a depres¬
sion of baroreceptor reflex function in capsaicin-
treated rats, whereas they did not.
The possibility exists that, during BCO, the fall in
carotid sinus pressure might, by reducing carotid
body blood flow, lead to stimulation of the carotid
body chemoreceptors. This would be liable to cause
reflex sympathetic vasoconstriction (McQueen &
Ungar, 1971), and the pressor response to BCO
might, therefore, be attributed partly to withdrawal
of inhibitory baroreceptor activity and partly to
chemoreceptor stimulation. Carotid chemoreceptor
stimulation did seem to occur during BCO in control
rats since respiration increased, albeit rather vari¬
ably, when the animals were breathing air, but to a
lesser extent when breathing 100% 02, a condition in
which chemoreceptor activity is greatly reduced.
However, pressor responses to carotid occlusion dur¬
ing air-breathing were not significantly different
from those obtained when on 100% 02, and this
finding suggests that the reflex rise in blood pressure
was mainly due to withdrawal of baroreceptor tone.
Chemoreceptor stimulation in spontaneously brea¬
thing animals is liable to activate the lung inflation
reflex which can mask the primary chemoreceptor
reflexes (Daly & Scott, 1962) and this might explain
why the pressor response to BCO during air-
breathing was no greater than obtained when the
control animals breathed 100% 02. The fact that
capsaicin-treated animals showed a much smaller
increase in RMV during BCOwhen breathing air and
virtually none during 02-breathing is consistent with
a reduction in the sensitivity of their peripheral
chemoreceptors.
Given that baroreflex activity was attenuated in
capsaicin-treated rats, it might be considered surpris¬
ing that basal BP was not elevated in these animals.
However, it has to be noted that baroreflex activity
had only been reduced, not abolished, and also that
the animals were anaesthetized; anaesthesia can
abolish the hypertension resulting from baroreceptor
deafferentation in rats (De Jong & Palkovits, 1976).
The similarity of control and capsaicin-treated rats in
their pressor responses to noradrenaline suggests
that the vascular component of the baroreceptor
reflex arc was not appreciably affected by capsaicin.
Chemoreceptor reflex
Sodium cyanide is a classical stimulant of peripheral
arterial chemoreceptors (see Heymans & Neil, 1958)
and appears to have no direct effect on baroreceptors
(McQueen, 1980a). Respiratory changes occurring
soon after its intravenous administration can reason¬
ably be attributed to stimulation of carotid body
chemoreceptors since it has previously been shown,
and confirmed in the present study, that the reflex
increase in respiration obtained following the injec¬
tion of cyanide in rats is abolished by destroying the
carotid bodies or cutting the carotid sinus nerves
(Colinet-Lagneaux et al., 1966; Colinet-Lagneaux,
Hermann-Gedang & Troquet, 1967; Sapru &
Krieger, 1977).
The reflex respiratory response to intravenous
sodium cyanide was significantly reduced in anaes¬
thetized capsaicin-treated rats, and it was also found
that RMV was lower and Paco2 higher than in the
controls. Reflex hyperventilation in response to bre¬
athing 10% 02 was not so pronounced in capsaicin-
treated animals as in controls. However, these latter
findings are difficult to interpret exclusively in terms
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of reduced responsiveness to arterial chemorcceptor
stimulation because in addition to stimulating
peripheral chemoreceptors, systemic hypoxia may
depress the CNS by a direct action. Also, reflex
hyperpnoea causes a fall in Paco2 and rise in pH
which will tend to remove central respiratory drive,
and the changes in blood pressure that accompany
hypoxia will also indirectly influence respiration.
Nevertheless, the evidence from these respiratory
studies can be taken as showing that the sensitivity of
the peripheral chemoreceptors and/or the central
components of the reflex had been altered by cap¬
saicin.
Substance P and unmyelinated fibres
Neonatal administration of capsaicin causes a sub¬
stantial reduction in the number of unmyelinated
afferent fibres, including those that originate from
internal organs and terminate in the brain stem nuclei
where baro- and chemoreceptor afferent fibres pro¬
ject (see Introduction). In preliminary studies we
have found that the population of unmyelinated
fibres in the carotid sinus nerves of capsaicin-treated
rats is severely reduced (Cervero & McQueen, un¬
published observations). Small myelinated fibres can
also be affected by capsaicin at the dose used in the
present study, but to a lesser extent (Nagy et al.,
1981). However, unmyelinated efferent fibres do not
seem to be affected by neonatal capsaicin (Cervero &
McRitchie, 1982), so we can therefore conclude that
the changes in baroreceptor and chemoreceptor re¬
flex function observed in the present experiments
most probably result from the loss of unmyelinated
afferent fibres.
SP-like material is associated with unmyelinated
primary afferent fibres, including those in cranial
nerves IX and X, since capsaicin treatment leads to a
substantial reduction in the SP content of these
fibres. Our results are not incompatible with SP
having a role in the baro- and chemoreflexes by being
released at the central endings of unmyelinated prim¬
ary afferent fibres in the brain stem, or possibly by
influencing events at the peripheral sensory endings
(see McQueen, 1980b). However, it is not possible to
interpret the findings in terms of a reduction in SP
because neonatal capsaicin does not specifically af¬
fect SP-containing fibres; there is evidence to suggest
that it can affect the levels of other peptides (e.g.
somatostatin in dorsal root ganglia: Kessler & Black
1981) as well as SP. Further studies are needed to
establish whether the changes in reflex activity we
have observed are due to changes in SP alone, to
changes in other substances, or to a combination of
factors.
Treatment of neonatal animals with capsaicin may
offer a preparation in which the relative contribution
of myelinated and unmyelinated nerve fibres to baro-
and chemoreceptor reflexes can be studied and the
central interaction between the two types of fibre
analyzed.
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Effects of Temperature on Carotid
Chemoreceptor and Baroreceptor Activity
d. s. McQueen and c. eyzaguirre
Department of Physiology, University of Utah College of Medicine,
Salt Lake City, Utah 84132
the object of the present work was to in¬
vestigate the influence of local temperature
changes on carotid chemoreceptor and
baroreceptor nerve discharges with the aim
of obtaining some insight into the mecha¬
nism of impulse initiation in these re¬
ceptors.
Ishiko and Loewenstein (12) have shown
that temperature changes have a profound
influence on the magnitude of the genera¬
tor potential of Pacinian corpuscles; also,
it is known that temperature is a potent
modulator of chemoreceptor activity (1, 9,
20). However, the latter studies suffer from
a lack of quantitative treatment. Therefore,
we felt that it was important to conduct a
quantitative study on the effects of tem¬
perature on the chemo- and baroreceptor
discharges, discharge being taken as a re¬
liable index of receptor activity.
The results are discussed in terms of in¬
formation they provide on chemoreceptor
mechanisms; they are necessarily indirect,
since we measured only carotid nerve activ¬
ity and no attempts were made to record
events occurring at the receptor level, such
as changes in potential of nerve endings or
glomus cells. The responses evoked by
asphyxia, ACh, and NaCN at different
temperatures are discussed.
METHODS
Cats of either sex weighing between 1.8 and
3.0 kg were anesthetized with sodium pentobar¬
bital (Diabutal, 40 mg/kg ip). A cannula was
inserted into the trachea low in the neck and
connected to a demand-valve respirator (En-
sco), spontaneous respiration being abolished
by gallamine triethiodide (Elaxcdil, 2 mg/kg
iv). The animal was ventilated with air and
Received for publication February 21, 1974.
the end-tidal C02 was continually monitored
by an infrared C02 analyzer (Beckman), the
Pco2 being maintained at 20-25 mm Hg (at¬
mospheric pressure being 638-650 mm Hg) by
adjusting the frequency and volume of respira¬
tion. A femoral artery was cannulated and
connected to a pressure transducer, a record
of arterial blood pressure being obtained on
a Grass polygraph and on magnetic tape (fre¬
quency response: DC to 2,500 Hz). A femoral
vein was cannulated and used for drug ad¬
ministration. The rectal temperature of the
animal was monitored and maintained at 37°C.
Alteration of carotid blood temperature
A common carotid artery was cannulated
both ways (Fig. 1) and blood pumped from the
animal at constant flow through siliconized
rubber tubing by a roller pump (Cole Parmer).
Before the blood was returned to the carotid
bifurcation it passed through a 16-cm spiral of
polyethylene tubing (240) positioned in close
contact with a thermoelectric module (Borg-
AVarner Thermoelectric), heat exchange being
assisted by coating the heat-exchange surfaces
with thermal compound. A thermistor was posi¬
tioned on the surface of the polyethylene tub¬
ing in the heat exchanger (H) and connected to
a servo control system (S), which allowed the
temperature of the blood circulating through
the heat exchanger to be increased or decreased
by controlled steps. The temperature of the
blood at the carotid bifurcation was measured
by a thermistor (T) probe (Yellow Springs
Instrument Co., time constant 0.1 s) inserted
via the external carotid artery, the output from
the thermistor being obtained on the pen
recorder and on tape. The sinus perfusion pres¬
sure was monitored (P) and maintained be¬
tween 130 and 160 mm Hg, which allowed a flow
rate of 1-3 ml/min, depending on the particu¬
lar animal. All the tubing was siliconized and
heparin (150 U/kg iv) was administered ini¬
tially and every 4 h thereafter.
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flow
fic. 1. Carotid perfusion system. Blood was
pumped from tire common carotid artery (CC)
through a heat exchanger (H) and hack to the
artery about 2 cm below the carotid bifurcation.
A thermistor bead mounted in H was connected
to a servo-control system (S) which allowed the
temperature in H, and hence that of the carotid
blood, to be varied by controlled steps. Sinus
perfusion pressure was monitored (P) and the tem¬
perature of the blood at the carotid bifurcation
was measured by a thermistor probe (T) inserted
via the external carotid artery (EC). With the ex¬
ception of the lingual and external carotid arteries
the blood vessels of the sinus region were not
ligated (IC = internal carotid artery).
Recording of carotid situis
nerve activity
The carotid nerve on the same side as the
cannulated carotid artery was dissected from
surrounding tissues under a binocular micro¬
scope. Unless otherwise indicated, the ganglio-
glomerular nerves (connecting the superior cer¬
vical ganglion with the carotid body-sinus
region) were cut. Exposed tissues were covered
with warm mineral oil. The carotid nerve was
sectioned centrally and fine strands were dis¬
sected from the nerve trunk. Recordings of
multiple or single barorcccptor or chcmorccep-
tor units were obtained by using bipolar
plaiinum-iridium electrodes. Sensory nerve dis¬
charges were amplified, displayed on an oscillo¬
scope, and recorded on tape. The output of
the tape channel containing the action poten¬
tials was fed to a pulse-height discriminator
and a counter-timer coupled with a digital-
analog converter, the output from which was
obtained 011 the pen recorder. I11 addition, the
output from the pulse-height discriminator was
fed to an analog-digital converter and spike
frequency was computed (I'DIMI). The analog
data stored 011 magnetic tape were later played
back through the oscilloscope and photo¬
graphed.
When multiple units (generally two to five)
were recorded, care was taken to ensure that
additional units were not recruited during the
course of temperature or drug-induced changes.
If recruitment did occur the nerve filament
was divided until only single or few active units
were present and no recruitment occurred.
C.I1cinoreceptor stimulants
The effect of chemoreccptor stimulants on
discharge frequency was investigated by inject¬
ing a small volume of the stimulant solution
(0.1 ml over 1-5 s) into the tubing before the
roller pump, against the direction of flow. In¬
jections were made every 5 min, 10 min after
the temperature had been set at a new level.
ACh chloride (Sigma) and NaCN (Merck)
were studied, both substances being prepared
in modified Locke solution: (NaCl 6.0 g, KC1
0.42 g, CaCl2 0.24 g, Trizma base 6.0 g, normal
HC1 39 ml, distilled water to 1 liter, pH 7.41
at 37°C). Doses referred to are those of the salts.
The Pco2 was varied by altering the volume
of air delivered by the respirator until the de¬
sired end-tidal C02 was attained.
Data analysis
Chemoreccptor units were identified by their
aperiodic pattern of discharge (2, 8) and their
increase in discharge frequency when NaCN
(5 (tg) was injected into the carotid perfusion
system. Baroreceptors were identified by their
synchronous discharge with the pressure oscil¬
lations generated by the roller pump. Stopping
the pump abolished or markedly reduced the
discharge frequency, and NaCN had no effect
on the activity of these units.
For both types of receptors, the discharge of
either single or multiple units was analyzed
over 30-s intervals, starting with a control
period and then continuing after the onset of
temperature changes for 2-4 min. Data were ob¬
tained as the average discharge over the 30-s
period, as the maximum count in 1 s within
this interval, and also as the total count for
the 30-s period. In general, results from tem¬
perature changes are expressed as the discharge
averaged over 30 s, starting 30 s after the
temperature had reached the new level.
When the rate of change of temperature was
studied, the temperature change was compared
with the alteration in discharge frequency, this
being performed directly from the data by
computer. For drug studies, the increase in dis¬
charge elicited by chcmorcceptor stimulants
was plotted against time (time from onset of
increase until return to control level) and both
the average anil the total counts were com¬
puted.
k k s u l t s
General temperature effects
Recordings obtained from cither single
or multiple chemoreceptor or barorecep-
101 units demonstrated that temperature
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changes affected the spontaneous afferent
activity. Raising the temperature increased
the discharge, while lowering the tempera¬
ture reduced it (Fig. 2).
The chemoreceptor response to a sus¬
tained temperature change was investi¬
gated in several animals. The carotid blood
temperature alteration was effected over
20-30 s and a new level of chemoreceptor
activity established about 00 s after onset
of the temperature change. Increasing the
temperature to 42.5°C and maintaining it at
this level for 20 min elicited an increase
in discharge, which remained reasonably
steady for 5-10 min and then declined
slowly, such that by 20 min the discharge
was 50% of that obtained at peak activity;
however, it was still 50% greater than the
control (37°C) discharge. Kyzaguirrc and
Lewin (9) noted a similar pattern of re¬
sponse in vitro and suggested that adapta¬
tion or exhaustion of the receptors may
have accounted for the decline in activity.
In the present experiments we found no
decrease in the ability of acetylcholine to
elicit a response during the decline in spon¬
taneous discharge at high temperature.
This observation may indicate that adapta¬
tion of the discharge took place during ex¬
posure of the receptors to a constant tem¬
perature level. In fact, in partially adapted
mcchanoreceptors the discharge can be
brought back to its original level if an
additional stimulus is applied during the
declining phase of discharge frequency (7).
It is possible that in the case of chcmore-
ccptors, the effects induced by temperature
and ACh on discharge frequency may be
additive.
Lowering the temperature to 20°C re¬
sulted in a diminished discharge which was
32 • C 42-C
1
I sec
nr.. 2. Recordings of sj)onianeoiis activity from
single barorcceptor (.4) and chcmorcceptor (Ii)
units, 40 s after the carotid blood temperature had
reached either 32 or 42°C.
maintained at a fairly constant value for
the duration of the cooling period (15 min).
The discharge returned to control values
after bringing the temperature back to 37°C,
this being the case for both the warming
and cooling procedures.
The data obtained showed that a new
steady state of spontaneous chemoreccptor
activity was attained about GO s after the
onset of temperature change, and that tem¬
perature could be maintained at cither low
or high values for about 10 min without
much change in the discharge. The tem¬
perature effects were reversible, as shown
by the return to control discharge when
the temperature was reset to 37°C.
Cycled temperature changes
Although the chemorcceptor discharge
was capable of returning to control values
after prolonged temperature changes, this
was investigated at only three temperatures.
Therefore, we decided to perform a more
detailed study on the response to increas¬
ing the temperature (by 2° steps over 20-30
s) every 2 min from 37 to 42°C, thence to
2G°C, and finally back to 37°C. The dis¬
charge was averaged over 30 s, 60 s after on¬
set of the temperature change. Data from 11
recordings of single and multiple chemore¬
ccptor units showed no apparent hysteresis
in the temperature-response plot. There was
a tendency for the discharge to reach a
maximal value at about T2"C, further in¬
crease in temperature often resulting in a
discharge which was less than that obtained
at 12CC. In two units, the discharge did not
return to control (37°) values after ex¬
posure to 26°C; another unit ceased firing
at temperatures above 39°C. The reasons for
this reduced activity were not investigated.
Data obtained during the cycled tempera¬
ture changes were pooled and arc shown in
Fig. 3. Consideration of the Arrhenius plot
(see later) suggested that two lines could be
fitted to the data, one for values above 32°C,
the other for values below 32°C. This
"break" in the plot at 32°C was subjective
but the observation that the slope of the
line fitting the data below 32°C differed
from the slope of the line above 32°C sug¬
gests a change in the relative importance
of the rate-limiting reactions at about 32°C
(H).
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CAROTID BLOOD TEMPERATURE
fic. 3. Pooled data from eight recordings in
seven cats in which the carotid blood temperature
was varied within the range 23—11°C. The spon¬
taneous chemorcceptor discharge obtained at a par¬
ticular temperature is expressed as percentage of
the discharge obtained from the same unit(s) at
37°C. J.incs were fitted by the method of least
squares using data obtained above 32°C for one line
and data obtained below 32°C for the oilier.
For a 5° change of temperature at either
side of normal carotid blood temperature
(36-37°C) a 50% alteration of spontaneous
chemoreceptor discharge was obtained.
Ramped temperature changes
In some chemoreceptor units a rapid
temperature change (elfected over 15-30 s)
elicited a discharge which was rapid in on¬
set, but which having reached a peak value
declined to a new steady-state level (Fig. 4).
This type of response was seen also in ani¬
mals with intact ganglioglomcrular nerves.
The chemoreceptor response to a rapidly
nr.. 4. Response of single chemoreceplor unit to
a 0° increase in temperature (!1G—12°C, continuous
line). This is typical of the response observed,
namely a fast resjHinsc with an overshoot (dynamic
component) followed by stabilization at an inter¬
mediate discharge frequency (static component).
applied temperature change thus appeared
to be divisible into a dynamic and a static
component. In order to study further these
two components, a ramp generator was
used to increment the temperature by fixed
amounts over different time intervals. The
data obtained (Fig. 5) show a linear rela¬
tionship between the rate at which the
temperature is changed and the rate at
which the chemoreceptor discharge alters,
this applying both to increases and de¬
creases in temperature. The chemorecep-
tors thus seem to be capable of making
rapid responses and during the ramp pe¬
riod do not show much adaptation, at least
not during the periods studied.
Only the rapidly applied temperature in¬
crease caused an overshoot of the chemo¬
receptor discharge, this also being observed
in one of seven baroreccptor units investi¬
gated. A small undershoot in chemorecep¬
tor activity was sometimes, although not
invariably, seen when temperature was de¬
creased. The pattern of response seemed
analogous to that of muscle spindles where
a dynamic and static component are ob¬
tained in response to stretch (15).
An overshoot in chemoreceptor discharge
is also observed when a stimulus of hypcr-
capnic blood is suddenly applied at the
carotid chemoreccptors (3, 17). We did not
investigate whether C02 changes were re¬
sponsible for the present observations (see
discussion).
Temperature coefficient (Q10)
The factor by which rate constants differ,
for a temperature increment of 10°C, is
] h;. it. Chemoreceptor units. The temperature
was increased by 6° from 3G°G (•) or decreased by
(i° from TJ°C (O) at different rates.
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termed Q10 (the temperature coefficient): The difference between the barorcccptor
Q10 = discharge frequency at (/ + 10)°C/ and chemoreceptor Q10 values implies that
discharge frequency at <°C. the energy of activation of the rate-limiting
Q10 values for the chemoreceptors were step for the two types of receptors is dif-
obtained by recording the activity of either fcrent.
single or multiple units and varying the
temperature such that steady-state values Apparent activation energy (pj
(GO s after onset of the temperature change) Although the Q10 provides a measure of
were obtained at about six temperatures t]ie influence of temperature on a biologi-
in the range 2G-44°C. ft was found for caj pr0cess and is widely used, it is merely
most units that a plot of log10 discharge an empirical description without theo-
(counts/s) against temperature resulted in tetical implications or justifications. A
a linear relationship in the range 32-42°C more sophisticated method of expressing
and the Q10 value was calculated from the quantitatively the effects of temperature on
discharge Irequencies at 32 and 42°C. Since biological systems is to apply the Arrhenius
we were not able to measure the tempera- equation (10, 13, 14).
ture within the carotid body the assump¬
tion was made that the carotid blood tern- v. =
perature would be directly proportional to
the carotid body temperature. where k is the velocity constant for the
The activity of baroreceptor units was particular reaction, A is a constant, p is a
influenced by temperature (Fig. 2). As constant referred to as the apparent (ex-
with the chemoreceptors, the discharge was perimental) activation energy, 11 is the gas
averaged over 30 s, 60 s after onset of the constant, and T the temperature in degrees
temperature change, and at the same per- absolute. A plot of In k against \/T should
fusion pressure. Most of the experiments give a straight line with a slope of — p/R.
were performed with a perfusion pressure The data obtained from experiments in
of 140 mm Hg, although one was per- which spontaneous chemoreceptor activity
formed with a pressure of 210 mm Hg was examined at different temperatures
(maximal stimulus). The nerve discharge at were plotted according to the Arrhenius
32°C was compared with that obtained at equation and a linear relation between the
42°C and the Qln calculated. logarithm of the discharge frequency and
Data obtained from chemorcccptors and the reciprocal of the absolute temperature
baroreccptors are summarized in Table 1. was obtained (see Figs. 3 and G). The sig-
Data were obtained also from two animals nificance of the p value will be discussed
in which the ganglioglomerular nerves were later in relation to results obtained with
not cut; chemoreceptor Q10 values of 3.03 ACh.
and 2.12 were obtained, these being sim¬
ilar to values obtained with the nerves sec- Tempeiatuic and gas-tension changes
tioned. In vitro experiments with super- In five cats the end-tidal CO: was raised
fused (Locke solution) cat carotid bodies by altering the stroke volume of the rcspira-
gave Q10 values similar to those obtained tor. Although the gas-tension changes are
in vivo (unpublished observations), suggest- expressed in terms of end-tidal C02, ic¬
ing that the high Q10 does not result from ducing the stroke volume of the pump
an effect of temperature changes on the would also adect the oxygen tension of the
blood or blood vessels (e.g., viscosity, lib- blood. The stimulus is thus an asphyxic
eration of vasoactive agents, etc.). one rather than a purely hypcrcapnic one.
table 1. Temperature coefficient Q10 determined between 32 and
Type of Unit No. of Recordings No. of Animals Qk, (Avg) SEM Range
Barorcccptor 8 5 1.27 O.OG 1.08-1.50
Chemorcccptor 16 9 2.9G 0.18 1.70-1.25
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fig. 6. Response of a single chcmorcccptor unit
(logI0 scale) to temperature changes at end-tidal
C02 levels of 3.2% (•) and 5.5% (o). The discharge-
is averaged over 30 s, GO s after the temperature
change. The value of p for both levels is 27 kcal.
Also shown is the response of another single chcmo¬
rcccptor unit to injections of ACh (10 pg) at
various temperatures (A). The averaged discharge
is shown and the p value for data between 29 and
42°C is 26 kcal. A similar p value is obtained if
total counts are plotted rather than averaged dis¬
charge.
30 -
TIME I SEC 1
fig. 7. Spontaneous chcmoreccptor discharge (two
units), averaged over 5-s intervals, against time
after slopping the respirator (at 0 s). For A the
carotid blood temperature was maintained at 37°C,
and for B it was 24°C. It took about 25 s for blood
to pass through the carotid perfusion system.
There is a dynamic component in the response at
37°C which is not seen at 21°C.
The influence of temperature on spon¬
taneous chemoreceptor activity at different
end-tidal CO, levels is illustrated by Fig. (5.
The data show that temperature has sim¬
ilar effects at the two CO, levels (Q,„ and p
values similar at the two levels). This im¬
plies that the energy of activation of the
rate-limiting reaction(s) is not affected by
raising the CO, tension (and probably low¬
ering the Oo tension) at the chemoreceptors.
In one experiment air was replaced by
100% O, as the ventilating gas. The Qln
for the chemoreceptor discharge was un¬
altered in both the control state (CO, 3.2%)
and with a hypercapnic stimulus (CO,
5.5%) as compared with the discharge ob¬
tained on air. The discharge was decreased
at all temperatures studied (2G^12°C) as
compared with the discharge obtained
when air was used as the ventilating gas.
In two cats (Fig. 7), recordings of chemo¬
receptor activity were obtained while the
respirator was stopped, the sinus region
being perfused at constant flow with blood
at cither 21 or 37°C. At 37°C a brisk increase
in chcmorcceptor discharge occurred after
stopping the respirator (time lag in the
sinus perfusion circuit being about 25 s)
and a new level of discharge was estab¬
lished which persisted for the duration of
asphyxia, about 1 milt. When the carotid
blood was cooled to 24°C, activity in the
same filament took longer to develop al¬
though it eventually reached the same level
of activity seen at 37°C. The discharge at
2-l°C did not show the overshoot seen at
37°C, but it persisted for the duration of
asphyxia.
This observation demonstrates that at
21 °C, the system is capable of producing a
maximal response (similar in magnitude to
thai obtained at 37CC), although the dy¬
namic component of the response does not
occur at low temperatures.
Temperature and drug ejects
ACh and NaCN were investigated for
their ability to elicit a chemoreceptor dis¬
charge at various carotid blood tempera¬
tures. The procedure was to inject doses
of the stimulants (ACh G-100 ug; NaCN
0.5-20 |ig) into the carotid perfusion sys¬
tem at blood temperatures of 21, 32, 37,
and 12 °C.
Dose-response data were obtained at the
different temperatures and were expressed
as: averaged discharge at .v°C (where .v =
21, 32, or 12' C/averagcd discharge at 37°C
elicited by the same dose of stimulant.
Values were also obtained using total
counts rather than the averaged counts (see
methods).
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The ratios obtained from different units
in different animals were pooled and arc
shown in Fig. 8, from which it can be seen
that the response to both ACh and NaCN
is affected by temperature and that al¬
though total counts and averaged counts
show a similar trend, there are differences
between the parameters at certain tem¬
peratures. At 24°C, both stimulants evoke a
reduced discharge as compared with that
obtained at 37°C, but there is still a marked
stimulant effect. The stimulants differed in
that although both acted equally well over
a longer period at reduced temperatures
(as compared to the effects at 37°C), NaCN
look much longer to act than did ACh.
This aspect of the results will be examined
in detail in a subsequent publication.
An Arrhenius plot of cbemoreceptor dis¬
charge elicited by 10 pg ACh at various
temperatures was made (Fig. G). The p
value calculated from the slope of the line
was very similar (within experimental er-
(7/3) (12/6) (15/71
fig. 8. Pooled data obtained from chcmoreccp-
tor units in response to injections of acetylcholine
or sodium cyanide at different carotid blood tem¬
peratures. For a particular dose of stimulant the
discharge elicited by 24, 32, or 42°C is expressed as
a percentage of the discharge evoked at 37°C. Data
arc expressed as the mean ± SEM, shaded rec¬
tangles representing the averaged discharge, ojkii
rectangles the total discharge. Figures in paren¬
theses arc the number of recordings per animals
studied.
ror) to that obtained with spontaneous ac¬
tivity or hypcrcapnia.
discussion
The results show that chemoreceptor ac¬
tivity is increased by raising the carotid
blood temperature and decreased by low¬
ering it, these changes in spontaneous dis¬
charge being readily reversed within the
temperature range studied. The findings
confirm earlier observations on the effects
of temperature on chemoreceptor activity
(see introduction). Baroreceptors respond
to temperature changes in a similar manner,
but the change in discharge frequency is
not so marked.
Spontaneous chcmorcccptor activity
In the majority of experiments, the
ganglioglomerular nerves were cut to en¬
sure that changes in carotid blood tempera¬
ture did not affect the chemoreceptor dis¬
charge reflexly via the sympathetic nervous
system. However, experiments in which the
ganglioglomerular nerves were left intact
showed similar results in terms of Q10 val¬
ues, discharge overshoot, and drug re¬
sponses.
A rapidly applied temperature change
would often evoke a chemoreceptor dis¬
charge with an overshoot or dynamic com¬
ponent. A similar dynamic component was
seen when the chemoreceptors were exposed
to ;tn asphyxic stimulus at 37°C. The mech¬
anism of the dynamic component was not
investigated.
The Q10 determined in the steady state
was 2.90 for chemoreceptors and 1.27 for
baroreceptors in the range 32-42°C. Our Q10
value for carotid chemoreceptors is thus
similar to the value of 2.5 obtained by
Paintal (20) for the cat aortic chemorecep¬
tors. The observation that chemoreceptors
have a high Q10 is suggestive that a chem¬
ical process is involved in the rate-limiting
reaction, while the low Q10 for baroreccp-
tors suggests that a physical process is in¬
volved in the rate-limiting step. However,
there arc problems associated with the use
of QI0 values to establish that a particular
reaction is either physical or chemical in
nature (see rcf 10, 11, 21). What we can
conclude from our data is that the energies
of activation of the rate-limiting reactions
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for the two types of receptors differ, this
being in contrast to Paintal's (20) conclu¬
sion that aortic chemoreceptors have Qi0
values "similar to mechanorecepiors in gen¬
eral." Furthermore, there was a linear re¬
lationship between the logarithm of the
chemoreceptor discharge and the reciprocal
of the absolute temperature over the range
32-42°C, thus conforming with the Ar-
rhenius equation and allowing calculation
of p. The high p values obtained (Fig. G)
provide strong evidence that a chemical re¬
action is involved in the rate-limiting
reaction at the chemoreceptors.
Chemoreccptor stimulation
Asphyxia at 37°C resulted in an increased
chemoreceptor discharge which was more
rapid in onset than the discharge elicited
by asphyxia at 24°C. The maximal level of
activity attained at the two temperatures
was similar and demonstrates that at 24°C,
the ability of the nervous mechanism to
conduct discharges had not been signifi¬
cantly affected. The slower rate of change
of discharge at lower temperatures in re¬
sponse to chemoreceptor stimulation has
been described previously (18, 20). The
present findings show that although the
metabolic process is slowed by the tempera¬
ture reduction, eventually the process is ac¬
tivated to about the same extent as at 37CC.
However, besides changes in metabolic ac¬
tivity, reduced temperature may influence
the sensitivity of the receptor region (12,
19, 20), cholinesterase activity (5), blood gas
tensions and pH, blood viscosity, and prob¬
ably other factors that may modify the
nerve discharge elicited in response to a
given stimulus. For instance, blood flow
through the carotid body may be affected
by temperature due to either constriction
or dilatation of the intraglomerular vessels.
These variations in blood flow may be
either total or regional; the latter may be
produced by internal redistribution of
blood if the carotid body a-v shunt changes
its lumen with temperature variations.
Changes in all these factors, evoked by dif¬
ferent temperatures, make it difficult to
ascribe Q10 changes exclusively to receptor
mechanisms. For instance, changes in blood
pi I and/or gas tensions may vary the in¬
tensity of the applied stimulus (asphyxia)
in addition to the reactivity (sensitivity) of
the receptor.
NaCN and ACh were examined for their
ability to influence chemoreceptor activity
at different temperatures. In interpreting
data from drug experiments, the problem
arose of whether to use the total discharge,
as advocated by Paintal (19), or the aver¬
aged discharge evoked during stimulation.
We measured both parameters and our data
suggest that they follow the same qualita¬
tive pattern, within the dose range and
temperatures studied, although there may
be differences between the two at particu¬
lar temperatures and/or doses.
ACh and NaCN were less effective in
evoking a chemoreceptor response at lower
temperatures, this being especially notice¬
able at 24°C. To explain the reduced re¬
sponse, one might speculate that the sensi¬
tivity of the receptor mechanism had been
affected by the reduced temperature. Thus,
if the sensitivity of the sensory mechanism
is a function of spontaneous chemoreceptor
activity, then at low temperatures meta¬
bolic activity, and hence sensory receptor
sensitivity, would be reduced.
Whatever the explanation for the reduc¬
tion in sensitivity to acetycholine, an im¬
portant point is that even at 24°C, the low¬
est temperature investigated by Paintal (20),
the stimulant is still active in evoking a
response from chemoreceptor units. In con¬
trast, Paintal concluded from his experi¬
ments that acetylcholine, because it elicited
a very poor chemoreceptor response at low
temperatures as compared with the efTect
evoked by hypoxia, is not likely to be a
transmitter at the chemoreceptors. It should
be noted that our experimental techniques
difler from those of Paintal, who studied
aortic chemoreceptors, used chloralose and
sodium pentobarbital anesthesia, cooled the
whole cat, and studied single doses of
acetylcholine with the animal atropinized.
We investigated carotid chemoreceptors,
applied local temperature changes to the
chemoreceptors, and obtained dose-response
data with acetylcholine. It is of interest
that Brown (4) has described how the cat
superior cervical ganglion docs not respond
well at low temperatures (20°C) to injected
ACh, although stimulation of the pregan¬
glionic nerve will elicit a contraction of the
TEMPERATURE ON CHEMORECEPTORS AND BARORECEPTORS 1295
nictitating membrane similar to that ob¬
tained at 37°C.
Krylov (1C) found that the sensitivity of
carotid chemoreceptors to ACh was not af¬
fected by reducing to I2°C the temperature
of fluid perfusing a carotid bifurcation.
Our results allow us to agree with the re¬
port to the extent that ACh does evoke
responses at reduced temperatures, but the
quantitative data show a definite reduc¬
tion in the response elicited. Krylov also re¬
ported that at 20°C the chemoreceptor stim¬
ulant action of NaCN was absent. Our data
at 24°C, in agreement with those of Nashat
and Neil (18), obtained at 2G°C, show the
response evoked by NaCN is less at lower
temperatures, but is nonetheless present.
Perhaps at 20°C there is a sudden loss of
response to NaCN, but not to ACh. The
lowest temperature we investigated was
24°C, at which temperature the responses
to ACh and NaCN are similarly reduced
(Fig. 8).
1 he evidence from the temperature
studies does not eliminate ACh from con¬
sideration as a chemoreceptor transmitter
substance. Indeed, the observation that the
p values for spontaneous chemoreceptor
activity, stimulation by hypercapnia and
stimulation by ACh are so similar (Fig. 6),
suggests that ACh and the physiological
transmission process have the same rate-
limiting step. This is compatible with en¬
dogenous acetycholine being a transmitter
at chemoreceptors (G).
s u M M A R Y
The influence of local temperature
changes on the activity of carotid chemo¬
receptors and baroreceptors has been in¬
vestigated in anesthetized cats. Q,0 values
of 1.27 for the baroreceptors and 2.9G for
the chemoreceptors were obtained and
there was a linear relationship between
chemoreceptor discharge and temperature
when the data were plotted according to
the Arrhenius equation.
At 24°C, asphyxia evoked a chemorecep¬
tor discharge which, although it took longer,
eventually reached the same maximal value
as attained with asphyxia at 37°C. Both ACh
and NaCN stimulated chemoreceptor activ¬
ity at low temperatures, although the ac¬
tivity was less than that evoked at 37°C. The
p value (from Arrhenius equation) for ACh-
induced chemoreceptor activity was very
similar to that obtained with physiological
stimulation of the chemoreceptors. The
findings from this investigation are com¬
patible with acetylcholine being a trans¬
mitter at chemoreceptors.
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EFFECTS OF SUBERYLDICHOLINE ON CAROTID
BARORECEPTORS AND CHEMORECEPTORS
D. S. McQueen*
Department of Physiology. University of Utah College of Medicine. Salt Lake City, Utah 84132
(Accepted I March 1974)
Summary—The actions of the nicotinic drug suberyldicholine (SDC) on carotid baroreceplors and
chemoreceptors in the cat have been examined. Subervldicholine has a direct stimulant effect on
chemoreceptors, followed by a small delayed clfcct which is probably not due to SDC stimulating
the superior cervical ganglion, since the effect is also present when the ganglio-glomerular nerves
are cut. The direct stimulant effect on chemoreceptors was reduced by mecamylamine or tubocur-
arine, but not by moderate doses of atropine. Suberyldicholine thus affects chcmoreceptor activity
via actions at a nicotinic site
There was no evidence of a direct action of SDC on carotid baroreceptors. even with high doses.
Delayed increases in baroreceptor activity occurred with high doses of SDC, but these were second¬
ary to the sizable changes in systemic blood pressure evoked by SDC.
The chemoreceptor-stimulating property of the nicotinic drug suberyldicholine (cor-
conium or subecholine; bis-(2 tri-methylaminoethyl) suberate diiodide) has been described
(Anichkov and Bellen'kii, 1963; Dardymov and Ger, 1964). However, there are reports
suggesting that drugs which stimulate chemoreceptors when injected into the carotid bifur¬
cation, also affect baroreceptors (Diamond. 1955; Heymans and Neil, 1958).
McQueen (1970) used SDC to stimulate carotid chemoreceptors during a study of che-
moreceptor reflexes and presented evidence which indicated it was unlikely that SDC, in
the concentrations used to stimulate chemoreceptors, affected baroreceptors directly.
Without electrophysiological evidence, however, the possibility could not be precluded.
There was also a possibility that the drug was acting at the superior cervical ganglion to
increase sympathetic nervous activity which would result in increased chemoreceptor acti¬
vity (Daly, 1954).
The object of the present investigation was to use electrophysiological techniques to
study the actions of SDC on carotid baroreceptors and chemoreceptors in the cat. The
data obtained show that SDC stimulates the chemoreceptors directly; no direct action on
the baroreceptors was observed in the dose range studied.
methods
Cats of either sex weighing between 1-9 and 4-6 kg were anaesthetized with sodium pen¬
tobarbitone (Diabutal. 40mg/kg i.p.). A cannula was inserted into the trachea, low in the
neck, and connected to a demand valve respirator (Ensco); spontaneous respiration being
abolished by gallamine triethiodide (Flaxedil. 2 mg/kg i.v.). The animal was ventilated with
* Dorothy Temple Cross Research Fellow from Department of Pharmacology. University of Edinburgh. Scot¬
land.
Address correspondence lo: Department of Pharmacology. University ol Edinburgh. George Square,
Edinburgh.
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air and the end-tidal C02 was continually monitored by an infra-red C02 analyzer (Beck-
man. LB-1), the Pco, being maintained at 20 25 mm Hg (atmospheric pressure 638-
650 mm Hg) by adjusting the frequency and volume of respiration. A femoral artery was
cannulated and connected to a pressure transducer, a record of arterial blood pressure
being obtained on a pen recorder (Grass Model 5) and on magnetic tape (frequency res¬
ponse = d.c. to 2500 Hz). A femoral vein was cannulated and used for drug administration.
The rectal temperature of the animal was monitored and maintained at 37°C.
Sinus perfusion and cliemoreceptor stimulation
A common carotid artery was cannulated both ways and blood was pumped from the
animal at constant flow through siliconized rubber tubing by a roller pump (Cole Parmer,
model 7565). Before the blood was returned to the carotid artery, about 2 cm below the
carotid bifurcation, it passed through a 16-cm spiral of polyethylene tubing which was
positioned in close contact with a thermoelectric module (Borg-Warner Thermoelectric,
Illinois; No. 920). The temperature of the blood at the carotid bifurcation was measured
bv a thermistor probe (Yellow Springs Instrument Co.. No. 520) inserted via the external
carotid artery, and maintained at 37 C by adjusting the thermoelectric module.
Sinus perfusion pressure was monitored and maintained between 120 and 160 mm Hg
which allowed a How rate of 1-3 ml/min depending on the particular animal. With the
exception of the lingual and external carotid arteries, the blood vessels of the sinus region
were not ligated. All the tubing was siliconized and heparin (150 units/kg i.v.) was adminis¬
tered initially and every 4 hr thereafter.
Chcmoreceptor stimulants were injected into the tubing before the perfusion pump,
against the direction of flow. Injections (01 ml over 1-2 sec) were repeated every 6min,
the drugs being prepared in modified Locke's solution; (NaCl. 60g; KC1, 0-42g; CaCl2,
0-24g; Trizma base, 60g; normal HC1, 39 ml; distilled water to 1 litre; pH 7-41 at 37°C).
Doses referred to are those of the salts.
The following drugs were used: acetylcholine chloride (Sigma), nicotine tartrate (K and
K Labs), sodium cyanide (Merck), suberyldicholine diiodidc. mccamylamine HC1 (Merck,
Sharp and Dohme). atropine sulphate (Mallinckrodt). (+ )-tubocurarinc chloride (Mann).
Recording ofcarotid sinus nerve activity
The carotid nerve on the same side as the perfused sinus was dissected from surround¬
ing tissues under a binocular microscope. Unless otherwise indicated the ganglio glomer¬
ular nerves (sympathetic nerves to the carotid bifurcation from the superior cervical gang¬
lion) were cut. Exposed tissues were covered with warm mineral oil. The carotid nerve was
sectioned centrally and fine strands were dissected from the nerve trunk. Recordings of
multiple or single baroreccptor or chemoreceptor units were obtained using bipolar plati¬
num electrodes. Sensory nerve discharges were amplified, displayed on an oscilloscope and
recorded on tape. The output of the tape channel containing the action potentials was fed
to a pulse height discriminator and a counter-timer coupled with a digital analog con¬
verter. the output from which was obtained on the pen recorder. In addition, the output
from the pulse height discriminator was fed to an analog digital converter and spike'fre-
quencv was analyzed by a digital computer (PDP-9).
Chemoreceptor units were identified by their aperiodic pattern of discharge (Eyza-
ca ikki and Li:\vi\. 1961; Biscoi: and Taylor. 1963) and their increase in discharge when
sodium cyanide (5/ig) was injected into the carotid perfusion system. Baroreceptors were
SDC on carotid baro- and chemoreceptors
identified by their synchronous discharge with pressure oscillations generated by the per¬
fusion pump. Stopping the pump abolished or markedly reduced the discharge frequency,
and sodium cyanide had no effect on the activity of these units.
For both types of receptor the discharge frequency of either single or multiple units
was computerized. Data were expressed as the averaged control discharge (counts/sec) and
the discharge elicited during the period of drug action (defined as the time from onset of
the response until return to control level) was expressed as the average (counts/sec), maxi¬
mal (counts/sec) and total counts.
RESULTS
Baroreceptors
Recordings of baroreceptor activity from 10 filaments (single or multiple units) in six
cats showed no evidence of direct baroreceptor stimulation following single intra-carotid
injections of SDC in the dose range 0 5-200 /ig. The usual response was a slight fall in bar¬
oreceptor discharge following the injection and a concurrent fall in perfusion pressure. The
decrease was attributable to the injection vehicle since injection of 01 ml Locke's solution
elicited the same response, the change in viscosity was probably responsible for the slight
fall in perfusion pressure and baroreceptor discharge.
After delay of 20-40 sec from the time a high dose of SDC (50-100 pg) entered the caro¬
tid bifurcation, there was an increase in baroreceptor activity which was associated with
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Fig. I. Response ol''a single baroreceptor unit to an injection of I IK) /ig SIX into the carotid per¬
fusion circuit. There was a 24-sec delay in the perfusion tubing before the drug reached the carotid
bifurcation. Nerve discharge, mean sinus perfusion pressure and arterial blood pressure arc shown.
The panels to the right show recordings of nerve activity taken at the points indicated on the trace.
Several small chemoreceptor units were present along with the large baroreceptor unit which had
a triphasic action potential. A: during control period: B: during chemoreceptor stimulation by
SDC. and it can be seen that the baroreceptor discharge frequency is not much affected although
the chemoreceptors are strongly stimulated. When the perfusion pressure increases as a result of
systemic actions of the drug, then baroreceptor activity is increased (C)
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increase in barorcceptor activity was dose dependent and the discharge could be reduced
or abolished by lowering the perfusion pressure (slowing the speed of the perfusion pump).
Chemoreceptors
Recordings of chemoreccptor activity from 16 filaments (single or multiple units) in 11
cats were obtained. Invariably SDG (0-2—200/rg) when injected into the carotid artery
evoked a dose-dependent increase in chemoreceptor activity which was rapid in onset (Fig.
3A). The duration of the response varied from animal to animal and unit to unit. It
depended on the perfusion How rate, the rate of injection and the dose of stimulant; higher
doses of SDC (20-200 /tg) generally evoked responses with longer durations than those
observed with lower doses. Analysis of the data from 79 tests in 11 cats showed than an
average dose of 20 //g SDC (range 0-2- 200 pg) evoked a response with an average dura¬
tion of 13-8 sec (range 3 0 36-1 sec). The following aspects of the response were investigated.
Dose-response relationship. Qualitative examination of the data showed that SDC
evoked a dose-dependent increase in chemoreceptor discharge. The problem arose con¬
cerning which parameter to select for quantitative analysis; that is, should one consider
the averaged discharge, total discharge or maximal discharge? The data were examined
using all three variables and it was found that a uniform pattern of response was obtained
when the dose-response plots were compared. In some experiments the total count con¬
tinued to increase with dose after the averaged discharge had reached a maximal value.
Thus, in some instances, higher doses could evoke more activity but this was spread over
a longer time such that the averaged discharge decreased.
Data obtained from single units were similar to those from multiple units in terms of
shape of the dose-response curve and the dose which elicited maximal discharge—gener¬
ally 50-100 fig SDC for most units. The type of response obtained is shown in Figure 2.
DOSE, jiq
Fig. 2. Dose response data from a recording ol chemoreceptor activity (2 units). The averaged (.v.
counts/sec) and total discharges (5 v) in response to various doses of SDC were obtained before
(O. #)and after (A. A) mecannlamine 11 mg i.a ): the response duration averaged 23 sec (range 58-
35 see) before mccann lamine and l(> sec (range 12 llJ see) after mecamvlamine. Both variables have
similar dose response curves.
SDC on carotid baro- and chemoroceptors
The maximal value was not shown to avoid confusing the figure, but the curve for this
parameter was similar to those shown and had a maximal value of 59 counts/sec at 50/ig
SDC.
Blocking drugs. Small doses of some blocking drugs which have been reported to in¬
fluence the response of chemoreceptors to stimulants were investigated. Mecamylamine
(1 mg), when injected into the carotid perfusion system, reduced the response evoked by
SDC (Fig. 2). In some instances this dose entirely abolished the response. Tubocurarine
(1-2 mg i.a.) was also capable of markedly reducing the response of the chemoreceptors
to SDC. Atropine, however, did not reduce the response until doses of 5-10 mg were in¬
jected into the carotid perfusion circuit, and even then there was only a short-lasting reduc¬
tion in the response to SDC. Atropine (1 mg i.v.) appeared to potentiate the response.
Influence ofganglio-glomerular nerves. The majority of experiments in this investigation
were performed with the sympathetic nerves to the carotid bifurcation (ganglio-glomeru¬
lar nerves) cut because one of the objectives was to determine whether SDC could activate
chemoreceptors directly. Two experiments were performed in which the nerves were left
intact; results obtained were very similar to those from experiments in which the nerves
were cut. The discharges elicited by SDC were similar in time-course and magnitude and
a secondary response was sometimes obtained in both situations (Fig. 3). This secondary
effect was associated with high doses of SDC and was not very obvious with lower doses
nor with acetylcholine or sodium cyanide. It commenced about 20 sec after onset of the
primary response and lasted longer. In most instances the primary response had ter¬
minated before onset of the secondary discharge and only the primary response was com¬
puterized.
Other effects
Suberyldicholine has been advocated as a chemoreceptor stimulant partly because of







Kig. 3. Osmoreceptor activity evoked by SDC (50/<g) injected into the carotid perfusion circuit
at the arrow in two different experiments. A: ganglio glomerular nerves cut. B: ganglio- glomerular
nerves intact. The secondary responses, present in both A and B. are among the largest observed.
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tine becomes blocked on repeated administration. The ability to evoke consistent re¬
sponses with SDC is attributed to destruction of the drug by cholinestcrase (Anichkov
and Belf.n'kii, 1963; Dardymov and Gi:r, 1964). In the present study it was found that
doses of SDC could indeed be repeated frequently (20 /ig once every minute) without
tachyphylaxis. Nicotine, in doses evoking similar responses, generally but not invariably-
blocked the response on repeated administration.
Suberyldicholine when injected into the carotid perfusion circuit eventually reached the
systemic circulation where it caused sizable increases in blood pressure (Figs. 1 and 3).
Nicotine, in doses which evoked similar discharges, did not produce much alteration in
blood pressure. The extensive cardiovascular changes caused by SDC would be disadvan¬
tageous during experimental studies requiring constant blood pressure.
DISCUSSION
Results from the present electrophysiological investigation confirm the observations of
Anichkov and Bflen'kii (1963) and Dardymov and Ger (1964) that SDC is a potent che-
moreceptor stimulant. The possibility that the drug acts via the superior cervical ganglion
to increase chemoreceptor activity (Daly, 1954) was precluded by cutting the sympathetic
nerve supply to the carotid body. There was some delayed increase in chemoreceptor dis¬
charge, seen with higher doses of SDC, which did not appear to be entirely secondary to
ganglion stimulation because it was also obtained when the ganglion-glomerular nerves
were cut. This secondary response was readily distinguished from the primary response
because it was delayed in onset, of longer duration and generally much less intense. The
secondary response may be due to catecholamines, released from the adrenal medulla by
SDC, reaching the carotid body or to SDC acting within the carotid body to release endo¬
genous catecholamines. However, explanations such as recirculation of SDC could be
advanced; in most instances the primary response had terminated before onset of any
secondary effect and the cause of the secondary discharge was not investigated.
It was found that both mecamylamine and tubocurarine are capable of reducing the che¬
moreceptor response to SDC, while atropine had little effect except in high doses. The find¬
ings with mecamylamine are compatible with the report of Dardymov and Gi:r (1964)
that hexamethonium suppresses respiratory stimulation evoked by SDC acting via the caro¬
tid chemoreceptors. Nishi and Eyzaguirre (1970) reported that 10 mg atropine injected
into the carotid artery of the cat reduced the chemosensory response to acetylcholine with¬
out causing a local anaesthetic action. If we preclude a local anaesthetic action, the
reduced sensitivity to SDC following high doses of atropine in the present experiments
may have been due to a nicotinic-blocking action of atropine.
Anichkov and Bllln'kii (1963) have suggested that the sensory receptor in the carotid
body is more like the nicotinic receptor in ganglia than that at the neuromuscular junction.
The present findings support the conclusion that SDC acts at a nicotinic site within the
carotid body, but further quantitative pharmacology will be required to characterize the
receptor.
There was no evidence that SDC affected the baroreceptors directly, even when large
doses which evoked a maximal chemoreccptor response were injected into the carotid
bifurcation. This supports the observation of McQueen (1970). that in doses used to stimu¬
late chemoreceptors, the baroreceptors are not affected directly by SDC. The delayed in¬
crease in baroreceptor activity seen with high doses of SDC seemed to be attributable to
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the increase in sinus perfusion pressure. The increase in perfusion pressure might be due
to retrograde How from collaterals and/or constriction of vessels leaving the sinus. It might
be argued that cutting the ganglio-glomerular nerves affected the ability of SDC to in¬
fluence baroreceptor activity. This is not likely to be the case because the sympathetic
nerves have very little or no influence on baroreceptor activity (Floyd and Neil, 1952).
Anichkov and Belen'kii (1963) suggested that one of the advantages of SDC as com¬
pared with nicotine is its ability to evoke consistent chemoreceptor responses even when
injected at frequent intervals. In the present investigation the ability of SDC to evoke con¬
sistent responses when injected at frequent intervals was confirmed, but SDC causes siz¬
able cardiovascular changes which may be undesirable in certain situations. Suberyldicho-
linc. however, does not have much action in the central nervous system and in clinical use
as a respiratory stimulant (Anichkov and Belen'kii, 1963) the hypertensive effect may be
advantageous.
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summary
1. Conflicting qualitative evidence exists concerning the effects on
chemoreceptor activity of some drugs which influence the cholinergic
system. Quantitative evidence has been obtained in the present study
which should resolve the conflict.
2. Experiments were performed in pentobarbitone-anaesthetized cats
in which the activity of chemoreceptor units in the sinus nerve was used
to assess chemoreceptor reponses. The effects of drugs on responses to
I.A. ACh and NaCN were determined from dose-response data obtained
from several animals and expressed as mean dose ratios.
3. The chemoreceptor response to ACh was slightly inhibited by atro¬
pine, a- and /S-bungarotoxin and HC-3, almost completely suppressed by
mecamylamine, and markedly potentiated by physostigmine.
4. Concomitant responses to NaCN were unaffected by atropine,
/?-bungarotoxin, mecamylamine or physostigmine. There was a slight
inhibition following a-bungarotoxin and a potentiation after HC-3.
5. The results do not support the theory that ACh is an excitatory
sensory transmitter in the carotid body.
introduction
It has long been known that acetylcholine (ACh) stimulates the carotid
chemoreceptors (e.g. Cordier & Heymans, 1935; Heymans, Bouckaert,
Farber & Hsu, 1936; Anichkov & Belen'kii, 1963), and in 1938 Schweitzer
& Wright made the suggestion that drugs or changes in the blood which
stimulate the chemoreceptor nerve endings might produce their effects
by liberating ACh as the chemical intermediary. This possibility has since
been explored by many workers, but the evidence which has accumulated
concerning the role of ACh in chemoreceptor sensory transmission is
equivocal and controversial (see reviews by Douglas, 1954; Heymans,
17-2
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1955; Heymans & Neil, 1958; Anichkov & Belen'kii, 1963; Eyzaguirre &
Zapata, 1968a; Torrance, 1968; Biscoe, 1971; Howe & Neil, 1972).
Much of the controversy has centred around the conflicting results
obtained from experiments in which drugs were used tomodify the response
of the chemoreceptors to physiological and pharmacological stimuli.
Heymans & Neil (1958) expressed the opinion 'that ACh has nothing
whatever to do with the normal transmission of the chemoreceptor
impulses' and went on to add: 'The reasons for the conflict of evidence
concerning the effects of anticholinesterases and ganglioplegic drugs on the
activity and sensitivity of the glomus nerve endings to normal or pharma¬
cological stimuli require further clarification.'
From consideration of the literature it seemed probable that the conflict
resulted from conclusions being based on qualitative pharmacological data,
obtained from a variety of preparations, which being difficult to evaluate
have been liable to subjective interpretation according to whether the
evidence was intended to support or reject involvement of ACh in chemo-
sensory transmission. The purpose of the present study was to try to
resolve this conflict by using a preparation that provides a reliable indica¬
tor of chemosensory activity to determine objectively the effects of
cholinergic drugs on the chemoreceptors.
METHODS
Experiments were performed on cats of either sex weighing between 2-0 and 4-9 kg
(mean 2-9 kg).
Anaesthesia. The animals were anaesthetized with pentobarbitone sodium, 42
mg/kg i.p., supplemented approximately every 1-5-2 hr during the experiment by
10% of the initial dose administered i.v.
General. A cannula was inserted into the trachea low in the neck and both femoral
arteries were cannulated, one catheter being connected to a B.P. transducer (Bell
and Howell, 4—442) and the other used for withdrawing blood Bamples for gas
analysis. The signal from the transducer was displayed on a pen-recorder (Devices,
M4) and recorded on one channel of an FM tape recorder (Tandberg, 100; frequency
response d.c. to 1250 Hz).
A femoral vein was cannulated and used for drug administration. The lingual
artery on the same side as the sinus nerve from which recordings were obtained was
cannulated with a catheter (o.d. 0-75 mm) with the tip positioned in the common
carotid artery 2 cm caudal to the caiotid bifurcation and this position was confirmed
post mortem. In some experiments another catheter was similarly positioned in the
contralateial common carotid artery.
Respiration. The lungs were artificially ventilated with room air by a respiratory
pump (S.R.I.) operating at 18 or 25 (later experiments) rev/min. End-tidal CO,
was continually monitored by an infra-red CO, analyser (med 1A; Grubb Parsons)
and maintained at 5% by appropriate adjustment of the pump stroke volume.
Anoxic stimulation was achieved by replacing air with 100% N, as the ventilating
gas and allowing the animal to inhale this for 2 min before returning to air.
Blood from a femoral artery was withdrawn approximately every hour during the
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oxporiment and P,iCOl> P,,ot an<l pH estimated using a Radiometer gas monitor
(BMS3 with PHM71 meter). Plasma bicarbonate was maintained between 20 and
25 mM either by adjusting the stroke of the respiratory pump or by the i.v. injec¬
tion of molar sodium bicarbonate solution, the base deficit being calculated from the
nomogram of Singer & Hastings (1048). The bladder was drained at regular intervals
and rectal temperature maintained at 38 ± 0-5 °C.
Recording of sinus nerve activity. The sinus nerve was identified and sectioned
central to its junction with the glossopharyngeal nerve. Exposed tissues were
covered with warm (37 °C) mineral oil. Electrical activity from single or multiple
chemoreceptor emits was recorded from filaments of the peripheral nerve using
bipolar platinum-iridium electrodes. Sensory nerve discharges were amplified by an
a.c. amplifier (Neurolog, Digitimer), displayed on an oscilloscope (Tektronix, 6103N)
and recorded on one channel of the tape recorder.
Chemoreceptor units were identified by their random discharge (Eyzaguirre &
Lewin, 1961; Biscoe & Taylor, 1963) and their increase in discharge frequency
following injection of 5 fig NaCN into the ipsilateral common carotid artery. The
ganglioglomerular nerves (one to three sympathetic nerves from the superior cervical
ganglion to the carotid sinus region (Eyzaguirre & Lewin, 1961)) were cut as were
nerves which were found to course between the carotid sinus and the nodose ganglion
in some animals. The ganglioglomerular nerves were cut in order to eliminate reflex
effects of sympathetic activity on carotid nerve discharge (Floyd & Neil, 1952;
Eyzaguirre & Lewin, 1961). Results obtained from this preparation (Fig. 1) agree
with reports that chemoreceptor discharge is largely independent of blood pressure,
at least over the physiological range (Hornbein, Griffo & Roos, 1961; Biscoe, Purves
& Sampson, 1970; Acker, Keller, Lubbers, Bingmann, Schulze & Caspers, 1973).
Single units were identified from the constant shape and amplitude of the action
potential. In most of the multi-unit recordings it was found that a high dose of
stimulant evoked a maximum discharge (Xm^x c.p.s.) which remained fairly constant
during the course ofan experiment. Ifa unit was recruited, or another ceased respond¬
ing. ^m.,. changed and this provided a quick method for monitoring the units and
was used in conjunction with visual checking of the action potentials on the oscillo¬
scope. Analysis was performed only if the number of units being examined, usually
2-3, remained constant throughout the experiment.
Data analysis. The output of the tape channel containing the action potentials was
fed to a pulse height discriminator, the upper and lower levels at which the dis¬
criminator operated being indicated by Z axis modulation. The analogue output,
which had been stored for 1 sec, was fed to a digital voltmeter (Schlumberger, A210)
coupled to a data transfer unit (Schlumberger, 3240) which drove an Addo 5 punch.
Average discharge (x) in the pre-stimulus or 'control' period, generally 20 sec, was
computed (PDP-8 computer, Digital Equipment Corporation) from the punched
tape. The average and total counts (Fx) were calculated for each response after its
duration (t sec) had been determined from a histogram of the response, displayed by
the computer on an x-y plotter (Complot, Houston Instruments). Responses were
expressed as increments above the control level by subtracting the appropriate
values, i.e.:
Ax = x (response)—x (control),
AFx = Fx (response) — Fx (control),
where Fx (control) = x (control) x t (response duration, sec).
A 'response' was defined as being from the first substantial (i.e. 3 times or more)
increase above tho mean control discharge frequency until the discharge returned
to the pro-injection level. Beidlcr (1954) expressed chemosensory receptor activity
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in terms of the integrated neural response (Ex) and the same approach has been
advocated for arterial chemoreceptor studies by Paintal (1971) because Ex allows
for differences in response duration. Data were therefore expressed in terms of AEx,
and also Ax because previous workers have generally used the averaged discharge
when evaluating drug effects. Expressing the drug results in terms of both variables
made it possible to determine whether there was an appreciable difference in the
information they provided (see also McQueen, 1974).
Dose-^responae data. Axand AEx were plotted against the log10 dose of the stimulant.
A straight line was fitted to the points in the linear portion of the dose-response
curve using the method of least squares. The slope (m) and intercept (c) were calcu¬
lated for each line and from the equation for a straight line, y = mx + c, it was pos¬
sible to calculate the response (y) elicited by a dose of stimulant (x).
A response in the central region of the control or pre-drug dose-response line was
selected arbitrarily and the dose of stimulant required to match this response follow¬
ing drug administration was calculated from the post-drug dose-response line. The
ratio of the dose required after drug administration to that required in the control
state is the dose ratic and this provided an objective assessment of a drug's influence
on responses evoked by chemoreceptor stimulants. Dose ratios obtained from different
experiments were pooled and data presented as the mean ratio ± s.e. of mean. The
s.e. ofmean is given to provide an estimate of the scatter of individual ratios about
the mean value, although they are not necessarily normally distributed. Data for
each drug were obtained from several animals in order to provide an estimate of the
population response.
Gallamine. The animals were paralysed during the experiment with gallamine
(3 mg/kg x.v.), the dose being repeated as required, usually every 1-1-5 hr. This
neuromuscular blocking drug was given to prevent muscle contractions, either
spontaneous or caused by the close-arterial injections ofACh, from moving the nerve
on the recording electrodes, and also to suppress spontaneous respiratory movements
which are associated with fluctuations in end-tidal CO, and blood pressure.
Chemoreceptor discharge frequency obtained with the animal artificially venti¬
lated and paralysed (end-tidal CO, 5 %, P. COj about 34 mmHg) was very similar
to that observed when it was breathing spontaneously, and remained relatively
constant throughout the experiment - providing that the sympathetic nerve supply
to the carotid body was cut and that mean blood pressure did not fall below 50 mmHg
(see Fig. 3). Further, it was established that this dose of gallamine did not appre¬
ciably affect the response of the chemoreceptors to either ACh orNaCN (see Fig. 5).
Chemoreceptor stimulation. The effect of a chemoreceptor stimulant was determined
by injecting 0-1 ml. of the solution into the common carotid artery via the lingual
catheter and washing it in with 0-2 ml. Locke solution. Injections were made over
2 sec commencing at the peak of the inspiratory phase of the respiratory cycle and
were repeated every 5 min. Other drugs were injected i.v. or intra-carotid over 5-20
sec and 10min allowed before retosting the stimulants. The dead-space in the catheter
was 0-1 ml. and it was flushed with 0-2 ml. Locke solution between injections.
Drugs. Drugs were prepared in modified Locke solution (NaCl 6-0 g; KC1
0-42 g; CaCl, 0-24 g; Tris base C O g; n-HCI 39 ml.; distilled water to 1 1.; pH 7-41
at 37 °C). Doses referred to are those of the salts.
The drugs used in this investigation were: pentobarbitone sodium (Abbott
Laboratories), gallamine triethiodido (May & Baker), acetylcholine iodide, sodium
cyanide, atropine sulphate, physostigmine salicylate, carbamylcholino chloride
(carbachol) (all B.D.H.); hemicholinium-3 (Aldrich), inecainylamine HC1 (M.S.D.),
a-bungarotoxin and /?-bungarotoxin (Miami Serpentariuin Laboratories, Miami,
Florida, U.S.A.).
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RESULTS
Experiments were performed on forty-three cats from which a total
of sixty-nine recordings (seventeen single and fifty-two multiple units) of
chemoreceptor activity were obtained.
Chemoreceptor responses to ACh and Na-CN
In all the recordings ACh and NaCN were effective chemoreceptor
stimulants. The threshold dose for stimulation varied slightly from record¬
ing to recording, generally being about 0-5 fig NaCN or 5 fig ACh. Maxi¬
mum responses were evoked by 25-50 fig NaCN or 125-250 fig ACh,
again with variation from one recording to another. NaCN elicited re¬
sponses which had a longer latency to onset and lasted longer than
comparable responses (Ax) to ACh.
Vascular effects
The experiment shown in Fig. 1 illustrates that chemoreceptor activity
in this preparation was largely independent of blood pressure. A large
dose of ACh injected into the contralateral carotid artery caused a fall in
blood pressure of the same magnitude as that seen following ipsilateral
administration of the same dose, but without the chemoreceptor stimula¬
tion.
Since the chemoreceptor stimulants were not confined to the sinus region
it was necessary to determine what effects they might have on recircula¬
tion. Experiments were performed on eight cats in which maximal or near-
maximal doses of stimulant were injected into the contralateral carotid
artery and the effect on chemoreceptor activity in the ipsilateral sinus
nerve examined. It was found that these doses, which were higher than
those used in dose-response studies, had little or no effect on the ipsi¬
lateral carotid body chemoreceptors, as can be seen from Fig. 1.
Analysis of chemoreceptor responses
It had been established by previous work (Diamond, 1955; McQueen,
1974) that there is a linear relationship between the log10 dose of stimulant
and the chemoreceptor response over part of the dose-response curve.
This was confirmed during preliminary experiments in the present in¬
vestigation. However, the responses were rather scattered and fitting a
dose-response line to the data by eye was subjective and, therefore, un¬
satisfactory. The relationship seemed to be sigmoidal, but the error in¬
volved in making the standard pharmacological assumption that response
is linearly related to log dose over the central portion of the curve is
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Fig. 1. Chemoreceptor unit from an experiment in which the influence of
a high dose of stimulant on chemoreceptor activity in the contralateral
sinus nerve was examined. A, ipsilateral injection of 125 fig ACh. B, the
same dose administered on the contralateral side. Average spontaneous
discharge was 0-8 c.p.s. before and 1-6 c.p.s. during the 20-30 sec period
after injection of ACh. It can also be seen that hypotension did not appre¬
ciably affect chemoreceptor activity. Panels show from above downwards:
nerve action potentials, the lower level at which the pulse height discrimina¬
tor was operating being indicated by the brightening pulses; counter out¬
put in counts/sec, calibration on right of panel: 50 c.p.s.; B.P., calibration
on left of panel: 0-100-200 mmHg; 1 sec time marker; injection marker.
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likely to be negligible. Further experiments showed that dose-response
curves obtained from one or two units were qualitatively similar to those
obtained from multi-unit recordings (see Fig. 2).









Fig. 2. Doso-response data obtained from two experiments. A and B are
from the same recording, A being data from 2 units, B from 5 units. C is a
single chemoreceptor unit obtained in a different experiment. Responses are
plotted in this and subsequent figures (log10 scale) as Ax (•—•) and AZx
(x x ) against the dose of either ACh or NaCN and the linos fitted to
the points by eye.
To determine the constancy of the preparation's responsiveness during
the long experiments required for dose-response studies, doses of stimu¬
lants were administered at regular intervals over several hours in three
animals. Similar results were obtained, data from one of the experiments
being shown in Fig. 3. These data provided an estimate of the variation in
response to ACh and NaCN that might be expected during the long
periods required for dose-response studies since other variables had been
controlled as far as was possible and ACh, NaCN, gallamine and pento¬
barbitone had been administered, procedures which were to be common to
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all other experiments. A variation of this magnitude in the dose-response
ratio had to be accepted as inherent. The response to NaCN changed during
the experiment, there being more counts elicited as the experiment progres¬
sed such that the AZx dose ratio decreased. However, the increased counts
occurred over a longer time so that the Ax dose ratio was not affected.
6 7-5
1
10 100 1 10 100 10 100
10 100 1 10 100 1 10 100 1 10 100
NaCN(//g)
Fig. 3. Dose-responso data from a single unit showing the effects of re¬
peated doses of ACh and NaCN. Four doses of ACh and four ofNaCN were
injected in random order over a 45 min period, the sequence being per¬
formed six times during the course of a 9 hr recording. Gallamine was ad¬
ministered after each completed dose-response sequence - it was not present
during the first cycle. Data arc plotted as Ax (•—•) and A2Tx ( x x )
against the dose ofACh or NaCN and the straight lines fitted by the method
of least squares. The over-all mean spontaneous discharge, determined from
the 20 sec control periods prior to injecting stimulants, was 2-6 ± 0-2 c.p.s.,
the average for individual sequences being in the range 1-8-3-4 c.p.s. The
mean dose ratio (comparison against the first dose-response line) for ACh
(20 /rg) was 1-4 ± 0-2 (Ax) and 1-2 ± 0-1 (AZx). The corresponding ratios for
NaCN (4/ig) were 1-0 ±0-1 and 0-6 + 0-1.
Drug effects
Drugs affecting the cholinergic system were used in this study and in¬
cluded antagonists such as mecamylamine, atropine and a-bungarotoxin,
an anticholinesterase, and agents which interfere with the synthesis
(HC-3) or release (/?-bungarotoxin) of ACh. The results have been sum¬
marized in Fig. 5.
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Mecamylamine. Mecamylamine itself caused inhibition of spontaneous
activity lasting 10-15 sec which was followed by a slight increase in the
discharge frequency, activity returning to control levels after about 30 sec.
The lowest dose investigated was 0-1 mg/kg i.a. which gave dose ratios
of 10 (Ax) and 4-2 (AZx) for ACh and 0-6 (Ax) and 0-5 (A2x) for NaCN,
the reduction in response to ACh lasting for about 1-5 hr. In the remaining
experiments mecamylamine was used at a dose of 1 mg/kg i.a. with, in
some experiments, an additional 5 mg/kg i.a. administered later in the
experiment.
Responses to ACh were blocked or substantially reduced by 1 mg/kg, it
being impossible to determine the dose ratio since massive doses of ACh
would have been required to overcome the inhibition and such doses
(greater than 5 mg ACh i.a.) were not used since they would have
caused substantial secondary effects. The ratio was therefore expressed
as being >10.
Whilst the response to ACh remained depressed for several hours,
that to NaCN was not appreciably affected by mecamylamine (see Fig. 5).
Even extremely high doses (up to 5 mg/kg i.a.), in excess of those reported
by Nishi & Eyzaguirre (1971) as being capable of inhibiting the response
to NaCN, had very little effect on the response to NaCN (see Fig. 4) even
though tested over several hours.
A final attempt was made to inhibit the response to NaCN by injecting
atropine (2 mg/kg) into the carotid artery about 1 hr after mecamylamine
(5 mg/kg) had been given i.a. Nishi & Eyzaguirre (1971) described how in
those chemoreceptor units in which the response to NaCN was not blocked
by hexamethonium it was always depressed by injecting atropine (4mg i.a.,
total dose). However, the results from the present experiments (see Figs. 4
and 5) showed only a slight inhibition of the cyanide effect, the response to
ACh remaining inhibited by mecamylamine, and that to anoxic stimulation
also being unaffected by the combination of mecamylamine and atropine.
The results show that mecamylamine, while reducing or abolishing the
stimulation action of ACh on carotid chemoreceptor activity, had little or
no effect on the response of these receptors to NaCN or anoxia.
Bungaroloxins. The response of chemoreceptors to ACh was reduced,
although somewhat variably, by a-bungarotoxin (0-25 mg/kg i.a.). The
reduction was not as great as that observed following mecamylamine
(0-1 mg/kg i.a.). The response to NaCN was slightly inhibited, again with
some variation from one experiment to another.
Responses to ACh and NaCN were examined before and after ad¬
ministering 13-bungarotoxin (0-5 mg/kg). When the toxin had been present
for 3 hr an additional dose of 0-5 mg/kg was injected i.a., and the animal
was then subjected to anoxia for three 2 min periods over the course of
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20 min. Nitrogen breathing evoked substantial and sustained increases
in chemoreceptor activity. During the following 4 hr the anoxic stimulus
was repeated from time to time, as were the chemical stimuli. The chemo-
receptors were stimulated strongly over the course of several hours




















Ui ' i u
0 5 2-5 10
1 5
NaCN(//g)
Fig. 4. Single cliemoreceptor unit from an experiment in which the in¬
fluence of high doses of mecamylamine and atropine on responses to ACh
and NaCN was investigated. A shows the control response to ACh 250 fig
and NaCN 5 //g, B the response to the same doses following mecamylamine
(5 mg/kg i.a.) and C the response after the addition of atropine, 2 mg/kg
r.A. Record details as for Fig. 1. The lower part of the figure shows the dose-
response lines for NaCN, the details being the same as in Fig. 3.
transmission takes some time to occur and develops faster if the prepara¬
tion is stimulated at a fairly high frequency (Chang, Chen & Lee, 1973).
The results obtained showed little or no change in the response of the
receptors to either ACh or NaCN, and although there may be a slight
inhibition of the ACh response, this was not intensified by the additional
dose of /?-bungarotoxin (see Fig. 5).
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Hemicholinium-3 (HC-3). The effects of doses of 2 mg/kg x.v. (similar to
that used by Eyzaguirre & Nishi, 1974) and 2 mg/kg i.a. were studied.
Following administration of HC-3 the animals were made anoxic for
three 2 min periods over the course of 20 min before testing the effects of
ACh and NaCN. The responses to ACh were not obviously affected, while
those to NaCN were found to be potentiated. Repeated anoxic stimuli
did not alter either the response to anoxia or that to NaCN, even when
continued for up to 5 hr after the i.a. dose of HC-3.
Additional data were obtained from four experiments in which a higher
dose of 4 mg/kg was given i.a. In two of these animals a-bungarotoxin
had previously been administered. Mean dose ratios of > 10 (Ax) and
1-8+ 1-1 (AEx) for ACh and 0-1 + 0-05 (Ax) and 0-5 ± O-l(AZx) for NaCN
were obtained. However, at this dose the blood pressure was very low
and spontaneous chemoreceptor activity had increased such that it be¬
came difficult to compare responses before and after HC-3 and the data
were not included in the results shown in Fig. 5. This inhibition of the
ACh response may well have been due to a blocking action of high doses
of HC-3 at the cholinergic receptor site (Martin & Orkand, 1961).
The results indicate that neither the response to NaCN or that to
anoxia is depressed by HC-3, and indeed the response to NaCN is aug¬
mented.
Atropine. The effect of 1 mg/kg i.v. was investigated because it was
intended to use this dose in experiments involving physostigmine -
atropine would prevent excessive muscarinic actions, particularly hypo¬
tension, following ACh administration. Experiments were performed in
which the 1 mg/kg i.v. dose was given and dose ratios determined for ACh
and NaCN. Then an additional dose of 1 mg/kg was administered, this
time close-arterial to the carotid body, and the dose ratios determined
again. The results obtained (see Fig. 5) were rather variable, the overall
pattern being a slight depression of the ACh response and no change or
slight inhibition of the NaCN response.
Physostigmine (Eserine). The influence of physostigmine on the respon¬
ses to ACh and NaCN was examined in atropinized cats (1 mg/kg i.v.).
An initial dose of 0-2 mg/kg potentiated the response to ACh but not
that to NaCN (see Fig. 5). An additional dose of 1 mg/kg i.a. further
augmented the response to ACh, while that to NaCN remained more or
less unaltered (see Fig. 5). The response to anoxia was not obviously
affected by physostigmine, nor was the spontaneous discharge altered.
During three experiments the effect of carbachol, a cholinergic an¬
tagonist not destroyed by cholinesterase, was determined before and after
physostigmine. The mean dose ratios obtained were 1-0 + 0-05 (Ax) and
1-2 + 0-2 (AZx) for the 0-2 mg, and 1-7 + 0*6 (Ax) and 1-9 + 0-4 (AZx) for
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the 1 mg/kg dose of physostigmine. This implies that physostigmine
potentiated ACh by inactivating cholinesterase and not by some non¬
specific action.
>10 >10
Drug: Gallamine Atropine Mecamylamine a- /f-Bungarotoxin hc-3 Physostigmine
Dose:
+Atropine
30 10 10 1 0 5 0 50+ 025 0-5 +0-5 20 20 0-2 +10
(mg/kg) 20
Route: I.V. I.V. I .A. I .A. I.A. I .A. I.A. I.A. I.A. I.V. I.A. I.A. l-A.
n: 7 5 4 4 3 3 4 2 2 3 4 4 4
Fig. 5. Summary of the dose ratio data. The upper histogram gives the
dose ratios + s.e. of mean based on Ax and the lower histogram the ratios
based on AEx. Open rectangles are the ratios for ACh, the shaded rectangles
the ratios for NaCN. The dashed line indicates the dose ratio of 1.
DISCUSSION
This study shows that drugs which affect the response of carotid
chemoreceptors to ACh have little or no effect on the sensitivity of these
receptors to NaCN or anoxia. The results are derived from a quantitative
pharmacological investigation of drug effects on chemoreceptor activity
and should be more reliable than those based on qualitative or semi¬
quantitative data. The extent to which this view is justified will be con¬
sidered before discussing individual drug results.
Ewhmtion of drug effects
Electrical activity recorded from chemoreceptor units provides a more
reliable indicator of chemosensory activity than do reflex changes, such
as studied by Schweitzer & Wright (1938) and Byck (1961), because there
are fewer secondary factors liable to influence the primary response and
subtle changes can be detected. Single units were recorded in the present
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investigation as were multiple units. There was no appreciable difference
in the dose ratio data obtained by selectively counting single and multiple
units (up to 6) in the same recording. This implies that the response of the
population recorded is homogenous. Paintal (19C7) found a difference
between fast- and slow-conducting aortic chemoreceptor fibres in their
responsiveness to ACh, the fast fibres being much less sensitive. The situa¬
tion seems to be different in the sinus nerve where both types of fibre are
sensitive to ACh and NaCN, the fast-conducting being slightly more
sensitive (Sato, Fidone & Eyzaguirre, 1968; Fidone & Sato, 1969).
Chemoreceptor stimulants evoke variable responses and this presents
problems when evaluating drug effects. If the variability resulted from
secondary changes it should have been possible to minimize it by con¬
trolling these variables. However, even when secondary influences were
controlled as far as was possible, some variation in response still occurred
(see Fig. 3). The majority of authors who have performed drug studies on
chemoreceptors support their conclusions by illustrating the response
elicited by a particular dose of stimulant before and after administration
of the drug being examined. The conclusions resulting from such single-
dose studies may well be appropriate, but in view of the variability of
chemoreceptor responses it would seem essential to provide quantitative
data as supporting evidence rather than to show 'typical' responses. Dose
ratios provide an objective estimate of a drug's effect on chemoreceptor
activity.
Drug effects
Both ACh and NaCN were studied because they are classical stimulants
around which much of the controversy concerning the ability of choliner¬
gic drugs to influence chemoreceptor activity has revolved. Anoxia was
also used and it provides a more physiological stimulus; the receptor's
sensitivity to anoxia under the conditions in these experiments is akin to
its sensitivity to NaCN. However, the response it evoked is gradual in
onset with a long time course of action and is difficult to compare directly
with the intense short-lasting responses evoked by ACh or NaCN.
Nicotinic antagonists
Probably the most controversial aspect of chemoreceptor pharmacology
has been the conflicting evidence obtained from experiments involving
ganglion blocking drugs. Some authors found that responses to ACh and
NaCN (or hypoxia) were depressed by these agents (Landgren, Liljestrand
& Zotterman, 1952; Joels & Neil, 1962; Nishi & Eyzaguirre, 1971;
Eyzaguirre & Nishi, 1974) while others reported that although the response
to ACh was depressed, that to NaCN or hypoxia was not (Moe, Capo &
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Peralta, 1948; Douglas, 1952; Dontas & Nickerson, 1956; Anichkov &
Belen'kii, 1963; Sampson, 1971). Tetraethylammonium (TEA) and hexa-
methonium were employed in the earlier studies while mecamylamine,
which more readily penetrates membranes (Eyzaguirre & Zapata, 19685),
was used in the present experiments.
Mecamylamine completely inhibited the response to ACh without
having much effect on the response to NaCN or anoxia even when high
doses were used and several hours allowed for the antagonist to act (see
Fig. 4). This finding is in agreement with the reports cited above that the
chemoreceptor response to NaCN is not appreciably affected by ganglion
blocking drugs. The argument of Moe et al. (1948) and Nishi & Eyzaguirre
(1971) that the cyanide response is not depressed because the ganglion
blocking drugs fails to reach an effective concentration at some 'intrinsic'
site is not supported by the present results, and has previously been
refuted by Gray & Diamond (1957).
There is a period of 1-2 min following the i.a. injection of high con¬
centrations of drugs such as mecamylamine and atropine when the chemo-
receptors do not respond to ACh, NaCN or anoxia. Nishi & Eyzaguirre
(1970) also noted this and although they established it is not due to local
anaesthesia, it seems unlikely that this short-lasting inhibition is a specific
antagonism ofendogenous ACh. It is probably a non-specific consequence of
administering high concentrations of salts close-arterial to the carotid body.
The available evidence suggested that the action of oc-bungarotoxin on
cholinergic nerves is confined to the motor nerve of skeletal muscle (Chang
& Lee, 1963). However, it was considered worth investigating the action
of this substance on the chemoreceptor cholinergic receptor because d-
tubocurarine is effective at this site and a-bungarotoxin appears to act at
the same site as d-tubocurarine at the neuromuscular junction (Simpson,
1974). a-Bungarotoxin inhibited the response to ACh to about the same
extent as did atropine. The inhibition was slight when compared with that
caused by mecamylamine, and further studies are needed to establish
whether the toxin is active at the same site as mecamylamine, or whether
it acts elsewhere to reduce the response to ACh and, to a lesser extent, that
to NaCN.
Muscarinic antagonist
Although it is generally agreed that the cholinergic receptor site in the
carotid body is nicotinic (see Anichkov & Belen'kii, 1963), there are
reports that atropine is effective in reducing chemoreceptor sensitivity to
ACh and NaCN (Liljestrand, 1951; Landgren et al. 1952; Eyzaguirre &
Nishi, 1974). This could be taken to imply that part of the response to
ACh is mediated by muscarinic receptors, although it is more likely to be
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a consequence of local anaesthesia (Heymans, Delaunois, Martini &
Janssen, 1953) or antagonism at a nicotinic receptor site (Nishi & Eyza-
guirre, 1971; McQueen, 1974). The results obtained showed atropine
slightly inhibited the response to ACh, and to a lesser extent, that to NaCN.
It is not known whether the inhibition observed was due to effects on
nicotinic receptors or to some other action of atropine.
HC-3 and ft-bungarotoxin
HC-3 has been used by Eyzaguirre and co-workers (Eyzaguirre &
Zapata, 19686; Nishi & Eyzaguirre, 1971; Eyzaguirre & Nishi, 1974) to
prevent the synthesis to ACh in the carotid body. They found that
treatment with HC-3 followed by periods of hypoxia (to deplete the
stores ofACh) resulted in a diminished response to NaCN without affecting
the response to ACh. In the present experiments the response to NaCN
was depressed, sometimes markedly, as shown by Ax dose ratio data
(Fig. 5). At first sight this agrees with Nishi & Eyzaguirre's findings.
However, if the AEx ratio is considered, it can be seen that the response
was slightly potentiated. The explanation for the difference between ratios
is that the integrated response was greater but spread over a longer
time, so that although the AZx ratio decreased, the Ax ratio increased.
Intra-arterial HC-3 further augmented the response to NaCN, both
variables giving similar dose ratios.
The potentiation of the NaCN response by HC-3, and also by low doses
of mecamylamine, could mean that the cyanide response is normally
partially suppressed by a cholinergic mechanism. This is, however, only
speculation since the cause of the potentiation following administration
of these drugs has not been determined.
ft-Bungarotoxin acts at the neuromuscular junction presynaptically and
prevents the release of ACh (Chang et al. 1973). If it acts in a similar way
at the chemoreceptor it would be expected that any stimulant which acts
by releasing endogenous ACh would be rendered ineffective. The response
to exogenous ACh should not be affected since there is no evidence of post¬
synaptic receptor blockade (Simpson, 1974). In the doses used in the
chemoreceptor experiments /?-bungarotoxin did not affect the cyanide
response. The negative result could mean that activity evoked by NaCN
is not dependent on ACh, but this would be the case only if /?-bungaro-
toxin at the dose level studied can be shown to be effective in preventing
the release of ACh in the carotid body. Further studies are required.
Anticholinesterases
The possibility that ACh might be involved in physiological transmission
at chemoreceptors was raised by Schweitzer & Wright (1938) because of
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the similar respiratory effects evoked by neostigmine and ACh. Others
found the response to hypoxia was potentiated by physostigmine (Lilje-
strand, 1951; Landgren et al. 1952) whereas Heymans, Bouckaert and
Pannier (1944) concluded from experiments in dogs that although the
response to ACh was potentiated, that to other stimulants was not.
Present results demonstrate that the response to exogenous ACh is poten¬
tiated by physostigmine while that to NaCN is definitely not influenced.
Both acetylcholinesterase and pseudocholinesterase are located in the cat
carotid body (Biscoe & Silver, 1966).
In conclusion, the increased chemoreceptor activity evoked by NaCN
was not affected by either atropine, mecamylamine or physostigmine in
the doses used, but was augmented by HC-3. Responses to ACh were quite
clearly inhibited by mecamylamine and potentiated by physostigmine,
this being in accord with the consensus in the literature. The thesis of
this study is that conflicting evidence concerning the actions of cholinergic
drugs on the chemoreceptors arises from subjective interpretation of
qualitative data. Since conclusions reached in the present work are based
on objective evidence obtained from quantitative pharmacological data,
they should help to resolve the conflict of evidence referred to by Heymans
& Neil (1958).
Cholinergic theory of chemosensory transmission
It should be appreciated that it was not the intention to investigate the
mechanism whereby ACh, NaCN, or anoxia excite chemosensory nerves.
However, the results obtained make it extremely unlikely that endogenous
ACh is involved as an intermediary in the chemoreceptor response to
NaCN and, therefore, do not support the theory that ACh is an excitatory
sensory transmitter in the carotid body. Some of the most persuasive
evidence in favour of the cholinergic theory has come from pharma¬
cological studies on isolated carotid bodies in vitro (Eyzaguirre & Zapata,
19685), but unfortunately direct comparison of this with evidence from
the present experiments is not feasible because of the completely different
experimental conditions.
The author gratefully acknowledges the financial support of the Medical Research
Council, the technical assistance of C. Calder and I. Maben, and Dr K. M. Spyer's
helpful comments on the manuscript.
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The effect of a-flupenthixol on the response of carotid chemo-
receptors to acetylcholine, sodium cyanide and dopamine in the cat
By R. J. Docherty and D. S. McQueen. Department of Pharmacology,
University of Edinburgh, Edinburgh EH8 9JZ
Dopamine (DA) may modulate sensory activity of cat carotid chemo-
receptors (Zapata, 1975; Osborne & Butler, 1975). If the theory advanced
















Fig. 1. Response of a chemoreceptor unit before (mean spontaneous dis¬
charge 2-8 + 0-1 c.p.s.) and after (2-7 + 0-1 c.p.s.) a-flupenthixol. Panels
show: action potentials; counter output; B.P.; 1 sec and injection markers.
suppressed by the continuous release ofDA, then block of the DA receptor
should substantially increase spontaneous chemoreceptor activity and
also, according to the theory, markedly reduce the response to ACh. We
used a-flupenthixol, a potent inhibitor of DA in the c.n.s. (Iversen, 1975)
to block the inhibitory effect of DA.
Experiments were performed on eight pentobarbitone-anaesthetized
cats in which ganglio-glomerular nerves were cut, the animals were
[P.T.O.
2
artificially ventilated and a gallamine (3 mg/kg) administered. Chemo-
receptor activity was recorded from the peripheral end of a sectioned sinus
nerve and stimulants injected into the ipsilateral carotid artery. The
results showed that a-fiupenthixol (0-2 mg/kg i.a.) abolished the inhibitory
effect of DA while the response to NaCN was augmented and that to
ACh slightly reduced. (Fig. 1).
Providing that exogenous DA is acting at the same site(s) as endogenous
DA, the results suggest that while there may be some tonic inhibition of
sensory activity by DA, this is not substantial. It is also unlikely that
ACh or NaCN act to any appreciable extent by inhibiting DA release.
This work was supported by an M.R.C. project grant.
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Inhibitory effects of acetylcholine and dopamine on rabbit carotid chemo-
receptors
By R. J. Docherty and D. S. McQueen. Department of Pharmacology, University
of Edinburgh, 1 George Square, Edinburgh EJ18 9JZ
During experiments in pentobarbitone-anaesthetized rabbits we observed that
intracarotid (i.e.) injection of acetylcholine (ACh, 5-250 fig) caused an immediate
Fig. i. ltocording of chomoreceptor activity obtained from a rabbit, illustrating
responses to ACh, DA and NaCN. Panels show: action potentials, B.p.; 1 sec and
injection markers.
inhibition of respiration, whereas NaCN (1-25 fig i.e.) markedly stimulated respira¬
tion. Cutting the ipsilateral sinus nerve abolished the response to NaCN and greatly
reduced the inhibitory action of ACh. The possibility that ACh was inhibiting chemo-




ACh (5-250 fig i.e.) caused a dose-dependent inhibition of discharge (Fig. 1). With
doses greater than 100 fig the inhibition was preceded by a slight transient increase in
discharge. Atropine (1-5 mg/kg i.v.) slightly reduced the response to ACh. Dopamine
(DA, 10 /ig i.e.) also inhibited chemoreceptor activity. To determine whether the
ACh-induced inhibition was secondary to DA release, we administered the DA
antagonist a-flupenthixol (0-25-0-5mg/kg i.v.). DA-induced inhibitionwas abolished,
whereas that caused by ACh was only slightly reduced.
In contrast to other species where ACh increases chemosensory activity, and has
been proposed as an excitatory transmitter (see review by Biscoe, 1971), our evi¬
dence shows that ACh has an inhibitory effect on rabbit chemoreceptors, implying
that endogenous ACh is unlikely to be an excitatory transmitter in this species.
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INHIBITORY ACTION OF DOPAMINE ON CAT
CAROTID CHEMORECEPTORS
By R. J. DOCHERTY and D. S. McQUEEN
From tfie Department of Pharmacology, University of Edinburgh,
1, George Square, Edinburgh EHS 9JZ
[Received 8 September 1977)
summary
1. The influence of some drugs which affect the dopaminergic system was studied
on chemosensory responses to dopamine (DA), acetylcholine (ACh), sodium cyanide
(NaCN) and hypoxia during experiments on pentobarbitone anaesthetized cats in
which chemoreceptor activity was recorded from the peripheral end of a sectioned
sinus nerve.
2. Spontaneous chemosensory activity was inhibited in a dose-dependent manner
by DA (0-5-5 pg, i.a.). Higher doses (10-50 pg) caused a delayed increase in discharge
and were associated with inconsistent inhibitory responses.
3. The DA antagonist a-flupenthixol (0-2 mg/kg, i.a.) blocked the inhibitory
response to DA without affecting either the spontaneous discharge frequency or the
response to ACh. The effect of NaCN was potentiated, and during hypoxia chemo¬
receptor activity increased more rapidly, although the maximum frequency attained
was not appreciably different from control values. Similar results were obtained with
haloperidol (0-5 and 1-0 mg/kg, i.v.).
4. Higher doses of a-flupenthixol (0-5-1-0 mg/kg, i.a.) increased spontaneous
chemoreceptor activity, but this was regarded as a non-specific effect of the drug
since at these doses the inhibitory effect of 5-hydroxytryptamine (5-HT) was also
abolished.
5. The animals were exposed to alternate periods of hypoxia and hyperoxia
following administration of the tyrosine hydroxylase inhibitor a-methyl p-tyrosine
(AMPT, 0-2-10 mg/kg, i.a.). The inhibitory response previously evoked by amphet¬
amine was abolished, and electron microscopic studies showed a great reduction in
the number of dense-cored granules, both of which suggested that DA levels in the
carotid body had been substantially reduced. Responses to NaCN and hypoxia were
slightly potentiated following AMPT, but neither spontaneous activity nor the
response to ACh was affected.
G. Apomorphine (0-05-0-2 mg/kg, i.a.) inhibited the chemoreceptor discharge for
up to 45 min, an effect which was antagonized by a-flupenthixol (0-2 mg/kg, I.a.),
implying it resulted from DA receptor stimulation. Although responses to NaCN,
hypoxia and higher doses of ACh were reduced following administration of apo¬
morphine, the reduction was not very marked.
7. These results are not compatible with the theory of Osborne & Butler (1975),
that in normoxia DA is tonically released in the carotid body and suppresses spon¬
taneous chemosensory activity.
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8. It is concluded that DA modulates chemosensory activity by influencing the
rate of increase in discharge, without affecting maximum discharge frequency. The
mechanism whereby DA is released in response to increased chemosensory activity
remains to be established.
INTRODUCTION
A new theory of carotid body chemoreceptor activity has recently been advanced
(Butler & Osborne, 1975; Osborne & Butler, 1975). This proposes that in normoxic
conditions dopamine (DA), which is known to be present in the cat carotid body
(Chiocchio, Biscardi & Tramazzani, 1966; Zapata, Hess, Bliss & Eyzaguirre, 1969),
is tonically released from Type 1 cells and suppresses the spontaneous discharge of
afferent nerve endings; in hypoxic conditions DA release is attenuated and conse¬
quently afferent nerve activity increases.
The present pharmacological study was undertaken to test this theory by investi¬
gating the response of cat carotid chemoreceptors to acetylcholine (ACh), sodium
cyanide (NaCN), DA, and hypoxia, before and after administering drugs which
influence the dopaminergic system. A preliminary report on some of the results has
been made to the Physiological Society (Docherty & McQueen, 1977).
METHODS
The experimental details have previously been described fully (McQueen, 1977) and only a
brief summary follows. Experiments were performed on cats of either sex weighing between
2-0 and 4-4 kg (mean weight 2-9 kg) which were anaesthetized with sodium pentobarbitone
(42 mg/kg, I.P.), supplemented approximately every 1-5-2 hr during the experiment by 10%
of the initial dose administered i.v. Blood pressure was recorded from a femoral artery, the
bladder drained at regular intervals and the rectal temperature maintained at 38 ± 0-5 °C.
A sinus nerve was cut centrally and electrical activity from single or multiple chemoreceptor
imits was recorded from filaments of the peripheral nerve. The ganglioglomerular nerves were
cut in order to eliminate the influence on chemoreceptor discharge of reflex changes in sympa¬
thetic nerve activity (Floyd & Neil, 1952; Eyzaguirre & Lewin, 1961). The animals were artifici¬
ally ventilated either with air, 5% 02 in 95% N, (hypoxic stimulus), or 100% Ot (hyperoxia).
They were paralysed by gallamine triethiodide (3 mg/kg i.v.).
Drug solutions (0.1 ml.) were injected into the common carotid artery ipsilateral to the sinus
nerve from which activity was being recorded and washed in with 0-2 ml. modified Locke
solution which had been bubbled with 5 % C02 in air in a water-batli at 37 °C (solution Pco,
32 mmHg; Pot 132 mmHg; pH7-0). Injections were made over a 2 sec period commencing at the
peak of the inspiratory phase of the respiratory cycle.
Nerve activity was recorded on magnetic tape (d.c. to 1250 Hz) and subsequently analysed to
provide data concerning the change in integrated discharge (ASa:) following drug administra¬
tion. Responses were plotted against log10 dose and straight lines fitted by the method of least-
squares to data obtained before and after the test procedures. A response in tho central region
of the control dose-response line was selected arbitrarily and the dose of stimulant required to
match this response following drug administration was calculated from tho post-drug dose-
response line. The ratio of the dose required after drug administration to that required in the
control state is the dose ratio. Dose ratios obtained from different experiments were pooled and
data presented as the mean dose ratio ± s.E. of mean. These ratios provided a quantitative
estimate of the effect of a drug on chemoreceptor responses to ACh and NaCN. Control values
were determined by calculating the average discharge in tho 20 see period preceding the test
stimulus. All the individual values were pooled to provide a mean control + s.e. of the mean for
spontaneous chemoreceptor activity which could be compared with that obtained following
administration of one of the drugs being studied. Inhibitory responses were calculated by
determining the integrated discharge (Z.r) observed during the response period (t see), defined
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as the time from onset of inhibition until return to control average discharge (x c.p.s.). The
inhibition was then expressed as:
— AEx = E,x — (x.t).
Drugs. Drugs were prepared in modified Locke solution (NaCl 6-0 g; KC1 0-42 g; CaCl„
0-24 g; Tris base, 6-0 g; normal HC1 39 ml.; distilled water to 1 1.) excepting a-flupenthixol and
a-methyl-p-tyrosine which were dissolved in 0-9% aqueous sodium chloride, and haloperidol
which was dissolved in 1 % aqueous tartaric acid.
The drugs used were: sodium pentobarbitone (Abbott Laboratories), gallamine triethiodide
(May & Baker), acetylcholine iodide, sodium cyanide (B.D.H.), dopamine hydrochloride (Koch
Light), a(cis)-flupenthixoI dihydrochloride (Lundbeck & Co.), apomorphine hydrochloride
(Macfarlan Smith), haloperidol (Janssen), 5-hydroxytryptamine creatinine sulphate, d-amphet-
amine sulphate (Sigma), dl-a-methyl-p-tyrosine (Labkemi A.B.).
Fig. 1. Dose-response lines showing the inhibitory effect of low doses of DA (plotted on
a log10 scale) on a single chemoreceptor unit before (0—0) and after ( x x ) ad¬
ministering a-flupenthixol (0-2 mg/kg, i.a.). The average spontaneous discharge was
2-5 + 0-3 c.p.s. before and 2-8 + 0-3 c.p.s. after a-flupenthixol. Straight lines were fitted
to the data by the method of least-squares.
results
Experiments were performed on fifteen cats from which a total of seventeen re¬
cordings (eight single, nine multiple units) of chemoreceptor activity were obtained.
Dopamine
DA reduced spontaneous discharge frequency in allfifteen experiments, the magni¬
tude of the inhibition being dose-dependent over the range 0-5-5 fig i.a. (see Fig. 1)
and the effect lasting for 5-45 see; Higher doses (10-50 fig i.a.) caused a delayed or
secondary increase in discharge which curtailed the primary inhibition and gave
inconsistent responses. A secondary increase in chemoreceptor discharge was also
observed by Zapata (1975) in his experiments with DA on the carotid body in vitro,
so it was unlikely that this delayed effect was attributable to vascular changes. Zapata
also reported that frequent administration of DA (dose unspecified) caused inhibitory
responses' to be converted to biphasic responses. In view of his findings and our
observations with high doses of DA, we confined our studies to low doses of DA
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administered infrequently and obtained consistent responses to both DA and the
chemoreceptor stimulants.
Early in experiments ungassed Locke solution caused a very slight inhibition of
spontaneous chemoreceptor activity, but later it caused an inhibition similar to that
evoked by low doses of DA. It was therefore necessary to use Locke solution which
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Fig. 2. Responses of a single clienioreceptor unit to DA and to 5-HT before and
after a-flupenthixol. A, control, li, after 0 05 mg/kg oc-flupenthixol, I.A. and C, after
an additional 0-5 mg/kg. D shows the effect of 0-3 ml. Locke solution, i.a. Injection
periods are represented by the horizontal bar below each panel and 1 sec timing
marks are shown below D.
had been bubbled with 5% C02 in air to wash in drug solutions (the gassed solu¬
tion did not cause any appreciable inhibition, even during long experiments; see
Fig. 2). There was a slight increase in mean li.r. which commenced about 10 sec after
an i.a. injection of high doses of DA ( > 10 //g). With lower doses there was no obvious
change in mean n.r.
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a.-Flupenthixol
a-Flupenthixol is a potent DA antagonist (Moller Nielsen, Pedersen, Nymark,
Franck, Boeck, Fjalland & Christensen, 1973; Miller, Horn & Iversen, 1974) which
acts post-synaptically (House & Ginsborg, 1976) and has very little anticholinergic
activity (Iversen, 1975). We used it to reduce the inhibitory action of DA and, while
responses to DA were suppressed, investigated the effects of ACh, NaCN and hypoxia.
Dose ratios showing the influence of a-flupenthixol on the responses were calculated
from the central region of ASx dose-response lines and the results obtained from
ten experiments are summarized in Fig. 3. Responses to DA could not be expressed
in the same way because after a-flupenthixol the slope of the DA dose-response line
became negative, reflecting the tendency for DA to evoke excitatory responses under
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Fig. 3. Pooled dose ratio data showing the effect of various doses of a-flupenthixol on
cliemoreceptor responses to ACh and NaCN. Data are presented as mean dose ratios
+ s.E. of the mean, and the dashed line represents a dose ratio of 1.
Low doses of a-flupenthixol (0-05 mg/kg, i.a.) reduced the inhibitory act ion of DA
and showed up a small delayed increase in discharge (see Fig. 2), without appreciably
affecting either spontaneous chemoreceptor activity or the responses to ACh and
NaCN (Figs. 2 and 3). A dose of 0-2 mg/kg, i.a. abolished the inhibitory effect of DA
(see Fig. 1), potentiated the response to NaCN, and was without much effect on the
spontaneous discharge frequency or the response to ACh. Higher doses of antagonist
(0-5 or 1-0 mg/kg, i.a., additional to 0-05 and 0-2 mg/kg respectively) resulted in
DA causing a brief period of excitation, and whereas responses to NaCN were still
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potentiated, those to ACh were slightly inhibited. There was also a tendency for
spontaneous activity to increase, particularly after the 1 mg/kg dose.
Following administration of a-flupenthixol the rate of increase of chemoreceptor
discharge during hypoxia was much greater than in the control, although the
maximum frequency reached was not appreciably different in the two states (see
Fig. 42?).
It has been reported that besides inhibiting the depressive action of DA in the
c.n.s., a-flupenthixol also antagonizes the depressive effect of 5-HT, being only
slightly more selective against DA (Straughan & Dray, 1976). Accordingly, in the
present study responses to both DA and 5-HT were obtained before and after ad¬
ministering a-flupenthixol so that the specificity of the antagonist on chemosensory
responses could be assessed. 5-HT caused a slight increase in discharge on injection
followed by a period of inhibition similar to that evoked by DA (see also Nishi,
1975). There was a tendency for low doses of a-flupenthixol to reduce the excitatory
action of 5-HT, although this was not consistent. The inhibitory effect was not
affected until doses of 0-5 mg/kg or more were used, when the response was abolished
(Fig. 2).This findingmeant that results obtained following high dosesof a-flupenthixol
(^ 0-5 mg/kg, i.a.) had to be interpreted cautiously because the drug was evidently
no longer acting selectively.
The dopamine antagonist haloperidol in cumulative doses of 0-2, 0-5 and TO mg/kg,
I.v. was studied in one experiment and the results obtained were similar to those
obtained with a-flupenthixol. The lowest dose was without much effect, but the
higher two reduced, but did not abolish, the inhibitory action ofDA while potentia¬
ting the response to NaCN and inhibiting that to ACh. Spontaneous discharge
frequency was 2.1 + 0-2 c.p.s. before and 3-1+0-4 after 0-5 mg/kg, and 2-1 ±0-3
c.p.s. after the additional 1 mg/kg dose of haloperidol.
a-Methyl p-tyrosine (AMPT)
As an alternative to using receptor antagonists to interfere with the actions of
endogenous DA, attempts were made to increase the turnover of DA in the presence
of AMPT, a drug which blocks the biosynthesis of catecholamines by inhibiting
tyrosine hydroxylase. The animals were exposed to two ten min periods of hypoxia
separated by a ten min period of hyperoxia over the course of 30 min and they were
then returned to breathing room air. This was done before and after administering
AMPT in doses of 0-2, 1-0 and 10 mg/kg, i.a. Results from three experiments showed
that the low dose slightly potentiated the responses to NaCN and hypoxia, an
example of this can be seen in Fig. 4^4 ; higher doses caused a further small increase.
Responses to ACh were only very slightly potentiated, even after the highest dose of
AMPT. Spontaneous chemoreceptor activity averaged 1-3 ±0-1 c.p.s. before and 1-3 ±
0-2 c.p.s. after AMPT, 0-2 mg/kg. The corresponding values for 10 mg/kg, i.a. were
1-3 + 0-1 and 1-5 + 0-1 c.p.s. Electron microscopy revealed thatdepletionof dense-cored
granules occurred following the 1 mg/kg dose, as compared with untreated carotid
bodies exposed to alternating periods of hypoxia and hyperoxia (K. Bell, R. J.
Docherty & D. S. McQueen, unpublished observations).
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Time (sec)
Fig. 4. The upper panel A shows the response of a single chemoreceptor unit (dis¬
charge averaged over 5 seo intervals) to 120 sec of hypoxia, represented by the hori¬
zontal black bar, before ( ) and after ( ) AMPT 0-2 (mg/kg, i.a.).
The centre panel D illustrates the response to hypoxia obtained from a recording
containing two chemoreceptor units before ( ) and after ( ) administering a-
flupenthixol (0-2 mg/kg, i.a.).
In the lower panel C the response of another two chemoreceptor units to hypoxia
is shown before ( ) and after ( ) apomorphino (0-2 mg/kg, i.a.). Administration
of a-flupenthixol (0-2 mg/kg, i.a.) reversed the inhibition caused by apomorphino and
potentiated the response to hypoxia ( ).
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D-Amphetamine
Amphetamine causes release of DA (Bunney, Aghajanian, & Roth, 1973) and
10 fig was injected i.a. before and after treating the animal with AMPT in two
experiments. This dose of amphetamine caused a slight inhibition of chemoreceptor
discharge in the control state (although not as marked as that observed following low
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Fig. 5. Dose-response lines, from a recording of chemoreceptor activity (three units),
illustrating the influence of apomorphine on responses evoked by ACh and NaCN. Doses
are plotted on a log10 scale and straight lines, fitted to the data by the method of
least squares, show: control response (#—#), responses after apomorphine, 0-05mg/kg,
i.a. ( x—.— x ), and after a further dose of 0-2 mg/kg, i.a. (A A)-
Mean control discharge frequencies were 3-8 + 0-4 c.p.s. before apomorphine and
0-9 + 0-1 and 1-7 + 0-2 after 0-05 and 0-2 mg/kg npomorphine respectively.
Apomorphine
Apomorphine was used in two experiments to provide a long-lasting stimulation
of the DA receptor. It was studied in cumulative doses of 0-05 and 0-2 mg/kg, i.a.
and caused an inhibition of spontaneous chemoreceptor activity which persisted for
up to 45 min. This allowed sufficient time to obtain dose-response data for ACh and
NaCN. Although background discharge frequency was reduced, DA could still evoke
an inhibitory response. Similar results were obtained in both experiments, dose-
response linesjfrom one of them being shown in Fig. 5 where it can be seen that
responses to NaCN were slightly inhibited as were responses to ACh, particularly at
the higher doses. The rate of increase of discharge during hypoxia was reduced
following apomorphine, an effect which was reversed by a-fiupenthixol (see Fig. 4C).
DISCUSSION
The present results confirm that DA inhibits chemosensory activity following close-
arterial injection to the cat carotid body (see also Black, Comroe & Jacobs, 1972;
Sampson, 1972; Zapata, 1975). This inhibitory effect of DA is primarily a direct
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action on the chemoreceptors and not a consequence of vascular changes (Zapata,
1975; Sampson, Aminoff, Jaffe & Vidruk, 1976a; Sampson & Vidruk, 1977). Higher
doses of DA caused a delayed increase in discharge which greatly reduced the dura¬
tion of the inhibitory response. This increase seems similar to that observed in vitro
by Zapata (1975) which was unaffected by dopaminergic or a-adrenergic blockers.
The cause of the delayed increase was not investigated in the present study and
remains to be determined.
Recently Sampson & Vidruk (1977) obtained reproducible DC potential changes
with DA, even when administered every 3-4 min (dose unspecified), using the in
vitro carotid body preparation, and they contrasted their results with Zapata's
finding that frequent administration of DA reduced the chemoreceptor inhibitory
response. However, whether results obtained using the mass receptor potential can
be compared meaningfully with those using chemosensory discharge frequency has
yet to be established. Sampson (1972) and Sampson et al. (1976a) apparently ob¬
tained repeatable inhibitory responses to DA in vivo using doses of 2-5 fig, which
accords with our results at these doses, but they did not study the higher doses
which we foundgave delayed increases in discharge and inconsistent inhibitory effects.
If Osborne & Butler's theory is correct (see Introduction), chemoreceptor activity
should increase when the inhibitory action of DA is blocked because spontaneous de¬
polarization of sensory nerve endings would no longer be suppressed. Furthermore,
according to their theory ACh is released from sensory nerve endings in the carotid
body and acts to suppress the release of DA from Type 1 cells, thereby causing an
increase in chemoreceptor discharge. In a situation where the inhibitory effect of DA
has been blocked, ACh should no longer cause excitation. Our results show that
blocking the inhibitory effect of DA with a-flupenthixol (0-2mg/kg, i.a.) did not affect
either spontaneous chemoreceptor activity or the response to ACh. Higher doses
(e.g. > 0-5 mg/kg, i.a.) did cause spontaneous activity to increase and reduced the
responses to ACh, but at this dose inhibitory responses to 5-HT were also blocked,
implying that the drug was not acting selectively against DA, which we assumed it
was at lower doses. It should be noted that a-flupenthixol has weak a-adrenergic
blocking actions (Moller Nielsen et al. 1973). After a-flupenthixol, 0-2 mg/kg, re¬
sponses to NaCN were potentiated and the increase in discharge during hypoxia was
nuch more rapid. Similar results were obtained with another DA antagonist,
haloperidol.
In addition to the experiments with DA antagonists, we also studied the response
of the chemoreceptors during prolonged DA receptor stimulation. Inhibitory re¬
sponses to DA injections were short-lasting, and although the use of DA infusion to
give a sustained inhibition was considered, this was rejected because of the possibility
of causing secondary increases in discharge. Instead the DA agonist apomorphine
(Bunney et al. 1973) was used and gave a long-lasting inhibition of spontan¬
eous chemosensory activity. Responses to NaCN and hypoxia were reduced by
apomorphine, as were those to ACh, but to a lesser extent. These results showed that
the responsiveness of the chemoreceptors to stimulants was only slightly reduced by
prolonged DA receptor stimulation. The inhibitory effect of apomorphine was
prevented by a-flupenthixol, an observation which provides indirect evidence that
apomorphine and DA were acting at the same site(s).
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We also tried a different approach to testing the theory, the objective being to
reduce endogenous DA levels in the carotid body using AMPT. Hypoxia reduces the
DA content of the carotid body, both when the sinus nerve is intact (Sampson,
Nicolaysen & Jaffe, 1975) and when denervated (Hellstrom, Hanbauer & Costa,
1976), and the presence of the tyrosine hydroxylase inhibitor AMPT (Moore &
Dominic, 1971) should reduce DA biosynthesis during and after hypoxia. In our
experiments AMPT was administered and the animals subjected to alternate periods
of hypoxia and hyperoxia (the latter because according to Osborne & Butler's theory
DA turnover should be greatest when the oxygen tension is higher than normal). The
results indicated that AMPT treatment slightly potentiated the response to NaCN
but had little effect on either spontaneous activity or the response to ACh. To test
for DA depletion we studied the inhibitory effect of D-amphetamine, which was
presumed to reflect DA release (Bunney et al. 1973) and which was reduced or
abolished by AMPT. We also assessed, qualitatively, the reduction by AMPT in
the dense-cored vesicle content of Type 1 cells, where DA is thought to be stored
(Chen & Yates, 1969; Kobayashi, 1971;seealso the review by Biscoe, 1971). Although
Zapata et al. (1969) reported that prolonged hypoxia in cats had no effect on either
the dense-cored vesicles or the catecholamine levels in the carotid body, more recent
studies by Hellstrom et al. (1976) have shown that 15 min of hypoxia (5% 02 in N2)
selectively reduced the DA content in the rat carotid body.
We have interpreted the results as showing that DA levels in the carotid body were
greatly reduced by the catecholamine-synthesis inhibitor AMPT, although other
interpretations are possible. For example, structural changes in the Type 1 cells may
reflect changes in the amount of complexing substances rather than DA content,
and noradrenaline in the cat carotid body (Chiocchio et al. 1966) may also be affected
by hypoxia (Mills & Slotkin, 1975; cf. Zapata et al. 1969), AMPT and amphetamine.
However, responses to stimulants following the combination of AMPT and hypoxia/
hyperoxia were in good agreement with results obtained using the DA antagonist
a-flupenthixol, which adds further support to the interpretation that AMPT was
reducing DA levels.
In summary, the present results demonstrate that responsiveness of the chemo-
receptors to stimulants was only slightly affected when the dopaminergic system was
influenced by blocking drugs (a-flupenthixol or haloperidol), a biosynthesis inhibitor
(AMPT), or a long-acting DA agonist (apomorphine). These findings do not support
the theory of Osborne & Butler (1975) that DA is tonically released in the carotid
body to suppress chemosensory activity. There is also evidence in the literature
which is at variance with this theory. For example, reserpine treatment does not
modify the response to chemoreceptor stimulants, even though DA levels in the
carotid body are substantially reduced (Eyzaguirre & Zapata, 1968; Zapata et al.
1969; Nishi, 1975). Also, Zapata (1975) found that the DA antagonist spiroperidol did
not increase spontaneous chemosensory activity in vitro and he concluded that 'a
continuous release of DA to maintain tonic inhibition of chemosensory fibres is not
very probable'.
Our results are, however, compatible with suggestions that DA may, through its
inhibitory action, modulate chemosensory activity (Mitchell & McDonald, 1975;
Zapata, 1975). We consider that increased afferent activity causes a release of DA
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which reduces the sensitivity of the sensory nerves; this does not preclude the
possibility that stimulants (e.g. hypoxia) also cause a direct release of DA from
storage sites. In this scheme DA release would be minimal in the normal resting
state, which explains why a-flupenthixol and AMPT had no appreciable effect on
spontaneous discharge frequency. Responses to ACh injections last for only 1-2 sec
(not very physiological) which may not be long enough to allow any DA released by
the increased activity to exert an inhibitory influence, thus explaining why responses
to ACh were not greatly affected by the DA inhibitors. Responses to NaCN and to
hypoxia are longer-lasting (4-10 sec for NaCN) and were evidently suppressed by
DA, since they were potentiated following a-flupenthixol or AMPT. We conclude,
therefore, that DA modulates an increase in chemosensory activity by influencing the
rate of increase in discharge, but not the maximum discharge frequency. The
mechanism whereby DA is released in response to increased chemosensory activity
remains to be established, but may involve reciprocal synapses, possibly utilizing
ACh (Hess & Zapata, 1972; McDonald & Mitchell, 1975), or release from Type 1
cells by increased efferent activity in the sinus nerve (Biscoe & Stehbens, 1967;
Biscoe, Lall & Sampson, 1970; Neil & O'Regan, 1971; Sampson, 1972; Sampson,
Aminoff, Jaffe & Vidruk, 19766), although the physiological importance of the latter
pathway has been questioned (McCloskey, 1975; Mitchell & McDonald, 1975).
This work was supported by a project grant from the Medical Research Council. R. J.
Docherty is in receipt of an M.R.C. Research Studentship. We are grateful to Lundbeck & Co.
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EFFECTS OF METHACHOLINE ON THE CAROTID CHEMO-
RpCEPTORS. By D. S. McQueen. From the Department of Pharmacology,
University of Edinburgh, 1, George Square, Edinburgh EH8 9JZ, Scotland.
(Receivedfor publication 8th July 1977)
The present electrophysiological study shows that methacholine (MCh), generally regarded as a
muscarinic agonist, stimulates the carotid chemoreceptors in pentobarbitone anaesthetized cats.
The response consisted of a primary increase in discharge, attributable to nicotinic actions of
MCh since it was unaffected by atropine but abolished by mecamylamine, and a delayed secondary
increase in discharge, due mainly to bronchoconstriction evoked by MCh. Physostigmine caused
similar potentiation of responses to acetylcholine and MCh which implies that acetylcholinesterase
is located close to the site(s) at which the drugs act to stimulate chemoreceptor activity. The
findings are in agreement with the general principle that chemosensory activity is increased
by nicotinic agonists but not by muscarinic agonists.
It is generally accepted that the peripheral arterial chemoreceptors are stimu¬
lated by nicotinic agonists but not by muscarinic agonists [e.g. see Mercier,
Rizzio and Delphaut, 1934; Philippot, 1937; Anichkov and Belen'kii, 1963].
There is, however, disagreement concerning the chemoreceptor-stimulating
properties of the muscarinic agonist methacholine (acetyl /? methylcholine;
MCh), a drug reported to be virtually devoid of nicotinic actions [Simonart,
1932; Hunt and Renshaw, 1934]. From studies based on reflex respiratory
changes in dogs De Wispeleare [1937a, b] claimed that MCh stimulates carotid
chemoreceptors, while in contrast Comroe and Starr [1933] found that MCh
did not stimulate the chemoreceptors in cats, this being confirmed by Philippot
[1937] and Comroe and Schmidt [1938] in dogs. The electrophysiological
investigation performed by Liljestrand and Zotterman [1954] does not clarify
the matter since they concluded that large doses of MCh stimulated the chemo¬
receptors in cats, but noted that the hypotension associated with MCh made it
difficult to interpret the results.
In view of these discordant results, it was decided that a quantitative electro¬
physiological investigation should be performed in order to establish whether
or not MCh stimulates the cat carotid chemoreceptors.
Methods
Experiments were performed on 7 cats, mean weight 3 0 kg, range 2-3-4-5 kg. Full details
of the experimental procedures have been described previously [McQueen, 1977], and only
a brief summary follows. The animals were anaesthetized with pentobarbitone sodium,
(42 mg.kg-1 i.p.), artificially ventilated with air and paralysed by gallamine 3 mg.kg-1 i.v.).
Blood pressure was recorded from a femoral artery and the lingual artery ipsilateral to the
sinus nerve from which recordings were obtained was cannulated, the tip of the cannula
being in the common carotid artery 2 cm caudal to the carotid bifurcation. The bladder was
drained at regular intervals and rectal temperature maintained at 38 ± 0-5°C.
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The sinus nerve was sectioned central to its junction with the glossopharyngeal nerve.
Electrical activity from single or multiple chemoreceptor units was recorded from filaments
of the peripheral nerve using bipolar platinum-iridium electrodes and an A.C. amplifier
(Neurolog, Digitimer). Chemoreceptor units were identified by their random discharge
[Eyzaguirre and Lewin, 1961; Biscoe and Taylor, 1963] and their increase in discharge
frequency following injection of NaCN (0-1 //mol) into the ipsilateral common carotid
artery. The ganglio-glomerular nerves were cut in order to eliminate reflex effects of
sympathetic activity on carotid nerve discharge [Floyd and Neil, 1952; Eyzaguirre and
Lewin, 1961]. Nerve activi'y was recorded on tape (Tandberg 100, frequency response
d.c.-1250 Hz) and subsequently replayed through a pulse height discriminator linked to a
PDP-8 computer. The average (x) and total count (Lx) were calculated for each response
after its duration (t s) had been determined. A 'response' was defined as being from the
first substantial (i.e. 3 times or more) increase above the mean control discharge frequency
until the discharge returned to pre-injection level. Responses were expressed as an increment
above control level by subtracting the appropriate control value, i.e. as Ax and A£x.
The effect of MCh was determined by injecting 0T ml of drug solution into the common
carotid artery via the lingual catheter and washing it in with 0-2 ml Locke solution. Injections
were made over 2 s and were repeated every 15 min. Other drugs were injected i.v. or
intra-carotid over 5-10 s and 20 min allowed before retesting MCh. The catheter dead-
space was 0T ml.
Drugs. Drugs were prepared in modified Locke solution (NaCl 6-0 g; KC10-42g;
CaCl2 0-24 g; Tris base 6-0 g; N HC1 39 ml; distilled water to 1 1; pH 7-41 at 37°C.)
The drugs used were: pentobarbitone sodium (Abbot Laboratories); gallamine
triethiodide (May and Baker); acetylcholine iodide, sodium cyanide, physostigmine
salicylate, carbamoylcholine chloride (carbachol), atropine sulphate—all B.D.H.; acetyl
ft methylcholine bromide (MCh)—Koch Light.
Results
Primary and secondary responses
In each of the seven experiments in which it was studied MCh evoked a
dose-dependent increase in chemoreceptor discharge when injected i.a. The
response could be divided into a primary and a secondary component. The
primary response was intense and commenced immediately following the injec¬
tion but it only lasted for 1-2 s. It was followed by a 5-10 s period of relative
inhibition before a sustained discharge gradually arose, this secondary
increase being associated with a fall in mean B.P. and a rise in end-tidal C02
(see Figs. 1 and 2A). MCh was 12-15 times less potent than acetylcholine (ACh)
in its primary chemoreceptor-stimulating ability (see Fig. 3), a similar ratio
being obtained when Ax rather than AIx data were used. The secondary
increase was not seen with ACh, even though B.P. fell.
Atropine
This muscarinic antagonist was administered in four experiments. The
primary response was not appreciably affected by 1 mg.kg-1 i.v. (see Figs. 1
and 2B) whereas the secondary increase was reduced. B.P. still fell quite low,
this being in agreement with reports by Simonart [1932] and Hunt and Renshaw
[1934] that the vascular effects of high doses of MCh cannot be blocked by
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atropine, even in high doses. There was only a slight increase in end-tidal COz.
Atropine was also administered close-arterial to the carotid body (1 mg .kg-1 i.a.)
in three of these experiments, but both the primary and secondary responses
evoked were very similar,to those observed after i.v. atropine.
Fig. 1. Recording of chemoreceptor activity showing the response evoked by MCh (2'08 //mol i.a.)
before (A) and after (B) atropine (1 mg.kg"1 t.v.). The secondary response can be seen in
the second panel where the discharge starting 35 s after the injection is shown. Primary
responses are presented in more detail in Fig. 2 (A and B).
Panels show fiom above downwards: nerve action potentials, the pulse height discrimi¬
nator being used to count a single unit at the level indicated by the brightening pulse;
counter output, which had been stored for 1 s, in counts, s"1, calibration on right of figure:
0-20 counts, s"1; blood pressure, calibration on left of figure: 0-100-200 mm Hg; 1 sec
time marker; injection marker.
Physostigmine (Eserine)
In two experiments the influence of physostigmine (1-2 mg.kg-1 i.a.)
on the response to MCh was studied in the atropinized cat and it was found that
the primary response was greatly potentiated (see Fig. 2C). Responses to
concomitantly administered ACh were also potentiated, as shown by data
from one of the experiments illustrated in Fig. 3. The control discharge was
not affected by physostigmine.
The assumption was made that the potentiation of responses to MCh and
C D
Fig. 2. Same recording as Fig. 1 showing the response to MCh (2-08 /rmol i.a.) (A) before and (B)
after atropine (1 mg.kg"1 i.v.), (C) after physostigmine (l-2mg.kg_1 i.a.), and (D) after
mecamylamine (1 mg.kg"1 i.a.).
Record details as for Fig. 1. In (D) the single unit was counted from the positive wave of
its action potential.
Fig. 3 Dose response data from a single unit showing the effects of MCh (#) and ACh (X) before
( ) and after ( ) physostigmine (1-2 mg.kg"1 i.a.) in an atropinized (1 mg.kg"1 i.v.)
cat. Straight lines were fitted to the data by the method of least squares. The dose is plotted
on a logio scale against ASx, the increase above control level of the integrated discharge.
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ACh resulted from a specific anticholinesterase action of physostigmine. This
was justified by the observation that responses to carbachol, a stimulant not
destroyed by cholinesterase, and NaCN were unaltered after administering
physostigmine, thereby making it unlikely that the anticholinesterase was
acting in some non-specific manner (e.g. to affect blood flow or sensory nerves
in the carotid body).
Mecamylamine
In three experiments the nicotinic antagonist mecamylamine was administered
(1 mg.kg-1 i.a.) in the atropinized preparation, in two of which physostigmine
had previously been given. Mecamylamine completely abolished the primary
response to MCh, even when doses as high as 10 /unol of the agonist were
given. The effect lasted for several hours, but was reversible. During the time
the preparation was refractory to MCh and ACh, it continued to respond
normally to NaCN.
Discussion
The present experiments demonstrate that MCh stimulates the carotid chemo¬
receptors causing a brief primary excitation followed by a delayed secondary
increase in discharge. Since the primary excitation was unaffected by atropine,
but was completely abolished by mecamylamine, it seems reasonable to conclude
that it is due to a nicotinic action of MCh. The secondary response was asso¬
ciated with a fall in B.P. and a rise in end-tidal C02, the latter being attributable
to the potent broncho-constricting action of MCh [De Wispeleare, 1937b].
Atropine reduced the secondary response by preventing much of the broncho-
constriction; blood pressure still fell, thereby showing that the greater part of
the secondary excitation observed before atropine resulted from broncho-
constriction and not hypotension.
It is difficult to compare existing reports concerning the actions of MCh on
carotid chemoreceptors because very little evidence is presented to support
the conclusions. De Wispeleare [1937a, b] showed that MCh given i.v. stimulates
the chemoreceptors in dogs. One might argue that part of the hyperpnoea he
observed may have been due to increased chemoreceptor activity secondary
to the reflex increase in sympathetic tone to the carotid body that would be
evoked by hypotension [Floyd and Neil, 1952; Eyzaguirre and Lewin, 1961;
Biscoe and Purves, 1967], Nevertheless, MCh can be seen to have increased
respiration before B.P. fell (see Fig. 13 in 1937b paper), so at least part of the
effect may have been due to a direct action on the chemoreceptors. On the other
hand, Comroe and Starr [1933] using cats, and Philippot [1937] and Comroe
and Schmidt [1938] using dogs, all found that MCh did not possess any
primary chemoreceptor-stimulating action. No evidence is given, so one can
only speculate that the failure to demonstrate the chemoreceptor-stimulating
action of MCh (i.a.) may have been a consequence of the use of reflex respira-
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tory changes as the indicator of chemosensory activity. The respiratory response
elicited would be determined by the phase of the respiratory cycle at themoment
of injection [Black and Torrance, 1967], and a short-lasting response, such
as MCh evokes, could easily have been missed. Comroe and Starr [1933] did
note a delayed change in respiration following i.v. MCh which they concluded
was secondary to the hypotension. Liljestrand and Zotterman [1954] undertook
what appears to have been the only electrophysiological investigation of the
actions of MCh on chemoreceptors, but again no evidence is presented to
support their assertion that MCh stimulated the chemoreceptors, but only
when high doses (at least ten times greater than ACh) were administered,
and they commented that the hypotension made it difficult to interpret the
results.
During this study the influence of physostigmine on the chemoreceptor-
stimulating action of MCh was examined. Physostigmine inhibits the activity
of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE, pseudo-
cholinesterase), both of which are present in low concentrations in the cat
carotid body, BuChE being predominant [Hollinshead and Sawyer, 1945;
Koelle, 1950; Biscoe and Silver, 1966], Knowing that ACh is a substrate for
both enzymes whereas MCh is only hydrolyzed by AChE (see Koelle and Gilman
[1949] for a review on anticholinesterases), the finding that responses to MCh
and ACh were potentiated to a similar extent by physostigmine (see Fig. 3)
suggests that both stimulants were being inactivated mainly be AChE. This
implies that AChE is located close to the site at which the drugs were acting to
increase chemoreceptor activity. Koelle [1951] and Biscoe and Silver [1966]
found BuChE and AChE were similarly distributed in the cat carotid body
whereas Ballard and Jones [1971], using electron microscopic techniques,
reported that AChE is localized to peripheral axons, and BuChE to the Type
II cells. However, as discussed by Jones [1975], conflicting evidence and problems
with the methodology mean that at present it is difficult to be certain about
the localization of AChE in the carotid body.
In conclusion, MCh does stimulate the cat carotid chemoreceptors and the
primary excitation is associated with nicotinic properties of the drug, this being
in accord with the principle referred to in the introduction that chemo¬
receptors are stimulated by nicotinic agonists but not by muscarinic agonists.
The generalization that MCh is virtually devoid of nicotinic actions may well
be correct when the effects of the drug on, say, autonomic ganglia are being
considered because the higher concentrations of AChE present there would
rapidly inactivate the stimulant [Sawyer and Hollinshead, 1945; Ord and
Thompson, 1950]. However, at a site such as the carotid body where AChE
levels are low, the nicotinic action is obtained and the generalization is invalid.
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THE EFFECTS OF ACETYLCHOLINE AND DOPAMINE ON CAROTID
CHEMOSENSORY ACTIVITY IN THE RABBIT
BY R. J. DOCHERTY AND D. S. MCQUEEN
From the Department of Pharmacology, University of Edinburgh,
1, George Square, Edinburgh EH8 9JZ
SUMMARY
1. Intracarotid (i.e.) injection of either acetylcholine (ACh) or dopamine in¬
hibited spontaneous chemosensory activity recorded from the peripheral cut end of
the sinus nerve in the anaesthetized rabbit.
2. High doses of ACh ( ^ 50 fig i.e.) evoked a slight increase in discharge which
preceded the inhibition. This excitation was attributable to a nicotinic action of the
drug since it was abolished by mecamylamine..
3. The muscarinic agonist bethanechol inhibited chemoreceptor activity, an effect
which was blocked by high doses of atropine, as was the inhibition caused by ACh.
Dopamine-induced inhibition was unaffected by atropine.
4. Atropine, in doses sufficient to abolish the vasodepressor effect of ACh, only
slightly reduced the inhibitory action of ACh on the chemoreceptors. Also, the
vasodilators sodium nitrite and sodium nitroprusside did not appreciably alter
chemosensory discharge. It seems unlikely, therefore, that the inhibitory response
to ACh is secondary to vascular changes.
5. The inhibitory response to dopamine, but not that to ACh, was blocked by the
dopamine antagonist a-flupenthixol. This implies that inhibition of chemosensory
activity evoked by exogenous ACh was not secondary to dopamine release.
6. The implications of the results are discussed, particularly with regard to the
possible phvsiologieal role of ACh as a modulator of carotid chemosensory activity.
INTRODUCTION
The present electrophysiological investigation was undertaken to examine the
effects of acetylcholine (ACh) and dopamine on carotid ehemosensory activity in
the rabbit. It is well known that ACh stimulates arterial chemoreccptors in the eat
(e.g. see Anichkov & Belen'kii, 19(53; Schweitzer & Wright, 1938) and dog (e.g.
Heymans, Bouckaert, Farber & Hsu, 1936), but there do not appear to be any
reports concerning the effects of ACh, or other drugs which affect the cholinergic
system, on the activity of rabbit carotid body chemoreceptors.
Dopamine seems to have species-dependent effects on the carotid chemoreceptors,
stimulating sensory activity in dogs (Jacobs & Comroe, 1968), but inhibiting it in cats
(Black, Comroe & Jacobs, 1972; Sampson, 1972; Zapata, 1975; Dochertv & McQueen,
1978«). We were interested in determining what effect dopamine has on chemoscn-
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sory activity in the rabbit, particularly since it is present in the carotid body of this
species (Dearnaley, Fillenz & Woods, 1968). A preliminary account of some of this
work has been presented to the Physiological Society (Docherty & McQueen, 19786).
METHODS
Experiments were performed on male rabbits (New Zealand White or Oalifornian) weighing
between 2-5 and 3-5 kg (mean weight = 2-9 kg).
Anaesthesia. Animals were anaesthetized with sodium pentobarbitone (30-50 mg/kg) or
urethane (400 mg/kg) and a-ehloralose (6 ml./kg of a 1 % solution in saline), administered
through an ear vein, with supplements as required (Korner, Uther & White, 1908).
General. A cannula was inserted in the trachea low in the neck. Blood pressure was measured
via a pressure transducer (Bell & Howell, 4-422) from a cannulated femoral artery, displayed
on a pen recorder (Devices, M4), and recorded by an FM tape recorder (Tandberg, 100; frequency
response d.c. to 1250 Hz). Arterial blood pH, and FCo, were measured at hourly intervals
using a Radiometer gas monitor (BMS 3 with PHM 71 meter). A femoral vein was cannulatcd
and used for drug administration. Rectal temperature was monitored and maintained at
39 ± 0-5°C by a heating pad.
The carotid bifurcation region was exposed and dissected free from surrounding tissue. A
cannula was inserted into the lingual artery and advanced until its tip lay in the common
carotid artery approximately 1-5 cm caudal to the carotid bifurcation. This cannula was used
for close-arterial administration of drugs to the cartoid body.
Recording sinns nerve activity. The animal was artificially ventilated with room air by a
respiratory pump (S.R.I.) operating at 38 strokes/min and gallamine triethiodide (3 mg/kg
i.v.) was administered to paralyse spontaneous respiration. This dose had no appreciable effect
on chemoreceptor responses to ACh or dopamine. In most experiments end-tidal CO, was
continuously monitored by an infra-red CO, analyser (Med 1A; Grubb Parsons) and the stroke
volume of the pump adjusted to maintain end-tidal CO, at 5%. The carotid sinus nerve ipsilateral
to the catheterizcd lingual artery was cut centrally and activity in the nerve was recorded as
described previously (McQueen, 1977). Chemoreccptor units were identified by their random
pattern of discharge, their increase in discharge frequency following injection of sodium cyanide
(5 /ig) into the ipsilateral common carotid artery, their increase in discharge in response to
hypoxia (breathing 5% oxygen in nitrogen), and by the inhibition of discharge in response to
hyperoxia (breathing 100% oxygen).
Drug administration. Intracarotid (i.e.) injections of drugs were made in a volume of 0-1 ml.
and the catheter (dead space = 01 ml.) flushed with 0-2 ml. modified Locke solution at 37 °C
which had been bubbled with a 5% carbon dioxide/95% air gas mixture. Injections were made
at the peak of the inspiratory phase of the respiratory cycle and completed over one respiratory
cycle, i.v. injections of drugs were made in a volume of 0-2-10 ml. and the catheter flushed with
0-5 ml. saline. In experiments with mecamylaminc, the appropriate volume of dextran solution
(2-5% dextran, 5% glucose in distilled water) required to maintain blood pressure at the control
level, was administered i.v. This treatment prevented the sustained fall in blood pressure which
would otherwise have accompanied administration of this ganglion blocking drug.
Data analysis. Action potentials were counted and data analysed as previously described
(McQueen, 1977). Responses to drugs were expressed as the absolute difference in discharge
following drug administration where
AS.t = IjX (response) — "Zx (control)
and
La- (control) = x (control) x 1,
ALrr = absolute difference in discharge,
T.x = total discharge,
x = average discharge (counts per second),
t = response duration (sec).
Drugs. Drugs were prepared in modified Locke solution (NaCl 0 0 g; KC1 0-42 g; CaCl, 0-24 g;
Tris base C O g; n-HCI 39 ml.; distilled water to 1 1.; pH = 7-41 at 37 °C), excepting a-flupen-
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thixol which was prepared in 0-9% (w/v) sodium chloride solution. Doses referred to are those
of the salts.
The drugs used in this investigation were: pentobarbitone sodium, gallamine triethiodide
(May & Baker); acetylcholine iodide, sodium cyanide, atropine sulphate; urothane (ethyl
carbamate), a-chloralose, sodium nitrite (B.D.H.); bethanechol chloride, dopamine hydro¬
chloride (Koch-Light); sodium nitroprusside (Griffin & Tatlock); mecamylamine hydrochloride
(M.S.D.); 5-hydroxytryptamine creatinine sulphate (Labkemi A. B.); suberyldicholine di-iodide
(kindly supplied by Dr A. Ungar, Department of Pharmacology, University of Edinburgh).
RESULTS
Experiments were performed on twenty-one rabbits from which twenty-three













Fig. 1. Dose—response data for sodium cyanide, NaCN (O—O) end acetylcholine,
ACh (# #) in one experiment (three chemoreceptor units). In this and subsequent
Figures doses {fig I.e.) are plotted on a log10 scale and responses expressed as ALa:
unless otherwise indicated (sec Methods section). Lines were fitted to the data by the
method of least squares.
Responses to cholinergic agonists
Acetylcholine. Injections of ACh (1-250 yg i.e.) caused an immediate, short-lasting
(1-30 sec) inhibition of chemoreceptor activity in all the experiments, including two
in which the ipsilateral superior cervical ganglion had been removed. There was an
approximately linear relationship between log10 dose and response (AE:r) over the
range 5-100 fig i.e. (see Fig. 1). Doses in this range, which always caused inhibition
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of chemoreceptor activity in the rabbit (either anaesthetic), are comparable to doses
which stimulate chemoreceptor activity in the cat (McQueen, 1977). With high doses
of ACh ( ^ 50 fig i.e.), the inhibition was preceded by a slight (2-3 times control
discharge), transient period of stimulation lasting less than 1 sec (see Fig. 2).
Mecamylamine. Mecamylamine is a potent ganglion blocking drug (Stone, Tor-
chiana, Navarro & Beyer, 1956; Bennet, Tyler & Zaimis, 1957), which can block the
increase in chemoreceptor activity evoked by ACh in the cat carotid body, both in
vitro (Eyzaguirre & Zapata, 1968) and in vivo (Sampson, 1971; McQueen, 1977).
Fig. 2. Chemoreceptor units from an experiment showing the early part of the response
to a high dose of ACh (50 /rg i.e.), before (A ) and after (D) administration of mecamyl¬
amine (0-5 mg/kg I.e.). Panels show from above downwards: action potentials, 1 sec
time markers, injection marker.
The inhibition of chemoreceptor activity evoked by ACh in rabbits was either
unaffected or potentiated following the administration of mecamylamine (1-5 mg/kg
i.v. or 0-25-0-5 mg/kg i.e.). The transient stimulation seen with high doess of ACh
was, however, abolished (Fig. 2).
Suberyldicholinc (SDCh). SDCh is a potent nicotinic agonist which has been shown
to stimulate the carotid ehemoreceptors of the cat (Anichkov & Belen'kii, 1963;
Dardymov & Ger, 1964 ; McQueen, 1974). Intracarotid injection of SDCh (10-50 fig)
in the rabbit had no consistent effect on carotid chemoreceptor activity.
Atropine. Atropine, in doses (1-10 mg/kg I.v.) sufficient to block the depressor
effects of ACh, caused only a slight reduction in the inhibition of chemoreceptor
activity produced by ACh (see Fig. 3). There was a large variation in the dose of
atropine required to block the vascular effects of ACh in different animals. However,
administration of atropine close-arterial to the carotid body (1 mg/kg I.e.) caused
a substantial reduction in the chemoreceptor response to ACh (Fig. 4A).
Beihanechol. Bethanechol is a muscarinic agonist which is relatively free of nicotinic
actions (Molitor, 1936). i.e. injection of bethanechol (10-100 fig) produced a dose-
related inhibition of chemorecepUr activity which was greatly reduced by admini¬
stration of atropine (1 mg/kg i.e.; sec Fig. 4B). Unlike the response to ACh, the
inhibition was not preceded by a stimulant effect at high doses.
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Responses to sodium cyanide
Sodium cyanide increased carotid chemosensorv activity in all the experiments,
including the two in which the ipsilatcral superior cervical ganglion had been
extirpated. The threshold dose of stimulation was about 2-5 /ig i.e. and a maximum
response was elicited by 25 /<g i.e. The effective dose range is comparable to that for
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Fig. 3. Response of carotid chemoreceptors (three units) to ACh (10 /tg i.e.) before (A)
and after (B) administration of atropine (10 mg/kg i.v.). Panels show from nbovo down¬
wards: discharge frequency (counts/sec), injection marker, mean blood pressure
(minHg), time (sec).
dose-response data for sodium cyanide, illustrating the approximately linear re¬
lationship between logn, dose and the response (AS.r) over this range.
The chemoreceptor response to sodium cyanide was not appreciably affected by
administration of either atropine or meeamylamine, although in some experiments
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there was a slight reduction in the response to sodium cyanide in the presence of
mecamylamine (see Figs. 5A, B).
Response, to dopamine and 5-hydroxytryptamine
Dopamine. The effect of dopamine on carotid chemoreceptor activity was studied
in sixteen experiments. A single injection (5-10/tg i.e.) caused an immediate, short-
lasting (5-20 sec) inhibition of chemoreceptor activity in every experiment (see
Fig. 7). The inhibition was sometimes followed by excitation, a phenomenon which
ACh BCh
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Fig. 4. Dose-rosponse data from ono experiment (three units) for ACh and bcthanochol
(BCh), before (O—O) and after (0 0) atropine (1 mg/kg I.e.).
has also been observed in cats (Zapata, 1975, 1977; Dochcrty & McQueen, 1978a).
The chemoreceptor response to dopamine was unaltered by mecamylamine (0-5-
5 mg/kg i.v. or 0-25-0-5 mg/kg i.e.) or atropine (1-5 mg/kg i.v. or 1 mg/kg i.e.).
a-Flupenthixol. a-Flupenthixol is a potent dopamine antagonist (Moller Nielsen,
Pederson, Nymark, Franck, Boeck, Fjalland <fc Christensen, 1973) which has been
shown to block the inhibitory action of dopamine on carotid chemosensory discharge
in the cat (Doeherty & McQueen, 1978a). Administration of a-Hupenthixol (0-25-
1 mg/kg i.v. or 0-25-0-5 mg/kg i.e.) in rabbits blocked the inhibitory action of
dopamine on carotid chemosensory activity (see Fig. OA) but did not reduce the
inhibitory response to ACh (see Fig. 0B). The excitatory response to sodium cyanide
was potentiated by a-tlupenthixol (Fig. 5C).
■~>-Hydroxytryptaminc (o-HT). The effect of 5-HT on carotid chemosensory activity
was studied in eight experiments. Intracarotid injection of 5-HT (5-10//g) caused
an intense but transient stimulation of chcmorcceptor activity followed by a period of
relative inhibition (5-15 sec; see Fig. 7). Both the excitatory and inhibitory com¬
ponents of the response were subject to considerable variation in any experiment,
making an accurate assessment of the effects of blocking drugs difficult. The response
did not appear to be modified by either mecamylamine or atropine. Low doses of
a-flupenthixol (0-25-0-5 mg/kg i.v.) had little effect on the chemoreceptor response to
5-HT although responses to dopamine were blocked. Higher closes of a-flupcnthixol
ACh AND DA ON RABBIT CHEMORECEPTORS 417
(0-25-0-5 mg/kg i.e.) blocked the inhibitory component of the response to 5-HT,
this being similar to the block of 5-HT inhibition observed in cats following higher
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Fig. 5. Dose-response data for NaCN, obtained during three experiments, before
(O—O) and after (0 0), A, mecamylamine (0-25 ing/kg I.e.), B, atropine
(2 mg/kg I.v.) and, C, a-flupenthixol (0-25 mg/kg I.v.). Data were from recordings of
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Fig. 6. Effects of dopamine (10/<g I.e.) and ACh (5 /ig i.e.) on spontaneous cliemo-
reccptor discharge (counts/sec), before (.4) and after (B) administration ofa-flupenthixol
(0-5 mg/kg i.v.). Injections of ACh or dopamine were made at the arrows. Panels show
from above downwards: discharge frequency (counts/sec), time (sec).
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Response to vasodilator substances
Sodium nitrite. Sodium nitrite is a potent vasodilator which acts directly on
vascular smooth muscle (Weiss, Wilkins & Haynes, 1937). Injection of sodium nitrite
(25-100 pg i.e.) evoked a very slight inhibition of chemoreceptor activity lasting
3-4 sec, but the magnitude of the inhibition did not appear to be dose-related and
was no greater than that caused by I.e. injection of an equal volume of modified
Locke solution (0-1 ml.).
1 Hii w
Fig. 7. Chemoreceptor units from an experiment showing the response to dopamine
(5 fig i.e.) and 5-hydroxytryptamine (5-HT) (5 fig I.e.). Details as for Fig. 2.
Sodium nitroprusside. Like sodium nitrite, sodium nitroprusside is a vasodilator
which acts directly on vascular smooth muscle (Johnson, 1929). Sodium nitro¬
prusside (10-50 /ig i.e.) evoked a feeble, short lasting inhibition of chemoreceptor
activity, independent of dose, followed by a secondary stimulation which was dose-
dependent. The magnitude of the initial inhibition evoked by sodium nitroprusside
was no greater than that caused by a control injection of an equal volume (0-1 ml.)
of modified Locke solution.
DISCUSSION
The results show that ACh and dopamine both inhibit spontaneous carotid chemo-
sensory activity in anaesthetized rabbits. The inhibitory response to ACh was un¬
expected, being in complete contrast to the stimulant action obtained in other
species (see Introduction). Experiments were performed to investigate the mech¬
anisms whereby the drugs cause inhibition, of chemoreceptor activity. The results
obtained are discussed below.
Vascular effects. Inhibition of chemoreceptor discharge could have resulted from
an action of ACh on vascular smooth muscle, although the short latency to onset of
the effect argues against this, at least for the early part of the response. Vasodilatation
of the carotid body vasculature would increase blood flow into the glomus and might
thereby be expected to reduce spontaneous chemosensory discharge frequency before
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any tendency for discharge to increase secondary to the delayed fall in b.f. caused
by circulation of the ACh (see Fig. 3), although autoregulation of blood flow that
can occur in the rabbit carotid body (McCloskey, 19C8) complicates the speculation.
The results from our experiments show that whereas a low dose of atropine blocked
the ACh-induced fall in systemic b.f., the inhibitory response of the chemoreceptors
to ACh was only slightly reduced. The vascular explanation therefore seemed un¬
likely, providing that the carotid body vascular responsiveness to ACh is similar to
that of the peripheral vasculature. This may or may not be the case. However, the
potent vasodilators sodium nitrite and sodium nitroprusside also had little effect on
chemosensory activity when administered close-arterial to the carotid body, the
increase in discharge associated with nitroprusside probably being due to the pro¬
duction of cyanide ions during the conversion of nitroprusside to thiocyanate. These
results with atropine and the vasodilator drugs indicate that although vasodilatation
may explain a small part of the inhibition of chemoreceptor activity evoked by
ACh, it is not responsible for the greater part of the effect. This view is supported
by the recent finding that ACh inhibits chemosensory activity of the superfused
rabbit carotid body in vitro (Monti-Bloch & Eyzaguirre, 1977), this being a pre¬
paration in which vascular effects are precluded.
Characterization of the cholinergic receptors. We attempted to identify the cholinergic
receptors responsible for the effects of ACh. High doses of ACh caused a transient
slight stimulation of the chemoreceptors, an effect which preceded the inhibition.
This excitation appeared to be attributable to a nicotinic action of ACh since it was
abolished by mecamylamine. We are unable to explain why the nicotinic agonist
SDCh was inconsistent in its ability to stimulate the chemoreceptors. In any event,
as the excitatory effect was slight and only seen following injection of high doses of
ACh, it is unlikely to have much physiological significance.
The inhibitory action of ACh was evidently mediated by a muscarinic mechanism
because the muscarinic agonist bethanechol, but not the nicotinic SDCh, also caused
inhibition, and the response could be blocked by the muscarinic antagonist atropine,
although relatively high doses were needed. Interpretation of data derived from
experiments involving the use of atropine in rabbits is complicated by the presence
of an atropinase enzyme in some rabbits (Ambache, 1955), a fact which may account
for the large variation in the dose of atropine required to prevent the vascular
effects of ACh. Nevertheless, it was possible to block the vasodepressor action of
ACh with doses of atropine which were lower than those required to block the chemo¬
receptor inhibitory response.
The possibility exists that the muscarinic receptors mediating the inhibition of
chemosensory activity evoked by ACh are 'atypical', perhaps being similar to those
in the adrenal medulla (Henderson & Ungar, 1977), or in sympathetic ganglia (Hilton,
1977), which are also fairly resistant to atropine blockade. Further studies are
required to investigate this possibility.
ACh-dopamine interaction. It has been suggested that ACh may release dopamine
from the rat carotid body via a muscarinic mechanism (Hellstrom, Hanbauer &
Costa, 1976). Since we found that dopamine inhibited rabbit chemosensory activity,
and it is known to be present in the rabbit carotid body (Dearnaley et al. 1968), the
possibility that ACh-induced inhibition was secondary to dopamine release became
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attractive. However, it is unlikely to be the case because the dopamine antagonist
a-flupenthixol, in doses sufficient to block the inhibitory response to exogenous
dopamine, did not reduce the inhibitory response evoked by ACh.
Although we found that dopamine inhibited carotid chemoreceptor activity in
the rabbit, as it does in the cat (Docherty & McQueen, 1978a), it should be noted that
Monti-Bloch & Eyzaguirre (1977) reported that it increases chemoreceptor discharge
of the superfused rabbit carotid body in vitro. We found there was a delayed ex¬
citation following some doses of dopamine, but this effect was invariably preceded
by an inhibition of chemosensory activity. A possible explanation for the difference
between the in vivo and the in vitro results is that vascular effects are responsible for
the inhibition observed in vivo; such vascular changes should not occur in the super-
fused preparation. Sampson, Aminoff, Jaffe & Vidruk (1976a) presented evidence
showing that vascular effects are unlikely to account for the dopamine-induced
inhibition of chemosensory activity in cats; whether a similar situation pertains in
the rabbit remains to be established. However, we consider it unlikely that the
inhibition observed in vivo is secondary to vascular effects of dopamine, particularly
since the latency to onset of effect following the start of an injection is so short
(1-2 sec), although we cannot entirely preclude the possibility. The discrepancy
between the results seems more likely to be attributable to variability of the in vitro
preparation's responsiveness to dopamine (Zapata, 1975) or to differences in dose used
and the time during which the drug is present in the carotid body. The delayed
excitatory effect observed in vivo may be mediated by a mechanism which perhaps
involves a different type of dopamine receptor, but further studies are required to
characterize this response.
Dopamine appears to be involved in modulating chemosensory activity in the cat
(Mitchell & McDonald, 1975; Zapata, 1975; Docherty & McQueen, 1978a) and it is
tempting to speculate that it has a similar role in the rabbit carotid body. However,
this remains to be established.
Physiological significance. It is difficult to reconcile the present finding that ACh
inhibits rabbit carotid chemosensory activity with the hypothesis that ACh is an
excitatory transmitter in the chemosensory mechanism (e.g. see reviews by Heymans &
Neil, 1958; Eyzaguirre & Zapata, 1968; Torrance, 1968; Biscoe, 1971; Howe & Neil,
1972). The nicotinic action of ACh in exciting sensory nerve endings may be non¬
specific, that is a direct action on the nerve endings which can be blocked pharmaco¬
logically without affecting the response of the endings to physiological stimuli (Brown
& Gray, 1948; Gray & Diamond, 1957). It could be that whereas non-specific ex¬
citation of chemosensory afferents is observed in the cat and dog, it is not obtained,
except transiently following high doses of ACh, in the rabbit. Could the threshold
for non-specific excitation by ACh be higher in the rabbit than in other species? Is
this related to levels of acetylcholinesterase? One could start speculating as to why
inhibition of chemosensory activity occurs in rabbits, but it would be more profitable
to study further the properties of the rabbit carotid body and sinus nerve and to
compare them with those of the cat and dog (e.g. Verna's (1975) ultrastructural
study of the rabbit carotid body).
It may well be that the inhibition evoked by ACh in rabbits is either indirectly
mediated or else non-specific and lacking physiological significance, but it seems
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worth exploring the possibility that these findings with exogenous ACh in rabbits,
free from any masking excitatory effect of the drug, provide a clue regarding the
physiological role of ACh in the carotid body. There is evidence for an efferent path¬
way running in the sinus nerve to the cat carotid body (e.g. see Biscoe & Sampson,
1968) and stimulation of this pathway inhibits carotid chemosensory activity (Neil &
O'Regan, 1969; Belmonte & Eyzaguirre, 1974). Several workers have reported that
this inhibition can be reduced by atropine (Willshaw, 1975; Goodman, 1975; Sampson,
Aminoff, Jaffe & Vidruk, 19766), although opinions differ about the mechanism of
the inhibition and the physiological significance of the pathway (McCloskey, 1975).
It remains to be established whether the rabbit carotid body receives an efferent
innervation via the sinus nerve, but the possibility exists that the inhibitory
effect of ACh on chemosensory activity in rabbits might result from an action
on receptors involved in an efferent pathway. In such a scheme ACh would be a
modulator or regulator of chemosensory activity rather than an excitatory neuro¬
transmitter.
We are grateful to K. Bell and I. Maben for technical assistance and to Lundbeck & Co. for
kindly providing the a-fiupenthixol. R. J. Docherty is in receipt of an M.R.C. research student¬
ship.
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EFFECTS OF ACETYLCHOLINE AND SODIUM CYANIDE ON CAT
CAROTID BARORECEPTORS
d.s. McQueen
Department of Pharmacology. University of Edinburgh, I George Square. Edinburgh. EH8 9JZ
1 The effects of intracarotid (i.a.) injections of acetylcholine (ACh) and sodium cyanide (NaCN) on
baroreceptor activity recorded from the sinus nerve have been investigated in cats anaesthetized with
pentobarbitone.
2 Two types of baroreceptor unit were recorded. The predominant type discharged at least 3 to 4
spikes per pulse wave at normal BP; they are referred to as 'polyspike' units and may have been
associated with A fibres. The other type discharged a maximum of 1 to 3 spikes per pulse wave, even
at high BP; they are referred to as 'few-spike' units and may have been from C fibres.
3 NaCN had no direct effect on either type of baroreceptor unit, even when injected in high doses
(2.04 to 5.1 pmol i.a.) which cause maximal chemoreceptor stimulation, and it is concluded that as far
as the cat's carotid baroreceptors and chemoreceptors are concerned, NaCN is a specific chemorecep¬
tor stimulant.
4 ACh had no direct effect on polyspike baroreceptor units unless very high doses (1.83 pmol i.a.)
were injected, when there was occasionally a transient slight increase in discharge. This effect
appeared to be secondary to muscle contraction caused by ACh since it was not seen when an
adequate neuromuscular-blocking dose of gallamine had been administered.
5 ACh stimulated the few-spike type of baroreceptor unit, an effect which was dose-related and
lasted for up to 3 s; the threshold dose for baroreceptor stimulation was higher than that needed to
excite chemoreceptor units. The increased discharge also occurred during experiments in which
gallamine had been administered. Only five of these units were recorded during the investigation,
despite an intensive search for them.
6 There was a delayed increase in baroreceptor sensitivity following the administration of ACh in
doses (37 to 366 nmol i.a.) which had no immediate direct effect on polyspike baroreceptor discharge.
The effect was evidently not secondary to changes in sympathetic nerve activity to the sinus region
since it was observed during an experiment in which the ganglioglomerular nerves had been cut.
Whether the increased sensitivity resulted from direct or indirect actions of ACh remains to be
determined.
7 It is concluded that low doses of ACh or other drugs with nicotinic properties are unlikely to
evoke baroreceptor reflexes on intracarotid injection, although they may cause delayed changes in
baroreceptor sensitivity. Higher doses of ACh do not directly affect baroreceptor polyspike (A fibre)
units, but transient barorcflex changes might result from stimulation of baroreceptor few-spike (C
fibre) units. It is most unlikely that NaCN has any direct effect on baroreceptor reflex activity when
injected into the carotid artery in doses used to elicit chemoreceptor reflexes.
Introduction
Sodium cyanide (NaCN) is a classical chemoreceptor
stimulant (see Heymans & Neil. 1958). However.
Fahim. Paintal & Torrance (1972) have found that
some aortic chemoreceptors in cats were not excited
by NaCN and some gastric stretch receptors were.
They conclude 'that NaCN is definitely not a specific
chemoreceptor stimulant'. Furthermore, Dontas
(1954) claimed that NaCN exerted a stimulant action
on the carotid baroreceptors and Paintal (1977) con¬
sidered that 'it would not be surprising if sodium cya¬
nide also stimulated the carotid baroreceptors with
non-medullated fibres'.
These points raise the question of whether investi¬
gators who used NaCN during the study of chemore¬
ceptor reflexes (e.g. see Heymans & Neil, 1958;
McQueen. 1970) were evoking responses which were
the result of mixed baro- and chemoreceptor stimu¬
lation They also cause one to question whether the
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identity of a unit recorded from the sinus nerve can be
based, reliably, on its responsiveness to NaCN. It was
decided to perform an electrophysiological study of
the effects of NaCN on carotid baroreceptors in the
cat in order to try and answer these questions. Re¬
sponses to acetylcholine (ACh) were also investigated
because there is some confusion in the literature con¬
cerning the effect of this drug on the baroreceptors.
Euler, Liljestrand & Zotterman (1941) found that
ACh increased chemoreceptor discharge without
affecting the 'great pressure spikes' in recordings of
sinus nerve activity, and Landgren, Skouby & Zotter¬
man (1953) considered that ACh was not an adequate
stimulus for the baroreceptors, although it did alter
their sensitivity to other stimuli. Diamond (1955) used
an in vitro preparation of the carotid sinus and found
that ACh stimulated the carotid baroreceptors.
Methods
Experimental animals
Cats of either sex weighing between 2.1 and 3.9 kg
(median weight 2.9 kg, n = 26 cats) were used. They
were anaesthetized with pentobarbitone sodium (42
mg/kg i.p.) supplemented approximately every 1 to 2
h during the experiment by intravenous administra¬
tion of 10% of the initial dose. For some of the experi¬
ments the animals breathed spontaneously, but for
the majority they were artificially ventilated with
room air and usually paralysed by gallamine triethio-
dide (3 mg/kg i-v.). End-tidal C02 was continuously
monitored by an infra-red C02 analyser (Med I A;
Grubb Parsons) and the Pctco,. ar>d pH of
femoral arterial blood samples measured at regular
intervals.
General details
Blood pressure was recorded from one femoral artery
and the other was cannulated for arterial blood sam¬
pling. Rectal temperature was maintained at
38 + 0.5°C by a heating pad and the bladder was
drained regularly.
Drug solutions (0.1 ml) were injected into the com¬
mon carotid artery ipsilateral to the sinus nerve from
which activity was being recorded and washed in with
0.2 ml modified Locke solution which had been but>-
bled with 5% C02:95% air in a water bath at 37"C.
The catheter was introduced into the common carotid
artery via the lingual artery and advanced until its tip
lay about 2 cm caudal to the carotid bifurcation.
Injections were made over a 2 s period.
Recording and analysis of sinus nerve activity
This has been fully described previously (McQueen.
1977; Docherty & McQueen. 1978) and only a brief
summary follows. A carotid sinus nerve was dissected
free from surrounding tissues, cut centrally, and the
electrical activity of single or few unit baroreceptor
units recorded from the peripheral nerve with bipolar
platinum-iridium electrodes and an a.c. amplifier
(Neurolog; Digitimer). Nerve activity was recorded
on tape (Tandberg 115; d.c.-1250 Hz) and subse¬
quently analysed with the aid of a computer (PDP-8;
Digital Equipment Corporation) in order to provide
data concerning discharge frequency (e.g. average dis¬
charge in ct/s); histograms were obtained from an x-y
plotter (Complot, Houston Instruments).
Identification of baroreceptor units
Baroreceptors were identified by the synchrony
between the bursts of nerve activity and the rise in
pulse pressure. Occlusion of the common carotid
artery caudal to the carotid bifurcation led to a reduc¬
tion or abolition of the discharge which was immedi¬
ately restored on removing the occluding artery clip.
Probing the sinus region caused increased unit ac¬
tivity, whereas injection of 0.3 ml Locke solution satu¬
rated with C02 had no effect on the discharge, al¬
though it strongly stimulated the chemoreceptors.
Individual units were identified from the constant
shape and amplitude of the action potential.
Drugs
Drugs were prepared in modified Locke solution
(McQueen & Eyzaguirre, 1974) and were; pentobarbi¬
tone sodium, gallamine triethiodide (May & Baker);
acetylcholine iodide, mol. mass 273; sodium cyanide
(BDH), mol. mass 49.
Results
Different types of baroreceptor discharge
The most common baroreceptor discharge, obtained
in 30 of the 35 units recorded (i.e. 86%). was of the
type illustrated in Figure 1. namely polyspike activity
associated with the increase in pulse pressure, the
number of spikes per beat being related to the mean
BP. There was usually no discharge below 40 to 50
mmHg. but above this threshold baroreceptor dis¬
charge increased with increasing pressure until a
maximum discharge was attained at about 200
mmHg. At physiological pressures (90 to 150 mmHg)
there were always at least 3 spikes per beat, usually 5
to 15, from a single unit.
The other type of activity observed is illustrated in
Figure 3. This was encountered in 5 of the 35 (14%)
units studied and was characterized by having a maxi¬
mum of I to 3 spikes per beat and a higher threshold

















Figure I Effects of acetylcholine (ACh) and sodium cyanide (NaCN) on baro- and chemoreccptor activity in a
non-paralysed spontaneously breathing cat with intact ganglioglomerular nerves: (a) shows the response to ACh
(0.37 pmol i.a.), the lower panel being a faster oscilloscope sweep of the injection period. It can be seen that this
dose of ACh markedly increased chemoreceptor discharge (smaller units) without affecting baroreceptor activity
(larger unit). When the dose was increased to 1.83 gmol ACh, (b). muscle contraction occurred and the signal was
distorted by movement of the nerve on the recording electrodes. A high dose of NaCN (4.08 pmol) (c) caused
strong chemoreceptor excitation, but had no effect on baroreceptor activity. Panels show from above downwards:
nerve action potentials; femoral BP; 1 s time marker; injection marker.
(mean BP, 70 to 100 mmHg). It was found that the
duration of the action potential tended to be longer
for the 'few-spike' group (1.5 to 4 ms) than it was for
the 'polyspike' group (0.5 to 1.5 ms).
An assumption was made, and will be justified in
the Discussion, that polyspikes are associated with
fast-conducting (A) fibres in the sinus nerve, whereas
the 'few-spike' type of activity is associated with slow-
conducting (C) fibres.
Responsiveness of baroreceptor polyspike units (A
fibres) to acetylcholine and sodium cyanide
ACh and NaCN were tested on 30 polyspike record¬
ings obtained from 24 cats. Doses injected ranged
from 3.7 nmol to 1.83 pmol (i.a.) for ACh and 20 nmol
to 5.1 pmol (i.a.) for NaCN. The discharge pattern
during the first 5 to 10 s following an injection was
compared with that observed following a control
injection of the same volume of Locke solution, which
occasionally evoked a slight increase in discharge dur¬
ing the injection period. It was evident from early
results that neither drug was having much effect on
baroreceptor activity, so in subsequent experiments
only the higher doses were studied.
GaUamine Experiments were performed on 5 cats
which were not paralysed. It was found that higher
doses of ACh (>0.18 pmol) caused a transient con¬
traction of the muscles in the neck which often
resulted in movement of the nerve on the recording
electrodes and distortion or loss of the signal. There
was no evidence of baroreceptor stimulation follow¬
ing high doses of ACh, although the situation during
the period of muscle contraction was difficult to
assess, nor did high doses of NaCN affect the dis¬
charge (see Figure 1).
In the other 19 cats, gallamine was administered to
prevent muscle movements from affecting discharge.
Neither ACh or NaCN in high doses had any stimu¬
lant action on the baroreceptor units in 16 of the
experiments. However, in 2 cats ACh (1.83 pmol i.a.)
did increase discharge during the injection (see
Figure 2). This effect coincided with slight muscle
contraction in the neck, indicating that there was
insufficient gallamine present to prevent the high dose
of ACh from contracting muscles and thereby tran¬
siently affecting discharge. Again, NaCN was without
effect.
Sympathetic innervation of the carotid sinus The
ganglioglomerular nerves (Floyd & Neil. 1952; Evza-
guirre & Lewin, 1961) were left intact in seven experi¬
ments and cut in the remainder. ACh and NaCN were
without effect in all the experiments in which the
sinus symapthetic innervation was intact. Five of the


















Figure 2 In (his experiment the cat was artificially ventilated, paralysed by gallamine and the ganglioglomerular
nerves were cut: (a) shows the effect of acetylcholine (ACh. 1.83 pmol i.a.), the lower panel being a faster sweep of
the injection period; (b) is the response to sodium cyanide (NaCN, 2.04 pmol). Both drugs stimulated the small
chemoreceptor units and ACh, but not NaCN, caused a transient excitation of the baroreceptors, an effect which
coincided with muscle contraction in the neck. Record details as for Figure I.
Responsiveness of haroreceptor few-spike units (C
fibres) to acetylcholine and sodium cyanide
ACh and NaCN were tested on 5 few-spike record¬
ings obtained from 5 cats in which the ganglioglomer¬
ular nerves had been cut. Two of the animals were
paralysed with gallamine, the others were not. Doses
of ACh (37 nmol to 0.92 pmol) and NaCN (0.1 to 2.04
pmol) were injected (i.a.) and it was found that
whereas higher doses of ACh sometimes increased
baroreceptor activity. NaCN was without effect. The
biggest response to ACh was obtained from an experi¬
ment in which gallamine had been administered (see
Figure 3). The lower dose of ACh had only a slight
effect on discharge, but the high dose caused an
intense discharge, unrelated to pulse pressure, which
lasted for 3 s. A high dose of NaCN did not cause any
increase in discharge.
Not all these units displayed the same sensitivity to
ACh. Thus, the barorcceptor shown in Figure 4a was
excited by ACh (0.18 pmol). the recording having
been obtained from a gallamine-treatcd cat. whereas
that shown in Figure 4b was unaffected by this dose
of ACh. An attempt was made to determine whether
the latter unit responded to 0.92 gmoi ACh, but un¬
fortunately the dose caused violent muscle contrac¬
tions and the recording was lost, this being one of the
hazards of injecting large amounts of ACh into non-
paralysed animals. NaCN (1.02 pmol i.a.) had no
effect on either unit.
Sensit isat ion of haroreceptors
The effect of various doses of ACh (37 nmol to 1.83
pmol) was studied on a single polyspike baroreccptor
recorded from an artificially ventilated paralysed ani-


















ACh (0.92/imol i.a.) NaCN (1.02pmol i.a.)
Figure 3 A recording of 'few-spike' baroreceptor activity from a paralysed cat in which the ganglioglomerular
nerves were cut: (a) shows the responses to 92 nmol and. below. 0.92 pmol of acetylcholine (ACh). The low dose
caused a slightly increased baroreceptor discharge and the high dose caused a marked increase in activity. In
contrast, sodium cyanide (NaCN. O.I and. below. 1.02 pmol) had no effect on the discharge. Record details as for
Figure I.
trial in which the ganglioglomerular nerves were cut.
It was noted that discharge was potentiated during
the period following the hypotension evoked by lower
doses of ACh, at a time when mean BP and pulse
pressure were about the same as in the control period
(see Figure 5). Discharge was not increased above
control levels following higher doses of ACh. but
mean BP remained below control levels during the
first 90 s after the injections. Allowing for the lower
BP. discharge was. in fact, potentiated. The increased
discharge could not be accounted for entirely by the
increase in heart rate, although this did make a small
contribution.
Discussion
None of the baroreceptor units recorded was stimu¬
lated by NaCN. despite the use of high doses which
cause maximal chcmoreceptor excitation (McQueen,
1977). Dontas (1954) presented no evidence to support
his assertion that NaCN (0.1 to 1 mg. i.a.) stimulates
barorcceptors in cats and dogs, and Paintal (1977)
was merely speculating when he suggested that cya¬
nide might stimulate baroreceptors with non-
mcdullated fibres. The lack of evidence in the litera¬
ture to support the notion that NaCN stimulates baro¬
receptors. and the present failure to demonstrate any
such effect, makes it reasonable to conclude that low
doses of NaCN used to activate the chemoreceptors
during the study of carotid chemoreceptor reflexes
will not directly affect the baroreceptors.
In contrast to the findings of Fahim ct al. (1972) on
aortic chemoreceptors. none of the carotid chemore¬
ceptor units obtained by the author from over 250
recordings in 168 cats has failed to respond to NaCN
(0.1 pmol i.a.). It appears, therefore, that as far as the¬
cal carotid haroreeeptors and chemoreceptors are
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Figure 4 Responses to acetylcholine (ACh, O.I8 gmol) recorded from 'few-spike' recordings of baroreccptors in
two different animals. The responses shown in (a) was from a paralysed cat; a fast sweep of the injection period is
shown below the slow oscilloscope sweep. Discharge was increased in this experiment, whereas in (b) a recording
from an unparalysed cat showed no baroreceptor response to the same dose of ACh, although chemoreceptor units
were stimulated. Record details as for Figure 1.
concerned. NaCN is a specific chemoreceptor stimu¬
lant. With ACh the situation is more complicated.
'Polyspike' baroreceptor units were only affected by
very high doses of ACh, and this effect was evidently
secondary to muscle contraction since it was not seen
when the neuromuscular blocking drug gallamine was
administered in doses which have no effect on the
response of the chemoreceptors to ACh (McQueen.
1977).
The 'few-spike' baroreceptor units, in contrast,
tended to be excited by ACh. although the doses
needed to do this were greater than those needed to
stimulate chemoreceptors. The effect was not due to
ganglionic stimulation by ACh of the sympathetic
supply to the carotid sinus (Kezdi. 1954; Sampson &
Mills, 1970; but cf. Floyd & Neil, 1952; Simon.
Zamorano, Yajcya & Belmonte. 1976) because it was
obtained during experiments in which the ganglio-
glomerular nerves had been cut. Neither was it
secondary to muscle contraction, since the increase in
baroreceptor discharge was observed in paralysed
animals.
The only baroreceptor units to respond to ACh
(<1.83 pmol i.a.) were of the few-spike type which
had long-duration potentials, a feature which could
be taken as evidence that they were associated with
slow-conducting (C) fibres (Gasser. 1950; Paintal,
1966). It would have been desirable to measure their
conduction velocity, but the short length of nerve
available makes this technically very difficult (see
Paintal. 1971). Howevef. Fidone & Sato (1969) found
that: 'baroreceptor C fibres seldom discharge more
than 1-2 impulses per pulse wave, whereas barorccep-
tor A fibres commonly respond with 3-5 impulses or
more". They also found that ACh, in doses greater
than those needed to excite chemoreceptor fibres,
caused a slight stimulation of baroreceptor C fibres.
Thus, the discharge pattern of the few-spike units.















Figure 5 Data obtained from an experiment on an artificially ventilated paralysed cat with the ganglioglomerular
nerves cut. Discharge of a single polyspike baroreceptor unit was counted and the computed discharge, plotted by
the x-y recorder, is shown on the right of the figure, with the accompanying record of BP on the left. Injections of
acetylcholine (ACh) in the following doses were made at the points represented by the arrows: (a) 37 nmol; (b) 0.37
pmol; (c) 0.92 pmol; (d) 1.83 pmol i.a. The average heart rate in the 10 s period immediately preceding the injection
was determined, as was the rate during the period 45 to 54 s (a) or 90 to 99 s (b—d) post-injection and the values
(beats/min) are given above the BP traces.
together with their responsiveness to ACh (a feature
of many non-myelinated fibres, Armett & Ritchie,
1961) strongly suggests that they were baroreceptor C
fibres.
The results obtained are not in conflict with the
finding of Euler et al. (1941) that ACh (5 to 10 pg) has
no effect on the great pressure spikes (probably A
fibre baroreceptors). Diamond (1955) showed that
ACh stimulates the cat carotid baroreceptors in vitro,
but comparison of his results with those from the
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present study is difficult because of the great differ¬
ence in experimental conditions. He found that small
spikes were more affected by ACh than were larger
spikes; indeed, some of the latter were unaffected even
by very high doses of ACh. This may be taken as
indirect evidence that C fibres (small spikes) were
more readily affected by ACh than were A fibres
(Kirchheim, 1976; but see Iggo, 1958), although it is
not clear what proportion of the small spikes were
chemoreceptors.
Landgren et al. (1953) found that although ACh (10
to 100 pg, i.a.) does not stimulate the baroreceptors, it
does increase the receptor sensitivity. Similar findings
were made in the present study and further experi¬
ments are needed to determine whether this increased
sensitivity results from direct or indirect actions of
ACh; it is evidently not dependent on intact sympath¬
etic innervation of the sinus because it was observed
when the ganglioglomerular nerves had been cut.
In summary, low doses of ACh or other drugs with
nicotinic properties are unlikely to evoke barorecep-
tor reflexes on intracarotid injection, although they
may cause delayed changes in baroreceptor sensi¬
tivity. Higher doses of ACh do not directly affect baro¬
receptor A fibres, but transient baroreflex changes
might result from stimulation of baroreceptor C
fibres, although any such changes would probably be
masked by the concomitant intense chemorefiex ac¬
tivity evoked by ACh.
This work was supported by a project grant from the
Medical Research Council. The technical assistance of
Miss S.M. Mills was much appreciated.
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Effects of Dihydro-/J-Erythroidine on the
Cat Carotid Chemoreceptors
d. s. McQueen
From the Department of Pharmacology, University of Edinburgh, l George
Square, Edinburgh EH& &JZ, Scotland
(RECEIVED FOR PUBLICATION 12 FEBRUARY 1980)
The efTecls of the nicotinic-blocking drug dihydro-^-erythroidine (DHE) on
chemoreceptor responses to physiological and pharmacological stimuli have been
examined in pentobarbitone anaesthetized cats in which chemoreceptor discharge was
recorded from the peripheral end of a sectioned sinus nerve. High doses of DHE greatly
reduced the excitatory action of ACh on the chemoreceptors and caused a reduction in
responses to C02. The efTect of NaCN was not much affected, even though the high
doses of DHE can reasonably be expected to have penetrated the carotid body tissues
very effectively. Low doses of DHE reduced the excitatory action of ACh but potentiated
responses to NaCN and C02, findings which are compatible with endogenous ACh
exerting an inhibitory influence on the chemoreccptors.
Conflicting evidence and controversy surround the effects of nicotinic
antagonists on the responsiveness of carotid chemoreceptors to physiological
stimuli and sodium cyanide [e.g. see Landgren, Liljestrand and Zotterman,
1952; Douglas, 1952; Dontas and Nickerson, 1956; Byck, 1961; Joels and Neil,
1962; Anichkov and Belcn'kii, 1963; Eyzaguirre and Zapata, 1968a; Sampson,
1971; McQueen, 1977]. Some attempts have been made to explain the reason
for this conflict. For example. McQueen [1977] suggested that it results from
the subjective interpretation of qualitative pharmacological evidence [see also
Dontas and Nickerson, 1956]. Others, however, consider that the conflict arises
because some nicotinic blockers, in the doses used, do not penetrate tissues very
well, and as a result the local concentration of antagonist at the intrinsic
'receptor site' is insufficient to prevent the action of the endogenous excitatory
transmitter presumed to be released by physiological stimuli [e.g. Landgren et
at., 1952; Moe, Capo and Peralta, 1948; Eyzaguirre and Zapata, 1968a.c; Nishi
and Eyzaguirre, 1971].
Dihydro-/J-erythroidine (DHE) penetrates the C.N.S. very rapidly and
effectively [see Curtis and Eccles, 1958] and is a good antagonist of the
nicotinic action of acetylcholine (ACh) on Renshaw cells [Eccles. Eatt and
Koketsu. 1954; Eccles, Eccles and Eatt. 1956; Curtis and Ryall. 1966], It
scented worth using quantitative neuropharntacological techniques to
investigate whether DHE could prevent the effects of physiological and
pharmacological stimuli on the cat carotid chemoreccptors in vivo, as it is
apparently capable of doing in vitro [Eyzaguirre and Zapata, 1968b].
qji r 22V
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In this paper the effects of DHE on chemoreceptor responses to ACh, sodium
cyanide (NaCN). carbon dioxide (CO,) and dopamine are discussed in relation
to the physiological significance of ACh in the carotid body.
Methods
Experiments were performed on 7 cats weighing between 2 2 and 4-5 kg, median
weight 3 0 kg. Full details of the experimental procedures have been given
previously [McQueen, 1977; Docherty and McQueen, 1978] and only a brief
summary follows. The animals were anaesthetized with pentobarbitone sodium,
(42mg.kg~' i.p.), artificially ventilated with air and paralysed by gallamine
(3mg.kg_1 i.v.). Blood pressure was recorded from a femoral artery, and the
lingual artery ipsilateral to the sinus nerve from which recordings were obtained
was cannulated, the tip of the catheter being positioned in the common carotid
artery about 15 cm caudal to the carotid bifurcation. In some experiments a
second catheter was introduced into the common carotid artery via the superior
thyroid artery.
Electrical activity of chemoreceptor units (1-5 units) was recorded from
filaments of the peripheral end of a sectioned sinus nerve, stored on FM tape
(Tandberg 115), passed through a pulse height (window) discriminator, and
quantified with the aid of a PDP-8 computer. The ganglioglomerular
(sympathetic) nerves were cut.
Drugs were dissolved in modified Locke solution [see McQueen, 1977]. Drug
solutions (01 ml) were injected into the common carotid artery (I.C.) via the
lingual catheter and washed in with 0-2ml Locke solution which had been
bubbled with 5",, CO,: 95",, air in a water bath at 37CC; injections were made
over 2 sec. Infusions were made into the common carotid artery via the thyroid
catheter over a 65 sec period using a Unita pump (Braun) set to deliver
05ml.min '. The tendency for B.P. to fall following DHE injections was
conteracted by slow i.v. injections of dextran 70 (2-5"„) glucose (5"-„) solution
(10-60ml).
Chemoreceptor responses were expressed as changes from pre-injection
control level by subtracting the appropriate control value; i.e. as A.v (change in
average discharge during a response of duration t sec) or AZ.v (change in total
count, i.e. AZ.v = L.v (total count in response period) —.v (control) x t). A
'response' was defined as being from the fust substantial change in spontaneous
discharge following drug administration until the discharge returned to the pre-
injection control level. Responses to chemoreceptor stimulants obtained after
administering DHE were expressed as a percentage of the responses evoked by
the same doses before DHE was given.
Drugs used were: pentobarbitone sodium, gallamine triethiodide (May and
Baker); acetylcholine iodide, sodium cyanide (B.D.H.); dopamine hydrochloride
(Koch Light); dihydro-/f-erythroidine hydrobromidc (Merck. Sharp and
Dohme).
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Results
Effects of DHE injections on chenwreceptor response to ACh, NaCN, C02 and
dopamine
Doses of ACh, NaCN, C02 and dopamine were injected I.C. in random order
with 5 min between successive injections. The sequence was performed before
and after injecting DHE (0-1-5 mg. kg-1 I.C.). The OTmg.kg-1 dose (given
i.v.) is effective in greatly reducing Renshaw cell responsiveness to stimulation
or ACh in cats [Eccles et «/., 1954], but it caused only a 50"/;, reduction in the
chemoreceptor excitation evoked by ACh during preliminary experiments in the
present series. Consequently, higher doses of DHE (l-5mg.kg~') were used in
the majority of experiments to ensure a greater antagonism of the ACh
response. These doses of DHE caused a fall in B.P., probably as a consequence
of ganglionic blockade [Merigan. Leary and Slater, 1955], and this was
compensated for by the slow i.v. infusion of dextran-glucose solution.
Figure 1 illustrates the results obtained when DHE 1 nig. kg-1 was
administered initially and followed by a further dose of 2mg.kg~' later in the
experiment. Responses to ACh were greatly reduced but not abolished by DHE
1 mg.kg~l, whereas those to C02 and NaCN were potentiated (dose-response
curve shifted to the left). The additional dose of 2mg.kg~' DHE caused a
further reduction in the excitatory response to ACh and an inhibition of the
response to C02. The potentiation of the NaCN effect which had occurred after
lmg.kg-1 DHE was reversed by 2mg.kg_l, the responses becoming similar
to those in the pre-DHE control (see Fig. 1). After 60 min without drug
treatment responses returned towards control levels, although those to ACh
were still reduced slightly and the effects of NaCN and C02 were slightly
potentiated. Thus, the action of DHE (1 mg + 2mg.kg_l I.C.) lasted for about
60 min.
The difficulty with performing dose-response studies over 50-60 min after
administering DHE was that the effect of DHE was gradually wearing off, as
could be seen by checking the response to a single dose of ACh at intervals
after the administration of DHE. However, the reduction of the ACh effect
seemed to be fairly constant for 10 20 min, so it was decided to use only a
single submaximal dose of each test substance before and after DHE, which
meant that a cycle could be completed within 15-20 min.
The results obtained from single-dose experiments are shown in Fig. 2, which
also includes neurograms from an individual experiment. It can be seen that
DHE (lmg.kg ') substantially reduced the response to ACh. but potentiated
the action of C02. Ip terms of the average discharge (Ax). the response to
NaCN was decreased by this dose of DHE, whereas the total discharge showed
a slight increase. The addition of a further 2 mg. kg 1 DHE reduced the
responses to C02 and NaCN. The greatest reduction in the NaCN response
was in Ax, and this arose because the response lasted longer, something which
can be clearly seen in the neurograms of Fig. 2. In two experiments a single
dose of 5mg.kg ' DHE virtually abolished the excitatory action of ACh,
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reduced thai of CO,, slightly reduced the A.v response to NaCN. hut increased
the cyanide-induced AL.v response (see Fig. 2).
Dopamine (5/ig l.C.) inhibited chemoreceptor discharge, as described
previously [Docherty and McQueen. 1978]. DHH lmg.kg 1 reduced the
response to 82 3 + 31 (#i = 3) of the pre-DHE inhibition, a somewhat variable
effect as can be seen from the standard error.
Effect of DUE on spontaneous chenwreceplor discharge
Injections of DHE (0-1—5 mg. kg""1) elicited either no change in spontaneous
discharge during the 30 sec post-injection period (3 experiments), a slight
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discharge (1 experiment). The immediate effects of DHE on spontaneous
chemoreceptor discharge were slight and did not appear to be dose-related.
The possibility that DUE had a delayed effect on spontaneous discharge was
investigated by comparing the pre-injection spontaneous discharge observed just
before injecting single doses of ACh, NaCN, C02 and dopamine. Before DE1E
(1 mg.kg-1 EC.) the average discharge was 1-8 + 0-5 c.p.s., and this increased to
2-4 + 0-8 c.p.s. after DHE (u=12 tests in 3 cats), an increase which was not
statistically significant (P> 005; Wilcoxoti signed rank test for two related
samples).
ACh 100 jjg NaCN 5pg C02 0-3 ml
B
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Fig. 2 The upper part of the figure shows neurograms, taken from one experiment, which illustrate
chemorcccptor responses to ACh. NaCN and C02: A before DHE; B after 1 mg.kg" 1
DHE I.C.; C after an additional 2mg.kg ' DHE l.C. Injections were made during the
period represented by the short horizontal bar, and the dots are I sec time marks.
The lower part is pooled data showing chemoreceptor responses (AZ.x and Ax) to ACh
100/ig, NaCN 5//g and CO, 0 3 ml expressed as mean percentages±s.e. of mean of the pre-
DHE responses represented by A the black rectangles (=l(K)"„). B is after 1 mg.kg"1
DHE (/i = 3 cats) and C after an additional dose of 2mg.kg"' DHE. The responses in D
were obtained following a single dose of 5 mg kg 1 DHE in two experiments.
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Effects of DHE infusions on responses to ACh, NaCN, and C02
In order to try and obtain a steady-state concentration of DHE in the carotid
body, infusions of DHE were made into the common carotid artery via the
thyroid artery, and test substances injected via the lingual artery. Responses were
obtained 5 min before starting a 65 sec infusion of DHE, and again 60 sec into
the infusion period. Responses to ACh recovered within 20 min of stopping the
infusion (2-5 mg. min -'), so in two experiments single doses of the test
substances were administered in random order with at least 20 min between
successive infusions. Results obtained are illustrated in Fig. 3. The low dose of
DHE reduced the response to ACh and slightly potentiated the effects of ACh
and NaCN. The higher dose (2-5 mg. min - 1) virtually abolished the excitatory
action of ACh and greatly reduced the response to C02. The total increase in
discharge (ALx) evoked by NaCN was unaltered, but the average (Ax) was
reduced (i.e. the same number of impulses occurred, but over a longer time).
INFUSION INFUSION
Fit;. 3 Effects of infusions of DUE on chemoreceptor responses to ACh, NaCN and C02. In one
experiment 0-Img.min"1 was infused I.C. for 65 sec in a 4-5kg cat and the stimulant
injected at 60 sec. Responses evoked by the single chemoreceptor unit counted were
expressed as a percentage of the response obtained during an infusion of Locke solution
(black rectangle = 100"/,,) and are shown as AEx and A.x.
In a second experiment 2-5 mg.minwas infused I.C. into a cat weighing 3 4 kg and
responses obtained from a 3-unit chemoreceptor recording are shown.
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The 2-5mg.min 1 infusion caused a slight fall in B.P. which was not
compensated.
Discussion
Low doses of DHE greatly reduced the excitatory action of ACh on the carotid
chemoreceptors, but did not reduce responses evoked by NaCN or C02.
Indeed, after injecting low doses of DHE, or during the infusion of low
concentrations of DHE, responses to C02 and NaCN were potentiated. This
finding is in accord with previous reports that responses to NaCN can be
potentiated by nicotinic-blocking drugs [e.g. Dontas and Nickerson, 1956;
Byck, 1961; McQueen, 1977], These observations are compatible with
endogenous ACh exerting an inhibitory effect on the chemoreceptors, a
possibility which warrants serious consideration in view of the finding that
chemoreceptor inhibition is the predominant action of ACh in rabbits
[Docherty and McQueen, 1979],
Higher doses of DHE caused a further reduction in the chemoexcitatory
action of ACh, although the inhibition was not as potent or as long-lasting as
that caused by mecamylamine [McQueen, 1977], which may mean that the
carotid body nicotinic receptor mediating the excitatory action of ACh is more
akin to that in ganglia than that at the neuromuscular junction or on
Renshaw cells [see Curtis and Ryall, 1966]. The high doses of DHE reduced the
excitatory action of C02, and this could be interpreted as meaning that ACh is
involved as an excitatory neurotransmitter in the process of chemoreception.
The fact that the response to NaCN was little affected by DHE, or by
mecamylamine [McQueen, 1977; but cf. Nishi and Eyzaguirre, 1971], is not
consistent with the 'cholinergic hypothesis', but could be explained as being a
consequence of NaCN, unlike physiological stimuli, acting via a mechanism not
involving an excitatory cholinergic transmitter.
However, the reduction in response to CO, was seen only with very high
doses of DHE injected close-arterial to the carotid body (i.e. 15 mg single dose),
and at these doses DHE may no longer be acting as a selective nicotinic
antagonist and could well be affecting other putative neurotransmitters, or
their receptors, within the carotid body (e.g. dopamine, noradrenaline, 5-HT,
polypeptides). The argument that insufficient blocking drug is reaching the
'synaptic' site at which the postulated excitatory transmitter acts (see
Introduction) is not applicable to DHE because the drug penetrates the C.N.S.
very well [Curtis and Eccles, 1958], and reasonably be expected to penetrate
the carotid body tissues equally effectively. Even if the local concentration of DH E
at the 'synaptic' site was insufficient to block completely the responses to NaCN
or CO, [see Eccles el al., 1954; Curtis and Eccles, 1958] it should have reduced
the total discharge evoked. The fact that responses to NaCN and C02 were
potentiated by lower doses of DHE seems more likely to be of physiological
interest than the reduction in response to CO, seen after massive doses of
DHE. However, the possibility that ACh acts as an excitatory transmitter.
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although considered very unlikely for the reasons stated, cannot entirely be
excluded.
In the present experiments DHE had no immediate or long-term effect on
spontaneous chemoreceptor discharge, in contrast to the marked stimulation
found in vitro by Eyzaguirre and Zapata [1968b], and nor was the reduction in
response to ACh as long-lasting as they found. These disparities could result
from fundamental differences in the preparations. Changes occur in the in vitro
carotid body preparation when blood is excluded [Joels and Neil, 1968]—the
in vivo preparation also has its limitations, such as changes in blood flow which
can complicate the interpretation of drug effects.
There is good evidence that ACh is present in the carotid body [Eyzaguirre,
Nishi and Fidone, 1972; Fidone, Weintraub and Stavinoha, 1976] and
Eyzaguirre's elegant Loewi-type experiments in vitro [Eyzaguirre and Zapata.
1968a] suggested that ACh, or a very similar substance, is released during
hypoxia. Since the evidence seems to be against ACh being an excitatory
transmitter in the carotid body, what is its function there? It could be that
during hypoxia ACh is released at more or less the same time as any excitatory
transmitter(s), a concept which has been advanced for other tissues [e.g.
Jenkins, Marshall and Naysmyth, 1976], or secondary to the increased sensory
activity, and acts to modify or inhibit chemoreceptor discharge (as discussed
above)—or has some other non-excitatory influence. In the Loewi-type
preparation, discharge of the 'downstream' or recipient carotid body may be
increased by ACh, released from the hypoxic donor carotid body, acting on the
more accessible 'extra-synaptic' nicotinic receptors [Eyzaguirre and Zapata,
1968a] in a non-physiological manner [Brown and Gray, 1948; Gray and
Diamond, 1957; McQueen, 1877] and masking any inhibitory action of ACh.
In conclusion, further studies are needed to establish the mechanism whereby
ACh exerts its inhibitory action on the carotid chemoreceptors, and to
determine whether this effect is of physiological significance.
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ALTERED DOPAMINE D2 RECEPTOR FUNCTION IN THE CAROTID BODY OF RABBITS
TREATED CHRONICALLY WITH DOMPERI DONE
D.S. McQueen*, A.K. Mir+ & S.R. Nahorski+, Department of Pharmacology, University
of Edinburgh, Edinburgh, EH8 9JZ, and "'Department of Pharmacology & Therapeutics,
University of Leicester, Leicester, LEI 7KH.
Previous studies on the rabbit carotid body have provided evidence for a dopamine
P2-receptor which, upon activation, causes depression of chemosensory discharge
(Mir et al, 1983). The present study was undertaken to investigate the effect of
chronic treatment with the selective dopamine D2 antagonist dcnperidone on rabbit
carotid body dopamine D2 receptors, using a combination of biochemical and neuro-
pharmacological techniques.
Rabbits (New Zealand White) were given domperidone orally (2-5 mg/kg/day in
drinking water) for 8 weeks and were used for experiments 4-9 days after with¬
drawal of the drug.
For biochemical studies, carotid bodies were removed frcm animals under
anaesthesia and washed membranes were prepared for D2 receptor binding assays
(Lazareno & Nahorski, 1982). Assays were performed at a single saturating
concentration of ^H-domperidone (0.45 nM) and the non-specific binding was defined
by 5 pM d-butaclamol. Tissue amine concentrations were also determined using
HPLC/EC, as previously described (Mir et al, 1982). Plasma danperidone levels
were monitored after oral dosing by modification of the method of Creese & Snyder
(1977). Carotid body content (proles/carotid body) of noradrenaline 102 ± 28,
dopamine 323 ± 57 and 5-hydroxytryptamine 122 ± 38 (n=5) in dcmperidone-treated
animals were not significantly different frcm vehicle-treated controls, 85 ± 19,
287 ± 48 and 103 ± 25 (n = 4) respectively, but binding of ^l-darperidone to
carotid body membranes was increased by 63% (5.9 ± 1.1 fmoles/carotid body)
conpared to the control value of 3.6 ± 0.55 fmoles/carotid body (P < 0.05). For
neuropharmacological experiments, rabbits were anaesthetised with pentobarbitone
(40 mg/kg i.v.), artificially ventilated with air and paralysed by gallamine
(3 mg/kg i.v.). Electrical activity was recorded frcm the peripheral end of a
sectioned sinus nerve and the depression of chemosensory discharge associated
with intra-carotid injection of dopamine was studied (see Docherty & McQueen,
1979). In untreated animals the ID50 (injected dose of dopamine causing a 50%
reduction in 'spontaneous' discharge averaged over the 5 s post-injection period)
was 3.8 ± 0.9 (n = 13) nmoles, whereas in donperidone-treated rabbits the ID50
was 0.59 ± 0.26 (n = 3) nmoles (P 4 0.01). The ID50 for the dopamine D2 receptor
agonist LY 141865 (Tsuruta et al, 1981) was 7.3 ± 1.9 (n = 4) nmoles in controls
and 2.8 ±2.1 (n = 3) in the chronically-treated animals.
These results show that following a period of chronic treatment with the dopamine
receptor antagonist donperidone, there is an. increase in the nunber of dopamine
D2 receptor binding sites in the carotid body, and this is accorrpanied by an
increase in the chanodepressant effect of injected dopamine. The responsiveness
of the chronically-treated animals to physiological stimuli e.g. hypoxia, are
being investigated in detail.
We acknowledge financial support frcm the MRC.
Docherty, R.J. & McQueen, D.S. (1979) J. Physiol. 288, 411-423.
Lazareno, S. & Nahorski, S.R. (1982) Eur. J. Pharmacol. 81, 273-285.
Mir, A.K. et al (1982) Brain Res. 252 , 335-342.
Mir, A.K. et al (in press) Brain Res.
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EFFECTS OF SELECTIVE DOPAMINE RECEPTOR AGONISTS
AND ANTAGONISTS ON CAROTID BODY CHEMORECEPTOR
ACTIVITY.
D. S. McQUEEN, Department of Pharmacology,University of
Edinburgh Medical School, 1 George Square, Edinburgh, EH8
9JZ, Scotland.
INTRODUCTION
The predominant effect of injecting dopamine into the
carotid artery of cats and rabbits in vivo is a depression
of carotid chemosen3ory discharge which can be reduced or
abolished by dopamine antagonists such as flupenthixol or
haloperidol (e.g. Black et al, 1972; Docherty 4 McQueen,
1978; 1979).
Various classifications have been suggested for
dopamine receptors, but a commonly accepted proposal is that
they can be divided into two general categories, D-1 and
D-2. Activation of D-1 receptors stimulates adenylate
cyclase and leads to increased formation of cyclic AMP,
whereas activation of D-2 receptors does not (3ee Kebabian A
Calne, 1979). Dopamine can affect both types of receptor, as
can other agonists such as apomorphine and antagonists such
as haloperidol. In order to characterise the receptor
involved in dopamine-induced depression of chemoreceptor
discharge in cats and rabbits, the present experiments were
performed u3ing 'selective' dopamine receptor agonists and
antagonists. The effects of dopamine receptor antagonists on
the responses of chemoreceptors to various physiological and
pharmacological stimuli were also investigated.
METHODS
Experiments were performed on seven cats and five
rabbit3 which were anaesthetised with pentobarbitone,
paralysed by gallamine (3 mg/kg i.v.) and artificially
ventilated with air. Chemoreceptor activity was recorded
from the peripheral end of a sectioned carotid 3inus nerve
(see McQueen (1977) for full details) and the ip3llateral
ganglio-glomerular (sympathetic) nerves were cut. Drugs were
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Injected Into the ip3llateral common carotid artery (i.e.).
Results were expressed as described previously (McQueen,
1977; Docherty 4 McQueen, 197-8).
The results obtained confirmed that depression of
'spontaneous' chemosensory discharge is the predominant
effect of dopamine (0.1-50 ug i.e.) in cat3 and rabbits. The
'selective' D-2 receptor agoni3t LY-1M865 (Tsurata et al,
1981) proved a very effective depressant of chemoreceptor
discharge, being about 50 times more potent and
longer-lasting than dopamine in cats, and slightly le3s
potent in rabbits (see Figs. 1 and 2). The D-1 receptor
agonist SKF-38393 (Stoof 4 Kebabian, 1981), in contrast, wa3
very ineffective both in rabbits and cat3 and was at least
1000 times less potent than LY-1I)1865. Relatively high doses
did cause a slight depression of discharge (Flg3. 1 and 2).
Experiments with the D-2 receptor antagonists (-)
sulpiride and domperidone showed them to be of similar
potencies (mw 3^1 and 397 respectively) in causing
dose-related decreases in the chemodepre3sant responses to
dopamine and LY-141865- Threshold effects were obtained with
doses as low as 0.1 ug/kg i.e., and higher doses (0.2 mg/kg
i.e.) virtually abolished the responses. The effects of
domperidone were very long-lasting ( > hrs). Both
antagonists were effective in cats and rabbits (Fig. 3), and
there was little evidence for any appreciable
chemoexcitatory action of either dopamine or LY-1U1865
following substantial reduction of their chemodepressant
effects by the antagonists.
Background (spontaneous) chemoreceptor discharge was
somewhat variably affected by the D-2 antagonists (Fig. it),
being sometimes increased for long periods following low
do3es, but in other experiments being unaltered by doses as
high as 0.2 mg/kg i.e. In general, there wa3 a tendency for
background discharge to increase following domperidone or
sulpiride in cats, but there was less effect in rabbits.
Responses to stimulants such as hypoxia, cyanide, CO and
ACh were also variably affected, particularly in cats. In
rabbits responses to hypoxia, cyanide and CO., were reduced
by domperidone, but the chemo-inhlbition associated with ACh
was not much affected. Most of the studies were performed
after administering 0.01 mg/kg antagonist, but
administration of a further 0.2 mg/kg i.e. generally didn't
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Figure l. Chemoreceptor discharge recorded from a cat carotid
rinuT nerve. The neurograms show the effects of injecting
(bar) the drug vehicle (Locke solution), dopamine, the 0-2
agonist LY-141865, and the D-l agonist SKF-38393.
Note that LY-141865 is more potent than dopamine, and
very much more potent than SKF-38393. The drug vehicle
(0.1 ml unbubbled Locke + 0.2 ml wash of Locke bubbled with


















Figure 2_. Chemoreceptor dose-response data obtained from a ca
Cupper part of figure) and a rabbit (lower part). The de¬
pression of discharge observed following injection of various
dopamine receptor agonists (dopamine, LY-141865, SKF-38393)
has been plotted against the dose injected (log,o scale) and
lines fitted to the data by eye. The reduction in discharge
(-AEx) is the difference between the number of action potent¬
ials counted during the period when the discharge was depress¬
ed, and the number anticipated in that period had discharge
(continued at the pre-injection frequency (see Docherty &
McQueen, 1978).
In the ca.t LY-141865 (mw 292) was about 50 times more
potent than dopamine (mw 190), and over 1000 times more potent
than SKF-38393 (mw 292) on a molar basis. The corresponding
ratios in one rabbit were ^10 and 2000.
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Figure 3. Chemoreceptor dose response data obtained from two
cats. The left-hand panels show the chemodepression caused
by dopamine before and after injecting a single dose of A
domperidone or B (-) sulpiride.
The right-Rand panels show the effects of LY-141865 in
the same experiments before and after the single dose of A
domperidone and B (-) sulpiride. See Fig. 2 for details re¬
garding the method of quantification.
To obtain the same chemodepression after domperidone as
before, it was necessary to increase the dose of dopame by a
factor of - 6 and that of LY-141865 by 4. The correspond¬
ing ratios after (-) sulpiride were 5.5 for dopamine and 14
for LY-141865.
In 1 wo rabbits (data not shown) the dose of dopamine had to be
increased by an average factor of -7 following domperMdone
(10 ug/kg i.e.), while in another rabbit the ratios were 6 for








figure 4. Chemoreceptor activity measured in cats and rabbits
after" "acihii ni steri ng domperidone or (different experiments)
sulpiride (0.01-0.2 mg/kg i.e.). Results are expressed as a
percentage change from control values obtained before the
antagonist was given and are shown as the mean (horizontal bar)
as well as the individual values, the latter providing an
estimate of the variability encountered.
Responses to mid-range doses of NaCN, CO2-equi1ibrated
Locke solution and ACh were calculated as ££x. For hypoxia,
chemoreceptor discharge plateaued about 2 min after switching
to ventilating the lungs with 10%02:90%N2, and was then aver¬
aged over a 30s period. Background (spontaneous) discharge
was averaged from ten separate 30s control periods at differ¬
ent times before and after the antagonist was administered.
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depression of chemoreceptor discharge observed following the
i.e. injection of either noradrenaline (5 ug) or adrenaline
(5 ug) was abolished by (-) sulpiride (0.2 mg/kg i.e.),
without affecting the delayed increase in discharge that
occurs in cat3.
DISCUSSION
If the classification of dopamine receptors into D-1
and D-2 types can be applied validly to the carotid body,
then the results obtained with selective agonists and
antagonists suggest that the receptor Involved in
dopamine-lnduced depression of chemoreceptor discharge in
cats and rabbits in vivo has the characteristics of a
dopamine D-2 receptor (i.e. which doe3 not stimulate
adenylate cyclase). It would appear that adrenaline and
noradrenaline can also affect this receptor, directly or
indirectly, causing a depression of chemo3ensory discharge.
The lack of potency associated with the D-1 agonist
SKF-38393, coupled with the lack of effect of dopamine after
high doses of the D-2 antagonist, suggests that either D-1
receptors are not present in the carotid bodies of cats and
rabbits, or else they have no significant effect on
chemosensory discharge under the conditions of the present
experiments.
Further studies are needed to determine why responses
to certain physiological and pharmacological stimuli are
variably affected by D-2 antagonists, and these may help to
establish the physiological role of the carotid body's D-2
dopamine receptors.
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DISCUSSION
ACKER: Is anything known about the diffusion constants of
these drugs. In tumour tissue it has been found that
different drugs have different diffusion constants within
the ti33ue. If this applies to your experiments, the actual
concentration of the drug at the receptor may be very
different for the various compounds.
McQUEEN: I cannot answer that question. I assume that the
drugs penetrate readily. The problem is that if you have a
compound that appears to be inactive, and I take your point
about diffusion, the only way to decide if it really is
inactive is to increase the dose. In the in-vivo experiment
you then become worried about systemic effects.
NAHORSKI: May I say that it is very unlikely that the
selective effects of D1 A D2 antagonists could be explained
on the basis of diffusion differences.
EYZAGUIRRE: I think your first slide 3howed that the
depressant effect of dopamine at a dose of 2.5 microgrammes
was followed by a rebound excitation. In your last slide,
when you applied one of the blockers, the inhibitory effect
of dopamine was apparently converted to an excitatory one.
McQUEEN: I find this excitation business very tricky because
in general with low doses you never see excitation in the
first ten seconds or so. However, in some experiments, you
get an increase in the discharge at a later time, whilst in
other experiments the discharge returns to pre-lnjection
levels. I have tended to interpret this variability in
response at some time after the injection to be due to
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changes in the environment of the receptor. Why these
changes occur in some experiments and not in others, I have
no idea.
EYZAGUIRRE: Do you see thl3 excitation with larger doses?
McQUEEN: With large dose3 I am concerned about the systemic
effects of the compound. Certainly you quite often get an
Increase in discharge but you always get systemic effects,
3uch as blood pressure changes, at the same time. Hence,
once you go more than thirty seconds beyond the primary
injection, effects on the chemoreceptors may be indirectly
mediated.
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Direct Biochemical and Neuropharmacological Identification of Dopamine
D2-Receptors in the Rabbit Carotid Body
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Key words: carotid body— chemoreceptor afferent discharge — dopamine — D,-receptors— D2-receptors— domperidone—
sulpiride — LY 141863 — SK & F 38393 — hypoxia — adenylate cyclase — cyclic AMP
Dopamine D2-receptors were directly identified in receptor binding assays with washed particulate preparations of rabbit carotid
body using the selective ligand, [3H]domperidone. High affinity, saturable specific binding of [3H]domperidone was clearly demon¬
strable and chronic section of the sinus nerve resulted in a 32% decrease in the labelling of the dopamine D2-sites. Adenylate cyclase
activity was also detected in rabbit carotid body homogenates and although this enzyme was stimulated 4-fold by 10 mM sodium fluo¬
ride, neither dopamine nor isoprenaline significantly altered basal activity. On the other hand, in the intact carotid body incubated in
vitro, 10~s M isoprenaline increased the basal cyclic AMP content 6-fold, though dopamine was again ineffective. The effect of various
selective dopamine receptor antagonists and agonists was also studied on chemoreceptor afferent discharge. The results confirm that
depression of 'spontaneous' chemosensory discharge is the predominant effect of dopamine (0.01-100 pg) in rabbits. The 'selective'
D2-agonist, LY 141865, proved very effective (ID^, 3.3 nmol) and was equipotent with dopamine (IDj^^), whereas, the D,-agonist,
SK & F 38393, was very ineffective (ID^ 150). The D2-antagonists domperidone and (—)-sulpiride produced a dose-related decrease
in the chemodepressant responses to dopamine and LY 141865. However, there was no evidence for any appreciable excitatory action
of either of these agonists after blockade of their chemo-depressant effects. The D2-antagonists variably affected the spontaneous ac¬
tivity, there being an increase in discharge on average, whereas responses to hypoxia, cyanide and C02 were reduced. The present re¬
sults from biochemical and neuropharmacological studies, provide strong evidence for the presence of functional dopamine D2-recep-
tors in the rabbit carotid body, and suggest that the receptor involved in dopamine-induced depression of chemosensory discharge is of
D2-type.
INTRODUCTION
The chemoreceptors of the carotid body are senso¬
ry receptors which initiate respiratory and cardiovas¬
cular reflexes in response to hypoxia, hypercapnia or
acidosis2-15. There is no agreement about the identity
of the primary receptor element (cells or nerve termi¬
nals) or what mechanisms are responsible for the on¬
set of sensory discharge in the afferent nerve fibre
(see ref. 10). Catecholamines, particularly noradren¬
aline and dopamine, are present in the Type I cells
of various mammalian carotid bodies26 and changes
in the output of these amines during hypoxia1 lu.24
may modulate chemosensory discharge25-31-38, but
their precise function remains to be established.
* To whom correspondence should he addressed
Studies on the effects of exogeneous dopamine on
carotid chemosensory activity have shown that it
commonly depresses the chemoreceptors, but can
also excite them, or cause biphasic changes in dis¬
charge10. The suggestion has been made that there
are species differences in the response of carotid che¬
moreceptors to dopamine4, but since investigators
have used different experimental preparations and
doses of dopamine, the results obtained are not really
directly comparable, regardless of species. Experi¬
ments with neuroleptic drugs such as spiroperidol,
haloperidol and a-flupenthixol8-9-38 have shown that
these drugs reduce or block the chemodepressant ef¬
fects of dopamine, but the excitatory effect of dop¬
amine on the chemoreceptors, when obtained, is
0006-8993/84/503.00© 1984 Elsevier Science Publishers H. V
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generally unaffected. However, although these
agents are known to be dopamine antagonists, their
specificity towards dopamine receptors is relatively
small32 both in central and peripheral tissues. One in¬
terpretation of the available evidence is that dop¬
amine has dual actions and can exert opposing effects
on the carotid body chemoreceptors, possibly by act¬
ing on more than one type of receptor.
Various classifications have been suggested for
multiple dopamine receptors6-34. Probably the most
widely discussed proposal, however, is that there are
two types of dopamine receptors, designated D, and
D218. Dopamine D^receptors are positively coupled
to the enzyme, adenylate cyclase, whereas the dop¬
amine D:-receptor is either not coupled to the en¬
zyme or is negatively coupled in some tissues6.
In the present study we describe experiments
which were designed to characterize the dopamine
receptors of the rabbit carotid body by using a combi¬
nation of radioligand binding, biochemical and neu-
ropharmacological techniques. The selective dop¬
amine D2-receptor ligand, [3H)domperidone'-2tl was
used to demonstrate the presence and localisation of
dopamine D2-receptors in the carotid body. Adeny¬
late cyclase activity was measured in carotid body ho-
mogenates in order to investigate whether the dop¬
amine receptors in this organ are coupled to this en¬
zyme. In addition, we also studied the receptor in¬
volved in the depression or inhibition of chemosenso-
ry discharge evoked by dopamine in vivo by deter¬
mining the effects of 'selective' dopamine receptor
agonists (LY 141865, D237; SK & F 38393. D,-35--36)
and antagonists (domperidone19, (—^sulpiride18-'7.
D2) and measuring the response of the chemorecep¬
tors to various physiological and pharmacological
stimuli. A preliminary abstract of part of this work
has appeared elsewhere2-3-27.
MATERIALS AND METHODS
Experiments were performed on male New Zea¬
land white rabbits (2.0-4.5 kg), given food and water
ad libitum and kept under circadian illumination.
Surgical procedures
The dissection of the carotid bodies and the proce¬
dure for denervation were as previously described26,
and performed in rabbits which were anaesthetized
with a mixture of ketamine (22 mgkg-1) and xylazine
(3 mg kg-1) given intravenously. For electrophysio¬
logical recordings the rabbits were anaesthetized
with pentobarbitone sodium (35 mgkg-1 i.v. supple¬
mented by administration of 10% of the initial dose
every 1-2 h). The trachea was cannulated and the
animal artificially ventilated with air and paralyzed
by gallamine triethiodide (3 mgkg-1 i.v.). For full
details of the experimental techniques see Docherty
and McQueen9.
Recording of chemoreceptor afferent nerve discharge
The carotid sinus nerve on one side was cut cen¬
trally. desheathed, and dissected into fine filaments.
Electrical activity from chemosensory fibres in the
filaments was recorded using bipolar platinum/iridi-
um electrodes and an amplifier system, as previously
described and provides an index of activity within the
carotid body sensory complex9-22. The ipsilateral
ganglioglomerular (sympathetic) nerves were cut,
and a fine catheter inserted via the lingual artery into
the common carotid artery, with its tip positioned
about 1 cm caudal to the carotid bifurcation, for
close-arterial injection of drugs (0.1 ml washed in
with 0.2 ml Locke solution which had been equili¬
brated with 5% C02-95% air at 37 °C over 1-2 s pe¬
riod, with a 5 min interval between doses) to the ca¬
rotid body. Nerve activity was recorded on magnetic
tape and subsequently processed using a pulse height
(window) discriminator (WP1 120) to select chemo¬
receptor potentials (generally 1-3) which were
counted every 0.1 s over a period of from 60 to 480 s
by a micro-computer (Commodore 3032), which also
calculated the mean discharge frequency (x cps) and
the integrated response counts) of the recorded
unit(s) to a drug or procedure.
Radioligand binding
Binding methods were similar to those described
previously for rat corpus striatal tissue20. Carotid
bodies (approx. 1 mg wet weight) were homogenized
in 100 vol. ice-cold buffer (Tris-HCl, 50 mM.
pH 7.6) with a Polytron homogenizer (setting 6,
15 s) and centrifuged at 48,000 g for 15 min at 4 °C in
a Sorvall RC5 centrifuge. The pellet was resus-
pended and the membranes were washed 3 times.
The amount of residual catecholamines were assayed
m aliquots of the membrane preparation using HPLC
I
and electrochemical detection as described previous¬
ly26. Membranes (100-200 pg protein) equivalent to
two carotid bodies in 2 ml Tris-HCl buffer (50 mM,
pH 7.6) were incubated to equilibrium in polypropy¬
lene tubes for 30 min at 22 °C for [3H]domperidone
and 20 min at 37 °C for [3H]spiperone, collected by
rapid filtration through glass-fibre (Whatman GF/C)
filters, washed rapidly with 15 ml buffer, suspended
in 3.5 ml Fisofluor 1, and the radioactivity was mea¬
sured in a liquid scintillation counter (Packard) at
about 40% efficiency. BSA (0.01%) was used in ra¬
dioligand stock solutions to reduce the binding of
[3H]domperidone to plastic tubes. Specific binding of
[3H]domperidone was defined as binding displaced
by 5 /rM D-butaclamol and that of (3H]spiperone de¬
fined by either 50 //M (±)-sulpiride or 5 /rM D-buta-
clamol20.
Adenylate cyclase activity and cyclic AMP assays
For the measurement of adenylate cyclase activity,
tissue was gently homogenized (teflon-glass; 1 carot¬
id body/100 ^1) in Tris-maleate buffer (2 mM, pH
7.4; EGTA 2 mM). 100 //I of the homogenate was
added to 150 /A of Tris-maleate buffer (pH 7.4 con¬
taining MgS04 4 mM; EGTA 0.2 mM; IBMX
1 mM) and 50 p\ of stimulating drug giving a final
concentration of 200 /tM dopamine or 10 ^M isopre-
naline, in the presence of 100 //M GTP. Following a
preincubation period of 10 min on ice, the tubes were
incubated for 1 min at 30 °C. ATP (50 //l) was added
to give a final concentration of 1 mM and the tubes
were further incubated for 10 min at 30 °C. Blanks
were prepared by boiling immediately after ATP ad-
lition. Cyclic AMP generation was also monitored in
intact carotid bodies. These were preincubated for 45
min in Krebs-Ringer-bicarbonate buffer at 37 °C,
gassed with 95% 02-5% C02. Subsequently, they
were transferred to fresh buffer containing the cate¬
cholamines, IBMX (1 mM) and 0.2 mM sodium
metabisulphite, and incubated for 15 min at 37 °C. In
both assays incubations were terminated by transfer¬
ring to a boiling water bath for 3 min. Homogenates
were centrifuged at 10,000 g for 15 min and cyclic
AMP assayed in 100 ,//I aliquots of the supernatant
using a protein binding saturation method5.
Drugs
[TlJSpiperone (25.7 Ci/mmol) and [3H]domperi-






















nsb (d-but.) (d-but.) (±-sulp.)
Fig. 1. Membrane preparations of rabbit carotid body were in¬
cubated with saturating concentrations of [3H]spiperone
(1.0 nM) and PHjdomperidone (0.4 nM). Specific [3H]spipe-
rone binding was measured as the difference between total
binding and binding in the presence of either 5 //M D-butacla¬
mol or 50//M (±)-sulpiride. Incubations were performed at
37 °C for 20 min. Specific [3H]dompcridone binding was de¬
fined by 5 «M (-t-)-D-butaclamol and incubations performed at
22 °C for 30 min. Results are expressed as fmol [3H)spipcrone
and pHJdompcridone bound (carotid body ± S.E.M.. n = 3).
gland Nuclear and [5',8-3H]cyclic AMP (45 Ci/m¬
mol) from Radiochemical Centre, Amersham, U.K.
Cyclic AMP (free acid), guanosine-5-triphosphate
and adenosine-5-triphosphate (Boehringer-Mann-
heim, Sussex, U.K.). Dopamine hydrochloride,
(—)-isoprenaline D-bitartrate, 3-isobutyl-l-methyl-
xanthine (IBMX) and bovine serum albumin (Sigma
Chemicals, Dorset, U.K.). The following were gen¬
erously donated: domperidone (by Janssen Pharma¬
ceuticals, Beerse. Belgium), D-butaclamol (Ayerst.
Hants, U.K.), (±)-sulpiride (Delagrange. Paris.
France), (—)-sulpiride (Ravezza Pharmaceuticals,
Milan), LY 141865 (Eli Lilly, Hants, U.K.), SK & F
38393 (Smith Kline & French, Herts, U.K.).
RESULTS
(■'H/Spiperone and /-'Hjdomperidone binding assays
In initial attempts to directly label putative dop-
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Free ^H-Domperidone (nM)
Fig. 2. Increasing concentrations of (3H]domperidone were incubated with rabbit carotid body membrane preparations. Specific bind¬
ing (□) was measured as the difference between total binding and non-specific binding (O) in the presence of 5 //M ( + )-butaclamol.
Incubations were carried out at 22 °C for 30 min. The data shown are representative curves for experiments performed in triplicate.
bound/free
amine receptors in rabbit carotid body-washed par¬
ticulate membrane preparations, we compared two
ligands, [3H]spiperone and [3H]domperidone. The
specific binding of these ligands, quantified as the dif¬
ference between total binding and binding in the
presence of 5 ,«M D-butaclamol, was very similar
(Fig. 1). However, in view of experience with these
ligands in the central nervous system16-20 and the indi¬
cation that specific binding of [3H]spiperone defined
by the D2 antagonist, sulpiride, was lower than that
displaced by D-butaclamol, it was decided that the
more specific D2 ligand, [3H]domperidone. would be
used in all further studies.
Carotid body membranes were incubated with 5
concentrations (0.02-0.8 nM) of [3H]domperidone
for 45 min at 22 °C. Results showed high affinity
binding, saturable over the tested concentration
range and a specific-to-total binding ratio of about
50% at 0.2 nM [3H]domperidonc (Fig. 2). Scatchard
analysis of specific binding gave a value for the equi¬
librium dissociation constant (Kn) of the 0.18 ±
0.05 nM (n = 3) and binding site maxima 3.2
± 0.3 fmol/carotid body. Hill analysis of the satu¬
ration data gave a Hill coefficient (nH) of 1.1. The
Kd value for [3H]domperidone in the carotid body is
very close to that reported for this ligand in the rat
striatum20.
Effect of chronic denervation
In order to obtain information concerning the lo¬
calization of the specific binding sites, we have exam¬
ined the effect of chronic denervation on [3H]dompe-
ridone binding. Membrane preparations of the nor¬
mal and denervated carotid bodies were incubated
with a single saturating concentration (0.4 nM) of the
ligand as described in the text. Chronic denervation
of the carotid sinus nerve resulted in a 32% decrease
in specific [3H]domperidone binding to denervated
carotid body membranes when compared to sham-
operated carotid bodies (Fig. 3).
Assay of adenylate cyclase and cyclic AMI' in vitro
Homogenates of rabbit carotid body contained a









Fig. 3. In a group of rabbits the carotid sinus nerve was unilater¬
ally transected under anaesthesia, 14 days prior to the binding
assay. The carotid body from the intact side was used as a con¬
trol. Membrane preparations of the normal and denervated ca¬
rotid bodies were incubated with saturating concentrations of
PH)domperidone (0.4 nM) and non-specific binding defined
by 5 ,«M d-butaclamol. Values are expressed as fmol specific
[3H]domperidone bound/carotid body ± S.E.M. (n = 3). As¬
terisk indicates statistical significance compared to the intact









Basal Fluoride Dopamine Isoprenaline
(10-2 K) (2 X 10-" M) (10-5 M)
Fig. 4. Homogenates of the rabbit carotid body were incubated
in vitro with NaF (Kb2 M), dopamine (200 fiM) and (—)-iso-
prenaline (10 /jM) at 30 °C for 10 min, as described in the text.
Control incubations were performed in the absence of NaF and
test drugs. Values are expressed as mean with S.E.M. given as
bar (n = 4). Asterisk indicates statistical significance as com¬
pared to control (P < 0.05)
min/carotid body, which was stimulated 4-fold by
10 mM sodium fluoride (Fig. 4). However, concen¬
trations up to 200 /<M dopamine and 10 /eM isoprena¬
line did not produce anv significant increase in the
basal activity. Since dopamine and isoprenaline









(10-5 M) (2 x 10-4 M)
Fig. 5. Intact carotid bodies were incubated in vitro in the pres¬
ence and absence of (—)-isoprenaline (1(F5 M) and dopamine
(2 x l(b-* M) in Krebs bicarbonate buffer with IBMX (1 mM)
for 15 min at 37 °C, as described in the text. Values are express¬
ed as mean with S.E.M. given as bars (n = 4). Asterisk indi¬
cates statistical significance as compared to control (P < 0.01).
mogenates, it remained possible that this enzyme un¬
couples from receptors following homogenization.
Therefore the ability of dopamine and isoprenaline
to stimulate cyclic AMP production, was examined in
intact carotid bodies in vitro. Incubation of intact
rabbit carotid bodies with 10 /eM isoprenaline in vitro
for 15 min at 37 °C resulted in a 6-fold increase in cy¬
clic AMP content as compared to the controls
(Fig. 5), whereas concentrations up to 200 eeM dop¬
amine did not produce any significant change as com¬
pared to the control cyclic AMP content.
Neuropharmacologies data
Results were obtained from experiments on 7
rabbits. Intra-carotid injection of dopamine
(0.01-100 /<g) invariably caused a dose-related de¬
pression of chemoreceptor discharge which com¬
menced within 1 s of the injection and lasted for
3-60 s (see Fig. 6). There was no evidence for any
consistent increase in chemoreceptor activity either
immediately on injecting dopamine or in the period





Fig. 6. Neurograms showing chemoreceptor activity recorded from the carotid sinus nerve of a rabbit and illustrating the effect of in¬
jecting (arrow) dopamine (5 /rg) before and after the antagonist drug domperidone (10 ^gkg-1 i.e.). The larger action potentials were
counted (output pulses from the window discriminator are shown beneath the neurograms) and the ramped trace is the chemoreceptor
discharge in cps.
charge, although a delayed increase in discharge was
sometimes obtained 15—60 s after an injection.
The changes in chemoreceptor discharge observed
following i.e. injections of dopamine, LY 141865 and
SK & F 38393 were examined in 3 rabbits and the re¬
sults evaluated by plotting the overall decrease in dis¬
charge (—AZ%) against the dose of drug injected.
Dopamine hydrochloride (mol. mass 190) and LY
141865 (mol. mass 272) were approximately equipo-
tent in depressing discharge, and although SK & F
38393 (mol. mass 272) caused some chemodepres-
sion, it was much less effective than the other two ag¬
onists (see Fig. 7).
Expressing the results in terms of —4lZ^ means
that a maximum response cannot be established since
higher doses of the drugs cause longer-lasting effects,
up to 2-3 min in the case of LY 141865. This also
makes it difficult to evaluate how much of the inhibi¬
tory response is a primary effect on the carotid che¬
moreceptor and how much is secondary to other ef¬
fects (e.g. cardiovascular) of the injected drug. To
overcome the problem, discharge was averaged over
the 5 s period immediately following the injection
and expressed as a percentage of the pre-injection or
control discharge averaged over 15-30 s. The maxi¬
mum effect (—100%) was obtained when a drug
caused a total abolition of discharge during the 5 s
period, and the dose causing a 50% reduction (ID50)
was calculated from dose-response lines. The mean
(± S.E.M.) ID50 values obtained were 4.2 ± 1.8 nmol
for dopamine (n = 6 experiments), 3.3 ± 1.3 nmol for
LY 141865 (n = 3) and 150 nmol for SK & F 38393
from the two experiments in which values could be
obtained — in one experiment an 1D5(, could not be
determined because even very high doses of SK & F
38393 caused only slight decreases in chemoreceptor
discharge.
Dopamine receptor antagonists
The effects of domperidone on chemoreceptor ac¬
tivity were investigated in 5 experiments; (—)-sulpi-
ride was studied in a single experiment. A dose of
10/tg kg-1 i.e. was used because it exceeded the
threshold dose of domperidone (0.1-1 /rgkg-')
needed for antagonism Of dopamine-induced chemo-
depression, but was not high enough to block com¬
pletely the responses to all doses studied, as occurred
after 200/rg-kg-'. Domperidone greatly reduced the
chemo-inhibitory effect of dopamine (Fig. 6) and
also antagonized the effects of LY 141865 and SK &
F 38393. The shift to the right in the dose-response
lines can be clearly seen in Fig. 7. No consistent in¬
creases in chemosensory activity occurred in re¬
sponse to injections of dopamine or LY 141865 fol-
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DOPAMINE LY141865 SKF 38393
Fig. 7. Data obtained from a recording of chemorcccptor activity in one rabbit in which the depression of discharge observed following
intra-carotid injection of dopamine, LY 141865 and SK & F 38393 has been plotted against the dose injected (log10 scale), and lines
fitted to the data by the method of least-squares. Filled circles and solid lines are responses obtained pre-domperidone, filled triangles
and dotted lines those after domperidone, 10 /rg kg~' i.e. The decrease in discharge (—is the difference between the number of
action potentials counted during the period when discharge was depressed, and the number anticipated in that period had discharge
continued at the pre-injection frequency (see Docherty and McQueen11). The open circles show the average effect of injecting the drug
vehicle and wash solution (respectively 0.1 ml unbubblcd Locke solution + 0.2 ml Locke solution which had been bubbled with 5%
C02-95% air in a water bath at 37 °C). The rabbit was artificially ventilated with air and analysis of arterial blood samples showed
there was no significant change in blood gas tensions or pH after domperidone. Background chcmorcceptor discharge (average of all
he pre-injection control values ± S.E M.) was 4.9 ± 0.4 cps before and 8.8 ± 0.5 cps after dompcridone (P < 0.01).
lowing treatment with domperidone.
The antagonism of dopamine-induced chemode-
pression lasted for at least 3 h following a single dose
of domperidone and this meant that studies, in addi¬
tion to those already described, could be undertaken
in most of the experiments. Responses to supra-
threshold submaximal doses of sodium cyanide,
Locke solution equilibrated with C02, were obtained
and expressed as the percentage change from control
responses obtained predomperidone. Similarly, the
effects of domperidone on background (sponta¬
neous) activity and on the discharge recorded at the
peak of the response to breathing 10% O2-90% N;
were determined. The results, summarized in Fig. 8,
showed that background activity was variably af¬
fected by domperidone, there being an increase in
discharge on average, whereas responses to hypoxia,
cyanide and C02 were reduced. (—)-Sulpiride
(10 /zg-kgi.e.) had effects on responses to dop¬
amine. LY 141865, SK & F 38393, hypoxia and cy¬
anide which were very similar to those of domperi¬
done
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Fig. 8. The percentage changes in background discharge and in
the responses of carotid chemoreceptors to hypoxia, sodium
cyanide, and C02-equilibrated Locke solution after domperi-
done (10 /rg-kg-1 i.e.) are shown. Each point gives the data ob¬
tained from an individual experiment, and the open bars repre¬
sent averaged changes from the pre-domperidone values.
DISCUSSION
A widely accepted classification of dopamine re¬
ceptors, first proposed by Kebabian and Calne18,
subdivides receptors into those that are positively
linked to adenylate cyclase (D,) and those that are
not associated with this enzyme (D2). More recently,
there is growing evidence that at least in some tissues
D2 receptors may suppress cyclic AMP formation6. It
is from this framework that we have attempted to
classify dopamine receptors in the rabbit carotid
body, since not only does there appear to be a differ¬
ent biochemical effector response associated with
each subtype, but there are a growing list of relative¬
ly selective agonists and antagonists to use in func¬
tional studies. It was therefore gratifying that the
present results from biochemical and neuropharma-
cological studies, provide strong evidence for the
presence of functional dopamine D2 receptors in the
rabbit carotid body.
Biochemical studies
In our initial attempts to label dopamine receptors
in carotid body homogenates, we used the high affini¬
ty ligand, [3H]spiperone. However, in view of evi¬
dence that this neuroleptic can label 5HT2 receptors
in the central nervous system16 33 and the indication
that the binding displaced in the carotid body by the
specific D2-antagonist, sulpiride, was less than that
displaced by butaclamol (which has high affinity for
both dopamine D2 and 5HT2 receptors), persuaded
us to perform all further studies with the selective D2
ligand, [3H]domperidone20. It should be noted that
Dinger et al.7 first reported specific binding of
[3H]spiperone to intact rabbit carotid bodies, though
it is not know what proportion of dopamine D2 and 5-
HT2 receptors were labelled in that study.
Although the lack of sufficient tissue precluded a
detailed pharmacological analysis of the [3H]dompe-
ridone sites in the carotid body, saturation analysis
clearly demonstrated a homogeneous population of
sites that possessed an affinity that was very similar to
that found in the rat striatum where a very detailed
pharmacological study has been completed20. Dom-
peridone has high specificity for D2 receptors and its
high affinity for carotid body sites precludes associa¬
tion with other receptors20.
The absence of functional dopamine D, receptors
is strongly indicated by the inability of dopamine to
stimulate adenylate cyclase in homogenates or cyclic
AMP accumulation in intact carotid bodies. This data
confirms earlier studies in the cat by Fitzgerald et
al.12 and, in view of the effectiveness of fluoride in
broken cells and isoprenaline in the intact prepara¬
tion, also suggests that this negative finding does not
relate to an uncoupling of D, sites during preparation
of carotid body homogenates or the inability of the
preparation to respond to agonist stimulation. It
should also be noted that dopamine did not produa
any significant inhibition of control cyclic AMP for¬
mation in the homogenates or cyclic AMP content in
intact tissue.
In an attempt to localize dopamine receptors in the
carotid body, Dinger et al.7 reported that chronic
section of the carotid sinus nerve reduced specific
[3H]spiperone binding by 64%. It should be em¬
phasized, however, that under the conditions of their
assay, it is not clear what proportion of dopamine D2
or 5HT2 receptors are being labelled, and it is signifi¬
cant that in the present study an identical denerva¬
tion procedure reduced the binding of the specific D2
ligand, [3H]domperidone by only 32%. This may sug¬
gest that there are both dopamine D2 and possibly
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5HT2 receptors on carotid sinus nerve terminals. In
the present context, it is also important to note that
the majority, at least, of D2 sites may be present on
cells (Type I and II), and it will be important to delin¬
eate their function (autoreceptors regulating trans¬
mitter synthesis and release?).
Neuropharmacological studies
Depression of chemosensory discharge was caused
by dopamine and by the selective D2-receptor agon¬
ist, LY 141865. The drugs were approximately equi-
potent, whether expressed in terms of the overall re¬
duction in discharge (—or as the ID50. The lat¬
ter index is based on the response in the 5 s post-in¬
jection period and has the advantage of excluding
drug-induced effects that might indirectly influence
chemoreceptor activity. In contrast, the D,-receptor
agonist, SK & F 38393, was very much less effective
in depressing discharge. The effects of dopamine and
LY 141865 were antagonized by the D2-receptor an¬
tagonists, domperidone and (—)-sulpiride, and the
fact that domperidone also antagonized the effect of
SK & F 38393 suggests that this agonist at high con¬
centration can act on dopamine D2-receptors29, but
not very effectively. Thus, the evidence obtained us¬
ing the selective dopamine D2-receptor agonist and
antagonists, coupled with the lack of effect of the D,-
agonist, even after antagonism of the D2-receptors,
suggests that the receptor mediating dopamine-in-
duced chemodepression can be classified as being a
D2 type, and that dopamine D,-receptors are either
not present in the carotid body (see above) or do not
influence chemoreceptor discharge significantly un-
ier the conditions of our experiments. Zapata et al.39
have also concluded that chemo-inhibition is me¬
diated by a dopamine D2-receptor in the cat carotid
body.
Previous studies in rabbits in vivo have shown that
dopamine-induced chemodepression is antagonized
by a-flupenthixol9 or haloperidol1?, drugs which are
D2-receptor antagonists. However, although these
results can be interpreted as supporting our present
conclusions regarding the presence of D2-receptors
in the carotid body, caution is needed because these
antagonists also have effects on other pharmacolog¬
ical receptors32.
Studies on the in vitro preparation of the rabbit ca¬
rotid body28 have shown a chemo-excitatory action of
dopamine, and Folgering et al.13 also found such an
effect in vivo following administration of haloperi-
dol. We failed to find evidence for any consistent che-
mo-excitation in response to injections of any of the
dopamine receptor agonists studied either before or
after domperidone. The differences between results
obtained from in vivo and in vitro carotid bodies may
be attributed to fundamental dissimilarities in the ex¬
perimental preparations being studied. The delayed
increase in chemosensory discharge observed by Fol¬
gering et al.13 could be blocked by the /3-antagonists,
propranolol and metoprolol, thereby implicating a /S-
adrenoceptor. However, the increase in chemore¬
ceptor discharge observed in dogs3-4 was antagonized
by D-tubocurarine (not acting as a nicotine antago¬
nist) and not by propranolol. It is difficult to know
how to interpret the evidence concerning the excita¬
tory actions of dopamine, but the fact that we failed
to detect such an effect under our experimental con¬
ditions, in which the ganglioglomerular nerves were
cut and the animals were normoxic and normocapnic,
may mean that much depends on the experimental
conditions and techniques used by different workers.
Chemoreceptor responses to hypoxia (steady-state
discharge), sodium cyanide and C02 were generally
reduced after a dose of domperidone which signifi¬
cantly attenuated the chemo-inhibition evoked by
exogeneous dopamine. This could be taken as evi¬
dence for endogeneous dopamine, acting via dop¬
amine D2-receptors, being involved in chemo-excita-
tion, but more detailed studies using a wider dose-
range for the antagonist(s) are needed to investigate
this possibility, particularly since the response to cy¬
anide is potentiated after a-flupenthixol9, as is the ef¬
fect of hypoxia after haloperidol13 in rabbits. It
should also be emphasized that there is no reason to
accept that exogeneous dopamine agonists and an¬
tagonists delivered via the carotid artery will interact
with the same receptors as endogeneously released
dopamine which may be excitatory". The important
point to be made is that the functional activity of rab¬
bit carotid body chemoreceptors is not grossly im¬
paired by D2-receptor antagonists under the present
experimental conditions.
The present work does not establish where in the
receptor complex the dopamine D2-receptors are lo¬
cated. The ligand binding results suggest some are as¬
sociated with carotid sinus nerve endings, and Okaji-
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ma and Nishi30 have presented evidence from experi¬
ments in cats, in which the carotid body is made is-
chaemic for 1 h, showing that chemo-inhibition in re¬
sponse to dopamine is still obtained when blood flow
through the organ is re-established, but excitation no
longer occurs. They interpret the results as meaning
that chemo-inhibition results from actions on nerve
endings, which, it is claimed, are relatively unaf¬
fected by ischaemia, and that chemo-excitation re¬
sults from actions on glomus (Type 1) cells which, it is
presumed, undergo degeneration during ischaemia.
However, whether ischaemia of the carotid body
really produces such selective effects on the Type 1
cells seems a moot point. As far as actions on the cells
are concerned, Matsumoto et al.21 recorded intracel¬
lular potentials from rabbit carotid body Type 1 cells
in vitro and found that dopamine (30-100 /xg) depo¬
larized some cells, but caused hyperpolarization fol¬
lowed by depolarization in others, and some cells
showed no change at all in resting membrane poten¬
tial in response to dopamine.
So, the questions of what the physiological role of
dopamine is, the precise role and function of dop¬
amine D2-receptors, and the relationship between
dopamine and other putative transmitters present in
the carotid body (e.g. noradrenaline, enkephalins,
substance P) remain to be established.
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INCREASED SENSITIVITY OF RABBIT CAROTID BODY CHEMORECEPTORS TO DOPAMINE
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D.S. MCQUEEN, A.K.. MIR, H.M. BRASH and S.R. NAHORSK.I, Increased sensitivity of rabbit carotid body
chemoreceptors to dopamine after chronic treatment with domperidone, European J. Pharmacol. 104 (1984) 39-46.
An increase in specific dopamine D2 receptor binding sites was observed in membranes prepared from the carotid
bodies of rabbits treated for 8 weeks and then withdrawn for 4-9 days from the D2 antagonist domperidone (2-5
mg/kg per day). Recordings of chemoreceptor afferent discharge from the carotid body also revealed that this change
in receptor density was accompanied by an increased sensitivity to the chemodepressant effects of exogenous
dopamine. The chemoreceptor responsiveness of the carotid body to hypoxia is blunted in rabbits treated chronically
with domperidone, but this can be restored to normal by an acute dose of the D2 antagonist. These experiments
provide evidence that is compatible with a chemo-inhibitory role for endogenous dopamine in the rabbit's carotid
body. Furthermore, these results suggest that the carotid body provides a useful model for the functional studies of
dopamine D2 receptors.
Dopamine D2 receptors Carotid body Chronic domperidone treatment Hypoxia
1. Introduction
Dopamine is known to be present in the carotid
body of various species, including the rabbit
(Chiocchio et ah, 1966; Dearnaley et ah, 1968; Mir
et ah, 1982). The findings that exogenous dopa¬
mine can modify chemosensory discharge (Black
et ah, 1972; Sampson, 1972; Zapata, 1975;
Docherty and McQueen, 1979) and that dopamine
is released from the carotid body during exposure
to hypoxia in vitro (Fidone et ah, 1982) have led to
suggestions that this catecholamine may be a mod¬
ulator of chemosensory discharge (see Eyzaguirre
and Fidone, 1980).
The predominant effect of dopamine when in¬
jected close-arterial to the rabbit carotid body in
situ is a depression of 'spontaneous' or back¬
ground chemosensory discharge (Docherty and
' Present address: Merrell International, Strasbourg. France.
* To whom all correspondence should be addressed.
McQueen, 1979) and evidence has been obtained
(Mir et ah, 1983) which suggests that this is media¬
ted via a dopamine D2 receptor, according to the
classification proposed by Kebabian and Calne
(1979).
The present study was undertaken in order to
provide further information on the possible role of
dopamine in the carotid body and, in particular, to
investigate whether 'supersensitivity' of the
dopamine receptor mediating chemodepression oc¬
curs following chronic treatment with a dopamine
receptor antagonist, such as occurs at certain sites
in the central nervous system after chronic admin¬
istration of neuroleptics (e.g. see Rupniak et ah,
1983).
Domperidone, a selective dopamine D2 receptor
antagonist, was used since it is effective in
antagonising the chemodepressant effect of
dopamine in the rabbit (Mir et ah, 1983) and does
not readily cross the blood-brain barrier (Laduron
and Leysen, 1979). Hopefully, this property should
0014-2999/84/$03.00 " > 1984 Elsevier Science Publishers B.V.
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preclude complications arising from indirect ef¬
fects on the carotid body resulting from central
dopamine receptor blockade. In the present study,
a combination of biochemical, neuropharmaco-
logical and neurophysiological techniques was used
to study carotid body dopamine receptors in the
rabbit after a period of chronic domperidone
treatment. Preliminary extracts of some of these
results have been published (McQueen et al., 1983;
McQueen, 1984).
2. Materials and methods
2.1. Animals
Experiments were performed on male New Zea¬
land white rabbits weighing 2.5-4.4 kg, median
weight 3.3 kg, given food and water ad libitum and
kept under circadian illumination.
2.2. Drug dosage
Domperidone was administered for 8 weeks to
one group of rabbits by adding the drug to drink¬
ing water so that the daily dose averaged 1-5
mg/kg. Domperidone was dissolved in acid and
diluted with tap water to stock solution containing
5 mg/100 ml. A second group of rabbits which
had the drug vehicle added to their drinking water
served as controls. Average intake of rabbits was
300 ml/day. Animals were used for experiments
4-9 days after cessation of treatment.
2.3. Biochemical assays
The surgical procedures for the dissection of the
carotid body were as previously described (Mir el
al., 1982). Preparation of washed carotid body
membranes free of contaminating dopamine and
assay of specific [-1H]domperidone binding has
been described in detail (Mir et al., 1983). In brief,
washed membranes from two carotid bodies were
incubated with [3HJdomperidone (0.4 nM) in 2 ml
50 mM Tris-HCl buffer, pH 7.6, for 30 min at
22°C. Membranes were then harvested on glass
fibre (Whatman GF/C) filters, washed rapidly
and counted for radioactivity. Specific binding
was defined as binding displaced by 5 \xM d-
butaclamol. An analysis of plasma levels of
domperidone was performed using a radioreceptor
assay, slightly modified from that described by
Creese and Snyder (1977). The content of
noradrenaline, dopamine and 5-hydroxytrypta-
mine was assayed using high performance liquid
chromatography coupled to electrochemical detec¬
tion, as previously described (Mir et al., 1982)
except that a reverse phase/ion pair 5 ft Ultra-
sphere column was used for amine separation.
2.4. Recording of chemosensory discharge
Rabbits were anaesthetised with pentobarbitone
sodium (35 mg/kg i.v. supplemented by 10% of
the initial dose every 1-2 h). The trachea was
cannulated and the animal artificially ventilated
with air and paralysed by gallamine triethiodide (3
mg/kg i.v.). Arterial blood pressure was recorded
from one femoral artery and the other artery was
cannulated and used for withdrawing samples of
arterial blood for analysis. A femoral vein was also
cannulated for intravenous administration of
drugs.
Electrical activity from filaments dissected from
the peripheral end of the centrally cut sinus nerve
was recorded using bipolar platinum/iridium elec¬
trodes, amplifiers, oscilloscope and FM tape-re¬
corder, as previously described (McQueen, 1977).
The ipsilateral ganglioglomerular (sympathetic)
nerves were cut, and a fine catheter inserted into
the common carotid artery until its tip was posi¬
tioned about 1 cm caudal to the carotid bifurca¬
tion. Drugs were injected close-arterial (i.e.) to the
carotid body from which activity was being re¬
corded by injecting into the lingual catheter (over
a 1-2 s period) 0.1 ml of drug solution together
with a wash consisting of 0.2 ml Locke solution
which had been equilibrated with 5% C02: 95% air
at 37°C. There was an interval of 5 min between
successive injections.
Changes in PaO, were achieved by altering the
inspired gas from air to either (a) 10% 02; 90% N2,
(b) 100% N2, or (c) 100% O,. Arterial blood gas
tensions and pH were measured at equilibrium in
samples of femoral arterial blood using a Radiom¬
eter BMS 3 analyser.
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2.5. Analysis of neural activity
The taped signal was replayed through an oscil¬
loscope linked to a pulse-height (window) dis¬
criminator (WPI 120) which was used to select
chemoreceptor action potentials for numerical
analysis. The output pulses from the discriminator
represented the summed activity of all the action
potentials discriminated (generally from 1-4 differ¬
ent chemoreceptor units) and these were counted
at 0.1 s intervals over periods ranging from 60 to
480 s by a custom-built counter/timer linked to a
Commodore 3032 microcomputer. The accu¬
mulated counts for each interval were read directly
through the digital 'User Port' interface of the
computer, displayed on the screen, and subse¬
quently recorded on disk (Commodore 3040 disk
drive). The computer was also used to calculate,
from the data stored on disk, the response of the
chemoreceptor unit(s) to a drug or procedure in
terms of, for example, mean discharge frequency
(x ct/s) or the integrated discharge (.Sx counts)
and a printout of such variables obtained (Com¬
modore printer 4022).
2.6. Statistical tests
Statistical comparison of data was made using
either Student's t-test or, where sample sizes per¬
mitted, the Wilcoxon two-sample test. Mean val¬
ues are shown ±S.E.M., and differences between
means were regarded as statistically significant
when P g 0.05.
2.7. Drugs
Dopamine hydrochloride (mol. mass 190,
Sigma); [ ' H]domperidone (59.9 Ci/mmol, New
England Nuclear); domperidone and ketanserin
were kindly donated by Janssen Pharmaceuticals;
LY-141865 (mol. mass 292, kindly donted by Eli







t-ig. 1. Comparison of mean specific j3H]domperidone binding
(fmol bound/carolid body ±S.E.M.) to rabbit carotid body
membranes in vehicle-treated rabbits and those which had been
treated chronically with domperidone. * Statistically significant
(P < 0.05, n = 4).
3. Results
J.J. Effects of chronic treatment with domperidone
on binding of [JH]domperidone to carotid body
membranes
The chronic administration of domperidone to
the rabbits was achieved by providing the drug in
the drinking water. The intake of drinking water
was monitored daily (average about 300 ml/day)
and this provided a daily dose of the D2 antagonist
of 2-5 mg/kg per day. Radioreceptor assay of
plasma domperidone in 3 rabbits at 6 weeks after
commencement of dosing gave a range 38-83
ng/ml plasma of domperidone equivalents (see
Creese and Snyder, 1977). Although we do not
know of comparable studies performed with this
drug in rabbits, the plasma levels are similar to
those reported 4 h after oral dosing of 40 mg
domperidone to man (Heykants et al., 1981). This
dosing schedule did not overtly alter the sponta¬
neous behaviour of the animals.
The specific binding of [3H]domperidone to
washed membranes of carotid bodies was signifi¬
cantly greater in rabbits that had been treated
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chronically with the D2 antagonist than in
vehicle-treated rabbits (fig. 1). In these experi¬
ments, because of the extreme paucity of mem¬
branes available, binding of the ligand was per¬
formed only at a single, though saturating (0.4
nM) concentration of [3H]domperidone (see Mir
et al., 1983). We would argue, however, that our
data closely reflects the maximal number of bind¬
ing sites and if any residual domperidone was still
present in the membranes, this would result in a
decrease rather than the observed increase in
specific binding.
In a few experiments, striatal membranes were
also examined from both domperidone and
vehicle-treated rabbits. The specific binding of
[3H]domperidone was unaltered by chronic treat¬
ment (data not shown) emphasising the inability
of this D2 antagonist to cross the blood-brain
barrier.
Analysis of noradrenaline, dopamine and 5-hy-
droxytryptamine in the carotid bodies of 4 control
and 5 domperidone-treated animals revealed no
significant difference between the groups in the
levels of individual amines.
3.2. Effects of chronic treatment with domperidone
on responses of chemoreceptors to dopamine and
LY-141865
Dopamine caused chemodepression when in¬
jected close-arterial to the rabbit carotid body in
doses of 0.01-50 pg i.e., and an index of chem-
oreceptor sensitivity to dopamine was derived by
calculating the ID50, i.e. the dose of dopamine
causing a 50% reduction from mean 'spontaneous'
or pre-injection chemosensory discharge level
during the 5 s period immediately following the
injection, as illustrated in fig. 2. Data obtained
from different experiments were pooled and it was
found that the average 1DS0 for dopamine was
significantly lower in rabbits that had been treated
chronically with domperidone (0.81 ± 0.23 nmol,
n = 6), in comparison with vehicle-treated controls
(3.8 ± 0.9 nmol, n = 13; P < 0.01). Background or
pre-injection chemosensory discharge averaged
11.1 ± 2.5 ct/s in controls and 12.5 ± 4.9 ct/s in
chronically treated rabbits, values that are not
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Fig. 2. Semi-log plot of dopamine injected i.c. against the
depression of chemosensory discharge observed in the 5 s
period immediately following the injection in a rabbit that had
been treated chronically with domperidone (• •). A
straight line was fitted to the data by the method of least
squares and the ID50 calculated (0.18 jig-0.95 nmol, dotted
line). In contrast (O O). an ID«,0 of value of 1.78 /xg
(9.4 nmol) was obtained from a rabbit that had been given only
a single dose of domperidone (5 mg kg 1 s.c.) 8 days before the
experiment. The effect of injecting the drug vehicle, Locke
solution, is also shown (a). The neurogram in the lower part of
the figure illustrates the effect of dopamine (1.25 fxg; 6.6 nmol
i.c. at bar) in the chronically treated animal. The ramped trace
is the cumulative output of the window discriminator, reset at 1
s intervals, and shows the response to dopamine of the 3 larger
chemoreceptor units that were counted.
significant difference between ID<,0 values ob¬
tained from untreated (values obtained from
re-analysis of previous experiments by Docherty
and McQueen, 1979) and vehicle-treated rabbits.
The dopamine D2 receptor agonist LY-141865
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(Tsuruta et al., 1981) gave 1D50 values of 7.3 ± 1.9
(mean ±S.E.M.) nmol from experiments in 4
vehicle-treated rabbits, and 2.8 ± 2.1 nmol (n = 3)
in animals that had undergone chronic domperi-
done treatment.
Administration of a single dose of domperidone
(10 jug kg-1 i.e.) greatly reduced the chemodepres-
sant effects of exogenous dopamine and LY-
141865. After domperidone, the 1DS0 for dopa¬
mine increased by an averaged factor of 83 (n = 4)
in vehicle-treated rabbits, and by 2900 (n = 4) in
the case of animals which had been treated chroni¬
cally with domperidone. Corresponding values for
LY-141865 were 173 (n = 2) and 803 (n = 4).
Overall background discharge increased from 8.2
+ 3.4 cps before the acute dose of domperidone to
12.3 ± 5.4 (n = 5) afterwards in vehicle-treated
rabbits, and from 13.7 to 7.2 to 20.6 ± 9.3 (n = 4)
in chronically treated rabbits. Background dis¬
charge increased by 44 ±11.5% on average after
the single dose of domperidone and the increase
was statistically significant in 3 of the 5 vehicle-
treated rabbits. The increase averaged 66 ± 25% in
the 4 ex-chronic domperidone animals, and the
rise was statistically significant in all 4 experi¬
ments. Mean background activity was not signifi¬
cantly different between the 2 groups, either be¬
fore or after the acute dose of domperidone (P >
0.05).
J.J. Effects of chronic treatment with domperidone
on responses of chemoreceptors to hypoxia
The responsiveness of the carotid body chem¬
oreceptors to hypoxia was assessed by switching
the inspired gas from room air to a hypoxic gas
mixture (10% 02:90% N2) for 4 min and plotting
chemosensory discharge against time. An equi¬
librium was reached after about 2 min when dis¬
charge plateaued (see fig. 3) and it was possible to
fit a straight line to the rising part of the curve.
The averaged plateau value was expressed as 100%,
to normalise the data, and the slope of the line
calculated. Discharge was submaximal on 10% 02,
and could be further increased by ventilating for
60 s with 100% N2.
Values obtained for the slopes of the 'hypoxia
lines' were pooled and are shown in fig. 4 where it
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Fig. 3. Data obtained from a rabbit which had been chronically
treated with domperidone (• •) compared with that
from a vehicle-treated control (O O). Chemoreceptor
discharge was averaged over 15 s intervals and plotted against
time. Switching to ventilating with hypoxic gas (10% 02)
during the period shown caused an increase in frequency which
plateaued after about 1-2 min and then remained steady about
a mean level which was taken as maximum, or 100%. Straight
lines were fitted by the least squares method to the values
obtained during the period when discharge was increasing after
switching to 10% 02, and the slope of the lines expressed in
terms of % maximum s" The slope was 0.8% max ■ s" 1 (r =
0.99) and average steady slate discharge (maximum) 19.0 ct/s
in the chronically treated rabbit, whereas the slope was steeper
(1.2% maxs~\ r = 0.99; maximum = 18.2 ct/s) in the
vehicle-treated control.
can be seen that the slope was significantly re¬
duced in animals that had been treated chronically
with domperidone, as compared with the vehicle-
treated controls. Background and 'plateau' (i.e. on
10% 02) discharge values were not significantly
different between the groups. Administration of a
single dose of domperidone (10 pg kg"1 i.e.) re¬
turned the slope towards control values (fig. 4).
Arterial blood samples were taken 3.5 min after
changing from air to the hypoxic mixture in several














Fig. 4. Values for the slope of the line relating chemosensory
discharge to time after switching to ventilating rabbits with the
hypoxic gas mixture (10% Oz) are shown. In 4 of the rabbits
which had been treated chronically with domperidone, after
obtaining the response to hypoxia a single dose of domperidone
was injected and the hypoxia test repeated. Background or
'spontaneous* discharge during ventilation with air was 4.4± 2.0
cps (mean ±S.E.M.) for controls, 7.4 ±2.1 cps for chronically
treated rabbits, and 13.8 ±3.1 cps in chronically treated rabbits
after the single acute dose of domperidone. The 'plateau' or
steady state discharge during ventilation with 10% 02 averaged
25.2 ±8.2 cps in controls, 31.6 ±6.5 cps in chronically treated
rabbits and 30.0 ±9.7 cps in chronically treated animals after
an acute dose of domperidone.
table 1. There were no major differences between
groups, apart from the pH being significantly
higher (P < 0.05) during hyppxia in ex-chronic
domperidone rabbits cf. vehicle-treated.
3.4. Other experiments
Measurement of dopamine IDS0 values and
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Fig. 5. Responses of chemoreceptors to dopamine (1D50 values)
and hypoxia (slope of hypoxic response line) obtained in indi¬
vidual rabbits 4. 10, and 30 days after stopping the 8 week
period of chronic treatment with domperidone (5 mg kg-1
daily). C shows the mean +S.E.M. control values from
vehicle-treated rabbits 4-9 days after stopping treatment.
hypoxia showed that, following treatment with
domperidone for 8 weeks, values were decreased to
similar extents during the 4-10 day period after
withdrawing the drug, and even one month after
stopping domperidone they had not returned to
control levels (fig. 5).
The possibility that the effects observed were
not attributable to the effects of chronic dosage
with domperidone, but merely due to some resid¬
ual traces of the drug, was tested by injecting a
single dose of domperidone (5 mg kg" 1 s.c.) into a
rabbit and then 8 days later examining the chem¬
oreceptor responses to dopamine and hypoxia.
The ID50 for dopamine was found to be 9.4 nmol
(see fig. 2), in the upper range of control values,
and the slope of the hypoxia line was 1.22% max •
s~\ which was close to the average for control
animals.
TABLE 1
Mean arterial blood gas tensions and pH ±S.E.M.










Controls 7.40 ±0.02 32 ± 0.94 82 ±3.2 14 7.35 ±0.03 32 + 2.2 48 ± 2.0 4




The results obtained from the present experi¬
ments using a combination of biochemical and
neuropharmacological techniques can be interpre¬
ted as providing evidence that an increased sensi¬
tivity of dopamine D2 receptors occurs in the
rabbit carotid body following a period of chronic
treatment with domperidone. Furthermore, this
altered responsiveness appears to accompany an
increased number of specific D2 binding sites in
this tissue. The strength of this combined ap¬
proach is highlighted in that the present data
provides the first quantitative functional evidence
that an elevation of dopamine D2 receptors is
probably associated with an increased sensitivity
of cells to both exogenous and endogenous
dopamine.
Although there has been a large number of
studies in the central nervous system that demon¬
strate increased numbers of dopamine receptor
binding sites following chronic neuroleptic ad¬
ministration, functional consequences of this phe¬
nomenon have been largely limited to indirect
measures of altered behaviour (see Rupniak et al.,
1983). However, Gallagher et al. (1978) have re¬
ported that low doses of dopamine agonists cause
a greater depression of dopamine cell firing after
chronic haloperidol, this presumably reflecting an
increased responsiveness of somatodendritic
dopamine autoreceptors. In the present study it is
by no means certain at which sites dopamine
receptors are elevated. Previous studies from this
laboratory (Mir et al., 1983) have revealed that
60-70% of specific D2 sites are on (glomus) cells
since they survive chronic denervation of the caro¬
tid body. Clearly in future studies it will be im¬
portant to examine the effects of neuroleptic treat¬
ment in animals with denervated carotid bodies.
Exogenous dopamine depressed chemosensory
discharge, as previously described (Docherty and
McQueen, 1979; Mir et al., 1983), and responsive¬
ness of the chemoreceptors in the present study
has been expressed in terms of the ID50 of the drug
so that a comparison could be made between
different animals with widely varying background
chemosensory discharge. The fact that the ID50 for
dopamine was significantly lower in animals which
had been treated chronically with domperidone
suggests that the dopamine receptors mediating
chemodepression may have become supersensitive.
The increase in sensitivity to the D2 agonist LY-
141865 was not so great. Whether this relates to
the partial agonist activity of this agent or to other
phenomena requires further investigation.
In order to examine the responsiveness of the
carotid body chemoreceptors to a physiological
stimulus, namely hypoxia, it was necessary to de¬
vise some way of comparing chronically treated
rabbits with the vehicle-treated controls, given that
the number of chemoreceptor units recorded and
their absolute discharge frequency in response to a
fixed stimulus varied from experiment to experi¬
ment. It was decided to use the rate at which
discharge increased on changing from ventilating
the animal with air to the hypoxic gas mixture
(10% 02), a reproducible stimulus, and to normal¬
ise the slope of the line fitted to data points by
expressing chemosensory discharge as a percentage
of the plateau or mean steady-state discharge ob¬
tained in response to the hypoxic stimulus. The
finding that the sensitivity of carotid body chem¬
oreceptors to hypoxia was significantly reduced in
rabbits treated chronically with domperidone, but
could be restored towards normal by a single low
dose of domperidone, provides evidence that en¬
dogenous dopamine can function as a depressant
of chemosensory discharge (see Introduction) un¬
der the conditions of our experiments in which the
carotid body was denervated. However, it is im¬
portant to stress that it was only the rate at which
chemosensory discharge increased in response to
the hypoxic stimulus, and not the absolute dis¬
charge frequency eventually attained, which was
significantly affected by chronic treatment with
domperidone.
If we assume that similar alterations in carotid
body dopamine receptor sensitivity may occur in
man following long term dopamine antagonist
treatment, then the functional consequences should
be considered. Since the carotid body has little
influence on ventilation under normal conditions,
one could argue that in normal individuals little
effect would be apparent. However, in those indi¬
viduals with chronic obstructive ling disease, the
blunting of sensitivity to hypoxia could potentially
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compound their respiratory problem.
In conclusion, the present experiments have
provided evidence for functional altered responsi¬
veness of chemoreceptor activity to dopamine and
increased dopamine D2 receptor sites in the caro¬
tid body following chronic but not acute
domperidone treatment. The blunted response to
hypoxia in treated animals also supports the con¬
cept of a chemo-inhibitory role for endogenous
dopamine in the carotid body.
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Changes in carotid body amine levels and effects of
dopamine on respiration in rats treated neonatallywith
capsaicin
D.S. McQueen & A.K.Mir'
Department of Pharmacology, University of Edinburgh Medical School, 1 George Square, Edinburgh 8 and
Department of Pharmacology and Therapeutics, University of Leicester, University Road, Leicester 1
1 Dopamine levels in rat carotid bodies and the effects of intravenous dopamine injections on
respiration in adult rats anaesthetized with pentobarbitone have been studied in animals which were
treated with capsaicin neonatally.
2 Levels of dopamine were five fold higher in the carotid bodies of capsaicin-treated rats as
compared with vehicle-treated controls, but there was no significant difference between capasicin-
treated and vehicle-treated rats in their ID50 values for dopamine-induced respiratory depression.
3 Domperidone, a dopamine D2-receptor antagonist, substantially reduced the respiratory depre¬
ssion caused by dopamine, both in capsaicin-treated and in control animals, suggesting that a
D2-receptor was involved in the response. Cutting the carotid sinus nerves greatly reduced the
ventilatory-depressant effect of dopamine, showing that sensory receptors, most probably arterial
chemoreceptors, were responsible for most of the response.
4 Substantially less reflex hyperventilation was evoked in capsaicin-treated rats by the peripheral
chemoreceptor stimulants hypoxia and sodium cyanide, in comparison with the controls, and
domperidone did not increase the responsiveness. About 80% of the reflex ventilatory change
originated from carotid body chemoreceptors.
5 The hypoventilation caused by breathing 100% 02 was not significantly different in capsaicin-
treated rats when compared with controls. Domperidone substantially reduced this response in
capsaicin-treated rats, but not in vehicle-treated animals.
6 Dopamine-induced respiratory depression in capsaicin-treated ratswas slightly enhanced, rather
than reduced, by oxygen breathing; domperidone remained an effective antagonist of dopamine-
induced ventilatory depression.
7 Most of the reduction in respiration caused by dopamine in rats anaesthetized with pentobar¬
bitone can be attributed to actions on a dopamine D2-reccptor located in the carotid body. However,
despite the increased levels of dopamine found in the carotid bodies, the reduced peripheral
chemosensitivity observed in anaesthetized capsaicin-treated rats does not appear to result from a
change in sensitivity to dopamine.
Introduction
Reflex increases in respiration evoked by stimuli that
activate peripheral arterial chemoreceptors are sig¬
nificantly reduced in anaesthetized adult rats which
have been treated neonatally with capsaicin (Bond et
al., 1982), but the cause of this change in sensitivity
remains to be established.
Dopamine depresses respiration in anaesthetized
1 Present address: Merrell Dow Research Institute, 16 rue
d'Ankara, 67084 Strasbourg, France.
rats apparently by inhibiting arterial chemoreceptors
(Hasan & Horn, 1980; Horn, 1981; Cardenas &
Zapata, 1981; Horn et al., 1984; Zapata etal., 1984)
and dopamine is present in rat carotid bodies and can
be released from them during stimulation (Hell-
strom, 1977; Hanbauer & Hellstrom, 1978). It
seemed possible, therefore, that excessive dopamine
release, or increased sensitivity of chemoreceptors to
dopamine, might explain the reduction in peripheral
chemosensitivity caused by capsaicin treatment. In
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order to test this possibility two separate series of
experiments were performed. Firstly, biochemical
techniques were used to measure amine levels in
carotid bodies taken from capsaicin-treated and from
control rats. Secondly, a series of experiments was
performed which involved recording ventilation in
anaesthetized rats. The respiratory responsiveness to
dopamine and domperidone, a dopamine D2-
receptor (see Kebabian & Calne, 1979) antagonist
that blocks dopamine-induced chemodepression in
cats and rabbits (McQueen, 1984; Mir et al., 1984),
of capsaicin-treated animals was compared with that
of vehicle-treated controls. The sensitivity of the
peripheral chemoreceptors to physiological and
pharmacological stimuli was also tested in both
groups.
Methods
Experiments were performed on Sprague-Dawley
rats. Animals were anaesthetized with halothane
(1% in 02) on day 2-4 after birth and injected with
either capsaicin (50mgkg"' s.c.) or drug vehicle
(10% ethanol, 10% Tween 80 in saline) as previously
described (Jancso et al., 1977; Bond et al., 1982).
Three to eight months later they were used for exper¬
iments.
Estimation ofamine levels in rat carotid bodies and
superiorcervicalganglia
Rats were anaesthetized with pentobarbitone
(42 mg kg"1 i.p.) and their carotid bodies and superior
cervical ganglia excised surgically as previously de¬
scribed (Mir et al., 1982). Carotid bodies and ganglia
were homogenized in 300 fil and 1000 pi respectively
of 0.1m ice-cold perchloric acid. The content of
dopamine, noradrenaline and 5-hydroxytiyptamine
(5-HT) was assayed using high performance liquid
chromatography (h.p.l.c.) coupled to electrochemi¬
cal detection, as previously described (Mir et al.,
1982) except that a reverse phase/ion pair 5 p ultras-
phere column was used for amine separation.
Respiratory experiments
Rats were anaesthetized with pentobarbitone
(60 mgkg"1 i.p., supplemented as required during the
later part of some experiments). The level of anaes¬
thesia, assessed qualitatively, was similar in the two
groups but capsaicin-treated rats sometimes required
a brief period (5-20 min) of artificial ventilation to
keep them alive during the 30-60 min after injecting
pentobarbitone. The trachea was cannulated as were
both femoral arteries (one for measuring BP, the
other for taking 300 pi arterial blood samples) and a
femoral vein (for drug administration). During some
of the experiments the carotid sinus nerves were
identified and cut at their junction with the glos¬
sopharyngeal nerves and both vago-sympathetic
nerves were cut in the neck.
Ventilation was measured with an integrating
pneumotachograph, as previously described (Mc¬
Queen, 1973). The animals breathed either room air,
100% 02, or a hypoxic gas mixture (10% 02: 90%
N2). The respiratory response to a hypoxic stimulus
was obtained by switching from air to 10% O2 for
3 min and taking an arterial blood sample at 2.5 min.
Ventilation was measured 1 and 3 min after changing
the inspired gas, and the same protocol was used for
hyperoxia (100% O2 inspired).
Drug administration
Doses of dopamine or sodium cyanide were injected
intravenously (0.1 ml drug solution washed in with
0.2 ml Locke solution over 2-3s) with at least 5 min
between successive doses. The respiratory volume
(R.M.V.) during the 20s period (2 x10 s ramps)
immediately following the injection was calculated
and expressed as a percentage change from the pre-
injection (control) value and logio dose-response
lines plotted. Mean arterial BP was measured before
and during the response period.
Statistical analysis
Mean values are given ± s.e. mean. Differences be¬
tween groups were compared by using either the
Wilcoxon two-sample test, the Wilcoxon signed
ranks test (for paired data) or Student's paired t test
(when there was insufficient data for the non-
parametric test) and the null hypothesis rejected at P
(2 tailed) <0.05.
Drugs
Capsaicin (Sigma) was prepared as described above.
Other drugs were dissolved in modified Locke solu¬
tion (Docherty & McQueen, 1978): dopamine HC1
(Koch-Light); sodium cyanide (B.D.H.); dom¬




Carotid bodies were excised from five capsaicin-
treated rats (1 male 450 g; 4 females 256 ± 9.6 g) and
from vehicle-treated controls (1 male 422 g; 4 female
249 ± 9.0 g) when the animals were four months old.
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The amine levels in their carotid bodies, as estimated
by h.p.l.c., are shown in Figure 1 and itwas found that
dopamine, noradrenaline and 5-HT levels were all
significantly higher in capsaicin-treated rats com¬
pared with the controls (P<0.05). There was no
significant difference between amine content of left
and right carotid bodies within either group.
Superior cervical ganglia (SCG) from capsaicin-
treated rats also had significantly higher dopamine
levels (215 ± 8.5 pmol per SCG, n = 9,P< 0.05) than
the controls (60.3 ± 1.7 pmol per SCG, n = 7), but
noradrenaline levels in capsaicin-treated animals
(142 ± 2.3 pmol perSCG, n = 9) were not significant¬
ly different from controls (142 ± 12 pmol per SCG,
n= 7,P> 0.05).


















Respiratory responses to dopamine
Dopamine (5.3-105 nmol) caused a dose-dependent
depression of ventilation (V) when injected i.v. in
capsaicin-treated and in vehicle-treated rats (Figure
2). The maximum reduction that could be obtained
during the 20 s post-injection period varied from
animal to animal, but averaged 55 + 4% in vehicle-
treated rats and 63 ±4% in the capsaicin-treated
group (P> 0.05). The dose causing half-maximal
depression of ventilation (ID50) was calculated for























































Figure 1 Amine levels, estimated by h.p.l.c., in carotid
bodies of vehicle treated (open columns) and capsaicin-
treated rats (hatched columns). Vertical lines show
s.e.mean. n = number of carotid bodies. •f><0.01 (Wil-
coxon two sample test). NA = noradrenaline,
DA = dopamine; 5-HT = 5-hydroxtryptamine.
Figure 2 Respiratory (V) and blood pressure (BP)
responses to two doses of dopamine (DA; 5.3 and
53 nmol i.v. at arrows) in an anaesthetized capsaicin-
treated rat (a) before and (b) after administering the
dopamine D2- receptor antagonist domperidone
(100 pg kg'1 i.v.). The respiratory trace reads from bot¬
tom to top with each step representing a single breath
and the total ramp height showing the volume breathed
in 10 s. Note that domperidone substantially reduced the
hypoventilation caused by dopamine, but not the rise in
blood pressure.
74± 14nmolkg~' (range 26-141, n = 8) in controls
and 108±24nmol kg*' (range 28-287, n=13) in
capsaicin-treated rats. Average ventilation pre-
injection was 30.6±2.4 ml 100g"1 min"1 in the
former and 32.0±2.3 ml 100g"1 min*1 in the latter
group. None of these values was significantly differ¬
ent between groups. Blood pressure changes were
minimal with lower doses of dopamine, but higher
doses caused a dose-related hypentesion (e.g. Figure
2). The mean rise in BP associated with the 26 nmol
dose of dopamine was 7 ± 5.5 mmHg in controls
(n = 8) and 12 ± 3.6 mmHg in capsaicin-treated rats
(n= 13; P> 0.05).
The dopamine antagonist domperidone
(100 pg kg"' single dose) greatly reduced the respirat-
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Figure 3 Dose-response plot of the respiratory re¬
sponses to dopamine (DA) obtained during the experi¬
ment shown in Figure 2 before (O O) and after
(• •) domperidone (lOOpgkg-1 i.v.) in a 286g
capsaicin-treated female rat. Straight lineswere fitted to
the data by the least squares method and the dose
required for half-maximal response (id50) calculated.
The id50 was 28 nmol kg-1 before domperidone, and
2611 nmol kg"1 for the same response after the antagon¬
ist. Mean ventilation (R.M.V.) averaged 39 ±1.6 ml
100g~Imin~1 pre-domperidone and 59.4 ±1.7 ml
100g~Imin~1 post-domperidone.
ory depressant effect of dopamine (see Figures 2 and
3) and the corresponding ID50 values obtained after
the antagonist were 2300 ±660 nmol kg"1 for con¬
trols (n = 7) and 3350 ± 990 nmol kg"1 for capsaicin-
treated rats (n = 11). The ID50 values were signific¬
antly higher after domperidone but the difference
between groups was not significant. Steady-state
ventilation was 31.7±2.5ml lOOg"1 min"1 in con¬
trol rats
100g
before domperidone and 37.8 ±5.1 ml
1 min 1 after domperidone (n = 7; P>0.05).
capsaicin-treated rats ventilation increased signific¬
antly from 32.6 ±2.7 ml 100 g"1 min"1 to
40.7 ± 3.0 ml lOOg"1 min"1 (n=ll, PC0.05-
Wilcoxon signed ranks test). Domperidone did not
antagonize the pressor response to dopamine (e.g.
see Figure 2).
Respiratory responses to hypoxia and hyperoxia
A reflex increase in ventilation occurred when rats
breathed 10% O2: 90% N2 instead of air, and al¬
though the response was present in both groups, it
was significantly greater in vehicle-treated rats (Fig¬
ures 4 and 5). Measurement of the percentage in¬
crease in respiration 1 and 3 min after starting a 3 min
period of hypoxia showed that hyperventilation was
well-maintained in vehicle-treated rats, but not in the
capsaicin-treated animals (Figure 5). Arterial blood
gas tensions and pH values are shown in Table 1.
When 100% O2 was breathed, respiration was
reduced to about 40% of the value on air, and this
decrease was not significantly different in the two
groups.
Domperidone
Domperidone (100 pg kg"1 single dose i.v.) signific¬
antly reduced (P<0.05; paired t test) the mean
increase in ventilation evoked by 10% O2 in controls
(Figure 5) but although the response was also re¬
duced in capsaicin-treated animals, with ventilation
at 3 min now being depressed rather than increased,
responses were variable and the differences from
pre-domperidone mean values were not statistically
significant (P> 0.05; paired / test).
In the presence of domperidone the reduction in
respiration caused by breathing 100% O2 was sig¬
nificantly attenuated in capsaicin-treated rats, but
although not so well sustained in controls, the differ¬
ence from pre-domperidone responses was not statis¬
tically significant.
Blood pressure values obtained before and during




































Samples were taken 1 min before and 2.5 min after switching from air to hypoxic or hyperoxic gas.
* P<0.05 vs vehicle-treated. All other capsaicin-treated, not significantly different (P :> 0.05) from corresponding
vehicle-treated values.
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Time (min)
Figure 4 Respiratory and blood pressure responses to switching the inspired gas from room air to 10% 0^:90% N2
for a 3 min period (commencing at arrow), (a) Vehicle-treated female rat (245 g). (b) Capsaicin-treated female rat
(296 g) showing a much reduced and poorly sustained hyperventilation in response to the hypoxic stimulus as
compared with the vehicle-treated control. The respiratory trace reads from top to bottom and interruptions at
approximately 2 min intervals are caused by automatic amplifier resetting in the electrospirometer. Other details as
in Figure 2.
hypoxia and hyperoxia, pre- and post-domperidone
are shown in Figure 6. During 10% 02 the mean BP
in capsaicin-treated rats was significantly lower than
in the vehicle- treated controls (P<0.05). After
domperidone there was no statistically significant
difference between groups. Duringoxygen breathing
BP was significantly lower in capsaicin-treated rats
compared with vehicle-treated controls (P<0.05).
There was no significant difference in B.P. values
pre- and post-domperidone measured during oxygen
breathing in capsaicin-treated rats, but there was a
small but significant difference (P<0.05, paired t
test) between pre- and post-domperidone values
from vehicle-treated animals.
Respiratory responses to sodium cyanide
NaCN was injected at two dose-levels, 1 and
4.1 pmol (50-200fig) i.v. which produced responses
that were suprathreshold but submaximal. Reflex
hyperventilation was significantly greater in vehicle-
treated controls than in capsaicin-treated rats (Figure
7). Domperidone reduced the ventilatory response to
the high but not the low dose of cyanide in capsaicin-
treated rats (P<0.05, paired t test), but in vehicle-
treated rats the responses to either dose of cyanide
before domperidone were not significantly different
from the corresponding responses obtained after the
antagonist.
Denervation experiments
In order to assess the relative contribution of differ¬
ent regions to the respiratory changes obtained, ex¬
periments were performed (mainly in vehicle-treated
rats because capsaicin animals did not tolerate the
procedure well) during which responses to
dopamine, hypoxia, hyperoxia and cyanide were ob¬
tained before and after cutting the carotid sinus
nerves. Subsequently, both vagosympathetic trunks
were cut in the neck. In some experiments, the in¬
verse sequence was followed, with the vagi being cut
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first, and the carotid sinus nerves sectioned later in
the experiment. Results obtained are summarized in
Figure 8 which shows that cutting both sets of nerves
totally abolished respiratory responses to hypoxia,
cyanide and hyperoxia. Cutting the carotid sinus
nerves, leaving the vagosympathetic trunk intact,
reduced the ventilatory response to hypoxia by 83%
(1st min), and the response was no longer well-
sustained, ventilation being depressed by 20% at
3 min. Hyperoxia caused an increase in ventilation
under these conditions, presumably reflecting re¬
moval of hypoxia-induced central respiratory depre¬
ssion, and the response to sodium cyanide was re¬
duced by 80% compared with the intact preparation.
Cutting the vagosympathetics abolished the residual
responses to hypoxia and cyanide.
When the vagosympathetic trunks were cut first,
leaving the carotid sinus nerve intact, the hyperventi¬
lation in response to hypoxia was only reduced by





































Figure 5 Mean changes in ventilation of vehicle-
treated control (open columns) and capsaicin treated
(hatched columns) anaesthetized rats in response to
switching from breathing room air to either 10% O2
(upper panels) or 100% O2 (lower panels) for 3 min
Vertical lines show s.e. mean. Responses (1 and 3 min
values shown for n animals) were obtained before and
after injecting a single dose of domperidone
(lOOpgkg-' i.v.). 'P< 0.05 in comparison with corres¬
ponding (i.e. pre- or post-domperidone) values from
vehicle-treated rats using theWilcoxon two sample test.
hyperoxia was increased slightly and the response to
cyanide reduced by 25% compared with the intact
preparation. Cutting the carotid sinus nerves
abolished the responses to hypoxia and sodium
cyanide.
Cutting both sets of nerves substantially reduced
the respiratory depressant action of dopamine ob¬
tained during air-breathing in vehicle-treated rats
and most of the reduction could be attributed to the
carotid sinus nerves since bilateral vagotomy alone
did not greatly affect the response to dopamine. The
effect of cutting both sets of nerves was thus rather
similar to that obtained by administering dom¬
peridone.
Physiological denervation of arterial chemoreceptors
was also attempted by ventilating the animal with
100% O2 until a steady ventilatory state was reached.
Responses to dopamine were studied during oxygen
breathing and the respiratory changes measured. In
vehicle-treated animals dopamine caused a depres¬
sion of ventilation during oxygen breathing, but this
was not a dose-related phenomenon. Domperidone
reduced this response to dopamine, as it did during







































































Figure 6 Mean arterial blood pressure of vehicle-
treated (open columns) and capsaicin-treated (hatched
columns) anaesthetized rats (A) during air breathing
and during (D) either 10% O2 (upper panels - at time of
maximum change in BP) or 100% O2 (lower panels) for
3 min before and after domperidone lOOpgkg"1, i.v.
Vertical lines show s.e. mean. *P<0.05 in comparison
with corresponding values (pre- and post-domperidone)
for vehicle-treated animals using theWilcoxon two sam¬
ple test.
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related respiratory depressant effect of dopamine
was potentiated slightly by oxygen, and this effect was
antagonized by domperidone. Dompamine-induced
reductions in respiration obtained during oxygen
breathing were greatly reduced by cutting the carotid
sinus nerves, but not by cutting the vagosympathetic
trunks in the neck.
Discussion
Our results are not compatible with the hypothesis
that the reduced arterial chemosensitivity observed
in anaesthetized adult rats which had been treated
neonatally with capsaicin is caused by a change in the
responsiveness of carotid chemoreceptors to
dopamine (see Introduction). Although dopamine
levels were five fold higher in the carotid bodies of
capsaicin-treated rats in comparison with vehicle-
treated controls, there was no significant difference
between the two groups in the depression of respira¬
tion caused by intravenously injected dopamine, as
judged from the ID50 values.
The respiratory data confirmed that the respirat¬
ory chemoreflex to stimulants such as hypoxia and





























Figure 7 Increases in respiration evoked by two doses
of cyanide (1 and 4 pmol i.v.) in n vehicle-treated control
(open columns) and capsaicin-treated (hatched col¬
umns) anaesthetized rats before and after domperidone
(lOOpgkg-1 i.v.). Vertical lines show s.e. mean. Mean
basal ventilation was 29.4 + 2.1 in controls and
34.6 ±2.9ml 100g_1 min_I in capsaicin-treated rats be¬
fore domperidone. Corresponding values post-
domperidone were 37.7 ±5.1 and 41.5 ±3.5 ml 100g_1
min"1.* P<0.05 in comparison with corresponding
vehicle-treated controls (Wilcoxon two sample test).
had been treated neonatally with capsaicin (Bond et
al., 1982). Capsaicin mainly destroys unmyelinated
sensory afferent fibres when injected neonatally in
the doses used in this study (Jancso et al., 1977) and
capsaicin-treated rats have fewer unmyelinated
fibres in the carotid sinus nerve as compared with
vehicle-treated controls (see Bond et al., 1982). Un¬
myelinated fibres account for 86% of the fibres in the
rat sinus nerve (McDonald, 1983), although it is not
known how many of these are chemosensory. The
question of how destruction of sensory afferents by
capsaicin is related to the increase in levels of
dopamine, noradrenaline and 5-HT in the carotid
body, and increased dopamine levels in the superior
cervical ganglia, cannot be answered by the results
from our study. It is also likely that other substances
will be affected by capsaicin treatment, including
substance P (Gamse et al., 1980; Keeler & Black,
1981) which has been found in the rat carotid body
(Jacobowitz & Helke, 1980) and might function as a
neurotransmitter at the central terminals of afferent
carotid sinus nerve fibres (Helke et al., 1980).
The selective dopamine D2-receptor antagonist
domperidone (Baudry et al., 1979; Lazareno &
Nahorski, 1982), which is effective in antagonizing
the chemodepressant action of dopamine in rabbit
carotid bodies (Mir et al., 1984), greatly reduced the
hypoventilation caused by dopamine both in
capsaicin-treated and vehicle-treated rats, the latter














Figure 8 Ventilatory responses to breathing 10% O2
or 100% O2, both measured 1 min after switching from
air, and to sodium cyanide 1 pmol i.v. during air brea¬
thing, were obtained before (open columns) and after
(solid columns) cutting both the carotid sinus and vagus
nerves in vehicle-treated rats. Vertical lines show s.e.
mean. Ventilation in the steady state averaged
25.3 ±3. lml 100 g~1 min-1 before and 22.9 ±2.4 ml
100 g_1 min-1 after sectioning the nerves.
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finding confirming the report by Horn ef al. (1984).
This evidence suggests that the respiratory-
depressant effect of dopamine is mediated via a
dopamine D2-receptor, and similar conclusions were
reached by Zapata et al. (1984) on the basis of
respiratory experiments in rats using the dopamine
antagonists sulpiride and metoclopramide. Since, in
general terms, dopamine does not cross the blood
brain barrier and neither does domperidone (Ladu-
ron & Leysen, 1979), it can be deduced that the
respiratory depressant effect of DA must involve
actions outside the CNS. The available evidence
points to the carotid body as the major site at which
dopamine acts to reduce respiration in rats (e.g. Horn
et al., 1984; Zapata et al., 1984). Electrical record¬
ings of chemosensory activity in the rat carotid sinus
nerve (Cardenas & Zapata, 1981) have shown that,
as in most species, dopamine depresses chemosen¬
sory discharge and would, therefore, be expected to
cause hypoventilation by reducing peripheral
chemoreceptor drive to respiration in rats anaesthet¬
ized with pentobarbitone (Horn et al., 1984).
Cutting both carotid sinus nerves greatly reduced
dopamine-induced ventilatory depression and also
attenuated the reflex hyperpnoea caused by hypoxia
or cyanide acting on the carotid chemoreceptors, and
this evidence is consistent with an inhibitory action of
dopamine on carotid body chemoreceptors. About
20% of the responses to hypoxia and cyanide sur¬
vived bilateral cutting of the sinus nerves, but cutting
both vagosympathetic nerves in the neck abolished
the residual responses. These extra-carotid effects
may have originated from thoracic or abdominal
chemoreceptors (see Cardenas & Zapata, 1983) or
perhaps from aortic chenioreceptors, although the
latter have been found to be non-functional in rats
(Sapru & Krieger, 1977a, b; 1978).
There were some differences from a previous study
(Bond etal., 1982), mainly in relation to the absolute
values for R.M.V. during steady state conditions, and
to the arterial blood gas tensions. These differences
may, in part, be explained by the fact that in the
present experiments the animals were more deeply
anaesthetized than was the case previously. This was
a deliberate policy in order to make the results more
directly comparable with those of Horn et al. (1984)
and Cardenas & Zapata (1981) who used a 60 mg
kg"' dose of pentobarbitone. Unexpected results
were obtained when dopamine was injected into
vehicle-treated rats which were breathing 100% O2
under steady-state conditions. It was anticipated that
the increased oxygen tension would virtually abolish
peripheral chemosensory activity ('physiological
denervation' of the chemoreceptors) and so prevent
dopamine from depressing ventilation (i.e. there
would be no respiratory drive from the chemorecep¬
tors for dopamine to depress). In fact dopamine still
caused some hypoventilation, but the responses were
not dose-related. Similar, although less intense, ef¬
fects can be seen in the results of Horn er al. (1984).
The cause of this responsiveness to dopamine in rats
breathing oxygen is difficult to ascertain, but since it
was partially antagonized by domperidone it appar¬
ently involves actions at dopamine D2-receptors.
Rats anaesthetized with pentobarbitone and brea¬
thing oxygen may still have a significant peripheral
chemoreceptor drive to respiration either originating
from within the carotid body (perhaps involving
CO2) or due to enhanced gain in the CNS, and this
possibility could be investigated by recording
chemosensory activity from the sinus nerve.
Although capsaicin-treated rats show a reduced
respiratory response to peripheral chemoreceptor
stimulation, sudden withdrawal of chemosensory
input as a consequence of switching to breathing
100% O2 caused just as marked a hypoventilation in
these animals as it did in the vehicle-treated controls.
This implies that, although chemoreflex activity is
reduced by capsaicin treatment, there is still suffi¬
cient chemoreceptor drive to respiration under the
conditions of our experiments to give a normal re¬
sponse to oxygen-breathing. Domperidone had no
significant effect on oxygen-induced hypoventilation
in controls, but did significantly attenuate the re¬
sponse in capsaicin-treated rats. However, it is dif¬
ficult to evaluate this evidence because systemic ar¬
terial blood pressure was significantly lower in
capsaicin-treated rats during oxygen breathing after
domperidone in comparison with vehicle- treated
controls, which complicates the interpretation.
Further studies on this aspect are needed.
Ventilatory responses to hypoxia and cyanidewere
not potentiated after domperidone, yet should have
been if endogenous dopamine was tonically inhibit¬
ing the chemoreceptors, particularly in capsaicin-
treated rats. In fact responses tended to be reduced
after the antagonist, although ventilation in the
steady state was increased, significantly so in the case
of capsaicin-treated rats. Horn et al., (1984) also
found a reduced respiratory response to hypoxia
following administration of the dopamine D2-
receptor antagonist sulpiride. Thus, domperidone
increases ventilation under normoxic conditions in
capsaicin-treated rats, which could be taken as evi¬
dence for a greater release of dopamine occurring in
the carotid bodies of these animals as compared with
the vehicle-treated controls. This assumes that ex¬
ogenous dopamine has similar effects to endogenous,
which need not be the case. In contrast, however, the
fact that domperidone reduced the ventilatory re¬
sponse to hypoxia could be regarded as evidence for
endogenous dopamine, acting via a dopamine D2-
receptor, being involved in chemoexcitation. This is
reminiscent of the 'dual effect' described by Car-
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denas & Zapata (1980) whereby dopamine reduced
chemoreceptor responses to low doses of cyanide but
potentiated the effects of higher doses. In our experi¬
ments, domperidone may, by blocking the actions of
endogenous dopamine, potentiate ventilatory re¬
sponses when dopamine release is low (i.e. during
normoxia) but reduce the responses when release is
high (during hypoxia). Whether or not this does
occur remains to be established.
In conclusion, within the limitations imposed by
working on whole animals where secondary changes
can affect primary reflex responses, and the
anaesthetic agent provides further complications, it
seems unlikely that the increased levels of dopamine
found in the carotid bodies of rats treated neonatally
with capsaicin are responsible for the reduced
peripheral arterial chemoreflex activity because: (a)
dopamine-induced ventilatory depression was not
significantly altered in capsaicin-treated animals, and
(b) the dopamine antagonist domperidone did not
increase the respiratory responses evoked by the
chemoreceptor stimulants hypoxia and cyanide.
Further studies, possibly in conscious animals, are
needed to determine how neonatal treatment with
the neurotoxin capsaicin causes a reduction in re¬
spiratory responsiveness to peripheral chemorecep¬
tor stimulation. It will also be interesting to investi¬
gate the extent to which central and/or peripheral
effects of capsaicin influence the actions and interac¬
tions of polypeptides such as substance P and the
enkephalins, which are present in the carotid body
and can co-exist with monoamines (Hansen et al.,
1982; Vamdell et al., 1982).
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DSM. We thank Mrs Susan Bond and Mrs Helen Gordon
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Effects of substance Pon carotid chemoreceptor and baroreceptor activity in
the cat
ByD. S. McQueen. Department of Pharmacology, University of Edinburgh, Edinburgh
EH8 9JZ
Substance P is a polypeptide which can activate sensory fibres in the rabbit ear
(Juan & Lembeck, 1974) and substance P-like material has been detected in peripheral
sensory nerve endings (Hokfelt, Johansson, Kellerth, Ljungdahl, Nilsson, Nygards &
Pernow, 1977). It was considered worth performing an electrophysiological investi¬
gation to determine whether substance P affects carotid chemoreceptor or baroreceptor
activity, particularly since it has been suggested that carotid body Type I cells may
secrete a polypeptide (Pearse, 1969).
Cats were anaesthetized with pentobarbitone and electrical activity recorded from
the peripheral end of a sectioned sinus nerve. The ganglioglomerular nerves were cut
(see McQueen (1977) for details). Low doses of synthetic substance P (1-5 /tg into the
ipsilateral common carotid artery (i.e.) over 2 sec) caused a small reduction in
spontaneous chemosensory activity, while higher doses (10-100 yg i.e.) increased
discharge by 1-5 c.p.s. over a 1-2 min period after a delay of 10-15 sec. There was a
dose-dependent fall in b.p.
Comparison of chemoreceptor responses obtained before and after administering
substance P showed that the excitatory effect of ACh was slightly reduced whereas
that of NaCN was slightly potentiated. The inhibitory action of dopamine was
unaffected by substance P. When the stimulants were injected i.e. during an infusion
of substance P (10/ig/min i.e. for 5 min), responses to ACh were reduced and those
to NaCN slightly potentiated. In two cats the effect of substance P (5-10 /ig I.e.) on
baroreceptor activity was investigated. There was no action on spontaneous activity
in the 5-7 sec period following the injection, and thereafter discharge followed
the changes in systemic b.p., falling initially, then recovering to control level.
The results show that substance P in the doses studied did not stimulate the carotid
baroreceptors and had only a weak effect on chemosensory activity. The slight
inhibition of the ACh response could be due to a nicotine-blocking effect of substance
P, such as that described for Renshaw cells (Ryall & Belcher, 1977), and weak nico¬
tinic block is known to potentiate the action of NaCN on carotid chemoreceptors
(McQueen, 1977). The physiological significance of these results with exogenous
substance P depends on whether or not substance P is present in the cat carotid body;
Hanbauer (1977) was unable to detect substance P in rat carotid bodies, despite the
use of a sensitive radioimmunoassay method.
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summary
1. The influence of substance p (sp) on spontaneous chemosensory discharge
and on responses of the carotid chcmoreccptors to various drugs lias been investi¬
gated in pentobarbitone anaesthetized cats in which chemoreceptor activity was
recorded from the peripheral end of a sectioned sinus nerve.
2. After an initial slight inhibition during the first 5-15 sec following the injection,
SP (0-1-100 pg i.a.) caused a dose-related increase in discharge which lasted for
45-300 sec in artificially ventilated cats, discharge being increased by about 50%
on average. The increase was of shorter duration when the animals were allowed
to breathe spontaneously.
3. The delayed increase in discharge was not secondary to the hypotension
caused by SP, nor was it entirely due to changes in bronchomotor tone resulting
from direct or indirect actions of SP, although such changes contributed to the
response. It was not possible to determine whether the excitation was due to a
direct effect of SP on the chemoreceptors.
4. Chemosensory excitation evoked by NaCN (5 //.g i.a.) was potentiated during
i.a. infusions of sp and also 10-20 min after sp (10//g i.a.) had been injected.
In contrast, responses to ACh (50 pg i.a.) were inhibited. These effects may be
due to a nicotinic-blocking action of sp on the carotid chemorcecptors. It was
also found that the inhibitory action of dopamine (5 /tg i.a.) was reduced during
sp infusion whereas that of 5-HT (10pg i.a.) was potentiated.
5. A sample of crude sp had effects on spontaneous chemoreceptor discharge
and responses to NaCN and ACh which were qualitatively similar to those obtained
using synthetic sp.
G. The physiological significance of the results is discussed and it is concluded
that the interpretation depends upon whether or not SP is present in the cat's
carotid body.
introduction
The carotid body type 1 cell is considered by Pearsc (1900) to be a member of
the APUD cell series (i.e. cells which share the characteristics of r/mino and amine
precursor uptake and decarboxylation, and polypeptide secretion). Penrse suggested
that the type 1 cell secretes a low molecular weight polypeptide, which he tentatively
named 'glomin'. Histological evidence has since been obtained which indicates
0022-3751/80/7970-0194 $07.50 © 1980 Tho Physiological Society
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that polypeptide or protein-containing granules are present in mammalian carotid
body cells (Capella & Solcia, 1971; Pearse, Polak, Rost, Fontaine, Le Lievre &
Le Douarin, 1973).
Immunohistochemical evidence (Hokfelt, Johansson, Kellerth, Ljungdahl, Nils-
son, Nygaards & Pernow, 1977; Cuello, 1978) shows that SP-like material is present
in the peripheral endings of various sensory nerves and it has also been reported thai?
synthetic SP can stimulate sensory nerve endings (Juan & Lembeck, 1974).
As there is a possibility that carotid body cells secrete a polypeptide, and it is
known that SP-like material is associated with some peripheral sensory nerve
endings, it seemed worth determining what effect SP has on the cat carotid chemo-
receptors. A preliminary report on some of the results has been made to the Physio¬
logical Society (McQueen, 1978a).
METHODS
Most of the details have been described previously (McQueen, 1977; Docherty & McQueen,
1978) and only a brief summary follows. Experiments were performed on cats of either sex
weighing between 2-2 and 3-7 kg (median weight 2-8 kg, n = 11) which were anaesthetized
with pentobarbitone sodium (42 mg/kg i.e.) supplemented approximately every 1-5-2 hr during
the experiment by i.v. administration of 10% of the initial dose. Blood pressure was recorded
from one femoral artery and the other femoral artery was cannulated for arterial blood sampling.
Rectal temperature was maintained at 38 ± 0-5 °C and the bladder drained at regular intervals.
A sinus nerve was dissected free from surrounding tissues, cut centrally, and the electrical
activity of single or multiple chemoreceptor units (two to four active units preferred)
recorded from the peripheral nerve using bipolar platinum electrodes and an a.c. amplifier
(Neurolog; Digitimer). The ganglio-glomerular nerves were cut in order to prevent changes
in sympathetic nerve activity influencing chemoreceptor discharge (Floyd & Neil, 1952;
Eyzaguirrc & Lewin, 1961a). For part of some experiments the animals breathed spontaneously
and respiration was recorded via an integrating pneumotachograph (CS3c; Mercury Electronics)
which was used in conjunction with a time clock (2112; Palmer) to provide a cumulative record
of total volume inspired over a period of 30 sec. A 'staircase' tracing was obtained on the
pen recorder (MX6; Lectromed) giving a breath-by-breath record of respiration with the
over-all height being proportional to the respiratory half-minute volume. For the rest of the
experiments the animals were artificially ventilated with room air and usually paralysed by
gallamine triethiodide (3 mg/kg I.v.). End-tidal 0O2 was continuously monitored by an infra¬
red C02 analyser (Med 1A; Grubb Parsons) and the P,>co , and pR °f femoral arterial
blood samples measured using a gas monitor (BMS3 with PHM71 meter, Radiometer).
Nerve activity was recorded on magnetic tape (Tandberg 100; frequency response d.c. to
1250 Hz) and subsequently analysed with the aid of a computer (PDP-8; Digital Equipment
Corporation) in order to provide data concerning discharge frequency. The average (x ct/sec)
and total count (E.r) were calculated for each response after its duration (t sec) had been
determined. Responses were expressed as a change from control level by subtracting the
appropriate control or background discharge (i.e. as AXr). Data from different experiments
were pooled and the results presented as the mean + s.K. of mean.
Drug solutions (0-1 ml.) were injected into the common carotid artery ipsilateral to the
sinus nerve from which activity was being recorded and washed in with 0-2 ml. modified Locke
solution which had been bubbled with 5% C()2 in air in a water bath at 37 °C; the wash solution
had no effect on spontaneous eheinorcceptor discharge. The catheter was introduced into the
common carotid artery via the lingual artery, and its tip lay about 2 cm caudal to the carotid
bifurcation. Injections were made over a 2 sec period and at least 20 min allowed to elapse
between doses of SP. Drug itifiuriotia were mnde through a second catheter situated in the
common carotid artery at its junction with the superior thyroid artery (through which the
catheter was introduced) using an infusion pump (Brnun) which delivered 0-5 ml./min of drug
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solution. Injections of stimulants NaCN or acetylcholine (ACh)) into either of the two carotid
catheters evoked very similar chemoreceptor responses.
Drugs were prepared in modified Locke solution (NaCl 0 0 g; KC1 0-42; CaCl2 0-24; Trie base
6 0 g; A/-HC1, 39 ml.; distilled water to 11.; pH 7-41 at 37 °C). Doses referred to are those of
the salts. Glassware used for SP was silanized. The drugs used in this study were: pentobarbitone
sodium, gallamine triethiodide (May & Baker); acetylcholine iodide, atropine sulphate, sodium
cyanide (B.D.H.); dopamine hydrochloride (Koch-Light); 5-hydroxytryptamine creatinine
sulphate, synthetic Substance P (Sigma; Beckman).
A sample of SP which had belonged to Professor Gaddum was kindly given to me by Dr
T. B. B. Crawford of this department. The 1 mg sample of crudo SP had been extracted from
horse intestine, adsorbed onto lactose and stored in a nitrogen-filled sealed ampoule. Its activity




In artificially ventilated cats SP injected close-arterial to the carotid body in
a dose of 0-1-100 /ig usually caused a slight inhibition of spontaneous chemoreceptor
discharge during the first 5-15 sec after the injection, an effect which did not
appear to be dose-related. The initial inhibition was followed by an increase in
discharge which, although not substantial, lasted for 45-300 sec and was dose-
related (see Figs. 1 and 2). Low doses of SP (0-1-2-5//g) did not always cause a
delayed increase in discharge: there was often no change. Tachyphylaxis seemed to
develop to the delayed increase in chemoreceptor discharge, although not to the
hypotension which also followed the injection of SP, and it was noted that the
biggest increases in discharge were obtained in female cats.
Data obtained from five experiments in which chemoreceptor discharge, expressed
as a percentage of the control spontaneous frequency, was pooled and plotted
against time after an i.a. injection of SP are shown in Fig. 2. This quantitative
evidence confirmed that higher doses of SP caused a delayed increase in chemo¬
receptor discharge, albeit a slight and somewhat variable effect. The duration
of the increase, but not necessarily the peak discharge, appeared to be dose-related.
SP also caused a fall in arterial blood pressure which lasted for 1-5 min and was
usually, but not invariably, polyphasic. The duration of the hypotension (i.e. time
taken to return to control b.p.) was generally dose-related although the magnitude
of the peak fall in pressure was not always related to the dose of SP (see Fig. 1). The
increase in chemoreceptor discharge associated with higher doses of SP coincided
with the onset of hypotension. However, although low doses of SP often caused
b.p. falls similar to those evoked by much higher doses (see also Vogler, Haefely,
Hurlimann, Studer, Lergier, Strassle & Berneis, 1963), there was often very little
or no increase in discharge, and sometimes an increase in discharge occurred which
was accompanied by a rise in b.p. (Figs. 3 and 4). These results suggested that the
increase in chemoreceptor activity was not necessarily secondary to the hypo¬
tension caused by SP, and this was confirmed by showing that chemoreceptor
discharge still increased when the fall in b.p. was prevented by infusing dextran
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Fig. 1. Response of a single chemoroceptor unit to various doses of SP injected i.a. in
random order with at least 20 min between successive doses. Each panel shows a
block diagram of the chemoreceptor discharge in ct/sec and femoral arterial blood
pressure. It can be seen in this particular experiment that although a similar fall in b.p.
was evoked by all the doses of SP, the delayed increase in chemoreccptor discharge was
dose-dependent.
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Fig. 2. Block diagrams showing chemoreceptor discharge following i.a. injections of
10 fig SP (A) and 50 fig SB (B). Discharge was averaged over 15 sec periods and
expressed as a percentage of the average discharge in the 15 sec control period
before the injection (black rectangle). Data obtained in different experiments were
pooled and are shown as the mean percentage ± s.e. of the mean. The over-all average
discharge in the control period was 2-8 + 0-9 ct/sec for the four experiments with
SP 10 fig i.a., and 2-5 + 0-8 ct/sec for the five experiments with SP 50 fig i.a.
Bronchial and respiratory changes
In some experiments end-tidal C02 increased slightly at the time when spontaneous
chemoreceptor discharge increased following SP i.a. This was reminiscent of the
delayed (bigger) increase in end-tidal C02 seen following i.a. methacholine, an effect
which was attributed to bronchoconstriction (McQueen, 19785). It was necessary,
therefore, to investigate whether the delayed increase in chemoreceptor discharge
observed in the present experiments was secondary to changes in blood gas tensions
resulting from a bronchoconstrictor action of SP; it is known that SP can cause
bronchoconstriction in guinea-pig lung (Bisset & Lewis, 1962; Bhoola, Collier,
Schachter & Shorley, 1962).
If bronchoconstriction were responsible for the delayed increase in discharge, one
would not expect to see the effect in a spontaneously breathing animal because
as soon as gas tensions began to change as a result of bronchoconstriction, the
central and remaining peripheral chemoreceptors would reflexly adjust ventilation.
Recordings of chemoreceptor activity were obtained in three experiments and
responses to SP obtained with the animals breathing spontaneously and again
when they were artificially ventilated and paralysed. The results obtained are
illustrated in Figs. 3 and 4. It was found that the increase in chemoreceptor discharge
occurred during spontaneous respiration, although the effect was not so sustained
2-2
d. s. McQueen
Fig. 3. Chemoreceptor discharge evoked hy SP during spontaneous respiration coin-
pared with the effect observed on tho same recording under conditions of artificial
ventilation. A is tho chemoreceptor discharge (three unit recording) in response to
SP 1 fig i.a. B is from a different animal (two unit recording) showing the effects of
SP 50 fig i.a. C presents the pooled data from three experiments in which SP 50 fig i.a.
was injected at time 0, block diagram details being tho same as for Fig. 2. The average
control discharge was 1-3 + 0-4 ct/sec during spontaneous breathing and 2-0 + 0-8 ct/sec
during artificial ventilation. The panels in A and B show, from above downwards,
end-tidal C02; block diagram of chemoreceptor discbarge in ct/sec ; femoral arterial b.p.
Injections represented by the arrows.
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as that seen following the i.a. injection of SP when the animals were artificially
ventilated (see Figs. 3 and 4). Arterial blood samples taken 45 sec after the injection
of SP showed a fall in P 0 and a rise in Pa_co in artificially ventilated cats, but
increases in PSio, and slight decreases in P& COj, or no changes at all, when the
animals were breathing spontaneously (see Fig. 4). The changes in gas tensions
seen under conditions of artificial respiration were only slight (1-3 torr increase in
Pa,COt; l-5 f°rr decrease in PajGj) but, because they interact (see Fig. 3 in Eyzaguirre
& Lewin, 19615), are probably responsible for some of the more delayed increases
in chemoreceptor discharge.
Increases in chemoreceptor discharge were obtained when the animals were
breathing spontaneously, despite the increase in respiration which occurred, even
after the lowest dose of SP studied (01 /<g i.a.). When the hypotensive action of
SP was prevented by infusing dextran i.v. (see Fig. 4), there was no longer any
marked change in respiration, thereby indicating that the increase in respiration
was secondary to the hypotension.
Influence of SP injections on responses to ACh, NaCN, dopamine and hypoxia
During the study of the effects of SP on chemoreceptor discharge, responses to
ACh (50 fig i.a.) and NaCN (5 fig i.a.) were determined before and 10-20 min after
injecting SP in three experiments on artificially ventilated paralysed cats. Results
obtained are shown in Fig. 5A and it was found that responses to NaCN were
potentiated following SP, whereas those to ACh were slightly reduced. Inhibition
evoked by dopamine (5 fig i.a.) was unaltered after SP. In two experiments SP
(10 fig i.a.) was injected at the peak of the response to hypoxia (animal breathing
5% 02/95%N2) and had no effect on discharge. Although the results showed a
potentiation of the response to NaCN, they were difficult to interpret because it
was not known whether SP was directly influencing the chemoreceptors 10-20 min
after it had been injected.
Infusions of SP
It was suspected that tachyphylaxis develops to the effects of SP on the chemo¬
receptors, so only short infusions of SP were studied in artificially ventilated
paralysed cats. Since it was impossible to obtain dose-response data from such
short infusions, single submaximal doses of chemoreceptor stimulants were used
and responses obtained before and during a 5 min infusion of SP (1-50 /^g/min) into
one of the carotid catheters (see Methods). Sodium cyanide was injected into the
other catheter 2 min after the infusion began, and ACh injected 4-5 min into the
infusion. A fall in b.p. occurred and was usually sustained for most of the infusion
period.
Results from three experiments are summarized in Fig. 5C. There was a dose-
dependent potentiation of responses to NaCN and an inhibition of responses to
ACh during the infusion of higher doses of SP. Responses to ACh and NaCN were
largely unaltered when the drugs were injected during an infusion of 1 fig SP/min,
or during the infusion of Locke solution. Spontaneous discharge was affected
variably during the SP infusions, there being no obvious trend (see Fig. 5).
B
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Shorter infusions of SP
These experiments were performed in order to avoid some of the problems associated
with longer infusions (e.g. the risk of tachyphylaxis; sustained changes in b.p. or
blood gas tensions leading to alterations in chemoreceptor sensitivity). Responses
to ACh, NaCN, dopamine, and 5-HT were examined individually during short
(60 sec) i.a. infusions of SP, the injection being made 45 sec after the start of the
SP infusion. The order in which the different concentrations of SP were infused
was varied randomly from experiment to experiment, and infusion of the same
volume of Locke solution (0-5 ml. over 1 min) had no effect on the responses.
Results obtained from three experiments are summarized in Fig. 5B. During these
short infusions there was a dose-related increase in responses evoked by NaCN, an
effect which although less intense, is similar to that seen during the longer infusions.
Responses to ACh were reduced, slightly during infusion of 1 /tgSP/min and more
markedly during 50/tg/min, this being similar to the results obtained during the
longer infusions. However, responses to ACh obtained during 10 /rgSP/min, although
somewhat variable, were potentiated, whereas they were inhibited during the longer
infusion.
The inhibiting response evoked by dopamine (5 fig i.a.) was reduced during
SP 1 /rg/min (to 52 ± 19 % of the pre-infusion or control response, n — 3; background
(control) = 3-6 + 2-9 ct/sec; during infusion = 1-1 + 0-7 ct/sec) and SP50/ig/min
(to 64 + 5%, n = 2; background (control) = 1-1+0-5, during infusion = 0-4 + 0-3
ct/sec). During SP 10/ig/min there was a very variable effect with, over-all, a
reduction of the inhibition (to 92 + 26%, n = 3; background (control) = 1-2 + 0-7,
during infusion 1-0 + 0-5 ct/sec). The trend was, therefore, a reduction in the
inhibitory response to dopamine during SP infusions, an effect which was not
obviously dose-related. It should be noted that background activity decreased
slightly during the SP infusions.
The brief stimulation of chemoreceptor activity evoked by 5-HT (10 /ig i.a.) was
reduced during SP infusions of 1 and 10/ig/min in one experiment. The delayed
inhibition which followed the initial excitation (see Docherty & McQueen, 1978)
was, however, potentiated during both the 1 and 10/ig/min infusions, although
background discharge was slightly decreased by the SP.
Spontaneous chemoreceptor discharge was affected variably during the infusions
of SP, there being a slight tendency for it to be decreased (see Fig. 5 and the dopamine
results).
Injection and infusion of crude SP
A sample of Gaddum's SP was injected i.a. in an artificially ventilated cat which
had not been paralysed. A slight fall in b.p. occurred and was followed by a rise
in pressure. There was no immediate change in spontaneous chemoreceptor discharge,
but after a delay of about 30 sec there was an increase which lasted for about 90 sec
(see Fig. 6). Injection of the same amount of SP i.v. caused a slight fall in b.p. and
also evoked a slight delayed increase in chemoreceptor discharge lasting from
40-120 sec after the injection.
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Fig. 5. Pooled data, obtained from the number of recordings indicated, showing the
influence of SP on the response of the chemoreceptors to ACh 50/rgi.A. and NaCN
5 fig i. a. Responses are expressed as a percentage of the response (AI.r) obtained before
SP was administered (black rectangle = control = 100%). a shows the responses
to ACh and NaCN injected 10 1 f> min after a single injection of SP (10 fig i.a.). B shows
the effect on the responses evoked by the stimulants of a 60 sec infusion of SP at
1, 10 or 50/ig/min, the ACh or NaCN being injected 45 sec after the start of the
infusion. C shows t he responses evoked during a 5 min infusion of SP, NaCN being
injected 2 min after the infusion started and ACh 4-5 min into the infusion. The
average chemoreceptor discharge in the control periods is shown.





























NaCN 5 gg i a
ACh 50 gg i a
60 sec
NaCN 5 gg i a
ACh 50 fig i a
60 sec
Fig. 6. Chemoreceptor activity (two units) from an experiment in which an extract
of 8P (1 mg extract =; U-:?S //g synthetic SI') was investigated. In A 100 //g extract
was injected i.a. at the time indicated hv tlie arrow, whereas in B the same dose was
administered l.v. The animal was artificially ventilated but not paralysed. C shows
responses to dopamine (DA) 5 /ig, NaCN 5 fig and ACh 50 /rg obtained dttring an
infusion of Locke solution, whereas those in D are the responses obtained during
a 6 ruin infusion of SP ('20 /ig extract/min). The ncurograms show the action potentials
with 1 sec timing marks below them, dopamine injections being represented by the
horizontal bar. Action potentials were counted at the level represented by the
brightening pulse. In the other panels, the upper trace is a bar diagram of chemo-
reeeptor discharge (in ct/sec) with the lower trace showing n.r.
(injected at 3-o min) was essentially similar to that obtained pre- and post-infusion
(see Fig. 0). The response to ACh (injected at 5-5 tnin) was, however, reduced by
about 30% (Ail.r) during the SI' infusion, and there was a prolonged inhibition of
spontaneous discharge following the initial excitation, an effect not observed before
or after the infusion. The inhibitory action of dopamine (5 /tg injected 1-5 min after
the infusion started) also seemed to be potentiated during the infusion of crude SI'.
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discussion
Effect of SP on spontaneous chcmoreccptor discharge
There was no evidence that exogenous SP caused any substantial change in
spontaneous chemorcceptor discharge, such as is seen during the first 10 sec following
an i.a. injection of ACh, NaCN or dopamine. However, about 10-20 sec after SP
had been injected a long-lasting dose-dependent increase in discharge occurred.
There were no consistent changes in spontaneous discharge during infusions of SP
(1-50 /ig/min i.a.), so it appears that the delayed increase is only obtained following
the injection of high doses of SP. A classical extract of SP caused a delayed increase
in discharge qualitatively similar to that evoked by synthetic SP.
Vascular effects. SP caused hypotension followed by a slight rise in b.p. (see also
Pernow, 1953), and the present results confirmed that although the duration of
the hypotension is dose-related (Vogler et al. 1963), it is often difficult to establish
a clear dose-response relationship for the effect in cats (Burcher, Atterhog, Pernow
& Rosell, 1977). The delayed onset of the increase in chemoreceptor discharge
caused by SP and the fact that it tended to coincide with the fall in b.p. raised the
question whether it was secondary to the hypotension. The sympathetic nerve
supply to the carotid body had been cut, thereby eliminating the possibility that
reflex changes in sympathetic activity, secondary to the hypotension, were respon¬
sible for increasing discharge by reducing blood flow through the glomus (Floyd &
Neil, 1952; Biscoe & Purves, 1967). Chemoreceptor discharge is largely independent
of b.p. over the physiological range (Hornbein, Griffo & Roos, 1961; Biscoe, Purves
& Sampson, 1970; Acker, Keller, Lubbers, Bingham, Schulze & Caspers, 1973), as
is demonstrated in the present experiments by the observation that although ACh,
like SP, causes a fall in b.p., there was no marked increase in discharge associated
with the hypotension (see Figs. 4 and 6).
The results showed that there was no correlation between the fall in b.p. and the
delayed increase in discharge. In spontaneously breathing cats hypotension increased
ventilation, an effect which is probably a consequence of several factors including
changes in blood flow to the c.N.s. (Schmidt, 1928) and alterations in baroreceptor
influences on bronchoinotor tone (Daly & Schweitzer, 1951; Heymans & Neil, 1958;
Widdicombe, 1963). Hyperventilation would tend to mask any delayed excitatory
action of SP on the chemoreceptors. Although it is conceivable that SP could be
influencing chemoreceptor discharge by altering the distribution of blood within
the carotid body, the balance of evidence makes it unlikely that the delayed increase
in chemoreceptor discharge is secondary to vascular effects of SP.
Bronchial effects. Evidence obtained from experiments on artificially ventilated
cats showed that injected SP causes delayed changes in arterial blood gas tensions.
This effect might have been the result of SP acting directly or indirectly in the
lung to cause bronchoconstriction, although whether this was in fact the mechanism
remains to be established. However, the increase in chemoreceptor activity, although
not so sustained, still occurred in spontaneously breathing cats, even though the
arterial blood gas tensions were either unaltered or changed in the opposite direction
(Pa.o, increased, Pa>co decreased) as a consequence of hyperventilation secondary
to the hypotension which followed the SP injection (see above). It appears, therefore,
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that the increase in ehemoreceptor discharge seen following an i.a. injection of
SP can occur independently of respiratory or bronchial changes caused by SP,
although such changes do modify the magnitude and duration of the increase. Since
vascular and bronchial changes caused by SP are unable to account entirely for the
increase in chemoreceptor discharge, particularly during the early phase of the
response, and since .some other potential secondary explanations can be precluded
(e.g. SP does not release catecholamines from the cat adrenal medulla (Feldberg &
Lewis, 19G4; Lewis & Reit, I960)), the effect could be due to a direct action of SP
on the chemoreceptors.
Direct action of SP on chemoreceptors. It is fairly well established that SP can
excite certain neurones in the c.n.s. (Otsuka, Konishi & Takahashi, 1975) and it
has been hypothesized that SP may have a physiological role as a central neuro¬
transmitter (Lembeck, 1953) or modulator of neural activity (Krivoy, Kroeger &
Zimmermann, 1977). As far as the peripheral nervous system is concerned, Juan &
Lembeck (1974) reported that synthetic SP excited peripheral sensory nerve endings
associated with paravascular pain receptors in the rabbit ear. They noted a delay
of '4-10 sec or more' before neural activity increased in their preparation and
Krnjevib (1977) also found a delay of 10-30 sec before an excitatory effect was
observed following the ionophoretic application of SP to central neurones in cats.
The latency and long time course of the effect has been attributed to the time
taken for SP to diffuse through neural tissue (Otsuka & Konishi, 1977). However,
the possibility that SP may be releasing another agent, or metabolized to an active
entity, cannot be precluded. In the present experiments it was not possible to
determine whether the chemoreceptors were uniformly affected by SP, or whether
there was a difference between, for example, units associated with A fibres and
those with C fibres. More recent evidence casts doubts on whether SP can, in fact,
stimulate sensory nerve endings. Lembeck, Gamse & Juan (1977) found that
synthetic SP was devoid of effect on paravascular pain receptors and were unable
to explain the increase in activity obtained with synthetic SP by Juan & Lembeck
(1974).
It is possible that SP was acting directly on the chemoreceptors to cause the
increase in discharge. Any early excitatory action may have been masked by
vascular effects of SP within the carotid body, or by an inhibitory action of SP,
directly or indirectly mediated, on the chemoreceptors. However, whether the
chemoreceptor-stimulating effect observed in the present experiments is due to
primary or secondary actions of SP can only be resolved by further studies using
a preparation, such as the in vitro carotid body (Eyzaguirre & Lewin, 1961c), which
avoids many of the secondary complications.
Influence of SP on chemoreceptor responses to ACh, NaCN and dopamine
The results showed that the stimulant action of ACh was reduced after injections
of SP and also during infusions of SP, with the exception of the unexplained
potentiation during the short 10//g/min infusion. In contrast, the excitant effect
of NaCN was potent iated after injections of SP and, in a dose-related manner, during
infusions of SP. Whatever effect SP was exerting on the chemoreceptors was evident ly
dose-dependent and fairly long-lasting: the response to NaCX was potentiated
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10-15 min after the injection of SP (10/rgi.A.). Responses during a prolonged
infusion of SP were slightly greater than those obtained during a short infusion,
which provides evidence that tachyphylaxis to SP did not occur and also that
changes in responsiveness during prolonged infusions were not secondary to sus¬
tained changes in b.f. or blood gas tensions evoked by SP.
SP has a nicotinic-blocking action, as has been shown by Ryall & Belcher (1977)
on Renshaw cells and by Livett, Kozousek, Mizobe & Dean (1979) on cultured
adrenal chromaffin cells. The present results are compatible with a slight nicotinic-
blocking action of SP on the carotid chemoreceptors because such an effect would
reduce the response to ACh and potentiate the action of cyanide (McQueen, 1977).
Further experiments are required to determine whether this is, in fact, the mechanism
of action of SP on the chemoreceptors.
The present results confirm previous reports that dopamine inhibits spontaneous
chemosensory discharge as does 5-HT, after a brief initial excitation (e.g. see
Docherty & McQueen, 1978). The inhibition evoked by dopamine was reduced
during SP infusions whereas that associated with 5-HT was potentiated. It was
not possible to determine what was responsible for these effects, nor what effect
SP was having on the release of dopamine or 5-HT, both of which are present
in the carotid body (Chiocchio, Biscardi & Tramezzani, 1967; Chiocchio, King,
Carballo & Angelacos, 1971). It has been shown in cats that intra-nigral SP results
in an increased release of dopamine (Ch6ramy, Niedullon, Michelot & Glowinski,
1977) and, in rats, that SP injected into the lateral ventricles stimulates the synthesis
and utilization of dopamine and 5-HT in brain (Carlsson, Magnusson, Fisher, Chang
& Folkers, 1977). SP has also been shown to be capable of affecting the release of
5-HT in the rat substantia nigra (Reubi, Emson, Jessell & Iversen, 1978). It would
seem worth investigating whether SP influences carotid body dopamine and 5-HT;
the outcome of such studies might explain the present results with exogenous
dopamine and 5-HT.
Physiological significance of the results
The finding that spontaneous chemoreceptor discharge is slightly increased
following close-arterial injection of SP to the carotid body, and that SP may be
causing a slight nicotinic-blocking action on the chemoreceptors, might be considered
to be of pharmacological rather than physiological interest because high doses of
SP were needed to show the effects. It has also to be borne in mind that exogenous
synthetic SP may not be mimicking the effect of any endogenous SP-like material
that may be present in the carotid body; vascular or other non-specific effects of the
injected SP may mask the primary action, and effects on cell metabolism (e.g.
affecting dopamine or 5-HT as discussed above), glomus blood vessels, or even
as a hormone, may be of more importance than any direct effect on sensory nerve
activity. In any event, the present experiments would only detect direct effects
of exogenous SP on the chemosensory mechanism which show up within a few
minutes, which may not be the appropriate time course for any physiological action.
A specific SP antagonist would have been very useful in the present experiments,
but unfortunately none exists; baclofen (Saito, Konishi & Otsuka, 1975) is not
a specific SP antagonist (Carlsson et al. 1977; Krnjevi6, 1977).
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The physiological significance of the results depends on whether or not SP is
present in the cat carotid body. As mentioned in the Introduction, there is evidence
that a polypeptide is present in the carotid body, and SP-like material has been
detected in various peripheral sensory nerves; SP is probably released from nerve
endings of small C fibres (Hokfelt et al. 1977). Recent immunohistochemical evidence
shows that SP-like material is present in some 5-HT-containing neurones in the
rat c.n.s. (Hokfelt, Ljungdahl, Steinbusch, Verhofstad, Nilsson, Brodin, Pernow &
Goldstein, 1978) and, as mentioned above, there are large numbers of 5-HT-con¬
taining cells in the cat carotid body. But is there any SP in the carotid body?
Hanbauer (1977) was unable to detect any in the rat carotid body using a sensitive
radioimmunoassay technique, but whether or not there is any in the cat carotid
body remains to be established.
The author gratefully acknowledges the financial support of the Medical Research Council
and the technical assistance of Mrs S. M. Bond.
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SUMMARY
Immunofluorescent studies have shown that substance P or substance P-
like material is present in the cat carotid body, being located in some of the
glomus cells and also in nerve axons. About 20% of the glomus cells were
substance P positive. Substance P may be stored in glomus cells containing
monoamine(s), but further studies are needed to investigate this aspect and
also to determine what role, if any, substance P plays in the process of
chemoreception.
Pearse [13] proposed that the carotid body type 1 cells, also known as
glomus, chief, or chemoreceptor cells [1], secrete a low molecular weight
polypeptide which he provisionally named 'glomin'. Evidence has since been
obtained which shows that polypeptide or protein-containing granules are
present in mammalian carotid body cells [2,14], but the identity of the poly¬
peptide remains to be established.
The carotid body has a high monoamine content [3,6] and neuroactive
peptides are often stored in cells which also contain monoamines [8,9],
Substance P has been found in various peripheral sensory nerve endings
[4,5,7] and the present immunofluorescence study was undertaken to
determine whether substance P is present in the cat carotid body.
An indirect immunofluorescent procedure was applied as previously
described [4], Carotid bodies of cats anaesthetised with pentobarbitone
sodium (42 mg/kg, i.p.) were fixed in 4% paraformaldehyde in 0.1 M phos¬
phate buffer (pH 7.2) for 2—4 h at room temperature and then transferred
for 1—4 days to the same buffer containing 5% sucrose. Thick sections (10 pm)
were obtained in a Dittes cryostat (Dittes, Heidelberg, F.R.G.) and incubated
with (1 : 40, v/v) a monoclonal antibody against substance P;immunocharac-
teristics of which have been described [4] obtained by the hybridoma
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strategy [10]. Control preparations were run by incubating alternate sections
with some antibody preparation preabsorbed with 200 Mg/ml of substance P
(Peninsula Labs, U.S.A.). As developing antiserum an antirat IgG, conjugated
with FITC (Miles-Yeda) was applied in 1 : 6, v/v. Preparations were observed
and photographed in a Leitz Dialux microscope equipped with epifluorescence
optics. Micrographs were taken on Kodak T-X film with an Orthomat camera.
In all 14 carotid bodies from 7 cats were examined. Low magnification
observations of these organs consistently showed the presence of cells which
displayed immunoreactivity following the application of monoclonal anti¬
body (Fig. 1). This immunoreactivity was absent when the material had been
incubated with monoclonal antibodies pre-absorbed with substance P (Fig. 2).
At higher magnification the non-specific fluorescent spots were seen in the
connective tissue space. The positive cells were distributed throughout the
carotid body and were sometimes organised in small clusters. No attempt
was made to quantify the number of positive cells, but they appeared to
comprise approx. 20% of the total population.
Closer observation at higher magnification showed that the positive cells
were glomerate in appearance (Fig. 2) and are therefore mainly glomus or
type 1 cells. They display a varying degree of immunofluorescence which
could be a representation of the physiological state and the amount of
substance P-like material intracellularly stored at the moment of fixation.
Alternatively, the weaker stained peptide may indicate the presence of an
Fig. 1. Low magnification composit micrograph revealing the presence of substance P
immunofluorescent glomus cells distributed along the entire carotid body. Double arrow
heads indicate unspecific fluorescence in the capsular connective tissue. Substance P
immunofluorescent axons are not readily visible at this magnification. Calibration bar =
100 »im.
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Fig. 2. A: aspect of a zone of the cat carotid body showing several glomerular cells with
varying intensity of substance P immunoreactivity as shown in the monoclonal antibody.
Arrow shows a long segment of a positive varicose nerve fibre running between substance
P positive and negative cells. Calibration bar = 50 )im. B: similar field to Fig. 2A from a
sequential section of the cat, carotid body incubated with a control solution (monoclonal
substance P antibody absorbed with 200 Mg/ml of the peptide). Spots showing unspecific
fluorescence in the connective tissue are indicated with double arrow heads. Calibration
bar = 50 mm.
unknown related peptide which partially cross-reacts with this antibody. At
higher magnification the presence of many thin varicose nerve fibres were
located in every portion of the carotid body (Fig. 2).
These observations strongly indicate that substance P, or a new polypep¬
tide closely related to it, is stored in the glomus cells of the cat carotid body.
Nerve fibers have also been observed to contain this peptide, and it is possible
that these are branches of the sensory fibres which form synapses with the
glomus cells, the cell bodies being in the petrosal (IX) ganglion. Dopamine,
noradrenaline and possibly 5-HT are present in type I cells [3,6] and it will
be interesting to determine whether substance P is stored in conjunction
with any particular carotid body amine (e.g. as it is in 5-HT-containing CNS
neurones [9]).
There is good evidence that carotid body cells (type I and presumably,
type II) are essential for the process of chemoreception [15]: the sensory
nerve-endings alone are probably not chemosensory, although there is some
disagreement about this [1,12]. Whether the cells release a transmitter
substance(s) which affects the sensory nerve-ending, or whether they exert
a trophic influence on the nerve-endings making them sensitive to physiological
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stimuli remains to be established. What role, if any, substance P may have in
the process of chemoreception is unknown and needs to be investigated.
Exogenous substance P causes a slight, delayed, long-lasting increase in spon¬
taneous chemoreceptor discharge, part of which is probably a primary effect
on the chemoreceptors [11].
In conclusion, the present results confirm Pearse's [13] suggestion that a
polypeptide is present in the carotid body. 'Glomin' will probably turn out
to be a mixture of peptides because preliminary experiments (Cuello and
McQueen, unpublished) suggest enkephalins are also present in the cat carotid
body. It will be interesting to investigate how substance P in the carotid body
interacts with monoamines, whose function also remains to be established,
and with other polypeptides since such studies might provide further insight
into the process leading to the classical function of the carotid body, namely
chemoreception.
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INHIBITORY ACTIONS OF METHIONINE-ENKEPHALIN AND
MORPHINE ON THE CAT CAROTID CHEMORECEPTORS
d.s. McQueen & j.a. ribeiro1
Department of Pharmacology, University of Edinburgh, 1 George Square, Edinburgh EH8 9JZ
1 The effects of intracarotid injections of methionine-enkephalin (Met-enkephalin) and morphine on
chemoreceptor activity recorded from the peripheral end of a sectioned carotid sinus nerve have been
studied in cats anaesthetized with pentobarbitone.
2 Met-enkephalin caused a rapid, powerful, inhibition of spontaneous chemoreceptor discharge, the
intensity and duration of which was dose-dependent,
3 Morphine was a less potent inhibitor of spontaneous chemoreceptor discharge, and the inhibition
it evoked was rather variable and tended to be biphasic. Low doses of morphine caused a slight
increase in discharge.
4 Naloxone (0.2 mg i.e.) slightly increased spontaneous discharge, greatly reduced the chemo-
inhibition caused by morphine, and reduced the inhibitory effect of Met-enkephalin. A higher dose
of naloxone (0.8 mg) caused a substantial reduction of the Met-enkephalin effect.
5 Chemo-excitation evoked by intracarotid injections of acetylcholine, C02-saturated Locke solu¬
tion, and sodium cyanide were only slightly and somewhat variably reduced following injections of
Met-enkephalin, whereas the inhibitory effect of dopamine was potentiated. Following morphine
administration, responses to acetylcholine and sodium cyanide were reduced slightly, whereas those
to C02 and dopamine were potentiated.
6 Responses to acetylcholine and C02 were slightly potentiated during infusion of Met-enkephalin
(50 pg/min, i.e.) and the response to sodium cyanide was slightly reduced.
7 It is concluded that naloxone-sensitive opiate receptors are present in the cat carotid body; when
activated they cause inhibition of spontaneous chemoreceptor discharge. The physiological role of
these receptors and the identity of any endogenous ligand remains to be established.
Introduction
Methionine-enkephalin (Met-enkephalin) is a potent
inhibitor of spontaneous chemoreceptor discharge in
the cat (McQueen, 1979), and the present neurophar-
macological study was undertaken to investigate
further this action of Met-enkephalin. It was also con¬
sidered of interest to determine whether morphine has
the same effect as Met-enkephalin on the cat carotid
chemoreceptors.
Methods
Experiments were performed on ten cats weighing
between 2.1 and 3.5 kg, median weight 2.9 kg. They
were anaesthetized with pentobarbitone sodium (42
mg/kg i.p. initially, supplemented by i.v. adminis¬
tration of 10% of the initial dose every 1 to 2 h),
1 Permanent address: Cenlro de Biologia. lnstituto Gul-
benkian de Cicncia, Oeiras, Portugal
artificially ventilated and paralysed by gallamine
triethiodide (3 mg/kg i.v.). Full details of the experi¬
mental techniques have been given previously
(McQueen, 1977; Docherty & McQueen, 1978).
Electrical activity of chemoreceptor units (1 to 5
units) was recorded from filaments of the peripheral
end of a sectioned sinus nerve, passed through a pulse
height (window) discriminator, and quantified with
the aid of a PDP-8 computer. The ganglioglomerular
(sympathetic) nerves were cut.
Drugs were dissolved in modified Locke solution
(McQueen, 1977). Drug solutions (0.1 ml) were
injected into the common carotid artery ipsilateral to
the sinus nerve from which activity was being
recorded, and washed in with 0.2 ml Locke solution
which had been bubbled with 5% C02: 95% air in a
water bath at 37°C; injections were made over 2 s.
The catheter was introduced into the common carotid
artery via the lingual artery and advanced until its tip
lay about 2 cm caudal to the carotid bifurcation. In
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Figure 1 The upper part illustrates the effects of various doses of methionine-enkephalin (ME) (a) and morphine
(b) on spontaneous chemoreceptor discharge. Discharge was averaged over 15 s periods following the injection and
expressed as a percentage of the averaged discharge in the 15 s pre-injection control period. Data from n experi¬
ments were pooled and are shown as the mean percentages; vertical lines show s.e. mean. Averaged values (ct/s)
+ s.e. mean for the control (100%) periods are given.
The neurograms in the lower part of the figure, taken from one experiment, show the early part of the somewhat
similar inhibition of chemoreceptor discharge caused by injecting (arrow) (a) ME 0.1 pg i.e. and (b) morphine 1000
pg i.e.
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some experiments a second catheter was positioned in
the common carotid artery, this time via the superior
thyroid artery, and used for the infusion of drug solu¬
tions (0.5 ml/min for 65 s; Braun, Unita).
Drugs used were: morphine sulphate, gallamine
triethiodide (May & Baker); sodium cyanide, acetyl¬
choline iodide (B.D.H.); methionine-enkephalin
(Uniscience); dopamine hydrochloride (Koch Light)
and naloxone hydrochloride (Endo), kindly given to
us by Professor W. Feldberg.
Results
Effect of methionine-enkephalin injections on spon¬
taneous chemoreceptor discharge
Met-enkephalin caused a dose-dependent reduction in
spontaneous chemoreceptor discharge with a rapid
onset, starting within 1 to 2 s of beginning the injec¬
tion. During the early part of the response there was
total inhibition of chemoreceptor discharge, then
spontaneous activity returned gradually, reaching
control (pre-injection) levels within 30 to 45 s follow¬
ing low doses of Met-enkephalin, but taking up to 5
min to recover after high doses (see Figure la). The
inhibitory effect was consistent, as can be gauged
from the standard errors, and there was no evidence
of tachyphylaxis occurring when doses were adminis¬
tered at 7 min intervals. The effect of Met-enkephalin
seemed to be potentiated slightly after morphine had
been injected. Intravenous injections of Met-
enkephalin (10 to 100 pg) also inhibited chemorecep¬
tor discharge, although to a lesser extent and after a
longer delay than the same doses by intracarotid
injection.
Low doses of Met-enkephalin had little or no effect
on blood pressure (BP), whereas higher doses (i.e. or
i.v.) caused a fall in BP (see Figure 2).
Effects of morphine injections on spontaneous chemo¬
receptor discharge
The over-all effect of morphine on spontaneous
chemoreceptor discharge was inhibitory, although the
lowest dose studied, 0.1 pg. caused a slight increase in
discharge (see Figure lb). Higher doses were associ¬
ated with an inhibition of discharge which began
within 1 to 2 s of starting the injection (Figure lb) and
was dose-related. The initial inhibition lasted for 15 to
45 s after which discharge returned towards pre-
injection control levels. There was then a delayed or
secondary inhibition of spontaneous discharge, an
effect which was most clearly seen after the highest
dose of morphine (see Figures lb, 3a).
Responses to morphine were rather variable, as can
be seen from the standard errors, but there was no
evidence of tachyphylaxis, and responses to a low
dose of morphine injected before and after the highest
dose were very similar. The higher doses of morphine
caused a fall in BP (see Figure 2).
Effects of naloxone
In an adequately anaesthetized cat, which had
received neither Met-enkephalin nor morphine, nalox¬
one (0.2 mg i.e.) caused a slight increase in chemo¬
receptor discharge and, after a delay of 15 to 45 s,
a rise in BP (Figure 2) lasting for at least 30 min.
Additional doses of naloxone (0.4, 0.8 and 1.6 mg i.e.
at 7 min intervals) had no further effect on chemo¬
receptor discharge or BP.
When naloxone (0.2 mg i.e.) was injected during
experiments in which Met-enkephalin and/or mor¬
phine had previously been administered, there was
also an increase, albeit somewhat variable, in spon¬
taneous chemoreceptor discharge (Figure 2) and a rise
in BP.
Comparison of responses to Met-enkephalin and to
morphine obtained before and after injecting nalox¬
one showed that, apart from a slight initial inhibition,
the inhibitory action of morphine was virtually abol¬
ished, and there was evidence of an over-all increase
in discharge. The chemo-inhibitory effect of Met-
enkephalin was much reduced (see Figures 2 and 3).
Dose-response data were obtained by expressing
the number of impulses in the post-injection period as
a percentage of the number of impulses which would
have been likely to occur in the same period had the
pre-injection control discharge (averaged over 15 to
30 s) continued unaltered, and plotting this value
against log10 dose. It can be seen from Figure 3 that
naloxone shifts the Met-enkephalin dose-response line
to the right, both for 60 s and 150 s post-injection
periods. After intracarotid injection of naloxone (0.2
mg), morphine tended to increase discharge over these
periods, this effect being inversely related to dose.
A higher dose of naloxone (0.8 mg i.e.) completely
abolished the inhibitory action of morphine (1 mg i.e.)
and greatly reduced the inhibitory reponse to Met-
enkephalin; over-all there was an increase in dis¬
charge following lower doses of Met-enkephalin (see
Figure 4).
Although naloxone reduced the hypotensive action
of Met-enkephalin and morphine, slightly after 0.2 mg
i.e. (see Figure 2) and to a greater extent after 0.8 mg
i.e., falls in BP were still obtained even when the
chemo-inhibitory response had been abolished.
Evoked responses
Injections (i.e.) of acetylcholine (ACh, 50 pg), carbon
dioxide-saturated Locke solution (C02. 0.3 ml),
sodium cyanide (NaCN. 5 pig) and dopamine (5 pg)
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Figure 2 In (a) the effect of naloxone (0.2 mg i.e.) on spontaneous chemoreceptor discharge in an experiment
during which no methionine-enkephalin (Met-enkephalin) or morphine had been administered is illustrated; (b) is
the averaged spontaneous chemoreceptor discharge from three experiments in which the same dose of naloxone
(0.2 mg i.e.) was injected following prior administration of Met-enkephalin and/or morphine. Details as for
Figure 1.
Met-enkephalin 100 pg i.e. (c) and morphine 1000 pg i.e. (d) were injected, at the arrows, before and after
naloxone (0.2 mg i.e.). Their effects on chemoreceptor discharge and BP are shown, and it can be seen that
chemoreceptor inhibition was greatly reduced by naloxone, whereas the hypotension was less affected by this dose
of naloxone.
were made before and 5 to 20 min after a series of
injections of either Met-enkephalin or morphine. The
results obtained (Table 1) showed that the stimulant
action of ACh, C02, and NaCN were slightly and
somewhat variably reduced after Met-enkephalin,
whereas the inhibitory effect of dopamine was poten¬
tiated. Following morphine administration, responses
to ACh and NaCN were reduced slightly, whereas
those to C02 and dopamine were potentiated.
Responses were also obtained before and during an
infusion of Met-enkephalin (50 pg/min i.e.). this dose
being sufficient to inhibit spontaneous discharge
throughout the infusion period. The effects of ACh
and C02 were slightly potentiated whereas the re¬
sponse to NaCN was slightly reduced (see Table 1).
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Figure 3 (a) Pooled data showing the effects of methionine-enkephalin (Met-enkephalin) 100 w { (n = 3) and
morphine 1000 pg (n = 2) on spontaneous chemoreceptor discharge before (—) and after (—) injec ting naloxone
(0.2 mg i.e.). Black rectangles represent the control discharge (100%), values for Met-enkephalin being 3.7 + 1.8 ct/s
before and 3.1 + 0.9 after naloxone, the corresponding values for morphine being 3.7 ± 1.7 and 4.9 + 2.4 ct/s. See
Figure 1 for further details, (b) is a plot of the total discharge over the 60 s post-injection period, expressed as a
percentage of the total discharge which would have occurred in the same period if control discharge had continued
unaltered (100% = dotted line), against log10 dose of methionine-enkephalin (ME) (pooled data fro m three experi¬
ments) or morphine (data from a single experiment) before (—) and after (—) naloxone (0.2 mg 'i.e.). Lines were
fitted by the method of least squares, (c) is similar to (b), but the plot is of total discharge in the 150 s post-injection
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Since spontaneous discharge was suppressed it was
not possible, under these conditions, to investigate the
effect of Met-enkephalin on the inhibitory response
evoked by dopamine.
Responses to ACh, NaCN, C02 and dopamine
were not appreciably affected by naloxone (0.2 mg
i.e.).
Discussion
Our results indicate that enkephalin inhibited spon¬
taneous chemoreceptor discharge by acting on
naloxone-sensitive receptors in the carotid body
Morphine also acted at these receptors, but it was less
potent than Met-enkephalin and c aused a more vari¬
able inhibition which tended to bf: biphasic.
Although Met-enkephalin and i morphine were able
to inhibit spontaneous chemorece ptor discharge, they
only slightly reduced excitatory r esponses evoked by
ACh and NaCN, and potentiate d dopamine-induced
inhibition. These were long-termi effects since the re¬
sponses were not studied until 5 to 20 min after injec¬
tions of Met-enkephalin or r norphine. When re¬
sponses were studied during an infusion of Met-
enkephalin sufficient to reduce 'spontaneous chemore¬
ceptor discharge substantially, the excitatory effect of
NaCN was slightly reduced whereas responses to
ACh and C02 were potentiated. These single-dose
studies are difficult to interpret, particularly since



















Figure 4 Efi fects of methionine-enkephalin (ME) on chemoreceptor discharge (plotted as a percentage of the total
discharge in 1 he 150 s post-injection period/control discharge x 150 s) before (—) and after (—) injecting naloxone
(0.8 mg i.e.). 1 .ines were fitted by the method of least squares. See Figure 3 for further details. Following this dose of
naloxone, low r doses of Met-enkephalin no longer inhibited chemoreceptor discharge; the tendency was for dis¬
charge to be i ncreased. This can be clearly seen in the neurograms which show the effect of Met-enkephalin (1 pg
i.e.), injected a t the arrow, before and after naloxone (0.8 mg i.e.).
Table 1 Effect s of methionine-enkephalin (Met-enkephalin) and morphine on evoked responses
Intracarotid injection: of;
A Following morphin e injections
B Following Met-enki tphalin injections





















Pooled data from r. i experiments showing chemoreceptor responses (ATx) (A) following injections of morphine and
(B) following injec tions of Met-enkephalin. The results are expressed as mean percentages ± s.e. mean of the
responses to the same doses administered before morphine or Met-enkephalin (i.e. pre-injection response = 100%).
Injections were also made 60 s after starting a 65 s infusion of Met-enkephalin and responses evoked compared
with pre-infusion va lues (C).
A£x = Zx (total spi ke count during response period, t s) — (3c. t) where x is the average pre-injection (control)
discharge in ct/s.
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Met-enkephalin may alter blood flow through the
carotid body, but the important point is that whereas
Met-enkephalin can reduce spontaneous chemorecep-
tor discharge, it has little effect on responses to
intense stitnuli of short duration. In the present ex¬
periments, the local concentration of Met-enkephalin/
morphine may have been high enough to suppress the
resting discharge but not that evoked by ACh, NaCN
or C02.
Injection of the specific opiate antagonist, naloxone
(see Sawynok, Pinsky & Labella 1979 for a review),
slightly increased chemoreceptor discharge, an effect
that was not simply due to reversal of residual Met-
enkephalin or morphine chemo-depression because it
was also observed when neither substance had been
administered. This may mean that there is some tonic
inhibition of chemoreceptor discharge by an opioid;
alternatively, the effect could be secondary to changes
(e.g. in BP) induced by naloxone acting elsewhere.
The dose of naloxone used (0.2 mg) is adequate for
reversing the fall in BP caused by morphine in cats
(Feldberg & Wei, 1977; McQueen, unpublished
observations) and for reversing the action of enkepha¬
lins in the cat substantia gelatinosa (Duggan, Hall &
Headley, 1977). In the present experiments it reduced
the chemoreceptor inhibition caused by Met-
enkephalin and, to a greater extent, that caused by
morphine. It is known that inhibition of neuronal fir¬
ing caused by morphine is more readily antagonized
by naloxone than is that caused by opioid peptides
(North, 1979). Increasing the dose of naloxone to 0.8
mg caused an even greater reduction of the Met-
enkephalin-induced inhibition of chemoreceptor dis¬
charge, and virtually abolished the morphine effect.
Higher doses of naloxone could have been studied,
but we were concerned that they might have exerted
non-specific actions, or reversed the anaesthetic
(Fiirst, Foldes & Knoll, 1977; Arndt & Freye, 1979;
Sawynok el al., 1979). It seems reasonable to conclude
that most of the chemoreceptor inhibition results
from actions of Met-enkephalin and morphine on
naloxone-sensitive receptors in the carotid body.
Low doses of morphine tended to increase spon¬
taneous chemoreceptor discharge, an effect that was
potentiated and also obtained with higher doses of
morphine, as well as low doses of Met-enkephalin.
after naloxone. Landgren, Liljestrand & Zotterman
(1952) found that an intracarotid injection of 3 mg
morphine hydrochloride in cats caused a moderate
increase in small action potentials (probably chemore-
ceptors) recorded from the sinus nerve, and Eyza-
guirre & Zapata (1968) showed that morphine caused
a transient increase in discharge recorded from the in
vitro carotid body preparation. Whether the exci¬
tation seen in the present study resulted from an
action on naloxone-insensitive opiate receptors, or
was caused by morphine/Met-enkephalin influencing
substances in the carotid body, as occurs in other
tissues (e.g. ACh (Paton, 1957), noradrenaline (Szerb,
1961; Snyder & Childers, 1979), 5-HT, or dopamine
(Loh. Brase, Sampath-Khanna, Mar, Way & Li,
1976)), requires further investigation. So does the
biphasic nature of the inhibitory response to mor¬
phine; could vascular changes be responsible for the
transient return of discharge to control levels?
High doses of Met-enkephalin and morphine
caused a fall in BP, and it is possible that some of the
changes in chemoreceptor discharge might result from
changes in blood flow through the carotid body.
However, the fact that chemo-inhibitory actions of
Met-enkephalin and morphine, (a) started within 1 to
2 s of the injection, (b) occurred following low doses
which had no effect on BP and, (c) were greatly
reduced by naloxone in doses which only slightly
reduced the hypotensive effect, all argue against vas¬
cular effects contributing much to the inhibition, at
least as far as the early part of the response is con¬
cerned. Further information could be obtained by
studying the effect of Met-enkephalin on the in vitro
carotid body preparation (Eyzaguirre & Lewin, 1961),
which would eliminate the vascular complications.
The chemo-inhibitory effect of low doses of Met-
enkephalin was very similar to that obtained with
dopamine, (5 pg i.e.), although it should be noted that
Met-enkephalin is 10 to 100 times more potent on a
molar basis. However, despite the similarities, it is
unlikely that Met-enkephalin acts directly, or, by
releasing dopamine within the carotid body, indirectly
at a dopamine receptor, because a-flupenthixol blocks
the inhibitory action of exogenous dopamine
(Docherty & McQueen, 1978) without affecting the
inhibitory response to Met-enkephalin (McQueen,
1979).
Substance P is present in the cat carotid body
(Cuello & McQueen, 1980) and causes an increase in
chemoreceptor discharge on intracarotid injection
(McQueen, 1980). It may be that Met-enkephalin is
acting to inhibit the release of substance P within
the carotid body in the same way as has been shown
to occur in the CNS (Jessel & Iversen, 1977), the
mechanism probably involving an action of Met-
enkephalin on Ca2+ channels (Mudge, Leeman &
Fischbach, 1979).
It has been suggested that adenosine might be the
mediator of the neuro-inhibitory action of opiates
(Sawynok & Jhamandas 1976; Stone & Perkins,
1979). Both adenosine (see Ribeiro. 1978) and
morphine (Henderson, Hughes & Kosterlitz, 1975) de¬
crease transmitter release in the central and peri¬
pheral nervous systems, and adenosine (Ribeiro, Sa-
Almeida & Namorado, 1979), morphine (Guerrero-
Munoz, Cerreta, Guerrero & Way, 1979), and
^-endorphin (Guerrero-Munoz, Guerrero, Way & Li,
1979) decrease the uptake of calcium by synapto-
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somes; Ca2+ is known to be involved in transmitter
release (e.g. Katz & Miledi, 1968). Opioids might
depress chemoreceptor activity by inhibiting the entry
of Ca2 + needed for the release of putative sensory
excitatory transmitter(s). Whether adenosine is the
mediator of the Met-enkephalin or morphine-induced
inhibition, and whether Met-enkephalin interacts with
other substances in the carotid body (e.g. substance P,
noradrenaline, 5-hydroxytryptamine, dopamine, ACh)
requires investigation. Preliminary results (Cuello &
McQueen, unpublished observations) suggest that
enkephalin-like material is present in the carotid
body.
In conclusion, the present results provide pharma¬
cological evidence for the presence of an opiate recep-
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EFFECTS OF SOME POLYPEPTIDES ON CAROTID
CHEMORECEPTOR ACTIVITY
D.S. McQueen, Department of Pharmacology, University of
Edinburgh.
Key UJords - Glomin, substance P, neurotensin, enkephalin,
bradykinin, somatostatin.
Pearse (22) suggested that carotid body type I cells
secrete a low molecular weight polypeptide (glomin). Histo¬
logical evidence has since been obtained which indicates
that polypeptide or protein-containing granules are present
in mammalian carotid body cells (3, 23).
The evidence that a polypeptide is present in the carot¬
id body, together with the fact that substance P (SP) - like
material is associated with some peripheral sensory nerve
endings (7, 12) prompted the present investigation into the
effects of SP, and some other polypeptides associated with
the nervous system, on the cat carotid chemoreceptors.
METHODS
Experiments were performed on cats anaesthetised with
pentobarbitone sodium (42 mg/kg i.p.), artificially ventil¬
ated with air and, usually, paralysed by gallamine (3 mg/
kg i.v.). Full details of the experimental technique have
been described previously (19) and only a brief description
is given here. A sinus nerve was cut centrally and elec¬
trical activity recorded from 1-5 chemoreceptor units re¬
corded from filaments of the peripheral nerve using bipolar
electrodes. The ganglioglomerular nerves were cut. Nerve
activity was recorded on tape and subsequently analysed with
the aid of a pulse height (window) discriminator and a PDP-
8 computer. Responses were expressed as a percentage of the
control, and data from different experiments pooled.
Drugs were injected (0.1 ml + 0.2 ml wash over 2 sec) or
infused (0.5 ml/min for 55 sec) into the ipsilateral common
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carotid artery via catheters in either the lingual or super¬
ior thyroid arteries. The following polypeptides were used,
dissolved in modified Locke solution (19): substance P, SP,
neurotensin, NT, (Sigma); Metenkephalin, ENK, (Uniscience);
somatostatin, SS, (U.C.B.); eledoisin-related peptide
(Calbiochem); bradykinin, BK, (Protein Research Foundation);
angiotensin amide, ANGIO, (Hypertension - Ciba); A.D.H.,
(Pitressin, Parke-Davis).
RESULTS
Spontaneous chemoreceptor discharge. Dose-response studies
established that the effects of the injected polypeptides were
dose-related; results obtained with the highest doses studied
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Fig. 1. Pooled data showing the effects of high doses of
polypeptides on spontaneous chemoreceptor discharge. Dis¬
charge was averaged over 15 sec periods and expressed as a
percentage of the pre-injection discharge. n = number of
recordings.
After a delay of 1 - 15 sec following injection, SP caused
a long-lasting (45 - 300 sec) dose-dependent increase in
discharge. Eledoisin-related peptide had very similar acti¬
ons. In contrast, ENK caused an immediate dose-dependent
reduction in discharge lasting for 15 - 150 sec (see Fig. 2),
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Fig. 2. Pooled data from det-enkephalin experiments (n = 4)
illustrating the dose-dependent nature of the inhibition.
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B.P. and discharge of a single chemoreceptor unit from one
of the experiments are also shown. Details as for Fig. 1.
Horizontal bar is the injection marker.
SS was associated with a short-lasting inhibition of
spontaneous chemoreceptor discharge followed, about 30 sec
later, by a longer-lasting reduction; B.P. fell slightly.
NT caused a slight and variable increase in chemoreceptor
discharge lasting for about 15 sec; there was a very slight
increase in B.P., followed by a fall. BK, ANGIO and A.D.H.
had rather variable effects on chemoreceptor discharge and
were associated with marked changes in B.P.
Responses to ACh and NaCN. A comparison was made of
responses to these chemoreceptor stimulants obtained before
a 65 sec infusion of polypeptide and 60 sec after starting
the infusion. Responses evoked by ACh (50 pg) were slightly
potentiated during ENK infusion and reduced by BK, SP, SS
and NT. Responses to NaCN (5 pg) were slightly potentiated
by SS and SP, but reduced during infusions of ENK, BK and NT.
- Flupenthixol and Naloxone. Dose-response data were
obtained for ENK injected before and after administering
sufficient a-flupenthixol to block the inhibitory action
of DA (5 g) on chemoreceptor discharge. The results are
shown in Fig. 3. Responses to ENK and DA were also obtained
before and after injecting the opiate antagonist naloxone
(0.2 mg i.v.). The inhibitory effect of ENK was greatly
reduced by naloxone, whereas that of DA was unaffected.
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Fig. 3. Recording of multi-unit chemoreceptor discharge
showing the effects of the DA antagonist a —flupenthixol on
inhibitory responses to DA and ENK. Horizontal bar is the
injection marker.
DISCUSSION
High doses of all the polypeptides investigated had
some effect on spontaneous chemoreceptor discharge, which is
perhaps not surprising in view of the vascular effects which
generally accompanied polypeptide administration. None of
them caused the intense chemoreceptor stimulation associated
with ACh, NaCN, CO^ or hypoxia. SP did evoke a slight but
consistent increase in discharge after a delay of 5 - 15 sec,
an effect which did not seem to be correlated with the fall
in B.P. It is difficult to establish whether this is a
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direct effect of SP, partly because of the lack of a specif¬
ic SP antagonist (A, 16). The finding that synthetic SP
excites certain peripheral sensory nerves (15) has not been
confirmed (17). NT caused a more transient and variable
increase in chemoreceptor discharge.
Infusions of SP reduced the chemoreceptor stimulant
effect of ACh but potentiated that of NaCN. SP is known to
have a nicotinic-blocking action (18, 24), and slight nico¬
tinic block reduces the chemoreceptor response to ACh and
potentiates that to NaCN (19). The present results are com¬
patible with SP having a slight nicotinic-blocking action on
the carotid chemoreceptors (20).
The effect of ENK on the chemoreceptors was quite dram¬
atic. There was an immediate reduction of spontaneous dis¬
charge, the intensity and duration of which was dose-depend¬
ent. The effect of low doses of ENK was very similar to that
of DA (5 g), with the polypeptide being much more potent on a
molar basis. Although the inhibitory effect was similar to
that caused by DA, it was not affected by a dose of the DA an¬
tagonist a -flupenthixol (8) sufficient to block the response
to DA. However, the ENK inhibition of chemoreceptor activity
was much reduced by the opiate antagonist naloxone, whereas
DA inhibition was unaffected. This evidence suggests that
an opiate receptor is present in the cat carotid body.
The distribution of opiate binding sites in the brain
stem and spinal cord shows striking similarity to sites at
which both ENK and SP are located (1, 6, 14). SP generally
excites neuronal activity in responsive cells, after a delay
(11, 16), whereas ENK usually inhibits neuronal discharge
(10), which is the same pattern as observed with the chemo¬
receptors. ENK can also reduce the release of SP from
primary afferent fibres (14), possibly by affecting Ca++
(21). SP has been shown to be present in some central 5-HT-
containing neurones (13) and 5-HT is located in the cat car¬
otid body (5 ).
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It is tempting to speculate about possible interactions
between ENK, SP, and catecholamines in the carotid body, and
also about whether SP might be stored with 5-HT in this organ.
Is SP Pearse's 'glomin': is there more than one polypeptide
in the carotid body? It would seem best to await the outcome
of histological studies aimed at establishing whether these
polypeptides are present in the cat carotid body before making
too much of the present results with exogenous ENK and SP.
In any event, the physiological role of polypeptides in the
nervous system is very much a matter for debate (2, 9, 10)
and further investigation.
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DISCUSSION
lillSHI: I have also injected substance P and enkephalin. In
the case of substance P, 100 mgm caused only a slight increase
in chemoreceptor discharge. In the case of enkephalin, I
could get a very dramatic effect, as you observed, and also
bradykinin is not so specific, most of the nerve ending is
sensitive to bradykinin.
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MCQUEEN: That is why I have said I concentrated mainly on
enkephalin and substance P; I quite agree with you about the
specificity of bradykinin, and that is why I have not spent
much time on it.
MftJCHERCZYK: Did you cut the sympathetic supply to the
carotid body.
MCQUEEN: Yes.
MflJCHERCZYK: Now, do you think it would be better if you had
done the experiment the way Michael Purues did some time ago,
that is, to perfuse the carotid body at constant pressure.
Because, obviously, as you have mentioned, you get drops in
blood pressure and that might have had some interaction with
your results, and the third thing is that we found that brad¬
ykinin has no effect, or very little effect on chemoreceptor
activity. However, there was an interesting feature. Uhen
we injected bradykinin into the carotid artery above the car¬
otid body, mainly to the cerebral circulation we could obser¬
ve a very marked increase in efferent activity going to the
sinus nerves. If you recorded the chemoreceptor activity in
the otherwise intact nerve with preserved efferent innervat¬
ion, the response to the injection of bradykinin could have
been different.
MCQUEEN: Perhaps. The question about flow; I've never been
very happy about perfusing the carotid body at constant flow
because I don't know how you do it. I mean, you can pump
the region with a constant flow but that doesn't mean the car¬
otid body will be perfused in constant flow.
ZflPflTfl: If I remember correctly there are some old clinical
observations that morphine treated patients when they re¬
ceive, by accident I should say, oxygen, become apnoeic. So
that is proof that their respiration was maintained by chemo-
receptors. If there are these opiate-receptors in the carot¬
id body it would mean that morphine is decreasing respirat¬
ion both at the central and peripheral levels. Is that true?
MCQUEEN: I would like to refrain from speculating on that
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because I haven't done morphine experiments yet. You have to
be a bit cautious because the actions of the enkephalins and
for that matter the endorphins may not be the same as those
opiates; there may be different receptors.
LAHIRI: We happen to have this information, Dr. Zapata, on
the effects of morphine on ventilation. The effect of mor¬
phine on the carotid chemoreceptor activity is small compar¬
ed to the effect of morphine on ventilation and therefore
the central effect seems to be much greater.
MCQUEEN; I think one has to remember also that for example,
Gaddum used to use it to block some of the effects of hydroxy-
tryptamine so one has to be a bit cautious about whether or
not the enkephalins do this sort of thing.
SMITH: Have you examined the effects of naloxone without
first administering enkephalin? In other words, you get
stimulation after enkephalin but if you simply give naloxone
alone do you get stimulation also?
MCQUEEN; The answer is that experiment was done only last
week and I haven't had a chance to analyse it.
FITZGERALD: There is in the hypothalamus precedent for
U.I.P. modulating dopaminergic neurones. Is there any prec¬
edent in the central nervous system for dopamine enkephalin
interaction?
MCQUEEN; There is certainly some evidence but I think it is
probably too early to speculate about this.
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Comparison of the depressant effects of leucinc-
and methionine-enkephalin on spontaneous
chemoreceptor activity in cats
d.s. McQueen & j.a. ribeiro'
Department of Pharmacology. UnicerMl \ of Edinburgh.
Edinburgh. EHN dJZ.
There is evidence thai methionine-enkephalin (mct-
ENK) and leucine-enkephalin (leu-ENK) are present
in cat carotid body type 1 cells (Lundbcrg, Hokfclt.
Fahrenkrug. Nilsson & Tcrcnius. 1979. Wharton.
Polak, Pearse. McGregor, Bryant, Bloom, Emson.
Bisgard & Will. 1980). Intra-carolid injection of met
ENK decreases spontaneous chemorcccptor discharge
in cats (McQueen, 1979; McQueen & Ribeiro. 1980)
The present study was undertaken to investigate the
effects of leu-ENK on the carotid chcmorcceptors and
to compare them with those of mct-F.NK
Experiments were performed on cats anaesthetized
with pentobarbitone (42 mg/kg i-P . supplemented
every 1-2 h). The animals were artificially ventilated
with air and paralysed by gallaminc (3 rng/kg i.v.)
Chemorcceptor activity was recorded from the peri¬
pheral end of a sectioned sinus nerve (McQueen.
1977). In the majority of experiments the ganglioglo-
merular (sympathetic) nerves were cut. Drug solutions
were injected into the ipsilateral common carotid
artery (i.e.) over a 2 s period.
Leu-ENK and mcl-ENK both decreased spon¬
taneous chemoreccptor discharge frequency in a dose-
dependent manner, being of similar potency (sec
Figure I). The intensity and duration of the depres¬
sion evoked by both peptides were reduced after
naloxone (0.2-0.4 mg i.e.). Similar responses were
obtained in all the experiments, regardless of whether
or not the sympathetic nerve supply to the carotid
body had been cut
These results suggest that leu-ENK and mct-ENK
depress spontaneous chcmorcccptor discharge by tid¬
ing on opiate receptors in the carotid body. Since the
enkephalins have potent effects on chemoreccptor dis¬
charge and are present in the carotid body, they may
function there as neurotransmitters or neuromodula¬
tors. Further studies are needed to establish their
physiological roles in the carotid body and lo identify
the opiate receptor(s) (Hughes. Koslcrlilz. McKnight.
Sosa. Lord & Watcrficld. 1978)
1
On leave from (iistiluto Gulbenkian cic Cicneia. Oeiras.
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EFFECTS OF /?-ENDORPHIN, VASOACTIVE
INTESTINAL POLYPEPTIDE AND CHOLECYSTOKININ
OCTAPEPTIDE ON CAT CAROTID CHEMORECEPTOR
ACTIVITY
d. s. McQueen and j. a. ribeiro*
Department of Pharmacology, University of Edinburgh Medical School, I George Square, Edinburgh EH8 9JZ
(RECEIVED FOR PUBLICATION 17 DECEMBER 1980)
summary
The effects of /(-endorphin, vasoactive intestinal polypeptide (VIP) and cholecystokinin
octapeptide (CCK-8) on carotid chemoreceptor activity have been investigated in cats
anaesthetized with pentobarbitone. Spontaneous chemoreceptor discharge was decreased by
intracarotid injection of /(-endorphin and by low doses of VIP, whereas it was increased by
CCK-8 and higher doses of VIP, these effects being relatively long-lasting and often associated
with changes in systemic blood pressure. The chemoexcitation evoked by acetylcholine and
sodium cyanide was reduced during intracarotid infusion of any of the three peptides studied,
and that caused by C02-saturated Locke solution was reduced by /(-endorphin, largely
unaltered by VIP and variably affected by CCK-8. The inhibitory effect of /(-endorphin was
greatly reduced by naloxone, implying that it probably involved actions at naloxone-sensitive
opiate receptors in the carotid body. Substance P was unable to overcome the chemoinhibitory
effect of methionine enkephalin. Possible functions of polypeptides in the carotid body are
discussed.
introduction
The ability of some polypeptides to modify spontaneous chemoreceptor discharge when
injected close-arterial to the cat carotid body has been described (McQueen, 1979, 1980).
Since then evidence has been presented which shows that substance P (SP), the enkephalins
and vasoactive intestinal polypeptide (VIP), or closely related immunoreactive substances,
are present in the cat carotid body (Lundberg, Hokfelt, Fahrenkrug, Nilsson & Terenius,
1979; Cuello & McQueen, 1980; Wharton, Polak, Pearse, McGregor, Bryant, Bloom,
Emson, Bisgard & Will, 1980).
The present neuropharmacological study was undertaken to investigate further the
actions of various polypeptides, including those identified as being present in the carotid
body, on the cat carotid chemoreceptors with a view to obtaining some insight into the
physiological role of these substances in the carotid body.
methods
Experiments were performed on nine cats weighing between 3 0 and 4 4 kg, median weight 3-5 kg. They
were anaesthetized with pentobarbitone sodium (42 rng.kg"1 i.p.), supplemented as required during
the experiments, artificially ventilated with air and paralysed with gallamine (3 mg.kg"1 l.v.). Full
details for most of the experiment procedures have been given previously (McQueen, 1977; Docherty
& McQueen, 1978) and only a brief description follows.
The lingual and superior thyroid arteries ipsilateral to the sinus nerve from which recordings were
* On leave from Instituto Gulbenkian de Ciencia, Oeiras, Portugal.
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obtained were both cannulated. the catheter tips being positioned in the common carotid artery; blood
pressure was recorded from a femoral artery. Electrical activity of chemoreceptor units (1-5 units)
was recorded from filaments of the peripheral end of a sectional sinus nerve, stored on FM tape, passed
through a pulse height (window) discriminator and quantified with the aid of a PDP-8 computer. The
ganglioglomerular (sympathetic) nerves were cut.
Drugs were dissolved in either modified Locke solution (see McQueen, 1977) or 0-9% w/v aqueous
sodium chloride solution, except /J-endorphin which was initially dissolved in 0-5% aqueous bovine
serum albumin solution, then diluted with saline. Injections were made in a volume of 01 ml into
the lingual catheter and washed in with 0-2 ml Locke solution which had been bubbled with 5%
C02:95% air in a water bath at 37 °C; they were made over a 2 s period. Infusions were made into
the common carotid artery via the thyroid catheter at a rate of 01 ml. min"1, using a Unita pump
(Braun), and lasted for 5-10 min; the catheter dead-space was 0-2 ml.
Drugs used were: pentobarbitone sodium, gallamine triethiodide (May & Baker), acetylcholine
iodide, sodium cyanide (B.D.H.), dopamine hydrochloride (Koch Light), substance P, methionine
enkephalin formate (Sigma), cholecystokinin octapeptide non-sulphated (Peninsula Labs), naloxone
hydrochloride (Endo), human /^-endorphin (Aalton Bio Reagents, Dublin), porcine /i-endorphin
(kindly given to us by Dr D. Smyth, National Institute for Medical Research, London) and vasoactive




In three experiments the effects of /^-endorphin on chemoreceptor activity were examined.
Since there was no appreciable difference between the actions of human and porcine
/7-endorphin, results have been expressed simply as responses to /Tendorphin.
Injections of /?-endorphin. Injections of /^-endorphin (0-1-50 pg i.e.) caused a decrease in
spontaneous chemoreceptor discharge (see Fig. 1 B and C). The response lasted for about
3 min following the highest dose investigated (50 pg) and was associated with a very slight
fall in systemic blood pressure (Fig. 1 A). Discharge was averaged over the 60 s period
immediately following yS-endorphin injection and expressed as a percentage of the averaged
pre-injection (control) discharge (Fig. 1 D). The results showed that the decrease in discharge
was dose-dependent and, from consideration of discharge during the second minute
following the injection (Fig. 1 E), fairly long-lasting. The reason for the somewhat variable
nature of the response, reflected in the scatter of points about the lines, was that responses
to //-endorphin were often bi- or triphasic; there was an initial decrease followed by a return
to control level, or to discharge frequencies greater than control, then a delayed decrease
in spontaneous discharge (see Fig. 2A). The overall effect was similar to that evoked by
morphine (McQueen & Ribeiro, 1980).
Following administration of the opiate antagonist naloxone (0-4 mg i.e.) //-endorphin
caused only a slight decrease in spontaneous chemoreceptor discharge, the main effect being
a rather variable increase in discharge (Fig. 2 B) which was not abolished by additional doses
of naloxone.
Infusions of(I-endorphin. Infusion of //-endorphin at a rate of 5 //g/min for 5-10 min resulted
in very slight changes in spontaneous chemoreceptor discharge and systemic blood pressure
(Fig. 3 A). Blood gas tensions and pH were unaffected by the infusion.
Evoked responses during infusion of (i-endorphin. The increases in chemoreceptor discharge
evoked by ACh, C02 and NaCN, together with the decrease caused by dopamine, were
determined before, during, and after an infusion of //-endorphin at a rate of 5 //g/min. The
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Fig. I. The left-hand side of the figure shows the effect of injecting (arrow)/(-endorphin (50 //g i.e.) on: A. systemic
arlerial blood pressure; B. spontaneous chemoreceptor discharge averaged over a 15 s periods and expressed
as a percentage (control discharge, I -5 ct/s = 100'%); C, the single chemoreccptor unit from which the data in
B. D and E were obtained. The right-hand side of the figure shows the discharge averaged over the first (D)
or second (£)minute following/f-endorphin injection. Discharge was expressed as a percentage of the pre-injection
frequency and plotted against dose of /f-endorphin (log,,, scale), straight lines being fitted to the responses (#)
by the method of least squares. O, illustrate the effect of injecting the drug vehicle (0-5% bovine serum albumin);
the pre-injection (control) discharge frequency (100%) was determined by averaging spontaneous discharge
during the 30-60 s immediately preceding each injection, and is represented by the dotted line.
results obtained are summarized in Fig. 4 and it was found that responses to the stimulants
were reduced by /7-endorphin in the concentration studied, whereas the inhibitory effect of
dopamine was potentiated. The influence of/7-endorphin on responses evoked by dopamine
and. to a lesser extent, NaCN. was still evident 15 min after the infusion had finished.
In a separate experiment the influence of/7-endorphin (5 //g/min) on the inhibition evoked
by an injection of methionine enkephalin (10 //g I.e.) was studied. The effect of methionine
enkephalin was found to be very slightly enhanced. (Discharge, averaged over 150 s after
the enkephalin injection and expressed as a percentage of the pre-injection discharge
frequency (100%) was 71 % before the infusion, 64% during the infusion, and 73% 1 5 min
after the infusion of /i-endorphin.)
Vasoactive Intestinal Polypeptide (VIP)
In two experiments the effects of VIP were studied. Only a limited amount of VIP was
available, but the results obtained were quite clear.
Injections of VIP. VIP injections (0 05—6-3 //g I.e.) produced the type ofeffects seen in Fig.
5. Low doses caused a decrease in spontaneous chemoreceptor discharge whereas higher
doses increased discharge. The effects were fairly long-lasting, being evident in the second
minute following the injection (see Fig. 5 D). There was a good correlation between dose
and response, and higher doses caused a fall in b.p. followed by a rise (Fig. 5.4).
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Fig. 2. Chcmoreceptor discharge following injection of /?-endorphin 10 //g i.e.. A, before and B, 5 min after
naloxone (0 4 mg I.e.). Pooled data from three experiments, discharge expressed as a percentage of the
pre-injection frequencies and shown as the average ± s.e. ofmean in 15 s intervals during the 150 s post-injection
period The averaged control values were 4-8 + 2-Oct/s before and 2-7+T6ct/s after naloxone.
Infusions of VIP. Infusion of VIP at a rate of 0-5 /tg/min for 5-10 min caused a sustained
increase in discharge and a fall in blood pressure (see Fig. 3 B). The chemoreceptor response
shown in Fig. 3 B, the biggest observed with the dose of VIP studied, was accompanied by
a slight fall in b.p. The control b.p. was rather low, and to preclude the possibility that the
increase in chemoreceptor discharge was entirely secondary to the systemic vascular effects
of VIP, the infusion was repeated later in the same experiment when mean systemic b.p.
was over lOOmmHg and dextran was infused to prevent the fall in b.p. Under these
conditions discharge still increased, although the increase was a little less than that obtained
at the lower pressure. Measurement of arterial blood gases and pH (see Fig. 3, legend)
showed that the increase in chemoreceptor discharge was not secondary to changes in
arterial blood gas tensions.
Evoked responses during infusion of VIP. Responses to ACh, C02 and NaCN were
determined before, during and after infusions of VIP at a rate of 0-5 //g/min. The results
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Fig. 3. Effects on spontaneous chemoreceptor discharge of infusing, during the periods represented by the
horizontal bars, A. //-endorphin 5 //g,'min i.e.; B, VIP 0 5 //g/min i.e.; C. CCK-8 10 //g/min i.e. Discharge (ct/s)
was averaged over 60 s intervals, commencing 60 s before starting an infusion, and plotted on the same time
scale as the b p. trace. Just before the end of the VIP infusion in B, an arterial blood sample was taken and
gave values of pH 7-31, Pa ( 0 107 mmHg. P„ c0 34 mmHg compared with pre-infusion sample values of pH
7-28, Pn.ro 105 mmHg, Pa co 36 mmHg. These results were obtained from three separate experiments, and
it should be noted that the catheters were primed with polypeptide solution (i.e. there was no dead-space to
be cleared after starting an infusion).
obtained from two experiments were pooled and are summarized in Fig. 4. It was found
that responses to the stimulants were reduced by VIP, whereas the inhibitory effect of
dopamine was only slightly reduced during the infusion, although there was a further
reduction after infusion. Responses to ACh and C02 recovered within 15 min, whereas the
NaCN and dopamine responses did not.
In one experiment the influence of a VIP infusion (0-5 //g/min) on the inhibition evoked
by methionine enkephalin (10 //g i.e.) was studied. Before the VIP infusion chemoreceptor
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Fig. 4. Responses (AI.v) to ACh (50 //g i.e.), NaCN (2-5 //g I.e.), C02 (0-3 ml C02-saturated Locke solution) and
dopamine (DA. 5 //g i.e.) were obtained; A, before a 10 min infusion of polypeptide into the second carotid
catheter; B, during the infusion; C, 5-15 min after finishing the infusion, and are shown as percentages
(pre-infusion response = 100°'o). In the case of /?-endorphin and CCK-8 data were from single experiments;
for VIP and Locke solution the data shown are averages from two experiments. AX.v = X.v — x.r. where X.v is
the number of action potentials counted during the response ofduration t s, a 'response' being defined as lasting
from the first substantia] change from background discharge frequency (X ci/s) until return to background level.
discharge averaged over the immediate 60 s post-injection period was reduced to 27% of
the pre-injection control frequency, and over the second minute it was reduced to 89% of
control. Corresponding values during VIP infusion were 46% in the first minute and 100";,
in the second, meaning that the inhibition caused by methionine enkephalin was reduced
during the VIP infusion.
Cholecyslokinin oclapeptide (CCK-8)
In two experiments the effects of CCK-8 on chemoreceptor activity were examined.
Similar effects were obtained in both experiments.
Injections of CCK-8. Injections of CCK-8 (0-1 — 100 //g i.e.) caused a somewhat variable
short-lasting biphasic effect on discharge, generally an initial decrease followed by an
increase (see Fig. 6). Higher doses caused a rise in b p. The quantitative evidence shown
in Fig. 6C and D confirms that responses were somewhat variable and short-lived.
Infusions of CCK-8. In one experiment CCK-8 was infused at a rate of 1 //g/'min. in the
other the rale was 10 //g/'min. There was little effect on spontaneous discharge with either
dose (Fig. 3C); arterial blood pressure rose.
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Fig. 5. The left-hand side of the figure shows the effect of injecting VIP (3-2 // g i.e.) on: A, systemic arterial blood
pressure; B, spontaneouschemoreceptor discharge, control frequency (100%) being 5-6 ct/s. The right-hand side
of the figure shows data obtained from the same experiment and illustrates discharge averaged over the first
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Fig. 6. The left-hand side of the figure shows the elfect of injecting CCK-8 (100 /ig i.e.) on: A. systemic arterial
blood pressure: B. spontaneous chemoreceptor discharge, control frequency (100",,) being 1 -9 ct/s. The right-hand
side of the figure shows pooled data from two experiments, illustrating discharge averaged over the first ((")
or second (/)) minute following CCK-8 injection Figure details as for Fig. I
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Fig. 7. The left-hand side of the figure shows chemoreceptor discharge (control (100%) values given in ct/s)
averaged over 60 s periods after starting intracarotid infusions (horizontal bar) of: A. Locke solution via lingual
and thyroid catheters; B, SP 25 //g/min via the lingual. Locke solution via the thyroid catheter; C, methionine
enkephalin 10 //g/min via the thyroid, Locke solution via the lingual; D, methionine enkephalin 10 //g/min via
the thyroid, SP 25 //g/min via the lingual. The accompanying blood pressure records are shown on the right-hand
side of the figure, the time scale being common to both sides. The catheter dead-space needed to be cleared
before the peptides arrived in the carotid artery, a process which took I -2 min after starting the infusion, except
in D where the thyroid catheter was fully primed with methionine enkephalin so that the action of this peptide
had begun before SP reached the carotid artery.
Evoked responses during infusion of CCK-S. Responses to ACh, NaCN and DA were
reduced during infusion ofCCK-8 at a rate of 1 //g/min. The response to C0.2 was unaffected
(Fig. 4). Although the ACh effect returned to pre-infusion levels within 15 min of finishing
the infusion, responses to NaCN and dopamine remained depressed. In a second experiment,
during which CCK-8 was infused at 10 //g/min, responses were somewhat similar except
that a sustained potentiation of the dopamine-induced chemoinhibition was observed and
there was a decreased response to C02 in the post-infusion period, although not during the
infusion (Fig. 4).
Substance P and methionine enkephalin
Previous experiments had established that both these polypeptides can influence chemo¬
receptor discharge (McQueen, 1979; McQueen & Ribeiro, 1980) and the present experiment
was undertaken to determine whether any interaction occurs on simultaneous infusion of
both peptides close-arterial to the carotid body. The results obtained are shown in Fig. 7.
Locke solution caused a very slight increase in spontaneous chemoreceptor discharge, SP
had a biphasic action (decrease followed by increase) and methionine enkephalin reduced
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discharge, an effect which was most pronounced in the early part of the response; when
the methionine enkephalin infusion was stopped discharge increased above pre-infusion
control levels. The delayed increase in discharge seen with SP was accompanied by a rise
in end-tidal C02; there was no change in end-tidal C02 during or after methionine
enkephalin infusion.
SP and methionine enkephalin were infused concurrently in equimolar concentrations,
it being so arranged that methionine enkephalin began to act before SP reached the carotid
artery (see Fig. 7). The pattern of response was very similar to that obtained with methionine
enkephalin alone, except that no post-infusion overshoot occurred. There was a rise in
end-tidal C02 towards the end of the infusion. Both peptides caused hypotension, and when
given together the overall effect on b.p. was approximately additive.
discussion
The present study showed that the polypeptides investigated can modify carotid chemo-
receptor activity in the cat. Spontaneous chemoreceptor discharge was decreased by
intracarotid injection of //-endorphin and by low doses of VIP, whereas it was increased
by CCK-8 and higher doses of VIP. The chemo-excitatory effect of VIP has been reported
by Fitzgerald, Raff, Garger, Fechter, Anand & Said (1979). The effects of these peptides
on chemoreceptor discharge may not seem very impressive when compared with those of
ACh, NaCN, C02 or dopamine, but it has to be remembered that the polypeptides have
a relatively high molecular mass so that, for example, whereas the excitatory response to
ACh was elicited by 180nmol (50/<g), that to VIP involved only 1 nmol (3-2//g).
Furthermore, although the peptide effects were generally less intense they tended to be longer
lasting than those associated with classical neurotransmitters. The prolonged action may
be related to various factors, such as molecular size, tissue penetration, dissociation from
receptors, activation of'second messengers', or to peptide inactivation, and needs to be
further investigated.
Responses evoked by ACh, NaCN, CO,2 and dopamine during polypeptide infusion, when
peptide levels in the carotid body were assumed to be relatively steady, showed that the
excitatory action of ACh and NaCN was reduced by all three peptides studied, and that
caused by C02 was reduced by both //-endorphin and VIP, but unaffected by CCK-8.
Dopamine-induced chemoinhibition was potentiated by //-endorphin, largely unaltered by
VIP and reduced by low concentrations ofCCK-8 but potentiated by higher concentrations.
Lack of sufficient peptide precluded full dose response studies (e.g. McQueen, 1977), but
although the results obtained with single submaximal doses may be less reliable, they do
indicate that polypeptides can influence evoked response when infused in fairly low
concentrations. It is particularly intriguing that polypeptides are sometimes stored with
putative neurotransmitters (see Pearse, 1969), for example VIP with ACh (Lundberg,
Hokfelt, Schultzberg, Uvnas-Wallensten, Kohler & Said, 1979), enkephalin with nor¬
adrenaline (Schultzberg, Lundberg, Hokfelt, Terenius, Brandt, Elde & Goldstein, 1978), SP
with 5-hydroxytryptamine (Hokfelt, Ljungdahl, Steinbusch, Verhofstad, Nilsson, Brodin.
Pernow & Goldstein, 1978) and CCK-8 with dopamine (Hokfelt, Johansson, Ljungdahl,
Lundberg & Schultzberg, 1980). All these putative neurotransmitters are present in tfie
carotid body (see Biscoe, 1972) and so, it appears, are several of the polypeptides. It will
be most interesting to determine whether similar dual localization of peptide and amine
occurs in the carotid body and whether the distribution of peptides and peptides/amines
within the carotid body is homogeneous, or whether different regions or nerve fibres (A
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and C, afferent, efferent) have different representation. It may transpire that all the different
substances in the carotid body, although activating different receptors, eventually influence
a common mechanism (e.g. adenylate cyclase) within the carotid body.
The action of /^-endorphin on the chemoreceptors was similar to that of morphine
(McQueen & Ribeiro, 1980), there being a tendency for inhibitory responses to be biphasic,
and greatly reduced by naloxone (0-4 mg i.e.). Following naloxone an overall increase in
discharge occurs (Fig. 2). These similarities might mean that both substances affect the same
receptors, with /^-endorphin being about twenty times more potent than morphine on a
molar basis. The enkephalins, in contrast, cause a much greater chemoinhibition which is
not so readily prevented by naloxone, and also have greater hypotensive effects
(McQueen & Ribeiro, 1980, 1981). Thus, the chemoinhibition caused by /Tendorphin
appears to result from actions on naloxone-sensitive opiate receptors, whereas the slight
chemoexcitation seen after naloxone does not. The latter effect may result from actions at
opiate receptors which are insensitive to naloxone in the doses used, or to direct or indirect
actions on non-opiate receptors.
The polypeptides influenced arterial blood pressure and this confirmed that, in the doses
studied, they were biologically active. The possibility that the effect of polypeptides on
chemoreceptor activity was secondary to vascular changes either within the carotid body,
or systemically, needs to be considered. The rapid onset of the peptide effect (within 1-2 s
of injection), the fact that effects on chemoreceptor discharge occurred before changes in
blood pressure were seen and persisted when such changes were prevented, and the
knowledge that chemoreceptor discharge appears to be largely independent of blood
pressure over the physiological range (Hornbein, Griffo & Roos, 1961; Biscoe, Purves &
Sampson, 1970; Acker, Keller, Lubbers, Bingman, Schulze & Caspers, 1973) and probably
carotid body blood flow (Acker & Lubbers, 1977) lead us to consider it unlikely that vascular
effects were responsible for the greater part of the responses observed.
The fact that most of the peptides affect the vasculature could be taken to imply that
the role of endogenous carotid body peptides is to modify blood flow. However, it is not
known whether endogenous polypeptides do in fact modify carotid body blood flow when
released, and many established neurotransmitters, such as ACh, noradrenaline and
dopamine, have marked vascular effects when injected. This, albeit together with other
evidence, has not prevented these latter substances, when present in the carotid body (e.g.
see Biscoe, 1972), from being considered as putative chemoreceptor neurotransmitters, so
by the same token the vascular effects caused by exogenous polypeptides should not exclude
them from consideration as putative neurotransmitters when found to be present in the
carotid body.
During the present study we investigated whether any interaction occurred in the carotid
body between SP and methionine enkephalin. These two peptides, or closely related
material, are present in the cat carotid body (see Introduction) and SP has been claimed
to be a neurotransmitter at the central nerve terminals of baro- and chemoreceptor afferent
fibres of cats (Gillis, Helke, Hamilton, Norman & Jacobowitz, 1980) and rats (Helke,
O'Donohue & Jacobowitz, 1980; Jacobowitz & Helke, 1980). It is also known that
methionine enkephalin can inhibit the release of SP from cultured sensory neurones (Mudge,
Leeman & Fishbach. 1979) and probably in the c.n.s. (Jessel & Iversen, 1977). Our results
showed that SP was unable to overcome the chemoinhibitory effect of methionine
enkephalin, something it might have been expected to do if release of endogenous SP is
crucial for chemoexcitation, and can be prevented by methionine enkephalin. However,
much may depend on the type of fibre being recorded and the background level of activity;
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SP is particularly associated with C fibres (Hokfelt, Johansson, Kellerth, Ljungdahl,
Nilsson, Nygards & Pernow, 1977) and it could be that A fibres were being recorded which
are, perhaps, affected more by methionine enkephalin than by SP. In the absence of
conduction velocity measurements this must remain speculation, and also we don't know
whether the concentration of injected SP in the carotid body was physiological. As far as
the other polypeptides were concerned, the inhibition evoked by methionine enkephalin was
slightly potentiated by /^-endorphin but reduced by VIP.
Evidence from other parts of the nervous system suggests that some polypeptides may
function as neurotransmitters (see Hokfelt el al. 1980), but the question ofwhat physiological
role the polypeptides play in the nervous system is still very much a matter for debate (see
Bishop & Polak, 1978; Guillemin, 1978; Hokfelt et al. 1980; Snyder, 1980). As far as the
carotid body is concerned, various exogenous polypeptides affect chemoreceptor activity
and several of these are known to be present in the structure. However, on its own this
information does not enable us to reach a conclusion regarding the role of the peptides in
the carotid body. Theymay function as neurotransmitters, neuromodulators, co-transmitters
affecting receptor sensitivity, neurohormones, trophic factors, or as agents modifying the
vasculature, and might be influenced by each other, by carotid body amines, by circulating
hormones (e.g. ACTH, /^-endorphin) or by other substances.
In conclusion, further studies are needed in order to determine the role of polypeptides
in carotid body chemoreception, and these will involve the use of drugs which can selectively
affect the peptidergic system (e.g. by destruction of nerve cells, blockade of receptors,
inhibition of enzymatic destruction, interference with biosynthesis) and also the correlation
of carotid body peptide release with chemoreceptor activity under various physiological
conditions. It will also be necessary to establish whether the polypeptides which appear to
be present in the carotid body are the endogenous physiologically active entities, or whether
they are converted to or derived from more active forms. Most of these ideals seem
unattainable at present because of lack of suitable drugs or techniques, but this situation
may change rapidly.
The authors gratefully acknowledge the technical assistance of Mrs S. Bond.
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The inhibitory effect of opiates on carotid body chemoreceptors
is not mediated by adenosine
J. A. Ktm.iitii, l>. S Mi. ( H i-.kn
I ic/airlaicut of Pharmacology, I aircrsitv oj luliabitrgli, L.I/A UJ '/., Scot/ami
It has been suyyested that the inhibition of neurotransmitter release produced by
opiates may be mediated by the initial release of adenosine "5 The idea was advanced
on the yrounds that adenosine mimicks the effect of morphine, and theophylline anta¬
gonizes the actions of both adenosine and morphine In the cat carotid body, adenosine
stimulates I and the opiates (morphine, methionine or leucine—enkephalin) depress
'2. 3 spontaneous cheinoreeeptor activitv. The present work was undertaken to inves¬
tigate t lie el leet on t he e hen a ireceptors of t heophvl line and it s inllnence on In it h adenosine
and opiates.
(experiments uere performed on eats anaesthetized with pento-barbitone .42 my ky.
i.p. supplemented everv 1-2 Itr). The animals were artificially ventilated with air and
paralysed with yallamiuc (2 my ky, i.v.). t'hemoreceptor activity was recorded from
the peripheral end of a sectioned carotid sinus nerve I : the yanylioyloinerular (sympa¬
thetic) nerves were usually cut. Druys were dissolved in Locke solution and injected
into the ipsilat ral common carotid arterv (i.e.) over a 2 sec period.
Theophylline (100-200 ay. i.e.) had little or no eliect on spontaneous chemoreceptor
discharye but a hiylter dose (I my, i.e.) depressed discharye. an effect which lasted for
about 30 s. The excitatory action of adenosine (1-100 ay. i.e.) was potentiated after
theophylline (1 my. i.e.) whereas the inhibitory action of methionine-enkephalin (10 ay.
i.e.) was unaffected and that of morphine (10-100 ay, i.e.) sliyhtly reduced (f> > 0 05).
Naloxone (400 ay. i.e.) antayonized the chemodepressant effects of morphine and methio¬
nine-enkephalin. but did not alter the chcmoexcitatorv effect of adenosine.
Since adenosine does not mimick the effect of opiates on the chemoreceptors. and
the actions of the opiates were not prevented bv theophylline, it appears unlikely that
adenosine mediates the chemoinhibitorv action of opiates in the cat carotid IxkIv.
I his work was supported bv an M.K.I', project yrant. J.A.K is on leave from the
Institute ( oilbenkian de Ciencia. (teiras. Portuyal.
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The brain-stem contains neurones which form part of the systems
involved in controlling respiration and blood pressure. Opioid
peptides are present in this region of the brain, and recent evidence
implicating these substances in central respiratory and cardio¬
vascular regulation will be reviewed in this paper.
I The Brain-Stem, Opioid Receptors mod Opioid Peptides
Cranial nerves IX and X convey information from peripheral
sensory receptors to the brain-stem—arterial chemoreccptors and
baroreccptors provide information to the central nervous system
(c.n.s.) concerning blood gas tensions and blood pressure/pulse
frequency respectively. A high proportion of these primary
afferent nerve fibres have their first synapse in the nucleus tractus
solitarii (NTS) of the medulla oblongata (see Palkovits Sc
Zaborsky. 1977)
It has been known for some time that certain regions of the
brain-stem, particularly the ventrolateral surface, are pharma¬
cologically sensitive, or "chemosensitive". and can give rise to
respiratory and/or cardiovascular changes when affected by-
various substances, including the opiate drug morphine
(l.oeschcke A Kocpchcn. 1958; Feldhcrg. 197b) The existence of
specific opioid receptors was demonstrated pharmacologically by
using stereoisomers of opiates and. more recently, naloxone which
antagonizes central actions of morphine and is regarded by many
as being a specific antagonist for opioid receptors. More recently,
binding sites for opiates have been localized in parts of the brain¬
stem involved in respiratory and cardiovascular control (sec Atweh
A Kuhar. 1977. 1983). as have enkcphalinergic neurones and their
terminals (Hbkfclt rt u! 1977). especially in the N TS (IJhl vt ul
1979)
2 Respiratory System
It is well known that therapeutic doses of morphine depress
ventilation, and this generally undesirable effect can be attributed
to a reduction in the sensitivity of neurones in the brain-stem to
carbon dioxide (Florcz et al. 1968). Iontophoresis of morphine or
(Met)cnkephalin reduces the peak discharge frequency Without
affecting basal discharge of respiration-related units in the tractus
solitarius, nucleus ambiguus and nucleus parabrachalis medialis of
the cat brain (Denavit-Saubie et al. 1978), and histochemica!
techniques have shown that opioid receptors and enkephalin-likc
material are present in these regions (see Fredenckson, 1977).
The ventral surface of the medulla oblongata is very sensitive to
the respiratory-depressant effects of opiates and opioids (Florez A
Media villa. 1977; Moss A Friedman, 1978; Florez et al. 1980), and
chemosensitive structures that monitor the extracellular pH and
?CO, of brain fluid are located 200-300pm beneath this area
(Mitchell et al. 1963). These chemosensitive zones are more super¬
ficially sited than arc the classical respiratory "centres**, which are
situated close to the floor of the fourth ventricle. It seems probable
that opioids depress the responsiveness of the chemosensors to
carbon dioxide (Zobrist et al. 1981) and may play a physiological
role in the control of respiration (Pokorski et al. 1981).
The peripheral chemosensors also contain enkephalins (Whar¬
ton et al. 1980), and in the case of the cat carotid body (Met)-
enkcphalin-like material appears to coexist with catecholamines in
glomus cells, possibly within the same vesicles (Hansen et al.
1982). Chemosensory discharge is depressed by exogenous
enkephalins (see Fig. I), but morphine and ^-endorphin are much
less potent than are (Met)- and (Lcu]-cnkephalin in depressing
carotid chemorcccptor activity in cats (McQueen A Ribeiro, 1980,
1981). Low doses of naxolone can abolish the depressant effects of
morphine and ^-endorphin on discharge, but higher doses arc
needed to produce a comparable reduction in the responses to
(Leu}- and [Met}-enkephalin (Fig. 2). This could be interpreted as
evidence for two types of opioid receptor in the carotid body,
namely p (morphine) and 5 (enkephalin) subtypes, the latter being
more potent in evoking depression of chcmoreceptor activity.
Since morphine's depressant effect on peripheral arterial chemo-
receptors is relatively slight, it follows that the greater part of
respiratory depression associated with this opiate results from
actions in the c.n.s. In contrast. (Met)enkephalin depresses peri¬
pheral as well as central chemosensors. The physiological function
of opioid receptors and opioids in the carotid body, and their
relationship to other substances, such as catecholamines. 5-
hydroxytryptamine. vasoactive intestinal polypeptide, substance P
and acetylcholine, which are also present in these sensory organs,
remains to be established. Naloxone itself causes a slight increase
in chemosensory discharge under normoxic and normocapnic
conditions (McQueen A Ribeiro. 1980). which could mean that
endogenous opioids act within the carotid body to reduce peri¬
pheral chemorecepior drive to respiration (Pokorski A Lahiri.
1981). This may have very important consequences because the
c.n.s. has no intrinsic mechanism for detecting hypoxia and
initiating respiratory changes, being reliant on the reflex stimula¬
tion of respiration which results from activation of arterial chcmo-
receplors under hypoxic conditions. F.xccssivc opioid release
w ithin the carotid NnJy. or high levels of circulating opioids, could
impair or blunt the reflex respiratory response to hypoxia
a Physiological Role
The presence of opioid peptides and opioid receptors in the
brain-stem and the potent respiratory-depressant effects of opioid
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FIG. 1. Effect of (Met)enkephalin on chemoreceptor discharge
(R*print*d. with permission, from McQueen. 1981)
Time offer injection (»)
• : 0.1 (Met)enkephalin b: 1 0|ig IMetjenkephalm c. 10uQ (Mefjenkephalm d: 100pg (Meljenkephahn
(Met)enkephslm injected into the carotid artery causes a dose-related depression of ch©mos«nsory discharge in cats. The left-hand panel shows data
pooled from four cats m which discharge was averaged over 15s periods following injection of (Mel)enkephalm and expressed as the mean percentage
( ♦ S.E.M.) of the pre-injection discharge (black rectangle - 100%). The central panel illustrates the effect of the opioid peptide (injected at arrow) on
femoral arterial blood pressure in one experiment, and the right-hand panel of neurograms shows the discharge of a single chemoreceptor unit recorded
in the same experiment illustrating the depressant effect of (Met]enkephalm (injected at the marker)
peptides and opiates applied locally to this area led to the
suggestion that these substances may be involved in regulating
respiration by exerting a tonic inhibition at one or more sites (e.g.
Moss A Scarpelli. I98I). If this is the case, it would be expected
that the opioid receptor antagonist naloxone would increase venti¬
lation. and several studies have shown that this docs indeed occur
(Stephen rt al. I976; Moss A Friedman. 1978; Lawson rt al 1979.
Moss A Scarpclli. 1979) In contrast, others report that naloxone
has no effect on ventilation (Chernick A Russell. 1978; Wilier rt al
1979; Flcctham rt at 1980). although it does reduce morphine
induced respiratory depression (Kaufman rt al 1981). Various
species, including man. have been used in these studies and it could
be argued that differences in species and doses of naloxone used
account for the discrepant results. However, it seems that the
conditions under which the experiments are performed determine
whether or not naloxone affects ventilation. For example, the
respiratory-stimulating effect of naloxone, in the absence of hypox-
aemia. is age dependent, being virtually abolished four to five days
after birth in rabbits (Ha/inski rt al. 1981). When stressed with
hypoxaemia adequate to produce respiratory depression, maturing
rabbits as well as very young animals show a marked increase in
respiration following naloxone administration (Stephen rt al. 1976.
Chernick rt al. 1980. Grunstein rt al. 1981). The observations with
naloxone provide indirect evidence that during acute hypoxacmia
endogenous opioid peptides are released and may act as respiratory
depressants.
The ventilatory response to moderate hypoxia in the human
neonate is. unlike that of the adult, biphasic. Initially ventilation
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FIG. 2. Responses of a single chemoreceptor unit to intracarotid (i.e.) injections (arrows) of [Met]- and [Leu]-
enkephalin and 0-endorphin bafore and after an initial intracarotid dose, followed by an intravenous (•-v-)
dose, of naloxone in an anaesthetized cat
(McOu««n. unpublished work)
2
increases, but instead of being sustained, as in the adult, a decrease
in ventilation occurs which may persist for a long time, despite
return to normoxic conditions (Cross el at. 1954). Might the
respiratory depression be caused by opioids? In this connection it is
interesting that levels of [V-endorph in-like material in umbilical
cords are increased in hypoxacmic infants (Wardlaw et al. 1979).
The respiratory responses of young animals to naloxone may
represent removal of an inhibitory influence of opioid peptides on
neuronal pathways involved in regulating respiration during early
postnatal life, and raises the possibility that certain abnormalities
in human neonates (e.g. periodic breathing and apnoea) and older
infants (e.g. sudden infant death syndrome—cot death) may be
related to actions of opioids. The role of opioid peptides in respira¬
tory control in the fetus needs more detailed investigation, but
initial reports suggest that naloxone does not increase breathing
activity during non-rapid-cyc-movcment (REM) sleep, and the
apnoca of prematurity is not ameliorated or abolished by naloxone
(see Chcrnick, 1981).
Naloxone increases respiration in anaesthetized animals (e.g.
Lawson et al. 1979). but these observations cannot be extrapolated
to the normal conscious animal because, apart from the direct
effects of the anaesthetic, the animals were exposed to the stresses
associated with anaesthesia and surgery. Stress leads to increased
blood levels of [^-endorphin (Rossier et a! 1977). and this peptide
can enter the c.n.s (Rapoport et al. 1980). When experiments are
performed on unstressed conscious humans, naloxone docs not
increase spontaneous respiration (Wilier et al 1979) or respiratory
responses to either hypoxia or hypercapnia. even following massive
doses (30mg intravenously (i.v.): Flcetham et al. 1980) of the
antagonist, several orders higher than needed for abolishing the
respiratory-depressant action of morphine in man Incidentally.
the administration of such high doses of naloxone to anaesthetized
or stressed patients is potentially dangerous for reasons which are
not clear, but may involve massive increases in sympathetic tone
(Andrce, 1980).
Naloxone improves respiration in rats following electro¬
convulsive shock (Holaday et al. 1978) or shock associated with
spinal cord transection (Holaday & Faden. 1980). The action of
the opiate antagonist is mediated centrally and is presumed to
result from a blockage of endogenous opioid peptide action
Some studies have been performed on patients suffering from
chronic obstructive pulmonary disease (c.o.p.d.) to determine
whether endogenous opioids, released in response to the stress of
chronic dyspnoea, might cause respiratory depression. Santiago et
al. (1981) found naloxone (2mg i.v.) restored flow-sensitive load
compensation without affecting respiratory sensitivity to CO;.
whereas Butland et at. (1981) were unable to demonstrate any
ventilatory effect in their patients who received 0.4—4mg nalox¬
one. Obtaining meaningful data from respiratory experiments in
conscious man, whether patients or healthy volunteers, is
notoriously difficult, and adequate controls arc needed
b Interactions with Putalnx* Transmitters
Morphine can affect the levels and release of substances such as
acetylcholine. 5-hydroxytrypiamine and noradrenaline in the
medulla oblongata, and morphine and opioid peptides may induce
respiratory depression by affecting one or more of these putative
transmitters (e.g. see Ahtcc &. Altila. 1980. Meldrum A Isom.
1981) Much more work needs to be done to see how opioid
peptides interact with neurones and neurotransmitters involved in
controlling respiration, but it would not be surprising to find that
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the release of one or more transmitters is affected by opioids. Tho
question to be addressed is whether such effects have any physio¬
logical or pathophysiological significance for respiratory control
3 Cardiovascular System
a Opiates
Morphine can affect systemic arterial blood pressure and heart
rate, the greater part of the effects resulting from actions on opioid
receptors in the c.n.s. Studies in anaesthetized artificially
ventilated cats have shown that morphine produces quite different
cardiovascular effects when injected into a lateral ventricle or into
the cisterns magna: pronounced tachycardia with a short-lasting
rise in blood pressure due to sympathetic stimulation on intra¬
ventricular injection, and bradycardia and a gradual long-lasting
fall in pressure due to removal of sympathetic tone to heart and
vessels on inlracistcrnal injection, the latter effect being similar to
that evoked by morphine (0.5-1 mg/kg) injected subcutaneously
(Feldberg A Wei. 1977). The bradycardia and prolonged fall in
blood pressure on intracistcmal injection resulted from an action
on structures reached from the subarachnoid space because, when
administered in this way. morphine does not enter the cerebral
ventricles. The structures affected by morphine are considered by
Feldberg A Wei (1978) to be at the dorsal surface of the medulla,
since the depressor effects were obtained when the drug was
applied topically to the dorsal but not to the ventral surface of the
brain. Morphine acts in the same region at the dorsal surface when
injected subcutaneously because the fall in heart rate and blood
pressure was prevented or restored by topical application of
naloxone (about lOpg) to this region. Feldberg A Wei suggest that
the commissural nucleus of the tractus soliiarius may be the
structure on which morphine is acting to inhibit sympathetic lone
to blood vessels and the heart on subcutaneous or intracisternal
injection.
b Opioid Peptides
Application of (Met)cnkephalin to the ventral surface of the
brain-stem causes a reduction in blood pressure, as well as
respiratory depression in cats, and these effects can be prevented
by naloxone (Fldrez A Mediavilla, 1977). Injections of (Leu)- and
(Met)-enkephalin into the brain produce cither hypertension or
hypotension according to where the injection is made. (Leujcnke-
phalin tending to cause hypertension in rats and cats (Schaz et ul
1980). This has led to the suggestion that there are at least two
types of opioid receptor within the medulla oblongata (Fuxe el at.
1979): one type is relatively resistant to naloxone and is involved
with vasopressor responses, whereas the other type is readily-
antagonized by naloxone and is involved with vasodepressor
responses. It is interesting to note that vasopressin appears to be
necessary for the (Lcu)enkephalin pressor effects, because Brattlc-
bro rats, which lack vasopressin, do not show pressor responses to
this opioid. Bisset ei ul. (1978) have described the release of
vasopressin by enkephalins, and this may account for the delayed
onset of the pressor response to (Lcujcnkephalin
C Opioid Peptide Intuitemenl in Curdnieascu/ur Regulation
The existence of opioid-containing nerves and opioid receptors
in brain-stem regions that arc involved in cardiovascular regula
tion. together with the effects of exogenous opioids and opiates on
blood pressure, has led to suggestions that opioid peptides arc
involved in the physiological control of the cardiovascular system
There is also evidence that they interact w ith Kith the sympathetic
and parasympathetic divisions of the autonomic nervous system,
which are involved in cardiovascular regulation (Laubic A
Schmidtt. 1981).
Morphine-like drugs cause a centrally mediated hypotension and
bradycardia, an effect which is very similar to that evoked by
activating arterial baroreccptors and raises the question of whether
opioids are involved in modifying activity of the baroreccptor
reflex pathway. In fact it appears that opioids act at p-receptors to
attenuate the baroreccptor reflex in conscious rabbits (Petty A
Reid. 1981), an action which is antagonized by naloxone.
Naloxone, given on its own, reportedly increases baroreflcx
activity, but the evidence is not particularly convincing. Ku-.
mazawa et al. (1981) found naloxone caused a slight rise in blood
pressure in anaesthetized dogs that had undergone bilateral
vagotomy and sectioning of the carotid sinus nerves, and this
action of naloxone (0.1 -2mg/kg i.v.) was not dose dependent. The
state of the experimental animal seems to determine whether
naloxone elicits a pressor response (see also Dashwood A Feldberg.
1980), and the antagonist appears to have no effect on heart rate
(Wilier et al. 1979) or blood pressure in normal man.
Naloxone can reverse the hypotensive effect of clonidine
(Farsang et al. 1980). and Kudos et al. (1981) have demonstrated
that clonidine releases a fi-endorphin-like peptide from slices of
brain-stem. The evidence is compatible with a depressor role for (5-
endorphin (sec also Petty el al. 1981). However, in order to
implicate the opioid peptides in central cardiovascular control it
will be necessary to show changes in their output within discrete
brain regions under varying physiological conditions.
d Shock
Naloxone acts at central opioid receptors to reverse the
hypotension, hypothermia and hypoventilation of spinal shock in
rats (Holaday A Fadcn, 1980). Hypotension associated with hypo¬
volemic shock in dogs can also be reversed by naloxone (Vargish
et al. 1980). and the opiate antagonist has little effect on cardio¬
vascular haemodynamics in normal animals. The stress associated
with bleeding anaesthetized dogs to a mean blood pressure of 6 kPa
causes release of (^-endorphin from the pituitary, and it is possible
that this contributes to the shock slate by affecting naioxone-
sensilive opioid receptors. Release of opioid peptides has been
implicated in the pathophysiology of endotoxic (Hotaday A Faden,
1978) and hypovolemic (Faden A Holaday. 1979) shock in rats.
The ability of intraventricularly administered ( —>-naloxone to
reverse the hypotension of shock, but not (+ ^naloxone which has
no appreciable effects as an opioid receptor antagonist, indicates
that the effects of naloxone in shock are mediated through opioid
receptors in the c.n.s. The receptors appear to be associated with
supraspinal parasympathetic pathways because transection of the
cord interrupts communication between higher brain centres. The
isolation of sympathetic neurones from higher control leaves the
parasympathetic nervous system as the primary means for neural
regulation of cardiovascular function. Holaday A Fadcn (1980)
have drawn attention to the possible therapeutic benefit of narcotic
antagonists in treating spinal cord injury by improving spinal cord
blood flow and thereby reducing spinal ischacmia
e Hypertension
Levels ol enkephalins in the neurohypophysis are raised in
spontaneously hypertensive rats, but not in animals with desoxy-
corticostcrone acctatc/salt-induccd hypertension (Morris et al
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1981). The changes in level of enkephalin could be due 10
decreased release or increased synthesis, and the relevance of the
observation to genetic hypertension remains to be elucidated
f Interactions with Putative Transmitters
Costa et aJ. (1978) have reviewed the interactions that can occur
between enkephaiinergic and other neuronal systems. Nor¬
adrenaline and adrenaline are considered to be important neuro¬
transmitters for cardiovascular control, noradrenaline causing
vasopressor and adrenaline vasodepressor responses (see Fuxe et
al. 1979), and noradrenaline- and adrenaline-containing neurones
are present in the NTS. Terminals of noradrenergic neurones have
specific opioid receptors (Starke, 1977), and activation of these pre¬
synaptic receptors by opioids could lead to a reduction in the
amount of transmitter released by each impulse. There is some
evidence for interaction between opioid peptides and catechol¬
amines in central cardiovascular regulation (Fuxe et al. 1980), and
morphine and opioid peptides can also modify brain monoamine
synthesis.
Since the precise role of adrenaline, noradrenaline, dopamine,
acetylcholine and 5-hydroxytryplaminc in central cardiovascular
control remains to be established, it is difficult to interpret
meaningfully the preliminary results that have been obtained from
experiments aimed at examining the interactions between these
putative transmitters and the opioid peptides. Furthermore, inter¬
actions between the opioids and other peptides (e.g. substance P.
which is claimed to be a transmitter at the central terminals of
baro- and chemo-reccptor afferent nerve fibres in the NTS: Gillis
et al. 1980) may also be involved in the central regulation of blood
pressure (Fuxe et al. 1980).
4 Summary
Experiments »n animals have shown fairly clearly that exogenous
opioid peptides can alter respiration and blood pressure by
affecting the central systems involved in respiratory and cardio¬
vascular control, although the precise mechanisms remain to be
established and actions may uke place at more than one site. The
interactions between various putative transmitters and opioid
peptides, some of which appear to coexist in certain neurones, and
may be core leased, are being studied.
Changes seen following administration of naloxone are generally
assumed to result from blockade of opioid receptors and are taken
as providing indirect evidence for opioid involvement. However,
some caution is needed lest naloxone should prove not to be a
selective antagonist for opioid receptors (Sawynok etal. 1979) or be
incapable, in the doses commonly used, of antagonizing the actions
of particular opioids in the brain (i.e. there may be naloxone-
insensitive opioid receptors: see Paterson et al. 1983). In order to
demonstrate involvement of an opioid in a system under physio¬
logical or pathophysiological conditions it would be best to obtain
evidence (e.g. by measuring opioid release, studying the effects of
inhibiting opioid inactivation. using other antagonists and
selective agonists) in addition to that provided by naloxone.
The available evidence, based on the interpretation of results
from studies with naloxone, does not support involvement of
opioid peptides in normal respiratory and cardiovascular control in
man. However, in stressful conditions (e.g. anaesthesia, surgery,
pain, hypoxia, shock, the neonatal state, and certain pathophysio¬
logical disorders) there is evidence from studies in animals and in
man that opioid peptides do affect the central regulation of the
respiratory and cardiovascular systems, and this has important
clinical implications.
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Changes in responses of cat carotid body chemoreceptors to 5-HT after
administration of the antagonist MDL 72222
By G. C. Kirby and D. S. McQueen. Department of Pharmacology, University of
Edinburgh Medical School, Edinburgh EH8 9JZ
The physiological role of the 5-hydroxytryptamine (5-HT) that is present in the
cat carotid body (Chiocchio, Biscardi & Tramezzani, 1967) has yet to be established.
Nishi (1975) found that intracarotid (i.e.) injection of 5-HT in cats caused a transient
increase in carotid chemoreceptor discharge that was followed by a period of
chemodepression. These responses were unaffected by the putative 5-HT antagonists
LSD, gramine and methysergide.
In the present study we have investigated the effects of MDL 72222 (a new
compound which appears to be a selective antagonist at neuronal 5-HT receptors -
Fozard, 1983) on the responses of carotid-body chemoreceptors to 5-HT, dopamine
and to changes in /^ 0j. Experiments were performed on cats anaesthetized with
a-chloralose (70 mg kg-1 i.v.) artificially ventilated and paralysed with gallamine
(3 mg kg-1 i.v.). Chemoreceptor activity was recorded from the peripheral end of a
carotid sinus nerve, and drugs were injected into the common carotid artery, as
previously described (Docherty & McQueen, 1978).
Injection of 5-HT (0-1-100 p% i.e.) caused a dose-dependent depression of 'spon¬
taneous' chemoreceptor discharge which was followed by a delayed excitation of
variable duration. Only occasionally was the chemodepression preceded by a
transient burst ofactivity, in agreement with the findings ofBlack, Comroe & Jacobs
(1972). After MDL 72222 the dose-response curve for 5-HT-evoked chemodepression
was shifted to the right, and following the higher dose of antagonist 5-HT caused a
prolonged dose-dependent chemo-excitation of rapid onset. The initial transient burst
of activity, when present, was also abolished by the antagonist. Chemodepression
evoked by dopamine and chemo-excitation caused by sodium cyanide were unaffected
by the doses ofMDL 72222 studied, and there were no marked changes in spontaneous
discharge or, as judged from preliminary experiments, in the response of the
chemoreceptors to alterations in P& 0j-
Our results show that MDL 72222 is capable of antagonizing the depressant effect
of 5-HT on carotid chemosensory discharge and may prove useful in helping to
determine the physiological role for 5-HT in the carotid body.
This work is supported by a project grant from the M.R.C. G.C. K. is a Houldsworth Scholar
of Edinburgh University. MDL 72222 was kindly donated by Merrell (Strasbourg).
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Effects of the antagonistsMDL 72222 and ketanserin
on responses of cat carotid body chemoreceptors to
5 -hydroxytryptamine
G.C. Kirby & D.S. McQueen
Department of Pharmacology, University of Edinburgh Medical School, Edinburgh EH8 9JZ
1 The effects of intracarotid (i.e.) injections of 5-hydroxytryptamine (5-HT; 1-50 fig) on carotid
chemoreceptor activity recorded from the carotid sinus nerve have been studied in anaesthetized
cats.
2 Three separate components in the complex response of the chemoreceptors to injected 5-HT
were identified. Firstly, a transient burst of activity was obtained during the injection period in 56%
of the recordings. Secondly, in all the recordings a period of chemodepression commenced a few
seconds after completing the injection and was usually dose-related. Thirdly, a delayed longer-
lasting chemoexcitation occurred in many experiments, concomitant with a fall in systemic blood
pressure.
3 The neuronal 5-HT receptor antagonist MDL 72222 (10-100 pg kg-1, i.e.) virtually abolished
the transient chemoexcitation evoked during 5-HT injections and also significantly increased the
mean ID50 for 5-HT-induced chemodepression; in 37% of recordings 5-HT caused a dose-related
chemoexcitation after the high dose of MDL72222. Neither the delayed chemoexcitation nor the
hypotension caused by 5-HTweremuch affected by the antagonist. MDL 72222 itself had a biphasic
effect on chemosensory discharge, causing depression followed by a delayed excitation.
4 The 5-HT2-receptor antagonist ketanserin (lOOpgkg-1, i.e.) had no appreciable effect on the
transient chemoexcitation evoked during 5-HT injections and caused a slight but significant increase
in the mean ID50 for 5-HT-induced chemodepression. The delayed chemoexcitation and accom¬
panying hypotension associated with 5-HT were both substantially reduced or abolished by the
antagonist. Ketanserin itself caused a short-lasting period of chemoexcitation.
5 All the effects of injected 5-HT on chemosensory discharge could be abolished by the combina¬
tion of MDL 72222 and ketanserin (100 pgkg-1, i.e.).
6 Neither MDL72222 nor ketanserin had any significant effect upon the response of the carotid
chemoreceptors to hypoxia. The rate at which discharge increased, and also the steady-state
discharge before and during hypoxia, were unaffected by the antagonists, alone or in combination.
7 At least two types of 5-HT receptor appeared to be involved in the response of carotid body
chemoreceptors to 5-HT. Transient excitation and chemodepression were mediated via
MDL 72222-sensitive (peripheral neuronal) receptors whereas the delayed chemoexcitation and
associated hypotension involved a ketanserin-sensitive, presumably 5-HT2-, receptor. It appears
unlikely that 5-HT plays a crucial role in chemoreception.
Introduction
Although it is well known that 5-hydroxytryptamine
(5-HT, serotonin) is present in the carotid body of
many species, including the cat (e.g. Chiocchio et al.,
1967), its physiological role there remains to be
determined. The effects of exogenous 5-HT on
chemosensory activity recorded from the carotid
sinus nerve have been studied in anaesthetized cats
(Black et al., 1972; Nishi, 1975; Docherty & Mc¬
Queen, 1978). A complex response is obtained fol¬
lowing the intracarotid injection of 5-HT, with a
common pattern being a brief period of chemoexcita¬
tion followed by a longer-lasting depression of back¬
ground chemoreceptor discharge. Nishi (1975)
found that the response to 5-HT was unaffected by
© The Macmillan Press Ltd 1984
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atropine or hexamethonium, which eliminates in¬
volvement of acetylcholine (ACh) receptors, but the
putative 5-HT antagonists lysergic acid diethylamide
(LSD), gramine and methysergide were also without
effect on the response of the carotid chemoreceptors
to 5-HT. Categorization of 5-HT receptors in the
peripheral nervous system is a complex problem (see
Gyermek, 1961; Wallis, 1981) and the value of
studies with drugs such as methysergide or LSD in
helping to characterize the carotid body 5-HT recep¬
tors has been questionable because they lack specific¬
ity as 5-HT antagonists. However, the recent advent
of more specific 5-HT antagonists such as
MDL 72222, shown to be potent in antagonizing the
actions of 5-HT at peripheral neuronal sites (e.g.
fibres mediating the Bezold-Jarisch reflex in rat -
Fozard, 1984), and ketanserin, which is reputed to be
a highly selective antagonist at 5-HT2-receptor sites
but inactive at 5-HTt-receptor sites (Leysen et al.,
1981), prompted us to study their effects on the cat
carotid chemoreceptors. The aim was to attempt a
characterization of 5-HT receptors involved in the
response of cat carotid chemoreceptors to 5-HT and,
by investigating the influence of the antagonists on
responses of the chemoreceptors to a physiological
stimulus, hypoxia, obtain information regarding the
physiological role of 5-HT in the carotid body.
A preliminary account of some of the results has
previously been presented (Kirby & McQueen,
1984).
Methods
Experiments were performed on fifteen cats of either
sex, weighing between 2.3 and 3.9 kg, median weight
3.0 kg. Animalswere anaesthetized with a-chloralose
(65-70 mgkg-1, intravenously) following induction
with halothane (5% in oxygen) and supplements of
chloralose were administered intravenously as re¬
quired. In two experiments pentobarbitone
(42mgkg_l, intraperitoneally) was used instead of
a-chloralose.
Full details of the experimental procedures have
been given previously (McQueen, 1977; Docherty &
McQueen, 1978) so only a brief description is pro¬
vided here. The carotid sinus region on one side was
dissected and the ganglioglomerular nerves, which
carry the sympathetic nerve supply from the superior
cervical ganglion to the carotid body, were cut. The
cats were artificially ventilated with room air, apart
from periods when hypoxic gas mixtures were used.
Gallamine triethiodide (3 mg kg-') was administered
intravenously to prevent spontaneous and drug-
induced muscle movements. Drugs were dissolved in
modified Locke solution or in 0.9% w/v NaCl solu¬
tion (saline) and injected, in volumes of 0.1 ml, into
the common carotid artery ipsilateral to the sinus
nerve from which electrical activity was recorded.
They were washed in with 0.2 ml Locke solution
which had been bubbled with 5% C02:95% air at
37°C; injections were generally completed within
1-2 s.
Electrical activity of single or multiple (2-4)
chemoreceptor units was recorded from the
peripheral cut end of the sinus nerve and stored on
tape for subsequent analysis using a pulse height
voltage discriminator linked to a microcomputer
(McQueen et al., 1984). The units were confirmed as
chemoreceptors by their random pattern of dis¬
charge, their increase in discharge frequency follow¬
ing injection of sodium cyanide (2.5 pg) into the
ipsilateral common carotid artery or in response to
hypoxia (breathing 10% oxygen in nitrogen), and by
the depression of discharge in response to hyperoxia
(breathing 100% oxygen).
Data analysis
A plot of chemosensory discharge (counts per
0.1s bin) against time wasmade for each test, and the
change in discharge frequency (xc.p.s.) from the
pre-injection control frequency calculated. In order
to standardize results from experiments with differ¬
ent absolute discharge frequencies, the response oc¬
curring in the first 5 s of the post-injection period was
expressed as a percentage change from control level
and plotted against logio dose. From lines fitted to the
dose-response data it was possible to calculate the
dose causing a particular response (e.g. ID50, dose
causing a 50% reduction in control discharge) and
obtain a mean value by pooling data from different
experiments.
Hypoxia
The animals were made hypoxic by switching the
inspired gas from air to 10% 02 plus 90% N2 for
4 min. For each test the control (air-breathing) dis¬
charge and steady-state discharge (hypoxia) were
measured and arterial blood samples taken before
and 3.5 min after onset of the hypoxic stimulus for
blood gas analysis. Discharge was measured over
consecutive 15 s periods and plotted against time,
and a straight line fitted to the values obtained when
discharge was increasing in response to the hypoxic
stimulus (i.e. until a steady-state maximum (100%)
or plateau discharge was obtained). The slope of this
line provided an index of the rate of increase in
chemoreceptor discharge in response to hypoxia, and
was expressed as % maxs-1.
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Statistics
Mean values are given ± s.e.mean. Statistical analysis
of differences between means was carried out using
the Wilcoxon two-sample test and the null hypothesis
rejected at the 0.05 level of probability (2-tailed).
Drugs
The following compounds were used, and doses are
expressed in terms of the salt: 5-hydroxytryptamine
creatinine sulphate complex, dopamine hydroch¬
loride (Sigma); MDL72222 (laH, 3a, 5aH-tropan-
3-yl 3,5-dichlorobenzoate) methanesulphonate salt,
kindly donated by Merrell International, Strasbourg;
domperidone and ketanserin, tartaric acid salt, kind¬




Sixteen recordings of chemosensory activity were
obtained, and intracarotid injection of 5-HT
(1-50 pg) consistently caused a depression of
chemosensory discharge which lasted for 3 -15 s. The
effect was dose-related in twelve of the recordings
(75%), as shown in Figure 1. In the other four
experiments chemodepression was not clearly re¬
lated to dose. 5-HT doses of less than 1 pg had only
slight effects on background discharge and these did
not differ significantly from those associated with
injection of the drug vehicle; the latter had variable
effects on chemosensory discharge causing, on aver¬
age, a 20.5% reduction during the 5 s post-injection
period. In nine recordings (56%) chemodepression
a b
i I I i 1
3 15i
(D 10-1 f
® 51 j .. :• , J„.
0 5 s 0 10 20 30 s
c 5-HT (pg) i.e.
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Figure 1 (a and b) Neurograms showing the effects of a single intracarotid (i.e.) injection of 5-hydroxytryptamine
(5-HT; lOpg, at arrow) on chemosensory discharge (3 units) and illustrating in (a) the initial burst of activity which is
followed by a period of relative inhibition. A delayed phase of excitation can be seen in (b), which shows the same test
displayed at a slower sweep speed. A ramped output below the neurograms gives the number of action potentials
counted cumulatively in successive 1 s intervals, (c) Dose-response data showing the relationship between 5-HT
dose and the percentage change in chemosensory discharge (from pre-injection control levels) that occurred during
the first 5 s after injecting 5-HT. The straight line was fitted to the data by the least squaresmethod, and the ID50 (i.e.
dose of 5-HT causing a 50% depression of discharge - see broken lines) determined. The mean of the five individual
control discharge values, from which the percentage changes were calculated, was 8.03 ±0.26c.p.s.. (♦) Effect
associated with injection of the drug vehicle.
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Figure 2 Neurograms of chemosensory discharge illus¬
trating the response to injecting, at the arrow, (a)
MDL 72222 (100 fig kg"1, i.e.) and, from a separate
experiment, (b) ketanserin (lOOfigkg"1, i.e.). The
ramped trace below each neurogram gives the number
of action potentials counted cumulatively in 1 s intervals.
was preceded by a transient burst of chemoreceptor
action potentials, usually occurring within the injec¬
tion period (Figure 1). The threshold for this more
variable excitatory effect (=10 fig) was generally
higher than that for chemodepression, but although
discharge increased substantially, by 800-1000% in
some experiments, a clear dose-response relation¬
ship was obtained in only three of the experiments,
and the response appeared to be subject to
tachyphylaxis. In the remaining 25% of recordings in
which 5-HT did not cause transient excitation,
chemodepression was still obtained. The averaged
ID50 for the dose-dependent chemodepression in the
recordings where the effect was dose-related was
5.8±1.9fig(n = 12).
In many of the experiments a delayed increase in
chemosensory discharge was observed following the
chemodepression (Figure 1). This effect was rather
variable, lasted for 10-60 s, and had no consistent
dose-response relationship. It appeared to be as¬
sociated with the fall in systemic blood pressure that
occurred following 5-HT injection (Figure 5).
Effects of the antagonistMDL 72222
Intracarotid injection of MDL 72222 (10-
100 pg kg"1) caused a depression of background
chemosensory discharge which was followed by a
delayed increase in discharge frequency (Figure 2a).
No chemoexcitation was observed during the period
of injection, and systemic blood pressure was not
significantly affected by the antagonist. MDL 72222
(10 fig kg"1, i.e.) was studied on seven recordings and
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Figure 3 (a) Chemodepressant effect of 5-hydroxytryptamine (5-HT) injected before (O O) and after
(• •) a low dose of MDL 72222 (10 fig kg"1, i.e.). The rightward shift in the logio dose-response curve caused
by the antagonist is shown. An additional dose of MDL 72222 (100 fig kg"1, i.e.) caused a further shift upwards and
to the right (■). (b) In a separate experiment the higher dose of MDL 72222 (100 fig kg"1, i.e.) completely abolished
the 5-HT-induced chemodepression (■ ■) and slight chemoexcitation was obtained in response to the lower
doses of 5-HT. Lines were fitted to the data by the method of least squares.
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Figure 4 Responses of chemoreceptors (multi-unit recordings) to intracarotid injections of 5-hydroxytryptamine
((a) Sand (b) 25 pg at arrows)before and after MDL 72222 (100 pg kg-1, i.e.). The initial transient chemoexcitation
and the subsequent depression of chemoreceptor discharge were both virtually abolished by the antagonist, and
chemoexcitation became evident within the 5 s post-injection period. The ramps show the number of action
potentials counted cumulatively in 1 s intervals.
5-HT to chemodepression was shifted upwards and
to the right (Figure 3), and the mean ID50 was
increased to 49.4 ± 33.6 pg (rt = 7; P<0.05 with re¬
spect to controls). When a dose of 100 pg kg-1 was
given (8 recordings, in 6 of which it followed the
lower dose) the ID50 increased to 638 ± 408 pg in five
(63%) of the recordings. In the other three cases
(37%) a dose-dependent chemoexcitation was ob¬
tained in the 5 s post-injection period (Figure 3), and
no chemodepression occurred unless very high doses
of 5-HT (250-1000 pg) were injected. It was possi¬
ble to calculate an ED30 (dose causing 30% increase
in discharge above pre-injection level), and this was
103.1 ± 9.0 pg (n = 3).
During the nine experiments inwhich 5-HT caused
an initial transient excitation, this part of the re¬
sponse was substantially reduced (totally abolished
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Figure 5 (a) Injection of 5-hydroxytryptamine (5-HT) injected (10 pg i.e., at arrow) affected chemosensory
discharge (lower trace, count of action potentials per 1 s interval) and also caused a fall in systemic blood pressure
(upper trace), (b) After administering ketanserin (100 pg kg" i.e.) the same dose of 5-HT had much less effect upon
blood pressure and there was less delayed chemoexcitation 10-15 s after the injection. However, both the initial
burst of activity and the subsequent chemodepression were relatively unaffected by the antagonist.
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MDL72222 (lOpgkg-1), and further reduced or
abolished by the higher dose (100 pgkg-1) - see
Figure 4. In one experiment the 5-HT-induced trans¬
ient chemoexcitation appeared only after
MDL72222 (lOpgkg-1) and was abolished by ad¬
ding the higher dose (100 pg kg-1) of antagonist. The
delayed or secondary chemoexcitation, which was
more obvious following higher doses of 5-HT, gener¬
ally increased in magnitude and became more rapid
in onset after MDL 72222 (10-100 pg kg-1), as
shown in Figure 6a.
Effects of the antagonist ketanserin
Intracarotid injection of ketanserin (100 pgkg-1) in¬
creased chemosensory discharge in the five record¬
ings studied, an effect which lasted for 10-30 s (Fig¬
ure 2b), and caused a longer-lasting fall in systemic
blood pressure. There was no depression of discharge
following ketanserin and no transient chemoexcita¬
tion during the injection period. The initial excitation
caused by 5-HT was present in three of these record¬
ings and was unaffected by the antagonist (Figure 5).
The ID50 for 5-HT-induced chemodepression was
14.2±5.0pg (n = 4), which represents a small but
significant (P<0.05) decrease in the average re¬
sponse after ketanserin - although much less marked
than the antagonism caused by MDL 72222
(10 pgkg-1), and ketanserin had little or no influence
in some of the tests (e.g. Figure 5). In all five record¬
ings the delayed increase in discharge was substan¬
tially reduced, as was the hypotensive effect of 5-HT
(Figure 5).
Effects of the two antagonists in combination
In five experiments where MDL 72222 (100 pg kg"')
was administered after ketanserin (100pgkg-1) the
normal responses to 5-HT injections were absent.
Dose-response data for the first 5 s of the responses
gave lines of such shallow slope that meaningful ID50
or ED30 values could only be obtained by extrapola¬
tion far beyond the range of doses that could feasibly
be used in the experiments, and these were not
considered to bemeaningful. Thiswas also the case in
the five experiments where ketanserin (100pgkg-1)
was injected after MDL 72222 (100 pg kg-1).
Responses to dopamine, and the effects of
domperidone
The chemodepressant effect of dopamine (0.1-
10 pg, i.e.) was obtained in all 16 recordings and
was unaffected by either ketanserin or MDL 72222
(Figure 6). The dopamine D2-receptor antagonist
domperidone (10-100pgkg,i.e.-1) was injected in
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Figure 6 Neurograms showing the response of a single chemoreceptor unit to injections (arrows) of (a) 5-
hydroxytryptamine 25 pg, i.e.) and (b) dopamine (lpg, i.e.) before and after administering MDL 72222
(100pgkg-1, i.e.). It can be seen that, whereas the chemodepression evoked by 5-HT was greatly reduced by the
antagonist, the dopamine-induced effect was unaltered. The ramps show the number of action potentials counted
cumulatively in 1 s intervals.
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Figure 7 Neurograms showing the responses of chemoreceptor units to injections (arrows) of (a) 5-
hydroxytryptamine lOpg, i.e.) and (b) dopamine (1 pg, i.e.) before and after administering the dopamine antagonist
domperidone (10 pg kg , i.e.). The antagonist virtually abolished the chemodepressant effect of dopamine but had
no appreciable effect upon the response evoked by 5-HT. The ramps show the number of action potentials counted
cumulatively in 1 s intervals.
eight preparations and reduced the depressant effect
of dopamine on the chemoreceptors without altering
the responses to 5-HT (Figure 7), whether injected
before (4 experiments) or after (4 experiments) the
5-HT antagonist(s). ID50 values for 5-HT-induced
chemodepression obtained after domperidone alone
were 10.8 ± 2.5 pg (n =4) and 8.1 ±3.1 pg(n = 2) for
the 10 and lOOpgkg-1 doses, respectively (P>0.05
in comparison with controls).
Responses to physiological (hypoxic) stimulation
The effect of hypoxic stimulation was studied in 14
experiments, and chemoreceptor responses obtained
before and after administering MDL 72222 or
ketanserin.
MDL 72222 Control chemosensory discharge fre¬
quency averaged 6.8 ± 1.5 c.p.s. on air, and increased
to 26.8 ± 5.3 c.p.s. on 10% O2 (n = 6). After
MDL72222 (lOpgkg-1) background discharge on
air increased to 10.8 ± 3.2 c.p.s., and rose to
27.3 ± 5.8 c.p.s. (n = 6) on 10% O2. The slope of the
line relating discharge to time during the period of
increasing discharge was 1.08 ±0.11% maxs"1 be¬
fore, and 1.04±0.12 after MDL72222. The time
taken to reach the plateau or steady state discharge
(i.e. maximum or 100%) was 112±6s before, and
109 ± 11 s after the low dose of MDL. A higher dose
of MDL72222 (lOOpgkg-1) was studied in 12 ex¬
periments (see Figure 8) in three of which ketanserin
had previously been injected. Background discharge
on air was 5.3 ± 1.0c.p.s., and it increased to
21.9± 3.2 c.p.s. on 10% O2, the slope being
1.02±0.07% maxs-1 and the time taken to reach
plateau (max) 114±4s. After MDL 72222 back¬
ground discharge was 7.7 ± 1.8 c.p.s., discharge on
10% 02 26.3±5.5, slope 1.08±0.11, and the time
taken to reach plateau 116±7s. None of these
parameters was significantly different from control
values, following either dose of MDL 72222.
Ketanserin In 6 hypoxia tests performed immediate¬
ly before the injection of ketanserin (in one of which
MDL72222 had been administered previously)
background activity in the pre-ketanserin control
state was 6.9 ± 2.0 c.p.s., and increased to
25.6±6.5c.p.s. on 10% 02, the slope of the line
being 0.99 ±0.06% maxs-1, reaching the plateau or
maximum value 112±6s after changing gases. Fol¬
lowing ketanserin (lOOpgkg-1) five hypoxia tests
were carried out, and there was no significant change




















i : 1 i 1 1 1 :
-60 -30 0 30 60 90 120 150 180
Time (s)
Figure 8 Increase in chemoreceptor discharge caused
by ventilating the animals with a hypoxic gas mixture
(10% O2:90% N2 during the 4min period starting at 0 s,
black bar) instead of room air. (a) Shows the discharge
averaged over 15s intervals, obtained before (O O)
and after (•—•) administering ketanserin
(lOOpgkg-1, i.e.). (b) Shows the responses obtained,
from a separate experiment, before (O O) and after
(•—•) administering MDL72222 (100 pgkg-1, i.e.).
Lineswere fitted to the data in the ranges shown by using
the least squares method. Neither of the antagonists had
any significant effect upon the response to hypoxia.
in any of the parameters (Figure 8). Background
discharge was 6.9 ± 2.0 c.p.s., increasing to 26.0 ± 9.5
during 10% 02, the slope was 1.02±0.14% maxs-1,
and time to plateau was 116 ± 17 s.
The mean values of arterial blood gas tensions and
pH during air breathing (PaC>2 12.7 + 0.7 kPa; PaCOi
4.3 ± 0.1 kPa; pH 7.30 ±0.01, n = 17) showed no sig¬
nificant differences between control values and those
obtained after the administration of antagonists.
Similarly, when the animals were made hypoxic,
there were no significant differences in blood gas
tensions and pH between the values obtained be¬
fore {Pa02 4.8±0.2kPa; PaCOz 4.1±0.2kPa;
pH7.32±0.01, n = 17) and after administration of
the antagonists.
Discussion
The present results show that 5-HT has complex and
somewhat variable effects upon chemosensory dis¬
charge in anaesthetized cats. We identified three
separate components in the response to 5-HT and
found that the 5-HT antagonists MDL 72222 and
ketanserin selectively affected different parts of the
response. Previous studies using respiration as an
index have provided evidence for both inhibitory and
excitatory effects of 5-HT on chemoreceptors in
various species including cat (Page, 1952; Douglas &
Toh, 1953; Ginzel & Kottegoda, 1954). 5-HT also
induces complex neurogenic and circulatory effects
which influence respiration independently of the
chemoreceptors (Mott & Paintal, 1953; Comroe el
al., 1953), which makes the respiratory effect a poor
index of chemoreceptor activity. We shall confine
ourselves to a consideration of neural data, looking at
the effects of antagonists on each of the components
of the chemoreceptor response to 5-HT.
Chemoexcitation
Transient chemoexcitation occurred during the in¬
jection period in about half the recordings, and this
effect has previously been described by Black et al.
(1972), Nishi (1975), and Docherty & McQueen
(1978). The increase was only occasionally dose-
related and seemed subject to tachyphylaxis. The
rapid onset suggests a direct or perhaps indirect (via
release of endogenous substance(s)) action on the
sensory nerve fibres (Eyzaguirre & Nishi, 1974), and
makes it unlikely to be due to vascular effects of
5-HT. The possible influences on the chemorecep¬
tors of increased sympathetic activity arising from the
ganglion-stimulating action of 5-HT (Trendelen¬
burg, 1958) were prevented by sectioning the gang-
lioglomerular nerves. This does not exclude the pos¬
sibility that 5-HT may release noradrenaline from
the terminals of sympathetic nerves within the
carotid body; such an action might be expected to
reduce blood flow through the carotid body and
could cause a delayed increase in discharge. The
finding that transient excitation was not obtained in
all recordings, in accord with Black et al. (1972),
could be because fibres differ in their sensitivity:
unmyelinated fibres may be more sensitive than
myelinated, or the concentration of 5-HT at the
receptor site following intracarotid injection may
vary between experiments. Tachyphylaxis to 5-HT
cannot explain the absence of excitation in response
to the initial doses of 5-HT, although in recordings
where excitation was occurring, repeated administra¬
tion of 5-HT in high doses did tend to attenuate the
response and may explain why there was no dose-
response relationship in many experiments. Nishi
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(1975), who evidently found transient chemoexcita-
tion by 5-HT to be more common and induced by
lower doses than was our experience, reported that
various antagonists were ineffective in blocking the
response. He was unable to characterize the receptor
responsible for excitation, although he did exclude
direct or indirect involvement of nicotinic and mus¬
carinic ACh receptors. Docherty & McQueen (1978)
found that the dopamine antagonist a-flupenthixol
could reduce excitatory responses to 5-HT, but in¬
consistently. We have not studied putative 5-HT
antagonists such as LSD or methysergide because of
concern over their specificity, but instead used the
newer 5-HT antagonists MDL 72222 and ketanserin.
The latter had no appreciable effect on the transient
chemoexcitation but MDL 72222 inhibited it. Thus
in some, but not all recordings of chemoreceptor
activity, 5-HT increases discharge transiently and
this occurs via actions, directly or indirectly
mediated, at a receptor, presumably within the
carotid body and perhaps associated with sensory
nerve endings, which is sensitive to the antagonist
MDL 72222. Recent studies have shown that
MDL 72222 blocks the excitatory action of 5-HT on
the cell bodies of rabbit vagal primary afferents
(Azami et al., 1984), and this evidence supports the
concept of 5-HT acting on neuronal or sensory recep¬
tors in the carotid body. The fact that MDL 72222
itself had some 5-HT-like actions could mean the
drug is a partial agonist.
Chemodepression
5-HT caused a short-lasting period of chemodepres¬
sion which commenced almost immediately upon
completion of the injection and was dose-related in
the majority of experiments. Again, the rapid onset
of the effect makes it unlikely to be secondary to
vascular changes caused by 5-HT. It was the most
commonly encountered component of the response
and occurred regardless of whether or not the initial
excitation was present. Depression of chemoreceptor
discharge has been demonstrated previously (Black
et al., 1972; Nishi, 1975; Docherty & McQueen,
1978). Earlier studies showed that very high doses of
a-flupenthixol reduced the relative inhibition caused
by 5-HT (Docherty & McQueen, 1978), but none of
the putative 5-HT antagonists examined by Nishi
(1975) had any effect. His suggestion that depression
might be secondary to the initial excitation seems
unlikely, for if this were the case, chemodepres¬
sion should not occur in the absence of an initial
depolarization, yet it did in our experiments. We
found that ketanserin had a rather variable effect
upon 5-HT-induced chemodepression, usually caus¬
ing a slight reduction (although sometimes a potenti¬
ation) of the effect. In contrast, MDL 72222
caused a substantial dose-related antagonism of
chemodepression, as shown by the increase in ID50
values, and higher doses (lOOpgkg-1) could com¬
pletely abolish the response, unmasking an excitatory
component. Dopamine also causes chemodepression
when injected in cats (Docherty & McQueen, 1978),
and in view of the fact that high doses of a-
flupenthixol can reduce responses to 5-HT as well as
to dopamine, we examined the responses to
dopamine and 5-HT before and after administering
the selective dopamine D2-receptor (Kebabian
& Calne, 1979) antagonist, domperidone. Dom-
peridone had no significant effect on any phase of the
chemoreceptor response to 5-HT when given in
doses which substantially reduced dopamine-
induced chemodepression, and responses to
dopamine were unaffected by either MDL 72222 or
ketanserin. Thus, we can conclude that chemodep¬
ression evoked by 5-HT does not involve a dopamine
D2-receptor and is mainly mediated by mechanisms
which are sensitive to MDL 72222. The results with
ketanserin couldmean that a small part of the depres¬
sion is attributable to actions on 5-HT2-receptors,
assuming the antagonist is selective and does not
affect MDL72222-sensitive sites in the doses
studied. Whether the depression of discharge results
from direct actions of 5-HT, or is secondary to the
release of an inhibitory substance, cannot be deter¬
mined from our study.
Delayed excitation
The final component of the response to injected
5-HT was a delayed (10-30 s) increase in discharge
that lasted longer than any of the other components.
However, it was very variable and tended to be
concurrent with the fall in blood pressure caused by
5-HT. The antagonist MDL 72222 had no effect on
blood pressure responses to 5-HT or on the delayed
excitation whereas ketanserin inhibited both the
hypotensive effect and the increase in discharge. The
chemoexcitation caused by ketanserin alone may
reflect some partial agonist activity of the drug. We
cannot tell from the data whether the delayed
chemoexcitation was due to the hypotension caused
by 5-HT, or resulted from actions of the amine on
5-HT2-receptors in the carotid body, perhaps as¬
sociated with the vasculature (Leysen et al., 1981) or
the nerves (e.g. sympathetic terminals - see earlier
discussion). Further experiments are needed to resol¬
ve the matter.
Classification of5-HT receptors
In the peripheral nervous system classification of
5-HT receptors is complicated (see Wallis, 1981)
and, in addition, new antagonists such asMDL 72222
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have yet to be fully characterized in vivo. According¬
ly, we can only conclude that at least two 5-HT
receptors appear to be responsible for changes in
carotid chemosensory discharge evoked by injected
5-HT. It is not possible to say whether or not the
transient excitation and depression are mediated
through a common MDL72222-sensitive mechan¬
ism, but overall our findings are consistent with re¬
ports showing that MDL 72222 is a selective an¬
tagonist of responses mediated through 5-HT recep¬
tors on peripheral nerves (Fozard, 1984) and that
ketanserin appears to be an effective antagonist at
vascular 5-HT2-receptors (Leysen el ai, 1981).
Physiological stimulation
Although the combination of MDL 72222 and
ketanserin antagonized the effects of exogenous 5-
HT on chemosensory discharge, the response of the
chemoreceptors to physiological stimulation by
hypoxia was unaltered. Assuming the antagonists
studied reach effective concentrations at sites within
the carotid body where locally-released 5-HT acts,
the implication is that endogenous 5-HT has no vital
role in the mechanism of chemoreception. However,
the possibility that 5-HT might exert subtle influ¬
ences, perhaps as a modulator or co-transmitter, that
were not detected in these experiments, cannot en¬
tirely be excluded. Neuronal co-storage of 5-HTwith
polypeptides, some of which are present in the cat
carotid body (e.g. substance P; Cuello & McQueen,
1980), and may be neurotransmitters (see Hokfelt et
al., 1980), could mean that if 5-HT is involved in
chemoreception it may function more as a modulator
than as a 'primary' transmitter. The conditions of our
experiments do not allow us to reach any conclusions
on this possibility, nor on the question of whether
5-HT may be released within the carotid body by
efferent nerves. However, the abundance of 5-HT in
the carotid body does imply that it has some function
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EFFECTS OF SUBSTANCE P ON RESPONSES OF CAT CAROTID BODY CHEMO-
RECEPTORS TO DOPAMINE/ NORADRENALINE AND 5-HYDROXYTRYPTAMINE
G.C. Kirby & D.S. McQueen, Department of Pharmacology, University of Edinburgh
Medical School, 1 George Square, Edinburgh EH8 9JZ, Scotland, UK
The cat carotid body contains substance P (SP)-like material (Cuello & McQueen,
1980) as well as the putative transmitters dopamine (DA), noradrenaline (NA), and
5-hydroxytryptamine (5-HT). Preliminary Investigations showed that SP can modify
spontaneous discharge and some drug-induced responses of the carotid chemo-
receptors (McQueen, 1980), and we have now studied the influence of SP on
responses of cat carotid chemoreceptors to DA, NA and 5-HT. Experiments were
performed on pentobarbitone-anaesthetized cats (12 mg kg-1 i.p., supplemented as
necessary), artificially ventilated and paralysed with gallamine (3 mg kg-1 i.v.).
Chemosensory discharge was recorded from the peripheral end of a cut sinus nerve,
and drugs were injected or infused into the common carotid artery as previously
described (McQueen, 1980). Infusions of SP (10 pg min-1) or drug vehicle (Locke
solution) were made at a rate of 0.1 ml min-1 for 2 min and injections of the
amines made 90 s after starting the infusion. This protocol was chosen to
minimise the tachyphylaxis caused by SP.
Within 15 s of onset of SP infusion there was a small but significant decrease
(P < 0.05) in spontaneous discharge from the pre-infusion control frequency;
Locke solution had no marked effect on discharge.
NA (0.1 - 50 pg i.e.) caused chemodepression followed by chemoexcitation;
chemodepression evoked by the higher, but not the lower doses of NA was poten¬
tiated during SP infusion, whereas the delayed chemoexcitation was reduced.
5-HT (1 - 25 pg i.e.) caused dose-related chemodepression that was potentiated
during SP infusion. Secondary excitation following chemodepression was smaller
in magnitude than that associated with NA, but, in contrast, was potentiated
during SP infusion. DA (0.1 - 10 pg i.e.) induced dose-related chemodepression
which was greater than that evoked by NA or 5-HT, but the effect was largely
unaltered during SP infusion.
Our results indicate that SP-monoamine interactions are rather complex, and there
is evidence for a differential effect of the peptide on the responsiveness of
carotid chemoreceptors to the amines studied. Thus, SP potentiated NA and 5-HT-
induced chemodepression, but had no effect on the depressant action of DA.
Delayed chemoexcitation caused by NA was reduced during SP infusion, but that
evoked by 5-HT was potentiated. It remains to be established whether SP modifies
chemoreceptor activity by acting directly on some element of the chemosensory
complex within the carotid body rather than indirectly by a non-specific action
(e.g. vascular effects which in turn influence chemoreceptor discharge).
Further studies are needed to determine whether the peptide-amine interactions
described have any physiological significance, and also to characterize the
type(s) of SP receptor involved in modifying chemoreceptor activity.
This work is supported by an M.R.C. project grant. G.C.K. is an Houldsworth
Scholar of Edinburgh University.
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The Modification by Prostaglandin E1 of Central
Nervous Interaction Between Respiratory and
Cardio-Inhibitor Pathways
D. S. McQUEEN and A. UNGAR
Department of Pharmacology, The School of Pharmacy, University of
of London, Brunswick Square, London
Dogs anaesthetised with morphine, chloralose and urethane often show
a marked sinus arrhythmia, the heart accelerating in inspiration and
slowing in expiration. This arrhythmia was shown by Anrep et al. (1936)
to be partly due to a reflex from the lungs and partly to central irradia¬
tion from respiratory to cardio-inhibitor pathways. For our experiments
dogs showing marked sinus arrhythmia were selected, and any reflex
component of the arrhythmia was excluded by surgical denervation of
the lungs in open-chested dogs or by applying positive pressure ventila¬
tion at a frequency unrelated to that of the arrhythmia to dogs paralysed
by decamethonium.
The cardiac period (duration of the cardiac cycle, beat by beat) was
computed electronically from the electrocardiogram. Prostaglandin Ea
(PGE^ was injected into the common carotid artery in doses of 5-30
nmoles/kg body weight. The arrhythmia was abolished or markedly
reduced in every experiment, the cardiac period becoming equal to
that in the inspiratory phase of the arrhythmia. PGE thus appears to
inhibit an expiratory slowing rather than an inspiratory speeding. The
effect, which was not altered by denervation of the carotid sinus region,
was apparent within 2. 5 seconds of the injection. This establishes a
central site of action. The arrhythmia returned after 5-20 minutes.
The central component of the Traube-Hering waves in arterial blood
pressure was abolished by PGEj in some, but not all experiments. This
effect was more transient than the corresponding abolition of sinus
arrhythmia.
While the response toPGEj was at its height, stimulation of the carotid
body chemoreceptors gave rise to a bradycardia similar to one evoked
before the injection of PGEj. The pathways for reflex cardiac inhibition
are thus not blocked.
If repeated doses of PGEj were injected at 20 minute intervals, tachy¬
phylaxis was seen after two or three injections.
Figure 1 shows the pooled results of our experiments. We have expressed
the arrhythmia quantitatively as the standard deviation of the cardiac
period divided by the mean cardiac period. This ratio we have called the
'standardised arrhythmia'. The abolition or reduction of the standardised
arrhythmia is statistically significant at the probability levels indicated
in each of the five animals studied.
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Fig. 1. Inhibition of sinus arrhythmia by PGEj Ordinate: standardised
arrhythmia = standard deviation of the cardiac period divided by the
mean cardiac period. Open columns: control values. Black columns:
values after prostaglandin Abscissa: dogs A to E.
A change in the respiratory pattern was also seen after injection of
PGEj but this appeared 2 or 3 breaths later than the inhibition of the
arrhythmia. There was an increase in pulmonary ventilation, sometimes
as great as 1007o, due to a reduction in the duration of expiration without
any change in other respiratory parameters including duration and ampli¬
tude of inspiration and inspiratory and expiratory peak flows. Such
responses, isolated to one respiratory parameter are not usually seen
with physiological stimuli or respiratory stimulant drugs,but have been
described with localised electrical stimulation of the brain stem
reticular formation in cats (Hugelin and Cohen, 1963).
Our results suggest that PGEj^ may have a selective action on a group
of neurones within the brain stem the effect of which is to inhibit the
irradiation of activity from respiratory to cardio-inhibitor and vasomotor
pathways.
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The effect of some prostaglandins on respiration in rats and cats
D. S. McQueen (introduced by E. W. Horton)
Department of Pharmacology, University of Edinburgh
It has been noted that certain prostaglandins can stimulate respiration in humans
(Bergstrom, 1967) and dogs (Said. 1967 ; McQueen & Ungar. 1969). This report
is on preliminary experiments performed on four cats and ten rats, anaesthetized
with pentobarbitone sodium 36 mg/kg, in order to investigate the actions of prosta¬
glandins on respiration.
Prostaglandins were administered by intravenous or intra-arterial infusion and
changes in respiratory rate, tidal volume, respiratory minute volume (RMV) and
mean arterial blood pressure during and following prostaglandin administration
were calculated. Figure 1 shows the response obtained following i.a. administration
of prostaglandin E1 (PGE,) to a cat.
The increases in RMV began about 15 sec after an infusion of prostaglandin and
the effect persisted for up to 5 min in both rats and cats ; PGEi, PGE2, PGA,, all
produced increases in RMV. PGF.,, and PGA, produced variable effects.
Bilateral vagotomy in cats and rats produced very little change in the size of the
respiratory response, and in two cats bilateral cutting of the sinus nerves after
vagotomy also produced no diminution in the respiratory response to prostaglandin
infusion. In one cat, blood pressure compensation (maintaining arterial blood
pressure within a few percent of the mean value) did not greatly affect the respiratory
response to PGE,.
Ganglion blocking drugs (hexamethonium bromide 1 mg/kg i.v. ; pentolinium
tartrate 0-2 mg/kg i.v.) reduced the respiratory effect following administration of
PGE, and PGE: in rats. In some rats the respiratory response to PGE2 was
reduced before that to PGE,.
It is concluded that prostaglandins can increase respiratory minute volume in
rats and cats, and that the mechanism of action does not appear to involve either
the arterial baroreceptors or chemoreceptors. The site of action may be within
the central nervous system.
fig. 1. Cat J 3 6 kg From above downwards the record shows: marker, i.a. administration of
I'GF,, 21 /ig/kg over a period of 30 sec; arterial blood pressure; one min time marker; and tidal
volume.
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THE EFFECTS OF PROSTAGLANDIN Ea, PROSTAGLANDIN Faa,
AND POLYPHLORETIN PHOSPHATE ON RESPIRATION AND
BLOOD PRESSURE IN ANAESTHETIZED GUINEA-PIGS
*
Daniel S. McQueen
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1 George Square, Edinburgh EH8 9JZ. Scotland.
(Received 19 October 1972; in final form 18 December 1972)
Summary
Prostaglandin Ej (PGEa) and prostaglandin Faa (PGFaa) Increased
respiratory rate when administered intravenously to anaesthetized
guinea-pigs. Polyphloretin phosphate (PPP) at a dose of
40 mg/kg i. v. did not markedly affect either the respiratory
response to PGEa or PGFaa nor the vasodepressor effect of PGEa.
The vasopressor effect of PGFaa was inhibited by PPP. This
evidence suggests that the respiratory stimulant property of
the prostaglandins is not affected by PPP.
Introduction
Polyphloretin phosphate (PPP), (1), antagonizes the effects of
prostaglandin Ea (PGE2) and prostaglandin F2<* (PGFaa) on certain smooth muscle
preparations (2). It antagonizes the bronchial and blood pressure changes
elicited by PGFa<* in the guinea-pig (3) and also protects this species against
anaphylactic convulsions (4).
PGEj and PGFaa are both capable of increasing respiratory rate in
anaesthetized rats and cats (5) and the present study was undertaken in order to
determine whether PPP could influence respiratory changes provoked by PGEj or
PGF2a in the guinea-pig.
* Present address: Department of Physiology, University of Utah,
Salt Lake City 84112, USA.
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Experimental Procedure
Eighteen male guinea-pigs of the Dunkin Hartley strain weighing between
550 and 840 g were used. The animals were fed on diet SGI (RHM Flour Mills
Ltd. , Leith, U.K.) with cabbage and water ad lib.
Anaesthetic
Two guinea-pigs were anaesthetized with urethane (ethyl carbamate
25% W/v aqueous solution; 1. 2 g/kg i. p.) and the remainder were anaesthetized
with pentobarbitone sodium (35 mg/kg i.p.). In most of the experiments it was
w
found necessary to use a local anaesthetic (procaine hydrochloride, 1% /v, 0.5 ml)
at the site of the neck incision. A dose of pentobarbitone sufficient to produce
surgical anaesthesia generally led to respiratory distress and the animals usually
died unless artificially ventilated. If the lungs were artificially ventilated, and
the animal survived, it could take as long as three hours after surgery before
spontaneous respiration was re-established; results obtained from these animals
were not used. There was a very small difference between the dose of
pentobarbitone which in conjunction with the local anaesthetic allowed surgery and
spontaneous respiration, and that which killed the animals.
Preparation of blood vessels
The animal was placed on a heated table and the trachea was cannulated.
The left jugular vein was cannulated with a nylon catheter and this catheter, linked
to a three-way tap, was used for intravenous drug administration. The left
carotid artery was cannulated with a nylon catheter and the catheter was
connected to a blood pressure transducer. Heparin (500 i. u./kg i.v.) was
administered to prevent blood clotting.
Vol. 12, No. 4 Polyphloretin-Prostaglandin Interactions 165
Recording procedure
The tracheal cannula was connected to a pneumotachograph head linked to
an integrating pneumotachograph (Model CS3c, Mercury Electronics Ltd. , Newton
Mearns, Glasgow, U.K.). A Palmer time clock (2112) reset the pneumotacho¬
graph every 10 seconds. A 'staircase' tracing was obtained on a pen recorder
which provided a breath by breath record of respiration, the overall height being
proportional to the respiratory volume in 10 seconds.
Blood pressure was recorded using a pressure transducer (Consolidated
Electrodynamics, L212) connected to the recorder, which was a Devices M4 hot-
stylus unit with DC2d pre-amplifiers (Devices Ltd. , Welwyn Garden City,
Herts., U.K.).
Drug administration
PGE2 or PGF2a* solutions warmed to 37°C were administered intravenously
by infusions of 30 seconds duration every 6-10 minutes using a pump (Model MRHE,
Watson Marlow Ltd. , Falmouth, Cornwall, U.K.). The stock prostaglandin
solutions were 1 mg/ml (in 10% ethanol/90% 0.9% W/v aqueous solution sodium
chloride) and these were stored at -20°C. A working solution of PGE2(10 pg/ml)
and PGF2a (30 pg/ml) was prepared freshly for each experiment by diluting the
w
stock solution with 0.9% /v aqueous sodium chloride.
One hundred mg PPP** was dissolved in 1 ml distilled water and this
solution was either injected over a period of 20 seconds or infused over 5-15 minutes.
The solution was re-used after storage at 4°C providing that it was no more than
5 days old.
* PGE2 and PGF2a were kindly supplied by Dr. J. E. Pike, Upjohn Co. ,
Kalamazoo, Michigan.
** Polyphloretin phosphate (PPP; Leo 101 k) kindly supplied by Dr. B. Hogberg,
A.B. Leo, Helsingborg, Sweden.
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Responses
From the trace obtained, blood pressure and respiratory measurements
were made Immediately before drug administration (0 seconds, control) and 10,
20, 40, 80, 160 and 320 seconds after the onset of drug administration. Changes
were expressed as percentages, the control values being 100%.
Results
Effects of PGEj and PGF2a
Both prostaglandins were found to be Individually capable of Increasing
respiratory rate and minute volume on Intravenous Infusion. A higher dose of
PGF2a was required to produce an Increase In respiratory rate comparable to
that provoked by PGEj. PGEj caused a marked reduction In blood pressure, while
PGF2a-caused a small blood pressure rise. The type of response obtained with
PGEj can be seen In Fig. 1, A, while that obtained with PGF2<* is shown In
Fig. l.C.
Effects of PPP
PPP (40 mgAg) was administered Intravenously, either as a single dose or
as divided doses over 5 minutes or more. Blood pressure fell and respiratory
rate Increased on PPP administration, this being particularly noticeable on single
dose administration, the effect produced being similar to that associated with
PGEj. In some experiments the blood pressure fell so low that the animal died.
After PPP had been administered and had exerted its effect, the control blood
pressure was slightly reduced and respiratory rate was slightly Increased when
compared with control values obtained before PPP administration. The blood
pressure and respiratory rate changes obtained In response to the Injection of
single doses of PPP (8 tests, 8 animals) are shown in Table 3.
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FIG. 1
Legend for Fig. 1: Record, from above downwards:- event marker; blood
pressure (0-100 mmHg calibration shown); one minute time marker; breath by
breath record of respiration showing respiratory volume every 10 seconds
(20 ml calibration shown).
A and B Pentobarbitone anaesthetized guinea-pig, 670 g. PGEj 12 fig/kg
infused at marker before (A) and 15 minutes after (B) PPP 40 mg/kg.
C and D Pentobarbitone anaesthetized guinea-pig 740 g. PGF2a
58 pgAg infused at marker before (C) and 15 minutes after (D)
PPP 40 mgAg.
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Respiratory rate responses to PGE2 and PGF2a were not significantly
affected by PPP at 40 mg/kg, It being Immaterial whether the prostaglandins were
administered 2, 10, 20, 60 or 100 minutes after PPP (see Fig. 1, B; Fig. 1, D).
The pooled results for PGEj (19 tests in 12 animals before PPP; 17 tests in
8 animals after PPP) and PGFaa (5 tests in 2 animals before PPP; 5 tests in
2 animals after PPP) are shown in Table 1 (respiratory rate) and Table 2
(blood pressure).
TABLE 1
Respiratory Rate Shown as the Mean Percentages - S. E. M. at Various Times After
the Onset of Prostaglandin Infusion (Control - 100%). PGEj (^.3 -1.3 /igAg Before
PPP 40 mgAg and 12 - 0.8 MgAg After PPP) and PGF2Qf (48 - 4 pgAg Before
PPP 40 mgAg and 54 - 1. 8 MgAg After PPP) Were Infused I. V. for 30 Seconds.
The Responses Obtained Were Submaximal.
Time(secs) PGEj PGEj after PPP PGF2a PGF2a after PPP
0 100 100 100 100
+ + + +
10 107 - 4.3 112 - 6.2 169 - 25 148 - 17
+ + + +
20 137 - 6.6 125 - 7.3 201 - 42 165 - 25
40 190 - 18 178 - 11 239 - 30 220 - 28
+ + + +
80 197 - 21 182 - 12 181 - 17 172 - 40
+ + + +
160 164 - 18 138 - 7.9 157 - 13 122 - 14
+ + + +
320 124 - 9.9 120 - 5.7 170 - 29 113 - 15
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TABLE 2
Blood Pressure Shown as the Mean Percentages - S. E. M. at Various Times After
Onset of Prostaglandin Infusion (Control = 100%). Other Details as for Table 1.
Time(secs) PGEz PGEj after PPP PGF2a PGF2a after PPP
0 100(56 mmHg) 100(49 mmHg) 100(49 mmHg) 100(45 mmHg)
10 98-1.5 97 i 1.6 99-1.5 101 - 2.6
20 89-2.3 92 - 2.4 102 - 3.1 103 - 3.1
40 65-3.7 64-2.8 115 - 4.7 101 - 4.5
80 60 - 3.7 63-3.6 112 - 12 101 - 5.4
160 60-4.3 65-4.2 99-8.1 104-6.5
320 68-3.8 79 ^ 4.3 88-4.3 106 - 2.9
Although the vasodepressor response to PGEj was not much affected by PPP
(the blood pressure recovered more rapidly), the Initial rise In pressure with
PGF2Qf was reduced In magnitude and the later fall (from 160 seconds on) was
prevented.
Higher doses of PPP (50-60 mg/kg) In divided doses over 5-15 minutes
invariably caused severe respiratory and blood pressure disturbances generally
terminating In the death of the animal.
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TABLE 3
Respiratory Rate and Mean Blood Pressure Shown as the Mean Percentages - S. E.M.
at Various Times After an Injection of 40 mg/kg PPP (Control = 100%).
Time(secs) Respiratory rate Blood Pressure
0 100 100(46 mmHg)
10 114 - 3.1 88-4.8
20 140 - 8.7 69-3.9
+
40 154 - 13 -4 0 1 cn o
80 142 - 9.1 55-4.9
160 100 - 14 60-7.9
320 95-6.6 90 - 13
Effect of anaesthetic agent
Two experiments were performed on guinea-pigs anaesthetized with
urethane. The respiratory and vascular responses to PGE^ were similar to those
obtained in pentobarbitone anaesthetized animals, both before and after PPP. The
respiratory rate of the urethane anaesthetized guinea-pigs was faster (65 breaths/
min) than the rate in pentobarbitone anaesthetized animals (35 breaths/min).
Discussion
In the present experiments both PGEj and PGFaa Increased respiratory
minute volume and respiratory rate following intravenous administration to guinea-
pigs anaesthetized either with sodium pentobarbitone or urethane. The
respiratory response of the guinea-pig to the prostaglandin infusions is thus
similar to that obtained in anaesthetized cats and rats (5) and differs mainly in
that PGF2a is less potent than PGEj in evoking the respiratory response.
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The blood pressure of guinea-pigs anaesthetized with either pentobarbitone
or urethane seemed low (mean 50 mmHg), but this pressure was routinely obtained
even in lightly anaesthetized animals, and is in accord with literature values (6).
PGEj lowered the blood pressure whereas PGF2a caused a pressure rise, as can
be seen in Fig. 1, C.
PPP on single dose administration (40 mg/kg) elicited a respiratory rate
increase and a fall in mean blood pressure (See Table 3). In three animals this
dose proved fatal, blood pressure falling to zero. PPP given by either single or
multiple doses did not markedly affect the respiratory or vascular responses to
PGEj as can be seen from Tables 1 and 2. The respiratory effect caused by
PGF2a was not much affected (Table 1) but the rise in blood pressure was reduced
(Table 2). The ability of PPP to antagonize the pressor effect evoked by PGF2a
in anaesthetized guinea-pigs has previously been reported (3) and confirms that the
PPP was active in the present investigation.
The conclusion that PPP does not appear to affect the respiratory rate
change provoked by either PGE2 or PGF2a, nor the blood pressure fall caused by
PGE^, is of Interest in that other workers (7) have also found PPP to be incapable
of blocking some responses to prostaglandin at dose levels similar to those used in
this investigation. Higher doses of PPP were tried, but respiratory distress and
very low blood pressure resulted in the death of the animals. It seems that
40 mg/kg of PPP is the highest dose which can be administered to an anaesthetized
guinea-pig if the animal is to continue breathing spontaneously.
The results obtained with PPP would seem to suggest that the respiratory
stimulating property of the prostaglandins is not secondary to actions at sites
where PPP antagonizes prostaglandin-induced changes.
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In conclusion, the experimental evidence shows that prostaglandins are
capable of stimulating respiration in a variety of species, even when the animals
are quite deeply anaesthetized by barbiturates. This effect of the prostaglandins
may have a clinical application.
This work was supported by a grant from the Medical Research Council.
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THE EFFECTS OF SOME PROSTAGLANDINS
ON RESPIRATION IN ANAESTHETIZED CATS
d.s. McQueen1
Department of Pharmacology, University of Edinburgh, 1 George Square, Edinburgh EH8 9JZ
1 Some prostaglandins have been found to be capable of affecting respiration in anaesthetized
cats.
2 Prostaglandins Elf E2, F2<*, Ai and A2 all elicited increases in respiratory frequency when
administered to cats anaesthetized with either pentobarbitone or a-chloralose. This effect was
abolished by bilateral vagotomy.
3 Prostaglandins of the E and A series, but not prostaglandin F2a, elicited increases in tidal
volume which were accompanied by falls in systemic blood pressure in cats anaesthetized with
pentobarbitone. The changes in blood pressure were also obtained in cats anaesthetized with
a-chloralose, but not the tidal volume changes.
4 It is unlikely that the prostaglandins influenced respiration by direct actions on arterial
chemoreceptors or baroreceptors.
5 Mechanisms by which the prostaglandins may be acting to affect respiration are discussed.
Introduction
Prostaglandins are known to be capable of influ¬
encing respiration. For example, in anaesthetized
dogs prostaglandin Ej has been observed to
increase respiratory rate (Maxwell, 1967; Hirose &
Said, 1971) and pulmonary ventilation (McQueen
& Ungar, 1969). Experiments in man (Carlson,
Ekelund & Oro, 1969) demonstrated that prosta¬
glandin Ei caused hyperventilation, the increase
being mainly due to increased tidal volume,
although increased respiratory frequency was
observed with higher doses. Other prostaglandins
have been found to affect respiration; both prosta¬
glandins E2 and Ai increase alveolar ventilation
(Said, 1968; Hirose & Said, 1971) while prosta¬
glandin F2o increases respiratory frequency but
decreases alveolar ventilation in anaesthetized dogs
(Said, Muren & Kirby, 1968). Prostaglandin F2a
also increases respiratory frequency in anaesthe¬
tized monkeys (White, Heaton & Denton, 1971).
It appears that no detailed investigation of the
respiratory changes induced by prostaglandins has
been performed and the object of the work
described here was to examine some prosta¬
glandins for respiratory effects in anaesthetized
cats. The respiratory and vascular responses of
anaesthetized cats to various prostaglandins are
described and some mechanisms whereby prosta-
1 Present address: Department of Physiology, University
of Utah, Salt Lake City, Utah 84132, U.S.A.
glandins may influence respiration are examined.
A preliminary account has been given of some
of the work described in this paper (McQueen,
1972).
Methods
Experiments were performed on 21 cats of either
sex weighing between 2.4 and 5.3 kg.
A naesthesia
Cats were anaesthetized either by an intra¬
peritoneal injection of pentobarbitone sodium (36
mg/kg body weight with supplements of 5 mg/kg
body weight given intravenously during the experi¬
ment as needed) or by an intraperitoneal injection
of a-chloralose, 90 mg/kg body weight. The
chloralose was dissolved in hot 0.9% w/v sodium
chloride solution (saline) and was cooled to body
temperature before injection.
Surgical procedures
In all animals the trachea was cannulated in the
neck. Rectal temperature was measured and main¬
tained at 37°C.
A femoral vein was cannulated with a nylon
560 d.s. McQueen
catheter, the catheter tip lying in the inferior vena
cava close to the junction of the venae cavae. This
catheter was used for the intravenous administra¬
tion of drugs and for the intravenous infusion of
prostaglandins.
The right femoral artery was cannulated with a
nylon catheter and this catheter was connected to
a blood pressure transducer.
The right carotid artery was cannulated at the
mid-cervical level with a nylon catheter, the
catheter tip being positioned in the ascending
aorta about 5 mm rostral to the aortic valves. This
catheter was used for the intra-aortic (i. aort.)
infusion of prostaglandins. The position of all the
catheters was confirmed during post-mortem
examination in each animal. In one cat one carotid
artery was cannulated both ways and blood drawn
from the lower carotid artery was pumped at
constant flow to the distal part of the same artery,
the contralateral carotid artery having been
occluded. Part of the head vascular system was
thus perfused at constant flow.
In two cats the left and right femoral arteries
were cannulated with short nylon catheters and
joined by a Y-piece to a blood pressure compen¬
sator. In another cat the abdomen was opened and
the abdominal aorta was cannulated between the
renal arteries and the inferior mesenteric arteries
and connected to the blood pressure compensator.
In cats in which a compensator was used, blood
pressure was recorded from a brachial artery. The
compensator used was as described by McQueen &
Ungar (1971).
In three cats, anaesthetized with pentobarbi¬
tone and artificially ventilated, the thorax was
opened by splitting the sternum in the mid-line.
The internal thoracic vessels were ligated. A nylon
catheter was positioned in a pulmonary vein via an
incision made in the left auricle. This catheter was
connected to a blood pressure transducer and a
record obtained of pulmonary venous pressure. A
similar catheter was positioned in the right ven¬
tricle via an incision made in the right auricle. This
catheter was connected to a blood pressure trans¬
ducer and a record obtained of right ventricular
pressure. Prostaglandins could be infused into
either of these catheters. The chest was closed, the
pneumothorax reduced, and the animal allowed to
breathe spontaneously. Results from these experi¬
ments were not incorporated with those obtained
in other experiments because the experimental
technique (opening and closing the thorax)
differed.
Both vagus nerves were dissected in the neck
and loops placed around them preparatory to
cutting. In two cats the carotid sinus nerves on
both sides were dissected and looped in prepara¬
tion for sectioning during the experiment.
R ecording procedure
In each experiment the tracheal cannula was
connected to a pneumotachograph head. In early
experiments the pneumotachograph was a Mercury
Electronics M3 micromanometer with a V2 con¬
tinuous integrator, a signal proportidnal to volume
being obtained. In later experiments a Mercury
Electronics CS3c integrating pneumotachograph
was used in conjunction with a Palmer time clock
(2112). A cumulative record of total volume
inspired over a period of 30 s was measured and
recorded on the pen recorder. A 'staircase' tracing
was obtained giving a breath by breath record of
respiration, with the overall height being propor¬
tional to the respiratory volume in half a minute.
Blood pressure
Arterial or venous blood pressure was recorded by
connecting a blood pressure transducer (Consoli¬
dated Electrodynamics, Type 4-326-L212) to a
catheter and recording the transducer output on a
pen recorder (1 mmHg = 1.333 mbar). All animals
were injected intravenously with 1000 i.u./kg
heparin to prevent blood clotting.
Blood flow
In two cats blood flow in a carotid artery was
monitored with an electromagnetic flow probe
(MDQ 7020 SCF 2 mm, Statham) connected to a
Statham Blood Flow meter (SP 2200). The meter
output was recorded by the pen recorder.
Blood gas analysis
In two cats blood from a cannulated femoral
artery was sampled before, during and after a
prostaglandin infusion. Pac02 pa02 and pH were
estimated by means of a Radiometer BMS 3 meter
with PHM 71, PHA 930, and PHA 931 attach¬
ments.
Recorder
A Devices M4 Hot-stylus recorder with DC2d
pre-amplifiers was used. Pens gave a frequency
response flat to 75 Hz.
Drugs
The following drugs were used, dissolved in saline
unless otherwise indicated:
Prostaglandins E) E2, F2tt, Ai and A2. Stock
solution of 1 mg/ml in 10% ethanol: 90% 0.9%
w/v aqueous sodium chloride kept frozen (-20°C)
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and diluted with saline before use. Working solu¬
tions of all the prostaglandins were 10 iig/ml. The
prostaglandins used were generously supplied by
Dr J.E. Pike of The Upjohn Company, Kalamazoo,
Michigan.
Atropine sulphate, histamine acid phosphate,
a-chloralose, sodium cyanide (B.D.H. Chemicals
Ltd), pentobarbitone sodium (Abbott Labora¬
tories Ltd), mepyramine maleate (May and Baker
Ltd), heparin B.P. (Weddel Pharmaceuticals Ltd),
propranolol (I.C.I. Ltd) and isoprenaline sulphate
B.P. (Boots Ltd).
The doses refer to the salts.
Drug administration
Drugs were either injected, or infused by means of
a Watson Marlow MRHE 200 pump. It was noted
during the course of the investigation that the
response to prostaglandins varied from animal to
animal, as did the frequency with which doses of
prostaglandin could be administered. In general, a
6 min cycle was followed for prostaglandins E,
and E2, with a 10 min time cycle for prosta¬
glandins A], A2 and F2a. The doses administered
provoked respiratory responses which were sub-
maximal.
Measurement of responses
The responses were measured at 60 s after the start
of the 30 s infusion. At this time a maximal
respiratory and vascular response was observed,
regardless of the dose of prostaglandin admini¬
stered.
The variables measured were respiratory minute
volume (RMV), respiratory rate or frequency (/)
and blood pressure (BP). Tidal volume (Ft) was
calculated from RMV and /. The results obtained
for each set of circumstances (i.e. type of prosta¬
glandin, route of infusion, whether or not vagoto-
mized) were pooled and are expressed as the mean
control value ± s.e. mean and the mean incre¬
mental change ± s.e. mean.
The dose is expressed as /ig/kg, this being the
total quantity administered over a period of 30 s
at a constant rate of infusion.
Statistical analysis
The null hypothesis that the incremental changes
observed were not different from zero was tested
using a paired t test on data obtained with
prostaglandins Ej and F2<». A t test was applied to
incremental changes obtained under different test
situations (e.g. i.v.: i. aort; before : after vago¬
tomy). The difference was said to be statistically
significant if P was less than 0.05.
Prostaglandins E2, A|, and A2 were found,
from a limited number of tests, to evoke changes
similar to those seen with Ei. Because the res¬
ponses to prostaglandin E] had been extensively
examined, further experiments with these other
prostaglandins were not performed.
Results
Prostaglandins Ef and F2a were investigated for
their ability to evoke respiratory changes. Prosta¬
glandins E2, Ai and A2 were found to be similar
to Ei in their ability to affect respiration, and the
results obtained with these prostaglandins will be
described qualitatively. Prostaglandins Ai and A2
were about twice as potent as Ei in eliciting
respiratory rate increases and hypotension. The
main difference between the E and A series was
that the latter caused sizeable falls in BP when
infused i.v., comparable with the effect seen on
i. aort. infusion of the same dose.
Prostaglandin E\
Data obtained from experiments with prosta¬
glandin Ei are summarized in Table 1. When
infused either i.v. or i. aort. prostaglandin Ei
evoked a dose-dependent increase in / and RMV;
Vt increased on i. aort. infusion but decreased on
i.v. administration. The change in / started about
10 s after the start of an i.v. infusion and
continued for the duration of the infusion, at least
up to 4 min which was the longest infusion period
studied. The rate increase was sometimes preceded
by one deep breath or by a period of respiratory
inhibition (Figure 1).
On i. aort. infusion prostaglandin Ei evoked an
increase in /, an increase in Vt and a fall in BP. The
/ increase started about 24 s after the start of the
infusion and the Ft increase was greatest at the
time when the hypotension was maximal
(Figure 2). The / increase obtained on Lv. admini¬
stration of prostaglandin Ei was significantly
bigger than that obtained on i. aort. administration
(P< 0.05) although smaller doses of prostaglandin
Ej were administered i. aort. before vagotomy in
order to avoid obtaining large vascular effects. In
those experiments in which equal doses were
infused by the two routes, the / response was
always greatest on i.v. infusion. The RMV increase
was greatest on i. aort. infusion (F< 0.01) and the
BP fall was greatest with L aort. infusions
(P< 0.01).
Bilateral vagotomy significantly reduced the /
increase (/'<0.01 for either route) but the K,




Fig. 1 Cat (male, 4.4 kg) anaesthetized with pentobarbitone. Prostaglandin E,, 12 pg/kg, infused over a period
of 3 minutes. Record, from above downwards: 1 min time marker; breath by breath record of respiration;
marker indicating period during which prostaglandin E, was infused.
present after vagotomy, although reduced in mag¬
nitude. The i. aort. RMV increase was significantly
reduced by vagotomy (P<0.01) and bilateral
vagotomy also resulted in prostaglandin E!
evoking a bigger depressor response (P< 0.05
pre/post vagotomy) although the response to L
aort. infusions was not significantly affected.
In two experiments measurements of Pac02
were made before and during the RMV increases
evoked by prostaglandin Ei infusions and it was
found that alveolar hyperventilation was occurring
since the P3co2 fell.
Prostaglandin F^a
Data obtained from experiments with prosta¬
glandin F2a are summarized in Table 2. Prosta¬
glandin F2a when infused Lv. increased respiratory
rate, this increase often being prolonged following
a 30 s infusion (Figure 3). No significant change in
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Fig. 2 Cat (male, 3.5 kg) anaesthetized with pentobarbitone. Prostaglandin E,, 0.9 pg/kg, infused i. aort. over a
period of 30 seconds. Record, from above downwards: event marker; arterial blood pressure; 1 min time marker;
breath by breath record of respiration, total height representing the respiratory volume in 30 seconds.
/ was observed on i. aort. infusion either before or
after vagotomy and there was no significant
change in Vt following prostaglandin F2Q admini¬
stration by either route, and vagotomy did not
alter this. Blood pressure fell slightly when prosta¬
glandin F2ct was infused i.v. but not when infused
i. aort. The / increase seen on i.v. administration
was markedly reduced after bilateral vagotomy
(P < 0.01).
Chloralose anaesthesia
A series of experiments was performed on cats
anaesthetized with a-chloralose in order to
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Fig. 3 Cat (female, 2.9 kg) anaesthetized with pentobarbitone. Prolonged response to an infusion of
prostaglandin F,a (4.1 pg/kg over a 30 s period) into the abdominal aorta. Record, from above downwards:
event marker; arterial blood pressure; 1 min time marker; breath by breath record of respiration, total height
representing the respiratory volume in 30 seconds.
!M /y7V / 250
Fig. 4 Cat (male 3.0 kg) anaesthetized with pentobarbitone, (a) Prostaglandin E,, 2.7 pg/kg, infused i. aort.
over a 30 s period; (b) prostaglandin E:, 2.7 pg/kg, infused i. aort. over a 30 s period, with blood pressure
compensator connected to the abdominal aorta. Record details as in Fig. 2, excepting that the mean blood
pressure is shown.
examine the possibility that the changes observed
in cats anaesthetized with pentobarbitone were
peculiar to the anaesthetic agent. Some of the
results obtained are summarized in Table 3. Prosta¬
glandin E| evoked an increase in respiratory rate
when administered either i.v. or i. aort. as did F2Q
i.v., and these increases were significantly reduced
after vagotomy (/*< 0.01). Vt fell on Lv. admini¬
stration, but there was no significant change when
the prostaglandin was infused i. aort. RMV was
not significantly affected by prostaglandin Ei i.v.,
but it was increased by E| or F2a administered
i. aort. BP fell when prostaglandin E! was infused
i.v. and a bigger fall was obtained when it was
infused i. aort. (P < 0.01). Prostaglandin F2Q did
not significantly affect blood pressure.
Blood pressure compensation
In three cats anaesthetized with pentobarbitone
the mean arterial blood pressure was compensated.
The results obtained are illustrated by Figure 4. BP
compensation reduced the increase in K, and a
larger increase in / was obtained. After bilateral
vagotomy BP compensation reduced the tidal
volume increment evoked by prostaglandin E) by
about 60%.
Blood flow to the head
When carotid blood was pumped to the head at
constant flow changes in respiration followed the
intravenous or intra-arterial (descending aorta)
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Fig. 5 Vagotomized cat (female, 3.6 kg) anaesthe¬
tized with pentobarbitone, showing the response to
prostaglandin E, (3.1 pg/kg infused over a 30 s
period) obtained before (stippled column) and after
















administration of prostaglandin Et; injection of
prostaglandin Ei into the head perfusion circuit
did not evoke any respiratory changes until the
prostaglandin had had time to recirculate. It
appears, therefore, that prostaglandins do not
affect respiration by actions within the vascular
territory perfused by the carotid arteries, and also
that even when part of the CNS is perfused at
constant flow, respiratory changes are still
obtained.
Experiments with an electromagnetic flow
probe positioned around a common carotid artery
revealed that flow in this vessel increased on i.v.
administration of prostaglandin E! but decreased
on i. aort. administration. Flow in the vertebral
arteries would be expected to follow the direction
of flow in the carotid arteries, and so it may be
concluded that blood flow to the CNS increases
during i.v. prostaglandin E| administration, even
though systemic blood pressure falls, and that
blood flow to the CNS falls during i. aort.
administration.
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Carotid sinus denervation
In two experiments on vagotomized cats anaesthe¬
tized with pentobarbitone the respiratory response
to prostaglandin E( was examined before and after
bilateral sectioning of the carotid sinus nerves. The
results obtained are illustrated by Figure 5. The
RMV increment was further increased following
sinus denervation and this was associated with a
larger fall in blood pressure and an increase in Vt.
The evidence argues against any direct activation




In three cats anaesthetized with pentobarbitone no
significant change in central venous pressure was
observed for any of the prostaglandins admini¬
stered by either the venous or arterial route.
Catheters were positioned in a pulmonary vein
and in the right ventricle in three cats. Pressure
recordings in the spontaneously breathing animals
showed no consistent change in right ventricular
pressure with prostaglandins E or A, although F2a
caused a rise in pressure. Pulmonary venous
pressure was reduced slightly by prostaglandin
F2Q, increased slightly by Ej and E2 and not
affected by Ai or A2 on i.v. infusion.
Infusions of prostaglandin into the right ven¬
tricle evoked respiratory changes similar to those
seen on i.v. administration, and infusion into a
pulmonary vein elicited a response akin to that
seen on i. aort. administration. The 'receptors' for
the / response seem therefore to be located in the
vascular territory between the right ventricle and
the larger pulmonary veins.
Blocking drugs
Mepyramine. It has been suggested (Willis, 1969)
that prostaglandin Ei may act in some situations
by releasing histamine from mast cells. In the
present work two experiments were performed on
pentobarbitone anaesthetized cats in which prosta¬
glandin E| was infused before and after 0.33
mg/kg mepyramine, a dose which blocked the
vascular response to injections of histamine. The
respiratory effect evoked by prostaglandin Et was
not markedly altered by mepyramine, thereby
suggesting that this prostaglandin does not pro¬
duce its respiratory effect via histamine release. It
is also unlikely that it acts by liberating 5-
hydroxytryptamine (Thompson & Angulo, 1969).
Propranolol. In two vagotomized cats anaesthe¬
tized with pentobarbitone, isoprenaline elicited an
increase in RMV, due mainly to increased Ft, and
a BP fall. Prostaglandin E, produced similar
effects, except that the RMV change was associ¬
ated with an f increase. Propranolol (0.25 mg/kg
i.v.) abolished the vascular and respiratory res¬
ponses to isoprenaline without altering the changes
evoked by prostaglandin E|. It is unlikely, there¬
fore, that prostaglandin Ei produces its effects by
actions, direct or indirect, at 0-adrenoceptors.
Discussion
Prostaglandins have been shown in the present
study to be capable of affecting respiration in
anaesthetized cats. The findings are in general
agreement with observations made in other species
(see Introduction).
The results obtained make it possible to elimi¬
nate certain potential mechanisms from involve¬
ment in the respiratory response to prostaglandin
administration. Thus, the respiratory stimulating
property of the prostaglandins examined did not
appear to be associated with actions at histamine
receptors or /3-receptors; indirect evidence suggests
that 5-hydroxytryptamine is unlikely to be
involved. Direct actions of the prostaglandins on
either the carotid baroreceptors or chemoreceptors
also appeared unlikely, and McQueen & Belmonte
(1974) have since confirmed this using electro¬
physiological techniques. The possibility that the
respiratory changes observed were secondary to
changes in bronchial structures was considered. It
is unlikely that the / change, the effect most
associated with the pulmonary system in the
present work, is secondary to changes in bronchial
tone because Hirose & Said (1971) demonstrated
that in dogs anaesthetized with pentobarbitone,
prostaglandin Ei evokes an increase in f without
altering dynamic lung compliance or airway resis¬
tance. However, it is possible that the cat may
differ from the dog in this respect.
It has not been possible in the present investiga¬
tion to determine how the prostaglandins elicit the
respiratory changes observed, but some evidence
has been obtained which implicates certain mecha¬
nisms and this will be discussed below in terms of
Vt and / changes.
Tidal volume
The results demonstrated that the tidal volume
increase was usually preceded by a fall in mean
blood pressure (see Figure 2). Prostaglandin F2a
which did not possess much depressor activity, did
not cause a significant increase in K,. Lowering the
BP by use of a compensator or a dilator drug such
as isoprenaline also increased Vt. The fall in BP
and the increase in F, were both greatest when the
prostaglandin (E or A series) was administered into
the ascending aorta. Results from experiments
with a blood pressure compensator (Fig. 4) suggest
that the BP fall evokes an increase in Ft, this
increase tending to mask part of the rate increase
elicited by the prostaglandin. It is known that a
reduction in blood flow to the CNS in cats
stimulates respiration, while an increase in flow
depresses respiration (Schmidt, 1928). A possi¬
bility is therefore that prostaglandins which
increase F, do so at least partly as a consequence
of reduced blood flow to the CNS, and this is
supported by the evidence that the Ft increase is
associated with reduced blood flow in the carotid
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artery. However, blood pressure reduction also
removes inhibitory tone from the baroreceptors
and such removal leads to an increase in respira¬
tion (Heymans & Neil, 1958). It will be necessary
to perform further studies in order to determine
the extent to which flow changes, removal of
inhibitory baroreceptor tone, or other mechanisms
contribute to the response.
It appears that the Vt changes are not seen in
animals anaesthetized with a-chloralose, although
the blood pressure fall is observed on prosta¬
glandin administration. The reason for this differ¬
ence between a-chloralose and pentobarbitone will
need further investigation.
Respiratory frequency
The / increase was observed with all the prosta¬
glandins examined, under both pentobarbitone
and a-chloralose anaesthesia. It was most apparent
on i.v. administration and took about 14 s longer
to develop on i. aort. administration. The region
from which the response appeared to be most
readily elicited lay between the right ventricle and
the large pulmonary veins. These observations,
coupled with the finding that the / response was
virtually abolished after bilateral vagotomy, sug¬
gests that the effect may be due to actions at a
sensory receptor with vagal afferents.
In the present study it has not proved possible
to establish the precise site and type of receptor
which may be involved in the / response. Daly,
Ludnay, Todd & Verney (1937) and Aviado, Li,
Kalow, Peskin, Turnbull & Hess (1951) described
receptors in the pulmonary venous system of dogs
which provoked an increase in respiratory rate
when activated by increased pulmonary venous
pressure. However, only slight and variable effects
on pulmonary vascular pressure were observed in
the present experiments. The possibility that
extensive changes in tone of pulmonary venules
might occur without this being reflected in
changes of pulmonary venous pressure should be
borne in mind.
The receptors described by Paintal (1955) are
unlikely to be involved because the delay in onset
of the / response after i.v. administration of
prostaglandin, 10 s, is longer than would be
anticipated for direct stimulation of these recep¬
tors, unless a prostaglandin metabolite is the active
agent.
It might be argued that bilateral vagotomy so
alters respiratory control that it becomes difficult
to establish whether prostaglandins are acting via
vagal afferents to affect f. Electrophysiological
experiments could be performed in order to
investigate directly the question of whether prosta¬
glandins affect pulmonary sensory receptors.
The possibility of prostaglandin actions within
the brain stem has not been excluded by the
present study and should also be investigated.
Respiratory changes can cause reflex alterations
through the lung inflation reflex (Scott, 1966).
When examining prostaglandins for effects in
whole animals it would seem advisable to note that
prostaglandins are capable of eliciting respiratory
changes.
This investigation was supported by a grant from the
Medical Research Council.
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THE EFFECTS OF PROSTAGLANDINS E„ A2 AND F2oi ON CAROTID
BARORECEPTORS AND CHEMORECEPTORS. By D. S. McQueen*,
and C. BELMONTEf. From the Department of Physiology, University of
Utah College of Medicine, Salt Lake City, Utah 84132.
(Received for publication 12thjune 1973)
The actions of prostaglandins E„ A, and F,a on the sensory receptors of the carotid
bifurcation have been investigated. Electrical activity of baroreceptor and chemo-
receptor fibres was recorded from the sinus nerve of anaesthetized cats. Prostaglandins
elicited alterations in blood pressure which were accompanied by changes in baro¬
receptor activity. Chemoreceptor spontaneous activity was modified by the injection of
prostaglandins; such variation did not occur in vitro and thus appears to be secondary
to changes in carotid blood flow. We have been unable to demonstrate any action of
the prostaglandins at the concentrations studied on baroreceptors or chemoreceptors
of the carotid bifurcation, apart from changes secondary to vascular effects.
There are reports based on indirect evidence which suggest that prostaglandins
can affect sensory receptors in the carotid artery. For example, Carlson and
Oro [1966] have proposed that prostaglandin Ej (PGEj) may have 'direct
actions on the carotid artery or on structures in this artery' to evoke reflex
vascular changes in dogs. Kaplan, Grega, Sherman and Buckley [1969] have
reported that in dogs part of the hypotensive response to PGEX administration
results from actions on the carotid sinus-body structures, most likely the baro¬
receptors. However, McQueen [1972] examined the respiratory and vascular
responses of the cat to various prostaglandins and concluded that it is unlikely
that either the carotid baroreceptors or chemoreceptors are directly involved
in the responses, but without electrophysiological evidence could not preclude
the possibility.
The object of this study was to establish directly whether prostaglandins
affect sensory discharges recorded from baroreceptor and chemoreceptor units
in the carotid sinus nerve of the cat. The results indicate that the observed
changes in baroreceptor and chemoreceptor activity are secondary to vascular
changes, and that prostaglandins in the concentrations studied do not affect
directly the sensory receptors of the carotid bifurcation.
Methods
Cats of either sex (2-0-2-7 kg) were anaesthetized with sodium pentobarbital (Dia-
butal, 40 mg/kg i.p.). A femoral vein was cannulated and used for drug administration,
the catheter tip lying in the mid-abdominal region. A cannula was inserted into the
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versity of Edinburgh, Scotland.
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trachea low in the neck and connected to a demand valve respirator (Ensco). Gall-
amine triethiodido (Flaxedil, 1 mg/kg) was administered i.v. to paralyse spontaneous
respiration. In some experiments a comparison of chemoreceptor activity, both
spontaneous and drug-induced, was made before and after gallamine administration.
The chemoreceptor discharges before gallamine were similar to those obtained after
administration of the drug and this is in agreement with other reports [see Torrance,
1968]. The animal was ventilated with air and the end-tidal C02 was continuously
monitored by an infra-red C02 analyzer (Beckman, LB-1), the PCOl being maintained
at 20-25 mm Hg (atmospheric pressure = 638-650 mm Hg) by adjusting the fre¬
quency and volume of respiration.
The carotid nerve and carotid body were dissected from surrounding tissues under
a binocular microscope. The ganglioglomerular nerves were cut and the carotid nerve
was sectioned centrally and placed on bipolar platinum-iridium electrodes for record¬
ing. Fine strands were dissected from the nerve trunk when recordings of single baro-
receptor or chemoreceptor units were required. Exposed tissues were covered with
warm mineral oil. The lingual artery on the same side as the sinus nerve from which
the recordings were to be made was cannulated, the tip of the catheter lying about
2 cm below the carotid bifurcation.
Sensory nerve discharges were amplified, displayed on an oscilloscope and recorded
on magnetic tape (frequency response, d.c. 2,500 Hz). The output of the channel
containing the action potentials was fed to a pulse height discriminator and a counter-
timer coupled with a digital-analog converter, the output from which was plotted on
a rectilinear recorder. The pulse height discriminator was used also in conjunction
with another counter unit (this one having variable time gates), in order to count the
number of baroreceptor impulses between successive R waves of the ECG. The counter
output was recorded as a 'staircase', each step representing one nerve impulse. A
femoral artery was cannulated and connected to a pressure transducer and a record
of arterial pressure obtained on the pen recorder and on tape. ECG was also recorded
on tape. The data stored on tape were later played back through the oscilloscope and
photographed. The rectal temperature of the cats was monitored and maintained at
37°C by use of a heating pad placed beneath the animal.
To study the isolated and superfused carotid body, the preparation described by
Eyzaguirre and Lewin [1961b] was employed. The supervision fluid was Locke's
solution with glucose (NaCl 6-0 g, KC1 0-42 g, CaCl2 0-24 g, glucose 1 g, Trizma base
6-0 g, normal HC1 39 ml., distilled water to 1 litre, pH 7-41 at 37°C) saturated with
100% 02.
The prostaglandins used were PGE2, PGA2, and PGF2a-tromethamine salt (M.W.
475-6). Each mg of E2 and A2 was prepared as the sodium salt by dissolving it in
0-1 ml. ethanol with the subsequent addition of 0-9 ml. aqueous sodium chloride
(0-9% w/v). The PGF2„ salt was water soluble but 0-1 ml. ethanol/mg was added.
The stock solutions (1 mg/ml.) were kept frozen (—20°C) and working solutions of
20 /xg/ml. prepared by diluting an aliquot of stock solution with Locke's solution.
Prostaglandins were injected either intravenously or via the lingual catheter into the
carotid artery over a period of 5-15 sec. An interval of 8 min was allowed to elapse
between successive injections.
For the in vitro experiments prostaglandins were prepared in Locke's solution
containing glucose to a final prostaglandin concentration of 10 pg/ml. This fluid,
saturated with 100% 02, was used to replace the Locke's solution which superfused
the carotid body during control periods. The prostaglandin solutions superfused the
preparation for up to 10 min. Prostaglandins (1 mg/ml.) were also applied locally
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to the carotid body in the in vitro studies: 10 /xl. (containing 10 /xg) of solution could
be applied directly onto the carotid body. NaCN (5 /xg in 10 /xl.) was also applied
directly onto the carotid body in order to stimulate the chemoreceptors. For the in




Records ofelectrical activity were obtained from carotid sinus nerves in five
cats. Filaments containing either single or multiple active units were studied.
The multi-unit recordings offer the advantage that they give a general indication
of the pattern of response of the preparation. Separation of individual units
was made by using the pulse height discriminator (see Methods). A total of
eight baroreceptor filaments (three cats) and 15 chemoreceptor filaments
(four cats) which contained only single or a few active units were studied, each
fibre being recorded over a period of from 1 to 6 hr.
Baroreceptors
Baroreceptors were identified by their synchronous discharge with the arterial
pressure oscillations [Heymans and Neil, 1958]. The prostaglandins were
injected either intravenously or into the carotid artery in order to examine
their effect on spontaneous baroreceptor activity.
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Fig. 1. Baroreceptor unit recorded from a filament of the carotid sinus nerve. The recording
shows, from above downwards: nerve activity, blood pressure, number of impulses in
each cardiac cycle. A is a control recording. B is 2-5 sec after the start of an injection of
pge2 (8 fig) into the lingual artery. C and D are 30 sec and 3 min respectively after the
injection. There is a respiratory fluctuation in blood pressure. The vertical bar is the blood
pressure calibration (from 50 to 150 mm Hg) and the horizontal bar represents 1 sec.
PGE2 (1-5-7-4 pg/kg i.v.; 0-7-3-0 pg/kg i.a.) evoked a dose-dependent reduc¬
tion in the number of baroreceptor impulses per cardiac cycle when administered
by either route. This reduction occurred with approximately the same latency,
15-20 sec, after onset of injection for both routes and was paralleled by a dose-
dependent reduction in arterial blood pressure. When a correlation was made
vol. lxx, no. 1 - 1974 6
66 McQueen and Belmonte
between the onset of the pressure fall and the decrease in baroreceptor activity,
it was clear that the decrease in baroreceptor activity followed beat to beat
the reduction in pressure. Figs 1, 2 and Table I show the parallelism between
arterial blood pressure changes and the alteration in baroreceptor firing
sequence together with the absence of any direct effect of the prostaglandins
on nervous activity (i.e. during the first 2-10 sec following close-arterial injec¬
tion, see Fig. 1). Similar observations were made with PGA2 (0-7-1-5 pg/kg i.v.
or i.a.), the only difference being the lower doses required to elicit similar
effects (PGA2 being about 2-3 times more potent than PGE2).
Fig. 2. Baroreceptor unit recorded from a filament of the carotid sinus nerve. Reoord details
as for Fig. 1. A is a control recording. B is 25 sec after the i.v. injection of PGE, (8 /ig)
and C is 3 min later.
Table I. Baroreceptor counts per second (c.p.s.) averaged over 10 sec from a single unit
after injection of prostaglandin into the carotid artery (i.a.) or intravenously (i.v.).
Blood pressure is in mm Hg.
At time of Three minutes
Before maximal B.P. after maximal
prostaglandin change B.P. change
PGE2 4 pg i.a.
4 pg i.v.
PGA2 2 pg i.a.
2 pg i.v.
PGFj„ 8 pg i.a.
8 pg i.v.
B.P. c.p.s. B.P. c.p.s. B.P. C.p.8,
109 37 74 11 105 33
100 30 68 9 105 32
110 29 70 10 102 24
91 25 55 6 111 29
115 37 105 27 114 36
105 33 112 42 105 33
PGF^ when injected i.a. (1-5-6-0 pg/kg) caused no constant changes in blood
pressure or in baroreceptor discharge frequency. When administered i.v.
(3-0-11 pg/kg) a transient rise in arterial pressure often occurred and this was
associated with an increase in baroreceptor discharge (see Table I and Fig. 3).
It appeared that the increased discharge frequency was secondary to the
pressure rise because in animals where the blood pressure fell slightly, so did
the discharge frequency.
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Fig. 3. Baroreceptor unit recorded from a filament of the carotid sinus nerve. Record details
as for Fig. 1. A is a control period, B is 25 sec after the i.v. injection of PGFa« (30 /xg)
and C is 3 min after the injection. There is a respiratory fluctuation in blood pressure.
Chemoreceptors
Chemoreceptor units were identified by their aperiodic pattern of discharge
[Biscoe and Taylor, 1963] and their increase in impulse frequency with hypoxia
or when NaCN was injected into the carotid artery.
PGE2 (0-4—8-0 jUg/kg) was injected into the carotid artery and the chemo¬
receptor discharge was reduced, this reduction occurring about 5 sec after
the onset of the injection and before blood pressure changes were seen. Although
the reduction in discharge frequency was dose-dependent, higher doses were
associated with a shorter-lasting reduction which was sometimes followed by
an increased chemoreceptor discharge and a fall in systemic blood pressure.
Fig. 4. Chemoreceptor unit recorded from a filament of the carotid sinus nerve. The recording
shows, from above downwards: blood pressure, number o£ impulses in every 0* 1 sec, nerve
activity. A is a control period, B is 10 sec after the injection of sodium cyanide (10 /xg) into
the lingual artery. C is a further control period before the injection of PGEa (4 /xg) into
the lingual arter}', D, and E is 3 min after the prostaglandin injection. Horizontal bar
represents 1 sec and the vortical bar is the blood pressure calibration (from 50 to 150
mm Hg).
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The reduction could be up to 90% of control values; it was not attributable to
the injection volume because injection of the same volume of Locke's solution
produced a transient reduction of chemoreceptor discharge seen only during
the first 5 sec following injection (Fig. 4).
PGE2 when injected i.v. (1-6-8-0 jag/kg) caused a dose-dependent increase
in the chemoreceptor discharge with a latency of about 20 sec, the discharge
frequency sometimes doubling. The increase in chemoreceptor discharge was
paralleled by a fall in blood pressure, and the bigger the pressure reduction,
the bigger was the increase in chemoreceptor discharge. Lowering the blood
pressure by withdrawing venous blood caused an increase in chemoreceptor
discharge (see Table II).
Table II. Cat 1-9 kg. Increase in chemoreceptor discharge from a multiple chemoreceptor
fibre in response to cumulative 2 ml. venous blood withdrawals. The discharge
was averaged over 10 sec at the point when the systemic B.P. was lowest.
Total
blood withdrawn Mean B.P. Discharge







PGA2 evoked responses similar to those seen with PGE2, although lower
doses were used (0-7-1-5 pg/kg i.v. or i.a.).
PGF2tI (1-5-8-0 pg/kg) injected into the carotid artery sometimes elicited a
slight increase in chemoreceptor discharge, and at other times a slight decrease.
These changes were not dose-dependent and were associated with small and
variable changes in systemic blood pressure. PGF2a (1-6-11 ^ig/kg) when
injected i.v. caused either a small increase or decrease in blood pressure or no
change at all. When the pressure fell the chemoreceptor discharge increased,
and when the pressure rose the discharge decreased.
In vitro experiments
In order to establish whether the changes in chemoreceptor activity following
prostaglandin administration were due to variations in carotid body blood
flow, experiments were performed on five isolated and superfused carotid
bodies from three cats. The chemoreceptor units exhibited a low frequency
spontaneous discharge during superfusion with oxygenated Locke's solution
and no change in discharge pattern could be detected during or after superfusion
for 10 min with Locke solution containing either PGE2 or PGF2„, 10 pg/ml.
Local application of 10 pg PGE2 (10 p.1.) to the carotid body did not affect
the discharge, whereas 5 pg sodium cyanide (10 /xl.) similarly administered
before and after PGE2 elicited an increase in discharge (Fig. 5).
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Fig. 5. Isolated superfused carotid body preparation from a 2-7 kg cat. The record shows nerve
activity recorded from a filament of the carotid sinus nerve. A and C are control record¬
ings and B shows the response 10 sec after the injection of sodium cyanide (5 fig) onto
the carotid body. D is the response 60 sec after the injection of PGE, (10 fig) on to the
carotid body. Horizontal bar represents 1 sec.
Discussiok
Our results suggest that PGE2, PGA2 and PGF2:i, at the doses used, do not
affect directly the baroreceptor activity of the carotid sinus, and that the
observed changes hi impulse frequency are secondary to variations in arterial
pressure elicited by these substances. If the pressure changes resulted from a
reflex initiated by a direct action of the prostaglandin on the sensory mechan¬
ism, then changes in baroreceptor activity should have preceded the pressure
changes, but this was not the case.
In our in vivo experiments the ganglio-glomerular nerves were sectioned in
order to avoid prostaglandin-induced changes in sympathetic activity altering
the chemoreeeptor discharge frequency. The sympathetic supply to the cat
carotid body exerts only a slight influence on chemoreceptor activity during
normal conditions [Floyd and Neil, 1952; Eyzaguirre and Lewin, 1961c] so it
is not possible to say whether flow through the carotid body was affected by
sympathetic denervation—one might predict a slight increase in flow. During
hypotension an active sympathetic supply to the carotid body increases
chemoreceptor activity [Floyd and Neil, 1952] and so our preparation would be
expected to show less chemoreceptor activity during hypotension.
Changes in systemic blood pressure are accompanied by changes in carotid
body blood flow in the cat [Daly, Lambertsen and Schweitzer, 1954] and it
has been shown that hypotension in cats elicits a marked increase in chemo¬
receptor discharge [Landgren and Neil, 1951; Floyd and Neil, 1952], Biscoe,
Bradley and Purves [1970] used a perfused carotid sinus preparation and
showed that lowering the perfusion pressure evoked an increase in chemo¬
receptor discharge, but that this was transient. We have found (see Table II),
in agreement with Eyzaguirre and Lewin [1961a], that in cats with ganglio-
glomerular nerves sectioned hypotension causes an increase in chemoreceptor
discharge.
Administration of prostaglandins in the whole animal led to a change in
chemoreceptor activity, but such alterations could not be obtained in vitro.
The superfused carotid body preparation has been used to determine whether
effects on ehemorcceptor activity seen in vivo are secondary to vascular changes
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[Zapata, Hess, Bliss and Eyzaguirre, 1969]. Our observations suggest that the
variations in chemosensory activity elicited by the prostaglandins in the whole
animal are evoked by changes in the carotid body blood flow.
PGE2 is slightly less potent than PGEj in evoking respiratory and vascular
effects in cats, but both are qualitatively similar [McQueen, 1972; unpublished
observations], PGE2 and PGA2 dilate systemic vessels [Horton, 1969] and
such an action could explain the decrease in chemosensory activity produced
by close arterial injection; blood flow to the carotid body would be increased.
On the other hand, when a more general vasodilatation is obtained, as occurs
on i.v. administration, an increase in chemoreceptor activity, secondary to the
reduction in blood flow that accompanies the decrease in arterial pressure,
could be expected.
PGF2i caused variable changes in blood pressure, in some animals a rise in
pressure being observed, in others a fall. The effect obtained depended upon
the route of injection and the dose injected as well as on the particular animal;
the reason why PGF^ evoked different responses was not investigated. The
impression that the alterations in chemoreceptor and baroreceptor discharge
frequency were secondary to vascular effects was confirmed by the results from
in vitro experiments.
Thus, our results suggest that prostaglandins do not affect directly either
the baroreceptors or the chemoreceptors of the carotid region, and so appear
contradictory to those of Kaplan et al. [1969]. The difference in experimental
species studied could be advanced as a possible explanation for the lack of
agreement. However, by a different interpretation of the data it is possible to
reconcile our observations. Kaplan et al. evidently had high chemoreceptor
activity in their preparations, because sinus denervation resulted in a fall in
mean blood pressure (see their Figs 2 and 3, also Table I) instead of the increase
that usually occurs after bilateral carotid nerve sectioning (Heymans and Neil,
1958). Increased chemoreceptor activity in dogs leads to increased sympathetic
tone to the blood vessels and a blood pressure rise (McQueen and Ungar, 1971).
If our evidence that prostaglandins do not affect the baroreceptors directly is
accepted, then the fall in blood pressure in the experiments of Kaplan et al.
can be explained by the reduction in chemoreceptor input to the central
nervous system following the close arterial injection of PGEj due to dilatation
of carotid bodyblood vessels resulting in increased blood flow through the carotid
body. This effect would not be seen after denervating the carotid sinus region.
To conclude, we have been unable to demonstrate in our preparations any
direct action of the prostaglandins, at the concentrations studied, on the baro¬
receptors and chemoreceptors of the carotid region. Modification of chemo¬
receptor activity is observed following prostaglandin administration, but this
appears to be associated with vascular effects, both locally within the carotid
body and systemically.
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The effects of ouabain on carotid chemoreceptor activity in the cat
By D. S. McQueen and J. A. Ribeiro. Department of Pharmacology, University of
Edinburgh, Edinburgh El18 9JZ
It is not clear whether ouabain increases (e.g. McLain, 1970) or decreases (Joels &
Neil, 1968) chemoreceptor activity, so the present study was undertaken to investi¬
gate further its effects on the cat carotid chemoreceptors.
Experiments were performed on pentobarbitone-anaesthetized cats which were
artificially ventilated and paralysed with gallamine (3 mg kg-1 i.v.). Chemoreceptor
activity was recorded from the peripheral end of a sectioned sinus nerve and quanti¬
fied (McQueen, 1977); the ganglioglomerular (sympathetic) nerves were left intact.
Drugs were dissolved in Locke solution and either injected or infused into the
ipsilateral common carotid artery (i.e.).
Ouabain was given either as successive injections (0-625, 1-25, 2-5, 5, 10, 20, 40,
80 fig in volumes of 0-1 ml. i.e., every 20-25 mill) or as a continuous infusion (3 fig
in 0-1 ml. min-1 i.e.). Its effect could be divided into two components, an initial
excitation followed by a decrease in chemoreceptor activity. Injections of ouabain
caused a dose-related increase in discharge lasting 1-2 min and a gradual increase in
spontaneous discharge. When about 80 fig had been injected spontaneous discharge
began to decrease, sometimes very rapidly, and further injections of ouabain were
less effective; ultimately discharge ceased entirely. Infusions of ouabain caused a
gradual increase in discharge frequency until about 20-30 fig had been infused when
discharge began to decrease, eventually ceasing. The depression lasted for at least
2-3 hr after stopping the infusion.
Responses to the stimulants NaCN (5 fig i.e. or 50 fig I.v.), C02 (0-3 ml. i.e. C02-
saturated Locke), acetylcholine (ACh, 50 fig i.e.) and to the inhibitor, dopamine
(5 /ig i.e.), were determined after injections and during infusions ofouabain. Responses
to NaCN, C02 and ACh increased during the early excitatory period and were greatly
reduced during the later period when discharge was decreasing. The effect of dop¬
amine persisted during the excitatory period and was potentiated during the period
of reduced discharge.
These results indicate that ouabain can both increase and then reduce the activity of
the carotid chemoreceptors. During the excitatory phase chemoreceptor sensitivity
to stimulants is increased, whereas during the later phase of decreasing discharge
sensitivity to stimulants is reduced and that to inhibitors is increased.
This work was supported by an M.R.C. project grant . J.A.R. is on loave from tho Institute
Gulbenkian do Ciencia, Oeiras, Portugal.
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Excitatory action of adenosine on cat carotid chemoreceptors
By D. S. McQueen and J. A. Ribeiro. Department of Pharmacology, University of
Edinburgh, 1 George Square, Edinburgh EH8 9JZ
There do not appear to be any reports concerning the action of adenosine on cat
carotid chemoreceptors. In view of the suggestions that adenosine may play a role
in neurotransmission (e.g. Ribeiro, 1979), it seemed of interest to study the effect of
adenosine on cat carotid chemosensory activity.
Experiments were performed on pentobarbitone-anaesthetized cats (42 mg kg-1
i.p. supplemented every 1-2 h). The animals were artificially ventilated with air and
paralysed with gallamine (3 mg kg-1 i.v.). Chemoreceptor activity was recorded from
the peripheral end of a sectioned sinus nerve (McQueen, 1977); the ganglio-glomerular
(sympathetic) nerves were usually cut. Drug solutions were injected into the
ipsilateral common carotid artery (i.e.) over a 2 s period.
Adenosine (0-01-100 fig I.e.) caused a rapid and marked increase of spontaneous
chemoreceptor discharge (e.g. Fig. 1), the intensity, duration and onset of which was
dose-dependent. Theophylline (01-1 mg i.e.), an adenosine antagonist (see Fredholm,
1980), decreased spontaneous chemoreceptor discharge but did not significantly alter
the excitatory action of adenosine.
I 1
Fig. 1. Recording of a single chemoreceptor unit illustrating the response to adenosine
(1 /tg i.e.). Panel shows from above downwards: action potentials, injection marker and
10 s calibration.
Responses to the stimulants NaCN (2-5 or 5 pg i.e.), C02 (03 ml i.e. C02- saturated
Locke), acetylcholine (ACh, 50 pg i.e.) and to the inhibitor, dopamine (DA, 5 pg i.e.),
were determined before and after adenosine injections, and expressed as ALx
(McQueen, 1977). Responses to NaCN and C02 were slightly and variably decreased
after adenosine whereas both the excitatory response to ACh and the inhibitory
response to DA were increased.
These results indicate that adenosine increases spontaneous chemoreceptor activity
and facilitates the action of both ACh and DA on the carotid chemoreceptors.
This work was supported by an M.R.C. project grant J A R. is on leave from the Instituto
Gulbenkian de Ciencia, Oeiras, Portugal
[ P.T.O.
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EFFECT OF ADENOSINE ON CAROTID CHEMORECEPTOR
ACTIVITY IN THE CAT
d.s. McQueen & j.a. ribeiro'
Department of Pharmacology,University of Edinburgh, 1 George Square, Edinburgh EH8 9JZ
1 The effects of intracarotid (i.e.) injections or infusions of adenosine on chemoreceptor activity
recorded from the peripheral end of a sectioned carotid sinus nerve have been studied in cats
anaesthetized with pentobarbitone.
2 Adenosine injections (0.1 -100 pg) caused a rapid and marked increase of spontaneous
chemoreceptor discharge, the intensity, duration and onset of which was dose-dependent. Infusion
of adenosine, 50 pg/min, also evoked an increase in discharge which persisted for the duration of the
infusion.
3 Both theophylline (1 mg i.e.) and aminophylline (1 mg i.e.) caused short-lasting decreases in
spontaneous discharge but did not prevent the excitatory effect of adenosine. Theophylline
increased the excitatory action of adenosine.
4 Naloxone (400 pg i.e.) antagonized the depressant effect of morphine on chemoreceptor
discharge but not the excitatory action of adenosine.
5 It is concluded that exogenous adenosine can excite the cat carotid chemoreceptors, an effect
which is not prevented by theophylline in the doses studied. The physiological significance of the
findings is discussed.
Introduction
There do not appear to be any reports concerning the
action of adenosine on peripheral arterial
chemoreceptors. In view of the suggestions that
adenosine may play a role in neurotransmission (e.g.
Ribeiro, 1979), it seemed of interest to study the
effect of adenosine on cat carotid chemosensory ac¬
tivity. A preliminary account of some of this work has
been presented to the Physiological Society (Mc¬
Queen & Ribeiro, 1981b).
Methods
Experiments were performed on 20 cats of either sex
weighing between 2.4 and 3.4 kg (median 3.1 kg).
The animals were anaesthetized with pentobarbitone
sodium (42 mg/kg i.p. initially, supplemented by i.v.
administration of 10% of the initial dose every 1 to
2 h), artificially ventilated and paralysed by gal-
lamine triethiodide (3 mg/kg i.v.). The ganglio-
glomerular (sympathetic) nerves were usually cut.
Full details of the experimental techniques, including
the recording of arterial blood pressure and monitor¬
ing and regulation of arterial blood gas tensions and
pH, have been given previously (McQueen, 1977;
Docherty & McQueen, 1978).
1
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Electrical activity of chemoreceptor units (1 to 6
units) was recorded from filaments of the peripheral
end of a sectioned sinus nerve, passed through a pulse
height (window) discriminator, and quantified with
the aid of a PDP-8 computer.
A catheter was introduced via the lingual artery
into the common carotid artery ipsilateral to the sinus
nerve from which activity was recorded and advanced
until its tip lay about 2 cm caudal to the carotid
bifurcation. In some experiments a second catheter
was positioned in the same common carotid artery,
this time via the superior thyroid artery, and used for
infusing drug solutions (0.1 ml/min).
Drugs were dissolved in modified Locke solution
(McQueen, 1977) or 0.9% w/v aqueous sodium
chloride (saline). Drug solutions (0.1 ml, except
adenosine lOOpg which was in 0.2 ml) were injected
into the common carotid artery and washed in with
0.2 ml Locke solution which had been bubbled with
5% CO2: 95% air in a water bath at 37°C; injections
were made over 2 s.
Results obtained from different experiments were
pooled and expressed as the mean ± s.e. mean of the
absolute values, which varied from experiment to
experiment according to the number of units re¬
corded. In order to determine whether changes ob¬
served were statistically significant, particularly when
such changes were small, responses to particular drug
©Macmillan Publishers Ltd 1981
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doses in the different experiments were compared
with the corresponding responses to the drug vehicle
in the same experiments using either the Wilcoxon
signed ranks test (when the number of pairs > 7) or
Student's paired t test (for < 6 pairs, and assuming
Gaussian distribution). The null hypothesis was re¬
jected if P<0.05 and the difference between groups
was considered statistically significant.
Drugs used were: adenosine, theophylline,
aminophylline (Sigma); morphine sulphate, pen¬
tobarbitone sodium, gallamine triethiodide (May &
Baker); naloxone hydrochloride (Endo).
Results
Injections of adenosine
The effectsof intracarotid injection of different doses
of adenosine on spontaneous chemoreceptor dis¬
charge in one experiment are illustrated in Figure 1.
Discharge for each test was averaged over 10 s
periods starting 10s before and continuing for 60s
after the injection. As can be seen from either the
neurograms or the averaged discharge, the main
effect of adenosine was a dose-dependent increase in
the frequency of discharge. No tachyphylaxis to the
action of adenosine was observed. Thus, when in¬
jected at intervals of 5 min over a period of 1 h, there
was no diminution of the effect on spontaneous
chemoreceptor discharge.
Low doses of adenosine (0.001 to 0.01 pg) caused
a decrease in chemoreceptor discharge during the
first 10 s following the injection (see Figure 1), an
effect which appeared to be most pronounced for the
lowest dose. However, an inhibition of spontaneous
discharge was also usually associated with injection
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Figure 1 Effects of intracarotid (i.e.) injections of adenosine on the frequency of spontaneous chemoreceptor
discharge, (a) Neurograms taken from one experiment show the increase in the discharge of a single unit (insert, i)
caused by injecting (arrow) adenosine 0.1 (ii) and 1 pg (iii); in (i) the duration of the action potential is shown, the
trace being of 10 consecutive superimposed spikes, (b) Responses of the chemoreceptor unit to i.e. injection of (i)
0.3 ml of the Locke solution and to adenosine: 0.001 pg (ii); 0.1 pg (iii) and 1 pg (iv).The graphs show the amplitude
and duration of the responses averaged over 10s periods following the injections.















5 0 10 20 30









Figure 2 Effects on spontaneous chemoreceptor dis¬
charge of injecting Locke solution 0.3 ml (i) and
adenosine 0.1 pg (ii); I pg (iii); lOpg (iv) and I OOpg (v).
Discharge was averaged over 5 s periods following the
injection. Data obtained from tests in 8- 10 cats were
pooled and presented as the mean with vertical bars
indicating s.e.mean. The lower panel shows the effect on
arterial blood pressure (BP) of injecting (arrow) lOOpg
of adenosine in one experiment. ' P< 0.05 compared
with Locke solution injections; **P<0.05 compared
with pre-injection control discharge; tP>0.05 com¬
pared with adenosine lOOpg.
(see Figures 1 and 2), so responses to the low doses of
adenosine were studied in five cats (results not
shown) and compared with responses to injectionsof
Locke solution (0.3 ml). There was no significant
difference (P> 0.05) between the responses to
adenosine and Locke solution in these experiments.
Data obtained from ten experiments were aver¬
aged over 5 s periods for 30 s after the injection,
pooled and plotted against time (Figure 2). This
quantitative evidence confirmed that the increase in
both amplitude and duration of the discharge were
dose-related. The peak of the discharge, averaged
over 5 s periods, for all doses (0.1 -100 pg) occurred
between 5 and 10 s after the injections, and that
caused by 0.1 pg was not significantly different from
that caused by the highest dose studied, lOOpg
(P> 0.05, n= 8 pairs). Injections of Locke solution
were also made in these experiments and the results
obtained are summarized in Figure 2. They confirm
the transient inhibitory effect of Locke solution illus¬
trated in Figure 1. A significant decrease in discharge
occurred during the first 5 s following the injection
(P<0.05, ti= 10, compared with the pre-injection
averaged discharge). This was less marked and not
statistically significant in the next 5 s (P> 0.05), and
thereafter discharge returned to the pre-injection
control levels.
Results from four experiments in which both aver¬
age discharge and maximum discharge, expressed as
ct/s, were obtained for different doses of adenosine
are compared and summarized in Table 1. The aver¬
age spontaneous chemoreceptor discharge was de¬
termined in the 15 s pre-injection control period
immediately preceding each injection and in the 15 s
post-control period commencing 45 s after the injec¬
tions. Responses to adenosine were evaluated by
determining the average discharge in the period dur¬
ing which discharge was increased above control
frequency. Apart from increasing the average dis¬
charge, adenosine also increased the maximum dis¬
charge frequency. This latter increase, however, was
not so marked as that averaged over the whole
period, showing that the overall increase in discharge
caused by adenosine resulted from a sustained in¬
crease throughout the response rather than from a
sudden transient increase, such as occurs with acetyl¬
choline (ACh) (cf. McQueen, 1977). The duration of
the adenosine response was dose-dependent, and the
delay to onset of the response was inversely related to
dose.
The effects obtained were not related to changes in
systemic blood pressure since adenosine in the doses
studied (0.001 to 100 pg) did not cause any consistent
or substantial changes in arterial blood pressure, as
can be seen from Figure 2. There were no changes in
arterial blood gas tensions or pH following administ¬
ration of adenosine.
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Theophylline (1 mg) was given as an intracarotid
(i.e.) injection in five cats and caused a decrease in
spontaneous chemoreceptor discharge, an effect
which lasted for about 30 s. The integrated response
(A£x) showed that the depression was significantly
greater (P< 0.05) than that caused by injecting
Locke solution. Although theophylline transiently
decreased spontaneous chemoreceptor discharge
(Figure 3), it did not prevent the excitatory action of
adenosine, and as can be seen in Figure 4, the log
dose-response curve to adenosine was shifted up¬
wards and to the left which is indicative of an increase
in the responses after theophylline; the response to
adenosine 100 pg was statistically significantly grea¬
ter after theophylline than it was before (P<0.05,
n = 4).
Injections of lower doses of theophylline
(100-200 jig) did not cause any significant effect on
the spontaneous discharge (P>0.05, n=3 pairs),
and the excitatory effect of adenosine (1-100 pg)
was unaltered by these doses (P> 0.05, n= 3 pairs).
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Figure 3 Effect on spontaneous chemoreceptor dis¬
charge of injecting theophylline 1 mg i.e. (heavy line,
) compared with that of injecting Locke solution
(0.3 ml) (thin line, ). Discharge was averaged over
10s periods following the injection. *P<0.05, n= 5
pairs. The upper panel shows the effect on arterial blood
pressure of injecting (arrow) 1 mg of theophylline in one
experiment.






Figure 4 Dose-response data for adenosine obtained
before (•) and after (■) theophylline (1 mg i.e.) in four
experiments. Doses (jig i.e.) are plotted on a logio scale
and chemoreceptor responses expressed as the mean
A Ex for the four experiments; vertical lines show
s.e.mean. AX x was calculated as the response during the
30s following the injections. (AXx = Xx-x.t, where
X x is the number of action potentials counted during the
response of duration ts, a 'response' being defined as
lasting from the first substantial change from back¬
ground discharge frequency (x ct/s) until return to back¬
ground level.) Lines were fitted to the data by the
mfethod of least squares. Averaged values ± s.e.mean
(ct/s) for the pre-injection (15 s) control periods are as
follows: adenosine 1 pg 4.5 + 1.0 before theophylline,
6.5 ± 1.4 after theophylline; adenosine 10 pg 5.5 ± 1.4
before, 7.8+1.7 after, adenosine 50pg3.5 ± 1.1 before,
5.2±1.4 after; adenosine lOOpg 3.9+1.7 before,
5.1+2.0 after. •/><0.05.
and the effect of adenosine (1 -100 pg) tested before
and after the injection. A transient depressant effect
similar to that seen with theophylline was observed,
and the excitatory action of adenosine was also undi¬
minished after aminophylline.
Neither theophylline (Figure 3) nor aminophylline
caused any marked changes in blood pressure and the
highest dose of adenosine did not alter arterial blood
pressure when injected after theophylline.
Naloxone
Four experiments were performed to investigate the
influence of naloxone (0.4 mg i.e.) on chemoreceptor
responses to adenosine and morphine. The
adenosine results were pooled and are shown in
Figure 5. No statistically significant difference was
detected between the pre- and post-naloxone re¬
sponse (P> 0.05). In two of these experiments mor¬
phine (10- 100 pg i.e.) was injected before and after
naloxone (Figure 5). A chemodepressant effect of
morphine was obtained in accordance with previous
observations (McQueen & Ribeiro, 1980). This de¬
pressant effect of morphine was converted to an
excitatory one by naloxone.
Infusions of adenosine
Adenosine, infused at a rate of 50 pg/min for 2 min in
two cats, caused a sustained increase in chemorecep¬
tor discharge, which returned to pre-infusion control
levels within 30 s of stopping the infusion (Figure 6).
The peak response was significantly different from
the control, whether this was taken as the pre-
infusion discharge or the discharge averaged during
an infusion of a Locke solution (0.1 ml/min). The
infusion of Locke solution did not affect spontaneous
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Figure 5 (a) Dose-response data for adenosine ob¬
tained before (•) and after (■) administration of nalox¬
one (400 pg i.e.) in four experiments. Doses (pg i.e.) are
plotted on a logio scale and chemoreceptor responses
expressed as the mean AXx for the four experiments;
vertical lines show s.e.mean. A£x was calculated as the
response during the 30 s following the injections. For
details see Figure 4. Lines were fitted to the data by the
method of least squares. Averaged values (ct/s) for the
pre-injection (15 s) periods ± s.e.mean were as follows:
adenosine 1 pg 4.5 ± 2.1 before naloxone, 5.7 ± 2.6 after
naloxone; adenosine lOpg 4.2±1.4 before, 6.7±1.5
after; adenosine lOOpg 6.5 ± 1.3 before, 5.0 ± 1.9 after,
(b) Effects of morphine (lOOpg i.e.) on chemoreceptor
discharge before (i) and after (ii) naloxone (400 pg i.e.)
in one experiment. Discharge was averaged over 10 s
periods following the injection.

























Figure 6 Pooled data from 6 infusions of adenosine
(50fjg/min) in 2 cats showing the effect on spontaneous
chemoreceptor discharge. The broken line represents
the typical discharge during an infusion of Locke solu¬
tion (0.1 ml/min). The upper panel shows a blood pres¬
sure trace recorded during one of the adenosine infu¬
sions. * P <0.05.
associated with changes in arterial blood pressure, as
can be seen from Figure 6.
Discussion
The results show that the predominant effect of
injecting or infusing adenosine close-arterial to the
cat carotid chemoreceptors is an increase in spon¬
taneous discharge frequency.
In many preparations exogenous adenosine de¬
creases the release of neurotransmitters (e.g. ACh
(Ginsborg & Hirst, 1972; Ribeiro & Walker, 1975;
Vizi & Knoll, 1976;Gustafsson, Hedqvist, Fredholm
& Lundgren, 1978); noradrenaline (Hedqvist &
Fredholm, 1976; Verhaeghe, Vanhoutte &
Shepherd, 1977; Wakade & Wakade, 1978),
dopamine (Michaelis, Michaelis & Myers, 1979) y-
aminobutyric acid (Hollins & Stone, 1978)). If
adenosine exerts a similar action in the carotid body,
its excitatory effect could be interpreted as being the
consequence of decreased release of an inhibitory
transmitter and/or modulator. Dopamine (Chioc-
chio, Biscardi & Tramezzani, 1966; Zapata, Hess,
Bliss & Eyzaguirre, 1969) and enkephalins (Lund-
berg, Hbkfelt, Fahrenkrug, Nilsson & Terenius,
1979; Wharton, Polak, Pearse, McGregor, Bryant,
Bloom, Emson, Bisgard & Will, 1980) appear to be
present in the cat carotid body and both exogenous
dopamine (Zapata, 1975; Docherty & McQueen,
1978) and the enkephalins (McQueen & Ribeiro,
1980; 1981a; McQueen, 1981) depress spontaneous
chemoreceptor activity. Osborne & Butler (1975)
suggested that tonically released dopamine may sup¬
press chemoreceptor discharge and although evi¬
dence which is not in agreement with their hypothesis
has been obtained (e.g. Docherty & McQueen,
1978), the present results could be explained in terms
of adenosine inhibiting the release of dopamine, or
some other substance which is tonically active in
inhibiting discharge (? enkephalins).
However, it has also been found that adenosine can
excite nerve cells. For example, Siggins, Gruol, Pad-
jen & Forman (1977) showed that adenosine de¬
polarizes neurones of explanted amphibian sym¬
pathetic ganglia, and Bleehen & Keele (1977) de¬
scribed algogenic actions of adenosine on the human
blister base. It appears that adenosine sensitizes the
carotid chemoreceptors to ACh and dopamine (Mc¬
Queen & Ribeiro, 1981b) which might be construed
as evidence that adenosine acts directly on the post¬
synaptic component of the carotid body chemosen-
sory synapse, i.e. on the sensory nerve ending. An
adenylate cyclase-cyclic AMP system is apparently
located in the sinus nerve endings (Fitzgerald, Rogus
& Dehghani, 1977) and it may be that adenosine
interacts with this in a manner similar to that de¬
scribed for the brain (e.g. Davies, Taylor, Gregson &
Quinn, 1980). Further investigation is needed to
explore this possibility.
Theophylline appears unable to prevent activation
of P2-purinoceptors. These receptors, as so far de¬
scribed, seem to be localized post-junctionally (see
Burnstock, 1978). De Mey, Burnstock & Vanhoutte
(1979) found that in the canine saphenous vein,
theophylline antagonizes the inhibitory effect of ATP
on neurogenic responses but not its direct contractile
effect. According to these authors this suggests the
presence of both inhibitory presynaptic (P]) and
excitatory postsynaptic (P2) receptors. In the present
study the excitatory effect of adenosine was unaf¬
fected by low doses of theophylline (0.1 -0.2 mg) but
potentiated by a slightly higher dose (1 mg), a finding
that is compatible with a P2-excitatory post¬
junctional effect. However, the potentiation might
also have resulted from theophylline antagonizing a
chemodepressant component of the adenosine re¬
sponse, which might normally be masked by the
excitatory component, or from mechanisms having in
common the ability to increase the cyclic AMP con¬
centration (e.g. theophylline by inhibiting phos¬
phodiesterases, and adenosine by activating the
adenylate cyclase).
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It has also been proposed that the inhibitory action
of morphine may involve the release of adenosine as
an intermediary (Sawynok & Jhamandas, 1976;
Stone & Perkins, 1979), and it has been shown that
morphine and enkephalins can inhibit spontaneous
carotid chemosensory discharge in the cat (McQueen
& Ribeiro, 1980; 1981a; McQueen, 1981). How¬
ever, naloxone reduces the inhibitory effect of mor¬
phine without reducing the excitatory response to
adenosine, so the effects of adenosine do not appear
to result from actions on naloxone-sensitive opiate
receptors in the carotid body.
Adenosine can cause vasodilatation (see Berne,
Foley, Watkinson, Miller, Winn & Rubio, 1979) and
we cannot, therefore, preclude the possibility that
adenosine was changing blood flow in the carotid
body and thereby, perhaps, altering chemoreceptor
discharge, even though it had little overall effect on
the systemic blood pressure. However, other vas¬
odilators (e.g. sodium nitrite, sodium nitroprusside:
Docherty, 1980) tend to cause a delayed decrease in
discharge, which is the opposite of the main effect
obtained following adenosine injections in the pres¬
ent experiments. We consider it unlikely that vascu¬
lar effects are responsible for the greater part of the
response to adenosine, but would wish to investigate
this with in vitro carotid body studies.
Adenosine is released into the circulation by a
number of physiological and pathophysiological pro¬
cesses (e.g. ischaemia; see Winn, Rubio & Berne,
1979), and a correlation between adenosine concent¬
ration and oxygen supply in rat brain has been sug¬
gested (Rubio, Berne, Bockman & Curnish, 1975).
In the present study, low doses of adenosine modified
chemoreceptor discharge and it seems reasonable to
speculate that adenosine might influence events tak¬
ing place in the carotid body, perhaps by modulating
any putative transmitter(s) which may be released
within the carotid body complex, and/or by directly
activating sensory nerve endings.
We gratefully acknowledge the financial support of the
Medical Research Council and the technical assistance of
Mrs S. Bond.
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SUMMARY
1. The effects of infusions of ouabain on chemoreceptor activity recorded from the
peripheral end of a sectioned carotid sinus nerve were studied in cats anaesthetized
with pentobarbitone.
2. Ouabain caused a marked increase in chemoreceptor discharge followed by a
decline in discharge to frequencies near or below the pre-ouabain level; during the
latter period further administration of ouabain had no effect.
3. Infusion of ouabain during hypoxia further increased the chemoreceptor
discharge, but this effect was short-lasting.
4. On intracarotid administration ouabain was less effective in cats with the
ganglioglomerular (sympathetic) nerves cut, whereas on intravenous administration
no significant difference was observed. Following intravenous administration of
ouabain the chemoreceptor peak discharge occurred with dose levels similar to those
needed to cause cardiac arrhythmias, but following intracarotid administration the
chemoreceptor discharge peaked at doses about 40% of those causing arrhythmias.
5. During ouabain-induced excitation the stimulatory action of NaCN, C02-
equilibratcd Locke solution and acetylcholine was potentiated, as was the chemo-
inhibition induced by dopamine. During the post-excitatory period the responses
evoked by these substances were reduced or abolished.
6. Neither mecamylamine, a nicotinic antagonist, nor physostigmine, an anti¬
cholinesterase, affected the response of the carotid chemoreceptors to ouabain.
7. The major finding of this study was that ouabain initially ' sensitizes' the carotid
body chemoreceptors and then 'desensitizes' them. The most likely mechanism
responsible for these effects is the well established Na+—K+-ATPase-inhibiting
property of ouabain.
INTRODUCTION
There are several reports concerning the effects of ouabain, a cardiac glycoside, on
carotid body chemoreceptor activity. For example, neural traffic recorded from the
carotid sinus nerve is increased by ouabain (McLain, 1970), although this includes
baroreecptor as well as chemoreceptor activity. Joels & Neil (1968) found that the
increase in chemosensory discharge evoked by perfusing vascularly isolated cat
* Present address and correspondent*: Institute Gulbenkian de Ciencia, 2781 -Oeiras, Portugal.
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carotid bodies with nitrogenated solutions is reduced by ouabain. Some, but not all
carotid body type I cells in vitro are depolarized by ouabain (Eyzaguirre, Baron &
Gallego, 1977).
We considered that, in order to establish the effects of ouabain on carotid
chemoreceptors in situ, further experiments were needed. Accordingly, we performed
a quantitative neuropharmacological investigation in cats; a preliminary report on
some' of the results from the study has been made to the Physiological Society
(McQueen & Ribeiro, 1980).
METHODS
The experimental details have previously been described fully (McQueen, 1977) and only a brief
summary follows. Experiments were performed on twenty-three cats ofeither sex weighing between
2-4 and 3-7 kg (mean 3-0+ 01 kg), anaesthetized with pentobarbitone sodium (42 mg/kg I.P.)
supplemented every 1-5-2 h by intravenous administration of 10% of the initial dose. The animals
were artificially ventilated with room air and paralysed with gallamine triethiodide (3 mg/kg I.v.,
supplemented every 1-1-5 h). Blood pressure was recorded from a femoral artery, and electro¬
cardiogram monitored throughout the experiment. The bladder was drained at regular intervals
and the rectal temperature maintained at 38 + 0-5 °C. End-tidal CO, was continuously monitored by
an infra-red CO, analyser (Med 1 A; Grubb Parsons) and the Ph COl, Pa,Dl and pH of femoral arterial
blood samples measured using a gas monitor (BMS 3 with PHM 71 meter, Radiometer).
Drug injections (Ol ml) were made into the common carotid artery ipsilateral to the sinus nerve
from which activity was being recorded, and washed in with 0-2 ml modified Locke solution which
had been bubbled with 5% CO,/95% air in a water bath at 37 °C. The injections were completed
over a 2 s period commencing at the peak of the inspiratory phase of the respiratory cycle. In two
cats successive injections of ouabain (1-25-160 /ig i.e.) were made every 15-25 min. However,
difficulties associated with interpreting the results from these pilot experiments led to the use of
ouabain infusions as described in Results. Drug infusions were made through a second catheter
situated in the common carotid artery at its junction with the superior thyroid artery (through
which the catheter was introduced) using an infusion pump (Ol ml/min; Braun Unita). The
catheter dead-space was 0-2 ml.
A sinus nerve was cut and electrical activity from single or multiple (two to six) chemoreceptor
units was recorded from filaments of the peripheral nerve using bipolar Pb-Ir electrodes. In thirteen
cats the ganglioglomerular (sympathetic) nerves were cut. Exposed tissues were covered with warm
(37 °C) mineral oil. Sensory nerve discharge was amplified by an a.c. amplifier (Neurolog), displayed
on an oscilloscope and recorded on one channel of a tape-recorder (Tandberg 115; frequency
response d.c. to 1250 Hz), and subsequently analysed with the aid of a microcomputer (Commodore
3032) in order to provide data concerning discharge frequency. The average (x counts/s) and total
counts (Ex) were calculated from each response after its duration (I seconds) had been determined.
Responses were expressed as a change from control level by subtracting the appropriate control
or background discharge (i.e. as AXx). Data from different experiments were pooled and the results
presented as the mean ±s.e. ofmean. When recording simultaneously from both carotid sinus nerves
another a.c. amplifier and a second channel of the tape-recorder were used.
Statistical analysis
The significance of differences between means was calculated using Student's paired or unpaired
t test ; P values of 0 05 or less were considered to represent statistically significant differences.
Drugs
Drugs were prepared in modified Locke solution (McQueen, 1977). Doses referred to are those
of the salts.
The drugs used were: sodium pentobarbitone, gallamine triethiodide (May & Baker), acetylcholine
iodide, sodium cyanide, atropine sulphate (B.D.H.), dopamine hydrochloride (Koch Light) and
ouabain octahydrate (Sigma)
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RESULTS
A typical response of the carotid chemoreceptors to an intracarotid infusion of
ouabain (3/ig/min) in a cat with intact gangliogloraerular nerves is shown in










Fig. 1. Neurograms illustrating the effect on chemoreceptor discharge of an infusion of
ouabain (3 /ig/min i.e.) in a cat with intact ganglioglomerular nerves, (i) Pre-infusion
(control) discharge; (ii) 10, (iii) 14, (iv) 16, (v) 25, (vi) 27, (vii) 30 min after starting an
infusion; (viii) 1 min after stopping the infusion. The broken line at the bottom of the
Figure is the time calibration in seconds.
in which ganglioglomerular nerves remained intact were pooled and are shown in
Table 1 (p. 228). Before starting a ouabain infusion, NaCN (5 fig) was injected via
the superior thyroid and lingual catheters and the chemoreceptor responses were
compared, in order to determine whether catheter position had any appreciable effect
on the amount of drug reaching the chemoreceptors. No significant differences were
detected in relation to the discharge evoked or the duration of response; the mean
time to onset of response was greater by 0-7 s for the thyroid catheter, though this
was not statistically significant (P > 0-05, paired t test).
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Infusion of the drug vehicle (Locke solution, 0-1 ml/min) via the superior thyroid
artery (control experiment) did not cause any appreciable changes in the frequency
of spontaneous chemoreceptor discharge (Fig. 2). In contrast, an infusion of ouabain
(3/tg/min I-c-) 'ed to an increase in chemoreceptor discharge. Discharge increased





Fig. 2. Effect of a ouabain infusion (3/ig/min i.e.) on chemoreceptor discharge in a cat
with intact ganglioglomerular nerves. The ordinates are the computed averages of the
number of chemoreceptor action potentials. The abscissa shows the time at which the
averaging began. A, Locke infusion (01 ml/min); #, discharge before or after ouabain
infusion; O- during ouabain infusion. The up[>er part shows the mean femoral arterial
blood pressure (b.r.) recorded concurrently. h.r. calibration 0-100-200 mmHg. The mean
values (three determinations) for Pa 0|, COl and pH determined before ouabain infusion
(at about the peak discharge) were: f\ 0, 12-5 kPa; Pa COl 4-2 kPa; pH 7-37. During
ouabain infusion they were: Ps,0, '2-6 kPa; cGl 3-9 kPa; pH 7-34.
increase was consistent in all experiments. Thereafter, the discharge rose and 3-5 min
later a sudden and marked increase occurred which was followed by a decline, with
discharge returning to a level of the same order or slightly below that recorded before
starting the ouabain infusion. The discharge remained at this reduced level after
stopping the infusion. Chemoreceptor discharge was followed post mortem in five
animals in which death had been caused by ouabain. During the 10-40 min after
cardiac arrest the chemoreceptors continued to discharge, although the frequency
tended to decay during these periods.
Fig. 2 also shows the mean femoral arterial blood pressure (b.p.). The over-all effect
ofouabain was to cause an increase in mean b.p. which began to be apparent 5-10 min
after starting the infusion. The averaged b.p. recorded at the time of peak discharge
for the seven experiments was 175+ 12 mmHg, whereas the control (obtained before
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starting ouabain infusion) was 142+11 mmHg (see Table 1). The difference,
33 + 8-3 mmHg, was statistically significant (P < 0 05, paired t test).
Under the present experimental conditions (extracellular recordings) no substantial
modification ofeither the amplitude or duration of the action potentials was detected
during ouabain infusions. The effects of ouabain were not a consequence of changes
o 10 20 30 40 50 60
Time (min)
Fig. 3. Effect on spontaneous chemoreceptor discharge (counts/s) of three consecutive
ouabain infusions (3/tg/min i.e.), during 10 min periods represented by the horizontal
bars, in a cat with intact ganglioglomerular nerves. Recordings from two or three
chemoreceptor units. Note the increase in the discharge after stopping the first ouabain
infusion, the decrease in the intensity and duration of the excitation during the second
infusion and the absence of effect during the third infusion.
'n 'a,o,> 'a,co, or pH °f blood since no substantial changes in these parameters
occurred during ouabain infusions in samples taken at the peak of the chemoreceptor
response. Values for P& Qj, P& COj and pH of the blood were as follows: P& Qj 12 0+ 0 4
kPa before and 12-1 +0-3 kPa during ouabain infusion; P& COj 4-0 + 0-2 kPa before and
4-2 + 01 kPa during infusion; pH 7-34 + 002 before and 7-30 + 002 during infusion
(n = 7).
The general pattern of chemoreceptor discharge was not markedly different when
counting either single or multiple units (two to six) from multi-unit recordings,
although in one experiment a single unit stopped discharging sooner than the other
units, which may be an indication of differential sensitivity to ouabain.
In an attempt to test whether the action of ouabain on chemoreceptor activity
could be related to a vascular mechanism, namely vasoconstriction caused by ouabain
infusion (Treat, Ulano & Jacobson, 1971), two experiments were performed in which
the ouabain infusion (3 //g/min i.e.) was stopped after 10 min. The results from one
of these experiments are shown in Fig. 3. The excitatory action of ouabain occurred
K pity
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after stopping the infusion, the effect being similar to that observed in experiments
in which the ouabain infusion was continued. Fig. 3 also shows the effect of a further
two infusions, each of 10 min duration, the first separated from the second by 20 min
and the third from the second by 10 min. The second infusion induced a short-lasting
increase in the chemoreceptor discharge and the third caused little or no effect on
discharge. Following the last infusion no chemoreceptor responses were obtained to
further ouabain infusions or to substances such as NaCN (5 fig i.e.), C02-equilibrated
Locke solution (0-3 ml i.e.), acetylcholine (ACh: 50 fig i.e.) or dopamine (5 fig i.e.)
(see section below on evoked responses during uninterrupted ouabain infusions).
Time (min)
Fig. 4. Effect on chemoreceptor discharge of hypoxic stimulation (breathing 10%
02/90% Nj), followed by 100% Nt, and then by hyperoxia (100% 0,) during an infusion
of Locke solution (0-1 ml/min i.e.) in a cat with intact ganglioglomerular nerves. After
discharge returned to a steady level on breathing air, ouabain (3 /zg/min i.e.) was infused.
The duration of the Locke infusion is indicated by the thin horizontal bar, that of the
ouabain infusion by the thicker bar. Recordings obtained from one or two chemoreceptor
units.
Comparison between the response of chemoreceptors to hypoxia and, to ouabain
In order to compare the response of chemoreceptors to hypoxia with that to
ouabain, an experiment was designed in which Locke solution was infused (0-1 ml/min
i.e.) and the animal made hypoxic by breathing 10% 02/90% N2. As a result of this
procedure peak chemoreceptor discharge occurred about 5 min after switching to the
hypoxic gas mixture and discharge remained elevated throughout the period of
hypoxic stimulation (30 min). Thereafter the hypoxic stimulus was intensified by
ventilating the cat with 100 % N2 for 90 s and a further increase in the discharge was
then observed (Fig. 4). On switching to breathing 02 (100%) for the next 60s
chemoreceptor discharge returned to a level below that recorded before starting the
hypoxic procedure. This protocol was an attempt to mimic the pattern of discharge
observed during ouabain infusions. After spontaneous discharge returned to a steady
level, which occurred after 10 min of air-breathing, an infusion of ouabain (3 /zg/min)
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was initiated. The glycoside caused an increase in discharge (Fig. 4) with the same
pattern as that described previously (see e.g. Fig. 2).
The effect of ouabain during hypoxia
The effect of ouabain (3 /zg/min infused i.e.) during hypoxic stimulation (animal
breathing 15% 02/85% N2) is illustrated in Fig. 5. An infusion of Locke solution was
used as control and the hypoxic stimulation applied in its presence. Within 5 min
Time (min)
Fig. 5. Kffect of a ouabain infusion (3 /ig/min i.e.) on chemoreceptor discharge evoked
by hypoxic stimulation (15% 02/85%X,) is illustrated in the right-hand side of the Figure.
The left-hand side shows the effect of a hypoxic stimulus (15% 0,/85 % N2) on spontaneous
chemoreceptor discharge in the presence of a Locke solution infusion (0-1 ml/min I.e.)
in a cat with intact ganglioglomerular nerves. The duration of the Locke infusion is
indicated by the thin horizontal bar, that of the ouabain infusion by the thicker bar.
Recordings obtained from one or two chemoreceptor units.
of switching to the hypoxic gas mixture chemorcceptor discharge increased to a level
which was sustained throughout the hypoxic stimulation period (30 min). Thereafter
the discharge returned to the pre-hypoxia levels. The hypoxic stimulus was again
applied, and when a steady chcmoexcitatory response had been obtained an infusion
of ouabain was begun. Under these conditions ouabain caused a slow increase in the
discharge during the first 10 min after starting the infusion which was followed by
a short-lasting peak (= 120 s), and a decay in chemoreceptor discharge to slightly
below the pre-infusion level.
The influence of the ganglioglomerular (sympathetic) nerves on the effects of ouabain on
chemoreceptors
Table 1 summarizes the results of investigations into the influences exerted by
ganglioglomerular nerves on chcmoreccptor responses to ouabain. Ouabain was
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administered by either intravenous or intracarotid infusion. For each route of
administration a comparison was made between cats with either intact or cut
ganglioglomerular nerves. It is evident that the mean dose of ouabain required to
increase chemoreceptor discharge maximally when the ganglioglomerular nerves were
cut is significantly greater (p < 0 05) than in cats with the nerves intact (Table 1).
Such a dose difference, however, was not detected when ouabain was infused
intravenously and recordings obtained from intact and denervated (opposite side)
carotid bodies of the same animal in three experiments (Table 1). The increase in
discharge during intravenous infusion was, however, significantly greater on the side
with intact ganglioglomerular nerves.
Table 1. Influence of the ganglioglomerular (sympathetic GG) nerves on the effects of ouabain on
chemoreceptor discharge
Pre-ouabain Ouabain effect Dose at bp. (mmHg)
control at the peak the peak -
Experimental conditions (counts/s) (counts/s) (/<g/kg) Control At the peak
Ouabain i.e. Group 1, 7 31 17-2 18-7 142 175*
GG intact ±1-1 ±3-6 ±1-8 ±11 ±12
Group 2, 6 2-2 16-9 36-8** 141 179*
GG cut ±0-8 ±3-2 ±3-5 ±9 ±10
Ouabain i.v.f Left side, 3 50 55-0 67-9
GG intact ±0-5 ±9-7 ±11-3 165 219*
Right side, 5-5 36-0*** 65-6 ±18 ±17
GG cut ±0-9 ±11-4 ±16-8
Data expressed as mean + s.e. of mean.
* P < 0-05, paired t test compared with control.
** P < 0 05, paired t test compared with group 1.
*** P < 0-05, t test compared with left side GG intact.
f Recordings from both carotid sinus nerves (left and right sides) were obtained concurrently.
Ouabain was infused at the same rate as i.e. (3 //g/min i.v.). Lingual arteries of both sides were
cannulated.
Cardiotoxic actions of ouabain
The doses of ouabain required to cause maximal chemoreceptor discharge are
shown in Table 1. Comparing these doses with those needed to cause ventricular
extrasystoles when administered by the intracarotid route (64 + 5 pg/kg, n = 3) or
intravenously (69 + 2 pg/kg, n = 6: Peres-Gomes & Ribeiro, 1979) showed that with
intracarotid ouabain a significant difference (p < O05) exists between chemoreceptor
activation and cardiotoxic doses, whereas little or no difference is apparent between
chemoreceptor activation and cardiotoxic effect when ouabain is administered
intravenously.
Evoked responses
Intracarotid injections of NaCN (5 pg), C02-equilibrated Locke solution (0-3 ml),
ACh (50 pg) and dopamine (5 pg) were made before and during ouabain infusions
(3 pg/m\n i.e.). These doses evoked ehemoreceptor responses which were supra-
threshold but sub-maximal. In Fig. 6 the times at which injections of these substances
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10 min periods over which the chemoreceptor discharge was averaged. Since no
substantial differences were detected in the responses evoked by these substances in
cats with intact ganglioglomerular nerves and those in which they had been cut,
responses evoked in both populations were pooled.
Sodium cyanide, CO^-equilibrated Locke solution and acetylcholine. The chemoexci-
tatory responses evoked by NaCN, C02 and ACh were enhanced during the increase







20 40 60 0 20
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Fig. 7. Effects of ouabain (3 //g/min I.e.) on chemoreceptor discharge in two different cats.
A. response to ouabain infusion performed after pre-treatment with physostigmine
(1 mg/kg I.e.). Recordings obtained from two or three chemoreceptor units in a cat with
the ganglioglomerular nerves cut. li, response to ouabain after pre-treatment with
mecamylamine (5 mg/kg i.e.). Recordings obtained from four to six chemoreceptor units
in a cat with intact ganglioglomerular nerves. The infusions of ouabain started at time
0. Dextran was administered intravenously to prevent falls in b.p. occurring following
mecamylamine injection.
phase in which discharge returned to pre-infusion (control) levels, or to levels below
control. However, the decrease in the ACh responses was not so accentuated as that
associated with either NaCN or C02 (Fig. 6).
Dopamine. The chemoinhibition evoked by dopamine was enhanced during the
increase in spontaneous chemoreceptor discharge induced by the ouabain infusion and
was decreased during the subsequent decline in discharge (Fig. 6).
Physostigmine and mecamylamine.. Ouabain releases ACh from both central and
jieripheral nerves (seeGillis & Quest, 1979). In order to determine whether endogenous
ACh could be responsible for the increase in chemoreceptor discharge caused by
ouabain, three experiments were performed. In one experiment physostigmine (a
potent anticholinesterase, effective against both acetylcholinesterase and pseudo-
eholinesterase: e.g. Koelle & Gilman, 1949) was used. Ouabain (3 //g/min i.e.) was
administered in this cat prc-treated with atropine (1 mg/kg i.v.) and physostigmine
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(1 mg/kg I.e.) and its effect was to induce the usual pattern of changes in
chemoreceptor discharges (Fig. 7).
Mecamylamine is a potent ganglion-blocking drug (e.g. Stone, Torchiana, Navarro
& Beyer, 1956) which can reduce or abolish the increase in chemoreceptor activity
evoked by ACh in the cat carotid body in vivo (Sampson, 1971; Nishi & Eyzaguirre,
1971; McQueen, 1977). In two experiments the effects of mecamylamine on the
chemoreceptor responses to ouabain were studied. An appropriate volume of dextran
solution (25% dextran, 5% glucose in distilled water) was infused intravenously to
maintain b.p. at the control level, thereby preventing the severe hypotension which
could have increased discharge. Mecamylamine (5 mg/kg i.e.) antagonized the
chemoexcitatory action ofACh (25-250 /ig i.e.), without affecting the general pattern
of the response to ouabain (Fig. 7).
discussion
The results obtained show that ouabain alters the activity of carotid body
chemoreceptors. Its effects can be divided into two components: an initial increase
in chemosensory discharge which is followed by a return to, or below, the pre-injection
level. Responses evoked by NaCN, COj-equilibrated Locke solution, ACh and
dopamine were potentiated during ouabain-evoked chemoexcitation, but reduced or
abolished during the later post-excitation phase. Thus, ouabain initially sensitizes the
chemoreceptors and then desensitizes them.
Several authors have reported effects of ouabain on arterial chemoreceptors (see
Introduction) and evidence has been presented that other cardiac glycosides can
affect chemoreceptor activity. Schmitt, Giith & Miiller-Limmroth (1958) found that
digitalis increased carotid chemoreceptor discharge in cats, and more indirect
evidence also suggested that cardiac glycosides might activate the chemoreceptors.
For example, Heymans, Bouckaert & Regniers (1932) and Zipf & Ehrlicher (1951)
concluded that digitalis activates sensory receptors in the carotid sinus and the
bradycardia produced by strospeside in cats was considered to result from activation
of carotid chemoreceptors (Abiko, 1963). Intracarotid injection of acetylstrophan-
thidin (a synthetic derivative of strophanthin; ouabain is strophanthin-G) in decere¬
brate cats caused a smaller increase in activity recorded from the sinus nerve after
destroying the carotid bodies with acetic acid (Quest & Gillis, 1971), implying that
part of the response to the glycoside resulted from increased chemoreceptor activity.
Another glycoside, scillarin A, enhanced the reflex increase in respiration evoked by
ACh and nicotine (Carpi, Konzett & Cerletti, 1957), and potentiation of the
respiratory stimulant effects of NaCN and ACh by intravenously-administered
digoxin has also been observed (Viana, 1973) ; respiratory stimulation was abolished
by surgically removing both carotid bodies from dogs (Viana, 1974). However, the
relative contribution made by chemoreceptors, as opposed to other sensory receptors,
to these glycoside-induced effects cannot be ascertained from the available evidence.
The present experiments with ouabain have confirmed that cardiac glycosides can
increase chemosensory discharge, but in addition we have found that ouabain
eventually depresses chemosensitivity. Joels & Neil (1968) also reported that in cats
ouabain decreases the chemoexcitation caused by nitrogenated solutions but, in
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contrast to our findings, this occurred without initially enhancing the response. Direct
comparison of their results with ours is not feasible because the experimental
conditionswere different and the duration ofthe ouabain infusions in theirexperiments
is not given.
There are variousmechanismswhereby ouabain could affect chemosensory activity.
For example, it might be argued that a reduction in blood flow through the carotid
body would increase chemoreccptor discharge, and ouabain is known to have a direct
effect on vascular beds (e.g. Ribeiro, 1976), can increase vascular resistance on
intracarotid infusion (Treat et al. 1971) and did increase the systemic b.p. in our
experiments. However, although we cannot entirely preclude such a vascular mecha¬
nism, we consider it unlikely because moderate alterations in carotid blood flow do
not cause sustained changes in chemoreceptor discharge (Biscoe, Bradley & Purves,
1970) and, in any event, chemocxcitation induced by ouabain was still manifest after
stopping the infusion, even though any vascular effects of ouabain would have
terminated (Treat et al. 1971).
It has been claimed that ouabain directly excites the carotid baroreceptors (Quest
& Gillis, 1974), and our results could be explained in terms of Biscoe's hypothesis
(Biscoe, 1971) that the sensory nerve ending behaves as a chemoreceptor, with
ouabain directly affecting the nerve endings. The hypothesis was originally proposed
on the grounds that the membrane potential of all nerve cells is determined by ionic
concentration gradients which are controlled by the sodium pump. A fall in oxygen
tension would slow the pump, allowing a loss of potassium which in turn depolarizes
the nerve endings and initiates action potentials in the afferent fibre; it has been
shown that raising the extracellular potassium concentration increases chemoreceptor
discharge (Jarisch, Landgren, Neil & Zotterman, 1952; Acker, 1978). The sodium
pump is inhibited by ouabain (e.g. Repke & Fortius, 1963), and it has been postulated
that there are two phases in the glycoside's action. Baker & Willis (1972) refer to a
primary phase that is a consequence of Na+-K+-ATPase inhibition and is
concentration-dependent but docs not follow simple first-order kinetics. This is
followed by a secondary phase resulting from the uptake of ouabain by nerve endings
and its subsequent interaction with the movement of calcium ions inside and outside
the cells. As far as the present results are concerned, the sensitizing component of
ouabain's effect on carotid chemoreceptors would represent inhibition of the
sodium/potassium pump, and the later desensitization of these receptors could be
related to paralysis of the pump. Considerable latencies occurred between the start
of ouabain infusions and the manifestation of significant excitatory effects, and these
latencies tended to decrease when infusions were repeated. This might indicate the
presence of two components in the mechanism leading to chemoexcitation: the first
associated with inhibition of sodium pumping sites located on the cell membrane, the
second unsaturable and associated with movement of ouabain in the cell interior (e.g.
Baker & Willis, 1972). An early slow component followed by a later exponential
component has been demonstrated for ouabain's actions at the frog neuromuscular
junction (Branisteanu, Proca & Haulica, 1979).
The eventual desensitization of chemoreceptors by ouabain seemed not to result
from chemoreceptor exhaustion (i.e. absence of responsiveness after severe and
prolonged activation of the receptors), because sustained hypoxia (10% 02/90% N2),
even when followed by [>eriods of maximal ohemoreoeptor discharge evoked by
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breathing 100% N2, did not affect the responsiveness of the chemoreeeptors on return
to normal conditions. At the neuromuscular junction 2,4-dinitrophenol (Beani,
Bianchi & Ledda, 1966) or a N2 atmosphere (Hubbard & Leyning, 1966) increase
the frequency of miniature end-plate potentials in a manner similar to that of
ouabain. The same pattern is generally observed with procedures that interfere with
regeneration ofATP (e.g. Alnaes & Rahamimoff, 1975). Although in the present study
ouabain appeared to mimic the hypoxic response to some extent, striking differences
were noted. First, the response of the chemoreceptors to hypoxia could be maintained
throughout the period ofstimulation, whereas during ouabain infusion chemoreceptor
discharge decreased shortly after peak discharge was reached. Secondly, on return
to normal conditions after a lengthy period of hypoxia, chemoreceptor discharge
returned to control levels and responses evoked by NaCN, C02, ACh and dopamine
were not altered substantially, whereas after a ouabain infusion lasting about the
same time as the period of hypoxia, responses to these substances were markedly
reduced or abolished. Interestingly, spontaneous discharge was generally not appre¬
ciably different from the pre-infusion control level. A reason for the differences
between ouabain and hypoxia on the carotid chemoreceptors may be that ouabain
acts specifically on the Na+—K+-ATPase, which behaves as a ouabain receptor, whilst
hypoxia acts indirectly by interfering with the synthesis of ATP, as occurs at the
neuromuscular junction (Birks & Cohen, 1968).
The carotid body contains several putative transmitters including ACh and
noradrenaline (e.g. Biscoe, 1971), and it is well documented that ouabain can release
ACh and noradrenaline, both in vitro (e.g. Gillis & Quest, 1979) and in vivo (Ribeiro
& Peres-Gomes, 1977). It also releases adenosine (Shimizu, Creveling & Daly, 1970;
Daval, Barberis & Gayet, 1980; Hollins & Stone, 1980; Hollins, Stone & Lloyd, 1980),
a substance which can stimulate the chemoreceptors (McQueen & Ribeiro, 1981).
Thus, the possibility exists that ouabain affects the chemoreceptors indirectly by
modifying the release of one or more substances which may function as transmitters
or modulators within the carotid body complex, and is an alternative to mechanisms
involving direct actions of the glycoside on sensory endings. The present results do
not enable us to establish the contribution made by these various mechanisms to the
effects of ouabain. However, ACh appears not to be particularly important since no
substantial change in the pattern of chemoreceptor response to ouabain was observed
in animals treated with either mccamylamine or physostigmine in doses which would
be expected to inhibit or potentiate any endogenous ACh released by ouabain —
assuming that these drugs are capable of affecting the actions of endogenously
released ACh.
Since ouabain inhibits Na+-K+-ATPasc, and it is likely that the components of
the carotid body contain this enzyme, the response of the chemoreceptors to ouabain
may be the net effect of the drug on all the elements of the receptor complex (i.e.
type I cells, type II cells, non myelinated and myelinated sensory nerve endings,
motor (efferent) nerve endings). Intracellular recordings have shown that some cells
are depolarized by ouabain (sec Introduction), but it remains to be established
whether this effect is associated with release of particular substances. In order to
determine how ouabain acts it will be necessary to correlate changes in chemoreceptor
activity induced by the glyclosidc with biochemical and biophysical changes within
individual elements of the carotid body.
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Sympathetic nerves to the carotid body appear to be affected by ouabain, since
on intracarotid infusion peak discharge occurs following a significantly lower dose of
ouabain in intact carotid bodies with intact sympathetic nerves than in those in which
the nerves were cut. This may reflect an increase in sympathetic activity, induced
centrally or by modification of transmitter release at the ganglia, which increases
chemosensory activity. A correlation between carotid body chemoreceptor activation
by cardiac glycosides and their cardiotoxic effects has been suggested (e.g. Gillis &
Quest, 1979), partly on the grounds that the maximal increase in respiration occurred
when the dose reached a level near that required to induce cardiac dysrhythmias
(Viana, 1973, 1974). Our animals were artificially ventilated, but the maximal
increase in chemosensory activity occurred with doses of ouabain (i.v.) similar to
those causing dysrhythmias, which is compatible with Viana's observations. It seems
probable that reflexes arising from sensitization of the carotid body chemoreceptors
induced by cardiac glycosides acting directly and indirectly will contribute to the
cardiovascular changes (e.g. hypertension, bradycardia, dysrhythmia) associated
with clinical use of these drugs. This effect may occur at lower doses of glycoside in
patients with an elevated level of chemoreceptor activity, which would be expected
in hypoxic individuals such as those with certain forms of chronic obstructive
pulmonary disease.
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On the specificity and type of receptor involved in
carotid body chemoreceptor activation by adenosine in
the cat
D.S. McQueen & J.A. Ribeiro1
Department of Pharmacology, University of Edinburgh Medical School, 1 .George Square, Edinburgh
EH8 9JZ
1 Experiments were performed on cats anaesthetized with pentobarbitone in which carotid
chemoreceptor activity was recorded from the peripheral end of a sectioned carotid sinus nerve.
2 Intracarotid injections of adenosine 5 '-triphosphate (ATP) (1 -100 pg i.e.) caused a dose-related
increase in chemosensory discharge which was delayed in onset.
3 The adenosine uptake inhibitor dipyridamole potentiated the chemoexcitatory effects of in¬
jected adenosine and ATP.
4 The stable ATP analogue ot-Jl-methylene ATP (10-100pgi.c.) depressed chemoreceptor dis¬
charge, which suggests the presence of a P2-purinoceptor in the carotid body, and provides evidence
that the chemoexcitatory effect of ATP results from its hydrolysis to adenosine 5'-phosphate
(AMP)/adenosine.
5 Adenine, inosine, guanosine, cytidine and uridine had no appreciable effect on chemoreceptor
discharge.
6 The adenosine R-site agonists 2'-chloroadenosine and N6-methyladenosine had chemoexcitat¬
ory effects which were similar to those of adenosine, whereas the P-site agonist 2'-deoxyadenosine
had no appreciable effect on discharge.
7 We conclude that the adenosine receptor in the cat carotid body has some of the characteristics of
an R-site receptor according to the classification of Londos & Wolff (1977).
Introduction
Adenosine excites the carotid body chemoreceptors
(McQueen & Ribeiro, 1981) and so too does
adenosine triphosphate (ATP) (Jarisch, Landgren,
Neil & Zotterman, 1952; Dontas, 1955; Anichkov &
Belen'kii, 1963; Ribeiro & McQueen, 1983) being
approximately equipotent in its chemoexcitatory ac¬
tions with adenosine, the parent nucleoside (Ribeiro
& McQueen, 1983). This raises the question of
whether it is ATP itself, or the metabolite adenosine,
which excites the carotid body chemoreceptors and
we decided to investigate the matter by studying the
effects on the chemoreceptors of stable analogues of
ATP, such as a-/3-methylene ATP, which are not
metabolized to adenosine.
We also undertook the characterization of the
1 Present address and correspondence: Laboratory of
Pharmacology, Gulbenkian Institute of Science,
2781 -Oeiras, Portugal.
adenosine receptors which are responsible for the
chemoexcitation. Two types of receptive site for
adenosine have been postulated by Londos & Wolff
(1977); one at which agonist activity is favoured by
an unsubstituted ribose moiety (R-type), the other at
which selective activation is associated with an un¬
substituted purine ring (P-type). The effects of vari¬
ous adenosine analogues which are regarded as being
selective agonists at either the P- or R-sites were
studied on the chemoreceptors, as were substances
such as adenine, purine nucleosides and pyrimidine
nucleosides in order to test the specificity of the
receptors for adenosine.
Methods
Experiments were performed on 23 cats weighing
between 2.8 and 4.4 kg, median weight 3.2 kg. They
© The Macmillan Press Ltd 1983
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were anaesthetized with pentobarbitone sodium
(42mgkg_1 i.p.). supplemented as required during
the experiments, artificially ventilated with air and
paralysed with gallamine (3 mg kg-1 i.v.). Full details
for most of the experimental procedures have been
given previously (McQueen, 1977) and only a brief
description follows.
The lingual and superior thyroid arteries ipsilateral
to the sinus nerve from which recordings were ob¬
tained were both cannulated, the catheter tips being
positioned in the common carotid artery. Blood pres¬
sure was recorded from a femoral artery. Electrical
activity of chemoreceptors (1-6 units) was recorded
from filaments of the peripheral end of a sectioned
sinus nerve, stored on FM tape, passed through a
pulse height (window) discriminator and quantified
with the aid of a microcomputer (Commodore 3032).
In the majority of experiments the ganglioglomerular








Figure 1 Recording of chemoreceptor discharge illus¬
trating (a) the delayed excitation evoked by an injection
(arrow) of ATP (100 fig i.e.) which contrasts with (b),
the depression of discharge caused by injecting the same
dose of a-p-methylene ATP. The lower part of each
panel is the output from a pulse-height discriminator set
at a fixed level to count the action potentials occurring
during 1 s intervals, each step representing a single
spike. The injections lasted 2 s and caused an immediate
transient increase in discharge, which was also obtained
when the drug vehicle was injected.
Drugs were dissolved in either modified Locke
solution (McQueen, 1977) or 0.9% w/v aqueous
sodium chloride solution, except for dipyridamole
(500 figml-1) which was initially dissolved in 25%
alcohol:75% polyethyleneglycol. Drug injections
were made in a volume of 0.1ml into the lingual
catheter (except for adenosine (100 pg and above)
and adenosine analogues (lOOpg) which were in
0.2 ml) and washed in with 0.2 ml Locke solution
which had been bubbled with 5% C02:95% air in a
water bath at 37°C; they were made over a 2s
period. Drug infusions were made into the common
carotid artery via the thyroid catheter at a rate of
0.1 mlmin-1 using a Unita pump (Braun) and lasted
for 5-10 min; the catheter dead space was 0.2 ml.
Statistical analysis
The significance of differences between means was
calculated using Student's paired or unpaired ftest; P
values of 0.05 or less were taken as being statistically
significant.
Drugs
The drugs used were: sodium pentobarbitone, gal¬
lamine triethiodide (May & Baker), adenosine,
adenosine triphosphate (ATP), ot-0-methylene ATP,
/5-y-methylene ATP, 2'-deoxyadenosine, 3'-
deoxyadenosine, N6-methyladenosine, 2'-
chloroadenosine, adenine, inosine, guanosine,




Injections of ATP (l-100pg intracarotid (i.e.))
caused a dose-related increase in chemosensory dis¬
charge (see Figures 1, 2 and 3) after a delay of 2-8 s.
In view of the delay to onset of the effect, we per¬
formed experiments to investigate the possibility that
chemoexcitation resulted from actions of a metabo¬
lite of ATP rather than the parent compound.
Accordingly, experiments were performed in
which the effects of ATP analogues were studied.
The actions of a-^-methylene ATP, a compound
which cannot be metabolized to adenosine, were
compared with ATP. The results obtained are illus¬
trated in Figures 1, 2 and 3 which show that, in
contrast to the excitatory effect of ATP, injection of
a-/J-methylene ATP caused a dose-related decrease
in chemosensory discharge that was associated with
an increase in arterial blood pressure; ATP had little
or no effect on blood pressure. Another ATP
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Figure 2 Quantitative comparison of the effects on spontaneous chemoreceptor discharge after injecting 10, 50
and 100 pg of (a) ATP, (b) o-P-methylene ATP and (c) (J-y-methylene ATP into the carotid artery in the same
experiment. Discharge was averaged over 5 s intervals and expressed as a percentage of the pre-injection frequency
(frequency shown in ct s"1 above solid columns which represent 100%).
analogue, /5-y-methylene ATP, which can undergo
metabolism to adenosine 5'-phosphate (AMP)
and/or adenosine, caused chemoexcitation which was
qualitatively similar to the effect of ATP (Figures 2
and 3) and had no appreciable action on blood pres¬
sure.
Dipyridamole
The effects of dipyridamole, an adenosine uptake
blocker, were studied and it was found that i.v.
infusidn (50pgmin_1) caused a slight increase in
spontaneous chemoreceptor discharge during the
period of infusion. The log dose-response curve to
adenosine was shifted upwards to the left during the
dipyridamole infusion (Figure 4).
Intracarotid infusion of dipyridamole, also at
50 pgrnin"1, caused a more marked increase in spon¬
taneous discharge. During the i.e. infusion of di¬
pyridamole the increases in discharge evoked by
injections of adenosine and of ATP (1 fig) were
greatly potentiated (Figure 5).
Specificity for adenosine
A number of nucleosides have actions on neurotrans¬
mission (e.g. Phillis, Edstrom, Kostopoulos & Kirk-
patrick, 1979), so it was considered of interest to
evaluate the effect of some of these substances on the
carotid body chemoreceptor activity in order to exp¬
lore the specificity of the adenosine receptor. Figure
6 summarizes results from 2 experiments in which a
metabolite of adenosine, adenine, and the purine
nucleosides inosine and guanosine, as well as the
pyrimidine nucleosides cytidine and uridine were
tested. The effects were compared with those of
adenosine itself. As can be seen neither adenine
(10-100 pg) nor the nucleosides inosine, guanosine,
cytidine or uridine caused any substantial increases in
the spontaneous chemoreceptor discharge, whereas
adenosine increased discharge.
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Figure 3 (a) Effects on spontaneous chemoreceptor discharge of injecting Locke solution (0.1 ml + 0.2 ml wash)
and ATP 1,10 and 100 jig i.e. Discharge (cts-1) was averaged over 5 s periods following the injection and is shown as
the mean from 6 experiments is.e.mean. *P<0.05 (paired /test - comparison with Locke solution), (b)
Comparison of the effects of injecting (arrow) 100 pg of non-hydrolysable ATP analogues a-j)-methylene ATP and
(1-y-methylene ATP with ATP on chemoreceptor discharge and on blood pressure showing the marked difference
between a-p-and (1-y-methylene ATP on both parameters, (c) Pooled data from 4 experiments showing quantitative¬
ly the effects of these ATP analogues and ATP on chemoreceptor discharge which was averaged over 10 s periods
following the injection of 1 nOO jig i.e.
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Figure 4 The effect on spontaneous chemoreceptor discharge k(ct/s~') of infusing dipyridamole (50 pgmin-1 i.v.)
(a). The solid column represents the pre-infusion control discharge frequency, (b) shows log dose-response lines for
adenosine injected before (•) and during (■) infusion of dipyridamole (50 pgmin-1 i.v.). Chemoreceptor responses
are expressed as the mean A £ x calculated as the response during the 30 s following injections A Xx = X x(response)
— Xx(control). Xx(control) = x, (control) X t (response duration in s). x = average discharge in cts . Pre-injection
control discharge alues (cts-1) were: adenosine 1 pg 2.7 before; 2.6 during infusion; 10pg-2.0, 2.5; 100 pg - 3.8,
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Figure 5 Effects on chemoreceptor discharge of injecting (a),(c) adenosine (1 pg i.e.) and (b),(d) ATP (1 pg i.e.)
before and during an infusion of dipyridamole (50 pgmin i.e.). Discharge (cts-1) was averaged over 10 s periods.
The dashed lines represent the pre-injection averaged discharge








Figure 6 Comparison between the responses of
chemoreceptors during the 10-30s post-injection
period to adenosine (•), adenine (O), inosine (A),
guanosine (♦ ), cytidine (0 ) and uridine (■) in 2 cats.
AZx has the same meaning as in Figure 4. Pre-injection
control discharge values (ct s ) for 10 and 100 fig
respectively were: adenosine 3.4, 3.0; adenine 2.3, 2.1;
inosine, 3.5, 3.2; guanosine, 6.3, 7.8; cytidine 3.1, 2.7;
uridine 1.5, 1.2.
Adenosine analogues
The responses of chemoreceptors to adenosine
analogues were investigated in 5 experiments. Re¬
sults obtained from one experiment, in which the
effects of the analogues were studied at 2 different
doses (10 and lOOfigi.c.), are shown in Figure 7, as
are results from 4 experiments in which only the
higher dose was used. These demonstrate that
N6-methyladenosine and 2'-chloroadenosine, re¬
garded as R-site agonists, increased spontaneous dis¬
charge in a manner similar to that of adenosine. The
compound 3'-deoxyadenosine, which can affect both
R- and P-sites, but has higher affinity for the former,
also increased chemoreceptor discharge. In contrast,
2'-deoxyadenosine, which is an adenosine agonist
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Figure 7 Response of carotid chemoreceptors to in¬
jecting 10 fig (first column) and 100 fig (second column)
of the adenosine analogues (a) 2'-chloroadenosine, (b)
N6-methyladenosine, (c) 3'-deoxyadenosine and (d) 2'-
deoxyadenosine illustrating the dose-dependent na¬
ture of the response to the first 3 of the 4 compounds.
The third column represents pooled data from 4 further
experiments in which the effects of injecting 100 fig of
each adenosine analogue were compared with the re¬
sponse to 100 fig of adenosine. Results are expressed as
the mean increase in discharge above background activi¬
ty (i.e. A£x)±s.e.mean (see Figure 4) during the
10-40s period following the injection. Background or
spontaneous period discharge frequency is shown below
each column. Adenosine caused an increase of 170 ± 40
counts, average background discharge 3.0±l.lcts~'
(n = 4). ,P<0.05 (comparison with any of the other
responses by paired (test).
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Discussion
The present results confirm the presence of an
adenosine receptor in the cat carotid body (McQueen
& Ribeiro, 1981); activation of this receptor causes
an increase in chemosensory discharge. Londos &
Wolff (1977) postulated the existence of membrane
bound adenosine receptors with an internally located
P-site and an externally located R-site. The P-site is
activated by 2'-deoxyadenosine and the R-site selec¬
tively affected by agonists such as N6-
methyladenosine and 2'-chloroadenosine. The pres¬
ent results are compatible with an R-site adenosine
receptor being present in the carotid body since the
R-site agonists (N6-methyladenosine, 2'-
chloroadenosine) caused effects very similar to those
of adenosine, whereas the P-site agonist (2'-
deoxyadenosine) had no appreciable effect on
chemosensory discharge. However, in many systems
the action of adenosine can be blocked effectively by
theophylline, whereas in the chemoreceptors it does
not seem to be antagonized (McQueen & Ribeiro,
1981). This could mean that a different type of
receptor is involved in the response of the
chemoreceptors to adenosine, but it should be noted
that some adenosine receptors are relatively insensi¬
tive to xanthines (Daly, 1983), and complications
may arise from the use of theophylline in vivo be¬
cause of the adenosine uptake-blocking and
phosphodiesterase-inhibiting properties of the drug.
Neither adenine, the purine nucleosides inosine and
guanosine, nor the pyrimidine nucleosides cytidine
and uridine had any appreciable effect on chemosen¬
sory discharge.
The adenosine receptor appears to be externally
located since the adenosine uptake antagonist, di¬
pyridamole, potentiated the chemoexcitation evoked
by injected adenosine. This further supports the pres¬
ence of an R-site adenosine receptor in the carotid
body, since it is a characteristic of these sites that they
are externally located (Daly, Bruns & Snyder, 1981).
However, our results do not allow us to establish
whether the adenosine receptor is associated with
sensory nerve terminals, glomus type I and/or type II
cells, blood vessels, or with all these structural com¬
ponents of the sensory complex. It seems unlikely
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On the Neuromuscular Depression and
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This chapter consists of two main sections. In the first, evidence for the action
of adenosine and related nucleotides at the neuromuscular junction is reviewed with
respect to the following: (a) the type of effect adenosine and related nucleotides
have at the neuromuscular junction, (b) their relative potencies, (c) the specificity
of their action, (d) the component of the neuromuscular junction at which adenosine
acts, (e) the type of purine receptors involved, and (0 some factors that can interfere
with the magnitude of the effect. The physiologic and pathophysiologic roles for
these substances remain in the domain of speculation. Similar questions as they
apply to an in vivo investigation of the effects of adenosine on cat carotid body
chemoreceptors are considered in the second section. The complexity of the carotid
body, particularly the presence of several putative neurotransmitters and the possible
existence of two kinds of synapses (motor and sensory), has prevented us from
obtaining adequate answers to some of these questions. Nonetheless, it is interesting
to note that adenosine, a regulator of oxygen supply to many tissues (see, e.g., ref.
2) affects the carotid body chemoreceptors, which are sensitive to small modifi¬
cations in the Pa02 of blood.
There are, in principle, two distinct actions of adenosine and related nucleotides
at synapses. One is the postsynaptic action; adenosine triphosphate (ATP) can
behave as a neurotransmitter and/or cotransmitter. The role of ATP as a neuro¬
transmitter has been extensively characterized by Burnstock (3) within the concept
of purinergic transmission. For a recent account of the steps that led to the for¬
mulation of the purinergic hypothesis, the recently edited monograph Purinergic
Receptors (4) should be consulted. The function of ATP and/or adenosine as co-
transmitters is poorly understood, but basically corresponds to their capacity to
sensitize the postsynaptic membrane to the effects of classic neurotransmitters, such
as acetylcholine (ACh) or norepinephrine (NE) (see, e.g., ref. 20).
The other action of adenosine at synapses is presynaptic and is manifest by a
reduction in transmitter release. This was first detected electrophysiologically by
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Ginsborg and Hirst (8,9) in the rat diaphragm and further confirmed within the
same laboratory by Ribeiro and Walker (27,28) in the frog sartorius preparation.
There is now extensive literature on the presynaptic action of adenosine and adenine
nucleotides (see, e.g., ref. 21).
ADENOSINE ON NEUROMUSCULAR TRANSMISSION
In both rat diaphragm and frog sartorius preparations previously depressed either
postsynaptically with tubocurarine or presynaptically with high Mg2+ and/or low
Ca2 + concentrations, adenosine reduces the amplitude of the evoked end-plate
potentials (EPPs) to about half the control values, which corresponds to a similar
reduction in the evoked release of ACh. The evoked release of ACh was measured
either by the ratio of the mean amplitude of EPPs to the mean amplitude of miniature
EPPs (MEPPs) recorded simultaneously and during the same period or, when the
initial quantal content of the EPPs was too low, by determining the natural logarithm
of the ratio of the number of impulses to the number of failures. Adenosine also
reduces the spontaneous release of ACh as measured by the frequency of MEPPs
(9,28). In relation to these effects: (a) adenosine is equipotent with ADP and ATP
(28); the effect of ATP might depend on its previous hydrolysis to adenosine, since
the nonhydrolyzable ATP analogs a-(3-methyIene ATP and (3-y-methylene ATP
were inactive (32); (b) the effect is specific for adenosine, since substances, such
as adenine, the purine nucleosides inosine and guanosine, or the pyrimidine deriv¬
atives cytidine and uridine, were ineffective (10); (c) the action of adenosine is
devoid of tachyphylaxis (9,28); (d) the effect of adenosine is presynaptic, since the
substance does not significantly change the mean amplitude of the MEPPs (9,28);
the effect probably is confined to the nerve endings, since adenosine does not
change the compound action potential in the frog sciatic nerve (23); (e) the effect
of adenosine appears to depend on previous neuromuscular depression; since aden¬
osine is devoid of effect in preparations previously depressed by tetrodotoxin (TTX)
(22), this previous neuromuscular depression must take place either postsynaptically
via the blockade of ACh receptors (e.g., by tubocurarine) or presynaptically at the
nerve endings by using high Mg2+ and/or low Ca2+ concentrations (24); (f) the
effect is antagonized by two substances that have opposite effects on the activity
of phosphodiesterases, namely, theophylline and imidazole (24). Both theophylline
(29) and imidazole (25) stimulate Ca2+ uptake by synaptosomes depolarized by
potassium, and the effect of adenosine is accentuated by verapamil (24). This
suggests that an interaction with Ca2+ probably is responsible for the adenosine-
induced neuromuscular depression. Further confirmation comes from the finding,
that the adenosine reduction of neuromuscular transmission is calcium related (22).
The calcium-related effect of adenosine agrees with its depressant effect on the
uptake of Ca2+ by synaptosomes stimulated by potassium (26); the depressant effect
of adenosine on the evoked release of ACh at the neuromuscular junction results
from its decreasing the influx of Ca2* that follows the depolarization of the nerve
terminals and triggers the release of transmitter. The reduction in the spontaneous
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release of ACh by adenosine and/or ATP might depend on its interaction with the
mechanisms that regulate the level of intracellular Ca2+ (see, e.g., ref. 23).
Considering the experimental conditions in which the release of ATP from rat
phrenic nerve endings has been detected (31), and that the amount of ATP being
released together with ACh can be of the same order as that found effective in
reducing the output of ACh, it was suggested (21,27) that ATP could be responsible
for the Wedenski inhibition.
Physiologic and Pathophysiologic Significance
Some of the points listed above deserve further comment. The possibility of ATP
and/or adenosine being responsible for the Wedenski inhibition has been hypoth¬
esized (21,27) on the grounds that ATP is released apparently together with ACh
from the phrenic nerve endings of curarized preparations after high frequency
stimulation (31) and that ATP and/or adenosine in the presence of tubocurarine
decrease the evoked release of the transmitter from the motor nerve endings (for
more detailed discussions, see ref. 21).
We attempted to test this hypothesis (J. A. Ribeiro, unpublished observations)
by comparing the Wedenski inhibition obtained before and in the presence of ATP
or adenosine applied to a phrenic nerve rat diaphragm preparation set up in similar
conditions to those described by Silinsky (31). In some experiments, we have been
able to observe a potentiation of the posttetanic inhibition in the presence of aden¬
osine or ATP. Unfortunately, however, these observations are not reliable because
it was not possible to obtain consistent controls; i.e., the overall picture of posttetanic
inhibition changes independently of the presence of adenosine or ATP. Thus, al¬
though we could not prove or disprove the hypothesis, its confirmation might be
of interest with respect to a potential role of adenosine on neuronal plasticity.
A point with a pathophysiologic implication emerges from observations in which
adenosine appears to be devoid of effect on undepressed preparations (24) and that
the neuromuscular depressant effect of adenosine is apparent only if a previous
postsynaptic blockade by tubocurarine causes a blockade of at least one-third of
the ACh receptors (22). Considering that ATP can be released presynaptically
(18,31) and/or postsynaptically (12) and that the neuromuscular blockade induced
by tubocurarine has many similarities to that of myasthenia gravis (11), taken
together with the report (5) that at the myasthenic end plate, the number of channels
opened by a packet of transmitter is decreased about one-third and the number of
functional receptors is also reduced in the same proportion, it is possible that an
ATP- or adenosine-like substance might be an aggravating factor of a myasthenic-
like neuromuscular blockade (22).
ADENOSINE ON CAROTID BODY CHEMORECEPTOR ACTIVITY
In this section, we discuss how exogenously applied adenosine affects carotid
body chemoreceptor activity.
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Methods
The experiments were performed in cats anesthetized with pentobarbital (42
mg/kg intraperitoneally) supplemented every 1 to 2 hr. The animals were artificially
ventilated with air and paralyzed with gallamine (3 mg/kg intravenously). Pa02,
P,C02, and pH of blood were maintained constant, and end-tidal C02, arterial blood
presstlre (BP), electrocardiogram, and rectal temperature were monitored throughout
the experiments. Recordings of action potentials were obtained from the peripheral
end of a sectioned carotid sinus nerve using conventional electrophysiologic tech¬
niques and quantified (see, e.g., ref. 13). In the majority of the experiments, the
ganglioglomerular (sympathetic nerves from the superior cervical ganglion to the
carotid body) were cut. Drugs were dissolved in Locke solution and either injected
(0.1 ml) or infused into the ipsilateral common carotid artery (1C). The injections
were made over a period of 2 sec.
Results and Discussion
Adenosine on Spontaneous Chemoreceplor Activity
As shown in Figs. 1 and 2, adenosine injections (0.1 to 100 pg IC) increased the
spontaneous chemoreceptor discharge. This effect was dose dependent in relation
to both size and duration of the response, and it was inversely dose related to the
delay to onset of the response. The threshold dose for the adenosine excitatory
action is between 10 and 100 ng. The effect was significantly different (p < 0.05)
from the control injection of drug vehicle (Locke solution). Since the injection of
Locke solution caused a decrease in chemoreceptor discharge, it is possible that
the threshold dose for the adenosine excitatory action is even lower. The effect of
adenosine does not appear to be secondary to changes in systemic arterial pressure,
since we did not detect any substantial modifications in BP during the period we
recorded the adenosine responses, even when we injected the highest dose (100 pg
IC) (Fig. 2). No tachyphylaxis to the action of adenosine was observed. Thus when
injected at intervals of 5 min over a period of 1 hr, there was no diminution of the
effect on spontaneous chemoreceptor discharge.
In another set of experiments, the excitatory action of adenosine was further
confirmed by infusing adenosine (50 pg/min IC in 0.1 ml). No substantial changes
in BP occurred during the infusions (17).
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FIG. 1. Effects of IC adenosine on the frequency of spontaneous chemoreceptor discharge.
Neurograms taken from one experiment show the increase in the discharge of a single unit
caused by injecting (arrow) adenosine (b) 0.1 n.g, and (c) 1 p.g (10 sec calibration). In (a), the
duration of the spike is shown, the trace being of 10 consecutive superimposed spikes (2 msec
calibration).
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FIG. 2. Effects on spontaneous chemoreceptor discharge (ct/s) of injecting Locke solution
(0.3 ml) and adenosine (0.001, 0.01,0.1, 1, 10, 50, and 100 pg). Discharge was averaged over
5 sec periods following injection. Data obtained from nine cats were pooled and presented as
the mean, with vertical bars indicating SEM. The right panel shows an arterial BP trace after
injecting (arrow) 100 p-g adenosine in one experiment. BP calibration, 0 to 100 to 200 mm Hg.
*, Compared with preinjection control period.
Dipyridamole
The absence of any relationship between the vasodilator properties of adenosine
and its chemoexcitatory action was further confirmed by injecting adenosine (1 to
100 |xg IC) in the presence of dipyridamole (J. A. Ribeiro and D. S. McQueen,
unpublished observations). Dipyridamole, an adenosine uptake blocker, is a po¬
tentiator of the vasodilator properties of adenosine (19). Dipyridamole (50 p.g/min
IC in 0.1 ml) itself increased chemoreceptor activity. In its presence, the effect of
the lower doses of adenosine (1 p.g IC) was markedly increased without substantial
changes in BP, whereas the chemoreceptor responses to the higher doses (100 p.g
IC) of adenosine were antagonized, and the monophasic excitatory action of aden¬
osine converted into a biphasic action with an early inhibitory component. This
effect was clearly associated with a marked fall in BP. The potentiation of the
chemoexcitatory action of the lower doses of adenosine during dipyridamole infusion
also suggests that the adenosine receptor is externally located.
Comparison Between the Effects of ATP, ADP, AMP, and Adenosine
The effects of ATP, adenosine diphosphate (ADP), and adenosine monophosphate
(AMP) were investigated in two cats and compared with those of adenosine (see
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Fig. 3). All four substances (1 to 100 pg IC) caused a dose-related increase in
spontaneous chemoreceptor activity, but the effects of lower doses (1 to 10 pg) of
ATP, ADP, and AMP were smaller than those obtained with adenosine. However,
if these doses are expressed in moles, ATP (MW, 507) has a similar action to that
of adenosine (MW, 267).
Comparing the delay to onset of the adenosine and ATP carotid body chemo¬
receptor responses, we detected that the responses to ATP usually had a greater
delay to onset. This suggests that the effect of ATP might depend on its prior
hydrolysis to adenosine.
Adenosine and Evoked Responses
To determine in which of the carotid body structures adenosine acts, we inves¬
tigated how the substance influenced the chemoreceptor responses evoked by sodium
cyanide (NaCN), C02-equilibrated Locke solution, ACh, and dopamine.
The general consensus concerning the mammalian carotid body is that it is
composed of type 1 cells and sensory nerve endings enveloped by type 11 cells; all
these components are contained in a rich vascular network. Two kinds of synapses
have been proposed; one is efferent or motor, and one is afferent or sensory (for
a review, see, e.g., ref. 6). It has been suggested that substances such as NaCN
or C02 act preferentially on type I cells, and substances such as ACh and dopamine
act predominantly on the sensory nerve endings.
Figure 4 illustrates how adenosine influenced the responses evoked by those
substances. Responses to NaCN and C02-equilibrated Locke solution were slightly
and variably reduced after adenosine injections (100 pg IC). This variability was
further confirmed by dose-response curves to NaCN performed during the infusion
of adenosine. The excitatory responses evoked by ACh and the inhibitory responses
evoked by dopamine were both increased after adenosine injections. This effect
was confirmed by dose-response curves to both ACh and dopamine obtained during
adenosine infusions. Since adenosine sensitized the chemoreceptors to the excitatory
FIG. 3. Comparison between the ef¬
fects of ATP, ADP, AMP, and adenosine
in two cats. Chemoreceptor responses are
expressed as the mean AXx calculated
as the response during the 30 sec follow¬
ing injections [AXx = Xx (response) - Xx
(control)]. Xx (control) = x (control) x t
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FIG. 4. Effects of adenosine injections (100 m-9 IC) (upper panel) on the chemoreceptor re¬
sponses evoked by NaCN, C02-equilibrated (open bars) Locke solution, ACh, and dopamine
(DA) before and after (hatched bars) adenosine. Lower panel, influence of adenosine (50 p.g/min
IC in 0.1 ml) on the dose-response curves to NaCN, ACh, and DA. Circles, before; squares,
during adenosine infusion. Lines were fitted to the data by the method of least squares.
action of ACh, and in particular to the inhibitory action of dopamine (Fig. 4),
adenosine might have a direct action on the sensory nerve endings, which are
postsynaptic in relation to type 1 cells.
Theophylline, Cyclic AMP, and Dibutyryl Cyclic AMP
The possibility that adenosine might act on chemosensory nerve endings also
emerges from the finding that theophylline does not antagonize, but instead poten¬
tiates, the chemoexcitatory action of adenosine (16,17). Adenosine can activate
adenylate cyclase, and theophylline can inhibit phosphodiesterases; i.e., both sub¬
stances might affect the same ultimate mechanism, namely, cyclic AMP concen¬
tration in sensory nerve endings. An adenylate cyclase-cyclic AMP system is apparently
located in the sensory endings of the carotid sinus nerve (7); both cyclic AMP and
dibutyryl cyclic AMP increase chemoreceptor activity (see Fig. 5).
Another possible explanation for the potentiation by theophylline of the action
of adenosine is that theophylline might act by inhibiting adenosine uptake, as has
been observed in rat brain synaptosomes (1). The results suggest that the receptors
involved in the chemoexcitatory action of adenosine in the cat carotid body are
relatively insensitive to blockade by theophylline.





FIG. 5. Effects of cyclic AMP (cAMP)
and dibutyryl cyclic AMP (Db-cAMP)
on spontaneous chemoreceptor activ¬
ity and their comparison with adeno¬
sine. A1x has the same meaning as
in Fig. 3. Lines were fitted to the data
by the method of least squares.
Adenosine is not the Mediator of the Inhibitory Action of Opiates on Carotid
Body Chemoreceptors
In contrast to what has been suggested (30,33) for smooth muscle and brain,
adenosine does not appear to be the mediator of carotid body chemoinhibitory action
of opiates (17). This can be concluded from the following observations: (a) Aden¬
osine does not mimic the action of morphine or enkephalins; these substances cause
a rapid and potent inhibitory action on chemoreceptor activity (14,15); (b) theo¬
phylline does not cause any substantial change in the inhibitory action of opiates
and potentiates the adenosine chemoexcitatory action (J. A. Ribeiro and D. S. McQueen,
unpublished observations); (c) naloxone, an opiate antagonist, antagonizes the in¬
hibitory action of opiates but does not cause substantial modifications in the ex¬
citatory action of adenosine (17).
CONCLUSIONS
The main conclusions that can be drawn from these results are: (a) Adenosine
increases spontaneous chemoreceptor activity through an externally located receptor,
probably on the sensory nerve endings; (b) since putative inhibitory transmitters
are present in the carotid body, and it is well established that adenosine decreases
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the release of neurotransmitters in many tissues, we cannot preclude the possibility
that this kind of effect may also contribute to the observed adenosine excitatory
action. The fact that adenosine is effective in simple systems, such as the neuro¬
muscular junction, as well as in more complex systems, such as the carotid body,
emphasizes it's importance in neurotransmission, particularly if considered in the
context of neurotransmitters, cotransmitters, or neuromodulators.
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A method for chronic cannulation of blood vessels In rats
By R. C. Dow* and D. S. McQueen. Department of Pharmacology and
*M.R.C. Brain Metabolism Unit, University of Edinburgh, 1 George Square,
Edinburgh EH8 9JZ
The method described here was developed in order to enable drugs to be
accurately and rapidly administered intravenously to conscious animals
with a minimum of disturbance to the animal, and for this to be repeatable





Fig. 1. Cross-section of the skull fitting. Dimensions shown in millimetres.
Black area indicates the rubber diaphragm.
The cannulation can be performed on any of the larger blood vessels in
the body, but we considered only the external jugular vein. In essence, the
method is to caimulate the jugular vein with a nylon catheter and to pass
the free end of the catheter under the skin of the neck and fit it to a stain¬
less-steel connector located on the skull. Injections are made through a
rubber diaphragm which fits over the stainless steel connector.
Rats of 200-300 g body weight were anaesthetized with halothane in
oxygen. Skin incisions were made medial sagittally on the skull and over
the jugular vein in the neck-pectoral region. The jugular vein was exposed
[r.T.o.
2
and cannulated with a nylon catheter (7 cm long with o.d. 0-75 mm), about
1-5 cm of the cannula being in the vein. The free end of the catheter was
blocked by a small pin and passed under the skin to the skull incision.
A hole was drilled in the skull with a No. 6 dental burr at a point mid-way
between the coronal and lambdoidal sutures and 3 mm laterally from the
sagittal suture; care should be taken not to penetrate the dura. The hole
was then tapped with an 8BA tap and the stainless-steel fitting (see Fig. 1)
screwed into position. The connector was firmly affixed to the skull by
applying cold-curing acrylic resin (Simplex), and the catheter attached to
the connector.
A hole was punched in the skin directly above the connector to allow the
rubber diaphragm to protrude. The wounds were then sprayed with poly-
bactrin antibiotic spray and closed using Michel clips. Surgical time is about
30 min and the wounds heal in 5-7 days. Daily flushing of the cannula
with 0-2 ml. heparinized saline (sterile) 100 units/ml. is recommended to
ensure patency, and the rubber diaphragm (obtained from a 1 ml. dispos¬
able syringe) may need to be changed once every 3 weeks.
Animals have survived for 3 months with patent cannulae; blood samples
can be taken using this technique but the cannula should be flushed with
sterile heparinized saline immediately after withdrawal.
Wo should like to thank Dr J. D. Fitzgerald of I.C.I. Ltd. for a gift of halothane.
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THE SPECIFICITY OF SOME
AGONISTS AND ANTAGONISTS FOR
NICOTINE-SENSITIVE RECEPTORS IN GANGLIA
R.B. BARLOW, FRANCES BOWMAN, R.R. ISON &t D.S. McQUEEN
Department of Pharmacology, 1 George Square, Edinburgh EH8 9JZ
1 The guinea-pig isolated ileum has been used to estimate the ability of substituted
phenylalkylonium salts (related to nicotine) to stimulate or block receptors in ganglia. The
effects of hexamethonium were used to indicate which were the most specific ganglion
stimulants; these were tested on the blood-pressure of pithed rats and for neuromuscular
blocking activity on the rat diaphragm preparation.
2 m-Hydroxyphenylpropyltrimethylammonium and 3,4-dihydroxyphenethyltrimethyl-
ammonium (coryneine. 'quaternary dopamine') were the most active and specific ganglion
stimulants but their usefulness in vivo may be limited by their neuromuscular blocking activity.
The analogous tertiary compounds are being investigated.
3 The affinities of substances which were blocking agents at ganglionic receptors were
measured on the isolated ileum with m-hydroxyphenylpropyltrimethylammonium as agonist.
The affinities of selected compounds for postganglionic receptors were measured in
experiments on the ileum in the presence of hexamethonium and with carbachol as agonist.
Some of the compounds were tested for neuromuscular blocking activity on the rat diaphragm.
4 Phenylbutyldiethylamine had ganglion-blocking activity greater than pempidine and little
postganglionic blocking or neuromuscular blocking activity. Its triethylammonium analogue
had higher ganglion-blocking activity but had appreciable neuromuscular blocking activity.
5 The aromatic ring system is not essential either for activity or affinity and the effects of
substituents are not related to their effects on electron distribution. Stimulant activity is
enhanced only by hydroxyl or amino groups in suitable positions; it is not improved by the
presence of rigid features (double or triple bonds or a cyclopropane ring) in the side chain.
Affinity is slightly increased by chloro or bromo groups in suitable positions but the
unsubstituted compounds are among those with the highest affinity. Substituents have similar
effects on affinity for postganglionic receptors, though for these receptors the compounds
mostly have only about one-tenth of their affinity for ganglionic receptors.
Introduction
Barlow, Thompson & Scott (1969) studied the
effects of many compounds related to nicotine on
the isolated rectus abdominis preparation of the
frog. Compounds were found with 50 times the
stimulant activity of nicotine; others had consid¬
erable blocking activity with values of log affinity
constant as high as 5.9.
The present paper describes the properties of
some of the most interesting of these compounds
at other sites containing nicotine-sensitive recep¬
tors, particularly in parasympathetic ganglia. In
addition some new compounds have been prepared
in attempts to discover substances with high and
specific ganglion-stimulant activity and others with
high and specific ganglion-blocking activity. These
included compounds with substituents not pre¬
viously examined (fluoro and methyl), a few
3,4-dimethoxy- and 3,4-dihydroxy- compounds,
and some unsubstituted compounds with un¬
saturated or cyclic (and therefore relatively rigid)
side-chains. The high nicotine-like activity of
3,4-dihydroxyphenethyltrimethylammonium (the
quaternary derivative of dopamine) has already
been reported by Cuthbert (1964); this compound
is also called coryneine and occurs in the cactus
Stetsonia coryne (Reti, Arnolt & Luduena, 1935).
The activity and specificity of ganglion-
stimulants was tested on the guinea-pig isolated
ileum by assessing activity relative to a standard
known to be reasonably specific and repeating the
assessment in the presence of hexamethonium.
Selected compounds were then tested separately
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with a range of concentrations of hexamethonium,
in order to see how far the dose-ratios obtained
were consistent with competition. Compounds
with ganglion-stimulant activity were also tested
on the blood-pressure of pithed rats.
The most specific ganglion-stimulant was then
used as an agonist in order to assess the affinity of
antagonists for ganglionic receptors in the guinea-
pig ileum. The extent to which the results were
consistent with competition gave some indication
of the specificity of the block. A rough idea of the
neuromuscular blocking activity of many of the
compounds was obtained by tests with the rat
diaphragm preparation. The affinity constants of
some of the compounds for postganglionic recep¬
tors in the ileum were also measured.
Methods
Guinea-pig ileum
The guinea-pig ileum was set up in aerated Tyrode
solution at 37 C; responses were recorded iso-
tonically with a load of about 0.5 gram. The
interval between doses was 5 min, as described by
Barlow & Franks (1971), to avoid desensitization.
The agonist was in contact with the tissue for 30s
and the drug solutions were applied by automated
apparatus (Abramson, Barlow, Mustafa & Stephen¬
son, 1969; Edinburgh Staff, 1970).
Agonists In the first group of experiments the
activity of agonists was assessed relative to a
standard, p-aminophenethyltrimethylammonium.
Groups of responses were obtained with two
concentrations of the standard, then with two
concentrations of the test drug, and then again
with two concentrations of the standard. The
concentrations producing comparable responses
were calculated from the average responses and the




Mean values of the log ratio were calculated ± the
s.e. mean.
In the second group of experiments the com¬
parison with the standard was performed in
exactly the same way but the Tyrode solution
contained hexamethonium (3 x IO^m). From the
estimate of the affinity constant of hexamethon¬
ium obtained by Barlow & Franks (1971), this
should produce a dose-ratio of 8.8 but if the
agonists are all acting at the same receptors as
those blocked by hexamethonium, this should not
affect their relative activities.
Some of the agonists were tested further by
measuring the dose-ratios produced by various
concentrations of hexamethonium. Responses
were obtained with two concentrations of the
agonist in the absence of hexamethonium and then
with increased concentrations of agonist in the
presence of hexamethonium. Usually two or three
concentrations of hexamethonium were tested in
any one experiment but in the present work the
dose-ratio was calculated using only the responses
obtained in the absence of hexamethonium at the
start of the experiment. In the work of Barlow &
Franks (1971) responses were also obtained in the
absence of hexamethonium after two concentra¬
tions of hexamethonium had been tested but these
were quite often found to differ appreciably from
those obtained at the start of the experiment; it is
probably more satisfactory to test a smaller
number of concentrations of hexamethonium in
any one experiment and to perform experiments
with more pieces of ileum.
Antagonists The antagonism produced by com¬
pounds was assessed by their effects on the
responses to m-hydroxyphenylpropyltrimethyl-
ammonium, which seemed to be the most suitable
agonist (see results). Each antagonist was usually
tested in two concentrations, producing dose-
ratios of about 10 and about 20, and the exact
dose-ratio and concentration of antagonist were
used to calculate the affinity constant. Results
were expressed as the mean value of log affinity
constant ± the s.e. Some compounds did not act
competitively and could be tested only in one
concentration because the antagonism was unsur-
mountable. This could be due to a postganglionic
blocking action (i.e. atropine-like activity) and
only a rough idea of their effects at ganglionic
receptors could be obtained.
Postganglionic receptors The affinity constants
of selected compounds for postganglionic recep¬
tors in the ileum were measured in experiments
with carbachol as agonist, allowed to act for 30s
and given once every 90s, and with hexamethon¬
ium, 2.76 x 10"4M, present in the Tyrode solution
(Barlow, Scott & Stephenson, 1963; Edinburgh
Staff, 1970; Barlow, Franks & Pearson, 1973). The
selection was intended to show the effects of chain
length and of type of substituent on affinity, for
comparison with their effects on affinity for
receptors in ganglia. Some compounds were also
included for which the results in the experiments
on ganglionic receptors (see above) suggested that
they should also be acting postganglionically.
Effects on blood-pressure
Pithed male Wistar rats, weighing between 250 and
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500 g, were anaesthetized with ether; the trachea
was cannulated, and a 14 gauge needle passed
through the eye and down the spinal cord.
Ventilation was maintained artificially with air
from a Palmer pump, at a rate of 1 stroke/s and
with a stroke volume of 5 ml. The animal was kept
on a heated operating table and the left external
jugular vein was cannulated with a nylon catheter
(0.63 mm o.d.), which was used for administering
drugs. The left carotid artery was cannulated with
a nylon catheter (0.75 mm o.d.) which was
connected to a Consolidated blood-pressure
transducer attached to a Devices M2 hot-stylus
recorder. Heparin (200 units) and atropine
sulphate (0.4 mg; 1.14 mmol) were administered
and the mean blood-pressure was recorded
continuously.
Drugs were given by infusion through the vein
cannula with a Watson Marlow MRHE pump in a
period of 15 seconds. Different doses were given
by altering the rate of infusion and the interval
between doses was 4 to 5 minutes. The activity of
compounds was expressed relative to that of a
standard, p-amihophenethyltrimethylammonium,
by comparing doses producing comparable rises in
pressure. The standard was tested twice at three
dose-levels during each experiment and it was
usually possible to compare two or three com¬
pounds with it in any one animal also at three
dose-levels tested twice. The rise in blood-pressure
observed was biphasic. The second rise was absent
after adrenalectomy and the first rise was blocked
by bretylium. Both these effects were expressed as
the rise in pressure divided by the blood-pressure
before the drug was given (which did not vary
much during the experiment) and the values were
used to calculate log dose-response lines by the
method of least squares. Equipotent molar ratios
were calculated from the ratios of the doses
producing responses which were 20% and 80% of
the maximum observed. With the particular com¬
pounds tested, these equipotent molar ratios for
the two phases in the response were approximately
the same so the results could be expressed as a
single ratio.
Rat diaphragm
Th6 rat isolated diaphragm preparation was set up
as described by Biilbring (1946) but in Krebs
solution instead of Tyrode (Edinburgh Staff,
1970). Responses were recorded isometrically with
a Devices strain-gauge and recorder. The phrenic
nerve was stimulated once every 10s by rectangu¬
lar pulses of about 0.5 ms duration, at a voltage
(usually about 2V) which produced maximal
twitch responses. Drugs were added by hand once
every 15 min and allowed to act for 5 minutes. In
each experiment compounds were tested in doses
of 0.02 and 0.04 ml of 10_1m solutions and
0.10 ml of 10"2m; the bath volume was approxi¬
mately 20 ml. The percentage inhibition of the
contractions was calculated and the total ('score')
for the three doses was taken. Each compound was
tested on two preparations and the average score
used as a very rough estimate of relative neuro¬
muscular blocking activity.
Compounds
The new compounds are listed in Table 1. The
other compounds tested have been described by
Barlow, et al. (1969). Pempidine tartrate, included
in the tests of ganglion-blocking activity, was
obtained from May & Baker; nicotine hydrogen
tartrate from BDH Ltd; dimethylphenylpiper-
azinium iodide (DMPP) from Aldrich.
The synthesis of some other new substituted
phenylpropyl compounds used has been described
elsewhere (Ison & Hassan, 1973).
T ranr-2-phenylcyclopropyltrimethylammonium
was prepared from the amine (Burger & Yost, 1948;
Smejkal & Farkas, 1963); phenylprop-l-ynyltri-
methylammonium was prepared from thedimethyl-
amino compound (Iwai & Hiraoka, 1963), which
was also partially hydrogenated using Lindlar
catalyst and a drop of quinoline to the cis form of
3-dimethylamino-l-phenylprop-l-ene and quater-
nized. Tra/tr-3-dimethylamino-l-phenylprop-l-ene
was prepared by dehydration of the alcohol (Ison &
Casy, 1971); the assignment of configuration was
supported by the intervinylic coupling constants (J=
16 Hz for the/wu-dimethylamino compound ;J= 8
Hz for the cir-isomer; both appeared to be
isonrerically pure).
Difficulties were experienced in the repetition
of the synthesis of leptodactyline (ni-hydroxy-
phenethyltrimethylammonium). Samples were ob¬
tained which had m.p. 251-2°C (cf. 163-4°C) and
had low biological activity even though the
analysis was acceptable for leptodactyline bromide
(found Br", 30.94; theory, 30.70%). the n.m.r.
spectrum however, indicated that this, and the
methoxycompound from which it was derived,
were tetrahydroiroquinoline derivatives, formed
by Pictet-Spengler cyclisation during the methyla-
tion of /u-methoxyphenethylamine. 6-Methoxy-
2-methyl-1,2,3,4-tetrahydro/soquinoline methio-
dide had m.p. 1 70-173°C (found 1", 39.77, theory,
3 9.75, cf. m-methoxyphenethyltrimethyl-
ammonium iodide, m.p. 182.3-182.6 C, theory, 1"
39.51). The theoretical content of bromide for
6-hydroxy-2-methyl-l, 2,3 ,4-tetrahydro/roqui-
noline methobromide is 30.94, identical with that
found. m-Methoxyphenethyldimethylamine was
therefore prepared from the reduction of the
dimethylamide (Epstein, Plapinger, Michel, Cable,
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Stcphani, Hester, Billington & List, 1964) and the
methobromide had m.p. 163-4°C.
Results
Ganglion stimulants
The relative activity of the compounds on the
guinea-pig ileum is shown in Table 2. Several of
them were more active than the standard, p-amino-
phenethyltrimethylammonium, but some of these
were even more active in the presence of hexa-
methonium (with positive values of A in Table 2)
indicating that they were acting, at least in part, at
postganglionic receptors (or ganglionic receptors
not blocked by hexamethonium). This was most
marked with the /3-pyridylmcthyl, phenethyl,
cyclopentylpropyl, phenylcyclopropyl, phenyl-
propynyl compounds and leptodactyline. With
Table 1 Melting points and analyses of new compounds.
R'C„ H4 CH, I^Me, X"
R' = X = m.p Found (X~) Theory
o-Me Br 206-8 32.62 32.72
m-Me Br" 218-9 32.58 32.72
p-Me I" 213 43.73 43.58
P-F r 248 42.71 42.99
R'R'CtH,CH,CH, ftMe, X"
R" = R' =
m- F H r 232-3 40.85 41.04
P-F H r 251-4 40.86 41.04
p-MeO m-MeO r 230 36.00 36.14
p-HO m-HO r 207-9* C, 41.1 40.9
H, 5.46 5.61
R"R'C6 H, CH, CH, l$Et, H X"
p-Br H CI 142 12.16 12.12
p-MeO m-MeO cr 126-7 13.19 12.95
R"R'C6 H, (CH,), i\iMe, X"
p-Me H r 119-120 39.45 39.76
p-MeO m-MeO r 133 34.68 34.75
p-HO m-HO Br" 200-201 C, 49.7 49.7
H, 7.08 6.95
BrCt H,CH==CHCH, &Et,H trans CI 161 11.69 11.65
Ct HsCECCH,NMe, L 226-8 42.01 42.13
C6 HSCH=CHCH, NMe, I" cis 116-7 42.16 41.86
trans 182-3 42.02 41.86
C, H, ANMe, I" trans 182-4 42.23 41.86
C6 Hs (CH, ) «(?Et, H Br " 99-100 27.85 27.90
C6 H, (CH, I's yEt, H Br" 79 26.62 26.61
C,H,(CH, ) , NMe, I 208 42.72 42.70
C5 H, (CH, )S^Et, H Br" 95-97 30.32 30.22
C,Hn(CH, ), NMe, I" 173 40.56 40.78
C6H„(CH, ), NEt, H Br" 118-9 28.72 28.72
Melting points were measured with a Mettler FP1 instrument, usually at a rate of heating of 2°C/min, and are
uncorrected. Analyses for halide are gravimetric (with samples of 50-250mg) and for C and Fl are micro- by Drs
Weiler and Strauss, Oxford. The quaternary derivative of dopamine, marked with an asterisk, was prepared by
Barger 8< Ewins (1911), who recorded m.p. 205°C and m.p. 232°C for the dimethoxy compound. Details of other
compounds studied are given by Barlow, et at., (1969) and Ison & Hassan (1973).
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some others hexamethonium reduced activity rela¬
tive to p-aminophenethyltrimethylammonium. In
most instances this indicated that the compounds
had postganglionic blocking activity and this was
investigated in experiments with carbachol as
agonist (see below). The variation in the effects of
hexamethonium on the actions of the phenyl-
propyl compound (Table 2) could be ascribed to a
lower sensitivity of the receptors in ganglia in the
second group of experiments with the consequent
need to use higher concentrations which produced
detectable postganglionic blocking effects.
The compounds which were considered to be
most interesting were tested in the presence of
various concentrations of hexamethonium in order
to see to what extent the antagonism appeared to




m-HOC6 H4 (CHj l,NMe,
pm-IHOI, C4 HjCH, CH, t^Me,
(coryneine)
m-HOC4 H4 CHjCHJ i^Me,
(leptodactyline)
p-H, NC6 H„ CHj CHj r$Me3
Ct H, CH=CHCHj l$Me3 trans
Ph(CHj)jfiMe3
pm-IHOIj C6 H, (CHj )3 f!iMe3





p-HOC6 H4 (CHj)3 fsjMe3
PhenylcyclopropylNMe3
trans
m-Hj NCt H4 CH=CHCHj &Me3
trans
p-Hj NCS H4 (CHj l3 iiiMe3
C4 Hs C=CCH, fviMe3
2-methyl-7-hydroxytetrahydro-
isoquinoline methiodide*
T.25 ± 0.06 (5)
T.52 ± 0.02 (4)
T.69 ± 0.02 (5)
T.82 ± 0.01 (4)
0.0 (standard)
0.07 ± 0.01 (4)
0.20 ± 0.02 (3)
0.42 ± 0.03 (6)
0.60 ± 0.04 (5)
0.61 ± 0.01 (3)
0.79 ± 0.04 (4)
0.84 + 0.02 (3)
0.86 ± 0.03 (4)
0.90 ± 0.06 (3)
0.91 ± 0.01 (4)
1.03 ± 0.01 (4)
1.12 ± 0.08 (3)
1.60 ± 0.06 (2)
3x W'M
7.73 ± 0.06 (3)
T.35 + 0.01 (2)
T.68 ± 0.02 (3)
1.92 ±0.02 (5) T.07 ± 0.02 (4)
0.0
0.47 ± 0.04 (3)
T.4
0.35 ± 0.02 (3)
0.68 ± 0.01 (3)
















The numbers show the mean estimate of the logarithm of the equipotent molar ratio relative to
p-aminophenethyltrimethylammonium ± s.e., with the number of estimates in parentheses. Note that a negative
number indicates greater activity because the same responses are produced with smaller concentrations. The
column marked A shows the effect of hexamethonium: if the compound is as specific as the standard the value
should be zero. A positive value suggests postganglionic stimulant (muscarine-like) activity; a negatkre value
suggests postganglionic blocking (atropine-like) activity. The phenylpropyl compound was tested in two separate
sets of experiments (1) and (2). and the effects of hexamethonium were found to be variable, though the relative
activity in the absence of hexamethonium was the same. The compound marked with an asterisk was found
accidentally in the synthesis of leptodactyline (see above) and is only very feebly active.
m-F3CC4 H4 (CHj )3NMe3, C6 Hs (CH3 )4NMe, and C6 H,, (CH3 )3NMe3 appeared to be inactive but the two
latter blocked the actions of carbachol. C3 H, (CHj )3 NMe3 appeared to be a partial agonist at postganglionic
receptors with log K about 4.2.
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be competitive; the results are shown in Table 3.
These agree reasonably with results already ob¬
tained for two of the compounds by Barlow &
Franks (1971). There are differences, which sug¬
gest that the errors may be bigger than the
variance indicates, but these could partly be due to
differences in experimental technique (discussed in
the methods section). With the lower con¬
centrations of hexamethonium there is good agree¬
ment between the experimental dose-ratios for
most of the compounds and those calculated
assuming a value of 2.6 x 10s for the affinity
constant of hexamethonium.
The low dose-ratios obtained with /J-pyridyl-
ethyltrimethylammonium show that it acts to a
large extent at receptors not blocked by hexa¬
methonium and the high dose-ratios obtained with
phenylpropyltrimethylammonium indicate that it
has appreciable postganglionic blocking (atropine-
like) activity, though this is not as much as that of
dimethylphenylpiperazinium (DMPP), for which
Barlow & Franks (1971) obtained dose-ratios of
12 with only 2 x 10-SM hexamethonium.
From the results obtained with the highest
concentration of hexamethonium, 1.6 x IO^m, it
seemed that m-hydroxyphenylpropyltri-
methylammonium was the most specific in that
the results were closest to those consistent with
competition. It was therefore chosen as the agonist
for testing ganglion-blocking activity with the
preparation. The results obtained with p-amino-
phenethyltrimethylammonium were not as con¬
sistent with competition as those previously ob¬
tained (Barlow & Franks, 1971), but these did not
include experiments with 1.6 x 1CT4m hexa¬
methonium. The results confirm the high nico¬
tine-like activity of the quaternary derivative of
dopamine (coryneine), reported by Cuthbert
(1964), but the compound is more difficult to
make than the p-aminophenethyl- and m-hydroxy-
phenylpropyl- compounds and slowly oxidizes
in solution, turning pink, so it was considered less
suitable for extensive use as a ganglion-stimulant. It
was, however, slightly more active than these com¬
pounds on the rat blood-pressure (Table 4).
Most of the ganglion-stimulants were also
potent blocking agents on the rat diaphragm
(Table 5) so their potential usefulness in vivo
might be limited by their neuromuscular blocking
properties. It was not possible to assess this from
the experiments on pithed rats because these were
artificially ventilated, but the lowest concentration
Table 3 Dose-ratios produced by hexamethonium with different agonists on the guinea-pig ileum.
Hexamethonium
concentration Ix 10-'M)
2 4 8 16
Calculated dose-ratio 6.2 11.4 21.8 42.5
p-H, NCt H4 CH2 CH, &Me3 7.2* 14.7* 21.0*
4.7 8.1 14.4 19.0
±0.5 ±0.3 ±1.0 ±2.9
(2) (2) (7) (2)




pm-(HO) 3 Ct Hj CHj CHj ftMe, 12.4 20.4 69.4
±1.6 ±2.6
(2) (3) (1)











4 x 10"* M
2.x 10"'M
3 x 10"* M
7 x 10"'M
1.1 x 10"5 M
5 x 10"'
Mean values are shown ± s.e., with the number of results in parentheses. Values marked with an asterisk were
obtained by Barlow & Franks (1971).
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used on the rat diaphragm was about 5 x 10~5m,
compared with concentrations of 2 or 3 x 10-"M
used to stimulate the guinea-pig ileum ( fable 3).
The results suggest then that m-hydroxy phenyl-
propyltrimethylammonium and coryneine should
have considerable specificity for ganglia unless
there are large differences in species sensitivity
(which is possible with desensitizing neuro¬
muscular blocking agents). In concentrations up to
3 x lCT^. pi-hydroxyphenylpropyltrimethyl was
without effect on guinea-pig strip preparations,
free from parasympathetic ganglia, nor did it
affect the responses to carbachol (Fiona Roberts,
personal communication).
(ianglion-blocking agents
Estimates of log affinity constant with in-hydroxy-
phenylpropyltrimethylammonium as agonist are
shown in Table 6. With several of the compounds
it was only possible to obtain dose-ratios less than
10; with higher concentrations, the antagonism
was unsurmountable, presumably because the
compounds blocked the postganglionic receptors.
A few compounds also caused the development of
spontaneous activity in the resting ileum. The
results in Table 6 also include estimates of relative
neuromuscular blocking activity on the rat dia¬
phragm. These are only very approximate, because
Table 4 Pressor activity in pithed rats.
R—NMej
R =
pm- (HO) 2C6 H, CH, CH, CH j -
(coryneine)
p-H, NCt H4CH,CH, -




pm- (HO), CjHjCHjCHj CH, -
0-pyridyFCH, -
0- pyridyFCH, -CH, -
Ct H, CH=CH-CH, - (trans)
o-H, NC, H4CH,CH,
m-HOC6 H4 CH, -


























The standard stimulant was p-aminophenethyltrimethylammonium and the figures show the logarithm of the
mean equipotent molar ratio (epmr) with the number of comparisons in parentheses. An asterisk indicates that
stimulant activity was accompanied by desensitisation which in some instances made it impossible to obtain a
quantitative result.
The following (trimethylammonium) compounds were blocking agents without themselves producing a rise in
blood pressure:
p-H, NCt Hs CH, p-MeC6 H4CH, -,p-FC6 H4CH,-,
o-MeC„ H4 CH, CH, p-MeOC6 H„ CH, CH,-,
pm-(MeO), Ct H, CH, CH,p-FC6 H4 CH, CH,
p-MeC6 «4CHj CHjCH, p-MeOC,, H4CH, CH,CH,
pm-(MeO), C„ H,CH, CH,CH, -, 0-pyridylCH, CH, CH,
C„ Hs CH=CHCH, - (c/s)
592 R.B. BARLOW, FRANCES BOWMAN, R.R. ISON & D.S. McQUEEN
Ihe result is greatly affected by the order in which
the compounds are given. They do indicate,
however, that although high ganglion-blocking
activity is often associated with high neuromuscu¬
lar blocking activity, with many chloro com¬
pounds for instance, though there are others, such
as p-bromobenzyldimethylamine, o-methoxyp-
henylpropyltriethylammonium, phenylpropyl- and
phenylbutyldiethylamine, where there appears to
be appreciable specificity for ganglia.
Affinity constants for postganglionic receptors
are shown in Table 7.
Ionization
Although some of the compounds studied were
tertiary bases, these are likely to be largely ionized
at body pH. Barlow, et a I. (1969) recorded a pK.a
of 9.14 for ghenethyldiethylamine in 40% v/v
ethanol at 25 C and we have obtained a value of
9.3 for this compound in pure water at 25°C. The
corresponding values for the benzyl, phenylpropyl
and phenylbutyl diethylamines were 9.1, 9.6 and
9.8, respectively.
Discussion
The results indicate the potential value of
m-hydroxyphenylpropyltrimethylammonium and
3,4-dihy droxy phene thy ltrimethylammonium
(coryneine) as ganglion stimulants in in vitro tests.
Further work is needed to see how far then-
usefulness in vivo may be limited by neuro¬
muscular blocking activity and it seems worth
testing their tertiary dimethylamino analogues to
see if these retain ganglion-stimulant activity but
lack neuromuscular blocking properties. The
change from triethylammonium to diethylamino
effectively restricts blocking activity to ganglia
(see below) so it is possible that the same may
occur with stimulants.
Table 5 Neuromuscular blocking activity of ganglion-stimulants on the isolated phrenic-nerve-diaphragm
preparation.
( + )-Tubocurarine chloride 300
p-HjNCjHjCHjCH^Me, 300
pm-(HO) j C6 Hj CH^CHj NMe3 (coryneine) 250
m-HOC< H4 CH2 CH2 CHa rsJMe3 240
m-HOC6 H4 CH2 CH j fvJMe3 (leptodacty line) 230
Decamethonium iodide 230
Ct H,, CH; CH, CHj ^Me3 180
The maximum score in the test is 300, indicating complete block in 5 min at all three dose-levels (0.04 and 0.02
ml of 10"'m and 0.1 ml of 10_1m added to a 20 ml bath). Each compound was tested on two preparations. Even
though the interval between doses was at least 15 min, the effects of a dose depend greatly on those of previous
doses and the error in the score is likely to be at least + 50.
Table 6 Ganglion-blocking activity on guinea-pig ileum and neuromuscular blocking activity.
X-CtH,-(CHJn-R
n= 1
R= f^Et3 H o m P H
X It o 5.57 (8)* 5.50 (4) 4.69 (11* 5.25
20 too 25 0





X = CI 5.35 (5) 5.53 (2) 5.82
5 80 10
Br 5.86 (7)




R= &Et, H o m p H










X=CI 6.11 (6) 6.04 (4)* 5.4** &06 (5)
60 90 80 0
R= rslEt,
X=CI 6.64(8) 6.30(3) 6.19(8)*
210 190 130
OH 5* 4.33 (3) *
85 50












PhCH=CHCH, NMe, (els) 4.11 (3)*
p-BrCt H. CH=CHCH, NEt, (trans) 5.81 (6) *
C, H, (CH,), NEt, 5.52 (6)






Mean estimates of log affinity constant are shown with the number of estimates in parentheses. The standard error
was usually less than 0.1 log units. Results for compounds with which it was only possible to obtain dose-ratios
less than 10 are marked with an asterisk; the others are based on dose-ratios of up to 20. Some compounds
produced a marked disturbance of the ileum which resembled spontaneous activity and this is indicated by a
double asterisk. The number in italics is the average score in the tests on the rat diaphragm (maximum = 300).
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Relationships between structure and activity
appear to be complex but this is partly because the
results in the experiments on the ileum are
complicated by actions at postganglionic recep¬
tors. The optimum chain length, for instance, is
apparently two methylene groups in the p-amino-
and 3:4-dihydroxy compounds but three methy¬
lene groups in the m-hydroxy- compounds. It is
also apparently two methylene groups in the
unsubstituted compounds, but this is partly due to
postganglionic stimulant activity in the phenethyl
compound. The further possible complication of
postganglionic blocking activity makes it impos¬
sible to say whether ganglion-stimulant acitivity
increases or decreases with side-chains longer than
three methylene groups.
Substitucnts other than hydroxyl or amino
markedly reduce activity and there is no reason to
link activity with the electronic effects of substi-
tuents. The aromatic nature of the ring may not,
in fact, be essential because the cyclopentyl
compound has some stimulant activity, though the
results are complicated by its weak postganglionic
stimulant activity (it appears to be a partial agonist
at postganglionic receptors). It has been suggested
that activity might be enhanced by the presence of
rigid features in the side chain (Wong & Long,
1962; Kirkendol, Woodbury & Elko, 1972) but
our results do not support this. cis-Phenylpropenyl-
trimethylammonium is a weak blocking agent and
although the trans isomer, and rransphenylcyclo-
propyltrimethylammonium have some activity
(Table 2), this is partly postganglionic. The present
results do not, however, rule out the suggestion
(Barlow, et al. 1969) that activity 'is associated
with the presence of substituents which can
interact with water molecules which may be
involved in the action of the drug at the receptor'.
With the ganglion-blocking agents it is possible
to observe the effects of substituents on affinity
for ganglionic and postganglionic receptors (Table
8) and it is remarkable how often the introduction
of a substituent reduces affinity and how seldom it
enhances it to any great extent. It is also striking
that the effects of substituents on affinity are
qualitatively similar even though the compounds
Table 7 Affinity for postganglionic receptors.
Ph(CH 3 )nNEt2
n= 1 2 3 4 5















C5 H, (CH2 )3 NEtj




















Values of log affinity constant are shown with the number of estimates in parentheses. The standard error of the
estimates was usually about 0.04 log units and never exceeded 0.10 log units. Compounds which disturbed the
resting intestine are indicated by an asterisk. The value for (+)-tubocurarine chloride is only approximate; the
compound did not appear to act competitively.
Table 8
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m— Br +0.42 +0.36
3 I X z -0.47
r>= 2
X= H 5.99 4.95
m— CI +0.16 +0.23
m-OjN -1.29 - 0.52
a i Xo -0.59
n- 3















Values of log K are shown for the unsubstituted compounds and the columns marked A show the effect
produced by the substituent. The subscripts g and pg refer to values for ganglionic and postganglionic receptors,
respectively.
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have usually about ten times the affinity for
ganglionic receptors as they have for post¬
ganglionic ones (this can be seen from the distribu¬
tion of + and — signs in Table 8). The affinity of
the cyclopentyl and cyclohexyl compounds (Table
6 and 7) indicates that the aromatic ring is not
essential for binding and there is no reason to
suppose that the effects of a group on affinity are
simply related to its effects on electron distribu¬
tion. The effects of a substituent on affinity arc
different in the different series of compounds and
the results support the view (Barlow, et a I. 1969)
that with these compounds affinity and substi¬
tuent cannot be fitted into an equation such as
those described by Hansch (Hansch, Maloney,
Fujita & Muir, 1962; review byTute, 1971).
The considerable specificity of the blocking
agents for ganglionic receptors is illustrated for the
unsubstituted compounds in Figure 1. 1'henyl-
butyltriethylammonium has some neuromuscular
blocking activity but this is much less in its
analogous tertiary base, phenylbutyldiethylamine.
This latter compound appears to be a ganglion-
blocking agent with considerable activity and
specificity, easy to make, and potentially capable
of crossing membranes, such as those of the
gastrointestinal tract or the 'blood-brain barrier'.
Phenylpropyldiethylamine is a weaker ganglion-
blocking agent that may be even more specific
(Table 6). The properties of these compounds
appear to be worth investigating in greater detail.
We thank Dr A. Ungar for a sample of suberylcholine.
Miss Evelyn Inglis for measuring affinity constants for
postganglionic receptors, Dr Fiona Roberts for tests with
guinea-pig intestinal strip, and Roche Products Ltd for the
award of a Fellowship to R.R.I.
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D. MCQUEEN and K. BELL, The effects of prostaglandin £, and sodium meclofenamate on blood pressure in
renal hypertensive rats, European J. Pharmacol. 37 (1976) 223—235.
Conflicting evidence exists regarding the ability of PGE, to normalize blood pressure in renal hypertensive
rats. We performed experiments to determine the effect of PGE, (15 pg/kg i.p. daily for 3 weeks) in renal
hypertensive Wistars and found no significant change in systolic pressure. A higher dose (150 Jig/kg i.p.) lowered
pressure after 14 days of treatment, but not back to control levels. Further investigations are required to establish
the mechanism whereby PGE, evokes this fall.
To test the hypothesis that endogenous prostaglandins have a hypotensive function in renal hypertension,
experiments were performed using sodium meclofenamate to inhibit prostaglandin biosynthesis. In chronic hyper¬
tensive rats the drug had no significant effect, while in the acute phase of renal hypertension there was a
dose-dependent inhibition of the pressure rise. The possibility is suggested that prostaglandins may initiate or
sustain the acute phase of renal hypertension in rats.
Sodium meclofenamate Renal hypertension Prostaglandins Blood pressure Rats PGE,
1. Introduction
It has been suggested that human essential
hypertension as well as experimental renovas¬
cular and renoprival hypertension may be a
result of an absolute or relative deficiency of
renal prostaglandins (Lee et al., 1965; Lee,
1967). There is a lot of evidence in favour of
this suggestion. Prostaglandins can lower blood
pressure (Bergstrom, 1967), they occur in the
kidney (Lee et pi., 1966), and renal ischaemia
provokes their release (McGiff et al., 1970).
The renal prostaglandin content increases in
experimental renal hypertension (Somova,
1971a) and there are reports that chronic
administration of PGE to renal hypertensive
animals lowers their blood pressure to normo-
tensive levels (Muirhead et al., 1967, 1968;
Somova and Dochev, 1970a; Somova, 1972).
The latter evidence is, however, equivocal since
Wendling and DuCharme (1974) found that
PGE, did not decrease arterial blood pressure
in renal hypertensive rats.
Somova (1972) and Wendling and Du¬
Charme (1974) used slightly different experi¬
mental techniques in arriving at different con¬
clusions regarding the ability of small doses of
PGE, to normalize blood pressure in renal
hypertensive rats. For example, the former
used Wistar rats while the latter used Sprague—
Dawleys. If was conceivable that the failure of
Wendling and DuCharme to confirm Somova's
findings stemmed from the slight procedural
differences. We decided that further investiga¬
tions on the effect of PGE, in rat renal hyper¬
tension were warranted, the object being to re¬
solve the conflicting evidence regarding the abi-
ability of PGE, to normalize blood pressure in
renal hypertensive rats. Somova's techniques
were followed as far as possible, the one major
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difference being that we used male Wistars
whereas Somova used an unspecified mixture
of males and females.
We also tested the hypothesis that endo¬
genous prostaglandins are involved as hypoten¬
sive agents in renal hypertension by using
sodium meclofenamate to inhibit their biosyn¬
thesis (see Flower, 1974 for a review on pros¬
taglandin synthesis inhibitors). If endogenous
prostaglandins have important antihyperten¬
sive functions, inhibition of their synthesis
should lead to a further rise of arterial blood
pressure in established hypertension, or ac¬
celerate the rise in blood pressure during the
acute phase of renal hypertension.
From our results we suggest that the possibil¬
ity be further examined that increased prostag¬
landin levels, or an imbalance between the
various prostaglandins, might directly or indi¬
rectly contribute to the acute phase of renal
hypertension in the rat.
2. Materials and methods
2.1. Animals
Wistar rats (8 and 9) weighing 150—180 g (2
months old) were used in the experiments.
They were individually coded and housed 5 to a
cage in a room with controlled temperature
(21°C), humidity (R.H. 50%) and lighting
(12 h light (08.00—20.00) alternating with 12
h darkness). Water and Oxoid modified 41B
diet were provided ad lib and the rats were
weighed once a week.
2.2. Blood pressure measurement
Measurements were made in the same cage
order and at the same time of day (09.15—
14.00), generally twice weekly. Systolic blood
pressure was measured indirectly by using the
tail cuff method, pulsations of the tail artery in
prewarmed rats being monitored by a photo¬
electric detector (Huntingdon Instruments Rat
Blood Pressure Monitor) and recorded on a
Devices M2 recorder together with cuff pres¬
sure.
The rats were prewarmed by placing them in
a glass-doored incubator at 35°C for 20 min.
The tail cuff was then applied while the rat
was loosely restrained in a heated (37°C)
holder and 5 consecutive readings of systolic
pressure obtained. Pressure was determined
by rapidly increasing pressure in the cuff until
the tail pulse disappeared, then gradually re¬
leasing the pressure at a reproducible rate over
10—15 sec and noting the pressure at which
the pulsations first reappeared. This was taken
as the systolic blood pressure (see fig. 1) and
the last 3 of the 5 measurements, if consistent,
were averaged to provide the systolic reading.
Occasionally a rat became agitated and it was
not possible to obtain a reading on that par¬
ticular day.
Consistent readings were obtained by fol¬
lowing a fixed routine and ensuring that the
same person performed the measurements at
the same time on each occasion. It was impor¬
tant also to ensure that the tail cuff was
consistently located on the same part of the tail
and that extraneous noise was kept to a mini¬
mum. The rats were trained in the routine by




Fig. 1. Sample trace showing tail artery pulsations
together with tail cuff pressure. The pressure corre¬
sponding with the reappearance of pulsations is
marked and this is taken as systolic blood pressure.
1 sec time marker.
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the first operation. We established that esti¬
mates of arterial blood pressure obtained from
conscious rats by the tail cuff method were not
significantly different from those obtained
concomitantly via an indwelling carotid artery
catheter, inserted under halothane anaesthesia
5 days prior to the measurements. It is neces¬
sary to use an indirect method of estimating
blood pressure for long-term experiments be¬
cause of the problem of keeping indwelling
catheters patent over long periods. The pre¬
operative systolic pressures obtained in the
present experiments are similar to those pre¬
viously reported for rats (Weeks and Jones,
1960; Finch, 1971; Wendling and DuCharme,
1974).
2.3. Operative procedure
Rats were anaesthetized with halothane and
the left kidney exposed by a retroperitoneal
incision. The renal artery and vein were sepa¬
rated and a sliver clip (6 mm X 2 mm X 0.25)
was placed around the artery and squeezed
until the renal artery was slightly constricted
(mean internal diameter of clip 0.30 mm). The
incision was sutured and the animal injected
with benzathine penicillin (22.5 mg i.m.).
After an interval of 2 weeks the right renal
artery was similarly clipped. Following re¬
covery from the operations the blood pressure
of most of the rats gradually increased. Hyper¬
tensive rats were arbitrarily defined as being
those with a systolic blood pressure in excess of
150 mm Hg.
Sham operations involved procedures essen¬
tially similar to those described, excepting that
the renal artery and vein were left untouched —
the renal arteries were not clipped.
2.4. Drug administration
The rats were arranged in groups of 6—16
and drugs administered by daily i.p. injections,
the injections being made at the same time each
day (approx. 15.00 h).
Drug solutions were prepared and coded by a
colleague such that we were unaware of which
drug was being administered to a particular
group until the experiment had been con¬
cluded. This was to minimise the influence of
any operator bias.
2.5. Drugs used
PGE, and sodium meclofenamate were in¬
vestigated. The former was injected at 2 dose
levels, namely 15 pg/kg and 150 pg/kg. To
assist solution, 0.25% ethanol was added to the
weaker solution and 0.5% to the stronger. The
same concentration of ethanol was present in
the saline controls, saline (sterile 0.9% w/v
aqueous sodium chloride) being the vehicle for
the prostaglandin. Sodium meclofenamate (5
mg/ml) was also dissolved in saline.
All the drug solutions were made up to
contain in 1 ml the dose to be injected per
kilogram of body weight. Prior to each injec¬
tion the rats were weighed and then injected
with the appropriate amount of solution. When
not in use the solutions were kept at —20°C,
and biological activity of the PGE, was
checked by assaying samples of the solutions
about one week after the experiment had
finished. All the solutions were of comparable
potency when assayed against freshly prepared
PGE,, using the depressor effect on an anaes¬
thetized rat's blood pressure as the test system,
and U.V. analysis showed only traces of PGA,
in the PGE, injection solutions.
2.6. Data analysis
Comparison of data from 'control' and
'treated' groups for any given measurement was
made by I-test. The null hypothesis was re¬
jected if p < 0.05 and the difference between
groups described as statistically significant. In
some experiments the same group provided its
own control values by the comparison of pre-
injection values with those obtained during the
drug study.
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3. Results
3.1. Controls
The first experiment undertaken involved 6
male Wistar rats, the object being to determine
how blood pressure varied with changes in age,
weight and tail diameter, and also to test the
reliability of the blood pressure measuring
technique.
Data obtained are given in table 1 from
which it can be seen that quite consistent
systolic blood pressure readings were obtained
despite the physical changes in the rats. The
experiment also established that neither the
stress of the operation nor that of repeated
blood pressure measurements had any notice¬
able effect on blood pressure.
3.2. PGE,
2 groups of rats were made hypertensive and
3 months after the first operation daily i.p.
injections were commenced. Blood pressure
was measured twice weekly. For the first 5 days
both groups received saline in order (a) to
provide control values for subsequent statisti¬
cal tests, (b) to show what influence the stress
of the injection procedure had on blood pres¬
sure, and (c) to act as a control for subsequent
injections since both groups were to be injected
with solutions containing low concentrations
of alcohol.
Following this period of saline injections,
one group of rats received 15 pg/kg PGE,
while the other group received the same volume
of drug vehicle. The results obtained are shown
in fig. 2. As there was no significant change in
the blood pressure of either group after 20 days
of treatment, the dose of PGE, was increased
to 150 pg/kg and the injections continued for a
further 21 days. A fall in blood pressure was
observed in the PGE,-treated group, this fall
being statistically significant from the four¬
teenth day after increasing the dose of PGE, .
The mean blood pressure was, however, still
significantly higher than the pre-operation con¬
trol values and had not been normalized. 3 days
after stopping the injections the pressure of the
PGE, -treated group was still significantly re¬
duced, although by the eighth day it was not
significantly different from pre-injection
values. There was no significant change ofmean
blood pressure in the vehicle-treated group.
There is a range of systolic pressures in any
group of hypertensive rats, and it is possible to
subdivide the group into those with 'moderate'
hypertension and those with 'severe'hyperten¬
sion. The result of doing this for the PGE-
treated group is shown in table 2 and the data
suggest that the change in blood pressure is
not related to the degree of hypertension
since it is similar for both sub-divisions.
3.3. Sodium meclofenamate
Sodium meclofenamate was used to investi¬
gate the role of endogenous prostaglandins in
renal hypertension (see the Introduction).
In the first series of experiments a control
TABLE 1
6 male Wistar rats—sham-operated. Mean systolic blood pressure and body weight before and after the operations
Pre-op. Days after first sham operation
25 46 95 127 141
Systolic B.P. (mm Hg) 138 131 141 130 135 133
Body weight (kg) 0.23 0.32 0.35 0.43 0.44 0.45
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Fig. 2. Male Wistar renal hypertensive rats. Systolic blood pressure (mean ± S.E.M.) and mean weight plotted
against time. The upper panel shows the values before, during and after daily i.p. injections, saline being admin¬
istered during the period indicated by the open rectangle, PGE, 15pg/kg during the hatched rectangle and
PGE, 150 pg/kg during the black rectangle. There were initially 15 rats in the group with a mean pre-operative
control pressure of 132 mm Hg; one rat died during the study. The number of rats measured on any given day is
shown and the dotted line represents the mean of the 3 measurements prior to commencing the injections. The
lower pane! shows the values of a control group of hypertensive rats which were injected concurrently with the
drug vehicle. There were initially 16 rats in this group with a mean pre-operative control pressure of 131 mm Hg;
1 rat died during the study. The symbol ® in the upper panel indicates values which were significantly different
(P < 0.05, t-test), in the case of the first three from the mean pressure on day 102 (saline injection), while in the
case of the last three symbols the difference is that between the two groups, the vehicle-injected animals serving
as a control group.
group of 15 unoperated male wistars was dosed
daily with 5 mg/kg i.p. of sodium meclo-
fenamate for 31 days. There was no statistically
significant change in the group mean blood
pressure during the period of treatment.
3.4. Sodium meclofenamate in established
renal hypertension
We used male and female Wistar rats of this
study. The females were much more difficult to
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TABLE 2
Results from the group of hypertensive rats treated with PGE, (fig. 2) rearranged to show the data in terms of
'severe' hypertension (systolic pressure > 200 mm Hg) and 'moderate' hypertion (systolic pressure between 150—
200 mm Hg). There were 7 rats in each group and the hypertensive control value is the average of the three read¬
ings prior to commencing treatment with PGE,.




























handle than were the males, but by being
patient consistent readings were obtained from
them. The experiment consisted of administer¬
ing sodium meclofenamate (5 mg/kg i.p. daily
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Fig. 3. Wistar renal hypertensive rats (8 females, 7
males) dosed during the period indicated by the black
bar with sodium meclofenamate, 5 mg/kg i.p. daily.
The systolic pressure (mean t S.E.M.) is plotted
against time as is the mean weight. The number of
rats measured on any given day is shown and the
dotted line represents the mean of the 3 measure¬
ments prior to commencing the injections.
operation and recording blood pressure. The
results obtained are shown in fig. 3 from which
it can be seen that there was a tendency for
blood pressure to rise during the treatment
period, although no statistically significant
difference was observed. When the results were
analyzed according to the sex of the rats, it was
found that initially the pressure of the male rats
fell while that of the females rose slightly. This
difference was also not statistically significant.
However, in view of the possibility that
different results might have been obtained with
an all-male group, an additional experiment
was performed in which a group of male renal
hypertensive rats was similarly treated with
sodium meclofenamate (5 mg/kg i.p. daily).
The group used was composed of rats previous¬
ly treated with PGE, (see fig. 2), it having been
established by the earlier experiment that
changes in prostaglandin levels, caused by
dosing with PGE, , resulted in blood pressure
changes. The results obtained are shown in
fig. 4 and it can be seen that no significant
alteration in systolic blood pressure occurred
during treatment with sodium meclofenamate.
The tendency was for the pressure to fall, but
this fall was not statistically significant. The
rats' weight was slightly reduced by the end of
the injection period, but this reduction was also
not statistically significant. The all-male group
thus responded similarly to the mixed group.
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Fig. 4. Wistar renal hypertensive rats (12 males) dosed during the period indicated by the black bar with sodium
meclofenamate, 5 mg/kg i.p. daily. Other details as for fig. 3.
TIME (days after starting injections)
Fig. 5. The influence of sodium meclofenamate in the acute phase of renal hypertension in male Wistar rats. Daily
i.p. injections during the period represented by the black rectangle of (X - ■ -x ) sodium meclofenamate 0.5 mg/kg;
(O O) sodium meclofenamate 5 mg/kg; and (• • ) saline. The blood pressure (mean ± S.E.M.) is
plotted against time and the number of rats measured in each group is shown (12), (a) meaning that 1 rat in the
low dose meclofenate group had died, there subsequently being only 11 measured in that group, (b) that a rat in
the high dose meclofenamate group had died and (c) that another died in this group, meaning there were only 10
survivors. The arrows indicate the days on which the first (1) and second (2) operations were performed, and
control pressures (day 0) are the mean of the three measurements preceding the first operation. « indicates a
significant difference (p < 0.05, i-test) between the mean pressure of the drug-treated group and that of the saline
group on the same day.
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Fig. 6. Acute renal hypertension in male Wistar rats. Details as for fig. 5, this graph showing mean of the group
weights against time.
3.5. Sodium meclofenamate in acute renal
hypertension
A further experiment was performed in
order to investigate the influence of sodium
meclofenamate on blood pressure during the
acute phase of renal hypertension. The blood
pressure of 3 groups of young rats was mea¬
sured in order to establish control levels, and
daily i.p. injections were commenced the day
before clipping the first renal artery and con¬
tinued for 27 days, at which time they were
stopped as the rats were losing weight. Blood
pressure measurements were continued
throughout the treatment period and for 2
weeks thereafter.
As in the previous experiments, the injec¬
tions were made 'blind'. One group received
saline, one sodium meclofenamate at 0.5 mg/
kg, while the third group received sodium
meclofenamate at a dose of 5.0 mg/kg. The
results obtained are shown in fig. 5 from which
it can be seen that during the period of treat¬
ment statistically significant differences were
observed between group systolic pressures. The
reduction in blood pressure, or the prevention
in pressure rise in the meclofenamate-treated
rats was dose-dependent and, in the case of the
higher dose level, returned blood pressure to a
level which did not differ significantly from the
pretreatment controls. It should be noted that
a significantly higher pressure was observed in
the low dose group, as compared with the saline
group, 5 days after the first operation.
When the injections were stopped the pres¬
sures of the drug-treated groups rapidly rose to
reach the same level as the saline group within 7
days. The rise in pressure of the high dose group
was very rapid and was associated with the
death of two of the rats at this time.
Fig. 6 shows the mean weights of the groups.
There was a slight fall in weight of the meclo¬
fenamate-treated rats after the second opera¬
tion, but this was not statistically significant
and the saline-treated group also stopped gain¬
ing weight as this time.
4. Discussion
We were unable to demonstrate any hypo¬
tensive effect of low doses of PGE, in chronic
renal hypertensive rats, and to that extent our
findings agree with those of Wendling and
DuCharme (1974). These authors reported that
PGE, at a dose of 150 pg/kg i.p. daily for 4
days in rats with established renal hypertension
failed to cause any significant change in blood
pressure. In contrast, Somova (1972) found
that PGE, , at the lower dose of 20 pg/kg i.p.
PGE, AND MECLOFENAMATE IN RENAL HYPERTENSION 231
daily, normalized blood pressure within 5 days.
Our results show no significant blood pressure
change after administering PGE, at a dose of
150 Mg/kg i.p. daily for 10 days. However, after
14 days of treatment with this higher dose,
blood pressure fell significantly, although at no
time did it return to control levels. Blood
pressure returned to pre-injection hypertensive
levels within 7 days of stopping the injections
(see fig. 2).
It could be argued that in the present investi¬
gation the degree of hypertension was greater
than that obtained by previous workers and
that therefore the results are not comparable.
The rise in pressure also occurred more rapid¬
ly, being evident within 10 days of clipping the
first renal artery, whereas Somova and Dochev
(1970a) reported that their rats were still nor-
motensive 21 days after clipping the first renal
artery. By grouping our rats according to their
degree of hypertension, we established that
those with 'moderate' hypertension (pressure
levels similar to previous reports) and those
with 'severe' hypertension responded to PGE,
with similar decremental changes in systolic
blood pressure (table 2). Since the response
eventually elicited by PGE, appears to be
unrelated to the degree of hypertension, com¬
parison of our findings with those from experi¬
ments involving less severe hypertension, as
judged from systolic blood pressure, appears
valid.
It is also unlikely that the fall in blood
pressure of the PGE, -treated group is directly
caused by the slight, but not statistically signifi¬
cant, weight loss. The vehicle-treated group
also lost weight, and yet their blood pressure
did not fall. What causes the slight weight loss
observed in the present investigation requires
further study, but it may have been a reaction
to the prolonged injection period of 46 days or
the presence of 0.5% ethanol in the injection
solution.
One might anticipate that low doses of PGE,
administered i.p. would be slowly absorbed,
probably into the hepatic portal system (Lukas
et al., 1971), and therefore rapidly cleared
from the blood by liver and lung metabolism
(Dawson et al., 1968; Ferreira and Vane,
1967). The implication would be that only
minimal quantities of PGE, reach the systemic
circulation. Perhaps these minimal amounts, or
metabolites of PGE, , are responsible for the
chronic fall in blood pressure? Experiments in
conscious normotensive rats (Somova, 1971b)
and in pentobarbitone-anaesthetized rats
(McCaig and McQueen, unpublished observa¬
tions) demonstrated that PGE, at a dose of 15
pg/kg i.p. causes a transient lowering of arterial
blood pressure, the effect lasting 20—40 min.
Assuming that this effect arises from actions on
the systemic vasculature, it is evident that
either PGE, on i.p. administration can reach
the systemic circulation (perhaps by overload¬
ing the prostaglandin inactivating mechanism,
which might not be very efficient in the rat
according to Papanicolaou and Meyer, 1972) or
that a metabolite is active in lowering blood
pressure. A cumulative effect of the acute
blood pressure changes is not a likely explana¬
tion of the chronic blood pressure reduction
which eventually develops since doses of 100
pg/kg PGE, i.p. daily for 9 months do not af¬
fect blood pressure in normal rats (Somova et
al., 1973), and nor does PGE, have significant
hypotensive effects in rats with sodium chlo¬
ride hypertension (Somova and Dochev, 1971).
The mechanism(s) responsible for the latent
blood pressure lowering effect of exogenous
PGE, (also described by Muirhead et al. (1968)
using much higher doses (0.75—3.3 mg/kgs.c.)
of PGE2 ) and its physiological significance
could not be deduced from our experiments
and further work is needed to clarify the
matter.
Since our results with low doses of PGE,
were negative in that we failed to detect any
hypotensive effect, we decided to employ
another approach to investigating the question
of whether or not prostaglandins play a role in
renal hypertension, and this involved the use of
sodium meclofenamate to inhibit prostag¬
landin biosynthesis. If endogenous renal pros¬
taglandins have a hypotensive function, as has
been proposed by Lee et al. (1965) and Muir¬
head et al. (1972), then inhibition of their
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synthesis, there being little stored in the kidney
(McGiff et al., 1974), should raise blood pres¬
sure to higher levels. However, whereas Davis
and Horton (1972) reported a pressure rise in
normotensive anaesthetized rabbits treated
with indomethacin, our results showed very
little change in the blood pressure of normoten¬
sive rats or of rats with established hyperten¬
sion when they were treated with sodium
meclofenamate (figs. 3 and 4). It has been
reported (Somova et al., 1974) that treatment
with aspirin or indomethacin (1 mg/kg/day
orally for 6 days) lowers the elevated prostag¬
landin levels in the kidneys of renal hyperten¬
sive rats, but does not affect arterial blood
pressure.
Prostaglandin release from the kidney fol¬
lowing renal ischaemia (McGiff et al., 1970)
might only be involved in lowering blood pres¬
sure during the acute phase of renal hyperten¬
sion or, alternatively, the two-clip renal hyper¬
tensive rat with established hypertension may
not be able to show blood pressure changes in
response to alterations in prostaglandin levels
because of damage to the vascular system as a
result of the sustained high pressure or because
of sodium volume dependency (Gavras et al.,
1975). Either of these possibilities would ex¬
plain why inhibiting synthetase activity in
established renal hypertension has no signifi¬
cant effect on blood pressure. We decided
therefore to examine the effect of sodium
meclofenamate during the acute phase of renal
hypertension. If the hypothesis that pros¬
taglandins have a hypotensive role is correct,
then inhibition of their biosynthesis during the
acute phase of hypertension should cause the
blood pressure to rise more rapidly.
The results we obtained (see figs. 5 and 6)
showed a dose-dependent reduction of the
pressure rise, this being particularly obvious
following clipping of the second renal artery.
There was a transient increase in pressure
(above the control group value) in the rats
treated with the low dose of meclofenamate 5
days after clipping the first renal artery. After
the injections were stopped blood pressure in
both drug-treated groups rapidly rose to a level
comparable with that of the control group,
thereby suggesting that sodium meclofenamate
was acting by causing a dose-dependent inhibi¬
tion of a system involved in raising blood
pressure in renal ischaemia, or perhaps in sus¬
taining the initial rise.
Interpretation of our findings depends upon
the specificity of sodium meclofenamate as an
inhibitor of prostaglandin biosynthesis. Meclo¬
fenamate was used in preference to indo¬
methacin because it is readily soluble in water,
is as potent when administered systematically
as when given orally, and as it has a long plasma
half-life it need only be administered once a
day (Glazko, 1972; Kurtz and Fitzgerald,
1972). Following meclofenamate dosage in
rats, drug levels are highest in the liver, kidney
and plasma (Glazko, 1972). Since we were
unable to find any data relating to the degree of
inhibition of prostaglandin synthesis which
would result from chronic treatment with so¬
dium meclofenamate in rats, we resorted to
selecting a dose based on the fact that meclo¬
fenamate is as potent or more potent than
indomethacin on most synthetase preparations
(Flower, 1974). Accordingly we used a dose of
5 mg/kg i.p. which, if equivalent to the same
dose of indomethacin, should produce sub¬
stantial inhibition of prostaglandin synthesis
(Flower, 1974) without causing toxic effects
(Kurtz and Fitzgerald, 1972). We did not in
fact detect any toxic effects other than slight
weight loss following prolonged treatment, and
this was not statistically significant. In the
acute hypertension experiment a dose of 0.5
mg/kg had effects which took longer to develop
but which were qualitatively similar to those
elicited by ten times the dose of meclofena¬
mate. Recently Pugsley et al. (1975) reported
that PGE, synthesis by rat renal medullary
slices incubated with plasma from rats treated
with indomethacin (5 mg/kg s.c. daily for 7
days) was reduced by 65%. However, without
biochemical data we cannot be sure to what
extent sodium meclofenamate was inhibiting
prostaglandin biosynthesis and nor can we
preclude the possibility that the dose used was
affecting other enzyme systems (e.g. renin—
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angiotensin). The same would still have been
the case had we used indomethacin or aspirin.
If sodium meclofenamate was inhibiting
prostaglandin synthesis specifically, our re¬
sults could be interpreted as' meaning either
that prostaglandins directly or indirectly
provoke the acute hypertension but have little
influence on established hypertension, or that
an imbalance of prostaglandins A, E and F
arises such that blood pressure becomes ele¬
vated, possibly as a consequence of altered
renal haemodynamics (McGiff et al., 1974).
Renal prostaglandin synthetase activity in renal
hypertensive rats initially falls and then rises
(Grodzinska et al., 1974) and it is tempting to
interpret our findings in terms of actions of
meclofenamate on the production of renal
prostaglandins. Malik and McGiff (1975) have
recently provided evidence that prostaglandins
of the E series modulate adrenergic transmis¬
sion .in the rat kidney and this results in an
enhanced vasoconstrictor response to sym¬
pathetic nerve stimulation, the effect also being
augmented by the prostaglandin precursor
arachidonic acid and reduced by indomethacin.
Laborit and Valette (1975) also found that
arachidonic acid worsened hypertension in uni¬
laterally nephrectomised rats treated with
DOCA/NaCl, although they attributed this to
central actions of PGE2 formed from the
arachidonic acid. There is thus other evidence
to support the suggestion that prostaglandins
may initiate or sustain the acute phase of
hypertension in renal hypertensive rats.
Pugsley et al. (1975) recently reported that
indomethacin causes a further rise in blood
pressure of rats with only one renal artery
clipped, the contralateral kidney being left
untouched. This is contrary to our finding, but
there is evidence that unilateral clip renal hy¬
pertension differs from that obtained with
bilateral renal artery occlusion, or unilateral
occlusion with contralateral nephrectomy
(Gavras et al., 1975). Our results are not,
therefore, directly comparable. It may be that
the unilateral clip renal hypertensive rat will
prove to be a more appropriate model in which
to study the effects of altering prostaglandin
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levels on the course of renal hypertension, but
the present investigation was concerned only
with the two clip model because it was from
this type of hypertensive rat that conflicting
evidence had been obtained concerning the
ability of prostaglandins to normalise blood
pressure in established hypertension.
Interpretation of data from either of the
types of hypertensive rat may well depend
upon dissociating the acute from the chronic
effects of altering prostaglandin levels and
also in determining the specificity of drugs
used to inhibit prostaglandin biosynthesis.
With regard to the latter point, it is interesting
to note than in rabbits arachidonic acid in¬
creases and indomethacin decreases plasma
renin activity (Larsson et al., 1974). However,
since it has been shown that the rat differs
from the rabbit as far as the effects of indo¬
methacin on responses elicited by sympathetic
nerve stimulation are concerned (Malik and
McGiff, 1975), the observations relating to
renin levels in rabbits may have no relevance
to the situation in the rat. Indeed Somova et
al. (1974) were unable to detect any change
in renin activity following treatment of hyper¬
tensive and normotensive rats with indometha¬
cin, and Vander (1968) reported that prostag¬
landins have no effect on renin release. Despite
this evidence to the contrary, it would seem
worth investigating further the possibility that
prostaglandin synthetase inhibitors affect,
directly or indirectly via changes in prostaglan¬
din levels, the renin—angiotensin system.
Further investigations into the nature and
extent of prostaglandin involvement in the
aetiology of bilateral clip renal hypertension
in the rat seem warranted.
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SUMMARY
Response patterns of single units in the medial parts of the pons and mid¬
brain were studied extracellularly in chloralose-anaesthetized rats, paralyzed
with pancuronium.
The units were tested with natural skin stimuli including slight touch and
hair-brushing in order to provide input from sensitive mechanoreceptors
supplied by myelinated afferent fibres. Noxious pinch and controlled nox¬
ious radiant heat were also used to provide nociceptive input. The influence
of these stimuli on unit activity was compared with that evoked by electrical
stimulation of the coccygeal nerve, which excited either the A-fibres only or,
with stronger stimuli A- and C-fibres. It has been shown that about half the
units responding to electrical stimulation of the A-fibres exhibited a second
peak of excitation with a latency of 100—300 msec when the stimulus
strength surpassed C-fibre threshold. A high and statistically significant cor¬
relation has been found to exist between increased excitability induced by
noxious heating and/or squeezing the skin on the one hand and the occur¬
rence of a C-fibre response on the other hand.
From this evidence it is concluded that a large proportion of the units in
the medial pons and midbrain receive nociceptive input from the skin and
that this input is mediated predominantly by C-fibres.
When applying controlled radiant heat it has been found that the dis¬
charge frequencies of-units responding to noxious input do not code the
stimulus strength exactly, rather the units usually switch from a lower to a
higher discharge frequency when noxious levels of stimulation are reached.
The functional implications of this are discussed.
* Supported by the DFG, Grant Ha 831/4.
** From the Dept. Pharmacol., University of Edinburgh. In receipt of a British Council-
DAAD Interchange Scheme award.
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INTRODUCTION
Several structures in the medial part of the midbrain might be involved in
the processing of nociceptive signals. During the last few years it has been
shown that electrical stimulation of structures in the periaquaeductal region
of the midbrain can suppress nocifensive responses [22,24], Furthermore,
the same brain region has emerged as a structure of importance for the anal¬
gesic action of morphine [11,15,23,34,35]. From these findings the hypoth¬
esis has arisen that this region, particularly the central grey and the midbrain
raphe nuclei, constitutes a "pain suppression centre" [23], On the other
hand, the central grey [27] and adjacent fields of the reticular formation [6,
27] might be involved in an ascending nociceptive system.
Anatomical [6,26,30] and evoked potential [20] studies provide evidence
for somatosensory input to midbrain reticular and central grey neurones, but
give little information on the type of the skin receptors involved. In the cat
several single unit studies have been performed to investigate the proportion
of units responsive to innocuous stimulation compared with those which
respond predominantly or exclusively to noxious stimuli [2,4,9,10,12,31,
36]. Little is known, however, about these proportions in the rat, the species
mainly employed in behavioural and pharmacological studies on the central
nociceptive system. Even the results obtained in the cat are controversial,
reports of the number of units responding to exclusively nociceptive input
ranging from none [31] to almost 100% [36],
The aim of the present work was to study the characteristics of cutaneous
input to midbrain central grey, raphe and reticular neurones in the rat with
special reference to input from the tail, since the "tail-flick" is the most fre¬
quently studied nocifensive behaviour in this species. In subsequent studies
we intend to study midbrain neurones in awake animals while testing the
"tail-flick" reaction.
METHODS
Results were obtained from experiments on 21 male albino rats (Sprague —
Dawley and Wistar strains) weighing between 250 and 350 g. The animals
were initially anaesthetized with a-chloralose (70 mg/kg i.p.) with supple¬
mentary doses of pentobarbital (2 mgat intervals of approximately 3 h) being
given i.v. A tracheotomy was performed and the right jugular vein was can-
nulated for drug administration. At the end of surgery the animals were para¬
lyzed with pancuronium (s.d. 0.5 mg) and artificially ventilated.
The ECG was monitored throughout the experiment and no further
recordings were attempted when signs of a cardiac conduction block
appeared. In the case of a complete AV block the experiment was termi¬
nated. The body temperature was kept near 37°C by infrared radiation.
For controlled electrical stimulation the left main trunk of the coccygeal
nerve was exposed at the tail base, cleared from the surrounding tissue for
a length of about 15 mm, and slotted into a polyethylene tube containing
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Fig. 1. Nerve volleys recorded with bipolar hook electrodes (platinum wires) from the
coccygeal nerve on electrical stimulation of the nerve by the device described in Methods.
A: stimulation above A-fibre threshold. Each trace 3—5 superpositions. Stimuli applied at
a rate of 1/3 sec. B: stimulation below and above C-fibre threshold. Single shock C-fibre
stimuli have been applied at a rate of 1/10 sec.
two platinum wires (0.1 mm in diameter, distance 8—10 mm) for stimula¬
tion. By this technique continuity in the nerve was maintained. The skin was
sutured over the stimulating electrode in order to prevent its dislocation and
to avoid drying of the nerve. In pilot experiments on 4 rats (not included in
the experimental sample) we tested the stimulation arrangement by moni¬
toring the nerve volley from the exposed nerve at a point 70—100 mm distal
to the stimulating electrodes. Fig. 1 shows typical results.
A nerve volley appeared when 100—200 mV, 0.1 msec square pulse stim¬
uli were delivered from an isolation unit (Digitimer). This volley represented
action potentials travelling at about 35 m/sec (skin temperature 30°C). A
stimulus strength of 3 V, 0.1 msec was always supramaximal for this A fibre
compound action potential. It was not usually possible to separate clearly an
Aa,|3 from an A5 volley. (But see the small A5 component in Fig.l.) A
C-fibre volley with conduction velocity between 0.8—2.0 m/sec appeared at
a stimulus strength of about 8 V when 0.5 msec square pulses were used. It
was saturated in all cases at 30 V, 0.5 msec stimulus strength.
In those experiments in which the aim was to record from midbrain units,
we eliminated the second nerve preparation, necessary for recording the
nerve volley, since it would have interfered with the natural skin stimulation.
Instead we tried to monitor the focal potentials in the midbrain, which
always had a threshold below a stimulus strength of 500 mV, 0.1 msec.
Natural stimulation of the skin receptors was performed by stroking the
skin with a brush, by slight tapping and by strongly squeezing the skin with
102
a serrated forceps. In order to apply a more precise noxious stimulus, con¬
trolled radiant heat as used in previous studies on the cat [3,13,14] was
employed. Briefly, a thermocouple was placed in good contact with the skin
at a point on which the radiation of a halogen bulb was focused. The focal
spot had a diameter of approximately 7 mm. The output voltage of the ther¬
mocouple was fed back to control the heating current of the bulb. A more
detailed description of the method is given elsewhere [3],
For recording activity of mesencephalic and pontine units, the rat was
placed in a stereotactic holder in the position specified by Koenig and
Klippel [19]. Recordings were performed with glass-coated tungsten micro-
electrodes, having an exposed tip of 1—5 pm, which were inserted through a
small hole drilled in the skull.
At the end of each track an electrolytic lesion was made. Usually only
one and never more than two tracks were performed in a rat, this being in
order to simplify histological reconstruction of the recording sites. Spike
recordings were amplified with a conventional AC coupled preamplifier.
All units which are documented in this study had primarily negative going
peaks and a stable form and size throughout the testing. A window discrimi¬
nator was used to distinguish unitary spikes from noise. Scatter displays of
activity evoked by electrical nerve stimulation were constructed on line using
the Z-input of a storage oscilloscope. Recordings were also stored in addition
on magnetic tape. Responses to natural stimulation of cutaneous receptors
were analyzed off-line constructing spike occurrence density histograms with
a PDP-12 computer.
At the end of an experiment the animal was killed by an overdose of pen¬
tobarbital and was perfused through the abdominal aorta with 7% formalde¬
hyde in saline. Frozen sections of the brain were cut at 30 thickness, and
stained by the Nissl method in order to facilitate reconstruction of the elec¬
trode tracks.
RESULTS
(1) Sample of units tested
A total of 146 units have been studied between the stereotactic bounda¬
ries +700 pm and —1700 pm in the frontal plane, and between +/— 1000 pm
lateral to the midline (stereotaxy according to the Koenig and Klippel atlas
supplemented for the most caudal sections by the figures of Palkovits and
Jacobowitz [19,32]).
Of these units 98 could be driven by electrical stimulation of the coccy¬
geal nerve. Thus 65% of units received input from the tail. It is uncertain,
however, if this proportion is representative of the neuronal population in
this region, since we used a search stimulus (1.0—3.0 V, 0.1 msec) delivered
to the coccygeal nerve when hunting for units. Non-responsive units with
very low spontaneous activity might have escaped our notice. Of the 98
units driven by electrical stimulation 92 were also tested for excitation by
"natural" skin stimulation. Seventeen of them (18%) could not be excited
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by application of any kind of natural stimulus.
The spontaneous activity of the units in our sample was rather variable,
ranging from 0.1 to more than 100 spikes/sec. Interval histograms (IHs) have
been constructed of the spontaneous activity of some of the units having a
level of spontaneous activity exceeding 20/sec. These IHs approximately
resembled Poisson, distributions in each case. Some units under study
switched once or twice during the testing period from higher to lower activ¬
ity or vice versa in the absence of experimentally induced stimulation. To
avoid incorrect classifications we assessed only those units which were shown
to be responsive to some type of natural stimulation and which responded
consistently to at least two repetitions of natural stimulation. In no instance
did we encounter discharges that were overtly correlated with respiratory
rate or with heart rate.
(2) Responses to electrical stimulation of the nerve
All units described as "responsive to electrical stimulation of the coccy¬
geal nerve" in this study had a determinable latency which could be demon¬
strated as a peak in a poststimulus time histogram constructed with a bin
width of 10 or 100 msec from 16 repetitive stimuli (cf., Methods for repeti¬
tion rate). All units which were found to fit the above criterion of respon¬
siveness to electrical nerve stimulation responded to weak stimuli which
activated A-fibres only. This response showed a latency of between 10 and
20 msec. The short latency found in the present study is in agreement with
an evoked potential study in the rat midbrain [20] and indicates an oligo-
synaptic input from the tail. As can be seen from an example shown in Fig. 2
there is some recruitment between stimuli which just surpass the threshold
for the largest A-fibres (Fig. 2A) and stronger stimuli (Fig. 2B), indicating an
additional input from smaller myelinated fibres, perhaps in the A5 range. In
5 out of 98 units the response to A-fibre stimulation consisted of an inhibi¬
tion of spontaneous activity instead of an early excitation. In most of the
other units the initial excitation was followed by an inhibition (cf., Fig. 2C)
which in some units lasted more than 1 sec.
When the strength of stimulation was increased above the threshold for
C-fibres, in about half of the units (43 of 83 units tested with C-fibre stim¬
uli) a second peak of excitation could be seen (marked by an arrow in Fig.
2D). Only once did we record a second peak at a stimulus strength of 3.0 V,
0.1 msec, which might have been a rebound excitation due to input from A-
fibres. In all other units the second peak required a stimulus intensity above
5.0 V, 0.5 msec. Since these high voltage and long duration stimuli only
recruit very slow 5-fibres (cf., below 10 m/sec) and C-fibres beyond the fibre
spectrum excited by weaker stimuli, the second excitation is presumably due
to input from these fibre classes. A comparison of two examples (cf., Figs. 2
and 3) from two different units (recorded in different rats) illustrates the
range of latencies of this second excitation.
In the case of Fig. 3, the central latency was only about 20 msec, if the



















Fig. 2. Response patterns of a midbrain unit to electrical stimulation of different inten¬
sity. At the top: sample record together with a corresponding raster display. Below: raster
displays and corresponding peristimulus time histograms of the discharges of the same
unit to electrical stimuli of different strength. Calibrations in (A) as in (B), and in (D) as
in (C), respectively.
conduction through the ascending system of the spinal cord seems to have
been much slower. It is possible, however, that in this specimen a first part
of an excitation by C input is masked by the preceding inhibition due to the
A-fibre input.
When stimuli above threshold for C-fibres were delivered, about half of
the units which responded to C-fibre stimulation exhibited an oscillation of
excitation and inhibition lasting up to several seconds (cf., Fig. 2D). Those
oscillations with 1—4 firing maxima/sec have also been observed during and
after noxious heat stimulation and might be characteristic of responses to
nociceptive input. Other units (cf., Fig. 3B), however, lacked those oscilla¬
tions. We found no systematic difference of the distribution of the units
with and without oscillations in different midbrain structures.
When stimulated above C-fibre threshold, 4 of the units which had been
judged to be non-responsive on the basis of the above criterion nevertheless
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Fig. 3. Response pattern of a midbrain unit to electrical stimulation below (A) and above
(B) the threshold for C-fibres. Dot displays as in Fig. 2. Each response sequence is shown
as a horizontal line of dots. First stimulus at top. Peristimulus time histograms derived
from the same data as dot displays. Stimulation frequencies: 1/3 sec in (A) and 1/10 sec
in (B).
showed a more diffuse increase in activity lasting several seconds. An exam¬
ple of such a change in activity is shown in Fig. 4. These 4 unite perhaps
received input from C-fibres, but not from fast conducting A-fibres. No unit
of this small sample, however, chapged its firing pattern significantly during
natural noxious stimulation.
When higher stimulus frequencies have been used, response patterns as
shown in Fig. 4 became similar to the "wind up" phenomenon which can be
| Stim 50 V. 0.5 ms
I 1 sec 1
Fig. 4. A: dot display of the discharge pattern of a midbrain unit during electrical single
shock stimulation above C-fibre threshold. The stimulus was applied 1/10 sec at the time
indicated by the arrow. First stimulus on the top line. B: peristimulus time histogram of
the same discharges.
106
seen in the spinal cord following noxious stimulation, sometimes even in
units lacking a strictly temporally locked, distinct excitation by the stimulus.
However, "wind up" phenomena were less frequently encountered than the
oscillations described above. An oscillating firing pattern has been described
previously in midbrain neurones of the rat following noxious stimulation
[18].
(3) Responses to natural stimulation of the skin
As stated above, 75 units could be driven by "natural" skin stimulation.
Only one of these units was driven exclusively by radiant heat stimulation,
the others were activated by mechanical stimuli or by both types of stimula¬
tion. All units were tested carefully over the whole posterior and on the scro¬
tum with the different kinds of mechanical stimuli described in Methods.
The belly was inaccessible for stimulation because of the position of the ani¬
mal in the stereotactic frame. The hindpaws and the tail were also tested
with radiant heat at different sites. Fifty-nine units, i.e., about 80% of the
mechanosensitive units, responded phasically to slight tapping of the skin,
the receptive fields not being smaller than one body quadrant. Fifteen units
out of this sample were driven in addition by stroking the fur of the rat with
a brush, presumably responding therefore to input from hair follicle recep¬
tors. Twenty units responding phasically to tapping also exhibited a tonic
high frequency response to strong squeezing of skin folds. The latter stimu¬
lus was certainly noxious. Sometimes the receptive field for the squeezing
response seemed to be wider than that for the tapping response. Receptive
field sizes were not studied systematically, however. Eleven units did not
respond to slight mechanical stimulation, but only to squeezing, or to squeez¬
ing and to noxious heat. Noxious radiant heat served as a quantitatively
adjustable stimulus in this study. Two programs were used, one which raised
the skin surface temperature stepwise (cf., ref. 14) up to noxious levels, the
other which raised it in a ramp function. These two forms of radiant heat
stimulation were used to get a rapid account of the relationship between
firing frequency and the stimulus parameters "level of temperature" and
"rate of change of temperature", since a more thorough and lengthy study
of the quantitative relationship using single heat pulses would have interfered
with the other aims of this study. As can be seen from Fig. 5, firing of mid¬
brain units usually did not closely follow the form of the stimulus.
Regardless of the slope of the stimulus temperature most units showed a
more or less pronounced "switching" to higher discharge frequencies when
noxious levels were reached. At noxious levels, however, the firing frequency
usually did not appear to closely reflect the level of temperature, as can be
seen from the histograms in Figs. 5 and 6. An analysis of interspike interval
distributions at different temperature levels (not documented in this paper)
supported this conclusion.
Often (cf., Fig. 5), but not always (cf., Fig. 6) an excitation by noxious
radiant heat was followed by long lasting afterdischarges, sometimes oscilla¬
tory in character. Oscillations of discharge frequency after heat stimulation
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Fig. 5. Spike occurrence density histograms of a unit responding to noxious heating of a
spot in the middle of the tail. The skin temperature was raised in a staircase function in
the upper record, and in a ramp function in the lower record. The two stimuli were
applied at 3 min intervals. Each histogram constructed from a single stimulus.
and oscillating discharges after electrical C-fibre stimulation were not always
seen in the same units. Usually a unit, which could be excited by heating of
the tail, could also be driven from the hindpaws (cf., Fig. 6). Commonly,
however, the receptive field had a centre of greatest input, extending over







tail - near tip lett hindpa'
Fig. 6. Spike occurrence density histograms of a single unit on heating different skin sites.
The heating program raised the skin temperature in a staircase function, as shown in the
traces at bottom. Each histogram constructed from a single stimulus.
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TABLE I
Units responding to heating and/or squeezing
+ — Total
Units responding to electrical + 39 5 44
C-fibre stimulation — 6 25 31
Total 45 30 75
(4) Correlation between different types of input
Although the receptor spectrum in the rat's tail is not well known, it can
be concluded from our knowledge of cutaneous receptors in other mam¬
malian species that heavy squeezing with serrated forceps and heating above
45° C excite C-fibre nociceptors. Both types of noxious stimulus might excite
either the same population of polymodal nociceptors [5], or partly overlap¬
ping populations of heat- and mechanonociceptors [3,17].
To test the hypothesis that C-fibre input is relevant for responses to nox¬
ious stimulation, we compared the occurrence of C-fibre responses to electri¬
cal nerve stimulation of the units responding to heating and/or squeezing the
skin with that of units receiving only tactile input. The results are shown in
Table I.
Eighty-seven percent of the units responding to noxious skin stimulation,
but only 17% of the units receiving a tactile input, exclusively had, in addition,
a late response to electrical nerve stimulation above C-fibre threshold. Thus the
correlation of a response to "natural" noxious input and a response to elec¬
trical C-fibre stimulation is evident and statistically significant (P < 0.01,
X2 test).
In the 6 units receiving noxious input, but showing no C-fibre response,
the latter presumably was concealed by a long lasting inhibition following
the early A-fibre response of the unit (cf., Figs. 2 and 3).
Thus our results indicate that responses to noxious radiant heat and to
noxious squeezing are most likely mediated by C-fibre input. Table II shows
the relationship between the two types of "natural" noxious input.
Fifty-one percent of all units responding to any type of noxious stimula¬
tion responded to both. The units responding to heating and also to squeez¬
ing represent 31% of the sample of units which were found to be responsive
TABLE II
Units responding to heating
+ — Total
Units responding to squeezing + 23 8 31
— 14 30 44
Total 37 38 75
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Fig. 7. Histological reconstruction of electrode tracks according to the atlas of Koenig
and Klippel, and the supplementary figures of Palkovits and Jacobowitz. Only tracks in
which units responding to noxious heating and/or squeezing were recorded are shown.
These units are indicated by dots. The horizontal strokes at the bottom of each track
indicate the location of the electrolytic lesion. Area covered by a raster: central grey.
Hatched areas: raphe nuclei.
to any kind of "natural" cutaneous input whereas another group of units,
40% of the sample, received neither form of noxious input, only tactile
input. Again the correlation is statistically significant (P< 0.05, x2 test). One
possible reason for the latter correlation is that polymodal nociceptors are
responsible for both heating and squeezing responses. A convergent input
from heat- and mechanonociceptors to the same units cannot be excluded,
however.
(5) Location of units responding to noxious stimulation
Fig. 7 shows the locations of units responding to noxious input. No func¬
tional differences were found between the nociceptive neurones found in
different structures of pons and midbrain. It can be seen that those units
were found in the central grey, in the mesencephalic and pontine reticular
formation, and in different raphe nuclei: the n. medianus raphe, the n. dor-
salis raphe and the n. raphe pontis. Location in raphe nuclei does not neces¬
sarily imply that serotonergic neurones found in these raphe nuclei are
included in our sample, since only some of the units in the raphe region are
serotonergic [33], More units have been found caudal than rostral to the
stereotactic zero plane. More input from the tail and the hindpaws to caudal
than to rostral midbrain regions has already been suggested previously [12,
20,35].
DISCUSSION
In this study the electrical activity of neurones was recorded in the central
grey, in the region of raphe nuclei and in the pontine and mesencephalic
reticular formation. Their response patterns to somatosensory input had
110
some similarity to those described previously in reticular fields [1,2,4,6,9,10,
12,31,36] and in raphe nuclei [18,28] of the midbrain and lower brain stem
of the cat. Characteristics of the latter are wide receptive fields, a low degree
of somatotopic organization and sensitivity to different qualities of cutane¬
ous input.
Most of the units of our sample could be excited by slight mechanical
stimuli and responded with a sustained discharge of higher frequency to nox¬
ious squeezing and/or heating of the skin. Sixteen percent of the sample of
units which could be excited by natural skin stimulation responded only to
noxious levels of stimulation. One could regard these units as "specific noci¬
ceptive" neurones. There are, however, arguments against this classification:
all units of this sample responding only to noxious natural stimulation also
responded to low level electrical stimulation which excited only the A-fibres
in the coccygeal nerve. Some of them had very low electrical thresholds and
thus certainly received input from thick myelinated nerve fibres. As far as we
know, mammals have nociceptors only among the thin myelinated and un¬
myelinated fibre classes [3,5,7,17]. It is likely therefore that this input from
myelinated fibres is a mechanoceptive one. It might have been too weak
under the conditions of our preparation to elicit spikes during natural stim¬
ulation.
In the present sample of brain stem neurones in the rat, we have found in
addition to the above features that the discharge frequency did not appear
to reflect closely the level and the rate of change of noxious heat stimuli
delivered in the form of ramps or staircases. A previous study with similar
stimuli showed a much closer relationship between these stimulus parameters
and the firing frequency of nociceptive C-fibres in the cat's plantar nerves
[14].
Another feature was the long afterdischarges which often followed nox¬
ious heating and squeezing. In particular we did not find qualitative differ¬
ences of nociceptive responses of units located either in the reticular forma¬
tion, in the central grey, or in the raphe nuclei. The units responding to nox¬
ious cutaneous inputs seem to be scattered throughout these areas.
The functional role of the nociceptive units in pons and midbrain is still
not clear. They may be part of the ascending reticular activating system. A
second hypothesis is that these units are part of a central pain processing sys¬
tem. Ascending nociceptive pathways passing not only through the mesen¬
cephalic reticular formation but also through the central grey have been
postulated on the basis of behavioural deficits of cats with lesions in this
brain region [27], The fact that electrical stimulation of the medial midbrain
often evokes escape reactions in animals [16] and the sensation of pain in
man [29] supports such a hypothesis. Even some of the experiments in
which it was shown that pain reactions can be suppressed by electrical stim¬
ulation of the central grey [22—24] or by local action of morphine [11,15,
21,35] perhaps fit into the hypothesis of an ascending pathway in this brain
region. Morphine might probably suppress units of such a pathway and if
high currents (more than 1 mA) are used in experiments with electrical
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brain stimulation, these could induce inexcitability in some neurones for
some time.
However, if the "pain suppression centre", which has been presumed to be
situated in this region, exists, and if units receiving nociceptive input are
involved in its action, our findings are consistent with the concept of a nega¬
tive feedback loop which is effective in suppressing pain.
We have shown in this study that the nociceptive input reaching neurones
in pons and midbrain of the rat is most probably transmitted by C-fibres in
the coccygeal nerves. Response patterns to electrically evoked C-fibre volleys
have rarely been described previously in brain stem neurones. Two studies
dealing with these responses in the cat reported extremely long latencies [4,
10] requiring a central conduction time of at least 1 sec in one case [4].
C-fibre responses with shorter latencies, indicating an oligosynaptic input,
have been reported in the monkey midbrain [25], The present findings in
the rat suggest the existence of oligosynaptic input from C-fibres to midbrain
neurones in this species. One cannot exclude, however, a possible contribu¬
tion from slowly conducting A5-fibres, which were either too few in number
or which had such different conduction velocities that they were not visible
in the compound nerve action potential.
Yet all units (even the sample of 18% units which were driven by nocicep¬
tor input, but could not be excited by non-noxious tactile input) could also
be activated by A-fibre stimulation in the nerve. Because of this 2-fold elec¬
trical input we do not assume that any of them are unimodal units, e.g.
exclusively nociceptive in the sense that they are anatomically connected
only to nociceptors. It could be, of course, that part of the input is sup¬
pressed in some behavioural situations and thus units are functionally uni¬
modal.
Any type of anaesthesia or decerebration induces a rather extreme func¬
tional state which might influence the properties of central neurones. Chlo-
ralose as used in this study has been found previously to enhance the recep¬
tive field to tactile input [1]. Responses to noxious stimulation might be less
frequent than in the decerebrate state [8]. Nevertheless, we have found a
high proportion of units responding to noxious input in our study. This may
indicate the functional importance of nociceptive input to the medial struc¬
tures of the upper brain stem in the rat.
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PERIPHERAL ARTERIAL CHEMORECEPTORS
D.S. McQueen and D.J. Pa I lot
This chapter describes the influence of the peripheral arterial chemo-
receptors on respiration and also examines the transduction mechanism
of these receptors. It is our intention to concentrate mainly on the
recent literature; readers requiring information about historical aspects,
or more detailed evidence than it is possible to give in this chapter, are
referred to reviews on chemoreceptors (e.g. Schmidt & Comroe, 1940;
Heymans & Neil, 1958; Dejours, 1962; Anichkov & Belen'kii, 1963;
Torrance, 1968; Biscoe, 1971; Eyzaguirre & Fidone, 1980) and the
proceedings of recent international meetings on arterial chemoreceptors
(Purves, 1975; Paintal, 1976; Acker et al., 1977; Belmonte et at., 1981).
The peripheral arterial chemoreceptors are sensory receptors which
monitor the oxygen and carbon dioxide tensions and pH of arterial
blood, and form part of the integrated system that controls respiration.
A fall in the partial pressure of oxygen in arterial blood (Pa02 ), a rise
in TaCOj or a fall in pH, increases the activity of these receptors,
increases discharge frequency in their sensory (afferent) nerves, which
terminate centrally mainly in the nucleus tractus solitarius, and
ultimately may stimulate respiration. Two main groups of arterial
chemoreceptors exist in mammals, namely the aortic and carotid
bodies located, respectively, near the arch of the aorta and in the
bifurcation of the common carotid arteries. The carotid body is very
vascular and is supplied with arterial blood by one or more arteries
originating from the bifurcation or the external carotid artery; venous
blood drains into the internal jugular vein. The aortic bodies are supplied
with blood from small branches of the aortic arch. In addition, pul¬
monary chemoreceptors have been described (Coleridge, Coleridge &
Howe, 1967) and tissue similar in structure to that of chemoreceptors
is found along the course of the abdominal aorta (abdominal para¬
ganglia, Abbot & Howe, 1972). This review will only be concerned
with chemoreceptors of the aortic and carotid bodies because it is
these which hrive been most extensively studied and they appear to
be of greatest importance.
Each carotid and aortic body receives nerve fibres from two sources.
The glossopharyngeal (cranial IX) nerve supplies sensory fibres to the
1
1
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carotid body (glomus caroticum) via a branch known variously as the
carotid nerve, the intercarotid nerve, the carotid sinus nerve, the sinus
nerve or llering's nerve, and the cell bodies of these sensory fibres are
located in the sensory (petrosal) ganglion of the lXth nerve. In addition,
the carotid body is also innervated by sympathetic fibres (ganglio-
glomerular nerves) from the superior cervical ganglion (see Figure 1.1).
Some sympathetic fibres also course down the sinus nerve. The aortic
bodies are innervated by the (aortic) vasodepressor nerve (a branch of
the vagus) which has its cell bodies in the nodose ganglion; they also
receive a sympathetic nerve supply from the stellate ganglion.
Figure 1.1: A Diagrammatic Representation of the Innervation of the
Cat Carotid Body. Note the dual innervation from the sinus nerve and
ganglioglomeruIar nerve. The aortic bodies also receive a dual innervation.
Petrosal & Erhrenritters
ganglia
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Histologically the carotid and aortic bodies consist of groups of cells
collected around numerous large capillaries. A connective tissue stroma
is found between groups of cells and contains numerous nerve fibres;
on closer examination each cell group is seen to contain two cell types
which have been given a variety of names (see Biscoe, 1971). We shall
apply the term Type 1 to the most common type of cell, and Type II
for the less frequently encountered cell which is often located at the
periphery of a cell group. The general histological features of the
carotid body are illustrated in Figure 1.2; and we shall make a more
detailed examination of the important structural features of peripheral
chemoreceptors in a later section.
The embryological origin of the carotid body has only recently
been established. Using a heterospecific grafting technique (Le Dovarin,
Le Lievre & Fontaine, referred to by Verna, 1979) which enabled
donor cells to be identified in the recipient, Pcarse and his colleagues
(see Verna, 1979) established that in birds Type 1 cells were definitely
derived from neural crest tissue, and Type II cells may also originate
from the same source. A number of studies have described the develop¬
ment of the carotid body (see Verna, 1979); all of these demonstrate
that the carotid body is structurally mature well before birth, a some¬
what surprising finding in view of the physiological immaturity of the
organ prior to the onset of respiration (see Chapter 8).
Two particularly interesting features of the carotid chemoreceptors
emerged from studies performed on cats. They have a very high oxygen
consumption of —9ml (1 OOg"1 )min~', indicative of intense metabolic
activity, together with a very substantial blood flow of 2 litres (100g-1)
min~' . The difference between arterial and venous blood oxygen
content is, however, fairly low (0.2 -0.5 ml/lOOml) and the venous
blood is quite red; this could result from low oxygen extraction from
the blood, or from direct passage of blood from arteries to veins via
extensive anastamoses in the carotid body.
Study of Peripheral Arterial Chemoreceptor Activity
Various techniques are employed for studying chemoreceptor activity,
including the classical approach of using reflexly induced respiratory
changes as an indicator of receptor activity (see Heymans & Neil,
1958). Electrophysiological techniques are now commonly used because
they avoid some of the complications associated with reflex studies,
such as the influence of the anaesthetic on the reflex pathway, or
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Figure 1.2: The Histology of the Carotid Body. Note how the cells are
set in a connective tissue stroma (ct) amidst numerous blood vessels
(c). Some bundles of nerve fibres are also seen (small arrow head).
Even at this magnification two cell types are visible on the basis of
nuclear morphology (T1 and large arrow heads), and position in the
cell groups.
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secondary changes such as those initiated by alterations in blood gas
tensions or by the lung inflation reflex. Such techniques are generally
regarded as providing more information about activity at the receptor;
what they actually provide is information from a small sample of
chemosensory fibres which is taken to represent the response of the
whole carotid body complex.
Recordings of single units (single active fibres) obtained using
extracellular recording electrodes show that action potentials associated
with chemoreceptor fibres occur irregularly. This distinguishes them
from the regular pressure-related discharge associated with baroreceptor
fibres (Figure 1.3). The interval between successive chemoreceptor
potentials is in fact random, following a Poisson distribution (see
Biscoe, 1971). Furthermore, unlike the baroreceptors which cease
firing when the arterial blood pressure falls below a certain level,
chemoreceptor afferents do not exhibit a firing threshold.
Figure 1.3: Electrical Recording of Sensory Activity in a Filament
Dissected from the Peripheral End of a Carotid Sinus Nerve which had
been Cut Centrally (A). Note the irregular discharge of the large
biphasic chemoreceptor unit and the regular discharge of the smaller
monophasic baroreceptor unit which is synchronous with the pulse
seen in the blood pressure record (B) (McQueen, unpublished record).
In (C) the lower part of the chemoreceptor action potential was used to
trigger 50 successive sweeps of a storage oscilloscope during intense
chemoreceptor stimulation evoked by sodium cyanide (5 pg intra-
carotid); it can be seen from the trace on the right-hand side of the
figure that no chemoreceptor tjction potential occurred within 7 ms
of a triggering potential. This observation, together with the shape
and amplitude of the action potential, enables it to be classified as
a single unit.
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The effects on chemoreceptor discharge and on respiration of
breathing gas mixtures containing different concentrations of C02 and
02 have been studied by various workers using both respiratory and
electrophysiological techniques (e.g. Lahiri & Delaney, 1975).
Function
As already mentioned, the arterial chemoreceptors respond to changes
in arterial blood gas tensions and pH and reflexly influence respiration.
The chemoreceptors are responsible for about 15 per cent of the
respiratory drive during eupnoeic (normal) respiration, most of this
contribution appears to come from the carotid chemoreceptors in man.
The carotid body is the only mechanism in the body for detecting
hypoxia and initiating rapid reflex respiratory adjustment. The central
chemoreceptors are not stimulated by hypoxia; rather breathing is
depressed by the direct effect of hypoxia on the CNS. This effect is
in contrast to that of C02-H+ in the physiological range which can act
centrally to increase respiration, as well as reflexly via the arterial
chemoreceptors. Very high levels of C02-H+ can cause a central depres¬
sion of ventilation. In this chapter we are concerned exclusively with
the influence of arterial chemoreceptors on respiration, but it should
be appreciated that these receptors reflexly influence other body
functions, such as control of the cardiovascular system (Heymans &
Neil, 1958; Anichkov & BelenTcii, 1963).
Peripheral chemoreceptor discharge increases when either Pa02 falls
or the PaC02 rises. The two stimuli interact in the peripheral chemo¬
receptors in such a way that hypoxia enhances the discharge associated
with hypercapnia, and vice versa. The interaction is additive or more
than additive (multiplicative) at lower discharge frequencies. Clearly as
the response to either stimulus alone approaches maximum, the poten¬
tiation produced by the two stimuli given together is less marked.
There is not much change in ventilation when Pz02 falls during normo¬
capnia in steady-state conditions, until a Pa02 of about 8.7 kPa
(lkPa 7.5 mmHg) is reached when breathing increases. Peripheral
chemoreceptor activity, however, increases when slight falls in oxygen
tension occur even at levels of Pa02 well in excess of the respiratory
'threshold'; chemoreceptor activity is not lineafly related to Fa02,
the curve of discharge against />a02 steepens as the />a02 falls. The
explanation for the lack of correlation between chemoreceptor dis¬
charge and ventilation is that the peripheral chemoreceptor drive is
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opposed by direct depression of the respiratory centre by hypoxia;
additionally the fall in RaC02 that occurs in response to the hyper-
ventEation decreases the drive from the central chemoreceptors. When
a critical Pa02 is reached, these factors are unable to negate the
increased input from the peripheral chemoreceptors, and respiration
increases.
There is an almost linear relationship between carotid chemoreceptor
discharge and PaC02 over the physiological range, the slope of the
curve steepening as Ta02 is lowered. A 'fan' of lines relates respiration
to PaC02 at different oxygen tensions in man (see Cunningham, 1974).
Below a certain faC02, known as the 'C02 threshold', ventEation
appears to be independent of PaC02 (even though peripheral chemo¬
receptor activity is not) and the overaE C02-ventilation curve is often
described as being 'dog-legged' in shape, something which is most
apparent under hypoxic conditions. Experiments in anaesthetised
animals show that ventilation is not totally independent of PaC02 in
the range 2.7 - 5.3 kPa, and apnoea can occur even in severe hypoxia
when the faC02 is very low. However, anaesthesia interferes with the
responses, as is shown by the fact that anaesthesia in man raises the
C02 threshold and the 'dog-leg' is not seen. Respiratory thresholds vary
from individual to individual, and even within individuals; it is thus
very difficult to obtain meaningful data from conscious animals and
man when breathing is subject to minimal drive because ventEation
becomes very irregular (see Cunningham, 1974). Hence it is difficult
to be sure what the C02 -respiration dog-leg signifies, but it may result
from C02-H+ acting in the medulla to modify afferent input from
the peripheral chemoreceptors.
Experiments in man using the single breath 02 test (see Dejours,
1962) enable assessment of peripheral chemoreceptor respiratory drive
to be made since the single breath wEl influence the arterial chemo¬
receptors before the CNS, and changes in respiration wEl not be compli¬
cated by the alterations in blood gas tensions and pH which accompany
alterations in ventEation under steady-state conditions. It is found that
a single breath of 100 per cent 02 causes a transient faE of about
15 per cent in respiration. This response has a latency of 1-3 breaths
due mainly to the circulation time from alveoli to arterial chemo¬
receptors, and is not obtained when the peripheral arterial chemo¬
receptors are denervated. If oxygen breathing continues, respiration
returns to normal because although removal of peripheral chemo¬
receptor drive initially reduces ventEation, C02 retention occurs and
the rise in PaC02 stimulates respiration, so that within one minute
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breathing is back to normal. This can be seen in Figure 1.5, where
respiration during breathing 100 per cent Oj in steady state is not
much different from that during air-breathing, although carotid chemo-
receptor discharge continues to be reduced by the high oxygen tension.
Figure 1.4: Discharge of a Single Chemoreceptor Unit Showing the
Effects of Intracarotid Injections of Different Substances at the Marker.
Also shown is the maximal discharge recorded 90 s after starting to










Peripheral chemoreceptors can respond to C03 or H+, but the
response to H+ is not as fast or intense as that to a transient C03
stimulus producing the same pH change. This is probably because
molecular C03 crosses biological membranes faster than H*. Carbonic
anhydrase inhibitors such as acetazolamide slow the hydration of C03
Peripheral Arterial Chemoreceptors 9
and reduce the speed and intensity of the chemoreceptor response to
C02, which suggests that at least part of this response involves con¬
version of C02 into H+/HC03". Part of the effect has been attributed
to molecular C02 because the chemoreceptor response to C03 under
steady conditions is greater than that to the equivalent change in H*.
The precise stimulus (C02 and/or H+-HC03~)at the peripheral chemo¬
receptor remains to be determined, and it will be necessary to ensure
that drugs like acetazolamide act specifically as inhibitors of carbonic
anhydrase in the chemoreceptors, and do not have other actions which
affect the response of these receptors to C02.
There has been some controversy concerning the ability of C02-H+
to stimulate the aortic chemoreceptors, and Hanson, Rao & Torrance
(1979) who investigated the C02 sensitivity of the cat aortic chemo¬
receptors concluded that although some of the aortic chemoreceptors
do respond to C02, the responses are very variable in the steady state.
This is in contrast to the marked effect C02 has on the carotid chemo¬
receptors, and the authors consider that the difference may be due to
a greater adaptation of the aortic receptors to C03. The fact that single
carotid chemoreceptor units can respond to both C02 and hypoxia,
as well as other stimuli, is illustrated in Figure 1.4.
It is generally agreed that activation of the carotid chemoreceptors
increases the tidal volume and, to a lesser extent, the frequency of
respiration. Aortic chemoreceptor stimulation has less effect on tidal
volume, but does increase respiratory frequency. The overall increase
in respiratory minute volume in response to the same stimulus is about
seven times greater for the carotid chemoreceptors than it is for the
aortic chemoreceptors in anaesthetised dogs (Daly & Ungar, 1966).
However, the overall contribution to respiration made by the aortic
and carotid bodies varies from species to species and depends on the
techniques used. Humans with denervated carotid bodies but intact
aortic bodies do not show an increase in tidal volume when exposed
to hypoxia whereas those with intact carotid bodies do (Wasserman
& Whipp, in Paintal, 1976). Hypoxia depresses the CNS and might
mask the input from aortic chemoreceptors, but people who had
undergone bilateral carotid body resection and were not hypoxic
showed no significant increase in ventilation following i.v. injection of
doxapram, a drug which can stimulate the peripheral chemoreceptors,
whereas normal individuals responded to the same dose with a signifi¬
cant increase in ventilation (Honda et al., 1979). Smith & Mills (1980)
however have demonstrated that cats which have undergone bilateral
section of the sinus nerve develop a renewed sensitivity to hypoxia
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after 2-3 months, presumably due to stimulation of the aortic bodies.
Chemoreceptor stimulation also indirectly affects respiration by
reflexly affecting bronchial airflow. Nadel & Widdicombe (1962)
concluded that carotid chemoreceptor stimulation in dogs reflexly
constricts the upper and lower airways, thus leading to changes in
blood gas tensions. Reflex changes in cardiac output and catecholamine
secretion from the adrenal gland may also indirectly affect blood gas
tensions. There is evidence that sudden application of stimuli (i.e.
abrupt changes in blood gas tensions) evoke respiratory responses only
if they reach the peripheral chemoreceptors at the appropriate point
of the respiratory cycle. Thus, chemoreceptor stimulation during
inspiration leads to an augmented breath and an increase in respiration,
whereas the same stimulus arriving during expiration may have no
effect on respiration (Black & Torrance, 1967). This type of stimulus
is not very physiological, but oscillations of P02, PC02 and pH related
to respiratory periodicity do occur in arterial blood (see Chapter 7).
Cat carotid chemoreceptors can follow oscillations up to a frequency
of about 20 Hz for Pa02 and 70 Hz for PaC02, the faster the frequency,
the smaller the oscillation in chemoreceptor discharge. The receptors
are, therefore, capable of signalling breath to breath changes in blood
gas tensions and pH. The phase relationship between chemoreceptor
afferent discharge and activity of the inspiratory neurones may well
be important in adjusting respiration during speaking, eating, swallowing,
yawning, laughing, crying and, perhaps, exercise. Temporal differences
between aortic and carotid chemoreceptor input to the CNS could
theoretically be used to compute blood/gas flow to the brain, but
recent work by Lahiri et al. (1980a) revealed that the latency to onset
of response following changes in the gas mixture breathed, or intra¬
venous injection of chemoreceptor stimulants such as cyanide, is
greater for the aortic than it is for the carotid chemoreceptors in cats.
Whether the CNS makes use of the temporal difference between carotid
and aortic chemoreceptor input, or input from myelinated and unmye¬
linated fibres, remains to be established. It has also been found that
rapid adaptation of chemoreceptor discharge occurs when C02 is used
as a stimulus, but not when hypoxia is used (Black, McCloskey &
Torrance, 1971) and the response to C02 is generally more rapid in
onset than that to hypoxia. The rapid or dynamic nature of the response
to peripheral chemoreceptor stimulation is a particularly marked
feature of these receptors and is illustrated in Figure 1.4.
Hypoxia can be induced in tissues receiving a normal blood flow by
lowering the oxygen tension of the blood (i.e. hypoxic hypoxia affecting
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the amount of oxygen dissolved in the plasma) or, by causing histotoxic
hypoxia, as does cyanide, by inhibiting cytochrome oxidase. Examples
of both these methods have already been given. An additional method
of producing hypoxia is to reduce the amount, of oxyhaemoglobin in
the blood, leading to anaemic hypoxia, and this can be achieved by
lowering the number of red blood cells or by using carbon monoxide
to form carboxyhaemoglobin, thereby reducing the oxygen content
of the blood without affecting the oxygen tension. One of the reasons
why carbon monoxide is so dangerous is that no hyperventilation
occurs during poisoning with this gas. There has been considerable
controversy over the question of whether or not carbon monoxide
stimulates arterial chemoreceptors, some workers finding carbon
monoxide to be without effect on carotid chemoreceptors, others that
it stimulates the aortic chemoreceptors and/or the carotid chemo¬
receptors. Recent work by Lahiri et al. (1981) appears to clarify
matters by showing that in cats in which carotid and aortic chemo-
receptor discharge are recorded simultaneously, carbon monoxide
inhalation during normoxia always stimulated aortic chemoreceptors
before it affected the carotid receptors, and that the steady-state
response of aortic chemoreceptors to carboxyhaemoglobin was greater
than that of most carotid chemoreceptors; only about 10 per cent of
the carotid chemoreceptor fibres tested showed any increase in discharge
frequency in response to moderate increases in carboxyhaemoglobin.
The authors hypothesise that the aortic bodies have a much lower
perfusion relative to their oxygen utilisation compared to the carotid
bodies, and as a consequence are able to monitor oxygen delivery and
initiate circulatory reflexes for oxygen homeostasis; whilst carotid
chemoreceptors monitor oxygen tension and initiate strong reflex
effects on respiration.
Thus, the carotid body chemoreceptors seem to be satisfied by the
oxygen dissolved in the plasma, and carbon monoxide poisoning is
unlikely to cause any reflex respiratory changes via the peripheral
chemoreceptors until the levels of carboxyhaemoglobin are quite high.
Results obtained from experiments in which the haematocrit was
reduced are consistent with the carbon monoxide results, a decrease
in the number of red blood cells during normoxia stimulated the
aortic chemoreceptors, but much larger reductions in haematocrit
seldom affected the carotid chemoreceptors provided the PaOj was
above 8.0 kPa.
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Blood Flow
The carotid body blood flow rate is very high, as already mentioned.
Purves (1970) performed experiments in anaesthetised cats from
which he concluded that carotid blood flow of the intact innervated
carotid body is linearly related to mean arterial pressure over the range
13.3 - 22.7 kPa, and hypoxia or hypercapnia can cause a small increase
in carotid body blood flow. Others have presented evidence that
autoregulation of blood flow occurs in the carotid bodies of some
species. In many vascular beds trauma, or extremes of perfusion pres¬
sure, abolishes autoregulation, and great care has to be taken not to
damage what can be a fairly delicate mechanism. Changes in arterial
blood pressure within the physiological range do not cause any signifi¬
cant alteration in carotid chemoreceptor discharge, but do affect the
aortic chemoreceptors; a fall in pressure increases discharge. It is
interesting to note that when a cat carotid body is removed from the
animal and superfused in vitro, chemoreceptor discharge recorded from
the carotid sinus nerve increases rapidly in response to a reduction in
flow of the superfusing fluid. Oxygen usage is also reduced. The flow-
sensitivity of the in vitro carotid body thus makes it more akin to
the in vivo aortic body.
The capillaries of the carotid body are fenestrated, and numerous
A-V shunts exist. There has been much discussion and experimental
work concerning the distribution of blood within the carotid and
aortic bodies and the suggestion has been made that 'plasma skimming'
may occur. This arises from non-Newtonian fluid flow in narrow tubes,
and the suggestion is that as the speed of the current is greatest and
the pressure lowest at the centre of the blood vessel, red cells will
migrate to the central axis and travel faster than the plasma at the side
walls. A small branch from a larger artery would receive blood with a
lower proportion of red cells, i.e. the plasma has been skimmed. Such
a mechanism would explain the observations by Acker & Lubbers (in
Acker et at., 1977) that the decrease in tissue P02 is the same under
zero flow conditions whether the organ is perfused by blood or saline
equilibrated with air. These authors propose that during progressively
increasing hypoxia an increasing number of red cells enter the carotid
body. The idea is attractive for it enables the tissue P02 to be main¬
tained. Unfortunately, however, preliminary quantitative histological
studies on the area occupied by red cells within the carotid body
vasculature at different levels of fa02 in rabbits do not support this
concept (Pallot & Verna, unpublished observations).
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Experiments with oxygen-sensitive microelectrodes (e.g. Acker &
Ltibbers in Acker et ai, 1977) have established that the/XDj in carotid
body tissue is about 5.3 kPa, much lower than the Pa02. However,
differing results have been obtained concerning the oxygen gradient
within the carotid body, and further refinement of the technique will
be needed before one can obtain reliable information concerning the
oxygen tension in the vicinity of the nerve endings and in the cells.
Influence of Exercise on Chemoreceptor Discharge
There has been considerable debate concerning the question of whether
or not arterial chemoreceptors contribute to the hyperpnoea of exercise
(see Cunningham (1974) for a detailed discussion of breathing in
exercise). There is some evidence which .favours peripheral chemo¬
receptor involvement. Thus, administration of oxygen reduces the
hyperpnoea of exercise, the respiratory response to exercise in ordinary
individuals is potentiated by hypoxia and it is absent in people who
have undergone bilateral carotid resection, as is their late, but not
early, respiratory response to exercise (Wasserman & Whipp, in Paintal
1976). If arterial chemoreceptors are involved in exercise hyperpnoea,
what is it that activates the receptors? Pa02, PaC02, pH and body
temperature change only slightly in the early stages, and although the
possibility exists that the sensitivity of the peripheral chemoreceptors
to these variables may alter during hypoxia, other influences need to
be considered. Sympathetic activity increases during exercise and
increased sympathetic drive to the peripheral chemoreceptors can
increase ventilation. Some results in man accord with this idea, but
Eisele, Ritchie & Severinghaus (1967) concluded that the steady-state
ventilatory response to moderate exercise in man is not influenced by
sympathetic innervation of the chemoreceptors since blocking the
stellate ganglia had no marked effect on the hyperpnoea of exercise.
Experiments in anaesthetised cats showed that moving the hind limbs
caused an immediate increase in carotid chemoreceptor discharge which
was abolished by removing the sympathetic innervation of the carotid
body or cutting the femoral and sciatic nerves(see Biscoe, 1971). Could
it be that in exercise, increased activity in muscle afferents reflexly
increases chemoreceptor discharge? Not according to Davies & Lahiri
(1973), who also performed experiments on cats (anaesthetised or
decerebrated), since they were unable to show any change in carotid
chemoreceptor activity during exercise, although hyperpnoea occurred.
14 Peripheral Arterial Chemoreceptors
The present position concerning the involvement of peripheral
chemoreceptors in exercise hyperpnoea is somewhat confusing, and
further studies appear to be necessary in order to establish their role.
It could be that muscle afferent activity acts centrally to increase the
influence on respiration of a given chemoreceptor input. It is also
possible that during exercise, changes in the oscillations of blood gas
tensions, cardiac output, circulating catecholamines or other hormones,
and carotid sinus nerve efferent activity, might influence arterial
chemoreceptor activity by acting either separately or interactively
(see also Chapter 7).
Chronic Resection of the Carotid Bodies
Many patients in Japan some 25 years ago underwent bilateral carotid
body resection for asthma. This procedure only temporarily relieved
their symptoms (see Honda et al., 1979). Treated patients have a
normal faCOj and pH, but a slightly reduced PaOj, do not show any
reflex increase in respiration while breathing hypoxic gas mixtures
in the steady-state; in single breath studies there is evidence of some
chemosensitivity. It appears that although aortic chemoreceptors can
prevent the central respiratory depression of hypoxia, they do not
elicit hyperventilation and so, according to Wasserman & Whipp (in
Paintal, 1976), are relatively insensitive respiratory control organs
in man. Using few-breath oxygen tests in conscious dogs, Ungar &
Bouverot (1980) have demonstrated that even moderate hypoxia can
cause a marked depression of respiration. Therefore, it may be that
aortic chemoreceptors do make an important contribution to respira¬
tion, but this is not apparent during hypoxia in the absence of carotid
chemoreceptors because of the substantial depressant effect hypoxia
exerts on central respiratory neurones.
Animal experiments show that different species vary in their ability
to recover peripheral chemosensitivity following bilateral carotid
body resection. Slight sensitivity returns in ponies, but in cats after
about 260 days peripheral chemoreflex activity apparently returns to
near normal. No chemoreceptor activity was recorded from the regener¬
ated carotid sinus nerve, and bilateral vagotomy abolished the reflex
respiratory response to physiological and pharmacological stimuli,
implying that the aortic receptors were being stimulated (Smith & Mills,
1980). The suggestion is that, about 30-40 days after bilateral carotid
body removal, aortic chemoreceptors increase their influence on
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respiration, possibly as a consequence of changes in gain of the central
component of the reflex pathway.
High Altitude
This topic will be dealt with in detail in Chapter 9 and we shall confine
ourselves to noting here that during adaptation to high altitude, respira¬
tion is stimulated by hypoxia acting via the peripheral chemoreceptors;
hypocapnia and alkalosis limit the hyperventilation. However, acclimiti-
sation can still occur after chronic denervation of the aortic and carotid
chemoreceptors which suggests that although the peripheral chemo¬
receptors do contribute to the process they are not absolutely essential.
It is interesting that carotid bodies taken from high altitude-dwelling
man and animals are greatly enlarged. This hypertrophy is also observed
in chronically hypoxic individuals at sea level and can be mimicked in
the laboratory. Thus, Dhillon, Barer & Walsh (in Pallot, 1983) have
shown a sixfold increase in carotid body volume after exposure of rats
to 10 per cent 02 for three weeks. Barer, Chiocchio & Pallot (unpub¬
lished) found a massive increase in catecholamine concentration in
rat carotid bodies after similar treatment.
Influence of Peripheral Chemoreceptors on Respiration in Neonates
The role of arterial chemoreceptors in initiating respiration, and the
influence of sympathetic nerves on peripheral chemoreceptors in the
new-born is considered in Chapter 8. We should like to concentrate
here on the question of whether failure of peripheral chemoreceptors
contributes to the sudden infant death syndrome (SIDS) or 'cot death',
in which apparently healthy infants die when aged between about
1 and 10 months (average 2-4 months in the study of Naeye et al.,
1976), while asleep. Histological studies of carotid bodies taken from
infants who had died of SIDS show abnormalities when compared
with carotid bodies taken from age-matched infants dying from other
causes, including congenital heart disease (Naeye et al., 1976; Cole
etal., 1979).
In general the carotid bodies in SIDS showed a reduction in the size
and number of cells and also a decrease in the dense cytoplasmic
granules in the cells, something which was not seen in the carotid
bodies of infants who had been chronically hypoxic thoughout life
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and eventually died of congenital heart disease. This suggests that
degranulation in SIDS is not secondary to hypoxia.
A correlation has been suggested between prolonged apnoea during
sleep, particularly REM sleep, and SIDS; infants considered at risk
for SIDS (Shannon, Kelly & O'Connell, 1977) showed hypoventilation
during sleep and a decreased ventilatory response to breathing C02.
While it is obvious that peripheral chemoreceptor involvement in SIDS
is far from established, and other causes have been suggested, there
seems sufficient evidence to warrant serious study of the possibility.
It could be that in this disorder arterial chemoreceptors do not function
normally because of some defect in the receptor mechanism, or alterna¬
tively the CNS fails to respond to chemoreceptor input during hypoxia;
perhaps excessive efferent activity in the sinus nerve during hypoxia is
a contributing factor. It will be necessary to determine how sleep
influences the arterial chemoreceptors and respiratory control. There
may be a case for using the single breath oxygen test to examine
whether peripheral chemoreceptor function is normal in young infants,
and this should be done while the child is asleep. Such a test may help
to identify those infants who may be at risk, and could give information
concerning the role of peripheral chemoreceptors in SIDS which is
otherwise going to be difficult to obtain from animal studies.
Peripheral Arterial Chemoreceptors and Respiratory Disorders
Although the arterial chemoreceptors may not be essential for ordinary
life in healthy individuals, the situation is very different in unhealthy
people. For example, patients with chronic obstructive lung disease
(emphysema, chronic bronchitis) are usually hypoxic, hypercapnic and
acidotic; such patients have chronically enlarged carotid bodies (see
Heath, Smith and Jago in Pallot, 1983).
The consequence of chronic C02 retention is that the central
chemoreceptors become less responsive to C02, respiratory depression
occurs, and the balance of respiratory drive shifts from the central to
the peripheral chemoreceptors; hypoxaemia depresses the CNS, but
the peripheral chemoreceptors are stimulated. A similar situation
can arise when the CNS has been depressed by drugs such as barbitu¬
rates or opiates.
Injudicious administration of oxygen to raise the Pa07 in patients
such as those described above can, by removing peripheral chemo¬
receptor drive, stop ventilation, thereby causing a further rise in/>aC02
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and a fall in fa02 . However, there is a definite need to increase the
Pi02 in patients with respiratory depression, particularly when hypo-
xaemic episodes associated with periods of hypoventilation occur
during REM sleep (compare SIDS) in 'blue and bloated' patients who
are already hypoxic (Douglas et al., 1979), and this requires controlled
oxygen therapy, with or without the assistance of mechanical ventila¬
tion or respiratory stimulant drugs.
Drugs which Stimulate the Peripheral Chemoreceptors
Drugs are chemicals and so it is not surprising that a large number of
them can affect the arterial chemo (chemical)-receptors. We shall
confine ourselves to considering here only those drugs which are
fairly specific chemoreceptor stimulants and which may have a clinical
use as respiratory stimulants. In passing, however, it is worth noting
that one widely used non-specific chemoreceptor stimulant, nicotine,
evokes reflex changes in B.P., heart rate, and respiration (see Ginzel,
1975). It remains to be established whether repeatedly stimulating the
arterial chemoreceptors by smoking cigarettes causes changes in the
receptors, which in turn leads to pathophysiological alterations in the
respiratory and cariovascular systems.
Suberyldicholine is a nicotinic receptor agonist which has been
advocated for use as a respiratory stimulant (Anichkov & Belen'kii,
1963) as it has advantages over centrally acting drugs. Doxapram
appears to act as a peripheral chemoreceptor stimulant (Mitchell &
Herbert, 1975) and has been used to test peripheral chemoreceptor
functioning in man. Some drugs may appear to be peripheral chemo¬
receptor stimulants, but in fact act centrally to potentiate input from
the chemoreceptors. It is necessary to be cautious when interpreting
results from experiments in which respiration is recorded and drug
effects studied. Abolition of the respiratory-stimulating property of
a drug by peripheral chemoreceptor denervation is not, on its own,
sufficient evidence that the drug stimulates the chemoreceptors and
more direct evidence, e.g. electrophysiological, is needed. The drug
might, for example, have been acting centrally, and changes in the
pattern of respiration following denervation may mask this action, or
it could have been indirectly affecting ventilation via the baroreceptors
since peripheral chemoreceptor denervation generally involves denervat-
ing the baroreceptors. Also, evidence from animals, anaesthetised or
conscious, is not necessarily directly applicable to man.
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A new chemoreceptor stimulant drug, which may be useful in
replacing hypoxic drive from the peripheral arterial chemoreceptors
during oxygen breathing, is almitrine. Experiments in cats (Figure 1.5)
show that intravenous infusion of almitrine increases carotid chemo¬
receptor discharge and respiration, even when the animal breathes
100 per cent 02; it does not seem to be a nicotinic agonist since its
action was not affected by hexamethonium or mecamylamine. Almitrine
may prove to be clinically useful for replacing hypoxic drive during
breathing oxygen-rich mixtures, and it will be interesting to determine
its mechanism of action on the peripheral chemoreceptors.
Mechanism of Chemoreception
It seems fair to state at the outset that there is no generally accepted
explanation of the mechanisms involved in chemoreception, and there
is still considerable debate concerning which of the elements present
in peripheral chemoreceptor tissues (cells, nerve Fibres, blood vessels,
connective tissue) is the primary receptor. Many hypotheses have been
advanced to explain how the physiological stimulus to the peripheral
arterial chemoreceptors (hypoxia and/or hypercapnia) is transduced
into the neural signal carried by sensory fibres to the CNS. The topic
is a complex one, partly because of technical difficulties inherent in
studying small structures such as the carotid and aortic bodies, and
partly because a lot of conflicting evidence has been amassed from
experiments, often performed on different species, using a variety of
experimental techniques. We propose to examine the different com¬
ponents in the chemoreceptors and then will review some of the main
hypotheses, finally finishing this chapter by considering some of the
more recent evidence which may suggest new interpretations of existing
information, or lines for future research.
Cells of the Arterial Chemoreceptors
Specific chemoreceptor tissue comprises about 50 per cent of the
carotid body in cat and rat. The tissues involved are the Type I and
Type II cells, blood vessels, nerve fibres and nerve terminals. The
Type 1 cell (see Figure 1.6) is present in the greatest number and
is about lOjrm in diameter. It has a large dense nucleus, vesicles con¬
taining electron-dense granules, an endoplasmic reticulum, Golgi
apparatus and microtubules, i.e. all the features associated with secret¬
ory cells. The cells are arranged in groups, with a single nerve fibre
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Figure 1.5: The Effects of i.v. Infusion of 50 pg (kg"1) min-1 Almitrine.
Panels show, from above downwards: respiratory half-minute volume 60s
after switching to breathing the gas indicated (each breath being repre¬
sented by a step in the pneumotachograph record); femoral B.P.:
counter output in counts s"1 for a single carotid chemoreceptor unit.
The neurograms to the right of the figure were recorded during oxygen
breathing. A is the control, B is 2 and 4 min after starting the infusion,
C is 6 and 8 min and D 10 and 12 min after starting the infusion.
AIR 100% Oj
■n»A<(n<iLi ■ '■■■ ■ ■ ••
c e mmmmm inimnnvr n
E ' " IIRHIII1IHII
Source: McQueen, Price and Ungar, unpublished data.
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Figure 1.6: The Ultrastructure of the Carotid Body. T1 — Type I cell;
Type II cell;>- nerve fibres; # endoplasmic reticulum; "k mitochon¬
dria; electron-dense cored vesicles; n.e. nerve endings. Fig 1.6a
shows two adjacent Type I cells. Note the mitochondria and electron-
dense cored vesicles. Most of the free surface of the Type I cells is covered
by attenuated processes of Type II cells (arrows); in some areas however
(small arrow heads) the Type I cells communicate directly with the
extracellular space. Fig 1.6b and 1.6c illustrate nerve endings. Note how
in 1.6b the ending contains mainly mitochondria, whilst those in 1.6c
contain many clear cored vesicles. In all three figures (and in F ig 1.2) note
the peripheral position of the Type II cells, and the numerous unmye¬
linated nerve fibres.
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Figure 1,6b and c (contd)
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sending branches to between 10 and 20 Type 1 cells; a fibre can inner¬
vate more than one cell group. The nerve terminals are intimately
associated with the cells, there being a synapse or gap of about 30 pm
between nerve terminal and Type I cell membrane. Cutting the inner¬
vation to cat and rat carotid bodies does not affect the appearance
of Type 1 cells, although the sensory fibres degenerate. In the rabbit,
however, section of the sinus nerve causes regression of the carotid
body (Kienecke et al., 1981; Tan, Pallot & Purves, 1981 both in Bel-
monte et al., 1981). Type I cells are also intimately associated with
the blood supply, being exposed to the pericapillary space where
the cells are only covered by a basement membrane. The Type II
cells which partially surround 4-5 Type I cells have not been studied
as extensively as Type 1 cells. They appear to contain carbonic
anhydrase and possibly other enzymes. Unlike the Type 1 cells, Type II
cells do not appear to be innervated, but they do encircle numerous
small unmyelinated nerve fibres. Pallot (1976 in Paintal, 1976) has
demonstrated that some of these unmyelinated fibres in the cat and
mouse carotid bodies terminate without forming Type I cell junctions.
The major ultrastructural features of the carotid body are illustrated in
Figure 1.6.
Various substances have been identified in carotid body cells and
the list includes dopamine, noradrenaline, adrenaline, 5-hydroxytrypta-
mine (5-HT, serotonin) and probably acetylcholine in amounts that
vary from species to species and even within a species. The fact that
these substances are neurotransmitters in other parts of the nervous
system has led to their being considered as putative transmitters in
arterial chemoreceptors. However, for a long time the carotid body was
regarded as a gland, particularly since it is morphologically similar to
the chromaffin cell of the adrenal medulla, and there have been sugges¬
tions that it may have an endocrine orparaneurone(Fujita&Kobayashi,
1979) function. Pearse (1969) classified the Type 1 cell in his APUD
(amine precursor uptake and decarboxylation) cell series and predicted
that they secrete a polypeptide which he named glomin. Recent work
using immunocytochemical techniques have established that VIP
(vasoactive intestinal polypeptide), substance P, methionine and leucine
enkephalin are present in the carotid body and it would not be surpris¬
ing if more polypeptides are found there. Substance P like material has
been identified in cells and nerve fibres of the cat carotid body (Cuello
& McQueen, 1980). Whether more than one of the putative neuro¬
transmitters coexist in the cells, and whether the different peptides are
stored and released with particular substances requires more detailed
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investigation as does the identity of the nerves with which the peptides
are associated.
The existence of so many substances in the carotid body, together
with evidence based on vesicle size and density measurements, has led
to the suggestion that Type I cell sub-types exist. This subject is reviewed
by Verna (1979) who casts doubt on the hypothesis that cells may be
subdivided on the basis of vesicle size.
Nerve Supply to the Arterial Chemoreceptors
The nerve supply to the arterial chemoreceptors has been most exten¬
sively studied in carotid body, but there is no evidence to suggest that
innervation of the aortic bodies is appreciably different. There is some
evidence that in rats a small proportion of nerve endings associated with
Type I cells are sympathetic in origin, (McDonald & Mitchell, 1975)
but the overwhelming majority of sympathetic nerve fibres from the
superior cervical ganglion innervate the carotid body vasculature. Most
of the Type I cell nerve endings are derived from nerve fibres in the caro¬
tid sinus nerve, and the classical opinion was that they are the termina¬
tions of sensory axons (De Castro, 1928). The evidence for this rested
on degeneration studies as illustrated diagrammatically in Figure 1.7.
Figure 1.7: Diagram to Explain the Degeneration Studies. 1 and 2 repre¬
sent extra- and intra-cranial sections respectively (T1 — Type I cell;
n.e. nerve ending; CNS brain stem).
1
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If, after section of the carotid sinus nerve at 1, the nerve endings
associated with Type I cells degenerate, then the parent axons run in
that nerve. Section of the nerve at 2, central to its sensory ganglion,
should differentiate between afferent and efferent nerve endings since
the peripheral process of an axon degenerates when severed from its
cell body. According to De Castro (1928) section of the carotid sinus
nerve at 1 results in degeneration of Type I cell nerve endings whereas
section at 2 does not affect the endings.
Physiological studies by Biscoe's group in the late 1960s (reviewed
by Biscoe, 1971) have demonstrated efferent or centrifugal activity in
the carotid sinus nerve which can be increased by hypoxia, hypercapnia
and i.v. adrenaline. In the intact preparation, activation of this efferent
pathway decreases afferent activity, and section of the carotid sinus
nerve increases chemosensory discharge (see Biscoe, 1971; O'Regan,
1977).
The presence of such a centrifugal pathway in the sinus nerve, and
the effects of section of the sinus nerve on chemoreceptor activity,
led Biscoe, Lall & Sampson (1970) to repeat the degeneration experi¬
ments referred to above (Figure 1.7). They found that three months
after section of the IXth nerve between the ganglia and brainstem there
was a 60-70 per cent reduction in the number of Type 1 cell nerve
endings; furthermore normal chemoreceptor afferent activity could still
be recorded from the sinus nerve. The authors suggested that many
of the Type 1 cell nerve endings represented the terminations of the
efferent pathway referred to above. These experiments have been the
object of considerable criticism, and subsequent attempts to repeat
them have failed (see Verna, 1979). In spite of this it is very difficult to
explain the degeneration unless one is to assume that one or other
(petrosal or Ehrenritters) ganglion was damaged by Biscoe et al. (1970).
This suggestion, which seemed unlikely in view of the normal
afferent discharge, may with hindsight prove to be correct. In this
respect it is interesting that Willshaw & McAllen (1981 in Belmonte et ai,
1981) have provided evidence that the cell bodies of the sinus efferents
are located outside the brainstem, in some as yet unidentified site.
Each nerve terminal is characterised by an accumulation of mito¬
chondria and/or clear vesicles (see Figure 1.6). In addition, some
endings contain dense-cored vesicles, neurofilaments, neurotubules and
glycogen particles. It is presumed that the clear and dense-cored vesicles
contain unidentified transmitter substance(s).
The evidence from degeneration studies which purports to establish
the nature (sensory or motor) of nerve fibres opposed to the Type I cell
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has been conflicting, and part of the difficulty seems to arise from the
lack of quantitative data. Morphological studies are unable to establish
the function of synapses, but the appearance of the nerve-cell junction
sometimes is in accord with a motor (efferent) synapse, with vesicles
in the nerve terminal apposed to the cell, sometimes a sensory synapse
(vesicles in cell), and occasionally a mixture of the two, referred to as
reciprocal synapses (McDonald & Mitchell, 1975; Blakeman & Pallot,
1983 in Pallot, 1983). Experiments performed on mutant mice (Pallot,
1978) have shown quantitatively that in these animals, which have a
motor disorder, few endings are found on Type 1 cells in the carotid
body as compared with normal mice, although the mutants have normal
chemoreceptor reflexes and this implies that a high proportion of
endings are motor, supporting the concept of an efferent pathway.
Against this is more recent evidence with radioactive amino acids such
as proline which, after injection into the petrosal (sensory) ganglion
where the cell bodies are situated, is transported to the carotid body. It
is claimed that a substantial proportion of nerve endings on Type I cells
in cats are labelled, implying that these are sensory nerve terminals.
Such a technique however does not lend itself to quantitative studies.
There is evidence from horseradish peroxidase studies which suggests
that only very few efferent fibres course from the CNS in the carotid
sinus nerve. Again, part of the problem in interpreting the results arises
from difficulties with the methodology and the quantification of
results. It will be necessary to establish where the cell bodies of the
efferent fibres are located.
Pallot and his colleagues (Morgan, Pallot & Willshaw, 1981; Pallot,
Morgan & Willshaw in Belmonte et ai, 1981) have recently provided
evidence for the existence of an efferent innervation of Type I cells in
the cat. They ventilated animals with either 10 per cent or 100 per cent
02 with one sinus nerve intact and the other cut and then examined the
vesicle content of the nerve endings. In all cases after ventilation with
100 per cent 02 there were more vesicles in the endings from the intact
nerve carotid body than the contralateral (sectioned nerve) organ.
After 10 per cent 02 there were fewer vesicles in the nerve endings of
the intact nerve carotid body than in the contralateral one. As the
stimulus to the carotid bodies themselves is similar, regardless of the
state of the nerve, this result indicates that the stimulus acted central to
the point of section, and is hence a direct efferent effect on these nerve
endings. Parallel purely structural studies (Pallot & Blakeman, 1983 in
Pallot, 1983) suggest that on the basis of nerve ending polarity some
50 per cent of endings might be efferents, assuming that the methods
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for assessing synaptic polarity in the CNS are applicable to the periphery
(see Verna, 1979).
The balance of evidence then, seems to suggest that both afferent
and efferent fibres terminate on Type I cells. In view of the serial
reconstruction studies (Biscoe & Pallot, 1972; Nishi & Stensaas, 1974)
which suggest that most cells receive innervation from a single axon,
it may be that afferent and efferent endings are found on different
Type I cells. Efferent fibres may also supply blood vessels since it has
been shown that sinus nerve stimulation affects carotid body blood
flow, an effect which can be prevented by atropine. The question arises
as to how physiologically important the efferent pathway to the
peripheral chemoreceptors is, as there is certainly no doubt that the
sensory pathway can continue operating in the absence of all efferent
nerve input to the chemoreceptors. The argument about afferent/
efferent fibres in the carotid sinus nerve has led to the compromise
suggestion (McDonald, 1980) that carotid sinus nerves can carry
impulses in both directions, being antidromically activated by potential
changes in the central terminals under certain conditions, but such a
mechanism cannot explain the observation referred to above. It is also
possible that some of the inhibition of chemosensory discharge seen
following stimulation of the sinus nerve results from substances being
released from sensory endings by antidromic nerve impulses (e.g.
polypeptides).
There are myelinated and unmyelinated fibres in the carotid and
aortic nerves and conduction velocity studies show about 66 per cent of
carotid chemoreceptor fibres conduct at 5-50 m/s (A fibres — presumed
to be myelinated), with the remainder conducting at 0.5-2 m/s (C fibres
- unmyelinated). Fidone & Sato (1969) found that the fibres differed
in their sensitivity to various stimuli, with A fibres being the most
sensitive to acetylcholine (ACh). In contrast, the C fibres of the aortic
chemoreceptors have been reported to be much more sensitive to ACh
than the A fibres in cats. There may be differences in the two chemo¬
receptor organs in the responsiveness of their myelinated and unmye¬
linated fibres to ACh, but Paintal (1971) has criticised the technique
used by Fidone & Sato for estimating the conduction velocity of fibres
in the very short length of carotid sinus nerve available for experimenta¬
tion, arguing that their results may be misleading.
Sympathetic Nerve Supply to Arterial Chemoreceptors
Arterial chemoreceptors receive a sympathetic nerve supply, as pre¬
viously mentioned, and there is general agreement that sympathetic
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nerve stimulation can increase carotid chemoreceptor discharge and
respiration although this is a somewhat variable effect. Blood flow
through the carotid body is reduced by the same procedure and oxygen
consumption falls. Cutting the ganglioglomerular (sympathetic) nerves
leads to an increase in blood flow through the carotid body. The fact
that sympathetic nerves have no effect on chemosensory discharge of
the in vitro carotid body preparation supports the notion that the
sympathetic nerves regulate blood flow in the carotid body.
Apart from effects on chemoreceptor discharge which are secondary
to changes in blood flow, there may also be some direct influence on
Type I cells. There is morphological evidence that Type 1 cells in rats
receive a pre-ganglionic sympathetic innervation. Sympathectomy has
no effect on the electron-dense granules in the Type I cells or on the
catecholamine content of cat carotid body (Zapata et al., 1969; Mir,
Al Neamy, Pallot & Nahorski, 1983 in Pallot, 1983) but in the rat
carotid body sympathectomy causes a 90 per cent reduction in nora¬
drenaline leveis (Mir et al., 1983, in Pallot, 1983).
Blood Vessels
There has already been some discussion concerning blood flow through
the carotid body, and it will be necessary to perform further studies
in vivo in order to compare flow in the aortic and carotid bodies, and
to determine how flow is regulated. Meanwhile, it is important to
realise that many physiological and pharmacological stimuli are likely
to influence blood flow in these organs. Performing experiments in
vitro may avoid these difficulties, but does introduce other complica¬
tions, such as the reduced 02 usage and the inability to sustain chemo¬
receptor discharge in response to a prolonged stimulus. It has been
suggested that responses alter if the carotid body is perfused by saline
rather than blood, and this may be due to the greater oxygen-carrying
capacity of blood compared with saline, or to the presence of some
essential factor in the blood.
Mechanisms of Chemoreception
Various hypotheses have been advanced to explain the mechanism
involved in chemoreception, and these will be considered in relation
to recent evidence. Biscoe (1971) proposed that free nerve endings in
the pericellular space are the chemosensors and the endings on Type I
cells are efferent, being involved in modulating sensory activity. The
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suggestion is that these fine nerve endings have a high metabolic rate,
which is needed to maintain their polarisation, and a large surface to
volume ratio. They respond rapidly to hypoxia, a fall in /'aOj leading
to depolarisation of the fibres as a consequence of reduced ion pump
(e.g. sodium pump) activity. Sympathetic nerve stimulation reduces
oxygen usage by the carotid body, but increases chemoreceptor dis¬
charge, and this could be interpreted as meaning that the oxygen supply
is locally rate limiting to metabolism, since sympathetically-induced
vasoconstriction would reduce flow, leading to chemoreceptor stimula¬
tion and reduced oxygen consumption. However, the oxygen consump¬
tion of the individual elements of the carotid body is not known,
and changes in the oxygen usage of the whole organ may not reflect
consumption of the nerve terminals. Further work is needed to charac¬
terise these 'free endings'.
Evidence showing that many of the fibres terminating on Type I
cells are sensory, has already been referred to, and is obviously not
compatible with the free ending hypothesis. Freezing the carotid body
causes a permanent loss of Type I and Type 11 cells, and although the
carotid sinus nerve regenerates and the vasculature appears normal,
no respiratory reflexes are elicited from the carotid body and nor can
chemoreceptor activity be recorded from the carotid sinus nerve.
Electrical stimulation of the regenerated nerve does evoke reflex
respiratory changes, so demonstrating that the afferent pathway is
normal (Verna, Roumy & Leitner, 1981, in Belmonte et al., 1981).
The difficulty with such experiments lies in assessing the damage to
the nerve endings. Crushing a carotid sinus nerve causes the sensory
fibres to degenerate and chemosensory activity is lost. The fibres
regenerate, but no chemosensory activity is recorded until the fibres
have grown fairly close to the Type 1 cells (Zapata, Stensaas & Eyza-
guirre, 1976), a situation which is similar to that seen in the skin where,
following a crush of the sensory nerve innervating the Merkel cells in
cats, the regenerating sensory endings show unspecialised sensitivity
while the axon is growing, and typical response characteristics are not
restored until the Merkel cell-nerve complex is reformed.
It appears from this evidence that chemoreception can only occur
when the regenerating fibres come close to the Type I cell — they do
not have to be as closely apposed as normal for function to be restored
(Zapata et al., 1976) — and this can be interpreted as meaning either
that the cells release a chemical (trophic factor) which activates the
sensory ending, or the cell causes the ending to become chemosensitive,
or vice versa. Kienecker, Knoche & Binmann (1981, in Belmonte et al.,
Peripheral Arterial Chemorecepton 29
1981) have reported that in rabbits chemosensitivity appears long
before the Type I cells are innervated, and it has been claimed that
carotid sinus nerve fibres allowed to regenerate into the adventitia of
the external carotid artery are chemosensitive (Bingmann et al. in
Belmonte et al., 1981; Tan, Pallot & Purves, 1981 in Belmonte et al.,
1981), but slight chemosensitivity may be a non-specific property of
neuromas (see Smith & Mills, 1981 in Belmonte et al., 1981). From
this it will be appreciated that the evidence is equivocal and different
species have been used by different workers in the studies. Tan et al.
(1981) seem to provide the best evidence for specific chemosensitivity
in neuromas as they demonstrate a recording from a neuroma which is
indistinguishable from that of a normal chemoreceptor afferent. Even
in this work there is the possibility of reinnervation of miniglomera by
sprouts from the regenerating sinus nerve. A useful experiment would
be to study the neuroma in vitro, when subsequent histology could
exclude this possibility.
A further hypothesis based on the sensory endings being the chemo-
sensors is that of Mitchell & McDonald (in Purves, 1975)which proposes
that sensory fibres apposed to Type 1 cells are directly affected by
hypoxia or hypercapnia and afferent activity leads to release of a
transmitter from the sensory nerve terminal, and the transmitter
activates the Type 1 cell (which is considered to be a dopaminergic
interneurone) and dopamine then inhibits the sensory terminal. Morpho¬
logical evidence for such reciprocal synapses has already been discussed
and, again, much hinges on the species and whether or not the nerve
endings are chemosensitive. However, the fact that cutting the carotid
sinus nerve does not change the levels of known putative transmitters
in the carotid body, something which might be expected to occur if
sensory fibres contain such a substance argues against this idea.
The hypothesis that physiological stimuli cause the Type 1 cell to
release a chemical (transmitter) which activates the sensory nerve
fibres (i.e. the Type 1 cell is the chemosensor) has been the subject of
a great many studies. The problem lies in determining whether chemical
transmission occurs and, if it does, establishing the identity of the
hypothetical transmitter(s). The oldest candidate, one might even call
it classical, is acetylcholine (ACh), and the evidence for and against its
role in chemoreception has been reviewed recently (Eyzaguirre & Fidone,
1980; Eyzaguirre, in Belmonte et aL, 1981). Briefly, ACh is released
in response to physiological stimuli and there appears to be a choline
uptake mechanism in Type 1 cells. The random nature of spontaneous
chemosensory discharge could, by analogy with miniature end-plate
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potentials of the neuromuscular junction, be due to release of quanta
of ACh. However, the properties of fine nerve terminals in the chemo¬
receptors (cf. Biscoe, 1971) could equally account for the randomness
of the normal discharge.
Figure 1.8: Response of Carotid Chemoreceptors (three units counted)
to Intra-carotid Injection of 100% C02-equilibrated Locke Solution,
NaCN and ACh Before and After Administering the Nicotinic Blocking
Drug, Pentolinium. The increase in discharge above baseline values (acx)
for each of the responses is submaximal and the baseline discharge in ct/s
is given at the foot of each column. After pentolinium the dose of ACh
had to be increased by a factor of 10 in order to approximate the pre-
pentolinium response, whereas responses to C02 and NaCN were not
appreciably affected by the nicotinic antagonist.
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Source: McQueen, unpublished record from 3.5 kg cat.
ACh levels in the cat carotid body are not affected by cutting either
the carotid sinus or the sympathetic nerves, implying that ACh is not
stored in nerves. ACh excites all chemoreceptor fibres (e.g. see Figures
1.4, 1.8, Fidone & Sato, 1969), although Paintal (1971) considers it
does not affect aortic myelinated chemoreceptor afferents, whereas
physiological stimuli do. The major argument against ACh being a
chemosensory transmitter in the chemoreceptors has been failure of
antagonists to cause any significant reduction in responses to physio¬
logical stimuli, although they virtually abolish the excitatory response
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evoked by exogenous ACh, and whereas anticholinesterases, such as
physostigmine, potentiate exogenous ACh, they have little or no
effect on more physiological stimulants (Figure 1.8, and McQueen,
1977, 1980).
Although the pharmacological evidence does not favour a chemo-
excitatory role for ACh, it can be argued that, if the concentration of
ACh released locally within the carotid body was high compared with
that which reaches the site following exogenous administration, or if
exogenous ACh acts at an 'extra-synaptic' site, concentrations of
drugs used to modify the action of ACh released by physiological
stimuli at the intrinsic site may not be adequate. This is difficult to
refute entirely, but the fact that very high doses of drugs which pene¬
trate tissues fairly readily, and which are allowed to act for prolonged
periods, affect responses to exogenous ACh without having much
effect on responses to physiological stimuli, taken together with the
observation that large-molecular-weight substances (e.g. horseradish
peroxidase) can readily penetrate the chemoreceptor tissues, makes the
argument appear improbable.
Results from autoradiographic experiments with labelled a-bungaro-
toxin (Dinger et al., 1981) show binding sites located on Type I, and
possible Type II cells, with no evidence of binding to nerves. The
authors equate the binding site fora-bungarotoxin with the acetylcholine
nicotinic receptor site, but does bungarotoxin in fact label that nicotinic
receptor which when activated causes an increase in chemosensory
discharge? The reason for caution is that a-bungarotoxin in the doses
used by McQueen (1977) was not very effective at antagonising the
excitatory action of ACh on the cat carotid body. It would be interest¬
ing to see whether labelled hexamethonium and mecamylamine,
established antagonists of the ACh response, bind to the same sites as
a-bungarotoxin. If it emerges that there are really no nicotinic receptors
on chemosensory nerve endings, or only on those from unmyelinated
fibres, it will be necessary to revise considerably the 'cholinergic'
hypothesis that ACh released from cells by physiological stimuli
depolarises the sensory fibres. The presence of ACh receptors on
Type I or Type II cells may mean that ACh released from one cell can
influence another cell in the group. In this way, ACh might release
one or more chemoexcitatory substances via actions on nicotinic and
possibly muscarinic receptors on cells, and these actions would be
susceptible to pharmacological antagonists. Physiological stimuli may
be acting through several mechanisms to cause chemoreception, such
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that loss (or potentiation) of the cholinergic component does not
greatly affect the overall response.
ACh may have more than one action on the chemoreceptor complex
for there is some evidence that it has an inhibitory role, and indeed
chemoinhibition is the predominant effect of ACh on the rabbit carotid
body (see Docherty and McQueen, 1979). Some of the inhibitory effects
of efferent nerve stimulation of the chemosensory discharge can be
prevented by atropine, and this suggests that ACh may be involved in
this pathway. Cholinergic receptors may also be involved in control of
blood flow through the carotid body.
Intracellular electrophysiological studies have shown that Type 1
cells are variably affected by physiological and chemical stimuli and
fairly insensitive to changes in ionic composition of their environment,
although they do respond to changes in temperature and osmotic
pressure. Hypoxia, ACh and NaCN have no consistent effect on the
membrane potential, sometimes hyperpolarising, sometimes depolarising
the cells, yet they invariably increase sensory discharge (see Eyzaguirre
& Fidone, 1980). One might suspect that these small cells are rather
badly damaged by the electrode because the average resting membrane
potential of -20mV seems low and as techniques improve, values nearer
to -60mV are being obtained. The variability of cells in their responses
to various stimuli may be a consequence of the technical difficulties
associated with recording from small cells, or from the fact that they
are in vitro, but it may also mean that individual cells in a glomerulus
differ in their sensitivity to stimuli, perhaps according to the type of
receptor(s) they carry. If graded (receptor) potentials are a require¬
ment for the primary receptor element, then the Type I cell does not
appear to fit the bill. However, the extent to which the cell membrane
potential and resistance are important for the primary transducer
element remains to be established. It is also noteworthy that the
cells of the arterial chemoreceptors in cats and rats do not seem to
be affected by chronic denervation of the sensory nerve, appearing
morphologically similar to 'normal' cells and showing similar changes
in membrane potential in response to stimulants, although voltage
noise is reduced. This contrasts with gustatory chemoreceptors of
the tongue, and touch receptors in the skin, where the taste bud cells
and Merkel cells disappear following sensory denervation, although
in the latter case this is species dependent. In this respect it is interest¬
ing that the rabbit carotid body does appear to involute following
section of the sinus nerve (Pallot, unpublished; Kienecker, personal
communication).
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The other putative neurotransmitters in the carotid body (nor¬
adrenaline, adrenaline, dopamine and 5-HT) have all been investigated
but as yet their role, if any, in chemoreception remains, like that of
ACh, to be established. We shall briefly consider evidence relating to
dopamine, which is present in the carotid body and released during
physiological stimulation of the chemoreceptors. Although there may
be species differences, in general low doses of dopamine inhibit spon¬
taneous chemoreceptor activity, whereas higher doses, or lower doses
after administration of drugs which block the inhibitory effect, cause
chemoexcitation (see Docherty & McQueen, 1978). Dopamine recep¬
tors in the carotid body may, therefore, be of two types, inhibitory
(DAi) and excitatory (DAe). Respiration in man is reduced by dopa¬
mine (Bainbridge & Heistad, 1980). It was suggested by Osborne
& Butler (1975) that in the carotid body dopamine is continually
released from Type I cells during normoxia and suppresses the tendency
of sensory endings to depolarise spontaneously. In hypoxia, dopamine
release is attenuated and the chemosensory activity increases. But
dopamine release is found to increase during hypoxia, and there is also
pharmacological evidence which is not in accord with the hypothesis
(see Docherty & McQueen, 1978).
The fact that administration of exogenous dopamine causes a
predominately inhibitory effect on carotid chemosensors has led to
various proposals concerning the involvement of dopamine in negative
feedback and the consensus is that it has a 'modulatory' role, modifying
ongoing discharge without being directly responsible for that discharge.
In contrast to the inhibitory action, it was suggested over 20 years ago
that catecholamines might stimulate sensory nerves in the carotid body
(see Biscoe, 1971), and Docherty (1980) recently presented pharmaco¬
logical evidence which is compatible with endogenous dopamine having
an excitatory influence on cat carotid chemoreceptors. Recently,
interest in the possible importance of noradrenaline to chemoreceptors
has revived and the debate continues as to whether more noradrenaline
than dopamine is present in the carotid body; it seems to be species-
dependent. One complication of studying the actions of catecholamines
in vivo is the well-known vascular effects of these substances, and this
has led to experiments being performed in vitro, where vascular effects
are eliminated. However, the extent to which results from the in vitro
blood-free preparations are directly comparable to those obtained
in vivo is a moot point as has already been mentioned.
Various other hypotheses exist concerning how the peripheral
chemoreceptors work. These include the following: intracellular
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bicarbonate ions regulate sensory discharge (see Torrance in Belmonte
et a I., 1981); Type II cells are the chemosensors, with changes in a low
affinity cytochrome enzyme leading to the establishment of a K+
gradient which can depolarise nerve terminals situated near the Type 11
cells (Mills & Jobsis, 1970); Type II cells are chemosensors, which
respond to changes in oxygen tension, by mechanically affecting the
sensory nerve ending and causing a depolarisation (see Paintal, 1977);
changes in cyclic nucleotides, particularly ATP, within chemoreceptor
tissue are involved in regulation of chemoreceptor discharge (Anichkov
& Belen'kii, 1963) — ATP and adenosine do affect chemosensory activity
(see Figure 1.4). These various hypotheses are supported, to a greater
or lesser degree by experimental evidence, but to date no single hypo¬
thesis has emerged as being generally acceptable, and the involvement
of chemical transmission in chemoreception remains to be established.
The variety of hypotheses may mean that different mechanisms
within the receptor complex are capable of increasing chemosensory
discharge, with the final stage of all the processes being the same.
Thus, hypoxia and hypercapnia might act via different cells and/or
mechanisms, and there is some evidence to suggest this may be the
case, but the final pathway which leads to increased chemosensory
discharge could be common, perhaps involving adenylate cyclase or
Ca2 +. Further studies using ion-sensitive electrodes, tissue slices, cultured
cells, and microanalytical techniques should enable a better understand¬
ing of the biophysical and biochemical processes to emerge in the near
future. It is often assumed that aortic and carotid chemoreceptors are
quantitatively similar, but we have already seen some evidence which
implies that this may not be the case. Results obtained with one set of
receptors, or in one species, should be applied with great caution to
the other set, or to other species, lest the basic mechanisms of chemo¬
reception differ.
We have not so far considered the role polypeptides might play in
the peripheral chemoreceptors. They do influence carotid chemo¬
receptor discharge when injected (see McQueen in Belmonte et al.,
1981), but because the role of polypeptides in the body has yet to be
established, one hesitates to suggest their function in the peripheral
chemoreceptors. They may be neurotransmitters or neuromodulators,
but could equally well have a neuroendocrine, trophic or other function
on cells and /or nerve endings. It will probably emerge that some of the
peptides are stored in chemoreceptor cells together with the 'classical'
putative transmitters, and may be released along with these substances.
Drugs which can specifically affect polypeptides (e.g. antagonists,
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enzyme inliibitors) are needed in order to facilitate study of the physio¬
logical role of polypeptides. In the present absence of such drugs, some
information may be obtained using specific antibodies to interfere
with the peptides. The presence of these various substances in the
chemoreceptor tissue may mean that the chemoreceptors are not
homogeneous, but rather made up of cell clusters in which the branches
of a single nerve fibre are influenced by cells with different character¬
istics, perhaps releasing different substances in response to physiological
and pharmacological stimuli, these substances having excitatory or
inhibitory actions, either directly or indirectly mediated (by influencing
sensitivity to physiological stimuli), on chemosensory activity. The
substances released may, besides influencing the sensory nerves, also
affect cells and blood vessels in the vicinity. The integrated input to
the CNS from such a glomerulus would be the algebraic summation of
the various components and might be subject to efferent feedback.
The role of Type I and Type II cells in chemoreception is prob¬
lematic — whether the cells release one or more chemical transmitters to
affect the sensory nerve endings, or whether cellular activity influences
the sensitivity of the nerve endings some other way, remains to be
established, as indeed does the more general question concerning which
of the chemoreceptor elements is the chemosensor. An alternative
proposal is that some of the ceEs are not directly involved in chemo¬
reception, but have a separate function, perhaps endocrine. In this
context it should be remembered that the carotid body was, for a
long time, considered to be a gland, and it could be that it has a dual
function - sensory organ and gland.
Although two types of chemosensory fibre exist, namely myelinated
and unmyelinated, it is not known whether they subserve different
functions and act by different mechanisms. Preliminary studies in
anaesthetised rats have demonstrated a significant reduction in basal res¬
piration and a loss of chemoreceptor responsiveness in anaesthetised
animals which were treated with capsaicin neonatally (Figure 1.9). This
drug causes a permanent loss of the majority of unmyelinated sensory
afferent nerve fibres and the results observed could be the consequence
of a destruction of the unmyelinated chemoreceptor afferents. The
reduced respiratory responsiveness may be due to a reduced peripheral
chemoreceptor input to the CNS, or some effect in the CNS consequent
to destruction of the primary afferent terminals. It has been suggested
that substance P is a neurotransmitter of chemoreceptor afferents in
the nucleus tractus solitarius of the rat (Gillis etal., 1980), and capsaicin
does cause a destruction of SP-containing fibres/However, it is also able
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to affect unmyelinated sensory fibres containing other polypeptides,
so the results cannot be interpreted exclusively in terms of a loss of
SP-containing fibres. The study of animals treated neonatally with
capsaicin may allow an assessment of the relative contribution made to
respiratory reflexes by myelinated and unmyelinated chemoreceptor
afferents, and may also be useful for investigating the physiological
role of polypeptides in the peripheral chemoreceptors.
Figure 1.9: Averaged Increase in Respiratory Minute Volume in Pento¬
barbitone Anaesthetised Rats During the 20s Period Following i.v.
Injection of NaCN (log!0 scale) in Vehicle-treated (-, n=3) and Capsaicin-
treated n=3) Animals. Lines were fitted to the data by eye. The rats
were seven months old when used for the study and had been injected
with either capsaicin (50 mg kg"1 s.c.) or drug vehicle 50:50 polyethy¬
lene glycol/saline) two days after birth. The body weights of the two
groups were not significantly different, but capsaicin-treated animals
had a significantly lower (P < 0.01) respiratory minute volume than the
controls (93±8.1 compared with 154±6.7 ml min"1) and their respira¬










McQueen and Cervero, unpublished observations.
Peripheral Arterial Chemoreceptors 37
In conclusion, the influence of the peripheral arterial chemoreceptors
on respiration has been investigated and is fairly well understood,
whereas the identity of the chemosensor(s) and the mechanism(s)
of transduction within the peripheral chemoreceptors remain to be
established. The pathophysiology of the aortic and carotid bodies
should be studied since respiratory and other disorders might follow
from changes in peripheral chemoreceptOr function, perhaps as a
result of 'sclerosis of the organs' (Gomez, 1908) or as a consequence
of repeated stimulation.
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Pharmacological studies involving the use of drugs such as selective agonists,
antagonists, enzyme inhibitors, biosynthesis inhibitors and neurotoxins proved very
valuable in helping to establish that chemical transmission occurs in the motor
nervous system, so it is not too surprising that, despite the structural differences
between motor and sensory synapses, a similar approach was adopted as part of the
attempt to determine whether transmitter (generator) substances are involved in the
sensory process of chemoreception, i.e. the mechanism whereby the physiological
stimulus is transduced into a neural signal by the peripheral arterial chemoreceptors.
Most investigators have chosen to study the carotid body chemoreceptors, and
consequently a considerable amount of information concerning the pharmacology of
these sensory receptors has accumulated - there is even a book on the topic
(Anichkov and Belen'kii, 1963). Although pharmacological studies have made an
important contribution to our knowledge of the carotid body, they have not provided
clear evidence for the involvement in chemoreception of any particular chemical, in
contrast to the situation with motor nerves. This is not to deny the existence of
evidence favouring chemical transmission in arterial chemoreception (e.g. see Eyza-
guirre and Zapata, 1968a), but the consensus appears to be that the case for chemical
transmission has yet to be proved, and it should be noted that hypotheses exist which
purport to explain chemoreception without invoking chemical transmission (e.g.
Paintal, 1967).
The aim of this chapter is to review the pharmacology of putative transmitters in
the carotid body and to provide some insight into the problems encountered in
studying the pharmacology of this organ and interpreting the results obtained. The
question of what is meant by the term "putative transmitter" immediately arises and,
in order to avoid entering into a somewhat semantic discussion about neuro¬
transmitters, co-transmitters, modulators and neurohormones, a fairly catholic
interpretation will be applied in the present context. The involvement of acetylcholine
(ACh) and the catecholamines in chemoreception will be considered in detail, but
some attention will be given to all the substances shown in Fig. 1 since they are
present within the carotid body and reputed to function as transmitters in other parts
of the nervous system. We shall also consider the actions in the carotid body of some
substances, listed in Table 1, which may be transmitters in other parts of the nervous
system, even though their presence in. or absence from, the carotid body remains to
be established. It is not always possible to detect and identify endogenous substances
when present in low concentrations within a very small structure such as the carotid
body. For example, pharmacological studies on the question of whether or not
acetylcholine is a chemosensory transmitter began over 40 years ago, yet it is only
recently that convincing evidence for the presence of this putative transmitter in the
carotid body has been obtained using gas chromatography-mass spectrometry
(GC-MS) (Fidone et al.. 1976). a technique that had not been devised when the first
suggestion that ACh might be a transmitter involved in chemoreception was made
(Schweitzer and Wright. 1938).
Peptides have been included in the list of putative transmitters somewhat
Acetylcholine (ACh)




















,H iRibosel (♦3<V)P= ATP)
Tyr Gly Gly Pne Leu
Methionine enkephalin




Met Leu Gly Phe-I
His Ser Asp Ala Vol Phe Thr ,
rArg Leu Arg Thr Tyr Asn Asp J
*-Lys Gin Met aio Val Lys Lys -i
Asn. Leu. He Ser Asnl.eu. Tyr J
NHj.CH; CHJ SO,H
Glutomate hooc ch2.ch2 ch< nh2).cooh
Pig. I. Chemical struclures of pulalivc Iransmitlers known to he present in the carotid body.
TABLE I
SUBSTANCES WHICH EVIDENCE SUGGESTS MAY BE TRANSMITTERS IN OTHER PARTS
OP" THE NERVOUS SYSTEM. BUT WHOSE PRESENCE IN THE CAROTID BODY IS NOT
ESTABLISHED




eholeeyslokinin octapeptide (CCK-X). neurotensin, glucagon, carnosine. somatostatin, bradykinin.
bombesin, angiotensin II. /(-endorphin (//-END), vasopressin (ADII)
152
tentatively as there is only limited evidence in favour of their having a transmitter
function, and it is not unreasonable to state that their precise role is unknown at
present. However, some of them do appear to be located in the carotid body and are
capable of modifying chemoreceptor activity (McQueen, 1981), so it seemed worth
considering their pharmacology in more detail than that of the others.
1.1. Theoretical considerations
Before making a start on the pharmacology of individual substances, consideration
will be given to general problems encountered in studying the pharmacology of
carotid body chemoreceptors. The carotid body is a receptor complex which
comprises nerve endings, type 1 cells, type II cells, blood vessels and connective tissue.
It is not known which of the receptor elements (nerve endings or cells) is the primary
site for chemoreception (see Eyzaguirre and Fidone, 1980). In addition to afferent or
sensory nerve fibres which course in the carotid sinus nerve and terminate near some
of the cells, the organ is innervated by efferent or motor fibres which originate from
the superior cervical ganglion (sympathetic nerves) and the carotid sinus nerve.
Efferent nerves terminate near blood vessels and some cells, and are capable of
modifying chemosensory activity (see Chapter 11). Chemical transmission in efferent
nerve pathways is well established, so it is very probable that some of the putative
carotid body transmitters are associated with efferent nerves. Potential sites of drug
action within the carotid body are shown schematically in Fig. 2, and it will be
appreciated that many problems are involved in trying to determine where within this
complex structure an exogenously administered putative transmitter, or any other
drug, is acting to affect chemosensory activity, particularly since effects at more than
one of the sites (sensory nerves, motor nerves, cells, vasculature) could be involved.
The possibility also exists that functionally dissimilar sites within the carotid body
may employ the same transmitter substance. Further complications arise ifmore than
one substance is involved in transmission at a single site (co-transmission), because
studies on the putative transmitter role of one substance in the absence of the other
may be misleading.
The cells of the carotid body have been likened to those of the adrenal medulla on
the basis of their morphology, and adrenal medullary cells are known to release
substances (catecholamines and opioids) which have a hormonal function. The
carotid body used to be thought of as a gland, and was even called the carotid gland,
but the convincing demonstration of its chemosensory properties (see Heymans and
Neil, 1958) has led to a more or less complete abandonment of the endocrine concept.
However, Pearse (1969) classified the type I cell in the APUD series of endocrine cells
and it could be that, in addition to its undoubted chemosensory function, the carotid
body does have an endocrine function. This has important implications for the
pharmacological study of putative transmitters in the carotid body since, by analogy
with the adrenal medulla, substances such as noradrenaline, adrenaline and possibly
opioids could have an endocrine (or paracrine) rather than a transmitter function, or





Fig. 2. Schematic representation of the carotid body "receptor complex" showing some potential sites
of drug action, namely: A, sensory nerve endings; ▲ . motor nerve endings; ■, postsynaptic receptors;0-
receptors on type I or type II cells that control the release of substances (arrows) which might affect other
cells, nerves, or blood vessels; ir, receptors in blood vessels. Note that not all the cells are innervated, and
that there are very few ganglion cells within the carotid body.
measuring changes that occur within seconds of administering a drug, and they are
not really suitable for detecting drug-induced effects that take several minutes or
hours to develop.
1.2. Practical considerations
Having considered some of the theoretical problems associated with carotid body
pharmacology, the intention is now to review the practical aspects of the subject.
Pharmacological studies on the carotid body have generated quite a lot of con¬
flicting evidence: Why is this? Part of the answer to the question is that the small
size of the carotid body in commonly studied species does not facilitate pharma¬
cological studies, but the real problem lies in the fact that a variety of techniques
involving different investigators, animal species, drug doses and methods of evalua¬
ting and expressing results have been used, such that it is difficult and sometimes
downright impossible to make a meaningful comparison of the evidence presented by
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different workers. If the carotid chemoreceptors are heterogeneous, i.e. comprising
different populations which do not share the same pharmacological properties, this
might also explain why conflicting evidence arises.
Some of the methods that have been used in studying the pharmacology of carotid
body chemoreceptors are listed in Table 2, and in general terms they fall into two
categories, namely those that utilize electrophysiological techniques, and those that
do not. Electrophysiological methods have provided a great deal of information
about the pharmacology of carotid chemoreceptors, but it has to be appreciated that
there are disadvantages associated with their use. In early studies it was difficult to
distinguish between chemoreceptor and baroreceptor potentials in the multiunit
recordings made from the mixed function carotid sinus nerve. As techniques
improved multiunit chemoreccptor recordings were obtained, but these are difficult
to interpret because it is not known if the population being recorded is constant, and
quantification of responses evoked by drugs is problematic. Single unit (single
functional fibre) studies overcame most of these problems, but meant that only very
small samples of the total fibre population (which in a sinus nerve runs into the
thousands) could be investigated. The sinus nerve contains chemoreceptor A and C
(fast and slow conducting fibres, probably myelinated and unmyelinated respectively)
fibres and these may not have identical pharmacological properties (Paintal, 1967;
Fidone and Sato, 1969). Single units are most liable to be recorded from the large
diameter (A) fibres since it is technically very difficult regularly to record from
small (C) fibres (Iggo, 1960). Consequently, single unit studies tend to be biased
towards those units which are most easily recorded, i.e. those which are spon¬
taneously active and associated with larger nerve fibres. Performing several experi¬
ments will provide a larger sample, but it will still be a very small and biased one. A
compromise is to record 3-4 units which can be separately identified from their
amplitude, rise time and shape, then counted by using a pulse height discriminator
operating in conjunction with a computer. With this technique drugs can be studied
on a larger population than is possible using the single unit method, and it is likely
that some of the smaller units recorded will be C fibres. Studies which have com¬
pared the drug-induced responses of single and multiple units show them to be
remarkably homogeneous (e.g. see Goodman. 1974; McQueen, 1977). Nevertheless,
the problem of sample bias remains, and it is actually very difficult to establish the
conduction velocity of a fibre in the carotid sinus nerve because of the short length of
nerve between stimulating and recording electrodes (see Paintal. 1971), so with the
methods commonly used it is not know n what type of fibre is being studied. A rough
idea can be obtained from the duration of the action potential when bipolar
recording electrodes are used because slower conduction is generally associated with
a longer duration (but see Iggo. 1958). Histology does not help to determine whether
the active fibre was myelinated because even a small filament from which a single
unit is recorded contains several fibres, some of which arc inactive, and it is
impossible to establish from which of these the electrical activity emanated.
Incidentally, the term "single fibre", as used in relation to extracellular recordings, is
rarely meant literally.
In vitro carotid body preparations have much to offer the pharmacologist who
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TABLE 2
METHODS USED IN STUDYING THE PHARMACOLOGY OF THE CAROTID BODY
Method Comments
Study of reflex respiratory, vascular, or
other changes following drug administra¬
tion in the whole animal (see Heymans
and Neil, 1958; Anichkov and Bclen'kii,
1963)
Study of motor changes provides only limited information
about the action of drugs on carotid body receptors. Com¬
plications arise from other actions of the drug, the anaes¬
thetic agent, and secondary changes (e.g. in blood gas tensions,
lung inflation reflex, blood pressure) which can modify the
primary chemoreceptor reflex. Integration in theCNS makes
it difficult to relate output (reflex change) to input (drug action
on chcmorcccptors). However, the method is fairly easy to
perform and does provide some information concerning the
actions of drugs and physiological stimuli on the whole
intact receptor population, although small changes in chcmo-
sensory discharge are unlikely to be detected.
Electrophysiological recording of chemo-
sensory discharge in the whole animal and
close-arterial drug administration to the
carotid body (see Hcymans and Neil.
1958; McQueen. 1977)
Recording action potentials in the carotid sinus nerve avoids
some of the problems associated with reflex studies and can
provide quantitative data concerning drug actions on the re¬
ceptor complex. Activity in efferent nerves can be eliminated,
and secondary influences can be minimised by careful
monitoring and control of blood gas tensions, temperature,
blood pressure and pH; anaesthetic agents do not exert much
direct influence on sensory endings. The disadvantage is that
this method does not reveal wherewithin the receptor complex
a drug is acting, and the sample of fibres studied is a limited
and biased one (see text); recording activity from cell bodies
in the petrosal ganglion may enable studies to be performed
on carotid chemoreceptors with identified conduction veloci¬
ties. Vascular effects of drugs may complicate interpretation
of results; however, many putative transmitters have vascular
effects, and this has nol prevented them from being studied in
the central and peripheral nervous systems of intact animals.
Electrophysiological recording of chcmo-
sensory discharge in vitro (see Eyzaguirrc
and Zapata, 1968a)
Removing the carotid body from the animal and supcrfu-
sing it with an appropriate physiological solution provides a
constant environment, avoids vascular complications, and
enables the concentration of drug reaching the receptors to
be predicted unlike the situation in vivo. The problem of
bias in the sample of units recorded remains, and it is nol
possible to tell where within the complex the drug is acting.
Drugs take longer to act in vitro as compared to in vivo, and
their effects last longer; those pharmacokinetic differences
between preparations may give rise to dissimilar results, and
it is perhaps relevant to note that fast or dynamic responses
arc one of the characteristic features of the carotid chemo-
reccptors in vivo. There is evidence to suggest that the
carotid body does not function as well in vitro as it docs in
vivo (see O'Rcgan. 1981). and this may be partly due to the




Electrophysiological recording in vitro;
Intracellular studies (see Eyzaguirre et al..
1975; Eyzaguirre and Fidone, 1980)
Pharmacological studies on chemo-
receptor neurones and cells in tissue cul¬
ture (sec Pietruschka et al., 1977; Acker
and Pietruschka, 1977)
Extracellular studies on the generator potential, and intra¬
cellular studies on identified chemoreceptor cells take one
much nearer to the receptor. The use of tissue slices, such as
elegantly employed by Eyzaguirre, offers the prospect of
direct application of drugs to cells and nerve endings, as has
been done at the neuromuscular junction (Kufflcr and
Yoshikami. 1975). Also noise analysis of potentials recorded
in single cells and fibres (e.g. Hayashida and Eyzaguirre,
1979; Hayashida et al., 1981) may reveal how putative
transmitters affect ion channels, as may studies with ion-
sensitive electrodes (e.g. Acker, 1978) and the patch clamp
technique. Problems associated with using in vitro prepara¬
tions, discussed above, and those associated with damage to
cells by the relatively large microeleclrodes remain to be
resolved. Sample bias arises because it is more likely that
larger rather than smaller cells and fibres will be recorded.
The effects of drugs on cell bodies of chemoreceptor fibres
can be studied using preparations of the nodose or the petro¬
sal ganglia.
This method would appear to offer great scope for ncuro-
pharmacological studies, such as those described above, but
also for receptor-labelling experiments and biochemical in¬
vestigations. It remains a moot point, however, whether
studies on isolated individual elements of the carotid body
complex provide information which is relevant to those
elements in the intact animal; but in principle it seems de¬
sirable to study the functioning of the basic units, then to
start investigating how these are modified in the more
complex structure. One might predict that pharmacological
studies on subcellular elements will be performed in the
future.
Various (see Christie. 1933; Cuello and
McQueen. 1980; Dinger et al., 1981a)
Various methods have been used to locate and identify
putative transmitter substances in the carotid body. These
include bioassay, biochemistry, immunohistochcmistry.
histofiuorescencc, electron microscopy and GC-MS. Recep¬
tor-binding sites can also be identified using auto¬
radiography and other techniques. These methods can be
used to study drugs which either mimic or modify the
actions of putative transmitters on the chemoreceptors. It
may be possible to use 2-deoxyglucose to determine which
cells in the receptor complex are metabolically active and to
investigate whether physiological stimuli and drugs modify
their activity.
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wishes to characterize receptors for putative transmitters either by determining
affinity constants for selective agonists and antagonists or using receptor-binding
techniques. Intracellular recording techniques may enable the actions of drugs on ion
channels to be studied. However, in common with all other biological systems, the
question of whether the isolated preparation retains essentially the same properties it
had in vivo is paramount; this gets harder to answer the more the original structure is
broken down in vitro into its constituent parts and the integrity of the system is
destroyed.
Most of the methods employed have made a contribution to our understanding of
carotid body pharmacology, and it is likely that pharmacological studies on the
carotid body will continue to use a wide variety of techniques. The problem is to find
ways of correlating the results obtained in different preparations. A standard
pharmacological tool used for evaluating drug effects is the dose response curve, and
although it means having to quantify responses and study drugs at different dose
levels, its use does provide' objective evidence concerning the effects of drugs on the
carotid body. Qualitative evidence, in contrast, is subjective and can be misleading;
single-dose studies can be difficult to evaluate, particularly if the drug is used at a dose
which produces a response that is either near threshold or is supramaximal. In
chemoreceptor studies it may be necessary to employ single doses, but in that event it
should be established that the dose used is one which produces a response within the
central region of the dose-response curve.
Chemosensory discharge is irregular, and consequently it is often difficult to
distinguish between weak drug-induced effects and spontaneous changes in dis¬
charge. Injecting the drug vehicle, generally Locke solution or normal saline, also
causes a transient decrease in discharge due to the low PCOj of the solution
(Landgren et al., 1952); this can be largely avoided by bubbling the wash solution
with 5% CO2 in air (see Fig. 12) and injecting small volumes. Chemoreceptors are
also sensitive to temperature (e.g. McQueen and Eyzaguirre, 1974), so solutions to be
injected close-arterial to the carotid body should be pre-warmed to blood tempera¬
ture. Recent reports suggest that carotid body chemoreceptors arc sensitive to
changes in osmotic pressure, both in vitro and in vivo (Gallego et al., 1979; Gallego
and Belmonte. 1979). Since some of the drug solutions injected close-arterial to the
carotid body are hyperosmotic (see Table 3), the question of the extent to which the
osmolality of the solution modifies the response naturally arises. Hyperosmotic
mannitol solutions injected in 3 limes the volume normally administered i.e. by
McQueen (1977) have no appreciable effect on spontaneous chemoreceptor discharge
(Fig. 3) nor do they affect responses evoked by physiological or pharmacological
stimulants. Hyperosmotic sucrose tends to cause a slight delayed increase in
discharge lasting for about 30 sec. These findings accord with older reports that
injections of hyperosmotic sodium chloride solutions have no marked effect on
chemoreceptor activity (e.g. Landgren el al., 1952). Gallego and Belmonte (1979)
considered that the decrease in chemoreceptor discharge they observed following
infusion of hyperosmotic sucrose in vivo, which contrasted with the increase found to




OSMOTIC PRESSURES OF SOME CONCENTRATED DRUG SOLUTIONS COMMONLY IN¬
JECTED IN A VOLUME OF 0.1 —p.3 ml CLOSE-ARTERIAL TO THE CAROTID BODY (McQueen,
unpublished data)
Drugs were dissolved in either Locke solution (L) or 0.9% aqueous sodium chloride solution (saline, S)
and osmotic pressure was measured using an osmometer (Advanced Instruments).
Drug Concentration Osmotic pressure
(mOsm)
Acetylcholine iodide 500 //g/ml (L) 297
Sodium cyanide 50 //g/ml (L) 295
100% C02-equilibrated Locke solution 334
Nicotine hydrogen tartrate 50 //g/ml (L) 306
5-HT creatinine sulphate 100 //g/ml (L) 295
Dopamine hydrochloride 50 //g/ml (L) 293
Adrenaline hydrochloride 100 //g/ml (S) 291
Adenosine 100//g/ml (L) 296
ATP, disodium 100 //g/ml (L) 299
Mecamylamine hydrochloride 10 mg/ml (L) 386
Atropine sulphate 10 mg/ml (L) 335
a-Flupenthixol dihydrochloride 10 mg/ml (S) 315
Substance P 100 //g/ml (L) 306
Met-enkephalin acetate 100 //g/ml (S) 288
Histiminc acid phosphate 1 mg/ml (S) 306
GABA 1 mg/ml (S) 309
Taurine 1 mg/ml (S) 308
Phenylbignanide 1 mg/ml (L) 330
Locke solution (drug vehicle) 295
Saline (drug vehicle) 298
2. Putative transmitters
2.1. Acetylcholine
2.1.1. Historical revie it'
Many pharmacological studies have been undertaken to test the "cholinergic
hypothesis" that ACh is released within the carotid body by physiological stimuli and
acts to excite chemosensory nerve endings. Only a brief review will be made in this
chapter since full details can be obtained from the reviews by Anichkov and Belen'kii
(1963), Eyzaguirre and Zapata (1968a), Biscoe (1971), and Eyzaguirre and Fidone
(1980).
Early studies suggested that the pharmacology of the carotid body is very similar
to that of ganglion cells in autonomic ganglia, particularly with regard to the
excitatory action of ACh, and this reinforced the notion that cells and nerve endings
of the carotid body are functionally akin to synapses, possibly using ACh as a
transmitter. Eyzaguirre's Loewi-type experiments in vitro (Eyzaguirre et al., 1965)
demonstrated that an hypoxic carotid body releases a chemical which is capable of
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Fig. 3. Data from 3 cats showing the effects on spontaneous diseharge of injecting (i.e.) mannitol or
sucrose solutions of different osmolality. Animals were anaesthetized with pentobarbitone, artificially
ventilated and paralyzed with gallamine (see McQueen. 1977. for full details). Discharge in individual
experiments was averaged over 15 sec periods and expressed as a percentage of the 15 sec period
immediately preceding the injection (i.e. control = 100%: mean absolute values given above the figure in
ct sec) Pooled data are shown as mean +S.F. M. (McQueen, unpublished observations.)
evoking increased chemosensory activity in a "down-stream" carotid body prepara¬
tion. This occurred even when the carotid body which was rendered hypoxic had
been chronically denervated. an observation which implies that the chemical
originates from cells, not nerves, in the carotid body. Further evidence was obtained
which showed that the increase in discharge of the down-stream carotid body could
be potentiated by the anticholinesterase drug physostigminc (eserine) and prevented
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by the ganglion-blocking drug mecamylamine (Eyzaguirre and Zapata, 1968b). An
ACh-like material was detected in the cat carotid body by Eyzaguirre et al. (1965) who
used bioassay methods, and the presence ofACh in the carotid body was confirmed by
Fidone et al. (1976) using the technique of GC-MS. Chronically denervated carotid
bodies contain the same levels of ACh as normal carotid bodies, and chronic superior
cervical ganglionectomy does not affect the ACh levels. These findings suggest that
ACh is present in cells with the carotid body complex, and a high affinity choline
uptake mechanism has been shown to be present in carotid body type I and, possibly,
type II cells (Fidone et al., 1977). All this evidence apparently favours the suggestion
that ACh is a transmitter or generator substance in the chemosensory mechanism.
However, some of the evidence concerning the putative transmitter function of
ACh in the carotid body can be queried. For example, are the techniques used for
measuring ACh levels within the carotid body capable of distinguishing between a
low concentration of ACh that might be present in nerve-endings and a very much
higher concentration associated with chemoreceptor cells? Because it is difficult to
show the presence of ACh in tissues, indirect methods have been used. But indirect
evidence, such as high affinity choline uptake by cells, is not proof of a cholinergic
function in vivo; additional evidence is required. It would be desirable to show the
distribution of choline acetyltransferase (CAT) within the carotid body, but at
present there is no specific antibody to CAT which could be used reliably in
immunocytochemical studies. Interpretation of results obtained using the carotid
body in vitro depends on whether the carotid body is functioning normally in this
type of preparation, and as discussed in an earlier section this is a moot point.
The strongest evidence against ACh being "the" chemosensory transmitter comes
from pharmacological studies with nicotine antagonists such as hexamethonium,
mecamylamine and dihydro-/f-erythroidine. Briefly, these demonstrate that the
blocking drugs can greatly reduce or abolish the excitatory action of exogenous ACh
on the chemoreceptors, but have little, if any, effect on responses to physiological
stimuli such as hypoxia and hypercania or to pharmacological stimuli such as sodium
cyanide (see Figs. 4 and 6) (Douglas, 1952; Eyzaguirre and Zapata, 1968a; McQueen,
1977; Bisgard et al., 1979; Eyzaguirre and Fidone, 1980). Some of the evidence is
conflicting, and McQueen (1977) suggested that this may be because different
experimental preparations which do not share the same pharmacological and
physiological properties have been used. Also much of the evidence is qualitative and,
consequently, difficult to evaluate objectively. In addition, certain ganglion-blocking
drugs (e.g. hexamethonium) appear to act by blocking ion channels which are opened
by the ACh-receptor interaction, whereas others (e.g. mecamylamine) compete with
ACh for receptor sites and apparently have little or no direct influence on ion
channels (e.g. see Rang, 1981). One can speculate about the implications of such a
situation in the carotid body. Suppose the physiological stimuli activate the same ion
channel(s) as ACh. but by a non-cholinergic mechanism: some blocking drugs would
affect reponses evoked both by ACh and the physiological stimuli, whereas antago¬
nists such as mecamylamine would inhibit ACh-induced responses, but have little
effect on responses to physiological stimuli. Such a scheme would help to explain








Fig. 4. Recording of'carotid chemorcccptor discharge showing responses to intracarolid injections
(arrows) of ACh. Locke solution equilibrated with 100% COj. and NaCN: A. controls: B. after
mecamylamine 1 mg kg i.e. (dextran solution infused i.v. to maintain blood pressure); C. after the addition
of atropine (I mg/kg i.e.) together with a further dose of mccamylaminc. The cat was artificially ventilated,
paralyzed with gallamine and the ganglioglomerular nerves cut. BP calibration 0-100-200 mm Hg.
(McQueen, unpublished observations.)
The failure of the nicotinic receptor-blocking drugs to reduce appreciably chcmo-
sensory responses to physiological stimuli when used in doses capable of very
substantially reducing the effect of exogenous ACh could be due to insufficient
blocking drug reaching the receptor site. It has been proposed that there are two types
of ACh receptors, those in the cell-nerve cleft, and those outside the cleft which are
referred to as "extrasynaptic" receptors (Eyzaguirre and Zapata, 1968a). Endogenous
ACh, probably in high concentrations, would act on the "intrinsic" receptors and
blocking drugs would not penetrate well and so not reach an effective concentration at
the intrinsic receptor site. Exogenous ACh acts on extrasynaptic receptors and its
action can be antagonized by blocking drugs because the receptor is more accessible. It
is difficult to refute completely this suggestion, but some points can be raised which cast
doubts on its validity. The barrier preventing blocking drugs from diffusing into the
"synaptic" cleft would have to be very substantial given the very high concentrations
applied close-arterial to the carotid body and the long lime allowed for equilibrium to
be reached, yet evidence shows that the enzyme horseradish peroxidase (mol. mass
40 000) rapidly penetrates all regions and intracellular spaces in the rat carotid body
(Woods. 1975). and it is a much larger molecule than any of the blocking drugs.
Furthermore, it remains to be established whether 'synaptic' and/or extrasynaptic










Nerve endings of unmyelinated afferent nerve fibres can be directly excited by ACh
(e.g. Douglas and Ritchie, 1962), whereas those of most myelinated fibres, are
relatively insensitive to the drug. Excitation by ACh need not mean that ACh is
involved in the normal functioning of sensory nerve endings, and it has been shown
that the effects of exogenous ACh on certain sensory receptors in the skin can be
prevented by excess nicotine or by nicotine antagonists without affecting responses to
the physiological stimulus (Brown and Gray, 1948; Gray and Diamond, 1957). Thus,
actions of ACh on sensory nerve endings may be "non-specific", although if ACh
receptors are in fact present on sensory nerves (see below), one might ask what their
physiological role is. Paintal (1967) presented evidence from studies on cat aortic
chemoreceptors which is consistent with the scheme just described, namely that
unmyelinated fibres were excited by ACh whereas myelinated fibres were not: both
types responded to physiological stimuli. Fidone and Sato (1969), in contrast,
reported that ACh can excite both types of chemoreceptor fibre in the cat carotid
sinus nerve. As already mentioned, it is difficult to measure conduction velocity in the
sinus nerve, and Paintal (1971) has criticized the method used by Fidone and Sato.
However, the discrepancy between the results may reflect a real difference between
aortic and carotid chemoreceptors in their responsiveness to ACh.
Experiments with radiolabeled a-bungarotoxin in cats show that binding occurs at
sites on chemoreceptor cells but not on nerves in the carotid body (Dinger et al.,
1981a). The question is whether a-bungarotoxin selectively labels those nicotinic
ACh receptors involved in the chemoexcitatory response to ACh, and here caution is
needed because a-bungarotoxin does not greatly affect chemosensory responses to
ACh in the cat (McQueen, 1977). Even if a-bungarotoxin selectively labels the
nicotinic receptors on cells, the apparent absence of receptors on the nerves may be
due to a failure of the toxin to bind to nicotinic receptors on nerves or, alternatively,
the technique may not be able to resolve the binding to receptors on nerves. Further
studies are needed to investigate the matter, particularly since it has obvious
implications for the synaptic-extrasynaplic ACh receptor hypothesis referred to
above. It is often assumed that ACh acts directly on nerve endings in the carotid body
because its effects on chemosensory discharge are so rapid in onset. However, if ACh
were to act by releasing a transmitter from chemoreceptor cells, or in some other way
indirectly affect chemosensory discharge, it is conceivable that a delay of 20-100 msec
is all that might be involved. Such a delay would not be detected by most of the
techniques currently used for studying chemorcceptor activity.
In addition to evidence that nicotine antagonists which penetrate tissues well (e.g.
mecamylamine, dihydro-/f-erythroidine) do not appreciably affect responses to
physiological stimuli (e.g. McQueen. 1977, 1980b; but cf. Nishi and Eyzaguirre.
1971). it has also been shown that other drugs such as anticholinesterases and
inhibitors of ACh biosynthesis, which might be expected to affect endogenous ACh.
have only slight effects on the responses to physiological stimuli (see Douglas, 1954:
McQueen, 1977; but cf. Eyzaguirre and Zapata, 1968a). The cumulative evidence
does not, on balance, appear to lend much support to the cholinergic hypothesis,
which is not to deny that some evidence favouring the hypothesis does exist. To
conclude this introductory section it can be said that proof'of a physiological role for
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ACh in the carotid body is lacking. Although it may turn out that ACh is not "the"
sensory transmitter substance, there is evidence to suggest that ACh may function in
the transduction process, perhaps acting as a co-transmitter or neuromodulator (see
Eyzaguirre and Fidone, 1980) and maybe affecting more than one site. Consideration
of ACh's pharmacology, free from the influence of the cholinergic hypothesis, may
provide a clue as to its function in the carotid body.
2.1.2. Agonist and antagonist drugs which have been used to characterize the ACh
receptor
These drugs could be called cholinergic agonists and antagonists, although purists
would argue that the term "cholinergic" should be confined to nerves or transmission
and not used for drugs. There is no doubt that receptors for ACh exist in the carotid
body because injected ACh clearly affects chemoreflex activity and chemosensory
discharge, the best-known effect being the chemoexcitation evoked by ACh in most
species studied (see Fig. 4) (Heymans and Neil, 1958; Anichkov and Belen'kii, 1963).
However, chemoinhibition is the predominant effect in rabbits (see Fig. 5) (Docherty
and McQueen, 1978a, 1979). Similar results are obtained from in vivo and in vitro
carotid body preparations, including chemoinhibition in vitro with rabbit carotid
body (Monti-Bloch and Eyzaguirre, 1980), although responses to ACh in vivo are
generally more rapid in onset and shorter-lasting than those in vitro. This temporal
differences may be due to the speed at which ACh gains access to the receptor site(s),
but the fact that responses are qualitatively similar in vivo and in vitro suggests that
vascular actions in vivo are unlikely to be responsible for most of the effects of ACh;
they also occur too rapidly. When intracellular potentials are measured, however, it is
found that some chemoreceptor cells afe hyperpolarized, some depolarized and some
t
l~ig. 5. Chemoreceptor discharge recorded from a rabbit carotid sinus nerve showing the effect of
injecting (arrow) ACh 25//g i.e. BP calibration 0 I(K) 2(K) mm Hg; time marker I sec. (Modified from
Docherty and McQueen, l97Ka.)
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unaffected by ACh (see Eyzaguirre and Fidone, 1980). Are these differences real, and
if so, do different types of ACh receptor exist on chemoreceptor cells, producing
opposing effects on cell membrane potential when activated? Or is there only one type
of receptor, but different cell populations? How much of the change in membrane
potential is secondary to, or modified by, actions of substances released by ACh in
the carotid body complex, as opposed to direct actions on an ACh receptor?
Considerations of Fig. 2 suggests various sites at which ACh might act, and by
analogy with other parts of the nervous system one could predict that effects of ACh
will probably result from actions on muscarinic receptors, nicotinic receptors, or a
mixture of the two. There is no reason for excluding the presence of a novel type of
ACh receptor in the carotid body (see later), but it is simpler to start by investigating
the established receptors. ACh acts at both muscarinic and nicotinic receptor sites
(i.e. it is not selective), so selective agonists and antagonists have been used to help
characterize the ACh receptor(s) present in the carotid body.
Chemoexcitation evoked by ACh appears to result from actions on a nicotinic
ACh receptor, as has been demonstrated in a variety of preparations by various
workers using agonists such as nicotine, lobeline and suberyldicholine (Heymans,
1955; Anichkov and Belen'kii, 1963; Eyzaguirre and Zapata, 1968a; McQueen, 1974).
The effect can be reduced or abolished, depending on the dose of antagonist and that
of the agonist, by nicotine antagonists such as hexamethonium, mecamylamine, D-
tubocurarine and dihydro-/f-erythroidine (e.g. Figs. 4 and 6) (Dontas and Nickerson,
1956; Byck, 1961; Eyzaguirre and Zapata, 1968a; Sampson, 1970; McQueen, 1977,
1980b). It appears that the ACh receptor responsible for chemoexcitation is more akin
to that in ganglia than that at the neuromuscular junction (Anichkov and Belen'kii,
1963; McQueen, 1980b), but no affinity constant has yet been determined, and it could
turn out to be a different type of receptor. T ransient weak chemoexcitation is evoked in
rabbits by some nicotinic agonists, a response which can be reduced or abolished by
ganglion-blocking drugs (see Docherty and McQueen, 1979; Monti-Bloch and
Eyzaguirre, 1980). It may be reasonable to conclude that a nicotinic receptor is
involved in the response, but it has to be noted that the nicotinic agonist
suberyldicholine, which is a very effective stimulant in cats (McQueen, 1974), has no
consistent effect op chemoreceptor discharge in rabbits in vivo (Docherty and
McQueen, 1979). This could mean that if a nicotinic ACh receptor is present in the
rabbit carotid body, it differs from that in the cat's carotid body. Further studies are
needed to investigate the matter.
Chemoinhibition evoked by ACh in rabbits is mimicked by the selective muscarinic
agonist bethanechol (Docherty and McQueen, 1979) and pilocarpine (Monti-Bloch
and Eyzaguirre, 1980) and substantially reduced by atropine, so it appears to involve
a muscarinic ACh receptor. However, in cats pilocarpine does not depress spontane¬
ous chcmosensory discharge, as is illustrated in Fig. 6 which shows responses evoked
by a spectrum of cholinergic agonists ranging from nicotine to muscarine. It can be
seen that although atropine alters the time course of some responses, the overall effect
is unaltered, whereas addition of mecamylamine virtually abolishes the excitation
evoked by several of these agonists, indicating that the effect resulted from activation
of nicotinic receptors (see also McQueen. 1978). ACh does not cause any appreciable
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Fig. 6. The actions of submaximal doses of various substances on chcmoreceptor discharge (2 units)
recorded during a single experiment on a pentobarbitone anaesthetized artificially ventilated paralyzed cat
in which the ganglioglomerular nerves had been cut. For each substance 3 blocks arc shown. The first
represents the background discharge, the second the discharge averaged over the 5 sec period immediately
following the i.e. injection, and the third is the discharge averaged over the next 5 sec, all in ct/sec. Drugs
included nicotine (Nic), suberyldicholine (SDC), propionylcholinc (PrCh), arccolinc (Arc), pilocarpine
(Pilo), methacholine (MCh). bethanechol (BCh), muscarine (Muse). A. controls: B. after atropine I mg/kg
i.e.; C, after mccamylaminc I mg/kg i.e.+ 5 mg/kg i.v. (McQueen, unpublished observations.)
depression of "spontaneous" chemoreceptor discharge when injected into a non-
atropinized cat shortly after a dose of mecamylamine sufficient to abolish the chemo-
excitatory response.(Fig. 4). This experiment incidentally demonstrates that changes in
chemosensory discharge are not secondary to direct effects ofdrugs such as ACh on the
vasculature since the fall in systemic blood pressure, and presumably actions of ACh
on carotid body blood vessels, are unaffected by mecamylamine. It has been noted that
chemoreceptor responses to sodium cyanide in cats can be potentiated by nicotine-
blocking drugs (e.g. Dontasand Nickerson, 1956; Byck, 1961; McQueen, 1977, 1980b)
and while this may be the result of some non-specific action of the blocker, it could be
interpreted as meaning that endogenous ACh can act via nicotinic receptors to depress
discharge. Might there be two populations of nicotinic receptors in the carotid body,
one associated with chemoexcitalion, the other with chemoinhibition?
Stimulating the carotid sinus nerve antidromically causes inhibition of spontane¬
ous chemoreceptor discharge recorded from a strand of the nerve, and also increases
blood flow through the carotid body (Neil and O'Regan, 1971). According to
Goodman (1973) this chemoinhibition is secondary to vascular effects and can be
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abolished by atropine, but Neil and O'Regan (1971) found that whereas atropine
blocked the vascular effects, the inhibition of chemosensory discharge remained and
can, in fact, be obtained even in the absence of blood flow (see O'Regan, 1977).
Belmonte and Eyzaguirre (1974) favoured a vascular explanation for the chemo-
inhibition because it was not observed when stimulating the carotid nerve of the in
vitro cat carotid body preparation, but they also reported that atropine was not very
effective at blocking the chemoinhibition in vivo. It has been proposed by Sampson et
al. (1975, 1976) that ACh or some substance whose actions are blocked by atropine is
released from sinus nerve efferent fibres and indirectly inhibits chemosensory
discharge by releasing catecholamines from type I cells. It is not the intention to enter
into a debate on the efferent pathway (see Chapter 11 for that), but rather to point
out that circumstantial evidence exists which can be interpreted as meaning that ACh
is involved in chemoinhibition (see above).
Further studies are needed to characterize the ACh receptor(s) present within the
carotid body, and intracellular recording techniques could be used to investigate
quantitatively the actions of selective cholinergic agonists and antagonists on chemo-
receptor cells and nerve endings. The possibility that ACh might be acting on a
receptor which is neither muscarinic nor nicotinic needs to be considered, particularly
as Kehoe (1972) has demonstrated in Aplysia that ACh receptors on certain neurones
are stimulated by arecoline but unaffected by muscarine, nicotine, atropine, hexa-
methonium or curare. However, ACh does not appear to have any effect on spon¬
taneous carotid chemosensory discharge in cats treated with mecamylamine and
atropine (e.g. see Figs. 4 and 6), so its actions can be explained in terms of nicotinic
and muscarinic ACh receptors, at least according to the available electrophysio¬
logical evidence. Furthermore, although arecoline has an excitatory action on cat
chemoreceptors, this can be blocked by mecamylamine, so presumably results from
actions on nicotinic receptors (Fig. 6).
2.1.3. Other drugs: anticholinesterases, biosynthesis inhibitors and neurotoxins
Acetylcholinesterase and pseudocholinesterase (butyrylcholinesterase) are both
present in low concentrations in the cat carotid body, pseudocholinesterase being
predominant (Hollinshead and Sawyer, 1945; Koelle, 1950; Biscoe and Silver, 1966).
There is general agreement that anticholinesterase drugs potentiate the effects of ACh
on chemosensory discharge, but have no influence on nicotine-like drugs such as
carbachol which are not destroyed by cholinesterase (see Anichkov and Bclen'kii.
1963; McQueen, 1977). Results obtained with physostigmine (eserine), a drug which
inhibits both types of cholinesterase, during studies on the effects of ACh and
methacholine. led McQueen (1978) to suggest that acetylcholinesterase is located close
to the site(s) at which nicotinic agonist drugs act to increase chemosensory discharge.
Ballard and Jones (1971) used electron microscope techniques and found that
acetylcholinesterase is localized to peripheral axons in cat carotid body, but conflicting
evidence and problems with the methodology mean that it is difficult to be certain
about the precise localization of acetylcholinesterase in the carotid body (Jones, 1975).
If ACh is a transmitter whose action is rapidly terminated by cholinesterase in the
carotid body, it might be expected that natural stimuli capable of evoking intense
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chemoreceptor discharge should, in the presence of an anticholinesterase drug such
as physostigmine, lead to paralysis of the system. This is what happens in
sympathetic ganglia (Feldberg and Vartiainen, 1935). Such an effect does not seem to
occur in cats (McQueen, 1977), although it should be noted that Eyzaguirre and
Zapata (1968a) reported that the response of chemoreceptors to stimulation by acid
is reduced by an excess of ACh, particularly in the presence of choline. As previously
stated, there is disagreement about whether or not anticholinesterases potentiate
submaximal responses to natural stimuli. Undoubtedly much depends on the
technique used, but in general terms it appears that potentiation is a variable and
inconsistent phenomenon (see Anichkov and Belen'kii, 1963) and on balance there is
more evidence against it occurring than there is for it.
The high affinity choline uptake mechanism that exists in the carotid body appears
to be associated with chemoreceptor cells because (a) chronic denervation of the
carotid body has no measurable effect on choline uptake and (b) radiolabeled
choline is concentrated mainly in chemoreceptor cells (Fidone et al., 1977). Low
concentrations of hemicholinium-3, a drug which inhibits choline uptake, reduced or
abolished synthesis of [3H]ACh from [3H]choline by the carotid body in vitro.
Treatment with hemicholinium-3 followed by prolonged periods of hypoxia (to
exhaust stores of ACh) reduces responses evoked by the chemoreceptor stimulant
sodium cyanide but has little effect on responses to ACh, and this occurred both in
vivo and in vitro (Eyzaguirre and Zapata, 1968c; Nishi and Eyzaguirre, 1971;
Eyzaguirre and Nishi, 1974). Results from cat experiments in vivo also showed that
hemicholinium-3 reduces average chemoreceptor discharge evoked by sodium cya¬
nide, but revealed that the integrated or overall response was increased (McQueen,
1977). The latter finding could mean that endogenous ACh depresses the chemo¬
receptor response to sodium cyanide, or else is involved in regulating the temporal
pattern of the response. On balance, however, the weight of evidence suggests that
hemicholinium-3 reduces responses to stimulants such as sodium cyanide, which is
compatible with ACh having a chemoexcitatory function. Having said that, it is
necessary to stress that none of the evidence is really satisfactory and further studies
are needed to correlate alterations in chemoreceptor responsiveness with changes in
ACh output following hemicholinium-3 treatment in vivo. Even then it will be
necessary to determine whether ACh has more than one function in the carotid body
(e.g. inhibition via an efferent pathway; excitation via an afferent pathway) since
hemicholinium-3 might affect these differentially.
Results from studies using various substances which can modify the storage or
release of ACh have provided evidence concerning the cholinergic nature of certain
neural pathways. For example, high concentrations of magnesium ions depress the
release of ACh from cholinergic nerves whereas lanthanum ions provoke its release.
As far as the carotid chemoreceptors are concerned, high magnesium reduces the
membrane potential of chemoreceptor cells (Eyzaguirre and Fidone, 1980) and
increases chemosensory discharge (Eyzaguirre and Zapata, 1968b) while lanthanum
ions cause an increase in spontaneous chemosensory discharge (Roumy and Leitner,
1977). These findings are consistent with ACh being involved in chemoexcitation, but
the posssibilily exists that they could be due to actions of the ions on some other
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transmitter in the carotid body since changes in chemoreceptor activity have not yet
been correlated with ACh output (see above).
There do not appear to have been any detailed studies on the effects of venoms and
toxins on the carotid chemoreceptors, which is perhaps not too surprising given the
nature of the 'drugs'. Botulinum toxin depresses the release of ACh from cholinergic
nerves, and is fairly specific, but black widow spider venom, which releases ACh, may
release other transmitters besides ACh. The snake venom /J-bungarotoxin has been
used to cause release of ACh at cholinergic junctions; release of ACh is followed by
block of transmission and a reduction in choline uptake. /J-Bungarotoxin had no
appreciable influence on responses of the cat carotid body chemoreceptors in vivo to
sodium cyanide (McQueen, 1977), which could be taken as evidence against ACh
being involved in chemoexcitation evoked by that stimulant. These experiments can
be criticized because it was not known whether the venom reached an effective
concentration in the carotid body, or for how long it was present. It will be necessary
to measure ACh output from the carotid body in order to reach meaningful
conclusions regarding the actions of /Tbungarotoxin, or any of the venoms and
toxins already mentioned, on chemosensory activity.
2.1.4. Conclusions
Much of the pharmacological evidence is inadequate or conflicting and does not
enable one to conclude whether or not ACh functions as a transmitter that is involved
in carotid body chemoreception. This state of affairs is rather disappointing,
particularly since very similar opinions were expressed nearly 30 years ago (Daly, 1954;
Douglas, 1954), but it simply reflects the facts of the matter. ACh appears to be present
in the carotid body and presumably has some function there, so why has it not been
possible to determine its role? Part of the answer is that fundamental problems remain
to be solved. For example, it has yet to be established whether the chemoexcitation
evoked by ACh results from direct or indirect actions on chemoreceptor cells, nerve
endings, or a combination of the elements in the carotid body complex. This situation
is not peculiar to ACh - the primary transduction site in the carotid body has also yet to
be established for physiological stimuli (Eyzaguirre and Fidone, 1980). A particular
deficiency is the lack of data relating output of (identified) ACh to chemosensory
discharge or changes in membrane potential ofchemoreceptor cells under the influence
of different physiological and pharmacological stimuli.
Further studies are obviously needed. It is probable that no single method will
establish what ACh does in the carotid body and a variety of techniques will be used
in future pharmacological studies. It is vital, therefore, that investigations should
provide quantitative evidence concerning drug effects on chemoreceptors in order to
minimize the possibility of conflicting evidence arising from qualitative evidence,
something which has dogged this field in the past. Similarly, it has to be appreciated
that results obtained in different species, or in the same species under widely differing
experimental conditions, may not be directly comparable.
As for the types of experiment that might be performed in the future, one can
envisage studies on carotid body slice preparations in which potentials are recorded
from identified chemoreceptor cells and from closely apposed nerve endings while
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drugs are applied locally by ionophoresis (e.g. applying techniques used by KulTler and
Yoshikami (1975) on snake and frog neuromuscular junctions; see also Eyzaguirre et
al. (1975) on the carotid body). Such studies may help to establish which is the primary
receptor element and provide information concerning the site(s) of action of ACh.
Carotid body preparations in vitro offer many advantages to the pharmacologist. For
example, vascular complications are eliminated, known concentrations ofagonists and
antagonists can be used, substances released during chemoreceptor stimulation can be
collected from the perfusion fluid, and studies with microelectrodes are greatly
facilitated. It will, however, be necessary to show the extent to which functioning of
chemoreceptors in vitro differs from that in vivo, something which might be difficult to
do, particularly if the cells are heterogeneous.
Much more work can be done to characterize the ACh receptor(s) present in the
carotid body, to determine which element(s) of the chemosensory complex these
receptors are associated with, and to establish what biophysical and/or biochemical
changes result from receptor activation. Existing techniques, or refinements of these,
could be used for some of the studies, but new techniques will have to be adopted or
devised for others. Modern analytical methods such as GC MS could be used to
investigate the possibility sometimes encountered in the literature (e.g. Heymans,
1955) that it is a choline esterwith similar properties to ACh which is involved in chemo-
excitation - rather than, or in addition to, ACh. Following this line of thought, ifACh
in the carotid body functions together with a co-transmitter (a fashionable concept,
e.g. ACh-VIP in sweat glands - Hokfelt et al., 1980a), then it is possible that drugs
which affect one of the putative transmitters without influencing the other might pro-
j «fvide results which do not necessarily reveal the physiological role of the "trans¬
mitter". The phenomenon of co-existence of transmitters (Hokfelt et al.. 1980b) could
be explored in the carotid body using modern histochemical and immunocytochemical
methods, although the fundamental problem of identifying ACh in tissues still has to
be solved. It is worth noting that various polypeptides, including VIP-like material, are
present in the carotid body, something which will be discussed in a later section.
It should be borne in mind that ACh may have actions in the carotid body that are
independent of any role(s) it may have in chemoreccption. Finally, the points
discussed in this section have related to ACh, but most of them apply in general terms
to any putative transmitter.
2.2. Catecholamines
2.2.1. Historical review
This field has recently been reviewed (see Mills et al.. 1978; Fyzaguirre and Fidonej
1980; Fidone et al., 1980) and these works should be consulted for a more detailed
discussion than is possible here. The carotid body contains the catecholamines
dopamine, noradrenaline and adrenaline, the absolute amount of each amine varying
from species to species, and even within a species. For example, Zapata et al. (1969)
found dopamine levels which were double those of noradrenaline in the cat carotid
body, whereas in the same species Mills et al. (1978) found nearly 5 times more
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noradrenaline than dopamine. Much appears to depend on the methodology used fcx*
estimating catecholamines and the state of the tissues when removed from the animal
but while the question of whether it is dopamine or noradrenaline which predomi.
nates awaits a definitive answer, there is general agreement that levels of adrenaline in
the carotid body are usually much lower than those of the other two amines.
What is known about the function of catecholamines in the carotid body? One
possibility is that they are transmitters associated with postganglionic sympathetic
nerves. However, the finding that chronic superior cervical ganglionectomy has no
appreciable effect on the catecholamine content of cat carotid bodies (Zapata et a|.,
1969) argues against such a pathway accounting for the greater part of the.
catecholamines. In rats about 50% of noradrenaline is lost after chronic sympathec¬
tomy, but dopamine levels are largely unaltered (Hanbauer and Hellstrom, 1978).
Even in this species a substantial part of the noradrenaline present in the carotid
body is not associated with sympathetic nerves. Chronic sectioning of the carotid
sinus nerve has no appreciable effect on the catecholamine content of the carotid
body (see Chapter 1) which implies that if catecholamines are associated with fibres
in this nerve the levels must be very much lower than those in the carotid body. Most
of the catecholamines are located in dense-cored vesicles in type I cells, although
whether different amines are stored in the same vesicles, in separate vesicles in the
same cell, or in separate vesicles in separate cells is unclear. Some evidence based on
size and electron density of vesicles has been interpreted as meaning that at least two
varieties of type I cell exist (e.g. Lever et al., 1959; McDonald and Mitchell, 1975),
but the quality of fixation, state of maturity of cells and lack of quantification of
vesicle size makes it difficult to assess the situation (see Chapter 1).
It has also been proposed that catecholamines in the type 1 cells are released by
efferent (motor) activity in the carotid sinus nerve (see Biscoe, 1971; Eyzaguirre and
Fidone, 1980; also Chapter 11) and act as modulators of chemosensory discharge.
Noradrenaline was found to cause rather variable effects on chemorcceptor discharge,
and the increase it generally evoked was considered to be secondary to reduced blood
flow through the carotid body caused by vasoconstriction (Joels and Neil, 1963). No
chemoexcitation was observed in vitro (Eyzaguirre and Zapata, 1968a), which
supports this interpretation (but cf. Biscoe, 1965). In contrast, dopamine was found
to depress spontaneous and evoked chemosensory discharge when injected close-
arterial to the carotid body in many species (Black et al., 1972; Zapata, 1975;
Docherty and McQueen, 1978b, 1979) by a non-vascular action (Sampson et al.,
1976) and it therefore became a likely candidate for the role of inhibitory transmitter
or modulator (e.g. Sampson, 1972; Mitchell and McDonald, 1975). Dopamine is
released from some carotid body preparations during hypoxia (see Fidone et al..
1980) and dopamine levels in rat carotid bodies fall during hypoxia, even when the
carotid sinus nerve is cut (Hanbauer and Hellstrom, 1978).
Osborne and Butler (1975) hypothesized that in the normal resting state dopamine
is tonically released from type I cells and suppresses the spontaneous depolarization
of afferent nerve endings; in hypoxia dopamine release is attenuated and conse¬
quently afferent nerve activity increases. This hypothesis seemed not to accord with
the finding that dopamine output increases during hypoxia (even in denervated
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carotid body) nor with results reported by Eyzaguirre and Zapata (1968a) showing
that, 24-48 h after injecting one or more doses of reserpine sufficient to reduce
catecholamine levels in the cat carotid body substantially, the carotid chemoreceptors
continue to function normally both in vivo and in vitro. Cowan and Greene (1965)
found that the respiratory response to hypoxia, but not that to sodium cyanide, was
almost completely abolished in a reserpinized cat, and a slow i.v. infusion of
noradrenaline restored the response to hypoxia. This experiment is difficult to
evaluate because central actions of reserpine may affect the reflex pathway, but it is
interesting that a difference between reflex responsiveness to hypoxia and cyanide
was obtained. Experiments with reserpine are difficult to interpret because (a) levels
of 5-HT, and possibly other substances, as well as catecholamines could be affected
and (b) a reserpine-resistant pool of amines may remain allowing normal functioning
even when tissue levels of the amines have been greatly reduced.
Pharmacological studies have been undertaken in an attempt to characterize the
catecholamine receptors which are present in the carotid body and to obtain some
insight into the role of catecholamines in this organ. Results from some of the
experiments will now be considered.
2.2.2. Dopamine
The predominant action of low doses of dopamine on cat and rabbit carotid bodies
in situ is a depression of both spontaneous and evoked chemosensory discharge
(Fig. 7) (Sampson, 1972; Nishi, 1975; Zapata and Llados, 1977; Docherty and
McQueen, 1978b, 1979; Lahiri et al., 1980). It was reported that excitation is
obtained in response to injected dopamine in dogs (Jacobs and Comroe, 1968; Black et
al., 1972), but Bisgard et al. (1979) found this only occurs with high doses depression
of discharge is seen following low doses. Chemoexcitation can sometimes also be
observed in cats and rabbits as a delayed effect (cf. the rapid response in dogs
Bisgard et al., 1979) following the rather variable inhibition induced by high doses of
dopamine, or with lower doses after a dopamine antagonist has been administered.
When cat or rabbit carotid bodies are studied in vitro chemoexcitation is more
commonly obtained (Zapata, 1975; Eyzaguirre and Monti-Bloch, 1980), and it
appears that in these preparations the dopamine receptor mediating inhibition
becomes desensitized (Zapata, 1975), something which does not occur in vivo (Llados
and Zapata, 1978a). However, dopamine hyperpolarized chemoreceptor nerve
endings of cat and rabbit carotid bodies in vitro, which would be associated with
chemoinhibition. and tachyphylaxis to this effect was not observed in the experiments
of Sampson and Vidruk (1977). The results obtained in vitro, therefore, need to be
interpreted carefully. So too do those from the carotid body in situ because, as several
workers have pointed out, alterations in chemosensory discharge may be secondary
to vascular changes caused by the drug. However, responses obtained during the first
10 20 sec after a close-arterial injection are unlikely to be due to vascular changes
because such changes take time to occur and the carotid body requires more time to
react to them. In addition, many drugs with pronounced actions on the vasculature
have very little effect on chemosensory discharge in cats unless blood pressure falls
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Fig. 7. Integrated response of chcmoreccplors (3 units) recorded Ln one experiment to i.e. injections of
catecholamines (5 jig) before (black blocks) and after (white blocks) (— (-sulpiride (0.2 mg/kg i.e.).
Background discharge frcqucney is shown in ct/scc. and the blocks represent dT.v. the total increase or
decrease in discharge from the control level occurring over a period whose duration is given. Note that the
depression of spontaneous discharge associated with all three amines was virtually abolished by the
dopamine antagonist, but the delayed excitation was unaffected, or potentiated. Responses to ACh.
NaCN and C02-Locke solution were unaffected by sulpiride. Cat, anaesthetized with pentobarbitone,
artificially ventilated and paraly7.cd with gallamine. Ganglioglomerular nerves cut. (McQueen, unpub¬
lished observations.)
establishing whether exogenously administered catecholamines have similar actions
to those of the endogenous amines released within the tissues by physiological
stimuli.
The observation that chemoexcitation can occur in response to dopamine under
certain circumstances, taken together with results from experiments in which selective
antagonists and other drugs were used, has led to suggestions that endogenous
dopamine in the carotid body may be chemoexcitatory (Docherty, 1979), which is in
accord with Lever and Lewis' (1959) suggestion that a carotid body catecholamine is
involved in impulse initiation. Cardenas and Zapata (1980) proposed that dopamine
has a dual action, inhibiting chemosensory discharge when released in response to
mild stimulation of the carotid body, but increasing the discharge when released in
greater amounts by stronger stimulation. Differences in the accessibility of drugs to
different sites in the carotid body might explain some of the apparent differences
observed between preparations and species (see Bisgard et al.. 1979).
What kind of receptors are involved in the response(s) of the carotid body to
dopamine? Sampson (1972) showed that the a-adrenoceptor antagonist phenoxy-
benzamine in a dose of 20 mg/Kg i.v. abolished dopamine-induced depression of
chemosensory discharge of the cat carotid body in situ. This could be interpreted as
meaning that chemodepression results from actions on an a-adrenoccptor. However,
subsequent studies revealed that lower doses of phenoxybenzamine (3 mg/kg). which
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were apparently adequate for blocking actions of noradrenaline on the systemic
vasculature, have no effect on the dopamine-induced depression of discharge in cats,
nor does the ^-antagonist propranolol (Zapata and Llados, 1977; Llados and Zapata,
1978b). Higher doses (15 mg/kg i.v.) did reduce the depression, but also increased
basal discharge frequency and caused a marked fall in systemic blood pressure
(Llados and Zapata, 1978b). These authors interpreted their results as meaning that
the reduction in the response to dopamine was a result of the hypotension, since it
was reversed upon restoration of blood pressure. However, it could also be the case
that high doses of phenoxybenzamine can antagonize dopamine receptors. Nishi
(1977) also found similar effects with phenoxybenzamine and phentolamine, and
concluded that a-receptors are not involved in the chemodepressant action of
dopamine. This conclusion is supported by the finding that any inhibition evoked by
noradrenaline is antagonized by dopamine antagonists, and not by phenoxy¬
benzamine (see later) and particularly by results showing that drugs which are
reasonably specific dopamine antagonists are capable of eliminating dopamine-
induced depression of discharge.
Various dopamine receptor antagonists have been tested in several species and it
has been established that haloperidol, trifluperidol, spiroperidol, chlorpromazine, a-
flupenthixol and some ergot alkaloids (e.g. dihydroergotamine) are able to reduce or
abolish the depressant action of dopamine (Zapata, 1975; Zapata and Llados, 1977;
Nishi, 1977; Llados and Zapata, 1978a; Zapata and Larrain, 1978; Docherty and
McQueen, 1978b, 1979; Bisgard et al„ 1979) and there seems little doubt that
chemoinhibition is mediated via a dopamine receptor. Some of the antagonists may
have actions on other receptors (e.g. a, 5-HT), but in the doses usually used the
consensus is that they are relatively specific. Similar chemoinhibitory effects are
obtained with apomorphine (Zapata and Llados, 1977; Docherty and McQueen,
1978b), amantadine (Llados and Zapata, 1978a) and certain ergot alkaloids such as
2-Br a-erocryptine (Zapata and Larrain, 1978) and these effects are associated with
activation of dopamine receptors.
One can enquire whether enough evidence exists to classify the dopamine receptor
involved in chemoinhibition as D-l (linked to adenylate cyclase) or D-2 (which does
not stimulate adenylate cyclase) as described by Kebabian and Calne (1979) for
central dopamine receptofs. The answer seems to be yes there is, because the
pharmacological profile of the receptor is compatible with it being a D-2 receptor.
Many of the dopamine antagonists are not capable of distinguishing between D-l
and D-2 receptors, but (— )-sulpiride is regarded as being selective for the D-2
receptor in pituitary cells (Stoof and Kebabian, 1981) and it virtually abolishes the
depression of chemosensory discharge associated with dopamine in the cat carotid
body (Fig. 7). Binding studies in the carotid body should reveal whether this
deduction concerning the D-2 dopamine receptor is correct.
Abolition of the dopamine depressant effect by selective dopamine antagonists is
often associated with an increase in basal discharge, which accords with Osborne and
Butler's (1975) hypothesis. However, much depends on the dose of antagonist used,
and Docherty and McQueen (1978b) did not find any significant change in
frequency using a dose of a-flupenthixol in cats which greatly reduced the chemo-
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depressant action of dopamine, nor did Zapata (1975) using spiroperidol in vitro.
Responses to sodium cyanide, hypoxia and hypercapnia are potentiated after
administering some dopamine receptor antagonists although excitation caused by
ACh is unaffected (Nishi, 1977; Docherty and McQueen, 1978b, 1979; Lahiri et al.,
1980) which is compatible with dopamine exerting an inhibitory effect on the receptor
complex. However, results have to be interpreted cautiously because these electro¬
physiological studies were performed in the absence of the putative efferent pathway
the carotid sinus nerve from which activity was recorded had been cut centrally.
It has been shown in anaesthetized cats that a slow intravenous infusion of
dopamine causes hypoventilation and a reduced respiratory response to hypoxia
which is greatly reduced by sectioning the sinus nerves (Nishino and Lahiri, 1981),
and this was correlated with a depression of chemosensory discharge recorded from
the sinus nerve (Zapata and Zuazo, 1980). In anaesthetized rabbits intracarotid
injection of dopamine also depressed ventilation, an effect which was abolished by
haloperidol, although the hypoventilation in response to dopamine was sometimes
preceded by a transient increase in ventilation following higher doses (Matsumoto et
al., 1980). Experiments in man (Bainbridge and Heistad, 1980) have shown that i.v.
dopamine reduces respiratory minute volume (RMV), an effect which is abolished by
haloperidol without there being any effect on RMV or pa02 measured during either
normoxia or hypoxia.\ These observations can be interpreted as demonstrating the
inhibitory actions of dopamine on the carotid chemoreceptors in humans, but central
actions of haloperidol may complicate matters. Boll et al. (1976) found that the
increased RMV in response to acute hypoxia in man was significantly potentiated
during treatment with chlorpromazine (75 mg daily) and they interpreted this as
being the result of an increased chemoreceptor input to the CNS. Again, possible
central actions via dopamine, 5-HT, a- or acetylcholine receptors complicate the
interpretation, but all the observations are consistent with dopamine exerting an
inhibitory action on peripheral chemoreceptors.
When the depressant action of dopamine has been blocked, an excitatory effect is
sometimes unmasked which is resistant to dopamine antagonists and to various other
blockers, including a-blockers (Fig. 7; Zapata, 1975; Nishi, 1977) and ^-blockers
(Jacobs and Comroe, 1968). The excitation caused by dopamine in dogs can be
antagonized by D-tubocurarine (Bisgard et al., 1979) but not by the nicotine
antagonist gallamine. The receptor mediating this might, as pointed out by Docherty
(1980), be similar to that asssociated with dopamine-induced depolarization of
neurones in the molluscan nervous system which is blocked by D-tubocurarine
(Ascher, 1972). A specific ligand for this receptor is LSD (Drummond et al., 1978), so
studies with LSD on the carotid body may be fruitful. Nishi (1975) noted that this
substance stimulates cat carotid body chemoreceptprs in vivo, but offered no
explanation for the effect. It must be stressed that some authors consider the
chemoexcitatory action of dopamine is non-specific (Zapata, 1975; Mills et al., 1978).
and more studies are needed to show whether or not a dopamine receptor (apparently
not D-2 and probably not D-l) is directly or indirectly involved.
Various drugs capable of affecting endogenous dopamine in other systems have
been tested for their ability to modify carotid chemorcceptor activity. Amphetamine
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has been reported to cause chemoinhibition in cats, an effect which can be blocked by
a-flupenthixol (Docherty and McQueen, 1978b). This might mean either that
amphetamine releases dopamine in the carotid body or alternatively that it acts as an
agonist at dopamine receptors. In contrast, however. Llados and Zapata (1978a)
found tyramine and amphetamine (even 2 mg i.e.) to be without effect in the same
species, and they concluded that dopamine is not released by these agents, suggesting
there is no uptake mechanism for dopamine in the carotid body. Some studies have
been performed on the carotid body using 6-OH-dopamine (e.g. see Murphy and
O'Regan, 1977; Zuazo and Zapata, 1978), but as is the case with reserpine, results are
difficult to interpret and there is a need for better correlation between the pharma¬
cology and biochemistry and effects on adrenergic nerves have to be separated from
those on type 1 cells. There is some evidence favouring an uptake mechanism in
chemoreceptor cells (see Kobayashi, 1975; Fidone et al„ 1980). but whether or not it
is specific remains to be established, and the possibility that species variation exists
has to be considered.
Studies with monoamine oxidase inhibitors, which potentiate the inhibitory action
of dopamine (Docherty, 1980), or the tyrosine hydroxylase inhibitor x-methyl-/>-
tyramine (Docherty and McQueen, 1978b) are difficult to interpret without bio¬
chemical data showing the effect of the drugs on catecholamine levels and turnover in
the carotid body.
Binding studies using [3H]spiroperidol in rabbit carotid bodies show that chronic
sectioning of the carotid sinus nerve reduces specific binding by 64% compared to
normal controls (Dinger et al„ 1981b). This is interpreted as showing that dopamine
receptors are present on afferent sinus nerve endings, although it could also mean
they are associated with efferent nerve endings. The remaining binding sites are likely
to be on chemoreceptor cells, sympathetic nerve endings, or blood vessels. However,
the ratio of non-specific to specific binding is very high, and further studies arc
needed to substantiate these interesting initial findings. Whether the binding sitc(s)
correspond to the dopamine receptor(s) will also need to be shown. The technique of
binding/displacement of radioligands has much to offer, and if its resolution can be
enhanced, may prove a very useful method for studying carotid body receptors.
2.2.3. Noradrenaline and adrenaline
The predominant effect observed following injection of these substances in many
species is chcmocxcitation preceded by a brief period of inhibition which is not a
"Hush" effect of the vehicle (see Fig. 7; Sampson, 1972; Llados and Zapata. 1978b).
In dogs noradrenaline usually causes inhibition (Bisgard et al.. 1979). The delayed
increase in discharge parallels the systemic vasopressor action and is abolished by
phenoxybenzamine (Sampson. 1972; Llados and Zapata, 1978b) in low doses which
prevent the vascular effects. Responses to various chemoreceptor stimulants are
unaffected by phenoxybenzamine (Sampson. 1972). Therefore, the conclusion reached
by Joels and Neil (1963) that the excitation seen following catecholamine administra¬
tion. or stimulating the sympathetic nerves to the carotid body, is related to
vasoconstriction seems quite reasonable. However. Bisgard et al. (1979) found the
excitation caused by noradrenaline in dogs could be blocked by iMubocurarine. an
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effect which is not due to block of nicotinic receptors. After a-blockade the depressant
actions of adrenaline and noradrenaline are enhanced, reflecting the fact that they are
normally partially masked by th? excitatory component of the response. The
chemodepression is blocked by dopamine antagonists (see Fig. 7; Zapata and Llados,
1977; Llados and Zapata, 1978b) so one could conclude that it results from direct or
indirect actions of the amines that can be blocked by dopamine (D-2) antagonists in
cats. The fact that there are two components to the noradrenaline and adrenaline
responses explains why administration of these catecholamines has been associated
with variable effects on chemosensory discharge and ventilation.
Given that the actions on a- and dopamine receptors can apparently account for all
the actions of injected catecholamines in cats, it is perhaps surprising to find reports
that //-adrenoceptor agonists and antagonists can affect chemosensory discharge
under certain circumstances. Biscoe (1965) studied the cat carotid body in vitro and
found that adrenaline, noradrenaline and isoprenaline increased discharge, an effect
which in this preparation cannot be secondary to vasoconstriction, and the effect of
these drugs was blocked by the //-blocker pronethanol. Responses to hypoxia and ACh
were also reduced by the //-antagonist and spontaneous discharge was depressed.
Eyzaguirre and Koyano (1965) and Eyzaguirre and Zapata (1968a) failed to detect any
chemoexcitation with the catecholamines in the same preparation, and they attributed
the reduction in sensory-discharge with dichloroisoprenaline, a drug reported by
Biscoe to be less effective than pronethanol, to nerve fibre block. Local anaesthesia is a
well-known property of some //-blockers in higher doses, but whether it can be invoked
to explain away Biscoe's results is another matter. Greene (1966) used respiratory
changes in anaesthetized cats to provide an index of chemosensory activity in response
to acute hypoxia, intracarotid nicotine or sodium cyanide. Since neither propranolol
(1 mg/kg i.v.) nor phenoxybenzamine (10 mg/kg i.v.) affected the responses, the author
concluded that noradrenaline appears not to be a chemical transmitter at the carotid
body. Heistad et al. (1972) consider their data in man demonstrate that //-receptors are
involved in a hyperventilatory response to noradrenaline and isoprenaline, but not to
hypoxia, whereas Patrick and Pearson (1978) concluded that propranolol has no effect
on the chemical control of breathing in man. Lahiri et al. (1981) used anaesthetized cats
and report that isoprenaline can stimulate chemoreceptors (see also Llados and
Zapata, 1978b; Wasserman et al., 1979; Folgering et al., 1980) but that the magnitude
of the response depends very much on the tension ofC02 and 02 in arterial blood (but
cf. Wasserman et al., 1979). Propanolol (0.5 mg/kg i.v.) blocked the vascular effects of
isoprenaline, and partially reduced,the response to isoprenaline and to hypoxia. A
slightly odd feature of the results is that increases in carotid chemoreceptor discharge
began within 2.5 sec of an intravenous infusion and peaked at 5 sec, which is very rapid
indeed for a direct action <?n the carotid chemoreceptors, given the time it takes for
substances to pass from the vein to the carotid arteries via the pulmonary circulation.
The authors conclude that the ventilatory effect of isoprenaline is mediated, in part, by
peripheral chemoreceptors. However, increases in cardiac output can raise the PaC02
and so increase chemosensory discharge, particularly in artificially ventilated animals.
Isoprenaline can affect oxygen consumption, and //-agonists and antagonists can act
within the CNS (Folgering. 1980), so interpretation of responses is complicated.
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Folgering concluded from cat experiments that /ii-receptors in the brain stem stimu¬
late the ventilatory control system: /f2-agonists (salbutamol) and antagonists
(butoxamine) had no clear effect on respiration. Further studies using selective -and
(12-agonists and -antagonists at different levels of PaC02 and PaC02, combined with
binding studies, should establish whether /^-receptors are present in the carotid body as
is suggested by some, but not all, the pharmacological evidence presently available. If
they are, it will be interesting to see whether they are associated with the vasculature or
the chemosensory cells/fibres and to determine whether endogenous noradrenaline
affects them directly or indirectly.
2.2.4. Conclusions
Depression of spontaneous and evoked chemosensory discharge by exogenous
dopamine results from actions on a specific dopamine receptor, probably of the D-2
type, in the carotid body complex. The chemoexcitation associated with higher doses
of dopamine, or seen under particular experimental conditions, appears not to be
reduced significantly by a-, /?- or dopamine antagonists that are commonly used.
Whether it results from direct or indirect actions of dopamine, and whether these can
be blocked by D-tubocurarine in species other than dog, possibly by antagonism at a
dopamine receptor, remains to be established.
Noradrenaline and adrenaline commonly cause biphasic changes in chemosensory
charge. Chemoinhibition caused by these amines seems to be mediated via
dopamine receptors (D-2?). The increase in sensory discharge can be greatly reduced
by oc-blockers. and failure to elicit the excitatory response in vitro has led some
authors to conclude that the response seen in vivo is the result of vasoconstriction
within the carotid body. Others have reported that D-tubocurarine blocks the excita¬
tion without affecting responses to ACh or nicotine, which raises the possibility
referred to above that a dopamine receptor is involved. However, D-tubocurarine may
be affecting an ion channel since the drug is apparently capable of blocking excitation
evoked by noradrenaline and 5-HT as well as dopamine. Biscoe's (1965) experiments
on cat carotid bodies in vitro indicate that under the conditions of his experiments
isoprenaline, adrenaline and noradrenaline can all increase discharge by affecting a /?-
receptor, which is supported by some, although not all, the data from other
experiments with isoprenaline or /(-blockers. It will be necessary to examine the
chemoexcitalory effect of noradrenaline to see whether it involved actions at more than
one site (i.e. a vascular effect involving a-receptors and some other action on the
receptor complex involving a /(-adrenoceptor or a D-tubocurarine-sensitive site).
The results obtained from pharmacological studies on the carotid body chcmo-
rcceptors depend on the doses of agonist and antagonist used,1 their specificity for a
particular receptor, the physiological state of the preparation (i.e. whether normoxic or
hypoxic; normocapnic or hypercapnic), the time for which the drugs act, the route by
which they reach the receptor(s), and their effects may be modified by actions on the
vasculature. It is not too surprising, given the complexity of the situation, that
opposing results are obtained by workers studying drug effects in different prepara¬
tions or species, particularly when using drugs such as a-blockers and dopamine
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antagonists whose specificity in the doses employed is not always so great as is claimed.
Conflicting data need not mean that real differences do in fact exist in different
preparations or species.
Results obtained from pharmacological experiments do not provide an answer to
the question of whether or not carotid body amines act as transmitters. They may
function as modulators, increasing or decreasing the gain of the chemoreceptors, but
they could also have other actions (e.g. hormonal, vascular) which influence
chemosensory activity only indirectly, if at all.
2.3. Polypeptides
2.3.1. Historical review
Historical is not really a very appropriate word because much of the work on
polypeptides is very recent and has yet to stand the test of time. Pcarse (1969)
classified the carotid body type I cell as a member of the APUD cell series (cells which
share the characteristics of amine and amine precursor wptake and r/ecarboxylation,
together with polypeptide secretion). He suggested that the type 1 cell secretes a low
molecular mass polypeptide which was tentatively named "glomin". Histological
evidence was subsequently obtained which indicated the presence of polypeptide- or
protein-containing granules in mammalian carotid body cells (Capella and Solcia,
1971; Pearse et al„ 1973), and Torrance (e.g. 1974) drew attention to the possible
physiological significance of peptides in the carotid body.
McQueen (1978) showed that substance P (SP) can influence chemoreceptor
activity, and at the 1979 International Arterial Chemoreceptor Meeting held in
Valladolid evidence was presented (McQueen, 198l)demonstratingthat various poly¬
peptides, including SP and methionine enkephalin, can affect chemoreceptor activity in
cats. Furthermore, at the same meeting Fitzgerald et al. (1981) reported, firstly, that
vasoactive intestinal polypeptide (VIP) is present in the carotid bodies ofcats and dogs,
and secondly, that VIP could modify chemoreceptor discharge recorded from cats. The
presence of VI P-Iike material in nerve fibres but not cells of the carotid body has been
confirmed by immunohistochemistry (Lundberg et al., 1979a; Wharton et al.. 1980).
The presence of SP-like immunoreactive material in some cells and nerve fibres of
the cat carotid body has also been demonstrated by the immunofluoresccnt technique
(Cuello and McQueen. 1980). and SP has also been reported to be present within
nerve fibres, but not cells, in cat carotid bodies (Lundberg et al., 1979a; Wharton et
al.. 1980). The latter group also confirmed the presence of SP-like material in cat
carotid body using radioimmunoassay. It is interesting to note that Hanbauer (1977)
used a sensitive radioimmunoassay for SP but did not find any SP in rat carotid body,
whereas Jacobowitz and Helke (1980) showed the presence of SP-likc immuno-
reactivity in some nerve fibres of the rat carotid body. Radioimmunoassay and
immunohistochemical techniques may provide different information because much
depends on the specificity and type of antibody used, the concentration of antigen in
the tissues, and the methods used for preparing the tissues. Differences in antibodies
or methods employed may also explain why Cuello and McQueen (1980) detected
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SP-like material in carotid body cells, whereas other workers did not, but it has also
to be realized that the antibodies may cross-react with peptides which are as yet
unidentified (e.g. an SP-precursor molecule), so it has to be stressed that what is being
detected is SP-like material, not necessarily SP. This sometimes seems to get
overlooked when discussing and interpreting results.
It has recently been suggested that SP is a central neurotransmitter of chemo-
receptor afferent fibres (Haeusler and Osterwalder, 1980; Helke et al„ 1980;
Jacobowitz and Helke, 1980), and if this were proved to be the case, it might mean
that SP in the carotid body is associated with the peripheral endings of primary
afferent chemoreceptor fibres (i.e. applying the "Dale principle", but in reverse
direction - Dale, 1935). The fact that SP-like material has been found in the petrosal
ganglion (Lundberg et al., 1979b) is in accord with this suggestion.
Enkephalin (ENK)-like immunoreactive material has also been detected in cells
but not nerves of the cat carotid body (Lundberg et al., 1979a; Wharton et al., 1980).
Both methionine-ENK and leucine-ENK have been identified in carotid body
extracts by radioimmunoassay, there being 3-4 times more met- than leu-ENK
(Wharton et al., 1980). The particular type(s) of cell with which this, or any of the
other polypeptides, is associated in the carotid has yet to be established, and the same
applies to the nerves in* which some of the peptides are present.
Polypeptides may act as neurotransmitters, but evidence relating to such a function
is not overwhelming, and they could have a neuroendocrine function (Meites et al.,
1979). Although the question of what physiological role they perform is still a matter
for conjecture and debate (e.g. see Guillemin, 1978; Fujita and Kobayashi, 1979;
Hokfelt et al., 1980), peptides have been included in this review partly because some
are present in the carotid body and can modify chemoreceptor activity, and partly
because of evidence from other parts of the nervous system which suggests they are
neurotransmitters (see Hokfelt et al., 1980; Nicoll et al., 1980).
2.3.2. Substance P (SP)
SP affects spontaneous chemosensory discharge when injected close-arterial to the
cat carotid body causing an initial slight depression followed by a dose-related increase
in discharge (Fig. 8) (McQueen, 1980a). Compared with the effects evoked by
injections of ACh or dopamine, the actions of SP are delayed, longer-lasting and less
intense, and part of the response is secondary to a rise in PaC02, possibly as a
consequence of SP altering bronchoeonstrictor tone or cardiac output. Difficulties are
encountered when interpreting delayed effects in vivo because of the possibility that
these are secondary to other actions of the drug, such as vascular effects, and although
steps can be taken to avoid or compensate for such secondary effects, it docs highlight
the fact that there is much to be said for studying effects on the in vitro preparation as
well as in vivo. Monti-Bloch and Eyzaguirrc (1980) reported that SP reduces
spontaneous chemorcceptor discharge recorded from the cat carotid body in vivo, and
similar effects are apparently observed when carotid bodies from rabbits and mice are
used (unpublished observations; see Eyzaguirre and Fidone, 1980). Disagreement
between results obtained from carotid bodies in vivo and in vitro may, as previously
discussed, reflect fundamental differences in the preparations or in the temporal









pattern of drug action, but could equally well be a reflection of the extent to which
secondary factors in vivo modify the primary response of the chemoreceptors.
Changes in discharge evoked by substances such as ACh, sodium cyanide or
dopamine are modified by SP (McQueen, 1980a). Responses to ACh and dopamine
are reduced during SP infusion, whereas those to sodium cyanide are potentiated. It
was concluded that some of these effects may be due to a blocking or modulating
action of SP on ACh at nicotinic receptors, such as is known to occur on Renshaw
cells (Ryall and Belcher, 1977). The delayed inhibition or depression of spontaneous
chemosensory discharge that follows injection of 5-HT (see Fig. 11) was enhanced
during SP infusion. It should be noted that Monti-Bloch and Eyzaguirre (1980) state
in their abstract that low concentrations of SP had no effect on responses evoked by
ACh in vitro, but high concentrations potentiated the stimulatory effect of ACh; the
inhibitory effect of dopamine was converted to an excitation in the presence of low
concentrations of SP. The absence of a full report makes it impossible to evaluate
their findings.
The results obtained from studies with SP on the chemoreceptors are of a rather
preliminary nature, and much remains to be done. For example, it has to be
established whether the peptide affects cells/nerve endings (are A and C fibres
similarly affected, or is there a differential action) in the carotid body, whether more
than one receptor/action is involved and whether this is of any physiological
significance. Is SP released by physiological stimuli, and if so, does it act on the same
receptor(s) as exogenously administered SP? Some answers might come from studies
with radiolabelled SP, or from labelling some of the amino acids which are
incorporated into SP. It should be possible to detect SP in the superfusion fluid from
carotid bodies by radioimmunoassay and to correlate its output with chemosensory
activity - this would also provide evidence relating to the question of whether or not
the time course of action of exogenous SP (seconds or minutes) is appropriate.
It1 might be argued that the relatively slight long-lasting effects evoked by
exogenous SP is evidence against endogenous SP having a transmitter role. Plowever,
it is possible that exogenous SP does not reach an effective concentration at an
intrinsic site (e.g because of enzymatic destruction) or affects other non-specific sites
in such a way as to mask the "primary" effect. Further pharmacological studies
might resolve some of the problems, but SP is a difficult drug to study because; (a) it
can cause tachyphylaxis, (b) there is no specific antagonist to it at present, (c) no
drugs are known which selectively affect its biosynthesis or destruction, and (d) it
might affect the release and/or synthesis of substances such as dopamine and 5-HT in
the carotid body, as it does in the CNS (e.g. Carlsson et al„ 1977; Reubi et ah, 1978).
SP may be stored with 5-HT in the carotid body, as it is in some neurones in the CNS
Fig. 8. Response of a single cat chemoreceptor unit to various doses of SP injected i.e. in random order,
with at least 20 min between successive doses. Each panel shows a block diagram of chemoreccptor
discharge in ct sec and femoral arterial blood pressure. It can be seen in this particular experiment that
although a similar fall in BP was evoked by all the doses of SP. the delayed increase in chemorcceptor

















Fig. 9. Effect of an injection of capsaicin (I mg i.c at arrow) on carotid chemoreceptor discharge
recorded from a cat anaesthetized with pentobarbitone, artificially ventilated and paralyzed with
gallaminc. The ganglioglomerular nerves were intact. This was a lethal dose, and the cat died about 60 sec
after the injection. (McQueen, unpublished observations.)
(Hokfelt et al., 1978). Capsaicin can be used to cause the release of SP within the
carotid body (see Virus and Gebhart (1979) for a review on capsaicin, which is the
active principle of hot peppers). Low doses of capsaicin (10 /ig) had only slight effects
on spontaneous chemoreceptor discharge when injected close-arterial to the carotid
body (McQueen, unpublished observations), and although a high dose did cause
some chemoexcitation (Fig. 9), it also killed the cat. Much may depend on the type of
nerve fibre being studied - capsaicin is particularly effective on unmyelinated afferent
fibres. In any event, it will be necessary to relate changes in discharge to SP output
from the carotid body before any meaningful interpretation could be applied.
The evidence relating to the effect of SP on carotid chemoreceptors is very
preliminary and does not really enable conclusions to be drawn concerning its role in
the carotid body. Indeed, it remains a possibility that the substance present in the
organ is not SP, but a very similar unidentified substance which cross-reacts with
antiserum to SP. The lack of a pronounced chemoexcitation following injection of SP
does not fit at all well with this peptide having an excitatory transmitter role in the
carotid body. It might be argued that exogenous SP exerts a dual action, with chemo-
inhibition masking the chemoexcitation. However, this is an argument that could be
applied to any putative transmitter which has only slight effects on chemosensory
discharge, and it seems somewhat artificial and suspect. In other systems reports that
SP stimulates sensory nerve endings (e.g. Juan and Lembeck. 1974) have not been
confirmed (Lembeck et al., 1977). If it should transpire that SP is not a sensory
transmitter, and it must be emphasised that this is mere speculation, what other
functions might it have in the carotid body? It may be a transmitter in an efferent
pathway, a co-transmiitcr (Hokfclt et al., 1980). a modulator acting to modify the
sensitivity of nerve endings or cells, a trophic factor, a hormone, or an agent
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concerned with regulating blood flow in the carotid body. Caution should be applied
when interpreting the results of experiments in which the carotid sinus nerve is
stimulated during studies on the efferent pathway in case SP is released from sensory
fibres by antidromic nerve activity, as occurs from some fibres in the skin (Hokfelt et
al., 1977), and acts to alter blood flow and/or chemosensory activity.
Further studies are needed to determine the precise localization of SP or SP-like
material in particular elements of the receptor complex, to characterize the SP
receptor(s), and to investigate the biophysical consequences of receptor activation.
Some information concerning the role of SP in the carotid body may also come from
studying animals which have been treated with capsaicin shortly after birth since this
procedure mainly destroys unmyelinated primary afferent nerves (Jancso et al., 1977),
particularly those containing SP (Gamse et al., 1980) - although other peptides may
also be affected (e.g. somatostatin - Keeler and Black, 1981).
2.3.3. Enkephalins and /(-endorphin
Met- and leu-ENK are approximately equipotent in causing a rapid and pro¬
nounced dose-related depression of spontaneous discharge recorded from the cat
carotid body in vivo (see Fig. 10) (McQueen and Ribeiro, 1980). There is no detailed
evidence relating to the effects of the peptides on the carotid body preparation in
vitro, only an abstract by Monti-Bloch and Eyzaguirre (1980) stating that met-ENK
increases chemosensory activity. Whether there is in fact a real difference between the
actions of ENK in vivo and in vitro must await the publication of a full report of
experiments in vitro. As far as /(-endorphin (/(-END) is concerned,, it too inhibits
chemosensory discharge in vivo (see Fig. 10) (McQueen and Ribeiro, 1981b), but the
effect tends to be bi- or tri-phasic, with excitation following the initial depression of
discharge. Its actions are, overall, more like those of morphine than ENK (McQueen
and Ribeiro, 1980).
Responses evoked by injecting ACh or C02-Locke solution were slightly potenti¬
ated during i.e. infusions of met-ENK, whereas the chemoexcitation caused by
sodium cyanide was reduced (McQueen and Ribeiro, 1980). Tests performed during
i.e. infusion of /(-END revealed a reduction in responses to ACh, C02-Locke and to
sodium cyanide, but a potentiation of the dopamine-induced depression of chemo¬
sensory discharge (McQueen and Ribeiro, 1981a). It is difficult to know how much
reliance can be placed on these results because only single doses of the test substances
were investigated, but they do show that opioid peptides are capable of modifying
evoked responses as well as spontaneous chemoreceptor discharge.
Low doses of the opiate antagonist naloxone greatly reduce or abolish the
chemoinhibition caused by /(-END, and indeed its effect becomes predominantly
excitatory (Fig. 10) (McQueen and Ribeiro, 1981a). The inhibition associated with
ENK is also reduced by naloxone, but not to the same extent, and even additional
high doses of naloxone do not entirely eliminate chemoinhibition (Fig. 10) (McQueen
and Ribeiro. 1980, 1981b) although the overall effect, particularly in response to low
doses of met-ENK, may become excitatory. Naloxone itself has only a very slight
effect on spontaneous chemosensory discharge (McQueen and Ribeiro, 1980). These
observations could be interpreted as meaning that /(-END causes chemoinhibition by
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Fig. 10. Responses of a single ehcmoreccptor unit to intracarolid injections (arrows) of enkephalins and
/(-END before and after naloxone at 2 dose levels. Cat anaesthetized with pentobarbitone, artificially
ventilated and paralyzed with gallaminc. Ganglioglomcrular nerves cut. (From McQueen. 1983. with
permission.)
acting on a /t-receptor which is readily blocked by naloxone (see Lord et al., 1977, or
Pert et al.. 1980. for discussion on different types of opiate receptor) whereas ENK
inhibits by affecting a <>-receptor which is more resistant to naloxone. The excitation
seen with /(-END, and some doses of ENK after naloxone, may be due to actions on
an opiate receptor which is naloxone-insensitive (k?). or to direct or indirect actions
of the peptides on other receptors. Much depends on the specificity of naloxone as an
opiate receptor antagonist, and it has been pointed out by Sawynok et al. (1979) that
it may not be quite so specific as some have assumed, particularly when used in high
doses.
The evidence is still rather preliminary, but it allows us to conclude that one or
more opiate receptors are present in the carotid body, that the predominant effect of
leu- and met-ENK is chemoinhibitory. but a slight excitatory action can be
unmasked by naloxone in vivo. In other parts of the nervous system evidence has
been obtained which suggests that ENK and /f-END affect Ca2+ uptake in excitable
tissue, and this action may lead to a depression of transmitter release (e.g. Guerrero-
Munoz et al.. 1979). It has been shown that chemoinhibition caused by ENK.
although somewhat similar to that caused by dopamine, is not appreciably affected
by the dopamine antagonist a-llupenthixol (McQueen. 1981) nor is the inhibition
evoked by dopamine antagonized by naloxone (McQueen and Ribeiro. 1980). SP was
unable to overcome or prevent the chemoinhibition caused by an intracarotid
infusion of met-ENK (McQueen and Ribciro. 1981 b).
How these peptides act to modify chemoreceptor activity, and the receptors and
biophysical/biochemical changes involved (e.g. is the effect linked with changes in
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cAMP — see Snyder, 1980), all remains to be established. It will be necessary to
perform further studies in order to determine whether opiate receptors in the carotid
body are affected solely by endogenous opioids or whether circulating opioids
released from the adrenal glands (e.g. Costa, 1980; Viveros et al., 1980) or by
sympathetic nerves (Wilson et al., 1980; Konishi et al., 1981) also affect them.
Whether ENK in the carotid body is stored with noradrenaline, as occurs in the
adrenal medulla (Schultzberg et al., 1978), how endogenous opioids are released
within the carotid body, and which elements within the receptor complex are
involved all needs to be investigated, and recent work on the adrenal medulla may
provide some useful insight into the role of these peptides in the carotid body (see
Viveros et al., 1980). Could opioids act as modulators or as co-transmitters with
other substances in the carotid body? Chemosensory responses to physiological
stimuli are not appreciably affected by naloxone and naloxone has only slight effects
on spontaneous chemoreceptor discharge under normoxic conditions according to
the results obtained to date. This may mean that if opioids in the carotid body have a
transmitter function, it is associated with an efferent pathway: it will be interesting to
see whether naloxone can block efferent inhibition of chemoreceptor discharge.
2.3.4. Vasoactive intestinal polypeptide (VIP)
VIP was shown by Fitzgerald et al. (1981) to cause a slight increase in spontaneous
chemosensory discharge when infused (5-25 pg in 0.5 ml over 10 sec) close-arterial to
the cat carotid body in vivo. McQueen and Ribeiro (1981a) confirmed that an
increase in discharge occurs which is sustained throughout a 5 min infusion of VIP
(0.5 ^g/min) into the carotid body. They also showed that injections of low doses of
VIP depress spontaneous chemoreceptor discharge whereas higher doses increase
discharge. Responses evoked by ACh, sodium cyanide, or C02-equilibrated Locke
solution were reduced during infusions of VIP, as was the depression of discharge
caused by met-ENK (10 pg i.e.).
The effects of VIP on spontaneous discharge are not as intense or dramatic as those
observed following an injection of ACh or sodium cyanide, but it has to be
remembered that polypeptides have a relatively high moecular mass compared with
the other substances and, furthermore, may be extensively inactivated before
reaching the "receptor" site. VIP affects the vasculature, causing a fall in systemic
blood pressure, and it will be necessary to perform experiments in vitro to confirm the
impression (McQueen and Ribeiro, 1981a) that vascular actions of VIP are not
responsible for the greater part of the chemoreceptor response.
VIP or a closely related material appears to be present in some cholinergic
neurones (Lundberg et al., 1979b) but whether VIP in the carotid body co-exists with
ACh in nerve fibres (A and/or C?) has yet to be investigated as has the question of
whether VIP stimulates formation of cAMP in the carotid body, as it does in brain
tissue, by activating adenylate cyclase. VIP is thought to function as a neuro¬
transmitter or neuromodulator and it has been hypothesized that VIP may be
released from the same nerve endings as ACh in sweat glands (see Hokfell et al.,
1980). Further studies on the actions of VIP in the carotid body must be performed
before any conclusions can be reached regarding its function in the organ.
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2.3.5. Various other polypeptides
The number of polypeptides known to be associated with nerves and other cells in
the body has increased dramatically over the last decade. Some of them are
considered to be transmitters in other parts of the nervous system (see Hokfelt et al.,
1980) and consequently it seemed worth examining their actions on the carotid
chemoreceptors: most of them do modify spontaneous chemosensory discharge when
injected in fairly high doses close-arterial to the carotid body, but whether this has
any physiological significance is another matter. The effects of neurotensin, somato¬
statin, bradykinin, angiotensin II and vasopressin (ADH) were described by
McQueen (1981) and results obtained from studies with CCK-8 on cat carotid
chemoreceptors have also been reported (McQueen and Ribeiro, 1981a). The
majority of peptides so far examined, including carnosine, glucagon and bombesin
(McQueen, unpublished), do not produce any marked change in spontaneous
chemoreceptor discharge, and it remains to be established whether the effects
observed are due to primary actions of the peptide on the chemoreceptors, or are
secondary to other actions (e.g. vascular effects).
2.3.6. Conclusions
More than 20 neuropeptides have been identified and it is likely that many more
will be discovered. It therefore becomes a problem knowing which of these to study
on the carotid chemoreceptor. The best policy may be to continue screening all
neuropeptides (e.g. motilin and avian pancreatic polypeptide (APP) have not yet been
tested on the chemoreceptors) but to study in depth only those which are shown to be
present in the carotid body or for which receptors exist in this organ (i.e. circulating
peptides may influence the chemoreceptors). It could also be worth investigating
whether the carotid body contains a unique peptide, in addition to those already
identified but known to be present in other parts of the body.
The results obtained so far do not enable any conclusions to be drawn concerning
the role of peptides in the carotid body. They might function as transmitters, co-
transmitters, neuromodulators, trophic factors, hormones, or agents controlling the
vasculature, and may act either directly or indirectly by influencing the biosynthesis,
storage or release of substances, including other peptides, in the carotid body, and
could have more than one action. This must all remain mere speculation until studies
are performed to investigate the type(s) of nerve (sensory A or C/efferent - sinus or
sympathetic) the peptides are associated with, the particular type of cell in which
some peptides are located, the characteristics of the peptide receptor, and the
biophysical and biochemical changes arising from receptor activation. It will also be
necessary to correlate peptide release and synthesis with the response to physiological
stimuli. Some of these studies should be fairly straightforward (e.g. selective
denervation of the carotid body to reveal which nerves corxain peptides, use of
radiolabeled peptides or precursors) but others will be very difficult to perform with
the techniques currently available. Advances in understanding the physiological role
of peptides in the carotid body can be expected to come from the use of selective
peptide antagonists or from drugs which selectively inhibit enzymes involved in
destroying peptides, but for most polypeptides such drugs do not exist at present.
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Problems associated with the interpretation of results obtained with colchicine, which
blocks axon transport of peptides, or from the use of specific antibodies to "block"
the activity of endogenous peptides, are likely to limit the usefulness of these
approaches, but experiments on cells of the carotid body and nerves (from petrosal
ganglion, superior cervical ganglion) grown in tissue culture may prove to be
rewarding.
2.4. Other putative transmitters
Various substances referred to in section 1 will be reviewed very briefly in this
section. 5-Hydroxytryptamine (5-HT; serotin) is present in the carotid body and when
injected close-arterial to the carotid body in situ it affects chemosensory discharge
(Fig. 11) (Black et al„ 1972; Nishi, 1975; Docherty and McQueen. 1978b, 1979;
Bisgard et al„ 1979). The overall effect varies according to species studied, but a
short-lasting increase in chemoreceptor discharge commonly occurs immediately on
injecting 5-HT, and this is followed by a longer-lasting inhibition of spontaneous
activity. By using very low doses of 5-HT it is possible to elicit only the inhibitory
component, at least in dogs (Bisgard et al„ 1979).
The response to S-HY in cats is unaffected by atropine, hexamethonium, LSD,
methysergide or gramine (Nishi, 1975) but the excitatory component can be
abolished by low doses of the dopamine antagonist, a-flupenthixol (Docherty and
McQueen, 1978b) - higher doses of this antagonist also blocked the depressant
component. In dogs the excitatory effect of 5-HT is reduced by D-tubocurarine and
the inhibitory response blocked by dihydroergotamine (Bisgard et al„ 1979). The
results obtained with D-tubocurarine in dogs need to be verified and extended to
other species, but they appear to show that noradrenaline, dopamine and 5-HT cause
chemoexcitation via a common mechanism that can be blocked by D-tubocurarine,
i 1
10s
Fig. I I. Single chemoreceptor unit showing the biphasic response (excitation followed by inhibition) to
an intracarotid injection of 5-HT (I() //g) (arrow). Cat. anaesthetized with pentobarbitone, artificially
ventilated, paralyzed with gallamine. Ganglioglomerular nerves cut. (Based on Docherty and McQueen.
197Kb.)
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but does not involve a nicotine-sensitive ACh receptor. Responses to physiological
stimuli are unaltered by doses of D-tubocurarine which abolish the excitatory action
of the amines. Is 5-HT acting directly, or is it releasing one of the other carotid body
amines, or some other substance? The lack of specific 5-HT antagonists and the
probable existence of more than one type of 5-HT receptor (Gaddum and Picarelli,
1957) complicate the pharmacological studies, and the fact that 5-HT is reported to
have no significant action on carotid body chemosensory activity in vitro (Eyzaguirre
and Koyano, 1965) could be taken to mean that some or all the responses obtained
with 5-HT in vivo are secondary to vascular effects. However, the failure ).o
demonstrate effects in vitro could equally well be related to deficiencies in the
superfused preparation or the techniques used for applying the amines.
Although the present evidence is insufficient to support a transmitter role for 5-HT
in the chemosensory mechanism, further pharmacological and biochemical studies
are needed to establish whether or not 5-HT is released in response to physiological
stimuli and to characterize the location and type(s) of receptor involved. An
interesting prospect also worth investigating is that 5-HT acts as a co-transmitter
with one of the carotid body peptides. Rapid advances can be anticipated once
specific 5-HT antagonists and uptake blockers become available, possibly in the very
near future.
There is virtually no,evidence to support the candidature of prostaglandins,
histamine or amino acids as putative transmitters in the carotid body. Prostaglandins
A2, E2 and F2a do have some effects on spontaneous chemosensory discharge
recorded from the cat carotid body in situ, but no action could be detected in vitro
(McQueen and Belmonte, 1974). The responses observed in vivo may, therefore, have
been secondary to the well-known vascular effects of prostaglandins. Similarly, the
balance of evidence suggests that neither histamine, antihistamines (Liljestrand,
1954) or various amino acids (Fig. 12) have any appreciable effect on spontaneous
chemo sensory discharge when injected close-arterial to the carotid body. Most of
these studies have been performed against normal or "resting" chemosensory activity,
and there may be a case for a more detailed investigation under conditions of hypoxia
or hypercapnia. Furthermore, the lack of effect on chemosensory activity may be due
to an insufficient concentration of drug at the "receptor" site, and experiments should
be performed either applying substances by ionophoresis (e.g. in slice preparations), or
using selective antagonists (where these are available (e.g. to amino acids, Davies et al.,
1980), in order to establish whether or not the receptors exist. This may seem rather
unnecessary given that the lack of effect of these substances on chemoreceptor activity
can more simply be interpreted as meaning that they are not involved in chemo-
reception. However, as long as the transduction mechanism remains unknown, it is
worth continuing to explore all the possibilities, par-particularly since some amino
acids are present in the bovine carotid body (Thorn, 1981).
Finally, adenosine and A TP can excite chemoreceptors when injected close-arterial
to the cat carotid body (Fig. 13) (Jarisch et al., 1952; Dontas, 1955; Anichkov and
Belen'kii, 1963) and ATP is present in type I cells of the cat carotid body, apparently
stored together with catecholamines (Bock, 1980). The Russian authors developed a




" S ' 1 m 1 r-,u or 5 4 4 0





0 15 30 45 60 0 15 30 45 60
TIME(S) AFTER INJECTION
10 pg 100pg
Fig. 12. Response of chcmorcccptors (2 units) to intracarotid injection of: A, 0.3 ml unbubbled Locke
solution; B. 0.3 ml Locke solution equilibrated with 5% C02:95% air illustrating that the transient
inhibition caused by unbubbled Locke is due to the low PC02 of the solution. Responses to injection of 10
and 100 /igof sodium glutamate (C). GABA (D)and taurine (E) are also shown. Taurine and glutamate have
been identilicd in the bovine carotid body, together with much lower concentrations of GABA (Thorn.
I9XI). Discharge was averaged over 15 sec periods and expressed as a percentage of the pre-injcction
discharge (black rectangle = 100%. Absolute value given in ct/sec). Cat, anaesthetized with pentobarbitone,






Fig. 13. Single chcmoreccptor unit showing the responses to injections (arrows) of adenosine (I /ig i.e..
upper panel) and ATP (I ;ig i.e.. lower panel). Cat. anaesthetized with pentobarbitone, artificially
ventilated, paralyzed with gallamine. Ganglioglomerular nerves cut. (McQueen and Ribeiro, unpublished
observations.)
carotid body (Anichkov and Belen'kii, 1963), a fall in ATP content of this organ
leading to chemoexcilation by an unspecified mechanism (see Duncan, 1965; but cf.
Joels and Neil, 1968). It is debatable whether exogenously administered ATP would
appreciably affect intracellular levels of the nucleotide, and an alternative explana¬
tion is that the effects result from actions on extracellular adenosine receptors (see
McQueen and Ribeiro, 1981 b) following the breakdown of ATP to adenosine.
Vascular effects of ATP and adenosine complicate matters. Again, it is impossible to
judge whether ATP or adenosine is a carotid body transmitter or modulator since
there is insufficient evidence. Further studies are needed, involving drugs that
selectively affect the uptake of purines or block purinoceptors, and also biochemical
measurements to show the relationship between ATP and chemoreceptor discharge
in response to a varieity of physiological and pharmacological stimuli. The possibility
that ATP functions as a co-transmitter, operating with one of the catecholamines
and/or a peptide is intriguing and could be investigated.
3. Summary
Pharmacological studies have provided support for the suggestion that some of the
substances reviewed in this chapter function as "modulators" of carotid chemo-
sensory activity, but there is no really overwhelming evidence that any of them are
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chemosensory transmitters. This could mean that chemical transmission is not
involved in the transduction mechanism, but alternative interpretations are that
either the experiments have failed to demonstrate a transmitter role for those putative
transmitters which have been tested, or the transmitter is a substance which is, as yet,
unidentified. The carotid body is a small structure and quite difficult to study.
Variations between species, preparations and investigators, coupled with vascular
and other non-specific drug effects, complicate matters. More emphasis needs to be
given to correlating drug responses under different physiological conditions with
biochemical (e.g. in levels of putative transmitters, adenylate cyclase, cAMP, cGMP)
and biophysical (e.g. Na + , K + , Ca2+ conductance) changes, and to providing
quantitative evidence.
The fact that substances regarded as transmitters in other parts of the nervous
system have been identified within the carotid body leads to their being classified as
putative transmitters in this organ. However, the possibility that they have some
other role(s) (e.g. secretory, hormonal, trophic) should not be overlooked, for
although the carotid body undoubtedly has a chemoreceptor function, it could also
have others.
Pharmacological studies have provided some information regarding the different
types of receptor present in the carotid body, and this may provide a clue regarding
the normal ligands for the'receptors and their function. However, it is necessary to
proceed cautiously because exogenously administered putative transmitters may act
at sites not normally affected by the endogenous substance, or be present in
concentrations which are either too low or too high compared with physiological
levels. In any event, receptors should not be classified on the basis of their responses
to exogenous substances, but according to their natural ligands. This means
establishing what the natural ligand is under physiological conditions, bearing in
mind that it may come from within the carotid body, or reach the organ via the
circulation (i.e hormone).
At present we do not know which of the elements in the receptor complex (cells or
nerves) is primary, and perhaps the transduction mechanism involves the whole
complex, such that it may prove impossible to investigate the role of individual
elements in isolation (e.g. in tissue culture). Separate mechanisms might operate in
the chemosensory mechanism (e.g. for A and C fibres, or even within a glomerulus)
possibly using distinct transmitters or co-transmitters. The fact is that we do not
know how transduction takes place in the chemoreceptors, but a lot of information,
much of it from pharmacological experiments, has accumulated and provides a
reasonable base for further studies on this fascinating subject.
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